,CUI1,CUI2,label
0,CDISC SEND Death Diagnosis Test Name Terminology,Cause of Death,0
1,CDISC CDASH Terminology,milligram,0
2,CDISC Variable Terminology,Cardiovascular System Findings Planned Time Point Number,0
3,Clinical Data Interchange Standards Consortium Terminology,Minute Times Picogram per Milliliter per Meter Squared,0
4,US Counties Terminology,"Panola County, MS",0
5,CDISC SEND Study Type Terminology,Pharmacokinetics: Metabolism,0
6,CDISC SDTM Terminology,NPI - Anxiety FxS Score,0
7,Clinical Data Interchange Standards Consortium Terminology,Benign,0
8,CDISC SDTM Terminology,Beta-1 Globulin Measurement,0
9,CDISC SDTM Unit of Measure Terminology,Gigabecquerel per Gram,0
10,CDISC SDTM Terminology,Coronary Veins,0
11,FDA Established Names and Unique Ingredient Identifier Codes Terminology,river birch pollen extract,0
12,CDISC CDASH Terminology,milliliter,0
13,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Device Properties Test Code Terminology,0
14,Clinical Data Interchange Standards Consortium Terminology,Slackia exigua,0
15,CDISC SDTM Microorganism Terminology,Corynebacterium glucuronolyticum,0
16,Pediatric Adverse Events Terminology,Subcapsular Renal Hematoma,0
17,CDISC Questionnaire Expanded DRS-PI Survivor Version Test Name Terminology,Expanded DRS-PI Survivor Version - Require Assistance Managing Emotions,0
18,Pediatric Infectious Disease Terminology,"Syphilis, secondary",0
19,SPL Marketing Category Terminology,Bulk Ingredient for Animal Prescription Compounding,0
20,CDISC SDTM Terminology,CDISC SDTM Unit for Vital Sign Result Terminology,0
21,Clinical Data Interchange Standards Consortium Terminology,Acanthocyte to Erythrocyte Ratio Measurement,0
22,CDISC SEND Terminology,Apolipoprotein B100 Measurement,0
23,CDISC SDTM Terminology,CDISC Questionnaire ESS Test Code Terminology,0
24,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Betacetylmethadol,0
25,Clinical Data Interchange Standards Consortium Terminology,Study Chair,0
26,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Amikhelline,0
27,CDISC SDTM Terminology,Dorsal,0
28,CTRP Terminology,DR5-targeting Tetrameric Nanobody Agonist TAS266,0
29,CDISC SDTM Terminology,Atrial bigeminy,0
30,Clinical Data Interchange Standards Consortium Terminology,"Cleft upper lip, upper jaw AND palate",0
31,CDISC SDTM Laboratory Test Terminology by Name,Erythropoietin measurement,0
32,FDA Manufacturer Evaluation Conclusion Code Hierarchy,Cause Traced to Manufacturing,0
33,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Percent Recovered from T1 to T2 Normalized by Surface Area,0
34,Clinical Data Interchange Standards Consortium Terminology,Bouvet Island,0
35,CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Name Terminology,NCCN-FACT FOSI-18 Version 2 - I Have Nausea,0
36,Clinical Data Interchange Standards Consortium Terminology,Skin Response Domain,0
37,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bromopride,0
38,CDISC Questionnaire Terminology,NCCN-FACT FBLSI-18 Version 2 - I Am Able to Enjoy Life,0
39,CDISC SEND Terminology,External upper lip,0
40,Clinical Data Interchange Standards Consortium Terminology,Left main bronchus structure,0
41,CDISC SDTM Holter ECG Test Code Terminology,Interpretation Process,0
42,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dobupride,0
43,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Penicillin G Potassium,0
44,CDISC SDTM Anatomical Location Terminology,Rib 1,0
45,Clinical Data Interchange Standards Consortium Terminology,Chlamydia trachomatis,0
46,CDISC SDTM Unit of Measure Terminology,Million RNA Copies per Milliliter,0
47,CDISC SEND Terminology,HDL-Cholesterol Subclass 3 Measurement,0
48,CDISC SDTM Terminology,Infrared Photocoagulation Therapy,0
49,Clinical Data Interchange Standards Consortium Terminology,Hemosiderin Measurement,0
50,CDISC Questionnaire Terminology,RDQ - Difficult to Get Out of a Chair,0
51,CDISC SDTM Terminology,Schistocyte Count,0
52,FDA Device Component Code Hierarchy,Microphone,0
53,Pediatric Adverse Events Terminology,Chemical burns of eye,0
54,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hepatitis B Virus,0
55,CDISC Variable Terminology,Adverse Event Body System or Organ Class,0
56,CDISC SEND Terminology,Phalanx of hand,0
57,CDISC SDTM Terminology,Phalanx of hand,0
58,Clinical Data Interchange Standards Consortium Terminology,Ulocladium,0
59,CDISC QRS Terminology,NPI - Aberrant Motor Behavior FxS Score,0
60,Newborn Screening Terminology,Strabismus,0
61,US Counties Terminology,"Wilkinson County, MS",0
62,NCIt Neoplasm Core Terminology,Lhermitte-Duclos disease,0
63,CDISC QRS Terminology,C-SSRS Since Last Visit - Number of Aborted Suicide Attempts,0
64,CDISC SDTM Laboratory Test Terminology by Name,Gastrin measurement,0
65,UCUM Terminology,Patch Dosing Unit,0
66,CDISC SDTM Terminology,Set of regional lymph nodes,0
67,Clinical Data Interchange Standards Consortium Terminology,Gram per Cage per Week,0
68,Clinical Data Interchange Standards Consortium Terminology,Impaired exercise tolerance,0
69,CDISC SDTM Anatomical Location Terminology,Cheek structure,0
70,CTRP Agent Terminology,Carbon C 11 Sarcosine,0
71,Clinical Data Interchange Standards Consortium Terminology,Stephanoascus ciferrii,0
72,CDISC SDTM Microorganism Terminology,Mobiluncus,0
73,Pediatric Terminology,Retroplacental hematoma,0
74,Quality of Life Questionnaire - Pancreatic Cancer 26,Troubled with Side Effects from Treatment,0
75,CTRP Terminology,Mature T-Cell and NK-Cell Neoplasm,0
76,Extremity Lifting Ability,Reduced Lifting Ability,0
77,Pediatric Adverse Events Terminology,Dysgeusia,0
78,CDISC SDTM Terminology,Valine measurement,0
79,CDISC QRS Terminology,HAMD-21 - Loss of Weight by History,0
80,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Utibaprilat,0
81,Clinical Data Interchange Standards Consortium Terminology,Cholesterol cleft,0
82,Clinical Data Interchange Standards Consortium Terminology,PANSS - Somatic Concern,0
83,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dodeclonium bromide,0
84,CDISC SDTM Terminology,Vertical Pixel Spacing,0
85,CDISC Questionnaire Terminology,GDS - Feel Downhearted and Blue,0
86,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Lifetime),0
87,Patient Problem Codes FDA CDRH,Traumatic injury,0
88,Clinical Data Interchange Standards Consortium Terminology,Lactobacillus,0
89,CTRP Terminology,Intermediate Cell Type Uveal Melanoma,0
90,CDISC SEND Terminology,Concentration Divided by Surface Area,0
91,Patient Problem Codes FDA CDRH,HIV,0
92,Clinical Data Interchange Standards Consortium Terminology,Mycobacterium smegmatis,0
93,FDA Individual Case Safety Report Terminology,Females,0
94,NCIt Antineoplastic Agent Terminology,Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001,0
95,Clinical Data Interchange Standards Consortium Terminology,Concentrate Dosage Form,0
96,CTRP Terminology,Adult L2 Acute Lymphoblastic Leukemia,0
97,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL Severe Dementia - Get Around Outside Home,0
98,US Counties Terminology,"Briscoe County, TX",0
99,CDISC QRS Terminology,SOAPP-R - Worried About Being Left Alone,0
100,Clinical Data Interchange Standards Consortium Terminology,Fused Placenta,0
101,NCPDP Dose Unit of Measure Terminology,Stick Dosing Unit,0
102,CDISC Questionnaire Terminology,MDS-UPDRS - Consistency of Rest Tremor,0
103,Human Activity Profile Test,Climbing 12 Steps,0
104,CTRP Terminology,Childhood Central Nervous System Embryonal Neoplasm,0
105,CDISC SDTM Unit of Measure Terminology,Kilogram Per Square Meter,0
106,Clinical Data Interchange Standards Consortium Terminology,Switzerland,0
107,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Appliance: Dryer,0
108,CDISC Questionnaire ADCS-ADL Test Name Terminology,ADCS-ADL - Appliance: Dryer,0
109,CTRP Terminology,Rabusertib,0
110,NCIt Antineoplastic Agent Terminology,Rabusertib,0
111,Clinical Data Interchange Standards Consortium Terminology,Dendritic Cell Lysosomal-Associated Membrane Protein Measurement,0
112,CDISC QRS Terminology,CDISC ADAS-Cog - Delayed Word Recall: Word 1,0
113,Pediatric Terminology,Behavior Rating Scale,0
114,US Counties Terminology,"Panola County, TX",0
115,CDISC SDTM Cardiovascular Test Code Terminology,Aortic Augmentation Index,0
116,CDISC SDTM Terminology,Leptospira,0
117,CDISC SDTM Tumor Response Assessment Test Name Terminology,Response in Non-Target Lesion,0
118,CDISC SEND Terminology,Glans penis,0
119,CDISC SDTM Terminology,Infrared Spectrophotometry,0
120,CDISC SEND Fetal Measurement Test Name Terminology,Crown to Rump Length Measurement,0
121,Clinical Data Interchange Standards Consortium Terminology,Saint Kitts and Nevis,0
122,US Counties Terminology,"Rains County, TX",0
123,CDISC SDTM Laboratory Test Terminology by Name,Endogenous Thrombin Potential Area Under Curve Measurement,0
124,CDISC SDTM Terminology,Parabacteroides distasonis,0
125,Clinical Data Interchange Standards Consortium Terminology,FAMS - Bothered by Muscle Spasms,0
126,Clinical Data Interchange Standards Consortium Terminology,Poultice (basic dose form),0
127,CTRP Terminology,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
128,CDISC SDTM Country Terminology,Thailand,0
129,CDISC SDTM Terminology,HLA Class II Panel Reactive Antibody Measurement,0
130,CDISC SDTM Terminology,Vector Genomes per Dose,0
131,CTRP Terminology,Non-Small Cell Lung Carcinoma,0
132,NCIt Antineoplastic Agent Terminology,Allogeneic Natural Killer Cell Line NK-92,0
133,Pediatric Terminology,Late Preterm Birth,0
134,CDISC SEND Terminology,Taiwan,0
135,Neonatal Research Network Terminology,Aortic Aneurysm,0
136,US Counties Terminology,"Middlesex County, MA",0
137,CTRP Terminology,Carcinoma of Male Breast,0
138,Neonatal Research Network Terminology,Cryptorchidism,0
139,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pararosaniline Pamoate,0
140,NCIt Antineoplastic Agent Terminology,Z-Endoxifen Hydrochloride,0
141,Charlson Comorbidity Index Chart Review Version,Has Hypertension,0
142,CDISC SDTM Terminology,Remnant-like Particle Cholesterol Measurement,0
143,CDISC Questionnaire GDS Test Name Terminology,GDS - Good Spirits Most of Time,0
144,CDISC SDTM Unit of Measure Terminology,mL/beat,0
145,Clinical Data Interchange Standards Consortium Terminology,Tanzania,0
146,NCI CTEP Simplified Disease Classification Terminology,Sarcomatoid Renal Cell Carcinoma,0
147,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Sarcomatoid Renal Cell Carcinoma,0
148,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Geranium maculatum,0
149,FDA Established Names and Unique Ingredient Identifier Codes Terminology,zopolrestat,0
150,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sequifenadine,0
151,CDISC SDTM Terminology,Natural sibling,0
152,CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology,C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act,0
153,CDISC SEND Terminology,Cartilage Not Fused,0
154,CDISC SEND Terminology,10 Lead Standard,0
155,CDISC SDTM Terminology,Femoral lymph node group,0
156,CDISC SDTM Terminology,Labyrinth,0
157,Clinical Data Interchange Standards Consortium Terminology,Indeterminate Response,0
158,Pediatric Terminology,Echolalia,0
159,Clinical Data Interchange Standards Consortium Terminology,Number of miscarriages or induced terminations of pregnancy,0
160,CDISC SDTM Terminology,CDISC SDTM Discharge Disposition Terminology,0
161,CDISC SDTM Laboratory Test Terminology by Code,Dehydroepiandrosterone Assay,0
162,CDISC SDTM Terminology,Half-brother with Father as Common Parent,0
163,CDISC Questionnaire OAB-q Test Code Terminology,OAB-q - Interfered with Getting Sleep,0
164,Clinical Data Interchange Standards Consortium Terminology,"Saint Martin, French",0
165,CDISC SEND Terminology,"Saint Martin, French",0
166,Neonatal Research Network Terminology,Congenital cataract,0
167,CDISC SEND Terminology,Liter per Microgram per Kilogram,0
168,CDISC SDTM Biospecimen Events Dictionary Derived Term Terminology,Thaw,0
169,CDISC Questionnaire SIQR Test Name Terminology,SIQR - Change Bed Sheets,0
170,CDISC SDTM Terminology,Capsule Dosing Unit,0
171,CTRP Agent Terminology,Levonorgestrel,0
172,CDISC SDTM Laboratory Test Terminology by Name,Ribonucleoprotein-70 Antibody Measurement,0
173,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Xylazine,0
174,CDISC SDTM Frequency Terminology,per year,0
175,US Counties Terminology,"Latah County, ID",0
176,Clinical Data Interchange Standards Consortium Terminology,Virologic End Of Treatment Response,0
177,Parent Rating Scales,Externalizing Problems Composite Score,0
178,CDISC SDTM Terminology,mL/dL,0
179,CDISC Questionnaire HAQ-DI With VAS Test Code Terminology,HAQ-DI With VAS - Able to Stand Up From Chair,0
180,CDISC SDTM Terminology,Hour Times Micromole Per Liter Per Milligram Per Gram Per Day,0
181,Clinical Data Interchange Standards Consortium Terminology,Potassium Clearance Measurement,0
182,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pyrogallol,0
183,Clinical Data Interchange Standards Consortium Terminology,Staining method,0
184,Pediatric Terminology,Numbness,0
185,Clinical Data Interchange Standards Consortium Terminology,Maximum Observed Excretion Rate Normalized by Surface Area,0
186,CDISC SDTM Terminology,Storage,0
187,Pediatric Terminology,Primary Exertional Headache,0
188,CDISC SDTM Terminology,peak expiratory flow (procedure),0
189,NCIt Antineoplastic Agent Terminology,"EMD 273063 antibody, human",0
190,US Counties Terminology,"Petersburg City, VA",0
191,CDISC SDTM Laboratory Test Terminology by Name,Homovanillic acid measurement,0
192,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Captamine,0
193,Clinical Data Interchange Standards Consortium Terminology,High Lateral Myocardial Infarction by ECG Finding,0
194,CDISC SDTM Terminology,GDS - Find Life Exciting,0
195,NCIt Antineoplastic Agent Terminology,Nilotinib Hydrochloride Anhydrous,0
196,Clinical Data Interchange Standards Consortium Terminology,Pus,0
197,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Belarizine,0
198,CTRP Agent Terminology,Horse antihuman thymocyte gamma globulin,0
199,CDISC SDTM Terminology,Pulmonary Valve Vena Contracta Area,0
200,Clinical Data Interchange Standards Consortium Terminology,Total Tissue,0
201,Clinical Data Interchange Standards Consortium Terminology,RAND-36 - Expect Health to Get Worse,0
202,CTRP Terminology,CBL0137,0
203,Patient Problem Codes FDA CDRH,Abdominal Cramps,0
204,ICH Unit of Measure Terminology,IU/kg,0
205,CDISC SDTM Unit of Measure Terminology,Packet - Unit dose,0
206,CDISC SEND Terminology,"Atmosphere, unit of pressure",0
207,CDISC Questionnaire FACIT-F Version 4 Test Name Terminology,FACIT-F Version 4 - I Am Able to Enjoy Life,0
208,CDISC SDTM Terminology,Hemoglobin A2 measurement,0
209,CDISC SDTM Terminology,CDISC Questionnaire FOSI Test Name Terminology,0
210,NCIt Antineoplastic Agent Terminology,Diarylsulfonylurea Compound ILX-295501,0
211,Patient Problem Codes FDA CDRH,Dislocations,0
212,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology,RAND-36 - My Health is Excellent,0
213,Clinical Data Interchange Standards Consortium Terminology,GDS - Prefer to Stay Home,0
214,CDISC Questionnaire SGRQ Past 4 Weeks Version Test Name Terminology,SGRQ Past 4 Weeks Version - Short of Breath When I Talk,0
215,CDISC Questionnaire SOAPP-R Test Code Terminology,SOAPP-R - Felt That Things Are Overwhelming,0
216,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tesamorelin acetate,0
217,CDISC Questionnaire FACIT-F Version 4 Test Code Terminology,FACIT-F Version 4 - I Have Accepted My Illness,0
218,Stern's Rating Scale for Edema,Edema Rating 2,0
219,FDA Established Names and Unique Ingredient Identifier Codes Terminology,atilmotin,0
220,CDISC CDASH Variable Terminology,Electrocardiogram Test,0
221,CDISC SDTM Laboratory Test Terminology by Code,Alpha Tocopherol to Vitamin E Ratio Measurement,0
222,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ethylestrenol,0
223,CDISC QRS Terminology,CDISC Questionnaire FOSI Test Code Terminology,0
224,CTRP Terminology,Kaposi Sarcoma,0
225,US Counties Terminology,"Lake of the Woods County, MN",0
226,CTRP Agent Terminology,emactuzumab,0
227,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sulbenox,0
228,CDISC SDTM Terminology,Gastrointestinal tract structure,0
229,Pediatric Terminology,Spontaneous Preterm Birth,0
230,CDISC SDTM Terminology,Bowel Control Scale Questionnaire,0
231,Clinical Data Interchange Standards Consortium Terminology,Right Posterior Descending Artery,0
232,Pediatric Adverse Events Terminology,Dystrophia unguium,0
233,SPL Pharmaceutical Dosage Form Terminology,Injectable Solution,0
234,CDISC SEND Terminology,Minute Times Mole per Liter per Meter Squared,0
235,CDISC QRS Terminology,Impact of Visual Impairment Scale Questionnaire,0
236,Parent Rating Scales,Functional Communication Scale,0
237,CDISC SDTM Laboratory Test Terminology by Code,Cortisol to Creatinine Ratio Measurement,0
238,NCIt Antineoplastic Agent Terminology,siRNA-transfected Peripheral Blood Mononuclear Cells APN401,0
239,CTRP Terminology,bexarotene,0
240,NCIt Antineoplastic Agent Terminology,Calculus bovis/Moschus/Olibanum/Myrrha Capsule,0
241,CDISC SDTM Terminology,Amyloid P Measurement,0
242,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Aliphatic carboxylic acid, C10:1",0
243,CDISC SDTM Holter ECG Results Terminology,Paroxysmal atrioventricular block,0
244,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sulpiride,0
245,"Geopolitical Entities, Names, and Codes Terminology",Somalia,0
246,CDISC SDTM Trial Summary Parameter Terminology by Name,Planned Subject Number,0
247,FACIT-Dyspnea 10 Item Short Form,Dyspnea Severity Lifting Something Weighing 10-20 Pounds,0
248,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Nanogram per Milliliter per Milligram per Meter Squared per Day,0
249,CDISC SEND Terminology,Alanine measurement,0
250,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acetohexamide,0
251,CDISC Questionnaire DAD Test Code Terminology,DAD - Total Score,0
252,Pediatric Adverse Events Terminology,Ileostomy Site,0
253,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Use Household Appliance to do Chores,0
254,CDISC Questionnaire ADCS-ADL Test Name Terminology,ADCS-ADL - Use Household Appliance to do Chores,0
255,CDISC QRS Terminology,CDISC ADAS-Cog - Word Recognition: Word 20,0
256,Clinical Data Interchange Standards Consortium Terminology,Liter Divided by Microgram per Day,0
257,CTRP Agent Terminology,dolasetron mesylate,0
258,National Health Interview Survey,Type - attribute,0
259,NCIt Neoplasm Core Terminology,"Histiocytosis, Langerhans-Cell",0
260,CDISC SDTM Terminology,RAND 36-Item Health Survey 1.0 Questionnaire,0
261,CTRP Terminology,Cystoscopy,0
262,Pediatric Terminology,Total Body Length,0
263,Pediatric Adverse Events Terminology,Precocious Puberty,0
264,CDISC SDTM Terminology,ADCS-ADL - Appliance: Washer,0
265,CDISC SDTM Contact Case Investigation Contact Type Terminology,Casual Contact,0
266,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Equilin,0
267,FDA Established Names and Unique Ingredient Identifier Codes Terminology,epristeride,0
268,CDISC QRS Terminology,CDISC Questionnaire PDDS Test Code Terminology,0
269,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oxamarine hydrochloride,0
270,CDISC Questionnaire Terminology,MNSI - Left Foot Ulceration,0
271,Clinical Data Interchange Standards Consortium Terminology,Helicobacter pylori IgG antibody measurement,0
272,Clinical Data Interchange Standards Consortium Terminology,IU/mg,0
273,CDISC CDASH Concomitant Medication Route of Administration Terminology,Topical Route of Drug Administration,0
274,Pediatric Terminology,Obsessive thoughts,0
275,Perinatal Terminology,Congenital ankyloblepharon,0
276,Clinical Data Interchange Standards Consortium Terminology,Rheumatoid Factor Antibody IgA Measurement,0
277,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Oxyphenonium,0
278,NCIt Antineoplastic Agent Terminology,Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E,0
279,CDISC QRS Terminology,NPI - Disinhibition Distress,0
280,CDISC Variable Terminology,Exposure as Collected Link Identifier,0
281,CDISC SDTM Terminology,Correctional Institutions,0
282,Clinical Data Interchange Standards Consortium Terminology,Can Dosing Unit,0
283,Clinical Data Interchange Standards Consortium Terminology,Lead I,0
284,Neonatal Research Network Terminology,Congenital hydronephrosis,0
285,Regulated Product Submission Reporting Terminology,Control of Drug Substance: Justification of Specification,0
286,CTRP Terminology,pemetrexed disodium,0
287,CTRP Terminology,Lymphoproliferative Disorders,0
288,CDISC QRS Terminology,FAMS - Urinate More Frequently Than Usual,0
289,Clinical Data Interchange Standards Consortium Terminology,Torulaspora delbrueckii,0
290,CDISC SDTM Terminology,DAD - Decide to Wash or Take a Bath or Shower,0
291,CTRP Terminology,Eflornithine,0
292,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Formaldehyde,0
293,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act,0
294,CDISC SDTM Terminology,Rheumatoid Factor Antibody IgG Measurement,0
295,Pediatric Nephrology Terminology,Infundibular Stenosis,0
296,CDISC Variable Terminology,Microbiology Susceptibility Numeric Result in Standard Unit,0
297,NCIt Antineoplastic Agent Terminology,iodine I 131 monoclonal antibody CC49-deltaCH2,0
298,NCIt Antineoplastic Agent Terminology,pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine,0
299,NCIt Neoplasm Core Terminology,Basal cell carcinoma of vulva,0
300,CDISC SDTM Terminology,Transitional Epithelial Cells Measurement,0
301,CDISC SDTM Terminology,Candida famata,0
302,CTRP Terminology,Computer-Assisted Smoking Cessation Intervention,0
303,CDISC QRS Terminology,FHS CVD 10-Year Risk Score - Risk Score,0
304,CDISC SDTM Respiratory Test Name Terminology,Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio,0
305,Newborn Screening Terminology,general appearance (physical finding),0
306,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Helleborus viridis,0
307,FDA Established Names and Unique Ingredient Identifier Codes Terminology,polyoxyl 35 castor oil,0
308,CDISC QRS Terminology,ADNI AVLT - List A Recall 6 (After B) Word 8,0
309,Medical Outcomes Study Social Support Survey,Someone to Give You Information to Help You Understand a Situation,0
310,Pediatric Rheumatology Terminology,Exanthema,0
311,CDISC QRS Terminology,CDISC ADAS-Cog - Remembering Test Instructions,0
312,Patient Problem Codes FDA CDRH,Ventricular hemorrhage,0
313,CDISC SEND Terminology,Hour Squared Times Micromole Per Liter,0
314,CDISC SEND Terminology,g/h,0
315,NCIt Antineoplastic Agent Terminology,fulvestrant,0
316,CDISC QRS Terminology,ADNI AVLT - List A Recall 6 (After B) Word 9,0
317,Clinical Data Interchange Standards Consortium Terminology,DAD - Decide to Care for His/Her Hair,0
318,PROMIS-43 Adult Profile v2.0,Ability to Run Errands and Shop,0
319,Wechsler Adult Intelligence Scale - Fourth Edition,wais-iv subtests block design,0
320,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tolpiprazole,0
321,CDISC Questionnaire DAD Test Code Terminology,DAD - Undress Himself/Herself Completely,0
322,CDISC SDTM PK Unit of Measure Gram Weight Terminology,Liter per Gram per Hour,0
323,NCIt Neoplasm Core Terminology,Lipoblastoma,0
324,CDISC SDTM Laboratory Test Terminology by Code,CD19 Expressing Cell Count,0
325,CDISC QRS Terminology,BPI - Warm Compresses to Relieve Pain,0
326,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dopamine,0
327,CDISC SDTM Terminology,Structure of xiphoid process of sternum,0
328,CTRP Terminology,tamibarotene,0
329,CDISC Questionnaire NPI Test Name Terminology,NPI - Aberrant Motor Behavior Frequency,0
330,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - Wish to Be Dead (Prior to Study Entry),0
331,CTRP Terminology,WT1 235-243 Peptide Vaccine,0
332,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Praxadine,0
333,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Triclodazol,0
334,CDISC SDTM Cardiac Procedure Indication Terminology,End of Expected Battery Life,0
335,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Liter per Gram per Minute,0
336,CDISC SDTM Terminology,CDISC SDTM Collected Race Terminology,0
337,NCIt Antineoplastic Agent Terminology,bizelesin,0
338,SPL Marketing Category Terminology,Marketed as Approved Drug Product Manufactured Exclusively for Private Label Distributor,0
339,US Counties Terminology,"Carteret County, NC",0
340,CDISC SDTM Terminology,Recurrent disease,0
341,CTRP Terminology,GTX-758,0
342,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Predicted Volume of Distribution of Absorbed Fraction,0
343,CDISC SDTM Terminology,Sporothrix schenckii,0
344,Clinical Data Interchange Standards Consortium Terminology,Milliliter per gram,0
345,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Proteus inconstans,0
346,CTRP Terminology,Stage IIA Colon Cancer AJCC v7,0
347,NCIt Antineoplastic Agent Terminology,Entospletinib,0
348,Pediatric Adverse Events Terminology,Hoarseness,0
349,NCIt Neoplasm Core Terminology,"Leukemia, Myeloid, Chronic-Phase",0
350,CDISC SEND Trial Summary Parameter Long Name Terminology,SEND Test System Common Name,0
351,Oral Health Impact Profile,Feel Tense due to Mouth Problems,0
352,CDISC Questionnaire FACT-G Version 4 Test Name Terminology,FACT-G Version 4 - I Feel Sad,0
353,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Sum Urine Volume,0
354,CDISC SEND Terminology,Sum Urine Volume,0
355,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ACETONE SODIUM BISULFITE,0
356,CDISC SDTM Terminology,HAQ-DI With VAS - Aids or Devices - Bathtub Bar,0
357,FDA Device Component Code Hierarchy,Joint Device,0
358,Clinical Data Interchange Standards Consortium Terminology,DLQI - Skin Has Been a Problem at Work or Study,0
359,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nitracrine,0
360,CDISC SDTM Anti-Viral Outcome of Treatment Terminology,Rapid Virologic Response,0
361,CDISC SEND Terminology,Slovakia,0
362,CDISC SDTM Terminology,Human Metapneumovirus,0
363,FDA Established Names and Unique Ingredient Identifier Codes Terminology,rocuronium bromide,0
364,Clinical Data Interchange Standards Consortium Terminology,Comamonas terrigena,0
365,Clinical Data Interchange Standards Consortium Terminology,Single Beat Q Wave Amplitude,0
366,NCIt Antineoplastic Agent Terminology,HDAC-42,0
367,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lorpiprazole,0
368,CDISC SDTM Terminology,Citrobacter farmeri,0
369,CDISC Questionnaire FACIT-F Version 4 Test Code Terminology,FACIT-F Version 4 - I Feel Tired,0
370,FDA Established Names and Unique Ingredient Identifier Codes Terminology,armodafinil,0
371,US Counties Terminology,"Colonial Heights City, VA",0
372,Pediatric Terminology,reproductive system disorder,0
373,CDISC Questionnaire Category Terminology,Epworth Sleepiness Scale Questionnaire,0
374,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Plum (Dietary),0
375,Clinical Data Interchange Standards Consortium Terminology,Paracoccus yeei,0
376,CDISC SDTM ECG Test Name Terminology,Aggregate RR Interval,0
377,CDISC SDTM Laboratory Test Terminology by Code,Hematocrit procedure,0
378,CDISC SDTM Laboratory Test Terminology by Name,Troponin measurement,0
379,Clinical Data Interchange Standards Consortium Terminology,Line Probe Assay,0
380,HL7 Unit of Measure Terminology,Miles,0
381,CTRP Terminology,Adult Central Nervous System Germinoma,0
382,Perinatal Terminology,Systemic Inflammatory Response Syndrome,0
383,Clinical Data Interchange Standards Consortium Terminology,CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Code Terminology,0
384,FDA Established Names and Unique Ingredient Identifier Codes Terminology,etifoxine,0
385,CDISC SDTM Device Events Action Taken with Device Terminology,Extraction,0
386,CDISC Variable Terminology,Questionnaire Baseline Flag,0
387,HL7 Unit of Measure Terminology,Survey Mile,0
388,CDISC SDTM Laboratory Test Terminology by Name,Sickle Cell to Erythrocyte Ratio Measurement,0
389,CTRP Terminology,Adult Desmoplastic Small Round Cell Tumor,0
390,CDISC SDTM Terminology,HAMD-21 - Retardation,0
391,CDISC SDTM Anatomical Location Terminology,Colon structure (body structure),0
392,CDISC SEND Terminology,Liver/Gallbladder,0
393,CDISC QRS Terminology,CDISC Questionnaire KFSS Test Name Terminology,0
394,CDISC SDTM Anatomical Location Terminology,Uvea,0
395,CDISC SDTM Terminology,Popliteal lymph node group,0
396,CDISC SEND Terminology,Cambodia,0
397,Pediatric Adverse Events Terminology,Delayed Puberty,0
398,NCIt Neoplasm Core Terminology,Primary cutaneous gamma-delta T-cell lymphoma,0
399,CTRP Agent Terminology,Anti-Interleukin 6 Monoclonal Antibody ALD518,0
400,Clinical Data Interchange Standards Consortium Terminology,Intraprostatic Route of Drug Administration,0
401,CTRP Agent Terminology,Brilacidin Oral Rinse,0
402,"University of Washington Quality of Life Scale, Version 4",Not Anxious About My Cancer,0
403,CDISC Questionnaire Terminology,FACT-B Version 4 - I Am Satisfied With My Sex Life,0
404,NCIt Antineoplastic Agent Terminology,Recombinant dHER2 Vaccine,0
405,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Niraxostat,0
406,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trimebutine,0
407,CDISC SEND Variable Terminology,Exclude Food and Water Consumption Data From Statistics Indicator,0
408,Extremity Supports,Support Always Needed,0
409,CDISC QRS Terminology,PHQ Screener Version - Anxiety Attack Afraid You Were Dying,0
410,Pediatric Adverse Events Terminology,Hypersexualism,0
411,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Oxabrexine,0
412,NCIt Antineoplastic Agent Terminology,indibulin,0
413,CDISC Questionnaire VFQ25-Interviewer Administered Format Test Name Terminology,VFQ25-Interviewer Administered Format - Overall Health,0
414,CTRP Terminology,progesterone receptor negative,0
415,CDISC SDTM Anatomical Location Terminology,Middle mediastinum,0
416,NCPDP Quantity Unit of Measure Terminology,Spray Dosing Unit,0
417,CDISC SEND Terminology,Spray Dosing Unit,0
418,US Counties Terminology,"Golden Valley County, ND",0
419,CDISC Questionnaire Terminology,CDISC Questionnaire MHIS-NACC Test Name Terminology,0
420,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ertiprotafib,0
421,Pediatric Terminology,"Hand, Foot and Mouth Disease",0
422,CDISC QRS Terminology,MFIS - Pace Myself in Physical Activities,0
423,CDISC SDTM Biospecimen Events Dictionary Derived Term Terminology,Quick Freeze,0
424,NCIt Antineoplastic Agent Terminology,SS1(dsFv)PE38,0
425,CTRP Agent Terminology,Tergenpumatucel-L,0
426,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ivabradine,0
427,Clinical Data Interchange Standards Consortium Terminology,Macrophage Inflammatory Protein 1 Alpha measurement,0
428,CDISC Clinical Classification APACHE II Test Name Terminology,APACHE II - Serum Creatinine,0
429,US Counties Terminology,"Spokane County, WA",0
430,CDISC SDTM Anatomical Location Terminology,Metatarsophalangeal Joint 4,0
431,NCCN Guidelines Distress Management Problem List Screening Tool Version 1.2011,Distress over Emotional Problem with Worry,0
432,CDISC Questionnaire HAQ-DI With VAS Test Code Terminology,HAQ-DI With VAS - Aids or Devices - Jar Opener (Jars Previously Opened),0
433,CTRP Agent Terminology,TALIMOGENE LAHERPAREPVEC,0
434,CDISC SEND Terminology,Neutrophil Elastase Measurement,0
435,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sodium polystyrene sulfonate,0
436,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline/Screening Version - Description of Interrupted Suicide Attempt,0
437,NCIt Antineoplastic Agent Terminology,Neoantigen-based Melanoma-Poly-ICLC Vaccine,0
438,CDISC Questionnaire GOSE Test Name Terminology,GOSE - Return to Normal Life: Similar Problems Before Injury,0
439,"Adaptive Behavior Assessment System, Adult Rating Form",Social Skills (ABAS-II),0
440,US Counties Terminology,"McHenry County, ND",0
441,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bacitracin zinc,0
442,CDISC SDTM Terminology,CRQ-SAS Follow-Up Administration Version - Felt Discouraged or Down,0
443,CDISC Questionnaire Terminology,C-SSRS Baseline - Most Lethal Suicide Attempt Damage,0
444,SPL Unit of Presentation Terminology,Troche Dosing Unit,0
445,FDA Established Names and Unique Ingredient Identifier Codes Terminology,salt substitutes,0
446,eCTD Telephone Number Type Terminology,Fax Number,0
447,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mitoflaxone,0
448,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bluensomycin,0
449,US Counties Terminology,"Tinian Municipality, MP",0
450,Clinical Data Interchange Standards Consortium Terminology,Reg upon Act Normal T-cell Exprd Secrtd Measurement,0
451,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Macitentan,0
452,CDISC SDTM Terminology,Proximal Interphalangeal Joint 5,0
453,US Counties Terminology,"Navarro County, TX",0
454,CDISC SEND Terminology,Unclassified Crystal Measurement,0
455,CDISC SDTM Terminology,"C-SSRS Children's Baseline - Frequency, Write Response",0
456,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Minute Times Milligram Per Milliliter Per Milligram Per Gram Per Day,0
457,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ferric Hypophosphite,0
458,Clinical Data Interchange Standards Consortium Terminology,Forced Expiratory Flow at 25-75 Percent,0
459,"Geopolitical Entities, Names, and Codes Terminology",Saint Barthelemy,0
460,CDISC SDTM Terminology,"Morganella morganii, Lysine-Positive",0
461,CDISC Questionnaire Terminology,Hemophilia Quality of Life Questionnaire Children's Long Version Age Group I,0
462,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pentobarbital Sodium,0
463,Pediatric Terminology,Brow presentation,0
464,CDISC SDTM Microorganism Terminology,Treponema pallidum ss. pertenue,0
465,Newborn Screening Terminology,Imaging Information,0
466,FDA Established Names and Unique Ingredient Identifier Codes Terminology,strontium chloride hexahydrate,0
467,CDISC SDTM Terminology,Genus Pneumocystis,0
468,NCIt Antineoplastic Agent Terminology,Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex,0
469,CDISC SDTM Terminology,Left Ventricular Apical Anterior Segment,0
470,Patient Problem Codes FDA CDRH,Flap Tissue Necrosis,0
471,Memorial Symptom Assessment Scale,How Much Distress Sweats,0
472,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Hour Times Picogram per Milliliter per Meter Squared,0
473,CDISC ADaM Derivation Type Terminology,Screening Observation Carried Forward Imputation Technique,0
474,CDISC Questionnaire Terminology,FACT-G Version 4 - I Get Support From My Friends,0
475,CTRP Terminology,Folate-FITC,0
476,CDISC QRS Terminology,C-SSRS Children's Baseline - Number of Aborted Suicide Attempts,0
477,NCIt Antineoplastic Agent Terminology,Ganetespib,0
478,FDA Established Names and Unique Ingredient Identifier Codes Terminology,mebanazine,0
479,CDISC SDTM Terminology,Marital Status - Polygamous,0
480,Clinical Data Interchange Standards Consortium Terminology,Corticosterone Assay,0
481,CDISC SDTM Terminology,Tooth Canal,0
482,Clinical Data Interchange Standards Consortium Terminology,Streptococcus gordonii,0
483,Pediatric Rheumatology Terminology,Enthesitis,0
484,CDISC SDTM Terminology,C-SSRS Children's Baseline - Number of Actual Suicide Attempts,0
485,CDISC SDTM Terminology,"MNSI - Left Foot Dry Skin, Callus",0
486,CDISC SEND Terminology,Intragingival Route of Administration,0
487,Patient Problem Codes FDA CDRH,Osteopenia,0
488,Regulated Product Submission Reporting Terminology,Transfer of Obligation,0
489,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Milli-International Unit per Milliliter per Kilogram,0
490,CDISC Questionnaire Terminology,CDISC Questionnaire CCQ 1 Week Version Test Code Terminology,0
491,FDA Device Component Code Hierarchy,Transmission Line Device,0
492,FDA Device Component Code Hierarchy,Brush device,0
493,CDISC SDTM Laboratory Test Terminology by Name,Glutathione-S-Transferase to Creatinine Ratio Measurement,0
494,Pediatric Infectious Disease Terminology,"Early latent syphilis, positive serology, negative cerebrospinal fluid, less than 2 years after infection",0
495,Clinical Data Interchange Standards Consortium Terminology,Minute Times mole Per Liter Per Milligram Per Gram,0
496,Neonatal Research Network Terminology,Thalassemia,0
497,CDISC SDTM Microorganism Terminology,Human immunodeficiency virus 2 (HIV-2),0
498,Clinical Data Interchange Standards Consortium Terminology,Streptococcus bovis group,0
499,Clinical Data Interchange Standards Consortium Terminology,Rhinovirus A,0
500,CDISC SDTM Terminology,FACT-P Version 4 - Satisfied With Comfort Level,0
501,CDISC SDTM Terminology,CDISC SDTM Reproductive System Findings Test Name Terminology,0
502,CDISC SDTM Terminology,CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Name Terminology,0
503,CDISC SDTM Terminology,AVLT-REY - List A Word 1,0
504,Clinical Data Interchange Standards Consortium Terminology,French Guiana,0
505,NCI CTEP SDC Chondrosarcoma Sub-Category Terminology,Chondrosarcoma,0
506,Pediatric Infectious Disease Terminology,Multidrug-Resistant Mycobacterium tuberculosis,0
507,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Total Clearance Predicted Normalized by Body Mass Index,0
508,CDISC SDTM Terminology,Junctional premature complex (disorder),0
509,Clinical Data Interchange Standards Consortium Terminology,Prolactin measurement,0
510,NCIt Antineoplastic Agent Terminology,Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine,0
511,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fexinidazole,0
512,CDISC Observation Class Terminology,Start Rule,0
513,Clinical Data Interchange Standards Consortium Terminology,Immature Neutrophils to Leukocytes Ratio Measurement,0
514,CDISC SDTM ECG Finding Terminology,T Waves Flat by ECG Finding,0
515,CDISC SDTM Terminology,NHLBI Coronary Artery Dissection Type C,0
516,CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology,C-SSRS Children's Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt,0
517,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology,MSQOL-54 - Trouble Keep Attention for Long,0
518,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Milliliter per Microgram per Kilogram,0
519,CDISC Functional Test BACS Test Code Terminology,BACS - Verbal Fluency Total,0
520,CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology,SGRQ Past 3 Months Version - I Get Exhausted Easily,0
521,Medical Outcomes Study Your Feelings Questionnaire,Did You Find Yourself Having Difficulty Trying to Calm Down,0
522,CDISC SDTM Collected Ethnicity Terminology,Spanish Person,0
523,CDISC SDTM Unit of Measure Terminology,Pounds,0
524,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cevimeline hydrochloride,0
525,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fosfomycin tromethamine,0
526,US Counties Terminology,"Fannin County, TX",0
527,Pediatric Infectious Disease Terminology,disease transmission,0
528,Pediatric Adverse Events Terminology,Lichenoid drug eruption,0
529,FDA Device Component Code Hierarchy,Buzzer Device,0
530,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Code Terminology,MSQOL-54 - Trouble With Memory,0
531,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clomegestone acetate,0
532,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Refametinib,0
533,CDISC Questionnaire GDS Test Code Terminology,GDS - Mind as Clear as It Used to Be,0
534,CDISC SDTM Terminology,BACS - Tower of London Correct Responses,0
535,Pediatric Terminology,Little's Disease,0
536,CDISC SDTM Terminology,CDISC Clinical Classification Child-Pugh Test Code Terminology,0
537,Clinical Data Interchange Standards Consortium Terminology,Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide,0
538,US Counties Terminology,"Graham County, AZ",0
539,NCIt Antineoplastic Agent Terminology,Tirabrutinib,0
540,FDA Device Component Code Hierarchy,Divider Device,0
541,Neonatal Research Network Terminology,Atrial Fibrillation,0
542,Clinical Data Interchange Standards Consortium Terminology,ESRS-A - Dystonia: Trunk/Neck,0
543,Pediatric Terminology,Corrected Age,0
544,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rilapine,0
545,Clinical Data Interchange Standards Consortium Terminology,BPI - Pain Right Now,0
546,CTRP Terminology,Stage III Rectal Cancer AJCC v7,0
547,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sertaconazole,0
548,CDISC Questionnaire BPI Test Name Terminology,BPI - Things that Make your Pain Worse,0
549,CTRP Terminology,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,0
550,Clinical Data Interchange Standards Consortium Terminology,Hour Times Millimole per Liter per Kilogram per Meter Squared,0
551,FDA Established Names and Unique Ingredient Identifier Codes Terminology,isopentane,0
552,CDISC SDTM Laboratory Test Terminology by Code,6-Monoacetylmorphine Measurement,0
553,CDISC SDTM Microorganism Terminology,Streptococcus pluranimalium,0
554,UCUM Terminology,Tablet Dosing Unit,0
555,CDISC SDTM Terminology,Tablet Dosing Unit,0
556,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Hour Times Micromole per Milliliter,0
557,Clinical Data Interchange Standards Consortium Terminology,Pseudopropionibacterium propionicum,0
558,Pediatric Terminology,Mullerian inhibiting factor deficiency,0
559,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tocainide,0
560,CDISC Questionnaire Terminology,BPI - Things that Make Pain Feel Better,0
561,Clinical Data Interchange Standards Consortium Terminology,Salmonella choleraesuis,0
562,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Moricizine hydrochloride,0
563,CareLex eTMF Terminology,Investigational Medicinal Product Documentation,0
564,CDISC SDTM Laboratory Test Terminology by Name,density,0
565,CDISC SDTM Terminology,"Staphylococcus, coagulase negative (organism)",0
566,CDISC SDTM Relationship to Subject Terminology,Biological Uncle,0
567,NCIt Antineoplastic Agent Terminology,SNS 314,0
568,CDISC Questionnaire SGRQ Past 4 Weeks Version Test Name Terminology,SGRQ Past 4 Weeks Version - Cannot Go Out to Do Shopping,0
569,CDISC SDTM Terminology,Washout Period,0
570,CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology,ST Elevation Myocardial Infarction by ECG Finding,0
571,CareLex eTMF Terminology,Clinical Trial Interfacility Standardization Method Document,0
572,Neonatal Research Network Terminology,"Tachycardia, Ventricular",0
573,CDISC SDTM Terminology,C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Lifetime),0
574,CDISC SDTM Terminology,msdRNA,0
575,CDISC SDTM Holter ECG Results Terminology,Acute Myocardial Infarction by ECG Finding,0
576,CDISC Questionnaire ADCS-ADL MCI Test Code Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Tennis",0
577,CDISC SDTM Terminology,Atypical Lymphocyte Count Measurement,0
578,Clinical Data Interchange Standards Consortium Terminology,Trichocephalus <invertebrate>,0
579,Clinical Data Interchange Standards Consortium Terminology,American Indian or Alaska Native,0
580,Perinatal Terminology,Hydrocephalus,0
581,Pediatric Terminology,Urinary straining,0
582,CDISC SDTM Terminology,FACT-P Version 4 - Satisfied With How I Am Coping,0
583,CDISC SDTM Terminology,msDNA,0
584,Attitudes and Preferences Questionnaire,Made Final Selection of My Treatment After Seriously Considering Doctor's Opinion,0
585,CDISC SEND Terminology,Sint Maarten (Dutch Part),0
586,CDISC SDTM Anatomical Location Terminology,Head,0
587,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bisbentiamine,0
588,US Counties Terminology,"Multnomah County, OR",0
589,CDISC SDTM Unit of Measure Terminology,Enzyme-Linked Immunosorbent Assay Unit,0
590,FDA Established Names and Unique Ingredient Identifier Codes Terminology,florifenine,0
591,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mycobacterium phlei,0
592,US Counties Terminology,"Jersey County, IL",0
593,CTRP Agent Terminology,mercaptopurine,0
594,CDISC QRS Terminology,FACT-P Version 4 - Enjoy Things I Usually Do for Fun,0
595,CDISC SDTM Laboratory Test Terminology by Name,Hydrogen-Ion Concentration,0
596,FDA Established Names and Unique Ingredient Identifier Codes Terminology,epinephrine bitartrate,0
597,CDISC QRS Terminology,ESRS-A - Dyskinesia: Hips/Lower Limbs/Feet,0
598,CDISC SDTM Terminology,Bacillus lentus,0
599,Perinatal Terminology,Precipitous Birth,0
600,CDISC SDTM Terminology,AUC from T1 to T2 Normalized by Surface Area,0
601,CTRP Agent Terminology,Modified-release Calcifediol Capsule,0
602,Clinical Data Interchange Standards Consortium Terminology,Alcaligenes,0
603,Clinical Data Interchange Standards Consortium Terminology,Deep (qualifier value),0
604,Pediatric Terminology,Contact Transmission,0
605,CDISC SEND Terminology,Nonspecific Intraventricular Conduction Delay by ECG Finding,0
606,Epworth Sleepiness Scale Questionnaire,Sitting and Reading,0
607,Clinical Data Interchange Standards Consortium Terminology,IIEF - How Often Did You Ejaculate,0
608,CDISC SDTM Terminology,Lung clearance index,0
609,CDISC SDTM Respiratory Test Name Terminology,Lung clearance index,0
610,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aloracetam,0
611,CDISC Variable Terminology,Exposure Planned Dose,0
612,CTRP Terminology,Trifluridine and Tipiracil Hydrochloride,0
613,CDISC Questionnaire Terminology,CHART-SF Paper Version - Live With Spouse or Significant Other,0
614,CDISC SEND Terminology,Collection Interval Midpoint,0
615,CDISC Questionnaire Terminology,FACT-P Version 4 - Content With Quality of My Life,0
616,Pediatric Adverse Events Terminology,Chronic pain,0
617,Clinical Data Interchange Standards Consortium Terminology,KFSS - Bowel and Bladder Functions,0
618,CTRP Intervention Terminology,Indwelling Catheter,0
619,CDISC Questionnaire HAQ-DI With VAS Test Code Terminology,HAQ-DI With VAS - Able to Run Errands and Shop,0
620,CDISC QRS Terminology,CDR - Home and Hobbies,0
621,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cimetidine,0
622,CDISC SDTM Terminology,Norwalk virus,0
623,CDISC SDTM Terminology,Granulicatella,0
624,Clinical Data Interchange Standards Consortium Terminology,Ejection fraction normal,0
625,FDA Established Names and Unique Ingredient Identifier Codes Terminology,celivarone,0
626,US Counties Terminology,"Vernon County, MO",0
627,CTRP Terminology,Dexrazoxane hydrochloride,0
628,CDISC SDTM Tumor Response Result Terminology,Complete Minimal Residual Disease Response,0
629,Pediatric Terminology,Macropsia,0
630,CDISC SDTM Respiratory Test Name Terminology,Forced Inspiratory Flow at 50%,0
631,Pediatric Terminology,Hemimelia,0
632,CDISC SEND Trial Summary Parameter Long Name Terminology,Good Laboratory Practice Type,0
633,FDA Established Names and Unique Ingredient Identifier Codes Terminology,enprofylline,0
634,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pelrinone Hydrochloride,0
635,FDA Established Names and Unique Ingredient Identifier Codes Terminology,gentamicin C1a,0
636,CTRP Terminology,Meningeal,0
637,FDA Established Names and Unique Ingredient Identifier Codes Terminology,toloxatone,0
638,ICH Unit of Measure Terminology,Becquerel,0
639,CDISC SDTM Route of Administration Terminology,Intraamniotic Route of Administration,0
640,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Gadolinium DTPA,0
641,Pediatric Terminology,Tooth Abnormalities,0
642,Comprehensive Score for Financial Toxicity,Feel Financially Stressed,0
643,eCTD Promotional Material Document Type Terminology,Presubmission Accelerated Launch Material,0
644,CDISC SEND Terminology,Systolic Pressure,0
645,CDISC SDTM Terminology,Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire,0
646,CDISC SDTM Route of Administration Terminology,Intravesical Route of Drug Administration,0
647,CDISC SDTM Terminology,Interlocutory Marital Status,0
648,NCIt Antineoplastic Agent Terminology,Fluzoparib,0
649,MD Anderson Symptom Inventory - Brain Tumor,Symptom Interference Score 4,0
650,CDISC Questionnaire Terminology,SIQR - Your Sleep,0
651,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Alprostadil,0
652,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Lifetime),0
653,Clinical Data Interchange Standards Consortium Terminology,School,0
654,CDISC SDTM Terminology,T Wave Notched by ECG Finding,0
655,CDISC QRS Terminology,6MWT - Distance at 6 Minutes,0
656,CDISC SDTM Anatomical Location Terminology,Hard Palate,0
657,CDISC SDTM Terminology,SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator,0
658,Clinical Data Interchange Standards Consortium Terminology,Expanded DRS-PI Survivor Version - Successful With Limited Choices,0
659,Pediatric Immunization Terminology,Meningococcal Conjugate Vaccine MCV4,0
660,CDISC SDTM Anatomical Location Terminology,Median Or Lower Cervical Lymph Node,0
661,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List A Recall 3 Word 14,0
662,CDISC Questionnaire FACT-P Version 4 Test Code Terminology,FACT-P Version 4 - Certain Parts of Body Experience Pain,0
663,CDISC Variable Terminology,Exposure Laterality,0
664,CDISC SEND Terminology,parathyroid hormone-related protein measurement,0
665,FACT-P Questionnaire,Score,0
666,Pediatric Infectious Disease Terminology,Dengue Fever,0
667,CDISC SDTM Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Lifetime),0
668,CDISC Questionnaire MDS-UPDRS Test Code Terminology,MDS-UPDRS - Speech Problems,0
669,Newborn Screening Terminology,Patient referral,0
670,CDISC Questionnaire BPI Test Code Terminology,BPI - Areas of Pain,0
671,CDISC Questionnaire DAD Test Name Terminology,DAD - Carry Out an Appropriate Telephone Conversation,0
672,Clinical Data Interchange Standards Consortium Terminology,BPI - Marital Status,0
673,Clinical Data Interchange Standards Consortium Terminology,Matrix Metalloproteinase 8 Measurement,0
674,CDISC SDTM Microorganism Terminology,Tsukamurella,0
675,CTRP Agent Terminology,Ubidecarenone Nanodispersion BPM31510n,0
676,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Past 3 Months),0
677,CDISC SEND Biospecimens Terminology,Calvaria,0
678,CDISC SDTM Terminology,Mansonella perstans,0
679,NCIt Antineoplastic Agent Terminology,Golnerminogene Pradenovec,0
680,NCI CTEP Simplified Disease Classification Terminology,"NCI CTEP SDC CNS-excluded Nervous System Neoplasm, Miscellaneous Sub-Category Terminology",0
681,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Day Times Picomole per Milliliter,0
682,NCPDP Strength Form Terminology,Vaginal Spray,0
683,CDISC SDTM Method Terminology,Ivy Incision Method,0
684,Cancer Patient Tobacco Use Questionnaire,How Long Since Last Cigarette,0
685,CDISC Functional Test Terminology,PASAT - Total Correct,0
686,CDISC QRS Terminology,CRS-R - Communication Scale,0
687,Clinical Data Interchange Standards Consortium Terminology,HAMD-21 - Obsessional and Compulsive Symptoms,0
688,CDISC QRS Terminology,MDS-UPDRS - Rigidity Neck,0
689,Clinical Data Interchange Standards Consortium Terminology,Picomole per Liter per Meter Squared,0
690,CDISC SEND Terminology,Glutamate dehydrogenase measurement,0
691,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dichlofenthion,0
692,CDISC Questionnaire Terminology,C-SSRS Baseline - Number of Aborted Suicide Attempts,0
693,CDISC Questionnaire GDS Test Code Terminology,GDS - Prefer to Avoid Social Gatherings,0
694,Pediatric Terminology,Exfoliative dermatitis,0
695,CTRP Agent Terminology,talaporfin sodium,0
696,Pediatric Nephrology Terminology,Nephrotic Syndrome - SMARCAL1 Associated,0
697,CTRP Agent Terminology,Technetium Tc 99m Medronate,0
698,CDISC SDTM Terminology,Cardiolipin IgA Antibody Measurement,0
699,CDISC QRS Terminology,Child-Pugh Clinical Classification,0
700,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Date,0
701,CTRP Terminology,Inalimarev,0
702,CDISC SEND Non-Neoplastic Finding Type Terminology,Experimental Organism Luteinized Unruptured Follicle,0
703,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Past X Years),0
704,CDISC QRS Terminology,GDS - Easy to Make Decisions,0
705,CDISC Clinical Classification Terminology,Hamilton Depression Rating Scale 21-Item Clinical Classification,0
706,Clinical Data Interchange Standards Consortium Terminology,Salmonella Serotype Paratyphi A,0
707,CDISC Questionnaire ASEX-Male Version Test Code Terminology,ASEX-Male Version - Comments,0
708,Pediatric Adverse Events Terminology,Intraventricular Hemorrhage with Parenchymal Hemorrhage of the Newborn,0
709,US Counties Terminology,"Benton County, MO",0
710,CTRP Terminology,Adult Myxopapillary Ependymoma,0
711,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Total Score,0
712,Neonatal Research Network Terminology,Beckwith-Wiedemann Syndrome,0
713,CDISC SDTM Terminology,AVLT-REY - List B Word 5,0
714,CDISC Questionnaire C-SSRS Screening Test Name Terminology,C-SSRS Screening - First Suicide Attempt Date,0
715,CDISC SDTM Laboratory Test Terminology by Code,Circulating Tumor Cell Count,0
716,Perinatal Terminology,Conception Age,0
717,US Counties Terminology,"Bollinger County, MO",0
718,Perinatal Terminology,Time of Onset of Labor,0
719,CDISC SDTM Terminology,Day Times Micromole Per Liter Per Milligram Per Gram,0
720,FDA Manufacturer Evaluation Result Code Hierarchy,Incorrect Algorithm,0
721,FDA Device Problem Code Hierarchy,Moisture or Humidity Problem,0
722,CTRP Agent Terminology,Denibulin Hydrochloride,0
723,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Egg Food Product,0
724,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire ODI v2.1a Test Code Terminology,0
725,Clinical Data Interchange Standards Consortium Terminology,AVLT-REY - List B Word 8,0
726,CDISC Questionnaire DAD Test Code Terminology,DAD - Safely Take the Adequate Mode of Transportation,0
727,CDISC SDTM Microorganism Terminology,Budvicia,0
728,CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Code Terminology,NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well,0
729,US Counties Terminology,"Livingston Parish, LA",0
730,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cicloxilic acid,0
731,Female Sexual Function Index,Never or Almost Never,0
732,Clinical Data Interchange Standards Consortium Terminology,Control Type (study treatment comparator),0
733,CDISC SDTM Terminology,Total Clearance Observed Normalized by Surface Area,0
734,CDISC Observation Class Terminology,Baseline Flag,0
735,CDISC Variable Terminology,Microbiology Susceptibility Sequence Number,0
736,CTRP Agent Terminology,Uridine,0
737,CDISC SDTM Terminology,Intraurethral Route of Drug Administration,0
738,CTRP Agent Terminology,Tapentadol hydrochloride,0
739,US Counties Terminology,"Allen County, IN",0
740,CDISC SDTM Terminology,Escherichia fergusonii,0
741,Clinical Data Interchange Standards Consortium Terminology,"Haemophilus parainfluenzae, Penicillinase Positive",0
742,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cyclobarbital,0
743,Pediatric Terminology,Vaccines,0
744,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sodium chromate Cr51,0
745,CDISC SDTM Terminology,Clostridium paraputrificum,0
746,Clinical Data Interchange Standards Consortium Terminology,Clostridium paraputrificum,0
747,CDISC SEND Terminology,CDISC SDTM Laterality Terminology,0
748,CDISC SEND Terminology,Average Concentration Normalized by Dose,0
749,CDISC SEND Terminology,Hour Times gram Per Milliliter Per Milligram Per Gram Per Day,0
750,CDISC SDTM Laboratory Test Terminology by Name,ASSAY OF CARBOHYDRATE DEFICIENT TRANSFERRIN,0
751,CTRP Terminology,Human Papillomavirus Vaccine V503,0
752,CDISC QRS Terminology,PROSQOLI - Urinary Problems,0
753,Multidimensional Body-Self Relations Questionnaire Appearance Orientation,Check My Appearance in Mirror Whenever,0
754,Clinical Data Interchange Standards Consortium Terminology,Lesion Revascularization Indicator,0
755,Clinical Data Interchange Standards Consortium Terminology,Gracilibacillus,0
756,CTRP Agent Terminology,"sodium calcium aluminosilicate, hydrated",0
757,CTRP Agent Terminology,linezolid,0
758,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire VFQ25-Self Administered Format Test Code Terminology,0
759,CDISC Functional Test BACS Test Name Terminology,BACS - Total Number Tokens in Container,0
760,US Counties Terminology,"Morgan County, GA",0
761,CDISC Questionnaire FAQ-NACC Version Test Name Terminology,"FAQ-NACC Version - Pay Attention, Understand, Discuss",0
762,CDISC SDTM Terminology,Clostridium perfringens,0
763,US Counties Terminology,"Pondera County, MT",0
764,Clinical Data Interchange Standards Consortium Terminology,Tissue Inhibitor of Metalloproteinase 1 Measurement,0
765,Clinical Data Interchange Standards Consortium Terminology,Erythrocyte Agglutination Measurement,0
766,SPL Drug Route of Administration Terminology,Ureteral Route of Drug Administration,0
767,CDISC Variable Terminology,Adverse Event associated with Hospitalization,0
768,FDA Established Names and Unique Ingredient Identifier Codes Terminology,THYROID (BEEF),0
769,FDA Established Names and Unique Ingredient Identifier Codes Terminology,BISOCTRIZOLE,0
770,CDISC QRS Terminology,FAQ-NACC Version - Remember,0
771,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index,0
772,US Counties Terminology,"Floyd County, IN",0
773,CDISC SDTM Terminology,Hepatitis C antibody measurement,0
774,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Since Last Visit - Wish to be Dead or go to Sleep and not Wake Up,0
775,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Amsilarotene,0
776,US Counties Terminology,"Ramsey County, ND",0
777,CTRP Agent Terminology,Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101,0
778,CDISC SDTM Holter ECG Results Terminology,ST segment depression (finding),0
779,CDISC QRS Terminology,BPI - Current Occupation,0
780,ICH Unit of Measure Terminology,Microgram per Liter,0
781,FDA Established Names and Unique Ingredient Identifier Codes Terminology,HC Orange No. 3,0
782,Clinical Data Interchange Standards Consortium Terminology,Prorubricyte to Total Cell Ratio Measurement,0
783,Pediatric Terminology,Isovaleryl-CoA dehydrogenase deficiency,0
784,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline - Description of Actual Suicide Attempts,0
785,CTRP Agent Terminology,iso-sulfan blue,0
786,CDISC QRS Terminology,MPAI-4 - Abilities: Nonverbal Communication,0
787,CTRP Terminology,filanesib,0
788,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Study Type Terminology,0
789,Clinical Data Interchange Standards Consortium Terminology,Non-cardiac chest pain,0
790,FDA eManufacturing Terminology,Terminal Sterilization,0
791,CDISC SDTM PK Unit of Measure Gram Weight Terminology,International Unit per Milliliter per Kilogram,0
792,CTRP Terminology,Oral Complication of Chemotherapy,0
793,US Counties Terminology,"New York County, NY",0
794,CDISC SDTM Terminology,Genus Mycobacterium,0
795,Pediatric Terminology,Pregnancy,0
796,CDISC SEND Terminology,Histone 2A Antibody Measurement,0
797,CDISC SDTM Method Terminology,"Spectrometry, X-Ray Emission",0
798,CTRP Terminology,Pexastimogene devacirepvec,0
799,CDISC SDTM Terminology,CD3 Cell to Lymphocyte Ratio Measurement,0
800,CDISC SDTM Laboratory Test Terminology by Code,"Oxygen measurement, partial pressure, arterial",0
801,Pediatric Adverse Events Terminology,Closed injury of eyeball,0
802,CDISC SDTM Laboratory Test Terminology by Name,HIV-2 Nucleic Acid Measurement,0
803,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Flavamine,0
804,Clinical Data Interchange Standards Consortium Terminology,Drug Administration via Hemodialysis,0
805,Device Evaluation ICSR Terminology,Device Evaluation Result,0
806,Clinical Data Interchange Standards Consortium Terminology,"Ganglia, Spinal",0
807,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Distigmine bromide,0
808,TAPS Tool - Interviewer Version,Once or Twice Response,0
809,CDISC SDTM Terminology,Granular Fine Cast Measurement,0
810,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"BUDESONIDE (11.BETA.,16.ALPHA.(S))",0
811,CDISC Variable Terminology,Vital Signs Elapsed Time,0
812,CDISC SDTM Method Terminology,Ziehl-Neelsen stain method,0
813,CTRP Terminology,PF-03758309,0
814,Pediatric Terminology,Medulloblastoma,0
815,Pediatric Nephrology Terminology,Bladder Sphincter Dysfunction,0
816,CDISC Questionnaire FACT-G Version 4 Test Name Terminology,FACT-G Version 4 - I Am Able to Work,0
817,CDISC SDTM Terminology,CDISC SDTM Culture Medium Type Terminology,0
818,Clinical Data Interchange Standards Consortium Terminology,Epinephrine measurement,0
819,CDISC SDTM Terminology,CDISC SDTM ARC Coronary Stent Thrombosis Grade Responses Terminology,0
820,CDISC SDTM Laboratory Test Terminology by Name,Herpes Simplex Virus 2 IgG Antibody Measurement,0
821,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ethyl sebacate,0
822,CTRP Agent Terminology,NY-ESO-1/LAGE-1 Peptide Vaccine,0
823,CDISC QRS Terminology,SOAPP-R - Others Expressed Concern Over Medication Use,0
824,Pediatric Nephrology Terminology,Hutch diverticulum,0
825,CDISC SEND Terminology,Five Times Monthly,0
826,NCIt Antineoplastic Agent Terminology,Edrecolomab,0
827,Clinical Data Interchange Standards Consortium Terminology,MDS-UPDRS - Left Finger Tapping,0
828,CDISC SDTM Relationship Type Terminology,Numerous,0
829,CDISC SEND Terminology,LDH Isoenzyme 4 to LDH Ratio Measurement,0
830,CDISC SEND Terminology,Lethal Injection and Exsanguination Euthanasia,0
831,CDISC SEND Terminology,Rectosigmoid Region,0
832,CDISC SDTM Terminology,Forearm Circumference,0
833,CDISC SDTM Laboratory Test Terminology by Code,HIV-2 Antibody Measurement,0
834,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Greasewood pollen extract,0
835,CDISC Questionnaire Terminology,OAB-q Short Form - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom,0
836,Clinical Data Interchange Standards Consortium Terminology,FACT-G Version 4 - I Am Able to Enjoy Life,0
837,CDISC SDTM Anatomical Location Terminology,Left Ventricular Mid Inferior Segment,0
838,Pediatric Terminology,Chronic iridocyclitis,0
839,CDISC QRS Terminology,AVLT-REY - List B Word 1,0
840,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mechlorethamine hydrochloride,0
841,Pittsburgh sleep quality index,Enough Enthusiasm to Get Things Done,0
842,CDISC SEND Terminology,Pulse Pressure,0
843,NCIt Antineoplastic Agent Terminology,NRX 194204,0
844,CDISC QRS Terminology,AVLT-REY - List A Word 12,0
845,Clinical Data Interchange Standards Consortium Terminology,Pichia kluyveri,0
846,CDISC Questionnaire RDQ Test Code Terminology,RDQ - Only Stand for Short Periods,0
847,Pediatric Infectious Disease Terminology,Bacterial myocarditis,0
848,Clinical Data Interchange Standards Consortium Terminology,Lymph node of mesentery,0
849,CDISC SDTM Terminology,Observational Study Sampling Method Description,0
850,CTRP Agent Terminology,Liposomal Docetaxel,0
851,CTRP Agent Terminology,rindopepimut,0
852,CDISC Questionnaire FIQR Test Code Terminology,FIQR - Symptoms Sub-Total,0
853,Pediatric Terminology,Chest Tubes,0
854,FDA eCTD Terminology,Social Media,0
855,CTRP Agent Terminology,PF-06647263,0
856,NCIt Antineoplastic Agent Terminology,olaratumab,0
857,CTRP Intervention Terminology,Scintimammography,0
858,CDISC SDTM Unit of Measure Terminology,Disintegration per Minute per 100 milligrams,0
859,CDISC Questionnaire WPAI:SHP v2.0 Test Name Terminology,WPAI:SHP v2.0 - Currently Employed,0
860,CDISC SDTM Ophthalmic Exam Test Name Terminology,Intraocular pressure finding,0
861,Contemplation Ladder Readiness to Quit Smoking Likert Scale,Readiness to Quit Smoking Score 0,0
862,CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Code Terminology,NCCN-FACT-FPSI 17 Version 2 - I Have Weakness in My Legs,0
863,CDISC SDTM Anatomical Location Terminology,Sacral vertebra structure,0
864,Clinical Data Interchange Standards Consortium Terminology,Leptomeningeal Neoplasms,0
865,Newborn Screening Terminology,"Reflex, Moro",0
866,CTRP Terminology,PR-104,0
867,CDISC SDTM Laboratory Test Terminology by Code,Fractional Excretion of Chloride,0
868,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Loflucarban,0
869,CDISC SDTM Terminology,Curie per Kilogram,0
870,Pediatric Terminology,Deficiency of butyryl-CoA dehydrogenase,0
871,CDISC SDTM Terminology,MNSI - Left Foot Monofilament,0
872,CDISC Questionnaire Terminology,MNSI - Left Foot Monofilament,0
873,CDISC Questionnaire RPQ Test Name Terminology,"RPQ - Being Irritable, Easily Angered",0
874,NCIt Antineoplastic Agent Terminology,Sorghum bicolor Supplement,0
875,CDISC SDTM Terminology,Drug Delivery Systems,0
876,Neonatal Research Network Terminology,Vein of Galen Malformations,0
877,CDISC SEND Terminology,Nipples,0
878,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acitemate,0
879,Clinical Data Interchange Standards Consortium Terminology,Clostridium innocuum,0
880,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime),0
881,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Inula helenium,0
882,CDISC SDTM Laboratory Test Terminology by Name,Pi-GST Excretion Rate,0
883,Clinical Data Interchange Standards Consortium Terminology,"RNA, Double-Stranded",0
884,CTRP Terminology,CPI-0610,0
885,NCIt Neoplasm Core Terminology,Lung Lymphoepithelioma-Like Carcinoma,0
886,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology,RAND-36 - Rate Your Health Compared to One Year Ago,0
887,Pediatric Adverse Events Terminology,Infantile Spasm,0
888,CDISC SDTM Terminology,"PHQ-9 - How Difficult have Problems Made it for You to Work, Take Care of Things, or Get Along with Other People",0
889,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Anagallis arvensis,0
890,CDISC SDTM Terminology,yard (length),0
891,FDA Established Names and Unique Ingredient Identifier Codes Terminology,amidephrine,0
892,CDISC SDTM Terminology,Ribonucleoprotein antibody measurement,0
893,Clinical Data Interchange Standards Consortium Terminology,Diagnostic radiologic examination,0
894,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chlortetracycline Calcium,0
895,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Detanosal,0
896,CDISC Variable Terminology,Subject Status Sequence Number,0
897,US Counties Terminology,"Vilas County, WI",0
898,CDISC SDTM Terminology,Immunoglobulin G Subclass 1 Measurement,0
899,FDA Device Problem Code Hierarchy,Inaccurate Synchronization,0
900,US Counties Terminology,"Camp County, TX",0
901,Clinical Data Interchange Standards Consortium Terminology,Talus,0
902,Clinical Data Interchange Standards Consortium Terminology,CDISC SEND Laboratory Animal Strain Terminology,0
903,CDISC QRS Terminology,ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification,0
904,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Nanomole per Liter per Milligram per Kilogram,0
905,Clinical Data Interchange Standards Consortium Terminology,Intravaginal Route of Administration,0
906,CDISC Variable Terminology,Questionnaire Test,0
907,CDISC SEND Terminology,Carbon dioxide content measurement,0
908,CDISC SDTM Terminology,Radiographic Examination,0
909,CDISC Questionnaire PHQ Screener Version Test Code Terminology,PHQ Screener Version - Eat a Lot Twice Week,0
910,CDISC SDTM ECG Test Name Terminology,Minimum ST Deviation,0
911,Pediatric Infectious Disease Terminology,Migratory arthritis,0
912,CTRP Terminology,CPG-ODN,0
913,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Glibutimine,0
914,CDISC Variable Terminology,Actual Arm Name,0
915,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"1,1,2,2-TETRAFLUOROETHANE",0
916,MD Anderson Symptom Inventory - Head and Neck,Shortness of Breath at its Worst,0
917,US Counties Terminology,"Mercer County, KY",0
918,Pediatric Terminology,polyvalent vaccines,0
919,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Atigliflozin,0
920,US Counties Terminology,"Beaver County, UT",0
921,CDISC SDTM Terminology,Roseolovirus,0
922,CDISC SDTM Terminology,Recumbent body position,0
923,CTRP Terminology,Healthy Stem Cell Donor,0
924,CDISC SDTM Terminology,C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Past 3 Months),0
925,Clinical Data Interchange Standards Consortium Terminology,Partial Response with Lymphocytosis,0
926,Pediatric Nephrology Terminology,Atrophy of testis,0
927,CDISC SDTM Submission Domain Abbreviation Terminology,Pharmacokinetic Parameters Domain,0
928,Clinical Data Interchange Standards Consortium Terminology,Pharmacokinetic Parameters Domain,0
929,CTRP Agent Terminology,Anti-CD45 Monoclonal Antibody AHN-12,0
930,CDISC SDTM Anatomical Location Terminology,Cerebral hemisphere structure (body structure),0
931,Clinical Data Interchange Standards Consortium Terminology,Absent,0
932,Report Source ICSR Terminology,Other,0
933,CDISC SDTM Terminology,RAND-36 - Health Limit Climbing Several Flights,0
934,Clinical Data Interchange Standards Consortium Terminology,MPAI-4 - Adjustment: Anxiety,0
935,CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Code Terminology,C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Lifetime),0
936,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Name Terminology,C-SSRS Children's Baseline/Screening - Most Severe Ideation,0
937,CDISC SEND Terminology,Unit per Animal,0
938,CDISC SDTM Microorganism Terminology,Bacteroides fragilis group,0
939,CDISC SDTM Country Terminology,Peru,0
940,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Edonentan Anhydrous,0
941,Stability Product Form Terminology,"GRANULES, DELAYED RELEASE",0
942,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Code Terminology,RAND-36 - Physical Health Limited in the Kind of Work,0
943,CDISC SDTM Terminology,VFQ25-Self Administered Format - Eyesight Using Both Eyes,0
944,CDISC SEND Non-Neoplastic Finding Type Terminology,Mesangiolysis,0
945,CTRP Agent Terminology,Ipafricept,0
946,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Spironolactone,0
947,NCIt Antineoplastic Agent Terminology,GM-K562 Cell Vaccine,0
948,CDISC Variable Terminology,Exclude Body Weight Data From Statistics Indicator,0
949,CDISC SDTM Terminology,CDISC Questionnaire RPQ Test Code Terminology,0
950,FDA Established Names and Unique Ingredient Identifier Codes Terminology,colistimethate,0
951,Clinical Data Interchange Standards Consortium Terminology,Fermentative Gram-negative bacillus,0
952,CDISC SEND Biospecimens Terminology,Bulbourethral gland structure,0
953,CDISC SDTM Terminology,Exiguobacterium,0
954,CDISC SDTM Terminology,"C-SSRS Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan",0
955,CDISC SDTM Terminology,Oral coated pellets capsule,0
956,Stability Product Form Terminology,Oral coated pellets capsule,0
957,Patient Reported Outcomes Version of CTCAE,Past Seven Days Ridges or Bumps on Fingernails or Toenails,0
958,NCIt Neoplasm Core Terminology,cystadenocarcinoma of intrahepatic bile duct,0
959,CDISC CDASH Terminology,Botswanan race,0
960,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,AUMC Infinity Predicted Normalized by Dose,0
961,CTRP Agent Terminology,Autologous GM-CSF-secreting Lethally Irradiated Leukemia Cell Vaccine,0
962,CDISC SDTM Specimen Condition Terminology,Specimen Condition - Clotted,0
963,Clinical Data Interchange Standards Consortium Terminology,Immunogenicity Study,0
964,NCPDP Strength Form Terminology,Non-Medicated Swab Dosage Form,0
965,FDA Established Names and Unique Ingredient Identifier Codes Terminology,halofuginone,0
966,CDISC Questionnaire UPS Test Code Terminology,UPS - Describe Your Experience When You Desire to Urinate,0
967,CDISC Questionnaire Terminology,UPS - Describe Your Experience When You Desire to Urinate,0
968,NCIt Neoplasm Core Terminology,Ovarian adenocarcinoma,0
969,CDISC SDTM Terminology,Bacteroides ovatus,0
970,CDISC SDTM Terminology,ESRS-A - CGI-S Parkinsonism,0
971,CDISC SDTM Terminology,CDISC ADAS-Cog - Word Recall Trial 2 Subscore,0
972,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Smilax china,0
973,CDISC SDTM Terminology,Expanded DRS-PI Caregiver Version - Able to Communicate Clearly,0
974,CDISC SDTM Specimen Condition Terminology,Calcified Specimen,0
975,CDISC SDTM Microorganism Terminology,Candida intermedia,0
976,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lorcaserin hydrochloride,0
977,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Influenza a virus a/uruguay/716/2007(h3n2) live (attenuated) antigen,0
978,CDISC SDTM Submission Domain Abbreviation Terminology,Trial Elements Domain,0
979,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mustard Gas,0
980,"Geopolitical Entities, Names, and Codes Terminology",Jarvis Island,0
981,FDA Device Component Code Hierarchy,Scaler Device,0
982,CDISC Variable Terminology,Body Weight Original Result,0
983,CDISC SDTM Terminology,Anatomical segmentation,0
984,CDISC SDTM Terminology,Burkholderia cenocepacia,0
985,Clinical Data Interchange Standards Consortium Terminology,Age at First Hospitalization,0
986,CTRP Agent Terminology,Akt Inhibitor SR13668,0
987,Regulated Product Submission Reporting Terminology,Module 3: Literature References,0
988,Clinical Data Interchange Standards Consortium Terminology,Skeletal Examination,0
989,CDISC Variable Terminology,Microbiology Specimen Origin,0
990,CDISC QRS Terminology,FIQR - Fibromyalgia Prevented Me from Accomplishing Goals for the Week,0
991,CDISC SDTM Laboratory Test Terminology by Name,Acetylcholine Receptor Antibody Measurement,0
992,NCIt Antineoplastic Agent Terminology,Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine,0
993,NCIt Neoplasm Core Terminology,Intracanalicular fibroadenoma,0
994,NCIt Neoplasm Core Terminology,Grade II Meningioma,0
995,CDISC Questionnaire Terminology,CDISC Questionnaire ADCS-ADL MCI Test Code Terminology,0
996,CDISC QRS Terminology,FAMS - Enjoying Things I Usually Do for Fun,0
997,Clinical Data Interchange Standards Consortium Terminology,"C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan",0
998,CTRP Terminology,AMG319,0
999,CDISC SEND Terminology,Cerebral Ventricles,0
1000,CDISC SDTM Terminology,CRQ-SAS First Administration Version - Felt Frustrated or Impatient,0
1001,CDISC SDTM Holter ECG Results Terminology,New Anteroseptal Myocardial Infarction by ECG Finding,0
1002,CDISC SEND Terminology,New Anteroseptal Myocardial Infarction by ECG Finding,0
1003,CTRP Terminology,Fentanyl Citrate Buccal Tablet,0
1004,NCIt Antineoplastic Agent Terminology,Nucleoside Analog DFP-10917,0
1005,CDISC SEND Terminology,Structure of posterior leaflet of mitral valve,0
1006,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Self Administered Format - Have Less Control Because of Eyesight,0
1007,GAIA Terminology,Cesarean Scar Pregnancy,0
1008,CTRP Terminology,Immune System Diseases,0
1009,CDISC SDTM Anatomical Location Terminology,Structure of trapezius muscle,0
1010,Pediatric Terminology,Neisseria meningitidis,0
1011,CDISC SEND Category for Clinical Observation Terminology,Qualitative Food Consumption,0
1012,NCIt Antineoplastic Agent Terminology,Aminocamptothecin Colloidal Dispersion,0
1013,Clinical Data Interchange Standards Consortium Terminology,Nose,0
1014,CDISC Questionnaire Terminology,VFQ25-Self Administered Format - Difficulty Recognizing People You Know,0
1015,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Self Administered Format - Difficulty Recognizing People You Know,0
1016,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tomoxiprole,0
1017,Extremity Manual Dexterity,Limited Manual Dexterity,0
1018,US Counties Terminology,"Cleburne County, AR",0
1019,CTRP Terminology,telavancin hydrochloride,0
1020,CDISC Questionnaire VFQ25-Self Administered Format Test Code Terminology,VFQ25-Self Administered Format - Difficulty Taking Part in Sports or Outdoor Activities,0
1021,CDISC QRS Terminology,HAMA - Somatic (Muscular),0
1022,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt,0
1023,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt,0
1024,EORTC/ROTG Late Radiation Morbidity Scoring Criteria,"LRMSC Grade 1, Subcutaneous Tissue",0
1025,NCIt Neoplasm Core Terminology,Plasmablastic lymphoma,0
1026,CDISC QRS Terminology,CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV Infection Category,0
1027,CDISC SDTM Terminology,Right Cardiac Ventricle Assist Device Procedure,0
1028,CDISC Questionnaire KFSS Test Name Terminology,KFSS - Other Functions,0
1029,CDISC SDTM Terminology,Caplet dose form,0
1030,NCIt Antineoplastic Agent Terminology,Allogeneic CD19-specific CAR-modified CD8 Plus Central Memory-derived Virus-specific T Cells,0
1031,CDISC SEND Terminology,Femtogram per Milliliter per Gram,0
1032,CDISC SDTM Country Terminology,Portugal,0
1033,CDISC SDTM Terminology,West Nile virus,0
1034,CDISC SDTM Laboratory Test Terminology by Name,Amorphous Sediment Measurement,0
1035,CareLex eTMF Terminology,Investigational Product Transfer Record,0
1036,Pediatric Terminology,Arch trunk position,0
1037,GAIA Terminology,GAIA Level 2 Dysfunctional First Stage of Labor,0
1038,CDISC SDTM Device Properties Test Code Terminology,Composition,0
1039,CTRP Terminology,Radionuclide Imaging,0
1040,Clinical Data Interchange Standards Consortium Terminology,Clotting factor II assay,0
1041,CDISC QRS Terminology,ADCS-ADL MCI - Description of Highest Level of Performance of Telephone Use,0
1042,CDISC SDTM Laboratory Test Terminology by Code,Prostaglandin D2 Synthase Measurement,0
1043,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Leukotriene B4,0
1044,CDISC Variable Terminology,Organ Measurements Assessment Character Result in Standard Format,0
1045,Occupation ICSR Terminology,Occupational therapist,0
1046,CDISC Questionnaire Terminology,CDISC Questionnaire EXACT Test Name Terminology,0
1047,Pediatric Terminology,Flat affect,0
1048,EORTC/ROTG Late Radiation Morbidity Scoring Criteria,"LRMSC Grade 3, Subcutaneous Tissue",0
1049,CDISC QRS Terminology,EPIC-CP - Quality of Erections,0
1050,CDISC Questionnaire Terminology,ADCS-ADL MCI - Converse Without Repeating,0
1051,CDISC SDTM Terminology,Pneumocystis jiroveci,0
1052,Operator of Medical Device ICSR Terminology,Invalid Data,0
1053,CDISC SDTM Tumor or Lesion Properties Test Code Terminology,Radiodensity,0
1054,CDISC SDTM Unit of Measure Terminology,Histamine Equivalent Prick Unit,0
1055,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Glycylglycine,0
1056,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire DLQI Test Name Terminology,0
1057,CDISC CDASH Variable Terminology,Electrocardiogram Results Clinically Significant Occurrence,0
1058,Clinical Data Interchange Standards Consortium Terminology,Mongolia,0
1059,CDISC SDTM Country Terminology,Mongolia,0
1060,CTRP Terminology,Radiation Therapy Treatment Planning and Simulation,0
1061,CDISC QRS Terminology,ADCS-ADL MCI - Read More Than 5 Minutes,0
1062,Work Productivity and Activity Impairment General Health V2.0 Questionnaire,Hours Missed from Work Because of Health Problems,0
1063,CDISC SDTM Terminology,Scedosporium prolificans,0
1064,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Observed Volume of Distribution,0
1065,CDISC Questionnaire MDS-UPDRS Test Code Terminology,MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity,0
1066,CDISC QRS Terminology,Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire,0
1067,CDISC SDTM Microorganism Terminology,Rahnella,0
1068,CDISC SEND Organ Measurement Test Code Terminology,Mean Thickness,0
1069,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Iolopride I-123,0
1070,CDISC SDTM Terminology,DNA Microarray Chip,0
1071,CDISC SDTM Terminology,Ankle Mortise,0
1072,CDISC SEND Terminology,Hour Times Nanogram Per Milliliter Per Milligram Per Gram,0
1073,CDISC SDTM Terminology,Hour Times Nanogram Per Milliliter Per Milligram Per Gram,0
1074,CDISC SDTM Submission Domain Abbreviation Terminology,Subject Characteristics Domain,0
1075,NCIt Antineoplastic Agent Terminology,CD19CAR-CD3zeta-4-1BB-CD28-expressing Autologous T-Lymphocytes,0
1076,CDISC Questionnaire MPAI-4 Test Code Terminology,MPAI-4 - Alcohol Use Post-Injury,0
1077,Hospital Anxiety and Depression Scale Questionnaire,Can Sit at Ease and Feel Relaxed,0
1078,CDISC SDTM Terminology,Tricuspid Valve Vena Contracta Area,0
1079,CDISC SEND Terminology,Renal Clearance for Dose Interval Normalized by Weight,0
1080,CDISC Questionnaire EPIC-26 Test Code Terminology,EPIC-26 - Change in Body Weight,0
1081,US Counties Terminology,"Braxton County, WV",0
1082,CTRP Terminology,Tetanus Toxoid Helper Peptide,0
1083,Clinical Data Interchange Standards Consortium Terminology,CDISC Functional Test AVLT-REY Test Code Terminology,0
1084,US Counties Terminology,"St. Bernard Parish, LA",0
1085,CDISC SDTM Anatomical Location Terminology,gastric fundus,0
1086,CDISC QRS Terminology,PHQ Screener Version - Back Pain,0
1087,Pediatric Infectious Disease Terminology,Suppurative parotitis,0
1088,Patient Problem Codes FDA CDRH,Foreign body sensation,0
1089,European Quality of Life Five Dimension Five Level Scale Questionnaire,I am unable to walk response,0
1090,CDISC SEND Non-Neoplastic Finding Type Terminology,Corpora amylacea,0
1091,Clinical Data Interchange Standards Consortium Terminology,Picomole per Ten Billion Cells,0
1092,CDISC Questionnaire SDS Test Code Terminology,SDS - Days Lost,0
1093,Neonatal Research Network Terminology,Aprosencephaly,0
1094,Pediatric Terminology,Contrast Media,0
1095,Clinical Data Interchange Standards Consortium Terminology,Body of stomach,0
1096,Clinical Data Interchange Standards Consortium Terminology,AQ20 - Chest Problem Make You Breathless at Work,0
1097,CDISC Questionnaire C-SSRS Screening Test Name Terminology,C-SSRS Screening - Description of Non-Specific Active Suicidal Thoughts,0
1098,Pediatric Terminology,Sotos' syndrome,0
1099,US Counties Terminology,"Taylor County, IA",0
1100,CTRP Terminology,Childhood Fibrosarcoma,0
1101,CTRP Terminology,cinacalcet hydrochloride,0
1102,CDISC SEND Terminology,Karyocytomegaly and Multinucleated Hepatocytes,0
1103,FDA Stability Data Standards Terminology,Stability Study Pause Description Terminology,0
1104,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Code Terminology,Expanded DRS-PI Caregiver Version - Need a Helper Always Close By,0
1105,CDISC SDTM Terminology,Expanded DRS-PI Caregiver Version - Need a Helper Always Close By,0
1106,CDISC SDTM Terminology,Extracted Lead,0
1107,MD Anderson Symptom Inventory - Core,Severity of Symptom Score 3,0
1108,NCIt Antineoplastic Agent Terminology,Efizonerimod alfa,0
1109,CDISC Questionnaire CCQ 1 Week Version Test Code Terminology,CCQ 1 Week Version - Breathing Problems Limit Social Activity,0
1110,Pediatric Adverse Events Terminology,Anuria,0
1111,NCIt Antineoplastic Agent Terminology,Tasisulam Sodium,0
1112,Clinical Data Interchange Standards Consortium Terminology,Ureaplasma,0
1113,CDISC SEND Terminology,Liter per Day per Microgram per Day,0
1114,CDISC SEND Terminology,Copies per Microliter,0
1115,CDISC SDTM Laboratory Test Terminology by Name,Antibody; Coccidioides,0
1116,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Prior to Study Entry),0
1117,Clinical Data Interchange Standards Consortium Terminology,Chinchilla<genus>,0
1118,CDISC SDTM Terminology,Volume Measurement,0
1119,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pork calcitonin,0
1120,CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology,C-SSRS Children's Baseline - Wish to be Dead,0
1121,Clinical Data Interchange Standards Consortium Terminology,Every Thirteen Hours,0
1122,UCUM Terminology,MHz,0
1123,Clinical Data Interchange Standards Consortium Terminology,CDISC SEND Nonclinical DART Sex Terminology,0
1124,HL7 Unit of Measure Terminology,Charriere,0
1125,Perinatal Terminology,Complete Maternal Surface of Placenta,0
1126,Clinical Data Interchange Standards Consortium Terminology,EQ-5D-5L - EQ VAS Score,0
1127,CDISC SDTM Microorganism Terminology,Ureaplasma urealyticum,0
1128,CDISC SDTM Terminology,deciliter,0
1129,Older Americans Resource Scale Multidimensional Functional Assessment Questionnaire,Get to Places Out of Walking Distance,0
1130,CDISC Questionnaire VFQ25-Self Administered Format Test Code Terminology,VFQ25-Self Administered Format - Accomplish Less Because of Vision,0
1131,CDISC SEND Terminology,Thigh structure,0
1132,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology,0
1133,US Counties Terminology,"Colbert County, AL",0
1134,FDA Established Names and Unique Ingredient Identifier Codes Terminology,inotuzumab ozogamicin,0
1135,Pediatric Adverse Events Terminology,Psychological Dependence,0
1136,CDISC SDTM Discharge Disposition Terminology,Psychiatric Facility,0
1137,CDISC Questionnaire Terminology,SGRQ Past 3 Months Version - How Long Did Worst Respiratory Attack Last,0
1138,DICOM Terminology,Distance Source to Detector,0
1139,FDA Established Names and Unique Ingredient Identifier Codes Terminology,HYDROXOCOBALAMIN ACETATE,0
1140,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clorgyline,0
1141,ICH Unit of Measure Terminology,Million Colony Forming Units,0
1142,CDISC SEND Terminology,S Wave Amplitude Aggregate,0
1143,CDISC SDTM Terminology,VFQ25-Self Administered Format - Limited in How Long You Can Work Because of Vision,0
1144,NCIt Antineoplastic Agent Terminology,Anti-CEACAM1 Monoclonal Antibody CM-24,0
1145,CDISC SDTM Terminology,DRS - Communication Ability,0
1146,Clinical Data Interchange Standards Consortium Terminology,PANSS - Disturbance of Volition,0
1147,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months),0
1148,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months),0
1149,Pediatric Terminology,Distal Renal Tubular Acidosis,0
1150,Clinical Data Interchange Standards Consortium Terminology,Spongy urethra,0
1151,CDISC SDTM Terminology,Picomole per Liter per Hour,0
1152,NCIt Antineoplastic Agent Terminology,PSA-OP Peptide Vaccine,0
1153,NCIt Antineoplastic Agent Terminology,BL-8040,0
1154,Clinical Data Interchange Standards Consortium Terminology,DRS - Motor Response,0
1155,NCIt Neoplasm Core Terminology,Papillary Meningioma,0
1156,CDISC Questionnaire PHQ Screener Version Test Name Terminology,"PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep",0
1157,CDISC SDTM Anatomical Location Terminology,Condyle of femur,0
1158,FDA Device Problem Code Hierarchy,Pacer Found in Back-Up Mode,0
1159,CDISC SDTM Terminology,Unit per Trillion Red Blood Cells,0
1160,Pediatric Terminology,Non-Cesarean Uterine Surgical Scarring,0
1161,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Femtogram per Milliliter per Microgram per Day,0
1162,US Counties Terminology,"Chariton County, MO",0
1163,CDISC SDTM Holter ECG Test Name Terminology,ECG Technical Quality,0
1164,Clinical Data Interchange Standards Consortium Terminology,Aorticopulmonary Septal Defect,0
1165,CDISC SDTM Terminology,Alpha one fetoprotein measurement,0
1166,CDISC Questionnaire PI v1 Test Name Terminology,PI - Least Pain Intensity For Various Time Periods of Evaluation,0
1167,Clinical Data Interchange Standards Consortium Terminology,PI - Least Pain Intensity For Various Time Periods of Evaluation,0
1168,CDISC SEND Terminology,Cessation of life,0
1169,CDISC SEND Terminology,nanogram,0
1170,CDISC SEND Terminology,Bioavailable testosterone,0
1171,CDISC SDTM Terminology,Cheson CLL 2012 Oncology Response Criteria,0
1172,CDISC SDTM Microorganism Terminology,Porphyromonas somerae,0
1173,CDISC SDTM Terminology,MSQOL-54 - Feel Worn Out,0
1174,CDISC SDTM Terminology,PR - Was There Perceptible Pain Relief,0
1175,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Iodine I-123 ADAM,0
1176,CTRP Terminology,dasatinib,0
1177,FDA Established Names and Unique Ingredient Identifier Codes Terminology,deferiprone,0
1178,Clinical Data Interchange Standards Consortium Terminology,Helicobacter pylori,0
1179,CDISC QRS Terminology,C-SSRS Children's Baseline/Screening - Preparatory Acts or Behaviors Toward Suicide Attempt,0
1180,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A 30 Min Delay Recall Word 9,0
1181,CDISC SEND Terminology,Macaca mulatta,0
1182,Voice handicap index,Clarity of Voice is Unpredictable,0
1183,CDISC SDTM Microbiology Test Code Terminology,Influenza B Antigen Measurement,0
1184,CDISC SEND Biospecimens Terminology,Mesentery,0
1185,CDISC Questionnaire DRS Test Code Terminology,DRS - Toileting,0
1186,FDA Established Names and Unique Ingredient Identifier Codes Terminology,imiglucerase,0
1187,Pediatric Adverse Events Terminology,Vitreous floaters,0
1188,NCIt Antineoplastic Agent Terminology,nitroaspirin,0
1189,NCPDP Quantity Unit of Measure Terminology,Cassette Dosing Unit,0
1190,CDISC SDTM Terminology,Medication Misplaced,0
1191,FACT-G Questionnaire,Family Accepts Illness,0
1192,CDISC SEND Terminology,Papilla of duodenum,0
1193,Newborn Screening Terminology,Galeazzi Test,0
1194,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,AUC Infinity Observed Normalized by Weight,0
1195,US Counties Terminology,"Kandiyohi County, MN",0
1196,Brief Pain Inventory Short Form Questionnaire,Pain at its Worst,0
1197,CDISC CDASH Terminology,Melanesian (ethnic group),0
1198,FDA Established Names and Unique Ingredient Identifier Codes Terminology,deboxamet,0
1199,Clinical Data Interchange Standards Consortium Terminology,Aliquotting,0
1200,Pediatric Terminology,Dracunculiasis,0
1201,CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology,VFQ25-Interviewer Administered Format - Difficulty Reading Ordinary Print in Newspapers,0
1202,CDISC SDTM Terminology,AUC Infinity Predicted Normalized by Body Mass Index,0
1203,CDISC SEND Terminology,Brain natriuretic peptide measurement,0
1204,CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Code Terminology,NCCN-FACT-FPSI 17 Version 2 - I Am Able to Enjoy Life,0
1205,CDISC SDTM Terminology,Anti-Phospholipid IgG Antibody Measurement,0
1206,CDISC Questionnaire UPDRS Test Code Terminology,"UPDRS - Motor Examination: Finger Taps, Left",0
1207,Extremity Manual Dexterity,Reduced Manual Dexterity,0
1208,Clinical Data Interchange Standards Consortium Terminology,Parapoxvirus,0
1209,FDA Established Names and Unique Ingredient Identifier Codes Terminology,privet pollen extract,0
1210,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alitame,0
1211,FDA Established Names and Unique Ingredient Identifier Codes Terminology,everolimus,0
1212,Neonatal Research Network Terminology,electrocardiogram RR interval,0
1213,Clinical Data Interchange Standards Consortium Terminology,Serum or Plasma,0
1214,Clinical Data Interchange Standards Consortium Terminology,Meningoencephalocele,0
1215,CTRP Terminology,Pulmonary Complication,0
1216,NCIt Antineoplastic Agent Terminology,Lyophilized Black Raspberry Saliva Substitute,0
1217,Clinical Data Interchange Standards Consortium Terminology,Ventricular Bigeminy by ECG Finding,0
1218,CDISC SDTM Intervention Model Terminology,Factorial Study,0
1219,CDISC SDTM Microorganism Terminology,Morbillivirus,0
1220,Attitudes and Preferences Questionnaire,Would Avoid Making Decisions About A Medical Test or Treatment if Experts Had Conflicting Opinions,0
1221,CDISC SDTM Terminology,Child-Pugh - Total Score,0
1222,US Counties Terminology,"Humphreys County, TN",0
1223,Clinical Data Interchange Standards Consortium Terminology,Multifocal,0
1224,CDISC SDTM Terminology,Staphylococcus haemolyticus,0
1225,CDISC Questionnaire CCQ 1 Week Version Test Name Terminology,CCQ 1 Week Version - Breathing Problems Limit Strenuous Activity,0
1226,CDISC SDTM Device-In-Use Test Code Terminology,Attenuation Correction,0
1227,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Past 3 Months),0
1228,CDISC SDTM Terminology,UPDRS - Activities of Daily Living: Dressing,0
1229,CTRP Terminology,Stage III Adult Soft Tissue Sarcoma AJCC v7,0
1230,CDISC SEND Terminology,CDISC SDTM Unit of Measure Terminology,0
1231,CDISC SDTM Terminology,Modified RECIST Lencioni Liver Cancer 2010 Oncology Response Criteria,0
1232,NCIt Neoplasm Core Terminology,Junctional nevus,0
1233,Clinical Data Interchange Standards Consortium Terminology,Half,0
1234,CDISC SDTM Terminology,Intermediate Risk,0
1235,CDISC SDTM Terminology,Lee Lung Cancer 2011 Oncology Response Criteria,0
1236,Pediatric Nephrology Terminology,Complex renal cyst,0
1237,Regulated Product Submission Reporting Terminology,Patent Information,0
1238,CDISC Questionnaire FIQR Test Code Terminology,FIQR - Prepare a Homemade Meal,0
1239,CDISC Observation Class Terminology,Original Result or Finding,0
1240,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Lifetime/Recent Version - Description of Interrupted Suicide Attempt,0
1241,FDA Established Names and Unique Ingredient Identifier Codes Terminology,mabuterol,0
1242,CDISC QRS Terminology,CCQ 1 Week Version - Breathing Problems Limit Moderate Activity,0
1243,CDISC SDTM Terminology,CDISC ADAS-Cog - Orientation: Date,0
1244,CDISC QRS Terminology,CDISC ADAS-Cog - Orientation: Date,0
1245,CDISC SEND Terminology,Lumbar Region,0
1246,Pediatric Adverse Events Terminology,"Liver Failure, Acute",0
1247,CDISC Questionnaire UPDRS Test Code Terminology,"UPDRS - Symptomatic Orthostasis: Pulse, Seated",0
1248,CTRP Terminology,Xerostomia,0
1249,CDISC SDTM PK Unit of Measure Gram Weight Terminology,Day Times Femtogram Per Milliliter Per Gram,0
1250,Pediatric Rheumatology Terminology,American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus,0
1251,CDISC SDTM Electrocardiogram Lead Terminology,Superimposition of Multiple Leads,0
1252,CDISC SDTM Terminology,Percent Recovered Infinity Predicted,0
1253,TAPS Tool - Interviewer Version,Use Cocaine or Methamphetamine,0
1254,FDA Established Names and Unique Ingredient Identifier Codes Terminology,morniflumate,0
1255,CDISC SDTM Country Terminology,Cocos (Keeling) Islands,0
1256,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Past 1 Month),0
1257,CTRP Agent Terminology,8-chloro-cyclic adenosine monophosphate,0
1258,Clinical Data Interchange Standards Consortium Terminology,Collagen Type IV Measurement,0
1259,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cupric glycinate,0
1260,NCPDP Strength Form Terminology,Disk Drug Form,0
1261,CDISC SDTM Terminology,In Situ Hybridization,0
1262,CDISC SDTM Microorganism Terminology,Vanrija humicola,0
1263,CDISC SEND Trial Summary Parameter Short Name Terminology,Study Agent CAS Registry Number,0
1264,Extremity Pain question,No Extremity Pain,0
1265,Oral Health Impact Profile,Sometimes,0
1266,CDISC SDTM Pharmaceutical Dosage Form Terminology,Augmented Ointment Dosage Form,0
1267,CDISC SEND Terminology,Invalid ECG Waveforms,0
1268,CDISC Questionnaire AIMS Test Name Terminology,AIMS - Lower Extremities,0
1269,eCTD Promotional Material Type Terminology,MISCELLANEOUS MEDICAL SUPPLY MISCELL. CARTON,0
1270,Clinical Data Interchange Standards Consortium Terminology,B-lymphocyte Crossmatch Measurement,0
1271,CDISC SDTM Laboratory Test Terminology by Code,B-lymphocyte Crossmatch Measurement,0
1272,CDISC SDTM Terminology,Endotracheal Intubation before Percutaneous Coronary Intervention,0
1273,Pediatric Adverse Events Terminology,Coombs test positive,0
1274,US Counties Terminology,"Owen County, KY",0
1275,FDA Individual Case Safety Report Terminology,Dietitian,0
1276,CDISC SDTM Pharmaceutical Dosage Form Terminology,Pastille dose form,0
1277,Regulated Product Submission Reporting Terminology,Label Comprehension Studies,0
1278,FDA Device Problem Code Hierarchy,Intermittent Shock,0
1279,CDISC SDTM Terminology,Millimole per Mole,0
1280,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cefazedone sodium,0
1281,CDISC SEND Terminology,CDISC SEND Death Diagnosis Test Name Terminology,0
1282,CTRP Terminology,Borderline serous tumor of ovary,0
1283,Clinical Data Interchange Standards Consortium Terminology,PCWG Bubley Prostate Cancer 1999 Oncology Response Criteria,0
1284,CDISC SDTM Terminology,Alpha Fetoprotein L2 Measurement,0
1285,CDISC Questionnaire Terminology,NPI - Any Other Behaviors That Make Him/Her Hard to Handle,0
1286,CDISC Variable Terminology,Macroscopic Findings Death Relationship,0
1287,integrated Cancer Repository for Cancer Research,Social Scientists and Related Workers,0
1288,CDISC SDTM Unit of Measure Terminology,Centimeter Per Minute,0
1289,Clinical Data Interchange Standards Consortium Terminology,Tampon Dosage Form,0
1290,CDISC Questionnaire HADS Test Code Terminology,HADS - Total Score Anxiety,0
1291,Stability Container Type Terminology,Packaging Case,0
1292,CDISC SDTM Terminology,Assay of Proinsulin,0
1293,FDA Established Names and Unique Ingredient Identifier Codes Terminology,silver picrate,0
1294,Clinical Data Interchange Standards Consortium Terminology,Not Measured Tumor Identification,0
1295,CDISC Questionnaire Terminology,CDISC ADAS-Cog - Orientation: Time,0
1296,CDISC SDTM Terminology,PCWG Scher Prostate Cancer 2008 Oncology Response Criteria,0
1297,"Geopolitical Entities, Names, and Codes Terminology",Colombia,0
1298,CDISC SDTM Tumor or Lesion Properties Test Name Terminology,Average Metabolic Standard Uptake Value,0
1299,US Counties Terminology,"Jack County, TX",0
1300,CTRP Agent Terminology,tasquinimod,0
1301,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Number of Interrupted Suicide Attempts,0
1302,CDISC SDTM Terminology,NPI - Shout or Curse Angrily,0
1303,CDISC SDTM ECG Finding Terminology,AV Block Second Degree Mobitz Type II by ECG Finding,0
1304,CTRP Terminology,tadalafil,0
1305,CTRP Terminology,Mycosis fungoides/Sezary syndrome NOS,0
1306,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Butanixin,0
1307,Clinical Data Interchange Standards Consortium Terminology,Rat Pars Intermedia Adenoma,0
1308,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Parsley - dietary,0
1309,NCIt Antineoplastic Agent Terminology,Corticorelin Acetate,0
1310,CDISC SDTM Tumor Response Assessment Test Name Terminology,Hematologic Response,0
1311,CDISC SEND Organ Measurement Test Code Terminology,Weight,0
1312,Perinatal Terminology,Fetal heart acceleration,0
1313,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt,0
1314,CDISC Questionnaire Terminology,ADCS-ADL - Pastime: Art,0
1315,Location of Event Occurrence ICSR Terminology,Clinic,0
1316,CDISC QRS Terminology,DRS - Eye Opening,0
1317,NCIt Antineoplastic Agent Terminology,Daporinad,0
1318,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List A Recall 4 Word 7,0
1319,CDISC QRS Terminology,NPS - Describe the Single Type of Pain All Time,0
1320,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tolcyclamide,0
1321,CDISC SDTM Terminology,Rothia <bacteria>,0
1322,Patient Reported Outcomes Version of CTCAE,Worst Severity Past Seven Days Anxiety,0
1323,Clinical Data Interchange Standards Consortium Terminology,Fragmented Parathyroid Hormone Measurement,0
1324,CDISC SDTM Tumor Response Assessment Test Code Terminology,Metabolic Response,0
1325,CDISC SDTM Unit of Measure Terminology,Milliliter per Day,0
1326,Clinical Data Interchange Standards Consortium Terminology,Beta-Hydroxybutyrate Measurement,0
1327,CDISC SEND Terminology,Phosphate to Creatinine Ratio Measurement,0
1328,Neonatal Research Network Terminology,Prune Belly Syndrome,0
1329,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Leucanthemum vulgare pollen,0
1330,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ZOFENOPRIL CALCIUM,0
1331,FDA Established Names and Unique Ingredient Identifier Codes Terminology,didrovaltrate,0
1332,CDISC SEND Terminology,Microscopic Findings Domain,0
1333,CTRP Agent Terminology,Polymyxin B,0
1334,Neonatal Research Network Terminology,Waardenburg Syndrome,0
1335,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cyclobenzaprine hydrochloride,0
1336,CDISC SDTM Terminology,C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Date,0
1337,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Date,0
1338,UCUM Terminology,Yocto,0
1339,FDA Device Component Code Hierarchy,Hinge Device,0
1340,CDISC SDTM Unit of Measure Terminology,Million per Gram,0
1341,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Alphacypermethrin,0
1342,Clinical Data Interchange Standards Consortium Terminology,Mean Residence Time to Last Nonzero Concentration by Extravascular Dose,0
1343,CDISC SDTM Biospecimen Events Dictionary Derived Term Terminology,sample fixation,0
1344,CDISC QRS Terminology,C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage,0
1345,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage,0
1346,Clinical Data Interchange Standards Consortium Terminology,SGRQ-C - Feel Breathless Walking Around the House,0
1347,CDISC Questionnaire Terminology,Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire,0
1348,Clinical Data Interchange Standards Consortium Terminology,Experimental Organism Malignant Mixed Sex Cord Stromal Tumor,0
1349,CTRP Agent Terminology,Berubicin Hydrochloride,0
1350,Pediatric Terminology,Peeling of skin,0
1351,CDISC SDTM Laboratory Test Terminology by Name,Liver Kidney Microsomal Type 1 Antibody Measurement,0
1352,FDA Device Component Code Hierarchy,Servo Device,0
1353,CTRP Terminology,Icotinib Hydrochloride,0
1354,National Health Interview Survey,Random,0
1355,CDISC Questionnaire Terminology,FAMS - Trouble Concentrating,0
1356,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology,"C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime)",0
1357,FDA Established Names and Unique Ingredient Identifier Codes Terminology,magaldrate,0
1358,ICH Unit of Measure Terminology,kBq,0
1359,Pediatric Terminology,Anti-dsDNA Antibody,0
1360,CDISC Questionnaire MHIS-NACC Test Name Terminology,MHIS-NACC - Somatic Complaints,0
1361,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pentopril,0
1362,CDISC QRS Terminology,ADNI AVLT - List A Recognition Total,0
1363,CDISC SDTM ECG Test Name Terminology,Median Ventricular Rate by Electrocardiogram,0
1364,Australia-Modified Karnofsky Performance Scale,Karnofsky Performance Status 60,0
1365,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alniditan,0
1366,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire GDS-SF Test Name Terminology,0
1367,CDISC SDTM Laboratory Test Terminology by Code,Glutamic Acid Decarboxylase 2 Antibody Measurement,0
1368,FDA Device Component Code Hierarchy,Magnifier Device,0
1369,CDISC SEND Terminology,Malrotated,0
1370,CDISC SDTM Coronary Artery Disease Presentation Terminology,Non-ST Elevation Myocardial Infarction by ECG Finding,0
1371,CDISC Questionnaire BDI Test Code Terminology,BDI - Magnitude of Effort,0
1372,CTRP Terminology,Duvelisib,0
1373,Pediatric Terminology,Coronary Anomaly,0
1374,Pediatric Terminology,pustule,0
1375,Clinical Data Interchange Standards Consortium Terminology,SGRQ-C - Not in Control of Respiratory Problems,0
1376,PROMIS Pediatric Short Form - Pain Interference,Hard to Stay Standing When in Pain,0
1377,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bromfenac sodium,0
1378,CDISC QRS Terminology,IVIS - Identify House Numbers or Street Signs,0
1379,CTRP Terminology,STAT Inhibitor OPB-111077,0
1380,Clinical Data Interchange Standards Consortium Terminology,Free Carnitine Measurement,0
1381,Clinical Data Interchange Standards Consortium Terminology,Buccal pouch,0
1382,Nurses' Health Study II Activity and Inactivity Questionnaire,Zero Activity Time,0
1383,CDISC SDTM Terminology,CDISC ADAS-Cog - Word Recognition: Word 13,0
1384,CDISC SEND Biospecimens Terminology,Structure of radial nerve,0
1385,CDISC Questionnaire TDI Test Name Terminology,TDI - Change in Magnitude of Task,0
1386,NCIt Antineoplastic Agent Terminology,Amsacrine,0
1387,NCIt Neoplasm Core Terminology,Small Lymphocytic Lymphoma,0
1388,CTRP Agent Terminology,Phellodendron amurense bark extract,0
1389,FDA Established Names and Unique Ingredient Identifier Codes Terminology,buclizine,0
1390,CDISC SDTM Laboratory Test Terminology by Code,Phosphorylated Tau Protein Measurement,0
1391,CDISC SEND Non-Neoplastic Finding Type Terminology,Spermatocele,0
1392,Pediatric Terminology,Gastroesophageal reflux disease,0
1393,US Counties Terminology,"Simpson County, MS",0
1394,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Antienite,0
1395,FDA Device Component Code Hierarchy,Computer Hardware Device,0
1396,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aurothioglucose,0
1397,CDISC QRS Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Lifetime),0
1398,CDISC SEND Terminology,Bronchial lymph node,0
1399,CDISC SDTM Terminology,Picomole per Liter per Microgram,0
1400,FDA Established Names and Unique Ingredient Identifier Codes Terminology,olanzapine pamoate,0
1401,CDISC SDTM Terminology,Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000,0
1402,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Lifetime),0
1403,CDISC SDTM Terminology,NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect,0
1404,CDISC QRS Terminology,AQ20 - Cough Often During the Day,0
1405,CDISC SDTM Terminology,CHART-SF Interview Version - Friends Contacted per Month,0
1406,Clinical Data Interchange Standards Consortium Terminology,Occult Blood Measurement,0
1407,CDISC Questionnaire FOSI Test Code Terminology,FOSI - I Have Cramps in My Stomach Area,0
1408,CDISC SDTM Terminology,JC Virus Antibody Measurement,0
1409,CDISC Questionnaire Terminology,FACT-G Version 4 - I Have Nausea,0
1410,CDISC SEND Tumor Findings Results Terminology,"Leydig cell tumor, benign",0
1411,CDISC SEND Terminology,Thromboxane B2 measurement,0
1412,CDISC QRS Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Lifetime),0
1413,Pediatric Terminology,Ear discharge,0
1414,NCIt Neoplasm Core Terminology,Gallbladder adenoma,0
1415,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Peplomycin Sulfate,0
1416,CDISC SEND Terminology,Amyloid Beta Precursor Protein Measurement,0
1417,Clinical Data Interchange Standards Consortium Terminology,MDS-UPDRS - Anxious Mood,0
1418,CDISC SDTM Terminology,Powder for prolonged-release suspension for injection,0
1419,NCIt Antineoplastic Agent Terminology,Pirarubicin,0
1420,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Code Terminology,RAND-36 - Pain Interfere With Normal Work,0
1421,Clinical Data Interchange Standards Consortium Terminology,RAND-36 - Pain Interfere With Normal Work,0
1422,Clinical Data Interchange Standards Consortium Terminology,Clostridium tyrobutyricum,0
1423,SPL Drug Route of Administration Terminology,Nasal Route of Drug Administration,0
1424,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ammonia,0
1425,Clinical Data Interchange Standards Consortium Terminology,Major Axis Cross-sectional Diameter at End Ventricular Systole,0
1426,Clinical Data Interchange Standards Consortium Terminology,FACT-G Version 4 - I have pain,0
1427,MD Anderson Symptom Inventory - Head and Neck,Mouth or Throat Sores at its Worst,0
1428,Pediatric Rheumatology Terminology,Undifferentiated Juvenile Idiopathic Arthritis,0
1429,CDISC SDTM Skin Response Test Code Terminology,Blistering Indicator,0
1430,CDISC SDTM Ophthalmic Exam Test Code Terminology,Astigmatism Axis,0
1431,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Phenformin,0
1432,Pediatric Terminology,Pulmonary vein obstruction,0
1433,Clinical Data Interchange Standards Consortium Terminology,Enzyme-Linked Immunosorbent Assay,0
1434,NCIt Antineoplastic Agent Terminology,At 211 Monoclonal Antibody 81C6,0
1435,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sodium thiosalicylate,0
1436,CTRP Terminology,Mesna,0
1437,CTRP Agent Terminology,Nelfinavir Mesylate,0
1438,FDA Established Names and Unique Ingredient Identifier Codes Terminology,betamethasone dipropionate,0
1439,CDISC Questionnaire Terminology,C-SSRS Screening - Deterrents to Most Severe Ideation,0
1440,CDISC SDTM Terminology,Piedraia hortae,0
1441,CDISC QRS Terminology,NPS - Describe the Background Pain,0
1442,NCIt Neoplasm Core Terminology,"Sarcoma, Myeloid",0
1443,FDA Established Names and Unique Ingredient Identifier Codes Terminology,calfactant,0
1444,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Code Terminology,C-SSRS Already Enrolled Subjects - Most Severe Ideation (Since Study Start),0
1445,CDISC QRS Terminology,BPRS-A - Anxiety,0
1446,CTRP Agent Terminology,Protein Kinase Inhibitors,0
1447,CDISC Questionnaire GDS Test Code Terminology,GDS - Hopeful About Future,0
1448,DICOM Terminology,Person Observer Role in Organization,0
1449,CDISC SDTM Terminology,HAMA - Gastrointestinal Symptoms,0
1450,Clinical Data Interchange Standards Consortium Terminology,Child-Pugh - Ascites,0
1451,CDISC Questionnaire Terminology,NPS - Describe the Flare-up Pain,0
1452,CDISC SDTM Terminology,Segmented Granulocyte to Total Cell Ratio Measurement,0
1453,US Counties Terminology,"Hamilton County, FL",0
1454,CDISC Questionnaire Terminology,SGRQ-C - Wheezing Worse In the Morning,0
1455,CTRP Terminology,Stage IVC Major Salivary Gland Cancer AJCC v7,0
1456,US Counties Terminology,"Spink County, SD",0
1457,CDISC Questionnaire PHQ Screener Version Test Code Terminology,PHQ Screener Version - Anxiety Attacks Come Suddenly,0
1458,CDISC SDTM Terminology,Tip of appendix,0
1459,CDISC Observation Class Terminology,Dose Rate,0
1460,CDISC SDTM Terminology,Immature Leukocyte Count,0
1461,CDISC Questionnaire Short-Form MPQ-2 Test Code Terminology,SF-MPQ-2 - Numbness,0
1462,CDISC SDTM Unit of Measure Terminology,mEq/L,0
1463,CTRP Terminology,Pinometostat,0
1464,CDISC QRS Terminology,BPI Short Form - Pain Interfered with Mood,0
1465,Modified Barium Swallow Impairment Profile,Pharyngeal Stripping Wave Absent,0
1466,eCTD Application Type Terminology,Emergency Use Authorization,0
1467,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lacidipine,0
1468,CDISC SEND Terminology,Single Beat P Wave Amplitude,0
1469,CTRP Agent Terminology,Tipapkinogene sovacivec,0
1470,Stability Product Form Terminology,Extended Release Core Dosage Form,0
1471,National Health Interview Survey,Statistical Estimation,0
1472,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mivotilate,0
1473,CDISC QRS Terminology,SGRQ-C - Short of Breath When Bend Over,0
1474,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Romergoline,0
1475,CDISC QRS Terminology,MNSI - Right Foot Infection,0
1476,Brief Fatigue Inventory,Fatigue Right Now,0
1477,CDISC Questionnaire Terminology,BPRS-A - Guilt Feelings,0
1478,European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30,Trouble Sleeping (question),0
1479,Neonatal Research Network Terminology,Port-Wine Stain,0
1480,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Iodecimol,0
1481,Clinical Data Interchange Standards Consortium Terminology,HLA-A23 Antibody Measurement,0
1482,Clinical Data Interchange Standards Consortium Terminology,Fatty Acid Binding Protein 1 Measurement,0
1483,CDISC QRS Terminology,BPI Short Form - Pain Interfered with Normal Work,0
1484,Pediatric Terminology,Sleep Paralysis,0
1485,Medical Research Council Breathlessness Score,Have to Walk Slower Than Most People on Level Ground,0
1486,CDISC SEND Terminology,Benign Ovarian Thecoma,0
1487,CDISC SDTM Graft Type Terminology,Cadaveric Arterial Graft,0
1488,CDISC SDTM Laboratory Test Terminology by Code,Osteocalcin Assay,0
1489,CDISC SDTM Laboratory Test Terminology by Name,Osteocalcin Assay,0
1490,Pediatric Terminology,Bulimia Nervosa,0
1491,Clinical Data Interchange Standards Consortium Terminology,Inclusion,0
1492,US Counties Terminology,"Josephine County, OR",0
1493,FDA Established Names and Unique Ingredient Identifier Codes Terminology,loreclezole,0
1494,Dose Denominator Qualifier ICSR Terminology,Animal Enclosure,0
1495,CDISC QRS Terminology,MNSI - Right Foot Other Abnormal Specify,0
1496,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology,C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Since Study Start),0
1497,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Mucosa-Associated Lymphoid Tissue Lymphoma,0
1498,CTRP Terminology,PI3K-gamma Inhibitor IPI-549,0
1499,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Citrus nobilis,0
1500,CDISC Questionnaire RPQ Test Name Terminology,RPQ - Restlessness,0
1501,NCIt Neoplasm Core Terminology,Grade 1 Colorectal Adenocarcinoma,0
1502,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hexocyclium methylsulfate,0
1503,CDISC Clinical Classification Terminology,JFK Coma Recovery Scale-Revised Clinical Classification,0
1504,Clinical Data Interchange Standards Consortium Terminology,Yersinia intermedia,0
1505,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Excretion Rate From T1 to T2 Normalized by Dose,0
1506,FDA Device Problem Code Hierarchy,Activation Difficult or Delayed,0
1507,NCIt Antineoplastic Agent Terminology,Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062,0
1508,CDISC SEND Terminology,Safety Pharmacology,0
1509,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fertirelin acetate,0
1510,CDISC QRS Terminology,ADNI AVLT - List A Recall 2 Word 1,0
1511,CDISC QRS Terminology,OAB-q - Carefully Plan Your Commute,0
1512,Clinical Data Interchange Standards Consortium Terminology,Mayo-Portland Adaptability Inventory-4 Questionnaire,0
1513,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Intriptyline Hydrochloride,0
1514,CTRP Terminology,IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine,0
1515,CDISC QRS Terminology,VFQ25-Interviewer Administered Format - Never Driven or Given Up Driving,0
1516,CDISC SDTM Terminology,HLA-A Mismatch Count,0
1517,CDISC SDTM Terminology,Toxic Granulation Measurement,0
1518,NCI CTEP Simplified Disease Classification Terminology,Renal Cell Carcinoma,0
1519,CTRP Terminology,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,0
1520,Clinical Data Interchange Standards Consortium Terminology,Tumor status,0
1521,Clinical Data Interchange Standards Consortium Terminology,percent positive cells,0
1522,CDISC Questionnaire RPQ Test Name Terminology,RPQ - Any Other Difficulties 1 (number),0
1523,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mannitol hexanitrate,0
1524,CDISC SDTM Terminology,ADNI AVLT - List A Recall 2 Word 4,0
1525,Clinical Data Interchange Standards Consortium Terminology,Country of Argentina,0
1526,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clonazepam,0
1527,CDISC QRS Terminology,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology,0
1528,CDISC SDTM Terminology,VFQ25-Interviewer Administered Format - Main Reason You Gave Up Driving,0
1529,CDISC SDTM Terminology,Passive Case Search,0
1530,FDA Device Component Code Hierarchy,Washer Device,0
1531,FDA Established Names and Unique Ingredient Identifier Codes Terminology,estrapronicate,0
1532,Pediatric Terminology,Membranous glomerulonephritis,0
1533,FDA Device Component Code Hierarchy,pump (device),0
1534,HL7 Unit of Measure Terminology,Gunter's Chain British,0
1535,Clinical Data Interchange Standards Consortium Terminology,Structure of right cusp of aortic valve,0
1536,CDISC SDTM Terminology,C-SSRS Children's Since Last Visit - Describe Most Severe Ideation,0
1537,FDA Established Names and Unique Ingredient Identifier Codes Terminology,motesanib,0
1538,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Hour Times Milligram per Milliliter per Kilogram per Meter Squared,0
1539,SPL Pharmaceutical Dosage Form Terminology,Powder Aerosol Dosage Form,0
1540,CDISC Questionnaire AQ20 Test Name Terminology,AQ20 - Chest Trouble Make You Feel Impatient,0
1541,CDISC SDTM Microorganism Terminology,Babesia,0
1542,NCIt Antineoplastic Agent Terminology,Xenogeneic Tyrosinase DNA Vaccine,0
1543,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cariporide,0
1544,"University of Washington Quality of Life Scale, Version 4",Have Too Little Saliva,0
1545,CDISC Variable Terminology,Cardiovascular System Findings Time Point Reference,0
1546,Clinical Data Interchange Standards Consortium Terminology,Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire,0
1547,Clinical Data Interchange Standards Consortium Terminology,Atopobium minutum,0
1548,CDISC SEND Biospecimens Terminology,Brain Stem,0
1549,Adult Hope Scale,Somewhat True,0
1550,CDISC QRS Terminology,DAD - Sub-Total Planning and Organization,0
1551,CTRP Agent Terminology,Tetrodotoxin,0
1552,Clinical Data Interchange Standards Consortium Terminology,"Melanoma, Amelanotic",0
1553,UCUM Terminology,Enzyme Unit per Milliliter,0
1554,SPL REMS Requirement Terminology,Complete Patient Form,0
1555,Pediatric Infectious Disease Terminology,Tuberculosis,0
1556,Pediatric Terminology,Tuberculosis,0
1557,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tibenzate,0
1558,CDISC SDTM Terminology,AQ20 - Feel Drained After a Cold Because of Chest Trouble,0
1559,CTRP Agent Terminology,liothyronine sodium,0
1560,CTRP Terminology,Solitary Pulmonary Nodule,0
1561,CDISC SDTM Microorganism Terminology,Avibacterium paragallinarum,0
1562,CDISC SDTM Country Terminology,Fiji,0
1563,CDISC SDTM Method Terminology,Multiple gated acquisition scanning,0
1564,CTRP Agent Terminology,pTVG-HP Plasmid DNA Vaccine,0
1565,Clinical Data Interchange Standards Consortium Terminology,Percent Recovered from T1 to T2 Normalized by Weight,0
1566,CDISC SDTM ECG Finding Terminology,Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding,0
1567,CTRP Agent Terminology,WT1 Protein-derived Peptide Vaccine DSP-7888,0
1568,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"L1 protein, Human papillomavirus type 6 Vaccine",0
1569,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Already Enrolled Subjects - Description of Aborted Suicide Attempt,0
1570,CDISC CDASH Terminology,CDISC CDASH Concomitant Medication Dose Units Terminology,0
1571,CDISC SDTM Microorganism Terminology,Ancylostoma caninum,0
1572,CDISC SDTM Anatomical Location Terminology,Left Main Coronary Artery Bifurcation,0
1573,SPL Package Type Terminology,Dose Pack,0
1574,FDA Established Names and Unique Ingredient Identifier Codes Terminology,minamestane,0
1575,Clinical Data Interchange Standards Consortium Terminology,Tumorigenicity,0
1576,CTRP Disease Terminology,Nasopharyngeal Differentiated Carcinoma,0
1577,US Counties Terminology,"Chaffee County, CO",0
1578,CDISC SDTM Tumor or Lesion Properties Test Result Terminology,Pathologic,0
1579,CDISC SEND Terminology,Accidental death,0
1580,CDISC SDTM Terminology,SOWS Subjective (Handelsman) - I Have Hot Flashes,0
1581,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Isosulpride,0
1582,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Potassium Iodide,0
1583,Pediatric Terminology,Brain Death,0
1584,CDISC SDTM Species Terminology,Tick-Borne Encephalitis Virus,0
1585,Patient Problem Codes FDA CDRH,Hypoxia,0
1586,CDISC SEND Terminology,Ulcer,0
1587,Pediatric Terminology,Fluid overload,0
1588,"Self-Report of Personality, College Version",Relations with Parents Scale,0
1589,ICH Unit of Measure Terminology,Becquerel per Milliliter,0
1590,US Counties Terminology,"Richardson County, NE",0
1591,CDISC SEND Terminology,Kidney Injury Molecule-1 Measurement,0
1592,Neonatal Research Network Terminology,Hemolytic disease of fetus OR newborn due to ABO immunization,0
1593,CDISC Questionnaire Category Terminology,Craig Handicap Assessment and Reporting Technique-Short Form Interview Version Questionnaire,0
1594,Quality of Life Questionnaire - Testicular Cancer 26,Concerned about Ability to Have Children,0
1595,CDISC SEND Terminology,Alternate Identifier,0
1596,Pediatric Terminology,Kernicterus,0
1597,Pediatric Nephrology Terminology,"Polycystic Kidney, Autosomal Dominant",0
1598,CTRP Terminology,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,0
1599,CDISC SEND Terminology,Skin of neck,0
1600,CDISC Questionnaire FIQR Test Name Terminology,FIQR - Tenderness to Touch,0
1601,US Counties Terminology,"Orange County, VT",0
1602,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Already Enrolled Subjects - Description of Preparatory Acts or Behaviors Toward Suicide Attempt,0
1603,US Counties Terminology,"Worth County, IA",0
1604,CDISC SDTM Terminology,Left Atrioventricular Artery,0
1605,FDA eCTD Terminology,Telephone Number Type,0
1606,CDISC Questionnaire ADAS-Cog CDISC Version Test Name Terminology,CDISC ADAS-Cog - Word Recognition: Word 7,0
1607,NCIt Antineoplastic Agent Terminology,iNOS Dimerization Inhibitor ASP9853,0
1608,CDISC SEND Trial Summary Parameter Long Name Terminology,Alternate Study Identifier,0
1609,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Talosalate,0
1610,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Octinoxate,0
1611,US Counties Terminology,"Forsyth County, GA",0
1612,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - Suicidal Behavior (Prior to Study Entry),0
1613,US Counties Terminology,"Chittenden County, VT",0
1614,CDISC SDTM Terminology,Hour Times Femtogram per Milliliter per Kilogram per Meter Squared,0
1615,Clinical Data Interchange Standards Consortium Terminology,Craniopharyngioma,0
1616,FDA Established Names and Unique Ingredient Identifier Codes Terminology,CORN BRAN,0
1617,Pediatric Terminology,Inflammatory Bowel Diseases,0
1618,Clinical Data Interchange Standards Consortium Terminology,Aortic Valve Regurgitant Jet Width,0
1619,CDISC SDTM Terminology,Mole per Liter per Microgram per Kilogram per Day,0
1620,Clinical Data Interchange Standards Consortium Terminology,Tryptase measurement,0
1621,FDA Established Names and Unique Ingredient Identifier Codes Terminology,belinostat,0
1622,CTRP Agent Terminology,belinostat,0
1623,CDISC SDTM Terminology,Protein S measurement,0
1624,Clinical Data Interchange Standards Consortium Terminology,Commissure of the Lip,0
1625,Clinical Data Interchange Standards Consortium Terminology,Lingula of left lung,0
1626,CDISC SEND Terminology,Proximal Interphalangeal Joint 3 of the Hand,0
1627,US Counties Terminology,"Lapeer County, MI",0
1628,Clinical Data Interchange Standards Consortium Terminology,Immunoglobulin G Subclass 4 Measurement,0
1629,Clinical Data Interchange Standards Consortium Terminology,CRQ-SAS First Administration Version - Felt Discouraged or Down,0
1630,Clinical Data Interchange Standards Consortium Terminology,NPI - Delusions Severity,0
1631,CDISC SDTM Terminology,Pharmacological Class of Investigational Therapy,0
1632,Modified Barium Swallow Impairment Profile,Partial Distension or Partial Duration of Pharyngoesophageal Segment Opening During Swallowing,0
1633,Clinical Data Interchange Standards Consortium Terminology,Candida pulcherrima,0
1634,CDISC Questionnaire Terminology,GOSE - Independence Outside the Home: Able to Shop Without Assistance,0
1635,US Counties Terminology,"Wyandot County, OH",0
1636,CDISC SDTM Terminology,Retrocrural lymph node,0
1637,CTRP Agent Terminology,Polyvalent Antigen-KLH Conjugate Vaccine,0
1638,Pediatric Nephrology Terminology,Nephrotic Syndrome - Frequently Relapsing,0
1639,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Description of Usual Performance of Eating,0
1640,CDISC SDTM Terminology,RDQ - Get Dressed With Help,0
1641,FDA Individual Case Safety Report Terminology,Product Problem,0
1642,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Cilazapril, Anhydrous",0
1643,CDISC SEND Fetal Pathology Findings Result Terminology,Muscular ventricular septum defect,0
1644,CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology,Stable angina,0
1645,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rubella Virus Vaccine Live (Wistar RA 27-3 Strain),0
1646,CDISC SDTM Terminology,"C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Some Intent to Act, without Specific Plan",0
1647,Clinical Data Interchange Standards Consortium Terminology,West Haven Hepatic Encephalopathy Grade 2,0
1648,CTRP Terminology,Childhood Soft Tissue Sarcoma,0
1649,Clinical Data Interchange Standards Consortium Terminology,NPI - Hallucinations Frequency,0
1650,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dehydrocholic Acid,0
1651,CDISC Functional Test ADNI AVLT Test Code Terminology,ADNI AVLT - List A Recall 1 Word 15,0
1652,Patient Problem Codes FDA CDRH,"Shock, Cardiogenic",0
1653,CDISC Questionnaire EPIC-CP Test Code Terminology,EPIC-CP - Sexual Symptom Score,0
1654,CTRP Terminology,Small Intestinal Lymphoma,0
1655,CDISC Questionnaire MNSI Test Code Terminology,MNSI - Legs Hurt When Walking,0
1656,CDISC SDTM Method Terminology,Enzyme Immunoassay,0
1657,CDISC Questionnaire Terminology,ADCS-ADL Severe Dementia - Alone Away From Home for Fifteen Minutes or Longer,0
1658,Clinical Data Interchange Standards Consortium Terminology,Expanded DRS-PI Survivor Version - Understand How to Get Dressed,0
1659,CDISC SEND Terminology,Hour Times Picogram per Milliliter per Kilogram,0
1660,CDISC Questionnaire Terminology,EPIC-CP - Vitality/Hormonal Symptom Score,0
1661,CDISC SEND Terminology,Endogenous Thrombin Potential Lag Time Measurement,0
1662,Clinical Data Interchange Standards Consortium Terminology,millimeter,0
1663,GAIA Terminology,Pediatric failure to thrive,0
1664,Clinical Data Interchange Standards Consortium Terminology,Minute Times Nanomole per Liter per Meter Squared,0
1665,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Minute Times Nanomole per Liter per Meter Squared,0
1666,NCIt Antineoplastic Agent Terminology,Camsirubicin,0
1667,CDISC Variable Terminology,Procedure Route of Administration,0
1668,CDISC SDTM Laboratory Test Terminology by Code,Oxygen saturation measurement,0
1669,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nabalus serpentarius,0
1670,CDISC SDTM Terminology,CDISC Questionnaire UPDRS Test Code Terminology,0
1671,Pediatric Adverse Events Terminology,Hallucinations,0
1672,Operator of Medical Device ICSR Terminology,Respiratory therapist,0
1673,CDISC SDTM Terminology,Repetition Time,0
1674,Clinical Data Interchange Standards Consortium Terminology,Clostridium difficile (bacteria),0
1675,FDA Device Component Code Hierarchy,Socket Adapter Device,0
1676,CDISC SEND Terminology,Kilogram,0
1677,Clinical Data Interchange Standards Consortium Terminology,Flare Size,0
1678,Newborn Screening Terminology,Epidural Anesthesia,0
1679,Clinical Data Interchange Standards Consortium Terminology,Age at First Treatment,0
1680,Pediatric Terminology,Hyperalgesia,0
1681,NCIt Neoplasm Core Terminology,Borderline Breast Phyllodes Tumor,0
1682,NCI CTEP Simplified Disease Classification Terminology,NCI CTEP SDC Salivary Gland Cancer Sub-Category Terminology,0
1683,CTRP Agent Terminology,Diflunisal,0
1684,Decisional Conflict Scale,Clear About Which Benefits Matter Most,0
1685,CTRP Terminology,Adult T-cell lymphoma/leukemia stage II,0
1686,Clinical Data Interchange Standards Consortium Terminology,Initial Volume of Distribution Normalized by Body Mass Index,0
1687,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Picogram per Milliliter per Meter Squared,0
1688,FACT-BMT Questionnaire,Have Bowel Trouble,0
1689,CDISC SEND Fetal Pathology Findings Result Terminology,Ablepharon,0
1690,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,IU/min,0
1691,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Anazocine,0
1692,CTRP Terminology,boswellia preparation,0
1693,CDISC SDTM Microorganism Terminology,Myroides odoratus,0
1694,CDISC SDTM Species Terminology,Myroides odoratus,0
1695,CDISC SEND Fetal Pathology Findings Result Terminology,Hemorrhage,0
1696,CDISC SDTM ECG Test Name Terminology,Sinus Node Rhythm and Arrhythmia ECG Assessment,0
1697,CDISC Questionnaire Expanded DRS-PI Survivor Version Test Name Terminology,Expanded DRS-PI Survivor Version - Require Special Aids or Equipment,0
1698,CDISC QRS Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Number of Interrupted Suicide Attempts,0
1699,CDISC Questionnaire Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Past 3 Months),0
1700,CDISC SDTM Respiratory Test Name Terminology,Forced Expiratory Volume in 1 Second Reversibility,0
1701,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"cinnamon oil, leaf",0
1702,US Counties Terminology,"Richland County, OH",0
1703,CDISC SEND Tumor Findings Results Terminology,Experimental Organism Benign Basalioma,0
1704,Clinical Data Interchange Standards Consortium Terminology,Third lumbar vertebra,0
1705,CTRP Agent Terminology,perillyl alcohol,0
1706,CDISC Questionnaire NPI Test Name Terminology,NPI - Elation/Euphoria FxS Score,0
1707,Clinical Data Interchange Standards Consortium Terminology,"C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan",0
1708,FDA eManufacturing Terminology,Coating of Device with Immunologic Reagents,0
1709,FDA Device Problem Code Hierarchy,Charging Problem,0
1710,CDISC Questionnaire Terminology,Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Mild Cognitive Impairment Questionnaire,0
1711,US Counties Terminology,"Greene County, AL",0
1712,CDISC Questionnaire HAQ-DI With VAS Test Code Terminology,HAQ-DI With VAS - Able to Take Tub Bath,0
1713,CTRP Terminology,Polyethylene Glycol Hydrogel,0
1714,CDISC Questionnaire Terminology,NPI - Apathy/Indifference FxS Score,0
1715,Memorial Symptom Assessment Scale,Usual Severity Weight Loss,0
1716,CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Code Terminology,NCCN-FACT FOSI-18 Version 2 - Worry My Condition Will Get Worse,0
1717,CDISC SEND Terminology,Renal lymph node,0
1718,CDISC SEND Terminology,Pharmacokinetics: Drug Interactions,0
1719,Pediatric Terminology,Thrombus of right atrium,0
1720,NCIt Antineoplastic Agent Terminology,ABT-767,0
1721,CDISC QRS Terminology,"NCCN-FACT FBLSI-18 Version 2 - Able to Have, Maintain Erection",0
1722,NCIt Antineoplastic Agent Terminology,binetrakin,0
1723,CDISC SEND Terminology,Nucleated red blood cell count procedure,0
1724,CDISC SDTM Laboratory Test Terminology by Name,Phosphate Clearance Measurement,0
1725,CDISC SDTM Terminology,Failure to Meet Randomization Criteria,0
1726,CDISC Questionnaire Terminology,NPI - Disinhibition FxS Score,0
1727,CDISC Variable Terminology,Start Date and Time of Procedure,0
1728,CDISC SDTM Country Terminology,Heard Island and McDonald Islands,0
1729,"Geopolitical Entities, Names, and Codes Terminology",Heard Island and McDonald Islands,0
1730,CDISC Variable Terminology,Disabling Adverse Event,0
1731,CDISC SDTM Terminology,High-priority Tuberculosis Subject,0
1732,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bryonia dioica,0
1733,CDISC SDTM Cardiovascular Test Name Terminology,Interpretation Process,0
1734,CDISC SEND Terminology,Million RNA Copies per Milliliter,0
1735,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Past 3 Months),0
1736,CDISC SDTM Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Past 3 Months),0
1737,Clinical Data Interchange Standards Consortium Terminology,Lysosomal Acid Lipase Measurement,0
1738,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Procainamide,0
1739,CTRP Agent Terminology,Recombinant TNF-Related Apoptosis-Inducing Ligand,0
1740,FACT-Cognitive Function,Cognitive Problems Have Interfered with Ability to Work,0
1741,CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology,SGRQ Past 3 Months Version - Walking Up a Flight of Stairs,0
1742,CDISC SDTM Cardiovascular Test Name Terminology,Systolic Anterior Motion Indicator,0
1743,CDISC SDTM Cardiovascular Test Code Terminology,Systolic Anterior Motion Indicator,0
1744,Clinical Data Interchange Standards Consortium Terminology,Myeloblast to Total Cell Ratio Measurement,0
1745,FDA Established Names and Unique Ingredient Identifier Codes Terminology,isobutane,0
1746,CDISC SDTM Terminology,C-SSRS Children's Baseline - Describe Most Severe Ideation,0
1747,US Counties Terminology,"Toa Baja Municipio, PR",0
1748,Clinical Data Interchange Standards Consortium Terminology,Milliliter per Milligram per Day,0
1749,CDISC SEND Terminology,blood phenylalanine measurement by Guthrie microbiologic assay,0
1750,Pediatric Adverse Events Terminology,Intrapartum Stillbirth,0
1751,CDISC Questionnaire GDS Test Code Terminology,GDS - More Memory Problems Than Most,0
1752,Pediatric Adverse Events Terminology,Neurologic Deficits,0
1753,CDISC Questionnaire Terminology,SOAPP-R - How Often Counted Pain Pills,0
1754,CDISC SEND Biospecimens Terminology,Bone structure of tibia,0
1755,CDISC SDTM Terminology,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Name Terminology,0
1756,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Digoxin,0
1757,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Guaisteine,0
1758,US Counties Terminology,"Bennington County, VT",0
1759,CDISC SDTM Laboratory Test Terminology by Code,Melatonin Measurement,0
1760,US Counties Terminology,"Litchfield County, CT",0
1761,CDISC SDTM Anatomical Location Terminology,Oropharyngeal,0
1762,CDISC SDTM Cardiovascular Test Name Terminology,Cross-sectional Thickness at End Ventricular Diastole,0
1763,CDISC SEND Terminology,Glucagon measurement,0
1764,CDISC SDTM Terminology,Heinz-Ehrlich Body Measurement,0
1765,CDISC Variable Terminology,Respiratory System Findings Numeric Result in Standard Unit,0
1766,SPL Marketing Category Terminology,Marketed under Over-the-Counter Drug Product Not Final Monograph,0
1767,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Toliodium,0
1768,Pediatric Terminology,Paronychial Inflammation,0
1769,FDA Established Names and Unique Ingredient Identifier Codes Terminology,mozavaptan,0
1770,CDISC SDTM Procedure Terminology,Pericardiostomy,0
1771,Perceived stress scale,How Often Felt Difficulties too High to Overcome in the Last Month,0
1772,CDISC Clinical Classification PANSS Test Name Terminology,PANSS - Somatic Concern,0
1773,CDISC SDTM Terminology,New Loss of Viable Myocardium by Non-invasive Imaging Technique,0
1774,CTRP Terminology,Iodine I 124 Phospholipid Ether Analogue CLR1404,0
1775,CDISC SEND Terminology,Rhabdomyoma,0
1776,US Counties Terminology,"Hatillo Municipio, PR",0
1777,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Amylose,0
1778,CDISC SEND Study Type Terminology,Respiratory Pharmacology,0
1779,CDISC SDTM Terminology,OAB-q - Feel Like There is Something Wrong with You,0
1780,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cronidipine,0
1781,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Econazole,0
1782,Clinical Data Interchange Standards Consortium Terminology,Mobiluncus mulieris,0
1783,Clinical Data Interchange Standards Consortium Terminology,NCCN-FACT FOSI-18 Version 2 - I Am Able to Get Around by Myself,0
1784,DICOM Terminology,Image Laterality,0
1785,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oleyl oleate,0
1786,CDISC SDTM Terminology,Apolipoprotein A4 Measurement,0
1787,CDISC SDTM Cardiovascular Findings About Results Terminology,New Regional Wall Motion Abnormality by Non-invasive Imaging Technique,0
1788,CDISC SDTM Cardiovascular Test Name Terminology,Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio,0
1789,CDISC QRS Terminology,UPDRS - Motor Examination: Speech,0
1790,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dodicin,0
1791,CDISC SEND Terminology,mg/kg/day,0
1792,US Counties Terminology,"Lewis County, WA",0
1793,Human Activity Profile Test,"Using Public Transport or Driving a Car, 99 Miles or Less",0
1794,CTRP Terminology,Lactobacillus rhamnosus GG,0
1795,Neonatal Research Network Terminology,Fetal valproate syndrome,0
1796,CDISC SDTM Microorganism Terminology,Corynebacterium pilosum,0
1797,Clinical Data Interchange Standards Consortium Terminology,Corynebacterium pilosum,0
1798,CDISC SEND Biospecimens Terminology,Tricuspid valve structure,0
1799,CDISC SDTM Medical Evaluator Terminology,Reader 2,0
1800,Clinical Data Interchange Standards Consortium Terminology,Aneurysm,0
1801,Clinical Data Interchange Standards Consortium Terminology,Structure of anterior tibial artery,0
1802,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Talviraline,0
1803,NCIt Neoplasm Core Terminology,Core binding factor acute myeloid leukemia,0
1804,US Counties Terminology,"Tyler County, WV",0
1805,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology,C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Since Study Start),0
1806,Neonatal Research Network Terminology,Perinatal Central Nervous System Depression,0
1807,Clinical Data Interchange Standards Consortium Terminology,Absolute Change From Nadir in Sum of Diameter,0
1808,CDISC SDTM Terminology,Periodic acid Schiff stain method,0
1809,CDISC SDTM Terminology,ADCS-ADL Severe Dementia - Description of Usual Performance of Eating,0
1810,CDISC SDTM Terminology,Short ST Segment by ECG Finding,0
1811,NCPDP Strength Form Terminology,Wash Dosage Form,0
1812,How Much Nausea During This Period,Seldom Have Nausea,0
1813,CDISC SDTM Terminology,Response in Non-Target Lesion,0
1814,CDISC SDTM Terminology,Active Ghrelin Measurement,0
1815,Pediatric Terminology,Transient Neonatal Hypoparathyroidism,0
1816,CDISC QRS Terminology,MNSI - Right Foot Vibration Great Toe,0
1817,UCUM Terminology,Mega,0
1818,CDISC Questionnaire Terminology,FIQR - Pain,0
1819,CDISC SDTM Method Terminology,Immunoprecipitation,0
1820,MD Anderson Dysphagia Inventory,Swallowing Difficulty Causes Lost Income,0
1821,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Etanercept,0
1822,Clinical Data Interchange Standards Consortium Terminology,Endogenous Thrombin Potential Area Under Curve Measurement,0
1823,Clinical Data Interchange Standards Consortium Terminology,Fibroblast Growth Factor 23 Measurement,0
1824,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Genista tinctoria,0
1825,CDISC SDTM Terminology,Beta-2 Glycoprotein 1 IgG Antibody Measurement,0
1826,US Counties Terminology,"Colfax County, NE",0
1827,NCIt Antineoplastic Agent Terminology,DPX-0907,0
1828,NCPDP Strength Form Terminology,Metered Dose Inhaler,0
1829,FDA Established Names and Unique Ingredient Identifier Codes Terminology,choriogonadotropin alfa,0
1830,FDA Individual Case Safety Report Terminology,Unspecified,0
1831,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rabbits,0
1832,CDISC SDTM Microorganism Terminology,Mycobacterium tuberculosis complex,0
1833,CDISC SDTM Terminology,SGRQ Past 4 Weeks Version - Walking Outside on Level Ground,0
1834,Clinical Data Interchange Standards Consortium Terminology,Alpha 1 globulin measurement,0
1835,CDISC SDTM Terminology,OAB-q - Decrease Participating in Social Gatherings,0
1836,FACIT-Dyspnea 10 Item Short Form,Can Do With Much Difficulty,0
1837,Stability Product Form Terminology,Augmented Cream Dosage Form,0
1838,CDISC SDTM Terminology,Aspartic Acid Measurement,0
1839,CTRP Terminology,Untreated Childhood Oligodendroglioma,0
1840,NCIt Antineoplastic Agent Terminology,Matrix Metalloproteinase Inhibitor MMI270,0
1841,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"STARCH, RICE",0
1842,Regulated Product Submission Reporting Terminology,Pharmacokinetics: Distribution,0
1843,Clinical Data Interchange Standards Consortium Terminology,Hour Times Microgram Per Milliliter Per Milligram Per Gram Per Day,0
1844,CDISC SDTM Holter ECG Results Terminology,Atrioventricular Nodal Reentry Tachycardia by ECG Finding,0
1845,CDISC SDTM Unit of Measure Terminology,Viral Particles per Dose,0
1846,CTRP Terminology,Untreated Childhood Pilocytic Astrocytoma,0
1847,CDISC Observation Class Terminology,Flow Rate,0
1848,CareLex eTMF Terminology,Data Management Tracking Document,0
1849,Pediatric Terminology,Tricuspid Atresia,0
1850,CDISC SEND Fetal Pathology Findings Result Terminology,Skin tag,0
1851,Clinical Data Interchange Standards Consortium Terminology,Metabolic Equivalent of Task Minute,0
1852,CDISC QRS Terminology,C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Past 1 Months),0
1853,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dichlorisone,0
1854,CDISC SDTM Laboratory Test Terminology by Name,Cabot Ring Count (lab procedure),0
1855,CDISC SDTM Terminology,West Haven Criteria - West Haven Hepatic Encephalopathy Grade,0
1856,CTRP Agent Terminology,Urea/Lactic Acid-based Topical Cream,0
1857,CDISC SDTM Terminology,CDISC Questionnaire C-SSRS Since Last Visit Test Code Terminology,0
1858,CDISC QRS Terminology,"C-SSRS Children's Baseline - Active Suicidal Ideation with Some Intent to Act, without Specific Plan",0
1859,Stability Product Form Terminology,Shampoo Suspension Dosage Form,0
1860,CDISC Functional Test ADNI AVLT Test Code Terminology,ADNI AVLT - List A Recall 2 Total,0
1861,CDISC SDTM Laboratory Test Terminology by Name,Herpes Simplex Virus 1 IgM Antibody Measurement,0
1862,Clinical Data Interchange Standards Consortium Terminology,GCS NINDS Version - Motor Response,0
1863,CDISC SDTM Terminology,Junctional Tachycardia by ECG Finding,0
1864,Patient Problem Codes FDA CDRH,Corneal burn,0
1865,CDISC SEND Terminology,Left lobe of liver,0
1866,Clinical Data Interchange Standards Consortium Terminology,Nonclinical Study Title,0
1867,Pediatric Terminology,Nephrotic Syndrome - LAMB2 Associated,0
1868,Clinical Data Interchange Standards Consortium Terminology,Viral Particles per Milliliter,0
1869,CDISC SDTM Terminology,Beta Lactamase Screening Method,0
1870,US Counties Terminology,"Potter County, TX",0
1871,SPL Marketing Category Terminology,Marketed as OTC Monograph Drug Product Manufactured Exclusively for Private Label Distributor,0
1872,CDISC Questionnaire Terminology,SIQR - Sit in a Chair for 45 Minutes,0
1873,Clinical Data Interchange Standards Consortium Terminology,Full Sibling,0
1874,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Intrusions 2,0
1875,CDISC SDTM Terminology,GCS NINDS Version - Confounder: GCS Accurate,0
1876,CDISC SDTM Terminology,CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology,0
1877,NCIt Antineoplastic Agent Terminology,saracatinib difumerate,0
1878,Neonatal Research Network Terminology,"Intraventricular (nontraumatic) hemorrhage, grade 3, of fetus and newborn",0
1879,CDISC SDTM Contact Role for Clinical Study Terminology,Facility Contact Backup,0
1880,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Minute Times Milligram per Milliliter per Meter Squared,0
1881,CDISC Questionnaire SGRQ Past 4 Weeks Version Test Code Terminology,SGRQ Past 4 Weeks Version - Coughing Hurts,0
1882,CDISC SDTM Laboratory Test Terminology by Name,Pseudoephedrine Measurement,0
1883,Outcome Satisfaction Questionnaire,Extremely Dissatisfied,0
1884,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bisorcic,0
1885,CDISC SDTM Laboratory Test Terminology by Code,Lymphocyte Count measurement,0
1886,CDISC SDTM Terminology,Bone structure of T6,0
1887,CDISC SDTM Terminology,Hemoglobin A measurement,0
1888,FDA eManufacturing Terminology,Crystallization Purification,0
1889,CTRP Terminology,mesalamine,0
1890,NCIt Antineoplastic Agent Terminology,Lapuleucel-T,0
1891,Patient Problem Codes FDA CDRH,Corneal edema,0
1892,CDISC SDTM Reproductive System Findings Test Name Terminology,Pregnant During the Study,0
1893,Pediatric Terminology,Irritable Mood,0
1894,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lomefloxacin hydrochloride,0
1895,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire FACT-B Version 4 Test Code Terminology,0
1896,Pediatric Terminology,Schistosomiasis Nephropathy,0
1897,Perinatal Terminology,Umbilical granuloma,0
1898,CDISC SDTM Terminology,Prevotella timonensis,0
1899,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cethromycin,0
1900,CDISC SDTM Microorganism Terminology,Micrococcus lylae,0
1901,CTRP Terminology,necitumumab,0
1902,Clinical Data Interchange Standards Consortium Terminology,Hour Times Milligram Per Milliliter Per Milligram Per Kilogram,0
1903,CDISC SDTM Holter ECG Results Terminology,Non Q Wave Myocardial Infarction by ECG Finding,0
1904,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sulfamethoxypyridazine,0
1905,NCIt Neoplasm Core Terminology,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,0
1906,US Counties Terminology,"Contra Costa County, CA",0
1907,NCIt Antineoplastic Agent Terminology,WT1 124-138 Peptide Vaccine,0
1908,NCIt Neoplasm Core Terminology,Stage 0 Colon Cancer AJCC v6 and v7,0
1909,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 4 Weeks Version - Treatment Interferes With My Life,0
1910,CDISC SDTM Terminology,CDISC Questionnaire FOSI Test Code Terminology,0
1911,CDISC Questionnaire Terminology,ADCS-ADL Severe Dementia - Obtain Beverage for Self,0
1912,CDISC SDTM Patient Ethnic Group Terminology,Hispanics,0
1913,CDISC SDTM Terminology,aVL - Lead site,0
1914,CDISC SDTM Terminology,week,0
1915,CDISC SEND Terminology,C3H/HeJ Mouse,0
1916,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bietamiverine Hydrochloride,0
1917,CDISC Questionnaire Terminology,SGRQ Past 4 Weeks Version - Take Long Time to Get Washed or Dressed,0
1918,CDISC SDTM Terminology,European race,0
1919,Clinical Data Interchange Standards Consortium Terminology,Undetermined Rhythm by ECG Finding,0
1920,US Counties Terminology,"Currituck County, NC",0
1921,Pediatric Terminology,Dystrophia unguium,0
1922,CDISC SDTM Microorganism Terminology,Urea-Positive Providencia stuartii,0
1923,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cliropamine,0
1924,Patient Reported Outcomes Version of CTCAE,Past Seven Days Bruise Easily,0
1925,CDISC SEND Terminology,Structure of base of heart,0
1926,CDISC Questionnaire HADS Test Name Terminology,HADS - I Feel Tense or Wound Up,0
1927,CDISC Questionnaire SGRQ Past 4 Weeks Version Test Name Terminology,SGRQ Past 4 Weeks Version - Cannot Take A Bath or Shower,0
1928,CDISC SDTM Terminology,Cortisol to Creatinine Ratio Measurement,0
1929,CDISC Skin Classification Terminology,Fitzpatrick Skin Type VI,0
1930,Pediatric Terminology,Neural Tube Defects,0
1931,CDISC Questionnaire Terminology,DAD - Sub-Total Effective Performance,0
1932,CDISC Variable Terminology,Microscopic Findings Sequence Number,0
1933,CDISC SDTM Terminology,Structure of endocardium of right ventricle,0
1934,CDISC SEND Terminology,Structure of endocardium of right ventricle,0
1935,NCIt Antineoplastic Agent Terminology,Ethinyl Estradiol,0
1936,CDISC SDTM Terminology,Injection,0
1937,CDISC Questionnaire ADCS-ADL Severe Dementia Test Code Terminology,ADCS-ADL Severe Dementia - Dispose of Garbage in Appropriate Place at Home,0
1938,US Counties Terminology,"Montgomery County, MS",0
1939,CDISC SDTM Terminology,CDISC Questionnaire SOWS Subjective Test Code Terminology,0
1940,CDISC SDTM Terminology,R Wave Amplitude Aggregate,0
1941,CDISC Questionnaire HAQ-DI With VAS Test Name Terminology,HAQ-DI With VAS - Able to Climb Up Steps,0
1942,US Counties Terminology,"Southampton County, VA",0
1943,Clinical Data Interchange Standards Consortium Terminology,Large unstained cell count (procedure),0
1944,CDISC Questionnaire NPI Test Name Terminology,NPI - Depression/Dysphoria Distress,0
1945,CDISC Questionnaire FACIT-F Version 4 Test Code Terminology,FACIT-F Version 4 - I Need to Sleep During the Day,0
1946,CDISC Variable Terminology,Electrocardiogram Time Point,0
1947,CDISC Questionnaire HADS Test Code Terminology,HADS - I Feel Restless as if I Have to be on the Move,0
1948,CDISC Questionnaire FAMS Test Code Terminology,FAMS - Bothered by Side Effects of Treatment,0
1949,FDA Established Names and Unique Ingredient Identifier Codes Terminology,itanoxone,0
1950,CTRP Agent Terminology,Vintafolide,0
1951,Clinical Data Interchange Standards Consortium Terminology,Ammonia measurement,0
1952,CDISC SEND Terminology,Vectorcardiograph Uncorrected,0
1953,CDISC Questionnaire MNSI Test Code Terminology,MNSI - Left Foot Other Abnormal Specify,0
1954,CDISC Clinical Classification HAMD 21 Test Code Terminology,HAMD-21 - Somatic Symptoms Gastro-intestinal,0
1955,FDA Device Problem Code Hierarchy,Unintended Ejection,0
1956,NCIt Neoplasm Core Terminology,Myeloid leukemia associated with Down Syndrome,0
1957,CTRP Terminology,Lymphomatous Involvement of Non-Cutaneous Extranodal Site,0
1958,CDISC SDTM Microorganism Terminology,Salmonella enterica subsp. salamae,0
1959,CDISC QRS Terminology,HADS - I Can Laugh and See Funny Side of Things,0
1960,NCIt Antineoplastic Agent Terminology,EGFR/HER2 Inhibitor AP32788,0
1961,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bornaprine,0
1962,CDISC QRS Terminology,CHART-SF Paper Version - Cognitive Assistance Away From Home per Day,0
1963,NCIt Antineoplastic Agent Terminology,afuresertib,0
1964,integrated Cancer Repository for Cancer Research,Air Transportation Workers,0
1965,FDA eManufacturing Terminology,Production of Nucleic Acid Detection Reagent,0
1966,CDISC QRS Terminology,FAMS - Feel Close to My Partner,0
1967,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oxilofrine,0
1968,CDISC SDTM Terminology,Corrected Prolonged QT Interval by ECG Finding,0
1969,Clinical Data Interchange Standards Consortium Terminology,Cellulomonas,0
1970,Clinical Data Interchange Standards Consortium Terminology,SIQR - Brush or Comb Your Hair,0
1971,Pediatric Adverse Events Terminology,Premature development of the breasts,0
1972,CDISC Questionnaire HADS Test Code Terminology,HADS - I Get Sudden Feelings of Panic,0
1973,CDISC SDTM Terminology,Streptococcus dysgalactiae subspecies dysgalactiae,0
1974,CDISC SDTM Terminology,Rhizopus oryzae,0
1975,Clinical Data Interchange Standards Consortium Terminology,Lead Site CV6LU,0
1976,"Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire",Pain Has Interfered with Normal Work,0
1977,CDISC SEND Tumor Findings Results Terminology,Benign Subcapsular Adrenal Tumor,0
1978,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Divabuterol,0
1979,CDISC SDTM Terminology,CDISC ADAS-Cog - Word Recognition: Word 22,0
1980,CDISC SDTM Terminology,Percent inhibition,0
1981,CDISC SDTM Terminology,CDISC SDTM Severity Intensity Scale for Adverse Event Terminology,0
1982,Perinatal Terminology,Fetal Bradyarrhythmia,0
1983,Adverse Event Outcome ICSR Terminology,Hospitalization,0
1984,CDISC SDTM Terminology,Alpha-2 antiplasmin functional assay,0
1985,Clinical Data Interchange Standards Consortium Terminology,NPI - Disinhibition Distress,0
1986,NCIt Antineoplastic Agent Terminology,Samalizumab,0
1987,FDA Established Names and Unique Ingredient Identifier Codes Terminology,2'-fluoro-5-ethylarabinosyluracil,0
1988,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology,RAND-36 - Felt Downhearted and Blue,0
1989,Pediatric Adverse Events Terminology,Night sweats,0
1990,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pemetrexed disodium,0
1991,Pediatric Nephrology Terminology,Nephrotic Syndrome - MYO1E Associated,0
1992,CDISC SDTM Holter ECG Test Name Terminology,Supraventricular Arrhythmia ECG Assessment,0
1993,"Adaptive Behavior Assessment System, Parent Rating Form",General Adaptive Composite Score,0
1994,CDISC Questionnaire FAMS Test Name Terminology,FAMS - Satisfied With How I Am Coping With Illness,0
1995,CTRP Terminology,enavatuzumab,0
1996,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acaprazine,0
1997,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Eflornithine,0
1998,CDISC QRS Terminology,ADNI AVLT - List A Recall 6 (After B) Word 7,0
1999,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cetyl alcohol,0
2000,Clinical Data Interchange Standards Consortium Terminology,GCS NINDS Version - Confounder: Alcohol or Drug of Abuse,0
2001,CTRP Terminology,Paget's disease and intraductal carcinoma of breast,0
2002,CDISC Questionnaire Terminology,VFQ25-Interviewer Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup,0
2003,CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology,VFQ25-Interviewer Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup,0
2004,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Predicted Steady State Volume of Distribution Normalized by Body Mass Index,0
2005,CDISC Questionnaire Terminology,FACT-B Version 4 - I Am Able to Work,0
2006,NCIt Neoplasm Core Terminology,Pleural Well Differentiated Papillary Mesothelioma,0
2007,Patient Problem Codes FDA CDRH,Ulcer of nipple,0
2008,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benzopyrronium,0
2009,Pediatric Nephrology Terminology,Congenital posterior urethral valves,0
2010,Clinical Data Interchange Standards Consortium Terminology,"CRQ-SAS Follow-Up Administration Version - Felt Restless, Tense or Uptight",0
2011,US Counties Terminology,"Johnson County, AR",0
2012,NCIt Antineoplastic Agent Terminology,verubulin hydrochloride,0
2013,Clinical Data Interchange Standards Consortium Terminology,Maximum Value Derivation Technique,0
2014,CDISC SDTM Terminology,Scopulariopsis brevicaulis,0
2015,Pediatric Terminology,DiGeorge Syndrome,0
2016,CDISC SDTM Terminology,CHART-SF Paper Version - Hours of Paid Work per Week,0
2017,CTRP Terminology,[18F]L-FMAC,0
2018,Pediatric Terminology,Cafe-au-Lait Spots,0
2019,Clinical Data Interchange Standards Consortium Terminology,CDISC SEND Body System Terminology,0
2020,FDA Established Names and Unique Ingredient Identifier Codes Terminology,GLYCERYL LAURATE,0
2021,FDA Device Component Code Hierarchy,Bacterial Filter Device,0
2022,NCIt Antineoplastic Agent Terminology,GM2-KLH vaccine/QS21,0
2023,CDISC SDTM Cardiovascular Test Code Terminology,Cusp Tethering Indicator,0
2024,CTRP Terminology,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,0
2025,CTRP Intervention Terminology,Double-Walled Airbag Breast Immobilization Device,0
2026,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Streptococcus constellatus,0
2027,CDISC SDTM Laboratory Test Terminology by Code,Oxygen measurement,0
2028,Clinical Data Interchange Standards Consortium Terminology,Netherlands,0
2029,CDISC SEND Terminology,Predicted Total Body Clearance Rate,0
2030,Clinical Data Interchange Standards Consortium Terminology,ASEX-Female Version - Sex Drive,0
2031,Pediatric Terminology,Congenital malformation of the urinary system,0
2032,Clinical Data Interchange Standards Consortium Terminology,Liter per Gram per Hour,0
2033,CDISC SDTM Unit of Measure Terminology,Nanomole per Liter per Hour,0
2034,CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology,VFQ25-Interviewer Administered Format - Difficulty Taking Part in Sports or Outdoor Activities,0
2035,CTRP Agent Terminology,crolibulin,0
2036,NCIt Neoplasm Core Terminology,Thymic Undifferentiated Carcinoma,0
2037,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bendacalol Mesylate,0
2038,CDISC SDTM Terminology,Average Concentration,0
2039,CTRP Terminology,Iodine I 124 PU-AD,0
2040,CTRP Agent Terminology,Iodine I 124 PU-AD,0
2041,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Wish to Be Dead (Prior to Study Entry),0
2042,CDISC SEND Terminology,Low Absorption Reticulocyte Measurement,0
2043,CDISC SDTM Terminology,Neoadjuvant Therapy Clinical Trial Setting,0
2044,CDISC Questionnaire Terminology,VFQ25-Interviewer Administered Format - Difficulty Seeing and Enjoying Programs on TV,0
2045,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Carbocysteine,0
2046,CTRP Agent Terminology,Octreotide Acetate,0
2047,Observation ICSR Terminology,Private Funding,0
2048,Neonatal Research Network Terminology,Ductus arteriosus premature closure,0
2049,Clinical Data Interchange Standards Consortium Terminology,DAD - Organize Finances to Pay Bills,0
2050,CDISC SDTM Microscopic Findings Test Detail Terminology,Allred Average Staining Intensity Score,0
2051,Pediatric Terminology,Hemangioma of intra-abdominal structure,0
2052,Clinical Data Interchange Standards Consortium Terminology,NPI - Loss of Appetite,0
2053,CDISC SDTM Terminology,Count of Unspecified Cells,0
2054,FDA Established Names and Unique Ingredient Identifier Codes Terminology,red alder pollen extract,0
2055,Clinical Data Interchange Standards Consortium Terminology,WHO Adverse Reaction Terminology,0
2056,CDISC SDTM Terminology,AURC from T1 to T2 Normalized by Body Mass Index,0
2057,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Guanisoquin Sulfate,0
2058,CDISC SDTM Terminology,C-SSRS Children's Baseline - Interrupted Suicide Attempt,0
2059,CTRP Agent Terminology,Derazantinib,0
2060,NCIt Antineoplastic Agent Terminology,TLR7/8/9 Antagonist IMO-8400,0
2061,Clinical Data Interchange Standards Consortium Terminology,Borg Category-Ratio 10 Scale Questionnaire,0
2062,Clinical Data Interchange Standards Consortium Terminology,Promonocyte to Lymphocyte Ratio Measurement,0
2063,CDISC SEND Terminology,Granule for Suspension Dosage Form,0
2064,CDISC SEND Terminology,Neuroblastoma,0
2065,CDISC SEND Biospecimens Terminology,Peritoneum,0
2066,CTRP Terminology,Adult Erythroleukemia,0
2067,FDA eCTD Terminology,Chemical Name,0
2068,CTRP Terminology,onartuzumab,0
2069,Medical Outcomes Study Your Feelings Questionnaire,"Have You Felt Restless, Fidgety, or Impatient",0
2070,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Liter per Minute per Milligram per Meter Squared,0
2071,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nalfurafine,0
2072,NCIt Antineoplastic Agent Terminology,orteronel,0
2073,CDISC Questionnaire Terminology,CDISC Questionnaire FAQ-NACC Version Test Code Terminology,0
2074,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pyrithione,0
2075,FDA Established Names and Unique Ingredient Identifier Codes Terminology,isopropamide iodide,0
2076,CDISC SEND Tumor Findings Results Terminology,"Adenocarcinoma, Scirrhous",0
2077,FDA Established Names and Unique Ingredient Identifier Codes Terminology,careless weed pollen extract,0
2078,Pediatric Terminology,Shoulder Dystocia,0
2079,Pediatric Adverse Events Terminology,Umbilical hernia with gangrene,0
2080,NCIt Antineoplastic Agent Terminology,Etoposide Prodrug CAP7.1,0
2081,CDISC SEND Terminology,Liter per Minute per Milligram per Meter Squared per Day,0
2082,CDISC Questionnaire DAD Test Name Terminology,DAD - Eat Meals at a Normal Pace and with Appropriate Manners,0
2083,Patient Problem Codes FDA CDRH,Infection of amniotic cavity,0
2084,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trimexiline,0
2085,CTRP Terminology,Hodgkin Disease,0
2086,CDISC SDTM Frequency Terminology,Alternate days,0
2087,CDISC SDTM Laboratory Test Terminology by Name,Codeine Measurement,0
2088,CTRP Terminology,Deglutition Disorders,0
2089,CDISC SEND Terminology,Seminal Vesicle/Coagulating Gland,0
2090,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bleomycin B2,0
2091,CDISC SEND Terminology,Primary Site Unknown,0
2092,FDA Established Names and Unique Ingredient Identifier Codes Terminology,rufinamide,0
2093,CDISC CDASH Variable Terminology,Death Related to Adverse Event,0
2094,NCIt Antineoplastic Agent Terminology,bevacizumab,0
2095,Clinical Data Interchange Standards Consortium Terminology,CDISC Clinical Classification West Haven Criteria Test Name Terminology,0
2096,CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology,SGRQ Past 3 Months Version - Take Long Time to Get Washed or Dressed,0
2097,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pacrinolol,0
2098,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Quadazocine Mesylate,0
2099,CDISC SEND Fetal Pathology Findings Result Terminology,"Scoliosis, unspecified",0
2100,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hyssopus officinalis,0
2101,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Brazil nut,0
2102,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Past X Months),0
2103,CDISC SDTM Laboratory Test Terminology by Code,Interleukin 25 Measurement,0
2104,CDISC SDTM Terminology,FACT-B Version 4 - I Am Satisfied With My Sex Life,0
2105,Clinical Data Interchange Standards Consortium Terminology,Abnormal,0
2106,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Isobutamben,0
2107,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cintredekin Besudotox,0
2108,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Day Times Nanomole per Liter per Meter Squared,0
2109,CDISC SDTM Laboratory Test Terminology by Name,Left Shift Neutrophil Measurement,0
2110,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ketorolac Tromethamine,0
2111,Pediatric Terminology,Pfeiffer Syndrome,0
2112,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Vaccaria hispanica Leaf,0
2113,FDA Established Names and Unique Ingredient Identifier Codes Terminology,beciparcil,0
2114,CDISC Questionnaire Terminology,C-SSRS Baseline - Most Recent Suicide Attempt Damage,0
2115,NCIt Antineoplastic Agent Terminology,LMP-400,0
2116,CTRP Terminology,batracylin,0
2117,CDISC SDTM Laboratory Test Terminology by Name,Lipoprotein (a) measurement,0
2118,CDISC Clinical Classification APACHE II Test Name Terminology,APACHE II - Serum Potassium,0
2119,CDISC Clinical Classification HAMD 21 Test Name Terminology,HAMD-21 - Anxiety Psychological,0
2120,FACT-Hep Questionnaire,Feel Fatigue,0
2121,CDISC Variable Terminology,Vital Signs Time,0
2122,CDISC SDTM Laboratory Test Terminology by Code,Sediment Analysis,0
2123,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ketotifen,0
2124,US Counties Terminology,"Alcona County, MI",0
2125,CTRP Agent Terminology,Mifepristone,0
2126,"University of Washington Quality of Life Scale, Version 4",Anxious About My Cancer,0
2127,CDISC SDTM Laboratory Test Terminology by Code,Monocyte Chemotactic Protein 1 Measurement,0
2128,CTRP Agent Terminology,brincidofovir,0
2129,Nausea Distress,Have Nausea Usually Feel Very Sick,0
2130,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lomefloxacin,0
2131,CDISC Questionnaire PHQ Screener Version Test Code Terminology,PHQ Screener Version - Feeling Restless,0
2132,FDA Established Names and Unique Ingredient Identifier Codes Terminology,enolicam,0
2133,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Allomethadione,0
2134,CTRP Terminology,Folate Receptor-Targeted Technetium Tc-99m EC20,0
2135,CDISC SEND Terminology,Abnormal U wave,0
2136,NCI CTEP SDC Ovarian Germ Cell Cancer Sub-Category Terminology,Dysgerminoma of ovary,0
2137,CDISC SDTM Holter ECG Results Terminology,Intra-Atrial Conduction Delay by ECG Finding,0
2138,CDISC CDASH Variable Terminology,Laboratory Test Original Result Unit,0
2139,NCIt Antineoplastic Agent Terminology,bruceanol B,0
2140,CDISC Questionnaire OAB-q Test Code Terminology,OAB-q - Affected Your Relationships with Family and Friends,0
2141,NCIt Antineoplastic Agent Terminology,Mps1 Inhibitor BAY 1217389,0
2142,CDISC SDTM Terminology,Lead site V2,0
2143,CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Name Terminology,CRQ-SAS Follow-Up Administration Version - Felt Discouraged or Down,0
2144,FDA Established Names and Unique Ingredient Identifier Codes Terminology,aluminum cation,0
2145,Clinical Data Interchange Standards Consortium Terminology,Template Incision Method,0
2146,CTRP Terminology,Colposcopic Biopsy,0
2147,CTRP Terminology,"Hydatidiform Mole, Invasive",0
2148,NCIt Antineoplastic Agent Terminology,Lentinan,0
2149,Clinical Data Interchange Standards Consortium Terminology,Opisthorchis felineus,0
2150,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ciramadol,0
2151,CDISC SDTM Terminology,BPI - Concerned with Too Much Pain Medication Use,0
2152,US Counties Terminology,"Griggs County, ND",0
2153,Perinatal Terminology,Fetal Distress,0
2154,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chlorotoxin,0
2155,GAIA Terminology,GAIA Level 4 Major Internal Structural Defect,0
2156,Clinical Data Interchange Standards Consortium Terminology,Ten Thousand per High Powered Field,0
2157,CDISC SDTM Terminology,Vancomycin resistant Staphylococcus aureus,0
2158,FDA Established Names and Unique Ingredient Identifier Codes Terminology,5-Hydroxytryptophan,0
2159,US Counties Terminology,"Calhoun County, SC",0
2160,NCIt Antineoplastic Agent Terminology,GO-203-2C,0
2161,CDISC SDTM Terminology,Box Dosing Unit,0
2162,CDISC SDTM Unit of Measure Terminology,Thousand per High Powered Field,0
2163,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Golden Raisin,0
2164,FDA Device Component Code Hierarchy,Frame Device,0
2165,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clometacin,0
2166,FDA Manufacturer Evaluation Result Code Hierarchy,Operational Problem Identified,0
2167,CDISC SDTM Terminology,Calcium Sulfate Measurement,0
2168,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate",0
2169,Edmonton symptom assessment system,Overall Well Being,0
2170,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Code Terminology,"MSQOL-54 - Health Limit Bending, Kneeling or Stooping",0
2171,CDISC QRS Terminology,Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire,0
2172,CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Code Terminology,"CRQ-SAS Follow-Up Administration Version - Happy, Satisfied or Pleased With Life",0
2173,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ephedrine sulfate,0
2174,Clinical Data Interchange Standards Consortium Terminology,Technician,0
2175,CTRP Terminology,Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F,0
2176,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Leucinocaine,0
2177,CDISC Clinical Classification Terminology,ESRS-A - Rigidity: Upper Limbs,0
2178,CDISC SEND Fetal Pathology Findings Result Terminology,Split-Hand/Foot Malformation,0
2179,integrated Cancer Repository for Cancer Research,Construction Trades Workers,0
2180,SPL Drug Route of Administration Terminology,Intragastric Route of Drug Administration,0
2181,CDISC SEND Terminology,Intragastric Route of Drug Administration,0
2182,FDA Device Component Code Hierarchy,"Stent, device",0
2183,Clinical Data Interchange Standards Consortium Terminology,FAMS - I Have Strength in My Legs,0
2184,CDISC QRS Terminology,GAD-7 - Worrying Too Much About Different Things,0
2185,NCPDP Quantity Unit of Measure Terminology,Tabminder Dosing Unit,0
2186,CTRP Terminology,Anti-ErbB3 Monoclonal Antibody CDX-3379,0
2187,CDISC Observation Class Terminology,Numeric Test Result,0
2188,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Strychnine,0
2189,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Dispose of Garbage in Appropriate Place at Home,0
2190,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cinoctramide,0
2191,US Counties Terminology,"Roseau County, MN",0
2192,Pediatric Nephrology Terminology,Diffuse Endocapillary Glomerulonephritis,0
2193,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Delavirdine,0
2194,CDISC SDTM Terminology,Substantia nigra structure,0
2195,CTRP Agent Terminology,Tozasertib Lactate,0
2196,Clinical Data Interchange Standards Consortium Terminology,Pseudomonas fluorescens/putida Group,0
2197,CTRP Terminology,Doxorubicin Hydrochloride,0
2198,CDISC SEND Terminology,Chordoma,0
2199,NCIt Neoplasm Core Terminology,Chordoma,0
2200,CDISC SEND Terminology,Structure of superficial lymph node,0
2201,CDISC SEND Variable Terminology,Body Weight Gain Reason For Exclusion From Statistics,0
2202,Newborn Screening Terminology,Last Screening,0
2203,Patient Problem Codes FDA CDRH,Phlebitis,0
2204,CDISC SDTM Terminology,FAMS - Have to Take Condition Into Account When Making Plans,0
2205,Pediatric Terminology,C3 Glomerulonephritis,0
2206,CDISC Questionnaire Terminology,CDISC Questionnaire C-SSRS Screening Test Code Terminology,0
2207,Pediatric Adverse Events Terminology,Macular retinal edema,0
2208,CDISC SEND Terminology,Structure of axillary artery,0
2209,CDISC QRS Terminology,C-SSRS Children's Baseline - Non-suicidal Self-injurious Behavior,0
2210,Neonatal Research Network Terminology,Deficiency of acetyl-CoA acetyltransferase,0
2211,CDISC SDTM Country Terminology,Congo,0
2212,FDA Established Names and Unique Ingredient Identifier Codes Terminology,mitoclomine,0
2213,NCIt Antineoplastic Agent Terminology,HER-2/neu Intracellular Domain Protein,0
2214,CDISC SDTM Terminology,Holter Lead Fail by ECG Finding,0
2215,NCIt Antineoplastic Agent Terminology,HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine,0
2216,CDISC SDTM Terminology,Positron emission tomography-magnetic resonance imaging,0
2217,CDISC SDTM Device-In-Use Test Name Terminology,Checkerboard Square Size,0
2218,Clinical Data Interchange Standards Consortium Terminology,CDISC Clinical Classification APACHE II Test Code Terminology,0
2219,CDISC SDTM Terminology,Moraxella atlantae,0
2220,National Health Interview Survey,Final,0
2221,CDISC SDTM Terminology,HADS - I Can Sit at Ease and Feel Relaxed,0
2222,NCIt Neoplasm Core Terminology,Atypical Lipoma,0
2223,Clinical Data Interchange Standards Consortium Terminology,FAMS - I Have Pain,0
2224,Clinical Data Interchange Standards Consortium Terminology,External Beam Radiation Therapy,0
2225,Medical Outcomes Study Your Feelings Questionnaire,Have You Felt So Down in the Dumps That Nothing Could Cheer You Up,0
2226,Clinical Data Interchange Standards Consortium Terminology,External iliac lymph node group,0
2227,CDISC Questionnaire FACT-P Version 4 Test Name Terminology,FACT-P Version 4 - I Have Trouble Moving My Bowels,0
2228,Clinical Data Interchange Standards Consortium Terminology,Craniorachischisis,0
2229,CDISC Questionnaire AUDIT-SR Test Name Terminology,AUDIT - How Often Have Alcohol Drink,0
2230,CDISC SEND Terminology,Every six hours,0
2231,Clinical Data Interchange Standards Consortium Terminology,Milligram per Milliliter per Kilogram per Meter Squared,0
2232,Pediatric Terminology,Double Outlet Right Ventricle,0
2233,CDISC Clinical Classification APACHE II Test Name Terminology,"APACHE II - Oxygenation, A-aDO2",0
2234,SPL Unit of Presentation Terminology,Syringe Dosing Unit,0
2235,CDISC SDTM Terminology,Mycobacterium Tuberculosis Measurement,0
2236,Clinical Data Interchange Standards Consortium Terminology,Mycobacterium Tuberculosis Measurement,0
2237,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Code Terminology,C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Potential Lethality,0
2238,Stability Product Form Terminology,Suture Dosage Form,0
2239,CDISC SEND Terminology,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,0
2240,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hydroxypethidine,0
2241,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Minute Times Micromole Per Liter Per Milligram Per Gram,0
2242,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lenperone hydrochloride,0
2243,CDISC SDTM Terminology,Pounds per square inch,0
2244,CDISC QRS Terminology,PHQ Screener Version - Anxiety Attack Nausea or Diarrhea,0
2245,CTRP Terminology,lumiliximab,0
2246,Pediatric Rheumatology Terminology,Diffuse Scleroderma,0
2247,NCIt Antineoplastic Agent Terminology,LMP1/BARF1/EBNA1-specific Cytotoxic T-lymphocytes,0
2248,NCPDP Dose Unit of Measure Terminology,fluid ounce,0
2249,CDISC SDTM Terminology,nmol/min/mL,0
2250,CTRP Agent Terminology,plocabulin,0
2251,Pediatric Terminology,Atrial Fibrillation,0
2252,CDISC SDTM Terminology,Intramuscular Route of Drug Administration,0
2253,Brief Pain Inventory Short Form Questionnaire,Pain Interferes with Mood,0
2254,Clinical Data Interchange Standards Consortium Terminology,Bone marrow of scapula,0
2255,NCI CTEP Simplified Disease Classification Terminology,NCI CTEP SDC Chondrosarcoma Sub-Category Terminology,0
2256,CDISC QRS Terminology,C-SSRS Already Enrolled Subjects - First Suicide Attempt Date,0
2257,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - First Suicide Attempt Date,0
2258,NCIt Antineoplastic Agent Terminology,mitomycin B,0
2259,Clinical Data Interchange Standards Consortium Terminology,Indonesians,0
2260,CTRP Terminology,AIDS-Related Diffuse Mixed Cell Lymphoma,0
2261,Clinical Data Interchange Standards Consortium Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Gardening",0
2262,Pediatric Terminology,Patau syndrome,0
2263,CTRP Agent Terminology,abagovomab,0
2264,Work Productivity and Activity Impairment General Health V2.0 Questionnaire,Health Problems Effect on Daily Activities Score 3,0
2265,CDISC QRS Terminology,GDS-SF - Dropped Activities and Interests,0
2266,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Talastine Hydrochloride,0
2267,CDISC SEND Terminology,AV Block First Degree by ECG Finding,0
2268,FDA Established Names and Unique Ingredient Identifier Codes Terminology,benzoin resin,0
2269,Pediatric Terminology,"Fractures, Open",0
2270,CDISC SEND Biospecimens Terminology,Knee joint,0
2271,Acetals,clavigerin B,0
2272,Acetals,clavigerin C,0
2273,Acetals,clavigerin A,0
2274,Acetamides,N-(2-methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide,0
2275,Acetamides,N-(2-(4-(aminosulfonyl)phenyl)ethyl)-2-(2-thienyl)acetamide,0
2276,Acetamides,"3,3,7,7-tetra(N-ethyl-N-benzyl(acetamide)-2-oxymethyl)-5- oxanonane",0
2277,Acetamides,2-cyano-6-fluorophenylacetamide,0
2278,Acetamides,mexiletine acetamide,0
2279,Acetaminophen,Acetaminophen / Codeine,0
2280,Acetanilides,"N-(4-(2-(8-cyano-1,3a,4,9b-tetrahydro(1)benzopyrano(3,4-c)pyrrol-2(3H)-yl)ethyl)phenyl)acetamide",0
2281,Acetanilides,N-acetyl-N-(2-methoxycarbonylbenzyl)-2-phenoxyaniline,0
2282,Acetanilides,6-fluoro-3-(iodoacetamido)benzoylurea,0
2283,Acetates,3-methoxybutyl acetate,0
2284,Acetates,phyllostoxin,0
2285,Acetates,diethoxymethyl acetate,0
2286,Acetic Anhydrides,dichloroacetic anhydride,0
2287,Acetoacetates,"ethyl 4,4-difluoro- 4-phenoxyacetoacetate",0
2288,Acetophenones,"2,4,6-trimethoxyacetophenone",0
2289,Acetophenones,diapocynin,0
2290,Acetophenones,clavatol,0
2291,Acetylgalactosamine,Ac(4)GalNAz,0
2292,Beta-N-Acetylglucosaminidase,"Ctbs protein, mouse",0
2293,Acetyltransferase,"Eaf5 protein, S cerevisiae",0
2294,Acetyltransferase,"Eaf6 protein, S cerevisiae",0
2295,Acetyltransferase,"Eaf7 protein, S cerevisiae",0
2296,Acetyltransferase,"calreticulin transacetylase, rat",0
2297,Acid Phosphatase,"PAP15 protein, Arabidopsis",0
2298,Acridines,tetrapyridoacridine,0
2299,Acridines,2-((4-(4-(acridin-9-ylamino)phenylthio)phenyl)(2-hydroxyethyl)amino)ethan-1-ol,0
2300,Acridines,3-((4-(4-(acridin-9-ylamino)phenylthio)phenyl)(3-hydroxypropyl)amino)propan-1-ol,0
2301,Acrylamides,4-acryloylmorpholine,0
2302,Acrylamides,"N-(-4-(N-(biphenyl-2-ylmethyl)-N-2-methylpropylamino)- 1-(2-(2,4-difluorobenzoyl)benzoyl)pyrrolidin- 2-yl)methyl-3-(4-(2,4-dioxothiazolidin-5-ylidenemethyl) phenyl)acrylamide",0
2303,Acrylamides,"(R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide",0
2304,Acrylates,hexyl acrylate,0
2305,Acrylates,4-(2-((4-methoxy-1H-indole-2-carbonyl)amino)-4-methylpentanoylamino)-5-(2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester,0
2306,Acrylates,"5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate",0
2307,Acrylic Resins,poly(tert-butylacrylamide-b-(N-acryloylmorpholine-co-N-acryloxysuccinimide)),0
2308,Acrylic Resins,diazeniumdiolated poly(acrylonitrile),0
2309,Acrylic Resins,Bulkamid,0
2310,Acrylic Resins,activ GP sealer,0
2311,Acrylic Resins,Vantris,0
2312,Acrylic Resins,poly(ethylene oxide)-block-poly(glycerol monoacrylate),0
2313,Actinin,"ACTN1 protein, human",0
2314,Actinin,"Actn1 protein, mouse",0
2315,Actinin,"Actn3 protein, rat",0
2316,Actins,"ACTC1 protein, human",0
2317,Acyl Coenzyme A,"(3,5-dihydroxyphenylacetyl)coenzyme A",0
2318,Acyl Coenzyme A,14-azidotetradecanoyl-CoA,0
2319,Acyl Coenzyme A,oct-2-yn-4-enoyl-coenzyme A,0
2320,Acyltransferase,"HIP14 protein, Drosophila",0
2321,Acyltransferase,"Mu Mom protein, bacteriophage Mu",0
2322,Acyltransferase,"Mboat4 protein, mouse",0
2323,Acyltransferase,"N-myristoyltransferase, mouse",0
2324,Acyltransferase,malonyl-coenzyme A-21-hydroxypregnane 21-O-malonyltransferase,0
2325,Adenine Nucleotides,RBI 1033,0
2326,Adenosine,kinetin riboside,0
2327,Adenosine Triphosphatases,"CAP-D3 protein, Drosophila",0
2328,Adenosine Triphosphatases,"HrtA protein, Staphylococcus aureus",0
2329,Adenosine Triphosphatases,"Snf2SR protein, S pombe",0
2330,Ca(2+)-Transporting ATPase,"ECA3 protein, Arabidopsis",0
2331,Ca(2+)-Transporting ATPase,"ACA2 protein, Arabidopsis",0
2332,Ca(2+)-Transporting ATPase,"SPCA2 protein, mouse",0
2333,Ca(2+)-Transporting ATPase,"ACA10 protein, Arabidopsis",0
2334,ADENYLATE KINASE,"Ak6 protein, Drosophila",0
2335,Adipates,"2,4,5-trihydroxy-3-methoxy-1,6-hexan-dioic acid",0
2336,Alcohol dehydrogenase,"ADH7 protein, human",0
2337,Alcohol Oxidoreductases,"retinol dehydrogenase 13, human",0
2338,Alcohol Oxidoreductases,"geraniol dehydrogenase, Carpoglyphus lactis",0
2339,Hexanols,2-ethyl-2-hexenol,0
2340,Aldehyde dehydrogenase (NAD+),"Aldh1a2 protein, mouse",0
2341,Aldehydes,isobicyclogermacrenal,0
2342,Aldehydes,lepidozenal,0
2343,Aldehydes,5-chloro-salicylaldehyde,0
2344,Aldehydes,"(E,Z)-5,7-dodecadienal",0
2345,Aldehydes,2-butyl-2-octenal,0
2346,Aldehydes,2-ethylhexenal,0
2347,Aldehydes,6-hydroxy-2H-pyran-3-carbaldehyde,0
2348,Aldehydes,aurocitrin,0
2349,Aldehyde Reductase,"YqhD protein, E coli",0
2350,Alginates,Biodritin,0
2351,Alkadienes,"2,5-dimethyl-1,6-heptadiene",0
2352,Alkaloids,CBT-1 (plant alkaloid),0
2353,Alkaloids,punarnavine,0
2354,Alkaloids,"10,11-dioxoerythratine",0
2355,Alkaloids,"10,11-dioxoepierythratidine",0
2356,Alkaloids,"10,11-dioxoerythratidinone",0
2357,Alkanes,bis(N-cyclobutylmethylmorphinan-3-yl) sebacoylate dihydrochloride,0
2358,Alkanes,siphonarienone,0
2359,Alkanes,"1,9-nonanedithiol",0
2360,Alkenes,cis-3-hexenyl cinnamate,0
2361,Alkenes,(Z)-pentacos-12-ene,0
2362,Alkenes,"trans-1,2-bis(4-cyanophenyl)ethene",0
2363,Alkenes,"3,4,5-trimethylenehepta-1,6-diene",0
2364,Alkenes,"4,4 -(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bis(phenol)",0
2365,Alkenes,tetramethyleneethane,0
2366,Alkenes,perfluoro-2-methyl-2-pentene,0
2367,Alkenes,bitungolide F,0
2368,Alkenes,sargahydroquinoic acid,0
2369,Alkenes,5-dimethylallylindole-3-carboxylic acid,0
2370,Alkenes,chrysogenamide A,0
2371,Alkynes,ortho-nitrophenylacetylene,0
2372,Alkynes,"9,10-epoxyheptadecan-4,6-diyn-3-one",0
2373,Alkynes,"1,4-bis(4-methoxyphenylethynyl)benzene",0
2374,Alkynes,scanlonenyne,0
2375,Alloys,Ti13Nb11Zr alloy,0
2376,Alloys,titanium aluminum alloy,0
2377,Allyl Compounds,allyl alpha-ionone,0
2378,Allyl Compounds,"5,6-O-isopropylidene-2-O-allylascorbic acid",0
2379,Allyl Compounds,"4-(1-propenyl)cyclopentane-1,2-diol",0
2380,alpha-Melanocyte stimulating hormone,Enkorten,0
2381,Amides,retrofractamide A,0
2382,Amides,N-(1-(2-(4-(2-methyl-3-(4-chlorophenyl)propionyl)-1-piperazinyl)-5-chlorophenyl)-3-methylbutyl)-3-(dimethylamino)propionamide,0
2383,Amides,3-ethylamino-2-(4-nitro-benzoyl)-but-2-enoic acid phenylamide,0
2384,Amides,DL-3-hydroxy-3-phenyl pentanamide,0
2385,Amides,N-(isopropyl)propionamide,0
2386,Amides,autantiamide acetate,0
2387,Amines,bis(amidoethyl-carbamoylethyl)octadecylamine,0
2388,Amines,"N'-(7-chloro-quinolin-4-yl)-N,N-dimethyl-ethane-1,2-diamine",0
2389,Amines,AG525E1,0
2390,Amino Acids,5-amino-2-((1-n-propyl-1H-imidazol-4-yl)methyl)pentanoic acid,0
2391,Amino Acids,2-(aminomethyl)-2-pentadecylheptadecanoic acid,0
2392,Amino Acids,N-methylnorcoronamic acid,0
2393,Amino Acids,polyoxamic acid,0
2394,Amino Acyl-tRNA Synthetases,"Zic4 protein, zebrafish",0
2395,Aminobutyrates,4-amino-3-fluorobutanoic acid,0
2396,Aminobutyrates,"2-amino-4-methylsulfanylbutyric acid 4-methoxy-6-(4-methoxybenzylamino)-2,2-dimethylchroman-3-yl ester",0
2397,Aminobutyrates,platensimide A,0
2398,Aminoglycosides,guanidinoneomycin B,0
2399,Aminoglycosides,A-102395,0
2400,Aminopeptidase,"Spt16 protein, S pombe",0
2401,Aminopyridines,"9-(((dimethylamino)sulfonyl)(methyl)amino)-N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidine-2-carboxamide",0
2402,Aminopyridines,"(3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridin-4-yl)(1-ethylpropyl)amine",0
2403,Aminopyridines,"N2,N6-bis(1,3-dimethylimidazolin-2-ylidene)pyridine-2,6-diamine",0
2404,Aminopyridines,"7-(7-amino-7-methyl-5-azaspiro(2.4)heptan-5-yl)-6-fluoro-1-(2-fluoro-1-cyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid",0
2405,Aminoquinolines,6-amino-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)-2-quinolinamine,0
2406,Aminosalicylic Acids,"N,N'-bis(5-aminosalicyl)cystine",0
2407,Transaminases,"2-amino-2-deoxyisochorismate synthase, Streptomyces globisporus",0
2408,Transaminases,"D-amino acid aminotransferase, Arabidopsis thaliana",0
2409,Transaminases,"branched-chain aminotransferase-3, Arabidopsis",0
2410,Amitriptyline,OMS 103HP,0
2411,Quaternary Ammonium Compounds,"poly(9,9-bis(6'-N,N,N-trimethylammonium)hexyl)fluorenephenylene bromide",0
2412,Quaternary Ammonium Compounds,hexadecyltrimethylammonium polymethacrylate,0
2413,Quaternary Ammonium Compounds,phenylenediammonium diperchlorate,0
2414,Quaternary Ammonium Compounds,ammonium dithionate,0
2415,Quaternary Ammonium Compounds,(2-hydroxyethyl) trimethylammonium hydroxide,0
2416,Quaternary Ammonium Compounds,ethylenediammonium sulfate,0
2417,Quaternary Ammonium Compounds,tetra-n-octylammonium formate,0
2418,Quaternary Ammonium Compounds,2-bromoethylammonium bromide,0
2419,Quaternary Ammonium Compounds,RP 12274,0
2420,Quaternary Ammonium Compounds,bis(12-(4'-octyloxy-4-azophenyl)dodecyloxy)dimethylammonium,0
2421,Quaternary Ammonium Compounds,"hexylidene-1,6-bis(dimethyloctadecylammonium)",0
2422,Quaternary Ammonium Compounds,3-dimethyl(methacryloyloxyethyl)ammonium propane sulfonate,0
2423,Quaternary Ammonium Compounds,meso-tetrakis(4-trimethylammoniumphenyl)porphyrin,0
2424,Androgen Binding Protein,"PARM-1 protein, human",0
2425,Androstadienes,delta1-cortienic acid,0
2426,Androstanes,"3,3-difluoro-5alpha-androstan-17-one",0
2427,Androstanols,3-hydroxyandrostane-17-carbonitrile,0
2428,Anhydrides,2-methyl-6-nitrobenzoic anhydride,0
2429,Anhydrides,glutamate anhydride,0
2430,Anhydrides,poly(octadecanoic anhydride),0
2431,Anhydrides,trimethyl carboxyphosphate,0
2432,Anilides,"3-((3,5-dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid",0
2433,Anilides,"2-((4-hydroxy-3-methoxybenzylidene)amino)-N-(2-methylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",0
2434,Anilides,"9,10-anthracene-bis(trifluoroacetylcarboxanilide)",0
2435,Anilides,"N-(2-iodo-4,6-dimethylphenyl)-2-methylbut-2-enamide",0
2436,Anilides,N-(2-((N-(4-phenoxypyridin-3-yl)acetamido)methyl)phenoxy)ethyl fluoride,0
2437,Aniline Compounds,Poly(aniline-2-sulfonic acid),0
2438,Aniline Compounds,4'-aminobenzo-15-crown-5,0
2439,Aniline Compounds,gem-dihalovinylaniline,0
2440,Aniline Compounds,2-phenylamino-3-methyl-6-di-n-butylaminofluoran,0
2441,Aniline Compounds,2-(2-((dimethylamino)methyl)-4-(2-fluoroethoxy)phenylthio)benzenamine,0
2442,Aniline Compounds,2-(2-((dimethylamino)methyl)-4-(3-fluoropropoxy)phenylthio)benzenamine,0
2443,Aniline Compounds,4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene,0
2444,Aniline Compounds,6-hydroxypropynyl-4-anilinoquinazoline,0
2445,Aniline Compounds,"4-tricyanovinyl-N,N-diethylaniline",0
2446,Aniline Compounds,PLAAP polymer,0
2447,Aniline Compounds,"2,4-bis(hydroxymethyl)aniline",0
2448,Aniline Compounds,navitoclax,0
2449,Aniline Compounds,"bis(2-(2,2-dimethylpropanoylamino)phenyl)disulfide",0
2450,Aniline Compounds,"2-(6-(2-trifluoromethylphenyl))-3-(hexen-1,5-diynyl)aniline",0
2451,Aniline Compounds,2-(4-hydroxyanilino)-4-(4-chlorophenyl)thiazole,0
2452,Aniline Compounds,N-(4-methoxy-2-nitrophenyl)hexadecanamide,0
2453,Aniline Compounds,poly(aniline-co-2-amino-4-hydroxybenzenesulfonic acid),0
2454,Anisoles,"1,4-bis(4-methoxyphenylethynyl)benzene",0
2455,Anisoles,"3,3',4,5'-tetramethoxystilbene",0
2456,Ant Venoms,"Myr p 3 allergen, Myrmecia pilosula",0
2457,Anthocyanins,cyanidin-3-(6-malonylglucoside),0
2458,Anthocyanins,cyanidin 3-xylosylrutinoside,0
2459,Anthocyanins,7-O-methylcyanidin 3-O-(6-O-(alpha-rhamnopyranosyl)-beta-galactopyranoside),0
2460,Anthracenes,"1,2,3,4-tetrachloro-5,6,7,8-tetrafluoro-9-methyltriptycene",0
2461,Anthracenes,"2-amino-2,3-dihydro-1H-cyclopenta(b)anthracene-2-carboxylic acid",0
2462,Anthracenes,"N,N'-2,6'-anthracenebis(oxamate)",0
2463,Anthracenes,bianthrone A2b,0
2464,Anthracenes,HL-37 compound,0
2465,Anthracenes,"9,10-anthracene-bis(trifluoroacetylcarboxanilide)",0
2466,Anthracenes,"poly(2,6-anthrylene)",0
2467,Anthracenes,terrylene,0
2468,Anthracenes,"9-(1',4',7',10',13'-pentaazacyclopentadecyl)methylanthracene",0
2469,Anthracenes,anthracenylmethyl homospermidine,0
2470,Anthraquinones,kaoxiadin,0
2471,Anthraquinones,chlorocyclinone C,0
2472,Anthraquinones,1-amino-4-bromoanthraquinone-2-sulfonic acid,0
2473,Anthraquinones,"2,6-diamino-9,10-anthraquinone",0
2474,Anthraquinones,tetraazaanthracenedione,0
2475,Anthraquinones,joziknipholone A,0
2476,Anthraquinones,joziknipholone B,0
2477,Anthraquinones,"2,6-dihydroxy-1-methoxy-3-methylanthraquinone",0
2478,Anthraquinones,alpomycin,0
2479,Anthraquinones,gaudimycin C,0
2480,Anthraquinones,1403P-3 compound,0
2481,Anthraquinones,Acid Blue 40,0
2482,Anthraquinones,hydroxyanthraquinone-aminopropyl methyl morpholinium methosulfate,0
2483,Anthraquinones,marcanine A,0
2484,Antibodies,tenoten,0
2485,Monoclonal Antibodies,1D4.1-325 DVD-Ig protein,0
2486,Monoclonal Antibodies,Fab MOR03268,0
2487,Monoclonal Antibodies,ofatumumab,0
2488,Monoclonal Antibodies,188Re-anti-CD20 monoclonal antibody,0
2489,Monoclonal Antibodies,necitumumab,0
2490,Monoclonal Antibodies,TSK114 monoclonal antibody,0
2491,Monoclonal Antibodies,1D09C3 monoclonal antibody,0
2492,Monoclonal Antibodies,213Bi-cDTPA-9.2.27 monoclonal antibody,0
2493,Monoclonal Antibodies,F8 monoclonal antibody,0
2494,Monoclonal Antibodies,golimumab,0
2495,Monoclonal Antibodies,2G12 monoclonal antibody,0
2496,Monoclonal Antibodies,64Cu-DOTA-1C1,0
2497,Monoclonal Antibodies,rhuMAb2H7,0
2498,"Antigens, Bacterial","YtgA protein, Chlamydia trachomatis",0
2499,"Antigens, Bacterial","31-kDa cell surface protein, Brucella abortus",0
2500,"Antigens, Bacterial","rv3879c antigen, Mycobacterium tuberculosis",0
2501,"Antigens, Bacterial","ES-20 protein, Mycobacterium tuberculosis",0
2502,"Antigens, Ly","Ncr1 protein, mouse",0
2503,"Antigens, Ly","Ly11 protein, mouse",0
2504,"Antigens, Ly","Ly6 protein, mouse",0
2505,"Antigens, Ly","Ly33 protein, mouse",0
2506,"Antigens, Ly","Ly7 protein, mouse",0
2507,"Antigens, Ly","Ncr3 protein, mouse",0
2508,"Antigens, Ly","Klrb1c protein, mouse",0
2509,"Antigens, Neoplasm","CTAG2 protein, human",0
2510,"Antigens, Neoplasm","colon cancer-specific antigen 2, human",0
2511,"Antigens, Neoplasm","CDCP1 protein, mouse",0
2512,"Antigens, Neoplasm","colorectal carcinoma-associated antigen, human",0
2513,"Antigens, Neoplasm","POTE-2alpha protein, human",0
2514,"Antigens, Neoplasm","POTE-2beta protein, human",0
2515,"Antigens, Neoplasm","POTE-2gamma protein, human",0
2516,Surface Antigens,"STRO-1 antigen, rat",0
2517,"Antigens, Viral","VP2 protein, porcine parvovirus",0
2518,"Antigens, Viral","EBNA-6 protein, human herpesvirus 4",0
2519,Antimony,antimony pentafluoride,0
2520,Antineoplastic Combined Chemotherapy Protocols,Xeloda-Oxaliplatin Regimen,0
2521,Aporphines,anonaine,0
2522,Aporphines,isofiliformine,0
2523,Aporphines,"1,2-methylenedioxy-3,10,11-trimethoxyaporphine",0
2524,Arachidonic Acids,arachidonoyltaurine,0
2525,Ascorbic Acid,pQ510 compound,0
2526,Aspartic Acid,copoly(aspartic acid-glutamic acid),0
2527,Aurovertins,aurovertin F,0
2528,Aurovertins,aurovertin G,0
2529,Aurovertins,aurovertin H,0
2530,Autoantigens,"NALP5 protein, human",0
2531,Autoantigens,"Hom s 2 autoantigen, human",0
2532,Avidin,PEI600-avidin,0
2533,Aza Compounds,"6-ethyl-1,4-dioxo-1,2,2a,3,4,6,7,7b-octahydro-5H-2,3,4a,6,7a-pentaazacyclopenta(cd)indene-2a,7b-dicarboxylate",0
2534,Aza Compounds,"6-ethyl-2a,7b-diphenyl-1,2,2a,3,4,6,7,7b-octahydro-5H-2,3,4a,6,7a-pentaazacyclopenta(cd)indene-1,4-dione",0
2535,Aza Compounds,"8,8,10,10-tetramethyl-1-azaspiro(5.5)undecane",0
2536,Azepines,"8-oxo-5,6,7,8-tetrahydro-thiazolo(3,2-a)(1,3)diazepin-3-carboxylate",0
2537,Azepines,5-tert-butylazepan-2-one,0
2538,Azepines,palmitoylcaprazol,0
2539,Azepines,"5,7-dihydro-6H-dibenz-(b,d)azepin-6-one",0
2540,Azepines,"N-(2-(((4-fluorobenzyl)amino)carbonyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido(1,2-a)azepin-10-yl)-N,N',N'-trimethylethanediamide",0
2541,Azepines,cazpaullone,0
2542,Azepines,stemonamine,0
2543,Azetidines,3-azido-4-oxoazetidine-2-carbaldehyde,0
2544,Azides,14-azidotetradecanoyl-CoA,0
2545,Azides,"N-(2-N-(N-(4-azido-2,5-difluoro-3-chloropyridin-6-yl)-3-aminopropionyl)aminoethyl)-2'-deoxycytidine-5'-triphosphate",0
2546,Azides,"2,3-dimethoxycinnamoyl azide",0
2547,Aziridines,"5-aziridinyl-3-hydroxyl-1-methylindole-4,7-dione",0
2548,Aziridines,di-tert-butyldiaziridinone,0
2549,Azo Compounds,4-hydroxy-4'-nitroazobenzene,0
2550,Azo Compounds,basic brown 1,0
2551,Azo Compounds,p-isopropylazobenzene,0
2552,Azo Compounds,naphthyl red,0
2553,Azo Compounds,acid orange 51,0
2554,Azo Compounds,bis(12-(4'-octyloxy-4-azophenyl)dodecyloxy)dimethylammonium,0
2555,Azo Compounds,X6G azo-dye light yellow,0
2556,Azo Compounds,Red BLI,0
2557,Azocines,"N-benzyl-N-(6,7,8,9,10,11-hexahydro-13H-azocino(2,1-b)quinazolin-13-ylidene)amine",0
2558,Bacterial Outer Membrane Proteins,"OipA protein, Helicobacter pylori",0
2559,Bacterial Outer Membrane Proteins,"Ail protein, Yersinia pestis",0
2560,Bacterial Outer Membrane Proteins,"NanC protein, E coli",0
2561,Bacterial Outer Membrane Proteins,"TolR protein, Haemophilus influenzae",0
2562,Bacterial Proteins,"eryF protein, Saccharopolyspora erythraea",0
2563,Bacterial Proteins,"cyclic lipopeptide, Bacillus subtilis",0
2564,Bacterial Proteins,"opdA protein, Sphingomonas",0
2565,Bacterial Proteins,"BB0365 protein, Borrelia burgdorferi",0
2566,Bacterial Proteins,"31-kDa cell surface protein, Brucella abortus",0
2567,Bacterial Proteins,"YczE protein, Bacillus amyloliquefaciens",0
2568,Bacterial Proteins,"Rv2560 protein, Mycobacterium tuberculosis",0
2569,Bacterial Proteins,"Rv2629 protein, Mycobacterium",0
2570,Bacterial Proteins,"TerB protein, Klebsiella pneumoniae",0
2571,Bacterial Proteins,"PPE68 protein, Mycobacterium tuberculosis",0
2572,Bacterial Proteins,"WaaL protein, Pseudomonas aeruginosa",0
2573,Bacterial Proteins,"TeiR protein, Comamonas testosteroni",0
2574,Bacterial Toxins,"cholix toxin, Vibrio cholerae",0
2575,bacteriocin,"cerein MRX1, Bacillus cereus",0
2576,bacteriocin,"kimchicin GJ7, Leuconostoc citreum GJ7",0
2577,bacteriocin,"corrodecin, Eikenella corrodens",0
2578,bacteriocin,"bacteriocin E 50-52, Enterococcus faecium",0
2579,bacteriocin,bacteriocin J46,0
2580,Benzaldehydes,"2,4,6-trimethylbenzaldehyde",0
2581,Benzaldehydes,3-chloro-4-methoxybenzaldehyde,0
2582,Benzaldehydes,darapladib,0
2583,Benzalkonium Compounds,"1,4-butyl-bis(dimethyldodecylammonium bromide)",0
2584,Benzalkonium Compounds,"1,12-dodecyl-bis(dimethyldodecylammonium bromide)",0
2585,Benzamides,"2,5-dihydroxy-N-(2-hydroxyethyl)benzamide",0
2586,Benzamides,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,0
2587,Benzamides,"4-chloro-N-(2,2-dichloro-1-(N'-(6-chloropyridin-3-yl)-N''-cyanoguanidino)propyl)benzamide",0
2588,Benzamides,"N,N',N''-tris(bis(sodium methyl phosphate)isophthalyl)-1,3,5-benzenetricarboxamide",0
2589,Benzamides,(R)-xanthoanthrafil,0
2590,Benzamides,2-chloro-N-(diethylcarbamothioyl)benzamide,0
2591,Benzamides,N-(4-chlorobenzoyl)-N-(3-methoxypropyl)-1-(2-phenylethyl)-3-piperidinamine,0
2592,Benzamides,"N-(6-Chloropyridin-3-yl)-3,4-difluorobenzamide",0
2593,Benzamides,naphthyl red,0
2594,Benzamides,4-fluoro-N-indan-2-yl-benzamide,0
2595,Benzamides,"N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide",0
2596,Benzamides,S 0859 compound,0
2597,Benzamides,N-(4-((1E)-3-oxo-3-(3-pyridinyl)-1-propenyl)phenyl)benzamide,0
2598,Benzamides,"4-methyl-N-(2,2,2-trichloro-1-(4-nitrophenylsulfanyl)ethyl)benzamide",0
2599,Benzamides,N-(3-phenethoxybenzyl)-4-hydroxybenzamide,0
2600,Benzamides,balicatib,0
2601,Benzamides,desiodoflubendiamide,0
2602,Benzamides,YM 758,0
2603,Benzamides,benzamidenafil,0
2604,Benzamides,"4-(5-(4-(aminoiminomethyl)phenoxy)5,4pentyloxy)-3-methoxy-N,N,-bis(1-methylethyl)benzamide-2-butenedionate",0
2605,Benzamides,2-amino-4-chloro-N-(1-(4-phenyl-1-(propylsulfonyl)piperidin-4-yl)ethyl)benzamide,0
2606,Benz(a)Anthracenes,parviflorene F,0
2607,Benzazepines,"1-phenyl-3-methyl-8-hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepine",0
2608,Benzazepines,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",0
2609,Benzazepines,"8-chloro-2,3,4,5-tetrahydro-5-phenyl-1H-3-benzazepin-7-ol",0
2610,Benzazepines,"7-chloro-8-hydroxy-3-(3'-fluoropropyl)-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine",0
2611,Benzazepines,"7-chloro-8-hydroxy-1-(4'-formylphenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine",0
2612,Benzazepines,"5-(4'-aminophenyl)-8-chloro-2,3,4,5-tetrahydro-3-methy-1H-3-benzazepin-7-ol",0
2613,Benzazepines,"7-chloro-8-hydroxy-3-(6-(N,N-dimethylamino)hexyl)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-cyanoborane",0
2614,Benzazepines,"7-chloro-8-hydroxy-3-(6-(dimethylamino)hexyl)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine",0
2615,Benzazepines,2'-tricarbonylcyclopentadienylrhenium-SCH-23390,0
2616,Benzazepines,3'-tricarbonylcyclopentadienylrhenium-SCH-23390,0
2617,Benzazepines,RWJ-339489,0
2618,Benzazepines,JNJ-17158063,0
2619,Benzazepines,RWJ-676070,0
2620,Benzene Derivatives,"1,2-dilithiobenzene",0
2621,Benzene Derivatives,4-hydroxy-4'-nitroazobenzene,0
2622,Benzene Derivatives,hexakis(4-(N-butylpyridylium))benzene,0
2623,Benzene Derivatives,"dimesityl-2,4,6-trimethoxyphenylmethane",0
2624,Benzene Derivatives,p-methoxy-diphenyl diselenide,0
2625,Benzenesulfonates,AMG 076,0
2626,Benzenesulfonates,vertigo blue 49,0
2627,Benzenesulfonates,5-bromo-2-((2-iodoacetyl)amino)benzenesulfonic acid,0
2628,Benzenesulfonates,5-amino-2-chlorotoluene-4-sulfonic acid,0
2629,Benzenesulfonates,"5,10,15,20-tetrakis(4-sulfophenyl)porphyrinatoiron(II)",0
2630,Benzenesulfonates,trans-4-(4-(dimethylamino)styryl)-1-methylpyridinium-p-toluenesulfonate,0
2631,Benzenesulfonates,X6G azo-dye light yellow,0
2632,Benzenesulfonates,phenylhydrazonopyrazolone sulfonate 1,0
2633,Benzhydryl Compounds,fesoterodine,0
2634,Benzhydryl Compounds,bis-4-cyanophenylmethanol,0
2635,Benzimidazoles,"6-anilino-5-chloro-1H-benzo(d)imidazole-4,7-dione",0
2636,Benzimidazoles,"2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide",0
2637,Benzimidazoles,1-isopropyl-3-methylbenzimidazole-2-selenone,0
2638,Benzimidazoles,"2,4,6-tris(4-((2-methylbenzimidazol-1-yl)methyl)phenyl)-1,3,5-triazine",0
2639,Benzimidazoles,"1,3,5-tris(4-((2-methylbenzimidazol-1-yl)methyl)phenyl)benzene",0
2640,Benzimidazoles,m-benziphthalocyanine,0
2641,Benzimidazoles,"benzimidazolo(2,1-b)benzo(e)thiazepin-5(10H)-one",0
2642,Benzimidazoles,5-methyl-2-(4-methylphenyl)-1H-benzimidazole,0
2643,Benzimidazoles,"2-(3,5-dimethylpiperazin-1-yl)-1-(1-(1-methylcyclooctyl)piperidin-4-yl)-1H-benzimidazole",0
2644,Benzimidazoles,2-chloro-4-methylbenzimidazole nucleoside,0
2645,Benzimidazoles,1-(1-(1-methylcyclooctyl)-4-piperidinyl)-2-((3R)-3-piperidinyl)-1H-benzimidazole,0
2646,Benzimidazoles,N-1H-benzimidazol-5-ylbenzenesulfonamide,0
2647,Benzimidazoles,2-(6-((2-(3-hydroxypropyl)-5-methylphenylamino)methyl)-2-(3-morpholin-4-ylpropylamino)benzoimidazol-1-ylmethyl)-6-methylpyridin-3-ol,0
2648,Benzimidazoles,"N-cyclohexyl-6-(((2-methoxyethyl)(methyl)amino)methyl)-N-methylthiazolo(3,2-a)benzimidazole-2-carboxamide",0
2649,Benzimidazoles,"N-((1S)-1-(aminocarbonyl)-2,2-dimethylpropyl)-3-(3-hydroxy-3-methylbutyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide",0
2650,Benzimidazoles,"1,5-bis(4-(5-methoxy-1H-benzimidazole-2-yl)phenoxy)pentane",0
2651,Benzimidazoles,BMS-566394,0
2652,Benzimidazoles,5-chloro-2-((1-ethyl-1-methylpropyl)thio)-6-(4-(2-hydroxyethyl)piperazin-1-yl)-1H-benzimidazole,0
2653,Benzimidazoles,2-(tert-butylthio)-5-chloro-6-((2R)-4-(2-hydroxyethyl)-2-methylpiperazin-1-yl)-1H-benzimidazole,0
2654,Benzoates,cinnamyl benzoate,0
2655,Benzoates,N-acetyl-N-(2-methoxycarbonylbenzyl)-2-phenoxyaniline,0
2656,Benzoates,7-(3-((4-hydroxyphenyl)butyl) glucopyranosid-O-6-yl) 4-O-glucopyranosylvanillin,0
2657,Benzoates,KP-496,0
2658,Benzoates,HZL 7 compound,0
2659,Benzoates,biphenylcarboxylic acid butanediol ester,0
2660,Benzodiazepines,RS 678,0
2661,Benzodiazepines,RS 779,0
2662,Benzodiazepinones,"1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one",0
2663,Benzodiazepinones,Z-360,0
2664,Benzodiazepinones,"2-(((3,5-difluorophenyl)acetyl)amino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide",0
2665,Benzodiazepinones,circumdatin I,0
2666,Benzoflavones,"2-pyridin-7,6-benzoflavone",0
2667,Benzofurans,CH 4512600,0
2668,Benzofurans,hordatine A,0
2669,Benzofurans,hordatine B,0
2670,Benzofurans,"5-hydroxy-7-methoxy-4,6-dimethylphthalide",0
2671,Benzofurans,usimine A,0
2672,Benzofurans,usimine B,0
2673,Benzofurans,usimine C,0
2674,Benzofurans,phomodione,0
2675,Benzofurans,dimethyl lithospermate,0
2676,Benzophenones,"4,4-bis(3-pyridinemethoxy)benzophenone",0
2677,Benzophenones,morintrifolin A,0
2678,Benzophenones,morintrifolin B,0
2679,Benzophenones,benzophenone-N-methylphthalimide,0
2680,Benzophenones,garciniaphenone,0
2681,Benzophenones,garcinielliptone HF,0
2682,Benzophenones,benzophenone 4-aminobenzoylhydrazone,0
2683,Benzophenones,"2,4',6-trihydroxy-4-methoxybenzophenone-2-O-glucoside",0
2684,Benzophenones,4-carboxybenzophenone,0
2685,Benzopyrans,kuraridinol,0
2686,Benzopyrans,daedalin A,0
2687,Benzopyrans,"N-(4-(2-(8-cyano-1,3a,4,9b-tetrahydro(1)benzopyrano(3,4-c)pyrrol-2(3H)-yl)ethyl)phenyl)acetamide",0
2688,Benzopyrans,3-(3-(4-(dimethylamino)phenyl)propenoyl)-2H-chromen-2-one,0
2689,Benzopyrans,"2-amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-4,7-dihydro-7-methylpyrano(2,3-e)indole",0
2690,Benzopyrans,dankastatin A,0
2691,Benzopyrans,dankastatin B,0
2692,Benzopyrans,kasanosin A,0
2693,Benzopyrans,kasanosin B,0
2694,Benzopyrans,"1-(((3-(dimethylamino)propyl)(methyl)amino)methylene)-7,11-dihydroxy-4-(methoxymethyl)-4a,6a-dimethyl-2,10-dioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno(4,5-h)isochromene-5-yl acetate",0
2695,Benzopyrans,KR-31762,0
2696,Benzopyrans,SC-75416,0
2697,Benzopyrans,NIP 151,0
2698,Benzopyrans,"7,3',4'-trihydroxy-3-benzyl-2H-chromene",0
2699,Benzopyrans,"2-amino-4-methylsulfanylbutyric acid 4-methoxy-6-(4-methoxybenzylamino)-2,2-dimethylchroman-3-yl ester",0
2700,Benzopyrans,"7-(isopropoxymethyl)-5-phenyl-7,8-dihydro-5H-(1,3)dioxolo(4,5-g)isochromene",0
2701,Benzothiadiazines,A 837093,0
2702,Benzoxazoles,4-amino-7-nitrobenzofurazan,0
2703,Benzoxazoles,4-sulfamoyl-7-aminobenzofurazan,0
2704,Benzoxazoles,5-methyl-2-(4-methylaminophenyl)benzoxazole,0
2705,Benzyl Compounds,benzyl cinnamate,0
2706,Benzyl Compounds,"(N-(4-(2,2,2-trifluoroethyl) benzylidene) (7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl) meth-anamine)",0
2707,Benzyl Compounds,"2,5-bis(4-methoxybenzylidene) cyclopentanone",0
2708,Benzyl Compounds,2-(4-fluorobenzylideneamino)-3-(4-hydroxyphenyl) propanoic acid,0
2709,Benzyl Compounds,"3,3,7,7-tetra(N-ethyl-N-benzyl(acetamide)-2-oxymethyl)-5- oxanonane",0
2710,Benzyl Compounds,p-hydroxybenzylideneimidazolinone,0
2711,Benzyl Compounds,amino-p-hydroxybenzylideneimidazolinone,0
2712,Benzylamines,"2-(N,N-dibenzylamino)butane-1,3-diol",0
2713,Benzylamines,"N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)-5-fluorobenzylamine",0
2714,Benzylamines,"N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)-5-bromobenzylamine",0
2715,Benzylamines,"N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)-5-iodobenzylamine",0
2716,Benzylidene Compounds,UPR1024,0
2717,Berberine Alkaloids,chelamine,0
2718,beta-Lactamase,"beta-lactamase IMP-18, Pseudomonas aeruginosa",0
2719,beta-Lactamase,"beta-lactamase CTX-M-57, Salmonella typhimurium",0
2720,Bibenzyls,"4,5-dihydroxy-3,3',alpha-trimethoxybibenzyl",0
2721,Bibenzyls,"4,4'-dihydroxy-3,3',5,alpha-tetramethoxybibenzyl",0
2722,Bibenzyls,"4-hydroxy-3,3',4',5,alpha-pentamethoxybibenzyl",0
2723,Bridged Bicyclo Compounds,"(8S,9S,10S)-8,10-dimethyl-1-octalin",0
2724,Bridged Bicyclo Compounds,Phosphabicyclononane,0
2725,Bridged Bicyclo Compounds,"1 alpha,3 alpha,5 alpha-3-aminomethyl-bicyclo(3.2.0)heptane-3-acetic acid",0
2726,Bridged Bicyclo Compounds,"5-hydroxymethyl-7,7,N-trimethyl-6-oxabicyclo(3.2.1)octane-1-carboxamide",0
2727,Bridged Bicyclo Compounds,phyllostoxin,0
2728,Bridged Bicyclo Compounds,3-methyl-6-phenyl-3-aza-bicyclo(4.1.0)heptane,0
2729,Biphenyl Compounds,YR301,0
2730,Biphenyl Compounds,4-cyano-4'-ethynylbiphenyl,0
2731,Biphenyl Compounds,odanacatib,0
2732,Biphenyl Compounds,L-873724,0
2733,Biphenyl Compounds,"1-terpyridyl-2,3,4,5,6-pentaphenylbenzene",0
2734,Biphenyl Compounds,"N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-(1,1'-biphenyl)-3-acetamide",0
2735,Biphenyl Compounds,diapocynin,0
2736,Biphenyl Compounds,biphenylcarboxylic acid butanediol ester,0
2737,Biphenyl Compounds,(2R)-((4-biphenylylsulfonyl)amino)-N-hydroxy-3-phenylpropionamide,0
2738,Boranes,9-Fluorenemethyl boranophosphonate,0
2739,Boranes,8-ethynyl-(2-para-carboran)-2'-deoxyadenosine,0
2740,Boranes,tris(perfluorophenyl)borane,0
2741,Borates,4-(2-(3-methoxyphenyl)ethenyl)-N-methylpyridinium tetraphenylborate,0
2742,Borates,1-hexyl-3-methylimidazolium,0
2743,Borates,N-(4-diazophenyl)maleimide tetrafluoroborate,0
2744,Camphanes,"bornyl (3,4,5-trihydroxy)-cinnamate",0
2745,Boron Compounds,4-iodo-4'-boranylchalcone,0
2746,Boron Compounds,BODIPY-LacCer,0
2747,Boron Compounds,"4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene",0
2748,Boron Compounds,ABEA-X-BY630,0
2749,Boron Compounds,4-(BODIPYFL-amino)-3-phenyllactic acid,0
2750,Boron Compounds,1-amino-closo-dodecaborate,0
2751,Boron Compounds,bodipy FL N-(2-aminoethyl)maleimide,0
2752,Boronic Acids,delanzomib,0
2753,Botulinum Toxins,CNBTX-A,0
2754,Bridged-Ring Compounds,"2',4'-BNA(NC)",0
2755,Bridged-Ring Compounds,PF1270A,0
2756,Bridged-Ring Compounds,PF1270C,0
2757,Bridged-Ring Compounds,PF1270B,0
2758,Bridged-Ring Compounds,gymnastatin Q,0
2759,Bridged-Ring Compounds,gymnastatin R,0
2760,Bridged-Ring Compounds,plagiochin E,0
2761,Bridged-Ring Compounds,platensimide A,0
2762,Bufanolides,3-acetyl 15beta-hydroxyl bufotalin,0
2763,Butadienes,"1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene",0
2764,Butadienes,poly(butadiene)107-poly(L-lysine)27,0
2765,Butadienes,poly-(butadiene-b-ethylenoxide),0
2766,Butadienes,"1,4-diphenylbut-2-ene-1,4-dione",0
2767,Butylene Glycols,"1,4-bis(thymin-1-yl)butane-2,3-diol",0
2768,Butylene Glycols,"2-(N,N-dibenzylamino)butane-1,3-diol",0
2769,Butanes,"4-(1,2-epoxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one",0
2770,Butanes,"3-methyl-4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",0
2771,Butanes,"4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",0
2772,Butanes,"1,3-dimethyl-3-butenyl salicylate",0
2773,Butanes,3-methyl-2-butenyl salicylate,0
2774,Butanes,"2,2'-di-tert-butyl-7,7'-dihydroxy-8,8'-biquinolyl",0
2775,Butanes,"2,3- O-isopropylidene-2,3-dihydroxyl-1,4-bis(diphenylphosphino)butane",0
2776,Butanes,octacyanobutanediide,0
2777,Butanes,"1,1-diethoxybut-2-ene",0
2778,Butanones,cis-alpha-damascone,0
2779,Butanones,2-butanone peroxide,0
2780,Butyrates,tert-butyl 3-tosyloxybutanoate,0
2781,Butyrates,S-tert-butyl 3-tosyloxybutanethioate,0
2782,Butyrates,"ethyl-3,4-epoxybutyrate",0
2783,C-reactive protein,"CrOctin protein, Carcinoscorpius rotundicauda",0
2784,Caffeic Acids,2-butyl-5-hydroxyphenyl dihydrocaffeate,0
2785,Caffeic Acids,"(R,S)-7-hydroxy-7-(3,4-dihydroxyphenyl)-ethyl-O-alpha-L-rhamnopyranosyl(1-3)-beta-d-(6-O-caffeoyl)-glucopyranoside",0
2786,Caffeic Acids,calceolarioside B,0
2787,Caffeic Acids,rosemarinic acid,0
2788,Calcium Phosphates,biocement D,0
2789,Calcium Phosphates,socket graft,0
2790,Calcium-Binding Proteins,"Eps15 protein, rat",0
2791,Calcium-Binding Proteins,"FRQ2 protein, Drosophila",0
2792,Calcium-Binding Proteins,"cetn4 protein, Xenopus",0
2793,Calcium-Binding Proteins,"Che a 3 allergen, Chenopodium album",0
2794,Calpain,"CAPNS1 protein, human",0
2795,Caprylates,"methyl (4E,7R)-7-hydroxyoctanoate",0
2796,Caprylates,"1,3-propanediol dicaprylate",0
2797,Capsaicin,ALGRX-4975,0
2798,Carbamates,pentyl 4-(N-doxazolidinylcarbonyloxymethyl)phenylcarbamate,0
2799,Carbamates,2-isopropylphenyl-N-methylcarbamate,0
2800,Carbamates,4-(hydroxybutyl)carbamic acid 2-(5-(1-(2-amino-2-methylpropionylamino)-2-benzyloxyethyl)tetrazol-1-yl)ethyl ester,0
2801,Carbamates,AVN 944,0
2802,Carbamates,5-(2-(3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)acetylamino)hexylcarbamic acid tert-butyl ester,0
2803,Carbamates,"(1,1'-biphenyl)-3-yl (2-(5-hydroxy-1H-indol-3-yl)ethyl)carbamate",0
2804,Carbamates,"(1-(N'-(4-hydroxy-4-(2-hydroxyindan-1-ylcarbamoyl)-5-phenylpentyl)-N'-(4-pyridin-4-ylbenzyl)hydrazinocarbonyl)-2,2-dimethylpropyl)carbamic acid methyl ester",0
2805,Carbazoles,"3,6-di(spirobifluorene)-N-phenylcarbazole",0
2806,Carbazoles,clausamine A,0
2807,Carbazoles,clausevatine D,0
2808,Carbazoles,clausamine B,0
2809,Carbazoles,clausamine C,0
2810,Carbazoles,murrayazoline,0
2811,Carbocyanines,benzothiazole styrylcyanine,0
2812,Carbocyanines,"3,3'-diethyl-2,2'-thiatricarbocyanine",0
2813,Carbolines,beta-carboline-3-carboxylic acid N-methylamide,0
2814,Carbolines,DH334 compound,0
2815,Carbolines,bengacarboline,0
2816,Carbolines,dichotomine C,0
2817,Carbolines,eudistomin Y6,0
2818,Carbolines,methoxy-annomontine,0
2819,Carbolines,naucleamide A-10-O-glucopyranoside,0
2820,Carbolines,"1-styryl-9H-pyrido(3,4-b)indole",0
2821,Carbolines,9-methyl-beta-carboline,0
2822,Carboxylic Acids,"3,5-pyrazoledicarboxylic acid",0
2823,Carboxylic Acids,"8-oxo-5,6,7,8-tetrahydro-thiazolo(3,2-a)(1,3)diazepin-3-carboxylate",0
2824,Carboxylic Acids,1-amino-2-phenylcyclopentane-1-carboxylic acid,0
2825,Carboxylic Acids,2-formyl-6-naphthoic acid,0
2826,Carboxylic Acids,1-amino-3-(2-iodoethenyl)cyclobutane-1-carboxylic acid,0
2827,Carboxylic Acids,1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid,0
2828,Carboxylic Ester Hydrolases,"SAY1 protein, S cerevisiae",0
2829,Carboxylic Ester Hydrolases,"Ptrh2 protein, mouse",0
2830,Carboxylic Ester Hydrolases,"L-ascorbate 6-phosphate lactonase, E coli",0
2831,Carcinoembryonic Antigen,"CEACAM5 protein, human",0
2832,Cardenolides,griffithin,0
2833,Cardiolipins,tetramyristoyl cardiolipin,0
2834,Carotenoids,"3,4-didehydrorhodopin",0
2835,Carotenoids,20-desmethyl-beta-carotene,0
2836,Carrier Proteins,rD-7 peptide,0
2837,Carrier Proteins,"A27 protein, vaccinia virus",0
2838,Carrier Proteins,"Zasp52 protein, Drosophila",0
2839,Carrier Proteins,"Naf1alpha protein, human",0
2840,Carrier Proteins,"Mub1 protein, S cerevisiae",0
2841,Carrier Proteins,"HRB1 protein, Arabidopsis",0
2842,Carrier Proteins,"HYPK protein, human",0
2843,Carrier Proteins,"ebitein1 protein, mouse",0
2844,Carrier Proteins,"Nkain1 protein, mouse",0
2845,Carrier Proteins,alanyl-glutamyl-seryl-asparagyl-glutamyl-aspartyl-glycyl-tyrosine,0
2846,Carrier Proteins,"Rip11 protein, mouse",0
2847,Carrier Proteins,"TARSH protein, mouse",0
2848,Carrier Proteins,"Keap1a protein, zebrafish",0
2849,Carrier Proteins,"Keap1b protein, zebrafish",0
2850,Carrier Proteins,"CTMP protein, mouse",0
2851,Carrier Proteins,"PPP1R16A protein, mouse",0
2852,Carrier Proteins,"Tex15 protein, mouse",0
2853,Carrier Proteins,"kif1bp protein, zebrafish",0
2854,Carrier Proteins,"Mig-14 protein, C elegans",0
2855,Carrier Proteins,"MMgT1 protein, mouse",0
2856,Carrier Proteins,"MMgT2 protein, mouse",0
2857,Carrier Proteins,"gemin2 protein, zebrafish",0
2858,Carrier Proteins,"Vangl1 protein, mouse",0
2859,Carrier Proteins,"GSARP1 protein, mouse",0
2860,Carrier Proteins,"PDLP1a protein, Arabidopsis",0
2861,Carrier Proteins,affibody protein ZAbeta3,0
2862,Carrier Proteins,"Scube1 protein, rat",0
2863,Carrier Proteins,"Wech protein, Drosophila",0
2864,Carrier Proteins,"traf3ip1 protein, zebrafish",0
2865,Carrier Proteins,"spastizin protein, human",0
2866,Carrier Proteins,"spastizin protein, rat",0
2867,Carrier Proteins,"SGT-1 protein, C elegans",0
2868,Carrier Proteins,"Vps74 protein, S cerevisiae",0
2869,Carrier Proteins,"RME-4 protein, C elegans",0
2870,Carrier Proteins,"Pirt protein, mouse",0
2871,Carrier Proteins,"APOA1BP protein, mouse",0
2872,Carrier Proteins,"CLVS1 protein, human",0
2873,Carrier Proteins,"Tpz1 protein, S pombe",0
2874,Carrier Proteins,"FNIP2 protein, human",0
2875,Carrier Proteins,"Myr1 protein, S cerevisiae",0
2876,Carrier Proteins,"Upf2 protein, mouse",0
2877,Carrier Proteins,"RPC6 protein, mouse",0
2878,Carrier Proteins,"Afi1 protein, S cerevisiae",0
2879,Carrier Proteins,"RNF24 protein, human",0
2880,Carrier Proteins,"VprBP protein, human",0
2881,Caseins,beta-casein F (133-138),0
2882,Catechols,gingerol,0
2883,Catechols,4-ethylcatechol,0
2884,Catechols,"2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone",0
2885,Catechols,inoscavin E,0
2886,Cathepsins,"CsCF-6 protein, Clonorchis sinensis",0
2887,Cephalosporins,FR 295389,0
2888,Ceramides,N-tetracosanoyl-(L)-serine tetradecyl ester,0
2889,Ceramides,D-erythro-2-N-(160-(1''-pyridinium)hexadecanoyl)sphingosine bromide,0
2890,Ceramides,N-(5-dodecyl-4-hydroxytetrahydrofuran-3-yl)-2-hydroxyheptadecanamide,0
2891,Ceramides,XM 462,0
2892,Ceramides,PC 104,0
2893,Ceramides,Bio 391,0
2894,Cerebrosides,"1-O-beta-D-glucopyranosyl-(2S,3R,4E,11E)-2-((2(R)-hydroxydocosanoyl) amido)-4,11-hexadecanediene-1,3-diol",0
2895,Cerebrosides,dicliptercerebroside,0
2896,Chlorobenzenes,"3-(2-chlorophenyl)-1-(2-hydroxy-4, 6-dimethoxy-3-((ethyl(methyl) amino)methyl)phenyl)prop-2-en-1-one",0
2897,Chlorobenzenes,dihydropyrazole-1-carboxylic acid-(4-chlorophenyl amide),0
2898,Chlorobenzoates,acremonisol A,0
2899,Cholestadienes,"24-ethyl-5alpha-cholesta-7,22(E)-dien-3-one",0
2900,Cholestadienes,"6-hydroximino-24-ethylcholest-4,22-dien-3-one",0
2901,Cholestenones,"cholesta-1,4-dien-3-one",0
2902,Cholestenones,alisol B 23-acetate,0
2903,Cholestenones,alisolide,0
2904,Cholestenones,alisol P,0
2905,Cholestenones,6-hydroximino-24-ethylcholest-4-en-3-one,0
2906,Cholestenones,6-hydroximinocholest-4-en-3-one,0
2907,Cholestenones,"6-hydroximino-24-ethylcholest-4,22-dien-3-one",0
2908,Cholic Acids,lucidenic acid B,0
2909,Cholic Acids,lucidenic acid C,0
2910,Cholic Acids,"3alpha,12alpha-dihydroxy-5beta-cholan-24-amine",0
2911,Choline Kinase,"choline kinase alpha, mouse",0
2912,Chondroitin Sulfates,Biodritin,0
2913,Chromans,"(3,4-trans)-1-oxo-4-undecyl-isothiochroman-3-carboxylic acid",0
2914,Chromans,SPD-304,0
2915,Chromans,"6,6',7,7'-tetrahydroxy-4,4,4',4'-tetramethyl-2,2'-spirobichroman",0
2916,Chromans,2-(4-hydroxyphenyl)-8-(3-methyl-but-2-enyl)-chroman-4-one,0
2917,Chromans,8-(3-methyl-but-2-enyl)-2-phenyl chroman-4-one,0
2918,Chromones,chaetomanone,0
2919,Chromones,2-acetonyl-8-(2'-O-feruloxyl)glucopyranosyl-7-methoxy-5-methylchromone,0
2920,Chromones,SF 1126,0
2921,Chromones,5-(2-(3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)acetylamino)hexylcarbamic acid tert-butyl ester,0
2922,Chromones,4'-methoxy-2-styrylchromone,0
2923,Chromones,pectolinarigenin,0
2924,Chromones,"3,8-dibromo-7-hydroxy-4-methylchromen-2-one",0
2925,Chromones,10-bromomethyl-11-demethyl-12-oxocalanolide A,0
2926,Chromones,"5,7-dihydroxychromone-2-carboxylic acid",0
2927,Chromones,cnidimoside A,0
2928,"Chromosomal Proteins, Non-Histone","RCC2 protein, Xenopus",0
2929,"Chromosomal Proteins, Non-Histone","Cep192 protein, human",0
2930,"Chromosomal Proteins, Non-Histone","aust protein, Drosophila",0
2931,"Chromosomal Proteins, Non-Histone","Spo22 protein, S cerevisiae",0
2932,"Chromosomal Proteins, Non-Histone","Cdc6 protein, rat",0
2933,"Chromosomal Proteins, Non-Histone","Hos15 protein, Arabidopsis",0
2934,"Chromosomal Proteins, Non-Histone","SmcHD1 protein, mouse",0
2935,"Chromosomal Proteins, Non-Histone","DMS3 protein, Arabidopsis",0
2936,"Chromosomal Proteins, Non-Histone","SWC6 protein, Arabidopsis",0
2937,"Chromosomal Proteins, Non-Histone","Smarcd1 protein, mouse",0
2938,Chrysenes,"benzo(g)chrysene-11,12-dihydrodiol",0
2939,Chrysenes,3-methylchrysene,0
2940,Chrysenes,4-methylchrysene,0
2941,Chrysenes,"naphtho(8,1,2-ghi)chrysene",0
2942,Cinnamates,calebin-A,0
2943,Cinnamates,pentyl cinnamate,0
2944,Cinnamates,benzyl cinnamate,0
2945,Cinnamates,cinnamyl acetate,0
2946,Cinnamates,cinnamyl benzoate,0
2947,Cinnamates,cinnamyl formate,0
2948,Cinnamates,cinnamyl isovalerate,0
2949,Cinnamates,cinnamyl propionate,0
2950,Cinnamates,cinnamyl tiglate,0
2951,Cinnamates,cis-3-hexenyl cinnamate,0
2952,Cinnamates,isoamyl cinnamate,0
2953,Cinnamates,cinnamyltrimethylsilane,0
2954,Cinnamates,"bornyl (3,4,5-trihydroxy)-cinnamate",0
2955,Cinnamates,"2,3-dimethoxycinnamoyl azide",0
2956,Cisplatin,NOV 002,0
2957,Citrates,Akmicare,0
2958,Citrates,citra-lock,0
2959,Cobalt,pentaamminechlorocobalt(III),0
2960,Cobalt,dicobalt octacarbonyl,0
2961,Cobamides,"adenosyl cobyrinic acid a,c-diamide",0
2962,Codeine,Acetaminophen / Codeine,0
2963,Coenzyme A Ligases,"AAE14 protein, Arabidopsis",0
2964,Collagen,preprocollagen,0
2965,Collagen,"col15a1a protein, zebrafish",0
2966,Collagen,dermicol-P35 30G,0
2967,Composite Resins,estelite flow quick,0
2968,Composite Resins,adamant composite resin,0
2969,Composite Resins,X-tra fil composite resin,0
2970,Composite Resins,Radica composite,0
2971,Coumarins,cleomiscosin A,0
2972,Coumarins,celtisine,0
2973,Coumarins,"4-methyl-7,8-dihydroxycoumarin",0
2974,Coumarins,LQB34 compound,0
2975,Coumarins,gamma-glutamyl-7-amido-methylcoumarin,0
2976,Coumarins,murrayacoumarin B,0
2977,Coumarins,selinidin,0
2978,Coumarins,10-bromomethyl-11-demethyl-12-oxocalanolide A,0
2979,Coumarins,"methylcoumaro-4a,10a-pyrone-3-carbaldehyde",0
2980,Coumarins,6-O-alpha-L-rhamnnopyranosyl daphnogirin,0
2981,Coumarins,6-O-beta-D-apiofuranosyl daphnogirin,0
2982,Cresols,p-cresyl salicylate,0
2983,Cresols,5-amino-o-cresol,0
2984,Crotalid Venoms,"crotarhagin, Crotalus horridus horridus",0
2985,Crotalid Venoms,"albolatin, Trimeresurus albolabris",0
2986,Crotalid Venoms,"trowaglerix protein, Tropidolaemus wagleri",0
2987,Crotalid Venoms,"Cr-IV 1 myotoxin, Calloselasma rhodostoma",0
2988,Cyanoacrylates,"ethyl 3-(2-amino-4,6-bis(dimethylamino)pyrimidin-5-yl)-2-cyanoacrylate",0
2989,Cyclic N-Oxides,"3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide",0
2990,Cyclic N-Oxides,"3-furylquinoxaline-2-carbonitrile 1,4-di-N-oxide",0
2991,Cyclic N-Oxides,"ethyl 3-phenylquinoxaline-2- carboxylate 1,4-di-N-oxide",0
2992,Cyclic N-Oxides,4-(dimethylamino)pyridine N-oxide,0
2993,Cyclic N-Oxides,3-(4-(methylnitrosoamino)-1-hydroxybutyl)pyridine N-oxide,0
2994,Cyclic N-Oxides,Hemi-GS-TEMPO 5-125,0
2995,Cyclic N-Oxides,"1-hydroxy-2,2,5,5-tetramethyl-3-imidazoline-3-oxide",0
2996,Cyclic S-Oxides,PF 00422602,0
2997,Cyclic S-Oxides,RS 678,0
2998,Cyclic S-Oxides,RS 779,0
2999,Cyclic S-Oxides,A 837093,0
3000,Cyclic S-Oxides,"2-benzyl-4-(4-(t-butyl)chlorobenzyl)-7-methyl-1,1,3-trioxo-2,4-dihydropyrazolo(4,5-e)(1,4)thiadiazine",0
3001,Cyclobutanes,squaric acid amide,0
3002,Cyclobutanes,KSQ-4,0
3003,Cyclobutanes,KSQ-3,0
3004,Cyclobutanes,1-amino-3-(2-iodoethenyl)cyclobutane-1-carboxylic acid,0
3005,Cyclobutanes,1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid,0
3006,Cyclodextrins,mono-6A-(1-butyl-3-imidazolium)-6A-deoxycyclodextrin,0
3007,Cyclohexanecarboxylic Acids,AMG 076,0
3008,Cyclohexanecarboxylic Acids,KW 4490,0
3009,Cyclohexanes,"4-(1,2-epoxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one",0
3010,Cyclohexanes,"N,N-dicyclohexyl-2-benzothiazolesulfenamide",0
3011,Cyclohexanes,"perfluoro-1,2-dimethyl cyclohexane",0
3012,Cyclohexanes,"cis-3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid",0
3013,Cyclohexanols,4-hydroxy-2-cyclohexenone,0
3014,Cyclohexanols,"cyclohex-2-ene-1,4-diol",0
3015,Cyclohexanols,citrantifidiol,0
3016,Cyclohexanones,"2,6-bis(benzylidene)cyclohexanone",0
3017,Cyclohexanones,2-methylcyclohexanone thiosemicarbazone,0
3018,Cyclohexanones,antheminone A,0
3019,Cyclohexanones,antheminone B,0
3020,Cyclohexanones,antheminone C,0
3021,Cyclohexanones,pacificanone A,0
3022,Cyclohexanones,pacificanone B,0
3023,Cyclohexanones,4-hydroxy-2-cyclohexenone,0
3024,Cyclohexanones,"4-hydroxy-4-(3'-glucopyranosyloxybutylidene)-3,5,5-trimethyl-2-cyclohexen-1-one",0
3025,Cyclohexylamines,"1-ethenyl-3,3,5,5-tetramethylcyclohexylamine",0
3026,Cyclohexylamines,N-(1-phenylcyclohexyl)propanamine,0
3027,Cyclopentanes,12-oxo-phytoenoic acid,0
3028,Cyclopentanes,2-hexyl-1-cyclopentanone thiosemicarbazone,0
3029,Cyclopentanes,5-trimethylsilylcyclopentadiene,0
3030,Cyclopentanes,1-amino-2-phenylcyclopentane-1-carboxylic acid,0
3031,Cyclopentanes,"2,2-bis-(4-hydroxyphenyl)-cyclopentanone",0
3032,Cyclopentanes,"3-(3-hydroxy-4-(hydroxymethyl)cyclopentyl)-6-(4-pentylphenyl)furo(2,3-d)pyrimidin-2(3H)-one",0
3033,Cyclopentanes,"6-ethyl-1,4-dioxo-1,2,2a,3,4,6,7,7b-octahydro-5H-2,3,4a,6,7a-pentaazacyclopenta(cd)indene-2a,7b-dicarboxylate",0
3034,Cyclopentanes,"6-ethyl-2a,7b-diphenyl-1,2,2a,3,4,6,7,7b-octahydro-5H-2,3,4a,6,7a-pentaazacyclopenta(cd)indene-1,4-dione",0
3035,Cyclopentanes,tris(cyclopentylphosphine),0
3036,Cyclopentanes,"2,5-bis(4-methoxybenzylidene) cyclopentanone",0
3037,Cyclopentanes,"4-(1-propenyl)cyclopentane-1,2-diol",0
3038,Cyclopentanes,lucidone,0
3039,Cyclopropanes,rac-dysibetaine CPa,0
3040,Cyclopropanes,"trans-1,2-bis(4-cyanophenyl)cyclopropane",0
3041,Cyclopropanes,3-hydroxymethylcyclopropene,0
3042,Cyclopropanes,"(1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone",0
3043,Cyclopropanes,N-methylnorcoronamic acid,0
3044,Cyclopropanes,1-benzyl-2-phenylcyclopropanecarboxylic acid,0
3045,Cyclopropanes,cycloprothrin,0
3046,Cysteine Desulfhydrase,"CYS3 protein, S cerevisiae",0
3047,Cysteine Endopeptidases,"metacaspase-8, Arabidopsis",0
3048,Cytochrome b Group,"Cyb561d2 protein, mouse",0
3049,Cytochrome c Group,"NrfG protein, E coli",0
3050,CYTOCHROME C OXIDASE,"Cox1 protein, S cerevisiae",0
3051,CYTOCHROME C OXIDASE,"cytochrome c oxidase subunit I, mouse",0
3052,CYTOCHROME C OXIDASE,"Cox5a protein, S cerevisiae",0
3053,CYTOCHROME C OXIDASE,"Cox5b protein, S cerevisiae",0
3054,Cytochrome P450,"Erg11 protein, S cerevisiae",0
3055,Cytochrome P450,"CYP710A1 protein, Arabidopsis",0
3056,Cytochrome P450,"CYP710A4 protein, Arabidopsis",0
3057,Cytochrome P450,"CYP130 protein, M tuberculosis",0
3058,Cytochrome P450,"cytochrome P-450 79B2 protein, Arabidopsis",0
3059,Cytochrome P450,"cytochrome P-450 79B3, Arabidopsis",0
3060,Cytokinins,pyratine 6,0
3061,Cytoskeletal Proteins,Ran binding protein 9,0
3062,Cytoskeletal Proteins,"kindlin-2 protein, mouse",0
3063,Cytoskeletal Proteins,"kindlin-3 protein, mouse",0
3064,Cytoskeletal Proteins,"CTNNAL1 protein, mouse",0
3065,Cytoskeletal Proteins,"OPHN1 protein, rat",0
3066,Decanoic Acids,beta-hydroxydecanoyl beta-hydroxydecanoate,0
3067,Dental Cement Material,Aegis Ortho adhesive,0
3068,Dental Cement Material,copper seal dental cement,0
3069,Deoxy Sugars,"dTDP-3-acetamido-3,6-dideoxyglucose",0
3070,Deoxyadenosines,5'-fluoro-5'-deoxyaristeromycin,0
3071,Deoxyadenosines,8-ethynyl-(2-para-carboran)-2'-deoxyadenosine,0
3072,Deoxyadenosines,2-N-tert-butylaminoxyl-2'-deoxyadenosine,0
3073,Deoxycytosine Nucleotides,"N-(2-N-(N-(4-azido-2,5-difluoro-3-chloropyridin-6-yl)-3-aminopropionyl)aminoethyl)-2'-deoxycytidine-5'-triphosphate",0
3074,Deoxyribonucleases,"yjeA protein, E coli",0
3075,Deoxyribonucleotides,5-fluorouracil dideoxyribonucleoside monophosphate,0
3076,Deoxyuracil Nucleotides,5'-phospho-2'-deoxyuridine-3-pyrophosphate (P-5)-adenosine-3-phosphate,0
3077,Dextrans,2-(pyridinyldithio)ethylcarbamoyl dextran,0
3078,Diamines,N-diethylendiamine,0
3079,Diamines,"(N,N'-bis((2-N-methylimidazol-1-yl)methylene))-2,2-dimethylpropane-1,3-diamine",0
3080,Diamines,"N-(3-aminopropyl)-1,3-propanediamine",0
3081,Dibenzazepines,dibenzazepine,0
3082,Dicarboxylic Acids,"1,1'-binaphthyl-2,2'-dicarboxylic acid",0
3083,Dicarboxylic Acids,octadecenedioic acid,0
3084,Dietary Fats,MAS063DP,0
3085,Diethylamines,bis(2-phenylthioethyl)methylamine,0
3086,Dihydropyridines,Bay w 9798,0
3087,Dihydropyridines,"3-(1-(2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl)-3,6-dihydro-2H-pyridin-4-yl)-6-chloro-1H-indole",0
3088,Dimethylpolysiloxanes,poly(dimethyldiphenylsiloxane),0
3089,Dimethylpolysiloxanes,lauryl PEG-PPG-18-18 methicone,0
3090,Dioxanes,"1,4-benzodioxan",0
3091,Dioxanes,phyllostin,0
3092,Dioxanes,"N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide",0
3093,Dioxanes,"2-methyl-c-5-(4-(5-methyl-2-phenyl-1,3-oxazol-4-yl)butyl)-1,3-dioxane-r-2-carboxylic acid",0
3094,Dioxanes,KW 4490,0
3095,Dioxolanes,furolan,0
3096,Dipeptides,copoly(aspartic acid-glutamic acid),0
3097,Dipeptides,leucine-methylglutamate copolymer,0
3098,Dipeptides,"1,4,7-triazanonylimino-bis(N-(oleicyl-cysteinyl-histinyl)-1-aminoethyl)propionamide",0
3099,Dipeptides,nikkomycin B,0
3100,Dipeptides,pyranosyl nikkomycin B,0
3101,Dipeptides,Z-Val-(2-aminobenzoyl)-Asp-fluoromethyl ketone,0
3102,Dipeptides,4-(2-((4-methoxy-1H-indole-2-carbonyl)amino)-4-methylpentanoylamino)-5-(2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester,0
3103,Dipeptides,N-(1-carboxy-3-phenylpropyl)phenylalanyl-asparagine,0
3104,Dipeptidyl-Peptidases and Tripeptidyl-Peptidases,"Dpp8 protein, rat",0
3105,Dipeptidyl-Peptidases and Tripeptidyl-Peptidases,"Dpp9 protein, rat",0
3106,Diphosphonates,"1-fluoro-2-(3-pyridinyl)ethylidene-1,1-bisphosphonic acid",0
3107,Diphosphonates,"(4-(((bis(phosphonopropyl))carbamoyl)methyl)-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetic acid",0
3108,Diphosphonates,"(90)Y-2,3-dicarboxypropane-1,1-diphosphonic acid",0
3109,Dipyridamole,"dipyridamole, prednisolone drug combination",0
3110,Disaccharides,resorufin-beta-D-cellobioside,0
3111,Disaccharides,dimyristoyl melibioside,0
3112,Disaccharides,dimyristyl maltoside,0
3113,Disaccharides,methyl 2-O-beta-L-fucopyranosyl alpha-D-glucopyranoside,0
3114,Disaccharides,incednine,0
3115,Disaccharides,rosavin,0
3116,Disaccharides,rosarin,0
3117,Disaccharides,apigenin-7-O-rhamnosyl-1-6-glucoside,0
3118,Disaccharides,5-(glucopyranosyl-1-6-glucopyranosyloxymethyl)-2-furancarboxaldehyde,0
3119,Disaccharides,2'-N-acetylparomamine,0
3120,Disulfides,CTX-Clv,0
3121,Disulfides,"3,3'-dinitro-2,2'-dithiodipyridine",0
3122,Disulfides,2-(pyridinyldithio)ethylcarbamoyl dextran,0
3123,Disulfides,RB 150,0
3124,Disulfides,RhoSS,0
3125,Disulfides,"bis(2-(2,2-dimethylpropanoylamino)phenyl)disulfide",0
3126,Diterpenes,neoandrographolide,0
3127,Diterpenes,13-epi-sclareol,0
3128,Diterpenes,ent-sandaracopimaradiene,0
3129,Diterpenes,indicol,0
3130,Diterpenes,10-hydroxykahukuene B,0
3131,Diterpenes,crotonkinin A,0
3132,Diterpenes,crotonkinin B,0
3133,Diterpenes,hemsleyanine C,0
3134,Diterpenes,hemsleyanine D,0
3135,Diterpenes,methyl tetrahydrosarcoate,0
3136,Diterpenes,"methyl 2,4,6-decatrienoate",0
3137,Diterpenes,15-ethoxy-hedyforrestin D,0
3138,Diterpenes,hedyforrestin D,0
3139,Diterpenes,quesnoin,0
3140,Diterpenes,spirovibsanin A,0
3141,Diterpenes,"5,14-bis-epi-spirovibsanin A",0
3142,Diterpenes,"5,19-cyclo-9beta,10xi-androstane-3,17-dione",0
3143,Diterpenes,15-acetoxy-labd-8(17)-en-18-oic acid,0
3144,Diterpenes,"(2E,6E)-2-(4-methylpent-3-enyl)-6-(3-(2-oxo-2,5-dihydrofuran-3-yl)propyli-dene)hept-2-enedioic acid",0
3145,Diterpenes,pterokaurane M1,0
3146,Diterpenes,pterokaurane M2,0
3147,Diterpenes,pterokaurane M3,0
3148,Diterpenes,7alpha-hydroxydehydroabietic acid,0
3149,Diterpenes,deltaline,0
3150,Diterpenes,maytenoquinone,0
3151,Diterpenes,6-deoxymaytenoquinone,0
3152,Diterpenes,"8,11,13-totaratriene-12,13-diol",0
3153,Diterpenes,austrochaparol,0
3154,Diterpenes,ent-15-oxo-kaur-16-en-19-oic acid,0
3155,Diterpenes,grandiflorolic acid,0
3156,Diterpenes,16-phyllocladanol,0
3157,Diterpenes,bipinnatin Q,0
3158,Diterpenes,"12,15-epoxy-8(17),13-labdadien-19-ol",0
3159,Diterpenes,cyslabdan,0
3160,Diterpenes,16-hydroxycommunic acid,0
3161,Diterpenes,14-dehydroxy-14-fluorotriptolide,0
3162,Diterpenes,trichodermamide C,0
3163,Diterpenes,scabronine J,0
3164,Diterpenes,cheiradone,0
3165,Diterpenes,ingenane,0
3166,Diterpenes,euphornin,0
3167,Diterpenes,antiochic acid,0
3168,Diterpenes,jatrophane,0
3169,Diterpenes,lathyrane,0
3170,Diterpenes,incensole acetate,0
3171,Diterpenes,"mulin-11,13-dien-20-oic acid",0
3172,Diterpenes,"16-hydroxymulin-11,13-dien-20-oic acid",0
3173,Diterpenes,"7alpha,16-dihydroxymulin-11,13-dien-20-oic acid",0
3174,Diterpenes,andrograpanin,0
3175,DNA,IRS 954,0
3176,Topoisomerase II,"CIN-4 protein, C elegans",0
3177,DNA-Directed DNA Polymerase,"Polk protein, Xenopus",0
3178,"DNA Topoisomerases, Type I","Bin4 protein, Arabidopsis",0
3179,DNA Helicases,"regulator of telomere length protein, mouse",0
3180,DNA Helicases,"CHD3 protein, Drosophila",0
3181,DNA Helicases,"Ruvb-1 protein, C elegans",0
3182,DNA-Binding Proteins,"VraR protein, Staphylococcus aureus",0
3183,DNA-Binding Proteins,"ATRIP protein, human",0
3184,DNA-Binding Proteins,"PATL1 protein, human",0
3185,DNA-Binding Proteins,"FocB protein, E coli",0
3186,DNA-Binding Proteins,"mtss-1 protein, C elegans",0
3187,DNA-Binding Proteins,"Rad18 protein, rat",0
3188,DNA-Binding Proteins,"LOV1 protein, Arabidopsis",0
3189,DNA-Binding Proteins,"Kid protein, mouse",0
3190,DNA-Binding Proteins,"MAMLD1 protein, human",0
3191,DNA-Binding Proteins,"Ankrd11 protein, mouse",0
3192,DNA-Binding Proteins,"Stm1 protein, S cerevisiae",0
3193,DNA-Binding Proteins,"SOB3 protein, Arabidopsis",0
3194,DNA-Binding Proteins,"ESC protein, Arabidopsis",0
3195,DNA-Binding Proteins,"GLUT4 enhancer factor, mouse",0
3196,DNA-Binding Proteins,"FAM5C protein, human",0
3197,DNA-Binding Proteins,"EGL3 protein, Arabidopsis",0
3198,DNA-Binding Proteins,"DrrB protein, Escherichia coli",0
3199,DNA-Binding Proteins,"killen protein, human",0
3200,DNA-Binding Proteins,"bun protein, Drosophila",0
3201,DNA-Binding Proteins,"zinc finger protein 521, human",0
3202,DNA-Binding Proteins,"NsrR protein, E coli",0
3203,DNA-Binding Proteins,"positive cofactor 4, S pombe",0
3204,DNA-Binding Proteins,"DDB2 protein, Arabidopsis",0
3205,DNA-Binding Proteins,"MSH5 protein, Arabidopsis",0
3206,Docosahexaenoic Acids,14-A4t-neuroprostane,0
3207,Domperidone,ovaprim,0
3208,Drug Combinations,Acetaminophen / Codeine,0
3209,Drug Combinations,lybrel,0
3210,Drug Combinations,ovaprim,0
3211,Drug Combinations,NOV 002,0
3212,Drug Combinations,gemals,0
3213,Drug Combinations,Enkorten,0
3214,Drug Combinations,OMS 103HP,0
3215,Drug Combinations,"dipyridamole, prednisolone drug combination",0
3216,"Drugs, Chinese Herbal",suanzaorentang,0
3217,"Drugs, Chinese Herbal",jie er yin,0
3218,"Drugs, Chinese Herbal",qingre yulin decoction,0
3219,"Drugs, Chinese Herbal",xinshuai mistura,0
3220,"Drugs, Chinese Herbal",shenbing mistura,0
3221,"Drugs, Chinese Herbal",yunpi zhixie,0
3222,"Drugs, Chinese Herbal",yishen huoxue decoction,0
3223,"Drugs, Chinese Herbal",biminne,0
3224,"Drugs, Chinese Herbal",fulu baoxin,0
3225,"Drugs, Chinese Herbal",shexiang baoxin,0
3226,"Drugs, Chinese Herbal",ginaton,0
3227,"Drugs, Chinese Herbal",qidan,0
3228,"Drugs, Chinese Herbal",jianpi liqi huoxue decoction,0
3229,"Drugs, Chinese Herbal",tongjiang,0
3230,"Drugs, Chinese Herbal",qindan,0
3231,"Drugs, Chinese Herbal",zhigancao decoction,0
3232,"Drugs, Chinese Herbal",longdan xiegan decoction,0
3233,"Drugs, Chinese Herbal",xiao yao wan,0
3234,"Drugs, Chinese Herbal",shenghe,0
3235,"Drugs, Chinese Herbal",jinqi jiantang,0
3236,"Drugs, Chinese Herbal",tongluo,0
3237,"Drugs, Chinese Herbal",huoxue qianyang,0
3238,"Drugs, Chinese Herbal",erdi biejia,0
3239,"Drugs, Chinese Herbal",yiweining,0
3240,"Drugs, Chinese Herbal",jianpi yishen,0
3241,"Drugs, Chinese Herbal",qinggan huoxue,0
3242,"Drugs, Chinese Herbal",shengqing,0
3243,"Drugs, Chinese Herbal",guben hutan tongmai,0
3244,"Drugs, Chinese Herbal",naomaitong,0
3245,"Drugs, Chinese Herbal",yiqi rougan,0
3246,"Drugs, Chinese Herbal",zhuhuang,0
3247,"Drugs, Chinese Herbal",tongxia huayu,0
3248,"Drugs, Chinese Herbal",bushen yisui,0
3249,"Drugs, Chinese Herbal",chaige qingre,0
3250,"Drugs, Chinese Herbal",ruyiping,0
3251,"Drugs, Chinese Herbal",yiqi kaimi,0
3252,"Drugs, Chinese Herbal",jinhong,0
3253,"Drugs, Chinese Herbal",qianggan,0
3254,"Drugs, Chinese Herbal",bufei quingyu,0
3255,"Drugs, Chinese Herbal",qingling dingxuan,0
3256,"Drugs, Chinese Herbal",qidi yiqi yangyin huoxue,0
3257,"Drugs, Chinese Herbal",yiqi yangyin quyu,0
3258,"Drugs, Chinese Herbal",bushen huoxue,0
3259,"Drugs, Chinese Herbal",jiangtang bushen,0
3260,"Drugs, Chinese Herbal",yiqi jiangzhuo,0
3261,"Drugs, Chinese Herbal",yisui shengxue,0
3262,"Drugs, Chinese Herbal",jinghua weikang,0
3263,"Drugs, Chinese Herbal",Yiqi Sanju formula,0
3264,"Drugs, Chinese Herbal",Weichang'an,0
3265,"Drugs, Chinese Herbal",Jianpi Huoxue decoction,0
3266,"Drugs, Chinese Herbal",qingxin-II,0
3267,"Drugs, Chinese Herbal",gehua jiejiu xiaozhi,0
3268,"Drugs, Chinese Herbal",shujin kechuan,0
3269,"Drugs, Chinese Herbal",Chai Qin Cheng Qi decoction,0
3270,"Drugs, Chinese Herbal",Rhizoma Smilacinus compound,0
3271,"Drugs, Chinese Herbal",wendan xiezhuo,0
3272,"Drugs, Chinese Herbal",xiongshao,0
3273,"Drugs, Chinese Herbal",tougu xiaotong,0
3274,"Drugs, Chinese Herbal",changlu,0
3275,"Drugs, Chinese Herbal",xuefu,0
3276,"Drugs, Chinese Herbal",shuangfujin,0
3277,"Drugs, Chinese Herbal",realgar-indigo naturalis,0
3278,"Drugs, Chinese Herbal",tangweikang,0
3279,"Drugs, Chinese Herbal",tongluo jiunao,0
3280,"Drugs, Chinese Herbal",yiqi huayu bushen,0
3281,"Drugs, Chinese Herbal",qingdu,0
3282,"Drugs, Chinese Herbal",qiqi,0
3283,"Drugs, Chinese Herbal",fuzheng jiangan,0
3284,"Drugs, Chinese Herbal",Xinnao Shutong,0
3285,"Drugs, Chinese Herbal",qianjin fubao,0
3286,"Drugs, Chinese Herbal",jiangu fufang,0
3287,"Drugs, Chinese Herbal",fuzhengyangying,0
3288,"Drugs, Chinese Herbal",shenle,0
3289,"Drugs, Chinese Herbal",wuzi yanzong,0
3290,"Drugs, Chinese Herbal",wenyang shengjing,0
3291,"Drugs, Chinese Herbal",wendan,0
3292,"Drugs, Chinese Herbal",huangbai,0
3293,"Drugs, Chinese Herbal",daotan,0
3294,"Drugs, Chinese Herbal",qishen yiqi,0
3295,"Drugs, Chinese Herbal",xianzhong,0
3296,"Drugs, Chinese Herbal",shenling yigan,0
3297,"Drugs, Chinese Herbal",shiwei,0
3298,"Drugs, Chinese Herbal",tiaoshen tonglin,0
3299,"Drugs, Chinese Herbal",qingjin runfei,0
3300,"Drugs, Chinese Herbal",gushukang,0
3301,"Drugs, Chinese Herbal",Salvia extract,0
3302,"Drugs, Chinese Herbal",guizhi decoction,0
3303,"Drugs, Chinese Herbal",ahnjeonbaekho-tang,0
3304,"Drugs, Chinese Herbal",hongbeiyegen,0
3305,"Drugs, Chinese Herbal",bushen zhuanggu,0
3306,"Drugs, Chinese Herbal",qanliexian,0
3307,"Drugs, Chinese Herbal",wenshenpingchuan,0
3308,"Drugs, Chinese Herbal",biejiajianwan,0
3309,"Drugs, Chinese Herbal",yiqigushen,0
3310,"Drugs, Chinese Herbal",yuxianling,0
3311,"Drugs, Chinese Herbal",shensuyin,0
3312,"Drugs, Chinese Herbal",maidang rutong,0
3313,"Drugs, Chinese Herbal",yishen yangnao,0
3314,"Drugs, Chinese Herbal",PC-Spes2,0
3315,"Drugs, Chinese Herbal",pangdahai,0
3316,"Drugs, Chinese Herbal",bailian caogen,0
3317,"Drugs, Chinese Herbal",naoan,0
3318,"Drugs, Chinese Herbal",shengdi,0
3319,"Drugs, Chinese Herbal",changtong,0
3320,"Drugs, Chinese Herbal",jingjielianqiao,0
3321,"Drugs, Chinese Herbal",VI-28 herbal formula,0
3322,"Drugs, Chinese Herbal",Shao-Fu-Zhu-Yu,0
3323,"Drugs, Chinese Herbal",Jinqi,0
3324,"Drugs, Chinese Herbal",menoprogen,0
3325,"Drugs, Chinese Herbal",dabuyin wan,0
3326,"Drugs, Chinese Herbal",yinqiao,0
3327,"Drugs, Chinese Herbal",fufang xiaojingtong,0
3328,"Drugs, Chinese Herbal",xinmaitong,0
3329,"Drugs, Chinese Herbal",sankang,0
3330,"Drugs, Chinese Herbal",suanzaoren,0
3331,"Drugs, Chinese Herbal",chuan xiong fang,0
3332,"Drugs, Chinese Herbal",bie jia jian,0
3333,"Drugs, Chinese Herbal",maxingganshi,0
3334,"Drugs, Chinese Herbal",qinxiangzhixie,0
3335,"Drugs, Chinese Herbal",kuijiekang,0
3336,"Drugs, Chinese Herbal",maxingshigan,0
3337,"Drugs, Chinese Herbal",jiawei simiaosan,0
3338,"Drugs, Chinese Herbal",sihuangshuimi,0
3339,"Drugs, Chinese Herbal",Zemaphyte,0
3340,"Drugs, Chinese Herbal",Hong Hua 29,0
3341,"Drugs, Chinese Herbal",qiangxin,0
3342,"Drugs, Chinese Herbal",fu zheng yang yin,0
3343,"Drugs, Chinese Herbal",liyan,0
3344,"Drugs, Chinese Herbal",shiquandabu,0
3345,"Drugs, Chinese Herbal",niuhuang shangqing,0
3346,"Drugs, Chinese Herbal",niuhuang qingwei,0
3347,"Drugs, Chinese Herbal",JCICM-6,0
3348,Dynein ATPase,"Dnah3 protein, mouse",0
3349,Elastin,ELPEC20,0
3350,Ellipticines,9-(dimethylaminoethoxy)ellipticine,0
3351,Myelin Basic Proteins,MBP-8298,0
3352,Endoribonucleases,"TRZ1 protein, Arabidopsis",0
3353,Endoribonucleases,"ERN1 protein, human",0
3354,Endoribonucleases,"RNase E, Arabidopsis",0
3355,Endorphins,"morphiceptin, Dmt(1)-Nal(3)-",0
3356,Methionine Enkephalin,Enkorten,0
3357,Epoxide hydrolase,"EPHX2 protein, rat",0
3358,Epoxy Compounds,preussomerin I,0
3359,Epoxy Compounds,preussomerin G,0
3360,Epoxy Compounds,"9,10-epoxyheptadecan-4,6-diyn-3-one",0
3361,Epoxy Compounds,"ethyl-3,4-epoxybutyrate",0
3362,Epoxy Compounds,preussomerin EG1,0
3363,Epoxy Compounds,preussomerin EG3,0
3364,Epoxy Compounds,preussomerin EG2,0
3365,Estrenes,"2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene",0
3366,Estrenes,"2-methoxyestradiol-3,17-O,O-bis(sulfamate)",0
3367,Estrenes,"2-methoxyoestra-1,3,5(10),16-tetraene-3-carboxamide",0
3368,Ethanolamines,2-diisopropylaminoethanol,0
3369,Ethanolamines,"1,2-dipalmitoylglycerophosphorylethanolamine",0
3370,Ethers,sodium nonylphenol polyoxyethylene ether sulfate,0
3371,Ethers,4-O-amino-phenol-4'-demethylepipodophyllotoxin ether,0
3372,Ethers,heptaoxyethylene dodecyl ether,0
3373,Ethers,pentaoxyethylene dodecyl ether,0
3374,Ethers,diethylene glycol vinyl ether,0
3375,Ethers,diphenylprolinol silyl ether,0
3376,"Ethers, Cyclic",2-methyleneoxetane,0
3377,"Ethers, Cyclic",cavitein LG2,0
3378,"Ethers, Cyclic",cavitein LG3,0
3379,Ethinyl Estradiol,lybrel,0
3380,Ethyl Ethers,"1,1-diethoxybut-2-ene",0
3381,Ethylamines,6-(3'-(thioethylamine)propylthio)purine,0
3382,Ethylamines,"3-amino-4-monomethylamino-2',7'-difluorofluorecein",0
3383,Ethylenediamines,"N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine",0
3384,Ethylenediamines,"1,4,7-triazanonylimino-bis(N-(oleicyl-cysteinyl-histinyl)-1-aminoethyl)propionamide",0
3385,Ethylenediamines,"1,2-bis(2-methylphenyl)ethylene-1,2-diamine",0
3386,Ethylenediamines,"N,N'-bis(2-(hydroxymethyl)benzyl)ethylenediamine",0
3387,Ethylenes,N-diethylendiamine,0
3388,Ethylenes,"1,2-bis(2-pyridyl)ethylene",0
3389,exodeoxyribonuclease,"Mre11 protein, S pombe",0
3390,Exoribonucleases,"Xrn3 protein, Arabidopsis",0
3391,Exoribonucleases,"Rex1 exonuclease, S cerevisiae",0
3392,Exotoxins,transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38),0
3393,Eye Proteins,"lengsin protein, mouse",0
3394,Eye Proteins,"Cplx3 protein, mouse",0
3395,Fatty Acids,palmitoylcaprazol,0
3396,Fatty Acids,9-hydroxynonanoic acid,0
3397,Fatty Acids,9-oxotetradocosanecarboxylic acid,0
3398,Fatty Acids,S-111-S-WB,0
3399,"Fatty Acids, Monounsaturated","2,4,6-trimethyl-2-octenoic acid",0
3400,"Fatty Acids, Monounsaturated",2-dodecenoic acid,0
3401,"Fatty Acids, Unsaturated",12-oxo-phytoenoic acid,0
3402,"Fatty Acids, Unsaturated","methyl 2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4-pentadienoate",0
3403,"Fatty Acids, Unsaturated",iso(4)levuglandin E2,0
3404,"Fatty Acids, Unsaturated","4-hydroxy-5,7,10,13,16,19-docosahexaenoic acid",0
3405,"Fatty Acids, Unsaturated","4,6,8-trimethyl-2,4-decadienoic acid",0
3406,"Fatty Acids, Unsaturated",skimmilaureol,0
3407,"Fatty Acids, Unsaturated","6,7-dimethylhexadec-7-enoic acid",0
3408,Fatty Alcohols,"3,9-dihydroxy-11-oxohexacosane",0
3409,Fatty Alcohols,docosanol,0
3410,Fatty Alcohols,10-undecyn-1-ol,0
3411,Ferric Compounds,2520A compound,0
3412,Ferric Compounds,"p-hydroxyphenylimidazo(f)1,10-phenanthroline ferrum(III)",0
3413,Ferrous Compounds,"1,1'-diisocyanoferrocene",0
3414,Ferrous Compounds,N-(ferrocenylmethyl)azetidin-2-yl(diphenyl)methanol,0
3415,Ferrous Compounds,cholesteryl glycinate ferrocenoylamide,0
3416,Ferrous Compounds,ferrocenyl aminonaphthyridine,0
3417,Ferrous Compounds,"1,2,3,4,5-pentamethylazaferrocene",0
3418,Ferrous Compounds,"2-(ferrocenylmethylamino)-7-methyl-1,8-naphthyridine",0
3419,Ferrous Compounds,"ferrocene-1,1'-dithiol",0
3420,Ferrous Compounds,"bis(2,2'-6',2''-terpyridine-4'-thiolato)iron(II)",0
3421,Ferrous Compounds,"N,N'-bisethoxyethane(12)amideferrocenophane",0
3422,Fibroblast Growth Factor,"FGF4 protein, Xenopus",0
3423,Fibronectins,"FNDC3A protein, human",0
3424,Flavonoids,tiliroside,0
3425,Flavonoids,artoindonesianin O,0
3426,Flavonoids,artoindonesianin N,0
3427,Flavonoids,kurarinol,0
3428,Flavonoids,"3,2'-dihydroxyflavone",0
3429,Flavonoids,7-O-beta-D-glucopyranosylchrysin,0
3430,Flavonoids,6-methylaromadendrin 3-O-beta-glucopyranoside,0
3431,Flavonoids,isoscutellarein 5-O-beta-glucopyranoside,0
3432,Flavonoids,apigenin 5-O-rhamnopyranosyl(1''''2'')(6''-O-acetyl)glucopyranoside,0
3433,Flavonoids,IKhFAN-10,0
3434,Flavonoids,"7,4'-dihydroxyflavylium",0
3435,Flavonoids,"(N,N-diethylamino)-4-hydroxyflavylium",0
3436,Flavonoids,epimedin A,0
3437,Flavonoids,6-hydroxyflavone,0
3438,Flavonoids,eriodictyol 7-O-(6''-feruloyl)-beta-D-glucopyranoside,0
3439,Flavonoids,eriodictyol 7-O-(6'-(3''-hydroxy-4''-methoxy cinnamoyl))-beta-D-glucopyranoside,0
3440,Flavonoids,citflavanone,0
3441,Flavonoids,erythrisenegalone,0
3442,Flavonoids,castilliferol,0
3443,Flavonoids,castillicetin,0
3444,Flavonoids,rhodionin,0
3445,Flavonoids,5-allyl-7-gen-difluoromethylenechrysin,0
3446,Fluorenes,"poly(9,9-bis(6'-N,N,N-trimethylammonium)hexyl)fluorenephenylene bromide",0
3447,Fluorenes,fluorenylmethoxycarbonyl-2-mercaptobenzothiazole,0
3448,Fluorenes,"9,9'-bis(4-(2'-hydroxy-3'-methacryloxyloxypropoxy)phenyl)fluorene",0
3449,Fluorenes,fluorenylmethoxycarbonyl-4-(1-chloroethyl)phenylalanine,0
3450,Fluorenes,fluorenylmethoxycarbonyl-O-(2-bromoisobutyryl)serine,0
3451,Fluorenes,Fmoc-GlyVal-GlyOH,0
3452,Fluorenes,"4,4,4-trifluoro-N-fluorenylmethoxycarbonyl-O-tert-butylthreonine",0
3453,Fluorenes,"2,5,7-trinitro-9-dicyanomethylenefluorene-C60",0
3454,Fluorenes,"3,6-di(spirobifluorene)-N-phenylcarbazole",0
3455,Fluorenes,9-Fluorenemethyl boranophosphonate,0
3456,Fluorenes,2-nitroso-7-nitrofluorene,0
3457,Fluorenes,2-nitroso-7-nitro-9-oxofluorene,0
3458,Fluorenes,"dispiro(indene-2,5'-indeno(2,1-a)fluorene-6',2''-indene)-1,1'',3,3'',11',12'-hexaone",0
3459,Fluorenes,"poly(9,9-dioctylfluorene-co-3,4-di-methylthieno(2,3-b)thiophene)",0
3460,Fluorenes,2-amino-7-nitrofluorene,0
3461,Fluorenes,2-hydroxy-7-nitrofluorene,0
3462,Fluorenes,2-deoxyriboside-7-nitrofluorene,0
3463,Fluoresceins,myristoyl-beta-alanyl-(arginyl)7-lysyl(flurosceine isothiocyanate)amide,0
3464,Fluoresceins,"4',5'-bis-aminomethyl-fluorescein",0
3465,Fluoresceins,4'-aminomethyl-fluorescein,0
3466,Fluoresceins,2-phenylamino-3-methyl-6-di-n-butylaminofluoran,0
3467,Fluoresceins,"3-amino-4-monomethylamino-2',7'-difluorofluorecein",0
3468,Fluoresceins,"4,7,2',7'-tetrachloro-6-(5-carboxypentyl)fluorescein",0
3469,Fluoresceins,"4,7,4',5'-tetra-chloro-6-(5-carboxypentyl)fluorescein",0
3470,Fluoresceins,"1,2,7,8-dibenzofluorescein",0
3471,Fluoresceins,6-oxy-(acetylethylenediamine)fluorescein,0
3472,Fluorides,antimony pentafluoride,0
3473,Fluorobenzenes,fluorapacin,0
3474,Fluorobenzenes,2-(18F)fluoro-ethoxy-3-methoxyphenyl)-1-(2-(4-fluoro-phenyl)ethyl-4-piperidine-methanol,0
3475,Fluorobenzenes,pentafluorobenzyloxime,0
3476,Fluorocarbons,cesium perfluorooctanoate,0
3477,Fluorocarbons,"2,3,3,3-tetrafluoropropene",0
3478,Fluorocarbons,"1,2,3,3,3-pentafluoropropene",0
3479,Formates,cinnamyl formate,0
3480,Formates,3-methoxybutyl chloroformate,0
3481,Fucosyltransferase,"F08A8.5 protein, C elegans",0
3482,Fumarates,poly(ethylene glycol fumarate-co-hexamethylene carbonate-fumarate),0
3483,Fungal Proteins,"PTP protein, Encephalitozoon hellem",0
3484,Fungal Proteins,"polar tube protein 1, Encephalitozoon hellem",0
3485,Fungal Proteins,"Endonuclease S1, Aspergillus",0
3486,Fungal Proteins,"Nuclease P1, Penicillium citrinum",0
3487,Furans,"2-(benzyloxy)-tetrahydro-5,5-dimethylfuran",0
3488,Furans,"3-(4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxyimino-3a,4-dihydro-3H-indeno(1,2-b)furan-2(8bH)-one",0
3489,Furans,"2-ethoxy-3,3,4,4,5-pentafluorotetrahydro-2,5-bis(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)furan",0
3490,Furans,furolan,0
3491,Furans,Gravacin,0
3492,Furans,etharvensin,0
3493,Furans,"1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-methyl-1,3-dihydrofuro(3,4-c)pyridine-7-ol",0
3494,Furans,N-(5-dodecyl-4-hydroxytetrahydrofuran-3-yl)-2-hydroxyheptadecanamide,0
3495,Furans,"3,4-di(alpha-styryl)furan",0
3496,Furans,4-deshydroxy-4-(N-methyl-(2-(((5-nitrofur-2-yl)methoxycarbonyl)(methyl)amino)ethyl)carbamoylmethyl)camptothecin,0
3497,Furans,5-(4-cyanophenyl)-N-(3-methylphenyl)furan-2-carboxamide,0
3498,Furans,"5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide",0
3499,Furans,acanthoside D,0
3500,Furans,bovidic acid,0
3501,Furans,hyphodermin A,0
3502,Furans,hyphodermin D,0
3503,Furans,isoeleutherin,0
3504,Furans,urceolatin,0
3505,Furans,5-glucopyranosyloxymethyl-2-furancarboxaldehyde,0
3506,Furans,5-(glucopyranosyl-1-6-glucopyranosyloxymethyl)-2-furancarboxaldehyde,0
3507,Furans,FD 838,0
3508,Furans,2-pentylfuran,0
3509,Furans,"9-O,9'-O-demethylvirgatusin",0
3510,Galactans,arabinoglucogalactan,0
3511,Galactosides,quercetin 3-O-(6''-O-malonyl)galactoside,0
3512,Galactosides,myricetin-3-O-galactoside,0
3513,Galactosides,trifolin acetate,0
3514,Galactosides,7-O-methylcyanidin 3-O-(6-O-(alpha-rhamnopyranosyl)-beta-galactopyranoside),0
3515,Galactosides,rosinidin 3-O-(6-O-(alpha-rhamnopyranosyl)-beta-galactopyranoside),0
3516,Galactosylceramides,4-hydroxy-3-nitrophenylgalactosylceramide,0
3517,Galactosyltransferases,"WbiP protein, E coli",0
3518,Galactosyltransferases,"MGD1 protein, Arabidopsis",0
3519,Galactosyltransferases,"alpha-1,3-galactosyltransferase 1, porcine",0
3520,Gangliosides,1-O-(9-O-methyl-(N-acetyl-alpha-D-neuraminosyl)-(2-6)-beta-D-glucopyranosyl)ceramide,0
3521,Gibberellins,18-hydroxygibberellic acid 1,0
3522,Glass (substance),Al2O3-La2O3-SiO2 glass,0
3523,Glass Ionomer Cements,Fuji VIII,0
3524,Gliadin,gliadin peptide B 3142,0
3525,Glucans,carboxymethylscleroglucan,0
3526,Glucans,"MP-I polysaccharide, Mytilus coruscus",0
3527,Glucosides,trifolirhizin,0
3528,Glucosides,6'-O-isobutyryl aloenin A,0
3529,Glucosides,2-acetonyl-8-(2'-O-feruloxyl)glucopyranosyl-7-methoxy-5-methylchromone,0
3530,Glucosides,calycosin-7-O-beta-D-glucoside,0
3531,Glucosides,7-O-beta-D-glucopyranosylchrysin,0
3532,Glucosides,cyanidin-3-(6-malonylglucoside),0
3533,Glucosides,isoscutellarein 5-O-beta-glucopyranoside,0
3534,Glucosides,hippomanin A,0
3535,Glucosides,"3,3',5,5'-tetramethoxy-4,4'-dihydroxy-7,9'-7',9-diepoxylignan-4-O-glucopyranoside",0
3536,Glucosides,"4,4',9-trihydroxy-3,3',5,5'-tetramethoxy-4,4'-dihydroxy-7,9'-epoxylignan-7'-one 9-O-glucopyranoside",0
3537,Glucosides,7-(3-((4-hydroxyphenyl)butyl) glucopyranosid-O-6-yl) 4-O-glucopyranosylvanillin,0
3538,Glucosides,3-glucopyranosyloxy-1-(4-hydroxyphenyl)butanone,0
3539,Glucosides,"3-hydroxy-1,5,7H-guaia-4(15),10(14),11(13)-trien-12-oic acid glucopyranosyl ester",0
3540,Glucosides,isopropyl-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside,0
3541,Glucosides,"C13-norisoprenoid, 3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3- O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside",0
3542,Glucosides,apigenin-7-O-(6''-butyryl-beta-glucopyranoside),0
3543,Glucosides,naucleamide A-10-O-glucopyranoside,0
3544,Glucosides,"flavone-3,4',7-trihydroxy-3'-methoxy-7-glucoside",0
3545,Glucosides,"3,5,7,4''-tetrahydroxyflavanone-7-O-(6''-acetyl)glucoside",0
3546,Glucosides,acanthoside D,0
3547,Glucosides,isorhamnetin-7-O-beta-D-glucopyranoside,0
3548,Glucosides,lariciresinol-4'-O-glucopyranoside,0
3549,Glucosides,2-glucose-SNAP,0
3550,Glucosides,6-O-acetylshanzhiside methyl ester,0
3551,Glucosides,calceolarioside B,0
3552,Glucosides,5'-methoxyisolariciresinol 3a-O-glucopyranoside,0
3553,Glucosides,"2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol",0
3554,Glucosides,naringenin-7-O-glucoside,0
3555,Glucosides,3-phenyl-2-propenyl-(E)-beta-D-glucopyranoside,0
3556,Glucosides,"6,7-di-O-glucopyranosylesculetin",0
3557,Glucosides,eriodictyol 7-O-(6''-feruloyl)-beta-D-glucopyranoside,0
3558,Glucosides,eriodictyol 7-O-(6'-(3''-hydroxy-4''-methoxy cinnamoyl))-beta-D-glucopyranoside,0
3559,Glucosides,luteolin 7-O-(6'-(3''-hydroxy-4''-methoxy cinnamoyl))-beta-D-glucopyranoside,0
3560,Glucosides,nitensoside A,0
3561,Glucosides,nitensoside B,0
3562,Glucosides,5-glucopyranosyloxymethyl-2-furancarboxaldehyde,0
3563,Glucosides,"2,4',6-trihydroxy-4-methoxybenzophenone-2-O-glucoside",0
3564,Glucosides,icariside C3,0
3565,Glucosides,quercetin 3-O-(6''-O-malonyl)glucoside,0
3566,Glucosides,luteolin-7-O-glucoside,0
3567,Glucosides,cnidimoside A,0
3568,Glucosides,luteolin-7-O-(2-rhamnosylglucoside),0
3569,Glucosides,quercetin 3-O-(2(G)-(E)-coumaroyl-3(G)-O-beta-D-glucosyl-3(R)-O-beta-D-glucosylrutinoside),0
3570,Glucosides,kaempferol 3-O-(2(G)-(E)-coumaroyl-3(G)-O-beta-D-glucosyl-3(R)-O-beta-D-glucosylrutinoside),0
3571,Glucosides,corymbiferin 3-O-beta-D-glucopyranoside,0
3572,Glucosides,swertiabisxanthone-I 8'-O-beta- D-glucopyranoside,0
3573,Glucosides,pinoresinol 4-O-glucopyranoside,0
3574,Glucosides,tricin 7-O-glucopyranoside,0
3575,Glucosides,"4-hydroxy-4-(3'-glucopyranosyloxybutylidene)-3,5,5-trimethyl-2-cyclohexen-1-one",0
3576,Glucosides,"apigenin-6,8-di-C-glycopyranoside",0
3577,Glucosides,methyl salicylate 2-O-beta-D-glucoside,0
3578,Glucosides,quercetin 5-O-glucoside,0
3579,Glucosyltransferases,"CSLD5 protein, Arabidopsis",0
3580,Glucosyltransferases,"Rumi protein, Drosophila",0
3581,Glutamates,glutamic acid bis(pentafluorophenyl)ester,0
3582,Glutamates,Carglumic acid,0
3583,Glutathione S-Transferase,"GSTO-1 protein, C elegans",0
3584,Glutathione S-Transferase,"GSTA4-4 protein, mouse",0
3585,Glycerides,SuO-BGL06 compound,0
3586,Glycerol-3-phosphate acyltransferase,"GPAT4 protein, human",0
3587,Glycerol-3-phosphate acyltransferase,"GPAT4 protein, mouse",0
3588,Glycolates,"N-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxothiazolidin-3-yl-(4-chlorophenoxy))acetamide",0
3589,Glycolipids,dimyristoyl melibioside,0
3590,Glycolipids,dimyristyl maltoside,0
3591,Glycolipids,"1-O-glucopyranosyl-2-N-(2'-hydroxytetracosanoyl)-1,3,4-trihydroxy-5,9-octadienine",0
3592,Glycols,"1,2-pentanediol",0
3593,Glycols,Texanol,0
3594,Glycols,lauryl PEG-PPG-18-18 methicone,0
3595,Glycopeptides,1-O-methyl-2-N-(1'-(argininocarbonyl)-4'-((4''-fluoro)benzylamido)cyclohexane)glucosamine,0
3596,Glycoproteins,"116 kDa glycoprotein, Ulmus davidiana",0
3597,Glycoproteins,"UL53 protein, human herpesvirus 2",0
3598,Glycoproteins,"US4 protein, human herpesvirus 2",0
3599,Glycoproteins,"corneodesmosin protein, mouse",0
3600,Glycoproteins,"SBTX protein, soybean",0
3601,Glycosaminoglycans,technetium 99m P1827DS,0
3602,Glycosaminoglycans,N-acetylheparosan,0
3603,Glycoside Hydrolases,"panomycocin protein, Pichia anomala",0
3604,Glycosides,isorhamnetin 3-O-alpha-rhamnopyranosyl(1-2)-beta-galactopyranoside-7-O-beta-glucopyranoside,0
3605,Glycosides,bulbophyllinoside,0
3606,Glycosides,tinosposinenside A,0
3607,Glycosides,tinosposinenside B,0
3608,Glycosides,tinosposinenside C,0
3609,Glycosides,tinosinenside,0
3610,Glycosides,6-methylaromadendrin 3-O-beta-glucopyranoside,0
3611,Glycosides,apigenin 5-O-rhamnopyranosyl(1''''2'')(6''-O-acetyl)glucopyranoside,0
3612,Glycosides,campneoside II,0
3613,Glycosides,"(R,S)-7-hydroxy-7-(3,4-dihydroxyphenyl)-ethyl-O-alpha-L-rhamnopyranosyl(1-3)-beta-d-(6-O-caffeoyl)-glucopyranoside",0
3614,Glycosides,genistein 7-O-beta-D-glucopyranoside-4'-O-(6'''- O-alpha-L-rhamnopyranosyl)-beta-sophoroside,0
3615,Glycosides,genistein 7-O-alpha-L-rhamnopyranoside-4'-O-(6'''-O-alpha-L-rhamnopyranosyl)-beta-sophoroside,0
3616,Glycosides,okhotoside B1,0
3617,Glycosides,okhotoside B2,0
3618,Glycosides,okhotoside B3,0
3619,Glycosides,6-O-alpha-L-rhamnnopyranosyl daphnogirin,0
3620,Glycosides,6-O-beta-D-apiofuranosyl daphnogirin,0
3621,Glycosides,synaptoside A,0
3622,Glycosides,synaptoside A1,0
3623,Glycosides,linderofruticoside A,0
3624,Glycosides,linderofruticoside B,0
3625,Glycosides,kurilensoside A,0
3626,Glycosides,kurilensoside B,0
3627,Glycosides,kurilensoside C,0
3628,Glycosphingolipids,rhizochalin C,0
3629,Glycosphingolipids,rhizochalin D,0
3630,Glycyrrhetinic acid,MAS063DP,0
3631,Guaiacol,"1,4-dimethoxycatechol",0
3632,Guanidines,ptilomycalin A,0
3633,Guanidines,"4-chloro-N-(2,2-dichloro-1-(N'-(6-chloropyridin-3-yl)-N''-cyanoguanidino)propyl)benzamide",0
3634,Guanidines,ptilomycalin D,0
3635,Guanidines,NeoG6 compound,0
3636,Guanidines,"N-(2-(2,5-diphenyl-pyrrol-1-yl)-acetyl)guanidine",0
3637,Guanidines,methyl 1-(diphenoxyphosphoryl)-2-(4-guanidinophenyl)ethylcarbamate,0
3638,Guanidines,methyl 1-(bis(4-acetamidophenoxy)phosphoryl)-2-(4-guanidinophenyl)ethylcarbamate,0
3639,Guanidines,2-(4-guanidynephenyl)-1-phenyl-ethanone,0
3640,Guanidines,lysianadioic acid,0
3641,Guanidines,hordatine A,0
3642,Guanidines,hordatine B,0
3643,Guanidines,N-(cyclopropylmethyl)-N'-(4-(aminomethyl)cyclohexylmethyl)guanidine,0
3644,Guanidines,"N-(5,6,7,8-tetrahydronaphthalen-2-yl)guanidine",0
3645,Proton-Translocating ATPases,"MON2 protein, human",0
3646,Haptoglobins,"Hp protein, rat",0
3647,Heat shock proteins,"hsp-16.1 protein, C elegans",0
3648,Heat shock proteins,"HSP23.6 protein, Arabidopsis",0
3649,Heat shock proteins,"Dnj-11 protein, C elegans",0
3650,Hemerythrin,rubrerythrins,0
3651,Hemoglobin,OxyVita,0
3652,Abnormal Hemoglobins,hemoglobin Bonn,0
3653,Heptanoic Acids,"7-(2-(4-fluorophenyl)-4-isopropyl-5-(4-methylbenzylcarbamoyl)-2H-pyrazol-3-yl)-3,5-dihydroxyheptanoic acid",0
3654,Heterocyclic Compounds,tris(o-phenylenedioxy)cyclotriphosphazene,0
3655,Heterocyclic Compounds,99-411 compound,0
3656,Heterocyclic Compounds,"(2-(4,7-biscarboxymethyl(1,4,7)triazacyclonona-1-yl-ethyl)carbonylmethylamino)acetic acid",0
3657,"Heterocyclic Compounds, Bridged-Ring",secu'amamine B,0
3658,"Heterocyclic Compounds, Bridged-Ring",secu'amamine C,0
3659,"Heterocyclic Compounds, Bridged-Ring",secu'amamine D,0
3660,"Heterocyclic Compounds, 1-Ring","1,7-dioxa-4,10-diazacyclododecane",0
3661,"Heterocyclic Compounds, 1-Ring","(4-(2-(bis(carboxymethyl)amino)-3-(4-nitrophenyl)propyl)-7-carboxymethyl(1,4,7)triazanonan-1-yl)acetic acid",0
3662,"Heterocyclic Compounds, 1-Ring",oxazaborolidinone,0
3663,"Heterocyclic Compounds, 1-Ring",stagonolide,0
3664,"Heterocyclic Compounds, 1-Ring","1,4,7-tris(carboxymethyl)-10-(vinylsulfone)-1,4,7,10-tetraazacyclododecane",0
3665,"Heterocyclic Compounds, 1-Ring","N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-10-acetamide",0
3666,"Heterocyclic Compounds, 1-Ring","(4-(((bis(phosphonopropyl))carbamoyl)methyl)-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetic acid",0
3667,"Heterocyclic Compounds, 1-Ring","8-benzenesulfonyloxy-5-N,N-dimethylaminosulfonylquinolin-2-ylmethyl-pendant 1,4,7,10-tetraazacyclododecane",0
3668,"Heterocyclic Compounds, 1-Ring",99-408 compound,0
3669,"Heterocyclic Compounds, 1-Ring","9-(1',4',7',10',13'-pentaazacyclopentadecyl)methylanthracene",0
3670,"Heterocyclic Compounds, 1-Ring","1,3-dithiolane-2-carboxaldehyde",0
3671,"Heterocyclic Compounds, 1-Ring","8,8'-(1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-7,16-diyl)-bis(methylene)diquinolin-7-ol",0
3672,"Heterocyclic Compounds, 2-Ring",DGS-666,0
3673,"Heterocyclic Compounds, 2-Ring",DGS-664A,0
3674,"Heterocyclic Compounds, 3-Ring",hylotelephin,0
3675,"Heterocyclic Compounds, 3-Ring",PF1270A,0
3676,"Heterocyclic Compounds, 3-Ring",PF1270C,0
3677,"Heterocyclic Compounds, 3-Ring",PF1270B,0
3678,"Heterocyclic Compounds, 3-Ring","phenyl(1,3,5-triaza-7-phosphatricyclo(3.3.1.1(3,7))dec-6-yl)methanol",0
3679,"Heterocyclic Compounds, 3-Ring",neoliacinic acid,0
3680,"Heterocyclic Compounds, 3-Ring",achalensolide,0
3681,"Heterocyclic Compounds, 3-Ring",pterocellin D,0
3682,"Heterocyclic Compounds, 3-Ring","5-chloro-10-oxa-3-thia-tricyclo(5.2.1.0(1,5))dec-8-ene-3,3-dioxide",0
3683,"Heterocyclic Compounds, 3-Ring","5-hydroxy-4-(4-methoxyphenyl)-10-oxa-4-azatricyclo(5.2.1.0(2,6))dec-8-en-3-one",0
3684,"Heterocyclic Compounds, 3-Ring",KSQ-4,0
3685,"Heterocyclic Compounds, 3-Ring",KSQ-3,0
3686,"Heterocyclic Compounds, 3-Ring","ethyl 2,3-O-isopropylidene-4-hydroxybicylco(3.1.0)hexanecarboxylate",0
3687,"Heterocyclic Compounds, 3-Ring",salograviolide A,0
3688,"Heterocyclic Compounds, 3-Ring",pestalotheol C,0
3689,"Heterocyclic Compounds, 3-Ring",dimeim,0
3690,"Heterocyclic Compounds, 3-Ring","(E)-3-(3-methylbut-1-enyl)-11-hydroxy-4-methoxy-9-methyl-7H-dibenzo(b,g)(1,5)dioxocin-5-one",0
3691,"Heterocyclic Compounds, 4 or More Rings",trifolirhizin,0
3692,"Heterocyclic Compounds, 4 or More Rings",myrobotinol,0
3693,"Heterocyclic Compounds, 4 or More Rings",hopeahainol A,0
3694,"Heterocyclic Compounds, 4 or More Rings",fortucine,0
3695,"Heterocyclic Compounds, 4 or More Rings",8-demethoxyrunanine,0
3696,"Heterocyclic Compounds, 4 or More Rings",paniculatine,0
3697,"Heterocyclic Compounds, 4 or More Rings",magellaninone,0
3698,"Heterocyclic Compounds, 4 or More Rings",PM031379,0
3699,"Heterocyclic Compounds, 4 or More Rings",lespedezol A1,0
3700,"Heterocyclic Compounds, 4 or More Rings",rosettacin,0
3701,"Heterocyclic Compounds, 4 or More Rings",8-acetylcyclostreptin,0
3702,"Heterocyclic Compounds, 4 or More Rings",ohioensin G,0
3703,"Heterocyclic Compounds, 4 or More Rings",ohioensin F,0
3704,"Heterocyclic Compounds, 4 or More Rings",rhazinicine,0
3705,"Heterocyclic Compounds, 4 or More Rings","4-methyl-6,7-(methylenedioxy)-9-((3,4,5-trimethoxyphenyl)amino)-3a,4-dihydrofuro(3.4-b)quinolin-1(3H)-one",0
3706,"Heterocyclic Compounds, 4 or More Rings",10-hydroxy-11-oxoerysotrine,0
3707,"Heterocyclic Compounds, 4 or More Rings",cernuine,0
3708,"Heterocyclic Compounds, 4 or More Rings","5-(3-bromophenyl)-1,3-dimethyl-5,11-dihydro-1H-indeno(2',1'-5,6)pyrido(2,3-d)pyrimidine-2,4,6-trione",0
3709,"Heterocyclic Compounds, 4 or More Rings",6-deoxy-7-demethylmangostanin,0
3710,"Heterocyclic Compounds, 4 or More Rings",preussomerin EG1,0
3711,"Heterocyclic Compounds, 4 or More Rings",preussomerin EG3,0
3712,"Heterocyclic Compounds, 4 or More Rings",preussomerin EG2,0
3713,Hexanones,soraphinol C,0
3714,hexosyltransferase,"Dad1 protein, rat",0
3715,High Mobility Group Proteins,"NHP10 protein, S cerevisiae",0
3716,High Mobility Group Proteins,"HMG-12 protein, C elegans",0
3717,Histone Deacetylase,"Hdac11 protein, mouse",0
3718,Histone Deacetylase,"Hst4 protein, S pombe",0
3719,Histones,"H1foo protein, mouse",0
3720,Histones,"H2AFX protein, mouse",0
3721,Hydantoins,UPR1024,0
3722,Hydrazines,2-methyl-5-nitrobenzenesulfonohydrazide,0
3723,Hydrazines,N-benzylidenesulfonohydrazide,0
3724,Hydrazines,"(1-(N'-(4-hydroxy-4-(2-hydroxyindan-1-ylcarbamoyl)-5-phenylpentyl)-N'-(4-pyridin-4-ylbenzyl)hydrazinocarbonyl)-2,2-dimethylpropyl)carbamic acid methyl ester",0
3725,Hydrazines,poly(ethylene glycol)-di-DT-hydrazide,0
3726,Hydrazines,"2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethanohydrazide",0
3727,Hydrazones,methyl pyrazinylketone 4-hydroxybenzoyl hydrazone,0
3728,Hydrazones,methyl pyrazinylketone 4-aminobenzoyl hydrazone,0
3729,Hydrazones,"rhodamine B 4-N,N-dimethylaminobenzaldehyde hydrazone",0
3730,Hydrazones,4-nitrobenzoic acid ((5-nitro-2-thiopheneyl)methylene)hydrazide,0
3731,Hydrazones,benzophenone 4-aminobenzoylhydrazone,0
3732,Hydrazones,phenylhydrazonopyrazolone sulfonate 1,0
3733,Hydrazones,"4,4'-dihydroxy-3,3'-dimethoxy-5,5'-biphenyl-1,1'-(diphthalazin-1-yl)methylhydrazone",0
3734,Hydrazones,1H-pyrazole-3-carboxy-4-methyl-5-phenyl-(1H-indol-3-ylmethylene)hydrazide,0
3735,Hydro-Lyases,"GDP-4-keto-6-deoxymannose-3-dehydratase, E coli",0
3736,Hydro-Lyases,"Phs1 protein, S cerevisiae",0
3737,"Hydrocarbons, Brominated",10-hydroxykahukuene B,0
3738,"Hydrocarbons, Brominated",laurenmariallene,0
3739,"Hydrocarbons, Brominated",p-trifluoromethylphenyl(difluoro)-lambda3-bromane,0
3740,"Hydrocarbons, Brominated",urceolatin,0
3741,"Hydrocarbons, Chlorinated",chlorotonil A,0
3742,"Hydrocarbons, Chlorinated",dechlorane plus,0
3743,"Hydrocarbons, Chlorinated",p-chloromethylphenyltrichlorosilane,0
3744,"Hydrocarbons, Chlorinated",polychlorotriphenylmethane,0
3745,"Hydrocarbons, Chlorinated","2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate",0
3746,"Hydrocarbons, Fluorinated","2-ethoxy-3,3,4,4,5-pentafluorotetrahydro-2,5-bis(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)furan",0
3747,"Hydrocarbons, Fluorinated","1,1,2,2-tetrafluoroethanesulfonic acid",0
3748,"Hydrocarbons, Fluorinated","dithiobis(2,3,5,6 tetrafluorophenyl undecanoate)",0
3749,"Hydrocarbons, Fluorinated",1-hexyl-3-methylimidazolium tris(pentafluoroethyl)trifluorophosphate,0
3750,"Hydrocarbons, Fluorinated",perfluoro-2-methyl-2-pentene,0
3751,"Hydrocarbons, Fluorinated","perfluoro-1,2-dimethyl cyclohexane",0
3752,"Hydrocarbons, Fluorinated",perfluoroheptane,0
3753,"Hydrocarbons, Fluorinated","2,3,5,6-tetrafluorophenylnitren-4-yl",0
3754,"Hydrocarbons, Fluorinated",S-111-S-WB,0
3755,"Hydrocarbons, Fluorinated",N-hydroxynaphthalimide triflate,0
3756,"Hydrocarbons, Fluorinated",4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid,0
3757,"Hydrocarbons, Fluorinated",8-2 fluorotelomer alcohol,0
3758,"Hydrocarbons, Fluorinated",tris(perfluorophenyl)borane,0
3759,"Hydrocarbons, Fluorinated","2-trifluoromethyl-8-(2-methoxybenzyl)-4-(N-methylamino)pyrazolo(1,5-a)-1,3,5-triazine",0
3760,"Hydrocarbons, Fluorinated",fluorosalinosporamide,0
3761,"Hydrocarbons, Fluorinated",KSPA-1,0
3762,"Hydrocarbons, Halogenated",chlorodifluoromethyl phenyl sulfone,0
3763,"Hydrocarbons, Halogenated",hexachlorocyclopentadienyl-dibromocyclooctane,0
3764,Hydrolase,"HsaD protein, Mycobacterium tuberculosis",0
3765,Hydroquinones,"2,5-dihydroxy-N-(2-hydroxyethyl)benzamide",0
3766,Hydroquinones,cordiaquinol I,0
3767,Hydroquinones,cordiaquinol J,0
3768,Hydroquinones,cordiaquinol K,0
3769,Hydroquinones,exiguaquinol,0
3770,Hydroxamic Acids,N-hydroxyasparagyl-alalnyl-prolyl-valyl-seryl-isoleucyl-prolyl-glutamine hydroxamic acid,0
3771,Hydroxamic Acids,metacept-1,0
3772,Hydroxamic Acids,indolyl-3-acetothiohydroxamic acid,0
3773,Hydroxamic Acids,suberoyl bis-hydroxamic acid,0
3774,Hydroxylamines,(2-hydroxyaminovinyl)triphenylphosphonium,0
3775,Mixed Function Oxygenases,"opdA protein, Sphingomonas",0
3776,Mixed Function Oxygenases,"tyramine beta-monooxygenase, Drosophila",0
3777,Mixed Function Oxygenases,"MOXD2P protein, human",0
3778,Mixed Function Oxygenases,"protopanaxadiol 6-hydroxylase, Panax notoginseng",0
3779,Hydroxyprogesterones,"4-pregnen-20,21-diol-3-one",0
3780,Hydroxyquinolines,PSI-421,0
3781,Hydroxyquinolines,5-amino-8-hydroxyquinoline,0
3782,Immunoglobulin G,"CD200-FC, mouse",0
3783,Imidazoles,1-butyl-3-methylimidazolium octyl sulfate,0
3784,Imidazoles,girolline,0
3785,Imidazoles,MF63 compound,0
3786,Imidazoles,5-amino-2-((1-n-propyl-1H-imidazol-4-yl)methyl)pentanoic acid,0
3787,Imidazoles,"(N,N'-bis((2-N-methylimidazol-1-yl)methylene))-2,2-dimethylpropane-1,3-diamine",0
3788,Imidazoles,fluoroproxyfan,0
3789,Imidazoles,CCT129202,0
3790,Imidazoles,CH 4512600,0
3791,Imidazoles,"1-(2-bromoethyl)-6-oxyl-5,5,7,7-tetramethyltetrahydroimidazo(1,5-b)(1,2,4)oxadiazol-2-one",0
3792,Imidazoles,"2-((2-(1H-imidazol-4-yl)ethyl)sulfanyl)-1,3-benzothiazole",0
3793,Imidazoles,5-methylimidazolium 3-carboxy-4-hydroxybenzenesulfonate,0
3794,Imidazoles,1-hexyl-3-methylimidazolium tris(pentafluoroethyl)trifluorophosphate,0
3795,Imidazoles,debromodispacamide B,0
3796,Imidazoles,debromodispacamide D,0
3797,Imidazoles,bis(2-(1-methyl-1H-imidazolyl)phenyl)phosphate,0
3798,Imidazoles,"5-(4-chlorophenyl)-N-cyclohexyl-4-(2,4-dichlorophenyl)-1-methyl-imidazole-2-carboxamide",0
3799,Imidazoles,"1-(4-(4-(adamant-1-yl)phenoxymethyl)-2-(4-bromophenyl)-1,3-dioxolan-2-ylmethyl)imidazole",0
3800,Imidazoles,4-t-butylphenyl-N-(4-imidazol-1-ylphenyl)sulfonamide,0
3801,Imidazoles,1-hexadecyl-3-methylimidazolium bromide,0
3802,Imidazoles,"7-(2-thienyl)imidazo(4,5-b)pyridine",0
3803,Imidazoles,"4(7)-amino-6(5)H-imidazo(4,5-d)pyridazin-7(4)-one",0
3804,Imidazoles,pratosartan,0
3805,Imidazoles,1-hexyl-3-methylimidazolium,0
3806,Imidazoles,1-octyl-3-methylimidazolium,0
3807,Imidazoles,BAG956,0
3808,Imidazoles,"1,9-dideoxypreaxinellamine",0
3809,Imidazoles,axinellamine A,0
3810,Imidazoles,axinellamine B,0
3811,Imidazoles,VN-66-1 compound,0
3812,Imidazoles,N-(12-imidazolyldodecanoyl)leucine,0
3813,Imidazoles,LNP640,0
3814,Imidazoles,"N2,N6-bis(1,3-dimethylimidazolin-2-ylidene)pyridine-2,6-diamine",0
3815,Imidazoles,"1-aminoimidazo(5,1-a)isoquinolinium",0
3816,Imidazoles,FD 838,0
3817,Imidazoles,dihydrosventrin,0
3818,Imidazoles,poly(imidazole-2-dimethylaminoethylamino)phosphazene,0
3819,Imidazoles,"7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido(3',2'-4,5)imidazo(1,2-a)pyrimidin-5-ium",0
3820,Imidazoles,3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide,0
3821,Imidazoles,"4,4'-bis(2-imidazolidinylimino)-1,2-diphenylethane",0
3822,Imides,N-cyclohexyl-N'-beta-(4-methylmorpholinium)ethylcarbodiimide,0
3823,Imides,"4-ethoxy-2-(2-hydroxy-3-(4-phenyl-1-piperazinyl))propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo(3,4-c)pyridine",0
3824,Imines,pyridine N-imine,0
3825,Imines,LYR 71,0
3826,Imino Acids,glycidyl methacrylate-iminodiacetic acid,0
3827,Immunoglobulin Variable Region,1D4.1-325 DVD-Ig protein,0
3828,Immunoglobulins,"Siglec-15 protein, human",0
3829,Immunoglobulins,"PUNC protein, human",0
3830,Immunoglobulins,"Skint1 protein, mouse",0
3831,Fab Immunoglobulins,Fab MOR03268,0
3832,Indans,N-((1-oxoindan-4-yl)carbonyl)isoleucine methyl ester,0
3833,Indans,"5,5'6,6'-terahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobisindane",0
3834,Indans,"2,2-difluorobenzo(1,3)dioxole-5-carboxylic acid indan-2-ylamide",0
3835,Indazoles,ABT 102,0
3836,Indenes,"trans-2,3,3a,7a-tetrahydro-1H-indene-4-carbaldehyde",0
3837,Indenes,"dispiro(indene-2,5'-indeno(2,1-a)fluorene-6',2''-indene)-1,1'',3,3'',11',12'-hexaone",0
3838,Indenes,"2-(4,5-dihydroxy-2-methylphenyl)-2-phenyl-2H-indene-1,3-dione",0
3839,Indenes,"2-(6-methyl-3,4-dioxocyclohexa-1,5-dienyl)-2-phenyl-2H-indene-1,3-dione",0
3840,Indenes,"1-(((3-(dimethylamino)propyl)(methyl)amino)methylene)-7,11-dihydroxy-4-(methoxymethyl)-4a,6a-dimethyl-2,10-dioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno(4,5-h)isochromene-5-yl acetate",0
3841,Indenes,"(6-chloro-2,3-dihydro-1H-inden-1-yl)acetic acid",0
3842,Indoleacetic Acids,1-(4-chlorobenzoyl)-5-hydroxy-2-methyl-3-indoleacetic acid,0
3843,Indoles,"5-aziridinyl-3-hydroxyl-1-methylindole-4,7-dione",0
3844,Indoles,"(R)-3-(4-(3-(1-((5-chloro-1,3-dimethyl-1H-indole-2-carbonyl)amino)ethyl)-5-fluoro-phenoxy)-2-ethylphenyl)propionic acid",0
3845,Indoles,"5,5',6,6'-tetrahydroxy-2,7'-biindolyl",0
3846,Indoles,1-hexylindolactam-V10,0
3847,Indoles,6-sulfonylindole,0
3848,Indoles,"N-(2-(1-((4-fluorophenyl)sulfonyl)-1H-indol-4-yloxy)ethyl)-N,N-dimethylamine",0
3849,Indoles,2-(1-(3-aminopropyl)indol-3-yl)-3-(indol-3-yl)-N-methylmaleimide,0
3850,Indoles,"3-(1-(2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl)-3,6-dihydro-2H-pyridin-4-yl)-6-chloro-1H-indole",0
3851,Indoles,5-(4-(4-chlorophenyl)piperazin-1-ylmethyl)-1H-indole,0
3852,Indoles,capparin A,0
3853,Indoles,capparin B,0
3854,Indoles,indolyl-3-acetothiohydroxamic acid,0
3855,Indoles,"N-(3-(1-cyclopropyl-1-(2,4-difluorophenyl)ethyl)-1H-indol-7-yl)methanesulfonamide",0
3856,Indoles,"N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-(1,1'-biphenyl)-3-acetamide",0
3857,Indoles,"(1,1'-biphenyl)-3-yl (2-(5-hydroxy-1H-indol-3-yl)ethyl)carbamate",0
3858,Indoles,2-methyl-2-((1-(3-phenyl-7-propylbenzo(d)isoxazol-6-yl)oxy)propyl)-1H-4-indolyloxypropanoic acid,0
3859,Indoles,"N-methyl-N-(3-((2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl)-pyridin-2-yl)-methanesulfonamide",0
3860,Indoles,SPD-304,0
3861,Indoles,"11-propyl-6H-indole(2,3-b)quinoline",0
3862,Indoles,centanamycin,0
3863,Indoles,"2-(indol-3-yl)-1,1,3,3-tetramethylthiouronium nitrate",0
3864,Indoles,2-chloro-4-fluoroindole nucleoside,0
3865,Indoles,PLX 4720,0
3866,Indoles,"2-amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-4,7-dihydro-7-methylpyrano(2,3-e)indole",0
3867,Indoles,monaspiloindole,0
3868,Indoles,Regulatory particle-Inhibiting Peptoid-1,0
3869,Indoles,ON09310,0
3870,Indoles,3-formylindole,0
3871,Indoles,SR 14150,0
3872,Indoles,"3-(1-methyl-1H-indol-3-ylmethylene)-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide",0
3873,Indoles,7-methyl-indole ethyl isothiocyanate,0
3874,Indoles,"1-methyl-2-(3',4',5'-trimethoxybenozyl)-3-amino-7-methoxyindole",0
3875,Indoles,SB-791016,0
3876,Indoles,"5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile",0
3877,Indoles,KR-31762,0
3878,Indoles,PCI 34051,0
3879,Indoles,cazpaullone,0
3880,Indoles,"1-chloromethyl-5-hydroxy-3-(5,6,7-trimethoxyindole-2-carbonyl)-2,3-dihydro-1H-benz(e)indole-7-carboxylic acid (beta-alanyl-tryptophyl-methionyl-aspartyl-phenylalanineamidyl)amide",0
3881,Indoles,3-bromo-1-methyl-4-(2-methylindolyl)maleimide,0
3882,Indoles,azaisoindigo,0
3883,Indoles,2-(2-chloro-5-((3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)methyl)phenoxy)propionic acid,0
3884,Indoles,"methyl(1-(10-chloroethyl)-3-((5-(2-(N,N-dimethylamino)ethoxy)indol-2-yl)carbonyl)-1,2-dihydro-3H-benz(e)indol-5-yl)-beta-D-glucopyranuronate",0
3885,Indoles,"(1-(10-chloroethyl)-3-((5-(2-(N,N-dimethylamino)ethoxy)indol-2-yl)carbonyl)-1,2-dihydro-3H-benz(e)indol-5-yl)-beta-D-glucopyranuronate",0
3886,Indoles,"2-(3-(5-fluoro-1H-indol-3-yl)-propyl)-6-methoxy-1,2,3,4-tetrahydro-isoquinoline",0
3887,Indoles,(E)-3-ethylidene-1-methylindolin-2-one,0
3888,Indoles,maremycin A,0
3889,Indoles,maremycin D1,0
3890,Indoles,5-dimethylallylindole-3-carboxylic acid,0
3891,Indoles,2-indolyl methanamine,0
3892,Indoles,1-(2-deoxy-beta-D-ribofuranosyl)-2-methyl-4-nitroindole,0
3893,Indoles,1-(2-deoxy-beta-D-ribofuranosyl)-2-phenyl-4-nitroindole,0
3894,Indoles,TDP223206,0
3895,Indolizines,"7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one",0
3896,Indolizines,rhazinicine,0
3897,Influenza virus vaccine,FluBlok,0
3898,Insulin,preproinsulin,0
3899,Insulin-Like Growth Factor I,"mechano-growth factor, mouse",0
3900,Interferons,locteron,0
3901,Interleukins,"Interleukin-34, human",0
3902,Iron-Sulfur Proteins,"NfuA protein, E coli",0
3903,Isoflavones,vestitone,0
3904,Isoflavones,glabridin,0
3905,Isoflavones,calycosin-7-O-beta-D-glucoside,0
3906,Isoflavones,derrubone,0
3907,Isoflavones,haginin A,0
3908,Isoflavones,genistein 7-O-beta-D-glucopyranoside-4'-O-(6'''- O-alpha-L-rhamnopyranosyl)-beta-sophoroside,0
3909,Isoflavones,genistein 7-O-alpha-L-rhamnopyranoside-4'-O-(6'''-O-alpha-L-rhamnopyranosyl)-beta-sophoroside,0
3910,Isoflavones,warangalone-4'-methyl ether,0
3911,Isoflavones,"(R)-3',5-dihydroxy-4',7-dimethoxyspiro(2H-1-benzopyran- 3(4H),7'-bicyclo(4.2.0)-octa(1,3,5)-trien)-4-one",0
3912,Isoflavones,hydroxyethylpuerarin,0
3913,Isoflavones,8-prenyldaidzein,0
3914,Isoflavones,irilone,0
3915,Isonicotinic Acids,2-methyl-3-hydroxy-4-pyridinecarboxylic acid,0
3916,Isonipecotic Acids,"methyl 1-(4-(2,4-diaminopteridin-6-ylmethylamino)benzoyl)piperidine-4-carboxylate",0
3917,Isonipecotic Acids,"methyl 1-(4-((2,4-diaminopteridin-6-ylmethyl)methylamino)benzoyl)piperidine-4-carboxylate",0
3918,Isoquinolines,7-deoxypancratistatin-1-carboxaldehyde,0
3919,Isoquinolines,"sodium pancratistatin 3,4- O-cyclic phosphate",0
3920,Isoquinolines,"1,2,3,4-tetrahydro-6,7-dimethoxy-2-((3-(3,4-dimethoxyphenyl)propylamino)cyanoiminomethyl)-1-(1-naphthylmethyl)isoquinoline",0
3921,Isoquinolines,"2-(3-(5-fluoro-1H-indol-3-yl)-propyl)-6-methoxy-1,2,3,4-tetrahydro-isoquinoline",0
3922,Isoquinolines,YM 758,0
3923,Isoxazoles,N-(4-chlorophenyl)-3-carboxyamidyl-5-methylisoxazole,0
3924,Isoxazoles,"5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide",0
3925,Isoxazoles,1-(4-(3-amino-7-methoxybenzo(d)isoxazol-4-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea,0
3926,Isoxazoles,tricholomic acid,0
3927,Isoxazoles,ABIO 0801,0
3928,Cytokeratin,"cytokeratin MNF116, human",0
3929,Ketones,6-methyl-2-octadecanone,0
3930,Ketones,14-methyl-2-octadecanone,0
3931,Ketones,"6,14-dimethyl-2-octadecanone",0
3932,Ketones,undecan-2-one,0
3933,Ketones,siphonarienone,0
3934,Ketones,poly(phthalazine ether sulfone ketone),0
3935,Ketoprofen,OMS 103HP,0
3936,Kinetin,kinetin riboside,0
3937,Kinins,prekininogens,0
3938,Lactams,fluvirucinine A1,0
3939,Lactams,1-hexylindolactam-V10,0
3940,Lactams,incednine,0
3941,Lactams,"3,3-pentamethylene-4-butyrolactam",0
3942,Lactams,mirabilin (macrolide lactam),0
3943,Lactates,4-(BODIPYFL-amino)-3-phenyllactic acid,0
3944,Lactates,HZL 7 compound,0
3945,Lactates,O-acetyl-3-phenyllactic acid,0
3946,Lactones,upial,0
3947,Lactones,eupalinin A,0
3948,Lactones,lycoperdic acid,0
3949,Lactones,8beta-epoxyangeloyloxy-9alpha-ethoxy-14-oxo-acanthospermolide,0
3950,Lactones,8beta-angeloyloxy-9alpha-ethoxy-14-oxo-acanthospermolide,0
3951,Lactones,"(4betaH)-5alpha-hydroxy-8alpha-(2-methylbut-2-enoyloxy)-2-oxo-1(10),11(13)-guaiadien-12,6alpha-olide",0
3952,Lactones,"(4betaH)-8alpha-(2-methylbut-2-enoyloxy)-2-oxo-1(5),10(14),11(13)-guaiatrien-12,6alpha-olide",0
3953,Lactones,"2,5-epoxy-2beta-hydroxy-4alpha-methoxy-8alpha-(2-methylbut-2-enoyloxy)-4(15),10(14),11(13)-germacratrien-12,6alpha-olide",0
3954,Lactones,xanthinosin,0
3955,Lactones,stagonolide,0
3956,Lactones,calealactone A,0
3957,Lactones,paeonilactone B,0
3958,Lactones,"1,11-dioxacycloicosane-2,12-dione",0
3959,Lactones,"2,9-dihydroxydehydrocostus lactone",0
3960,Lactones,5-deoxystrigol,0
3961,Lactones,deoxyelephantopin,0
3962,Lactones,AT-11 compound,0
3963,Lactones,renchanglactone A,0
3964,Lactones,polyrhacitide A,0
3965,Lactones,polyrhacitide B,0
3966,Lactones,fluorosalinosporamide,0
3967,Lactones,vorapaxar,0
3968,Lactones,nepetanudone,0
3969,Lactones,nepetaparnone,0
3970,Lactones,ainsliadimer A,0
3971,Lactose,1-benzyl-lactose,0
3972,Lactosylceramides,BODIPY-LacCer,0
3973,Lactosylceramides,lactosyl-beta1-1-N-octanoylsphingosine,0
3974,Laminin,laminin G-like 4-5 peptide,0
3975,Laminin,AG73T peptide,0
3976,Laurates,S-lauroylglutathione,0
3977,Gonadorelin,ovaprim,0
3978,Lidocaine,Strepsils,0
3979,Ligase,"salicyl-AMP ligase, Mycobacterium tuberculosis",0
3980,Ligase,"CRSH protein, Arabidopsis",0
3981,Linoleic Acids,Akmicare,0
3982,Linoleic Acids,N-linoleoyltyrosine,0
3983,Lipoproteins,"BB0365 protein, Borrelia burgdorferi",0
3984,Malates,3-isopropylmalate methyl ester,0
3985,Maleates,N-ethylmaleamic acid,0
3986,Maleimides,2-(1-(3-aminopropyl)indol-3-yl)-3-(indol-3-yl)-N-methylmaleimide,0
3987,Maleimides,N-methylmaleimide,0
3988,Maleimides,N-(4-diazophenyl)maleimide tetrafluoroborate,0
3989,Maleimides,3-bromo-1-methyl-4-(2-methylindolyl)maleimide,0
3990,Maleimides,fluorodeoxyglucose F18-maleimidehexyloxime,0
3991,Maleimides,bodipy FL N-(2-aminoethyl)maleimide,0
3992,Mannitol Phosphates,"mannitol-1,6-bis-phosphate",0
3993,Mannosidase,"endomannosidase, rat",0
3994,Mannosides,TMC-151A,0
3995,Mannosides,myricetin-3-O-rhamnoside,0
3996,Marine Toxins,"SHTX-I toxin, Stichodactyla haddoni",0
3997,Marine Toxins,"SHTX-II toxin, Stichodactyla haddoni",0
3998,Marine Toxins,"SHTX-III toxin, Stichodactyla haddoni",0
3999,Membrane Glycoproteins,"Pfs47 protein, Plasmodium falciparum",0
4000,Membrane Glycoproteins,"TRAM2 protein, rat",0
4001,Membrane Glycoproteins,"MUC21 protein, human",0
4002,Membrane Glycoproteins,"CALHM1 protein, human",0
4003,Membrane Proteins,"TYROBP protein, human",0
4004,Membrane Proteins,"FIS1 protein, human",0
4005,Membrane Proteins,"KIAA1432 protein, human",0
4006,Membrane Proteins,"Npc2a protein, Drosophila",0
4007,Membrane Proteins,"PL6 protein, human",0
4008,Membrane Proteins,"VMP1 protein, human",0
4009,Membrane Proteins,"Cdr-6 protein, C elegans",0
4010,Membrane Proteins,"Cdr-4 protein, C elegans",0
4011,Membrane Proteins,"LRRTM1 protein, human",0
4012,Membrane Proteins,"TMEM30a protein, human",0
4013,Membrane Proteins,"TMEM30B protein, human",0
4014,Membrane Proteins,"Siglec-15 protein, human",0
4015,Membrane Proteins,"Epb4.1l5 protein, mouse",0
4016,Membrane Proteins,"OPA1 protein, Drosophila",0
4017,Membrane Proteins,"Marf protein, Drosophila",0
4018,Membrane Proteins,"Fld1 protein, S cerevisiae",0
4019,Membrane Proteins,"PGRL1 protein, Arabidopsis",0
4020,Membrane Proteins,"YczE protein, Bacillus amyloliquefaciens",0
4021,Membrane Proteins,"Nkain1 protein, mouse",0
4022,Membrane Proteins,"PATMK protein, Entamoeba histolytica",0
4023,Membrane Proteins,"OC-STAMP protein, mouse",0
4024,Membrane Proteins,"Rv2560 protein, Mycobacterium tuberculosis",0
4025,Membrane Proteins,"PPP1R16A protein, mouse",0
4026,Membrane Proteins,"MOXD2P protein, human",0
4027,Membrane Proteins,"CPR5 protein, Arabidopsis",0
4028,Membrane Proteins,"D8L protein, vaccinia virus",0
4029,Membrane Proteins,"MMgT1 protein, mouse",0
4030,Membrane Proteins,"MMgT2 protein, mouse",0
4031,Membrane Proteins,"Vangl1 protein, mouse",0
4032,Membrane Proteins,"SRP-27 protein, rat",0
4033,Membrane Proteins,"TMEM74 protein, human",0
4034,Membrane Proteins,"YhjD protein, E coli",0
4035,Membrane Proteins,"SLAC1 protein, Arabidopsis",0
4036,Membrane Proteins,"Scube1 protein, rat",0
4037,Membrane Proteins,"TMEM43 protein, human",0
4038,Membrane Proteins,"spry1 protein, Xenopus",0
4039,Membrane Proteins,"TMPRSS4 protein, human",0
4040,Membrane Proteins,"CLEC-38 protein, C elegans",0
4041,Membrane Proteins,"neurobin protein, mouse",0
4042,Membrane Proteins,"Pirt protein, mouse",0
4043,Membrane Proteins,"NimC4 protein, Drosophila",0
4044,Membrane Proteins,"CLTRN protein, Xenopus",0
4045,Membrane Proteins,"ring finger protein 122, human",0
4046,Membrane Proteins,"Lrig3 protein, Xenopus",0
4047,Membrane Proteins,"ERS25 protein, human",0
4048,Membrane Proteins,"ERS25 protein, mouse",0
4049,Membrane Proteins,"Blcap protein, mouse",0
4050,Membrane Proteins,"SMAP2 protein, mouse",0
4051,Membrane Proteins,"REF4 protein, Arabidopsis",0
4052,Membrane Proteins,"VPR-1 protein, C elegans",0
4053,Membrane Proteins,"endomannosidase, rat",0
4054,Membrane Proteins,"VAPB protein, mouse",0
4055,Membrane Proteins,"VAPB protein, rat",0
4056,Membrane Proteins,"RNF5 protein, mouse",0
4057,Membrane Proteins,"CSM4 protein, S cerevisiae",0
4058,Membrane Proteins,"peroxin IIb, Arabidopsis",0
4059,Membrane Proteins,"EOLA1 protein, rat",0
4060,Membrane Proteins,"Dfm1 protein, S cerevisiae",0
4061,Membrane Proteins,"TeiR protein, Comamonas testosteroni",0
4062,Membrane Proteins,"MSL9 protein, Arabidopsis",0
4063,Membrane Proteins,"MSL10 protein, Arabidopsis",0
4064,Membrane Proteins,"MPV17 protein, human",0
4065,Membrane Proteins,"Qvr protein, Drosophila",0
4066,Membrane Proteins,"derlin-1 protein, mouse",0
4067,Menotropins,hMG-IBSA,0
4068,Metalloporphyrins,zinc octaethylporphyrin,0
4069,Metalloporphyrins,"5,10,15,20-tetrakis(4-sulfophenyl)porphyrinatoiron(II)",0
4070,Metalloporphyrins,nickel(III) tetra(tbutyl)porphyrin dicyanide,0
4071,Metalloporphyrins,chlorooxo(porphyrin)manganese(III),0
4072,Metalloporphyrins,"(5,15-dicyano-10,20-bis(3,5-di-tert-butylphenyl)porphyrinato)zinc(II)",0
4073,Metalloporphyrins,"oxo(5,10,15,20-tetra(4-pyridyl)porphyrinato)titanium(IV)",0
4074,Metalloproteins,"Lmo2 protein, Xenopus",0
4075,Metalloproteins,"Exc-9 protein, C elegans",0
4076,Metalloproteins,"VALV-1 protein, C elegans",0
4077,Metalloproteins,"Jxc1 protein, mouse",0
4078,Metallothionein,"MT1A protein, human",0
4079,Methacrylates,"9,9'-bis(4-(2'-hydroxy-3'-methacryloxyloxypropoxy)phenyl)fluorene",0
4080,Methacrylates,poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate),0
4081,Methacrylates,poly(ethylene glycol)-co-(glycidyl methacrylate-iminodiacetic acid),0
4082,Methacrylates,glycidyl methacrylate-iminodiacetic acid,0
4083,Methacrylates,diurethane dimethacrylate,0
4084,Methacrylates,polyisobutylene-block-poly(methacrylic acid),0
4085,Methacrylates,3-sulfopropyl methacrylate,0
4086,Methacrylates,2-sulfoethyl methacrylate,0
4087,Methacrylates,X-tra fil composite resin,0
4088,Methacrylates,3-dimethyl(methacryloyloxyethyl)ammonium propane sulfonate,0
4089,Mesylates,N-(2-(4-t-butylbenzyl)-3-(pivaloyloxy)propyl)-2-(3-fluoro-4-(methylsulfonylamino)phenyl)propionamide,0
4090,Mesylates,N-(2-(4-t-butylbenzyl)-3-(pivaloyloxy)propyl)-2-(3-chloro-4-(methylsulfonylamino)phenyl)propionamide,0
4091,Mesylates,4-(2-amino-1-methyl-2-oxoethyl)phenyl trifluoromethanesulfonate,0
4092,Methionine,methione-equine growth hormone,0
4093,METHIONINE ADENOSYLTRANSFERASE,"MAT2A protein, human",0
4094,METHIONINE ADENOSYLTRANSFERASE,"Mat2beta protein, human",0
4095,Methyl Ethers,methyl-tert-octyl ether,0
4096,Methyl Ethers,dithiomethylether,0
4097,Methylamines,5-dimethylaminopropargyl deoxyuridine,0
4098,Methylamines,2'-o-dimethylaminoethoxyuridine,0
4099,Methylamines,"8-(2-methoxybenzyl)-4-(N-methylamino)-2-n-propylpyrazolo(1,5-a)-1,3,5-triazine",0
4100,Methylamines,2-indolyl methanamine,0
4101,Methylglucosides,"4-(3,4-dihydroxybenzoyloxymethyl)phenyl-O-beta-D-glucopyranoside",0
4102,Methyltransferase,"16-methoxytabersonine methyltransferase, Catharanthus roseus",0
4103,Methyltransferase,"Set11 protein, S pombe",0
4104,Methyltransferase,"nucleomethylin protein, human",0
4105,Methyltransferase,"PRMT10 protein, Arabidopsis",0
4106,Methyltransferase,"diphthine synthase, Pyrococcus horikoshii",0
4107,Methyltransferase,"ISG95 protein, human",0
4108,Methyltransferase,"HMPrmC protein, human",0
4109,Methylurea Compounds,"2-(indol-3-yl)-1,1,3,3-tetramethylthiouronium nitrate",0
4110,Microfilament Proteins,"TWF2 protein, human",0
4111,Microfilament Proteins,"girdin protein, mouse",0
4112,Microfilament Proteins,"ACTR8 protein, human",0
4113,Microfilament Proteins,"JRAB protein, human",0
4114,Microfilament Proteins,"leiomodin 2 protein, human",0
4115,Microfilament Proteins,"fli-1 protein, C elegans",0
4116,Microfilament Proteins,"Cindr protein, Drosophila",0
4117,Microfilament Proteins,"SSH1 protein, rat",0
4118,Microfilament Proteins,"SSH2 protein, rat",0
4119,Microfilament Proteins,"nesprin 3 protein, human",0
4120,Microtubule-Associated Proteins,"Nedd1 protein, mouse",0
4121,Microtubule-Associated Proteins,"Dia2 protein, mouse",0
4122,Microtubule-Associated Proteins,"CEP68 protein, human",0
4123,Microtubule-Associated Proteins,"CLASP protein, Arabidopsis",0
4124,Microtubule-Associated Proteins,"Snph protein, mouse",0
4125,Microtubule-Associated Proteins,"Spo16 protein, S cerevisiae",0
4126,Microtubule-Associated Proteins,"Dam1 protein, S pombe",0
4127,Microtubule-Associated Proteins,"Ubr4 protein, mouse",0
4128,Microtubule-Associated Proteins,"RANBP10 protein, human",0
4129,Microtubule-Associated Proteins,"NEDD1 protein, Xenopus",0
4130,Microtubule-Associated Proteins,"GCP3 protein, Arabidopsis",0
4131,Mollusk Venoms,"conorfamide-Sr2, Conus spurius",0
4132,Molybdenum,PM-17 polyoxomolybdate,0
4133,Monosaccharides,"4-C-acyloxymethyl-3,5-di-O-acyl-1,2-O-(1-methylethylidene)-beta-L-threo-pentofuranose",0
4134,Monosaccharides,4-(2-isocyanovinyl)phenyl alpha-L-rhamnopyranoside,0
4135,Monosaccharides,rhodionin,0
4136,Morphinans,noroxymorphone,0
4137,Morphinans,"2,2'-disinomenine",0
4138,Morphinans,"7',8'-dihydro-1,1'-disinomenine",0
4139,Morphinans,bis(N-cyclobutylmethylmorphinan-3-yl) sebacoylate dihydrochloride,0
4140,Morphine Derivatives Including Cocaine,6-desoxymorphine,0
4141,Morpholines,JNJ 28871063,0
4142,Morpholines,2-(cyclohexylthio)-1-thiomorpholinoethanone,0
4143,Morpholines,4-acryloylmorpholine,0
4144,Morpholines,"(1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone",0
4145,Morpholines,3-morpholinopropyl isothiocyanate,0
4146,Morpholines,N-cyclohexyl-N'-beta-(4-methylmorpholinium)ethylcarbodiimide,0
4147,Morpholines,"1,3-dimethyl-1,3-p-fluorophenyl-1,3-(3-morpholinopropyl)-1,3-disiloxane",0
4148,Morpholines,flumorph,0
4149,Morpholines,GYY 4137,0
4150,Morpholines,N-tert-butoxycarbonyl-2-hydroxymethylmorpholine,0
4151,Morpholines,N-tert-butoxycarbonyl-2-morpholine-2-carboxylic acid,0
4152,Morpholines,hydroxyanthraquinone-aminopropyl methyl morpholinium methosulfate,0
4153,Morpholines,4-benzylamino-2-((4-morpholin-4-ylphenyl)amino)pyrimidine-5-carboxamide,0
4154,Mucins,"3-O-(2-acetamido-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-beta-galactopyranosyl)-beta-glucopyranosyl)-2,4,6-tri-O-acetyl-alpha-galactopyranosyl bromide",0
4155,Mucins,"MUC21 protein, human",0
4156,Mucoproteins,"Agr2 protein, mouse",0
4157,Multienzyme Complexes,"ERN1 protein, Xenopus",0
4158,Multienzyme Complexes,"PAP15 protein, Arabidopsis",0
4159,Muscle Proteins,"kindlin-2 protein, mouse",0
4160,Muscle Proteins,"SRP-27 protein, rat",0
4161,Muscle Proteins,"leiomodin 2 protein, human",0
4162,Muscle Proteins,"mighty protein, mouse",0
4163,Muscle Proteins,"sarcosin protein, mouse",0
4164,Muscle Proteins,"Ndrg4 protein, zebrafish",0
4165,Mycotoxins,"panomycocin protein, Pichia anomala",0
4166,Myosin ATPase,"Myo10A protein, Drosophila",0
4167,Myosin ATPase,"XIE protein, Arabidopsis",0
4168,Myristates,1-sulfate-3-myristoyl-5-pentadecylbenzene,0
4169,NADPH-Ferrihemoprotein Reductase,flavocytochrome P450 BM3 monoxygenases,0
4170,Naphthacenes,"tetraceno(2,3-b)thiophene",0
4171,Naphthalenes,"1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one",0
4172,Naphthalenes,"1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene",0
4173,Naphthalenes,"methyl 2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4-pentadienoate",0
4174,Naphthalenes,"N,N'-1,5-naphthalenebis(oxamate)",0
4175,Naphthalenes,1-(2-naphthyl)-3-methyl-5-pyrazolone,0
4176,Naphthalenes,SA6817,0
4177,Naphthalenes,6-methoxycomaparvin,0
4178,Naphthalenes,6-methoxycomaparvin 5-methyl ether,0
4179,Naphthalenes,8'-O-demethylnigerone,0
4180,Naphthalenes,8'-O-demethylisonigerone,0
4181,Naphthalenes,"3-(2-(4-(naphthalen-1-yl)piperazin-1-yl)ethyl)benzo(d)(1,2,3)triazin-4(3H)-one",0
4182,Naphthalenes,dehydromonacolin-MV2,0
4183,Naphthalenes,"4-propyl-3,4-dihydro-2H-naphtho(1,2-b)pyran-5,6-dione",0
4184,Naphthalenes,"1,1'-binaphthyl-2,2'-dicarboxylic acid",0
4185,Naphthalenes,neojusticin C,0
4186,Naphthalenes,procumbenoside D,0
4187,Naphthalenes,procumbenoside C,0
4188,Naphthalenes,2-formyl-6-naphthoic acid,0
4189,Naphthalenes,6-dodecanoyl-2-(N-methyl-N-(carboxymethyl)amino)naphthalene,0
4190,Naphthalenes,6-((E)-3-oxo-1-dodecenyl)-2-(N-methyl-N-(carboxymethyl)amino)naphthalene,0
4191,Naphthalenes,JTK-101,0
4192,Naphthalenes,AC-262536,0
4193,Naphthalenes,PB183 compound,0
4194,Naphthalenes,hyphodermin A,0
4195,Naphthalenes,hyphodermin D,0
4196,Naphthalenes,((3-bromo-7-cyano-2-naphthyl)(difluoro)methyl)phosphonic acid,0
4197,Naphthalenes,"(3,3'-diphenyl-1,1'-binaphthyl)-20-crown-6",0
4198,Naphthalenes,VANOL ligand,0
4199,Naphthalenes,"naphtho(8,1,2-ghi)chrysene",0
4200,Naphthalenes,4-fluorobenzoyl-RR-(L-3-(2-naphthyl)alanine)-CYEK-(L-citrulline)-PYR-(L-citrulline)-CR,0
4201,Naphthalenes,6-bromo-2-naphthoic acid,0
4202,Naphthalenesulfonates,"phenyl hydrazine-1,2-dihydroxynaphthalene-3,6-disulfonic acid",0
4203,Naphthalenesulfonates,orange DNA13,0
4204,Naphthalenesulfonates,"2,3-dihydroxynaphthalene-6-sulfonic acid",0
4205,Naphthalenesulfonates,"4,5-dihydroxynaphthalene-2,7-disulfonic acid",0
4206,Naphthols,"6-((2-(4-phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol",0
4207,Naphthols,epoxymollugin,0
4208,Naphthols,eleutherinol,0
4209,Naphthols,2-((1-(hydroxymethyl)cyclohexyl)methyl)naphthalen-1-ol,0
4210,Naphthoquinones,diospyrin diethylether,0
4211,Naphthoquinones,2-methoxynaphthoquinone,0
4212,Naphthoquinones,2-propoxynaphthoquinone,0
4213,Naphthoquinones,2-isopropoxynaphthoquinone,0
4214,Naphthoquinones,"2-bromo-1,4-naphthoquinone",0
4215,Naphthoquinones,annulin B,0
4216,Naphthoquinones,isoeleutherin,0
4217,Naphthoquinones,"4-((2-N,N-dimethyl)amino)ethylspiro((dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno(2,3-b)naphtho-4',9'-dione))",0
4218,Naphthoquinones,"4-(2-pyrrolidine)ethylspiro((dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno(2,3-b)naphtho-4',9'-dione))",0
4219,Naphthoquinones,A80915G-8'-acid,0
4220,Naphthyridines,"1-tert-butyl-1,4-dihydro-7-(4,4-dimethyloxazolidin-3-yl)-6-nitro-4-oxo-1,8-naphthyridine-3-carboxylic acid",0
4221,Naphthyridines,"2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile",0
4222,Naphthyridines,GPD-1116,0
4223,Naphthyridines,"2,6-diauro-1,5-naphthyridine",0
4224,Naphthyridines,JNJ-26076713,0
4225,Naphthyridines,ferrocenyl aminonaphthyridine,0
4226,Naphthyridines,"2-ethyl-8-(4-fluorophenyl)-6-methyl-3,4-dihydro-2H-(2,7)naphthyridin-1-one",0
4227,Naphthyridines,"2-(ferrocenylmethylamino)-7-methyl-1,8-naphthyridine",0
4228,Naphthyridines,"N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-10-acetamide",0
4229,Naphthyridines,"4-(3-(7-methyl-1,8-naphthyridin-2-ylamino)propyl)-7-N,N-dimethylaminosulfonylbenzo-2-oxa-1,3-diazole",0
4230,Naphthyridines,"2-amino-5,6,7-trimethyl-1,8-naphthyridine",0
4231,Naphthyridines,pumafentrine,0
4232,Neoplasm Proteins,"GSDMB protein, human",0
4233,Neoplasm Proteins,"Dnd1 protein, human",0
4234,Neoplasm Proteins,"ovarian cancer immuno-reactive antigen domain containing 1, human",0
4235,Neoplasm Proteins,"Blcap protein, mouse",0
4236,Neoplasm Proteins,"FAM83A protein, human",0
4237,Nerve Tissue Proteins,"AAAS protein, human",0
4238,Nerve Tissue Proteins,"PANX1 protein, human",0
4239,Nerve Tissue Proteins,"Nalp1 protein, rat",0
4240,Nerve Tissue Proteins,"Nalp5 protein, rat",0
4241,Nerve Tissue Proteins,SALLRSIPA,0
4242,Nerve Tissue Proteins,"Huntingtin protein, rat",0
4243,Nerve Tissue Proteins,"Sema3C protein, rat",0
4244,Nerve Tissue Proteins,"Crmp-4 protein, mouse",0
4245,Nerve Tissue Proteins,"LRRTM1 protein, human",0
4246,Nerve Tissue Proteins,"Ndrg4 protein, mouse",0
4247,Nerve Tissue Proteins,"protocadherin 20 protein, mouse",0
4248,Nerve Tissue Proteins,"LNP-1 protein, C elegans",0
4249,Nerve Tissue Proteins,"Taip2 protein, mouse",0
4250,Nerve Tissue Proteins,"FEZ1 protein, human",0
4251,Nerve Tissue Proteins,"RBM17 protein, mouse",0
4252,Nerve Tissue Proteins,"GPCR101 protein, rat",0
4253,Nerve Tissue Proteins,"Cngb1 protein, mouse",0
4254,Nerve Tissue Proteins,"Cyfip2 protein, mouse",0
4255,Nerve Tissue Proteins,"Cplx3 protein, mouse",0
4256,Nerve Tissue Proteins,"PIKE protein, mouse",0
4257,Neuraminidase,"Neu2 protein, rat",0
4258,Neuropeptides,"insulin-like peptide 7, Drosophila",0
4259,Neuropeptides,"protocadherin beta16, mouse",0
4260,Neuropeptides,cortistatin-8,0
4261,Neuropeptides,"conorfamide-Sr2, Conus spurius",0
4262,Neuropeptides,"TAFA5 peptide, rat",0
4263,nickel,Ni3O4,0
4264,Nicotinic Acids,"2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid",0
4265,Nicotinic Acids,"5-(2-fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate",0
4266,Nitrates,"1-hydroxyethyl-4-amino-1,2,4-triazolium nitrate",0
4267,Nitrates,urea nitrate,0
4268,Nitriles,2-methylene-3-phenylpropanenitrile,0
4269,Nitriles,4-cyano-4'-ethynylbiphenyl,0
4270,Nitriles,"1,2-dicyanodisilane",0
4271,Nitriles,"trans-1,2-bis(4-cyanophenyl)ethene",0
4272,Nitriles,"trans-1,2-bis(4-cyanophenyl)cyclopropane",0
4273,Nitriles,"2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile",0
4274,Nitriles,"3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide",0
4275,Nitriles,"3-furylquinoxaline-2-carbonitrile 1,4-di-N-oxide",0
4276,Nitriles,3-fluoro-5-((pyridin-3-yl)ethynyl)benzonitrile,0
4277,Nitriles,4-(2-isocyanovinyl)phenyl alpha-L-rhamnopyranoside,0
4278,Nitriles,"8,16-dicyano(2.2)metacyclophane-1,9-diene",0
4279,Nitriles,octacyanobutanediide,0
4280,Nitriles,"3-((3-(trifluoromethyl)phenyl)amino)pyrazine-2,5-dicarbonitrile",0
4281,Nitriles,"(2,6-pyridinediylbis(methylene nitrilo)) tetraacetic acid",0
4282,Nitriles,"4-tricyanovinyl-N,N-diethylaniline",0
4283,Nitriles,"2-((2-amino-4,6-di-1-piperidylpyrimidin-5-yl)methylene)malononitrile",0
4284,Nitriles,3-hydroxyandrostane-17-carbonitrile,0
4285,Nitriles,cycloprothrin,0
4286,Nitriles,2-cyano-6-fluorophenylacetamide,0
4287,Nitro Compounds,ortho-nitrophenylacetylene,0
4288,Nitro Compounds,5-amino-3-methyl-1-(2-nitrobenzoyl)pyrazole,0
4289,Nitro Compounds,"4-nitro-13-amino-(2,2)paracyclophane",0
4290,Nitrobenzenes,2-methyl-5-nitrobenzenesulfonohydrazide,0
4291,Nitrobenzenes,4-nitrophenyloxycarbonyl-polyethyleneglycol,0
4292,Nitrobenzenes,2-nitrobenzyloxymethyl,0
4293,Nitrobenzoates,2-methyl-6-nitrobenzoic anhydride,0
4294,Nitrogen Mustard Compounds,SN 28343,0
4295,Nitrosamines,3-(4-(methylnitrosoamino)-1-hydroxybutyl)pyridine N-oxide,0
4296,Nitroso Compounds,2-nitroso-7-nitrofluorene,0
4297,Nitroso Compounds,2-nitroso-7-nitro-9-oxofluorene,0
4298,Nicotinamide-Nucleotide Adenylyltransferase,"NMNAT1 protein, rat",0
4299,Nicotinamide-Nucleotide Adenylyltransferase,"NMNAT3 protein, rat",0
4300,Norpregnanes,3beta-OH-tibolone,0
4301,Norpregnatrienes,"21-(2-N,N-diethylaminoethyl)oxy-7-methyl-19-norpregna-1,3,5(10)-triene-3-O-sulfamate",0
4302,Nuclear Proteins,"REV1 protein, human",0
4303,Nuclear Proteins,"Sim3 protein, S pombe",0
4304,Nuclear Proteins,"Daxx protein, Drosophila",0
4305,Nuclear Proteins,"Huntingtin protein, rat",0
4306,Nuclear Proteins,"ric8b protein, zebrafish",0
4307,Nuclear Proteins,"SRRT protein, human",0
4308,Nuclear Proteins,"Ars2 protein, mouse",0
4309,Nuclear Proteins,"SRG8 protein, human",0
4310,Nuclear Proteins,"TSPYL5 protein, human",0
4311,Nuclear Proteins,"MAMLD1 protein, human",0
4312,Nuclear Proteins,"Pch2 protein, S cerevisiae",0
4313,Nuclear Proteins,"Taip2 protein, mouse",0
4314,Nuclear Proteins,"POT1A protein, Arabidopsis",0
4315,Nuclear Proteins,"NUT protein, human",0
4316,Nuclear Proteins,"Daxx protein, rat",0
4317,Nuclear Proteins,"Tex19 protein, human",0
4318,Nuclear Proteins,"Tex19 protein, rat",0
4319,Nuclear Proteins,"Tex19 protein, mouse",0
4320,Nuclear Proteins,"colon cancer-specific antigen 2, human",0
4321,Nuclear Proteins,"nucleomethylin protein, human",0
4322,Nuclear Proteins,"OPHN1 protein, rat",0
4323,Nuclear Proteins,"COPRS protein, human",0
4324,Nuclear Proteins,"SBDS protein, zebrafish",0
4325,Nuclear Proteins,"Anp32a protein, mouse",0
4326,Nuclear Proteins,"C10orf27 protein, human",0
4327,Nuclear Proteins,"THOC5 protein, human",0
4328,Nuclear Proteins,"Ndc80 protein, Xenopus",0
4329,Nucleoside-Phosphate Kinase,"cytidylate kinase 2, human",0
4330,Nucleosides,"(5-(6-amino-purin-9-yl)-2,5-dihydrofuran-2-yloxymethyl)phosphonic acid",0
4331,Nucleosides,"4'-C-acyloxymethyl-2',3',5'-tri-O-acyl-beta-L-threo-pentofuranosylthymine",0
4332,Nucleosides,nikkomycin B,0
4333,Nucleosides,pyranosyl nikkomycin B,0
4334,Nucleosides,3-cyano-4-(2'-deoxyribofuranosyl)aniline,0
4335,Nucleosides,2-chloro-4-fluoroindole nucleoside,0
4336,Nucleosides,2-chloro-4-methylbenzimidazole nucleoside,0
4337,Nucleosides,"7-ribofuranosylthieno(3,4-d)pyrimidine-3,6-dione",0
4338,Nucleosides,"1-ribofuranosyl-3-ethynyl-(1,2,4)triazole",0
4339,Nucleotidases,"calcium-activated nucleotidase, human",0
4340,Nucleotides,ENA nucleotide,0
4341,Nucleotides,"2',4'-BNA(NC)",0
4342,nucleotidyltransferase,"CGM1 protein, Trypanosoma brucei",0
4343,nucleotidyltransferase,"NAADP synthase, Lytechinus pictus",0
4344,Nylons,Bpy5 compound,0
4345,Octanes,1-butyl-3-methylimidazolium octyl sulfate,0
4346,Octanes,"N,N-dimethyloctylamine-N-oxide",0
4347,Oleic Acids,4-methyl-N-oleoyldopamine,0
4348,Oleic Acids,3-methyl-N-oleoyldopamine,0
4349,Oligodeoxyribonucleotides,CpG ODN 2216,0
4350,Oligodeoxyribonucleotides,CpG ODN 2395,0
4351,Oligodeoxyribonucleotides,R-Sp1 ODN,0
4352,Oligodeoxyribonucleotides,d(CGCGCG)-BP,0
4353,Oligodeoxyribonucleotides,d(TATATATATATA),0
4354,Oligodeoxyribonucleotides,1-(2-deoxy-beta-D-ribofuranosyl)-2-methyl-4-nitroindole,0
4355,Oligodeoxyribonucleotides,1-(2-deoxy-beta-D-ribofuranosyl)-2-phenyl-4-nitroindole,0
4356,Oligonucleotides,amino-LNA,0
4357,Oligonucleotides,ENA-1 oligonucleotide,0
4358,Oligonucleotides,LY 2181308,0
4359,Oligopeptides,myristoyl-beta-alanyl-(arginyl)7-lysyl(flurosceine isothiocyanate)amide,0
4360,Oligopeptides,NGR peptide,0
4361,Oligopeptides,"2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide",0
4362,Oligopeptides,SF 1126,0
4363,Oligopeptides,gadolinum-DOTA-aspartyl-glutamyl-valyl-aspartic acid 4-trifluoromethoxybenzylamide,0
4364,Oligopeptides,tyrosyl-prolyl-serinamide,0
4365,Oligopeptides,arginyl-leucyl-alanyl-arginine,0
4366,Oligopeptides,lysyl-leucyl-alanyl-arginine,0
4367,Oligopeptides,Fmoc-GlyVal-GlyOH,0
4368,Oligopeptides,aspartyl-tryptophyl-glutamyl-tyrosyl-seryl-valyl-tryptophyl-leucyl-seryl-asparagine,0
4369,Oligopeptides,N-hydroxyasparagyl-alalnyl-prolyl-valyl-seryl-isoleucyl-prolyl-glutamine hydroxamic acid,0
4370,Oligopeptides,"arginyl-(N-(2,4-dichlorophenethyl)glycyl)-N-(2-(indol-3-yl)ethyl)glycinamide",0
4371,Oligopeptides,YPPPPPW peptide,0
4372,Oligopeptides,octapeptide P1,0
4373,Oligopeptides,"handle-region peptide, rat",0
4374,Oligopeptides,Val-Lys-Lys-Val-Leu-Gly-Asn-Pro,0
4375,Oligopeptides,"bis(N-alpha-amido-tyrosyl-tyrosyl-tyrosine)-1,5-pentane dicarboxylate",0
4376,Oligopeptides,Ac-Arg-(Cys-Met-Ava-Arg-Val-Tyr-Ava-Cys)-NH2,0
4377,Oligopeptides,arginyl-arginyl-phenylalanyl-prolyl-tryptophyl-tryptophyl-tryptophan,0
4378,Oligopeptides,tryptophyl-tryptophyl-tryptophyl-prolyl-phenylalanyl-arginyl-arginine,0
4379,Oligopeptides,norleucyl-prolyl-glycyl-phenylalanyl-alanyl-glutaminyl-alanine,0
4380,Oligopeptides,methionyl-leucyl-prolyl-histidyl-histidyl-glycyl-alanine,0
4381,Oligopeptides,YW12d peptide,0
4382,Oligopeptides,"(3H)Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH",0
4383,Oligopeptides,MA-2029,0
4384,Oligopeptides,asparagyl-aspargyl-tryptophyl-asparagyl-asparagine,0
4385,Oligopeptides,(18)F-FB-BBN-RGD,0
4386,Oligopeptides,ornicorrugatin,0
4387,Oligopeptides,N(4)-(2-(diethylamino)ethyl)-2-iodo-N(1)-(4-methyl-1-(4-methyl-1-(4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-yl)terephthalamide,0
4388,Oligopeptides,myristoyl-SIYRRGARRWRKL,0
4389,Oligopeptides,pyroglutamyl-arginyl-glutamyl-arginyl-tyrosinamide,0
4390,Oligopeptides,acetyl-(2-naphthyl)alanyl-4-chlorophenylalanyl-3-(3-pyridinyl)alanyl-seryl-histidyl-n5-aminocarbonylornithyl-tryptophyl-tyrosyl-prolyl-alaninamide,0
4391,Oligopeptides,Ac-Cys-Pro-Phe-Cys-NH2,0
4392,Oligopeptides,NKISK peptide,0
4393,Oligopeptides,glycyl-phenylalanyl-glycine,0
4394,Oligopeptides,dragonamide D,0
4395,Oligopeptides,dragonamide C,0
4396,Oligopeptides,valyl-leucyl-prolyl-valyl-proline,0
4397,Oligopeptides,Asp-Tyr-Leu-Lys,0
4398,Oligopeptides,Lys-Leu-Tyr-Asp,0
4399,Oligopeptides,glutamyl-phenylalanyl-leucyl-arginyl-isoleucynamide,0
4400,Oligopeptides,prolyl-phenylalanyl-tyrosyl-arginyl-isloleucynamide,0
4401,Oligopeptides,"handle-region peptide, mouse",0
4402,Oligopeptides,seryl-seryl-seryl-arginine,0
4403,Oligopeptides,ariakemicin A,0
4404,Oligopeptides,ariakemicin B,0
4405,Oligoribonucleotides,r(GCUUCGGC) RNA tetraloop,0
4406,Oligosaccharides,nerolidol-3-O-rhamnopyranosyl-1-4-rhamnopyranosyl-1-2-(rhamnopyranosyl-1-6)-glucopyranoside,0
4407,"Oncogene Proteins, Viral","E6 protein, human papillomavirus type 20",0
4408,Organometallic Compounds,tetracarbonylacetato(ethyl(3-(2-pyridyl)-1-pyrazolyl))molybdenum(II),0
4409,Organometallic Compounds,Gd-AA2TAC17,0
4410,Organometallic Compounds,Gd-DO3A-diph,0
4411,Organometallic Compounds,"1,2-dilithiobenzene",0
4412,Organometallic Compounds,4-fluorophenylzinc chloride,0
4413,Organometallic Compounds,gadolinum-DOTA-aspartyl-glutamyl-valyl-aspartic acid 4-trifluoromethoxybenzylamide,0
4414,Organometallic Compounds,dimethylcuprate(I),0
4415,Organometallic Compounds,diethylcuprate(I),0
4416,Organometallic Compounds,zinc(II)tetra-tert-butylphthalocyanine,0
4417,Organometallic Compounds,pQ510 compound,0
4418,Organometallic Compounds,"trans-dichlorobis(2,2-dimethyl-1,3-diaminopropane)chromium(III) chloride",0
4419,Organometallic Compounds,Cu(II)-2-(2-pyridyl)-benzimidazole,0
4420,Organometallic Compounds,bis(eta(5)-cyclopentadienyl)zirconium(IV) dichloride,0
4421,Organometallic Compounds,bis(2-amino-5-methylthiazole)tetrachlororuthenate(III),0
4422,Organometallic Compounds,Pd(8)(micro-CO)(4)(micro-OOCCMe(3))(8)(micro-NO(2))(4),0
4423,Organometallic Compounds,"68Ga-1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO-acetyl(Cys(3,4,10),Phe(7),Arg(7))aplha-MSH(3-13))",0
4424,Organometallic Compounds,Evans blue-DTPA-gadolinium,0
4425,Organometallic Compounds,"tris-(4,7-diphenyl-1,10-phenanthroline)3Cr(III)",0
4426,Organometallic Compounds,ruthenium (3-(2-phenanthren-9-yl-vinyl)-pyridine),0
4427,Organometallic Compounds,5-methyl-2'-deoxycytidine glycol-dioxoosmium-bipyridine,0
4428,Organometallic Compounds,cesium perfluorooctanoate,0
4429,Organometallic Compounds,trans-bis(glycine)nickel(II),0
4430,Organometallic Compounds,"bis(mu-6,6'-dimethoxy-2,2'-(propane-1,2-diylbis(iminomethylene))diphenolato)bis(aquacopper(II)) dihydrate",0
4431,Organometallic Compounds,"2,2'-bis(1,3,4-triphenyl-4,5-dihydro-1H-1,2,4-triazol-5-ylidene)nickel(0)",0
4432,Organometallic Compounds,ruthenium-dUTP,0
4433,Organometallic Compounds,"(mu-N,N'-bis(2-(dimethylamino)ethyl)oxamidato(2-)-kappa(6)N,N',O'-N'',N''',O)bis((2,2'-bipyridine-kappa2N,N')copper(III))",0
4434,Organometallic Compounds,"(2,6-diacetylpyridine bis((2-(hydroxyimino)propanoyl)hydrazone)(2-))nickel(II)",0
4435,Organometallic Compounds,bis(acetylacetonato)zinc(II),0
4436,Organometallic Compounds,"bis(1-(2-hydroxyethyl)-4,10-diazapyrazolo(4,3-b)fluoren-5(1H)-one thiosemicarbazonato)zinc(II)",0
4437,Organometallic Compounds,"catena-poly((aqua(3-(2-pyridylsulfanyl)propionato N-oxide-kappaO1)copper(II))-mu-(3-(2-pyridylsulfanyl)propionato N-oxide-kappa3O3-O1,O1') dihydrate)",0
4438,Organometallic Compounds,"catena-poly((acetatohexaaqua(mu4-2,6-bis(bis(carboxylatomethyl)aminomethyl)-4-methylphenolato)trizinc(II)) octahydrate)",0
4439,Organometallic Compounds,(tert-butylmethylphosphino)(di-tert-butylphosphino)methane rhodium complex,0
4440,Organometallic Compounds,tetraaquabis(sulfisoxazole)nickel,0
4441,Organometallic Compounds,bis(sulfapyridine)nickel,0
4442,Organometallic Compounds,"mer-trichloro(acrylonitrile)(dipyrido(3,2-d-2',3'-f)quinoxaline)ruthenium(III)",0
4443,Organometallic Compounds,ruthenium phthalocyanine,0
4444,Organometallic Compounds,"manganese(II)(N,N-bis(2-pyridylmethyl)amine-N-ethyl-2-quinoline-2-carboxamide)",0
4445,Organometallic Compounds,"(1,2-bis(5-(trimethylaminomethyl)salicylidenamino)ethane)nickel(II)",0
4446,Organometallic Compounds,"(2,3-bis(5-(trimethylaminomethyl)salicylidenamino)butane)nickel(II)",0
4447,Organometallic Compounds,(N-((5-(propylaminocarbonyl)pyridin-2-yl)methyl)-(5-(trimethylaminomethyl)salicylidenamino)acetamide)nickel(II),0
4448,Organometallic Compounds,"2,5-di-(2-(3,5-bis(2-pyridylmethyl)amine-4-hydroxy-phenyl)-ethylene)-pyrazine-Zn",0
4449,Organometallic Compounds,"chloro(1,10-phenanthroline)(N-propylnorfloxacinato)copper(II)",0
4450,Organometallic Compounds,bis(2-(5-chloro-2-pyridylazo)-5-diethylaminophenolato)cobalt,0
4451,Organometallic Compounds,"bis(chloro)-1,4-bis(dimethyl-3 or 4-pyridylsilyl)benzenepalladium(II)",0
4452,Organometallic Compounds,tetramethyltetratelluronaphtalene,0
4453,Organometallic Compounds,tetrakis(tris(hydroxymethyl)phosphine)copper(I),0
4454,Organometallic Compounds,bis(bis(bis(hydroxymethyl)phosphino)ethane)copper(I),0
4455,Organometallic Compounds,phenylethynyl lithium,0
4456,Organometallic Compounds,"(N(1),N(8)-bis(1-methyl-4-nitropyrrole-2-carbonyl)triethylenetetramine)magnesium(II)",0
4457,Organometallic Compounds,bis-dipicolylamine-Zinc(II),0
4458,Organometallic Compounds,"diruthenium(II,III) bis(tetramethyl-1,3-benzenedipropionate)",0
4459,Organometallic Compounds,64Cu-DOTA-VEGF(DEE),0
4460,Organometallic Compounds,64Cu-DOTA-1C1,0
4461,Organometallic Compounds,"(N,N'-ethylene(salicylideneiminato)-5-sulfonato)oxovanadium (IV) dihydrate",0
4462,Organometallic Compounds,nickel(II) bis(3-(heptafluorobutanoyl)-(1R)-camphorate),0
4463,Organometallic Compounds,"gadolinium per(3,6-anhydro)-alpha-cyclodextrin",0
4464,Organometallic Compounds,"(5,9,14,18,23,27,32,36-octabutoxynaphthalocyanine)copper(II)",0
4465,Organometallic Compounds,"(5,9,14,18,23,27,32,36-octabutoxynaphthalocyanine)cobalt(II)",0
4466,Organometallic Compounds,UO(2) (VI) complex,0
4467,Organometallic Compounds,"bis(2,2'-bipyridine)(4,4'-bis(4-aminobutyl)-2,2'-bipyridine) ruthenium perchlorate",0
4468,Organometallic Compounds,"(4'-(4-methacryloyloxymethylphenyl)-2,2'-6',2''-terpyridine)(4'-(4-methoxyphenyl)-2,2'-6',2''-terpyridine)ruthenium(II)",0
4469,Organometallic Compounds,"chloro(1,4,7,10-tetrakis(2'-pyridylmethyl)-1,4,7,10-tetraazacyclododecane)europium(III)",0
4470,Organometallic Compounds,"bis(2,2'-bipyridine)(4,4'-bis(4-aminobutyl)-2,2'-bipyridine) ruthenium perchloroate",0
4471,Organometallic Compounds,"(1,5,9,13-tetrathiacyclohexadecane-3,11-diol)rhodium(III) astatide",0
4472,Organometallic Compounds,"(1,5,9,13-tetrathiacyclohexadecane-3,11-diol)iridium(III) astatide",0
4473,Organometallic Compounds,"bis(2,2'-bipyridine)(11-aminopteridine(6,7-f)(1,10)phenanthrolin-13(121H)-one)ruthenium(II)",0
4474,Organometallic Compounds,"dichloro(4-cymene)(1,3,5-triaza-7-phosphatricyclo(3.3.1.1)decane)ruthenium(II)",0
4475,Organometallic Compounds,ethylglyoxal bis(thiosemicarbazonato)copper(II),0
4476,Organometallic Compounds,TMPMgCl.LiCl,0
4477,Organometallic Compounds,"1,4,8,12-tetraazacyclotetradecane osmium(III) chloride",0
4478,Organometallic Compounds,"carbonyl(tris(3-tert-butyl-5-methyl-1,2,4-triazolyl)borate)copper(I)",0
4479,Organophosphorus Compounds,poly((ethyl alanato) (p-phenyl phenoxy) phosphazene),0
4480,Organophosphorus Compounds,"phenyl(1,3,5-triaza-7-phosphatricyclo(3.3.1.1(3,7))dec-6-yl)methanol",0
4481,Organophosphorus Compounds,(2-hydroxyaminovinyl)triphenylphosphonium,0
4482,Organophosphorus Compounds,"(1S,2R)-2-hexyloxy carbonylamino-1 methyl-2-(3-methoxyphenyl) ethyl disodium phosphate",0
4483,Organophosphorus Compounds,N-phosphonomethylaspartic acid,0
4484,Organophosphorus Compounds,tris(o-phenylenedioxy)cyclotriphosphazene,0
4485,Organophosphorus Compounds,P(OH)(2)TBCS(n),0
4486,Organophosphorus Compounds,AGP 524,0
4487,Organophosphorus Compounds,AGP 527,0
4488,Organophosphorus Compounds,nucleoside C-2 tris(dimethylamino)phosphonium hexafluorophosphate salt,0
4489,Organoplatinum Compounds,"Pt(O,O'-acac)(gamma-acac)(DMS)",0
4490,Organoplatinum Compounds,CD-37 compound,0
4491,Organoplatinum Compounds,cis-(Pt(histamine)Cl2),0
4492,Organoplatinum Compounds,"(5,6-dimethyl-1,10-phenanthroline)(1,2-diaminocyclohexane)platinum(II)",0
4493,Organoplatinum Compounds,"(5-methyl-1,10-phenanthroline)(1,2-diaminocyclohexane)platinum(II)",0
4494,Organoplatinum Compounds,"(5,6-dimethyl-1,10-phenanthroline)(ethylenediamine)platinum(II)",0
4495,Organoplatinum Compounds,"2,2'-bipiperidine(dimethylmalonato)platinum(II)",0
4496,Organoplatinum Compounds,dichloro(6-aminomethylnicotinate)platinum(II),0
4497,Organoplatinum Compounds,cis-diammine(pyridine)chloroplatinum(II),0
4498,Organothiophosphorus Compounds,BPH-652,0
4499,Organothiophosphorus Compounds,GYY 4137,0
4500,Organotin Compounds,di-n-butyliodotin hydride,0
4501,Organotin Compounds,"5'-(tributyltin)-2',3'-O-isopropylidene-4'-trityladenosine",0
4502,Organotin Compounds,trichlorophenylstannane,0
4503,Organotin Compounds,dichlorodimethylstannane,0
4504,Oxadiazoles,"7-nitrobenz-2-oxa-1,3-diazole",0
4505,Oxadiazoles,"5-bromo-7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonic acid",0
4506,Oxadiazoles,Wf-516,0
4507,Oxadiazoles,"4-(2-(N,N-dimethylamino)ethylaminosulfonyl)-7-N-methylhydrazino-2,1,3-benzoxadiazole",0
4508,Oxadiazoles,"1,2,5-oxadiazole 2-oxide",0
4509,Oxadiazoles,GSK690693,0
4510,Oxadiazoles,"4-(3-(7-methyl-1,8-naphthyridin-2-ylamino)propyl)-7-N,N-dimethylaminosulfonylbenzo-2-oxa-1,3-diazole",0
4511,Oxadiazoles,LC15-0133,0
4512,Oxadiazoles,"6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol",0
4513,Oxadiazoles,poly(dimethyldioctylquaterthiophene-alt-oxadiazole),0
4514,Oxadiazoles,HCK-123,0
4515,Oxadiazoles,"2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole",0
4516,Oxadiazoles,"2-(3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)acetic acid",0
4517,Oxazines,"1,3-diaza-2-oxophenoxazine",0
4518,Oxazines,resorufin-beta-D-cellobioside,0
4519,Oxazines,7-hydroxy-(8-oxazine-2-one)-quinoline,0
4520,Oxazines,"5,9-diaminodibenzo(a,j)phenoxazine",0
4521,Oxazines,7-epi-FR900482,0
4522,Oxazines,Basic Blue 3,0
4523,Oxazocines,KRP-103,0
4524,Oxazoles,5-fluoro-4-(trifluoromethyl)-2-phenyloxazole,0
4525,Oxazoles,"1-(2-bromoethyl)-6-oxyl-5,5,7,7-tetramethyltetrahydroimidazo(1,5-b)(1,2,4)oxadiazol-2-one",0
4526,Oxazoles,bengazole E,0
4527,Oxazoles,bengazole B,0
4528,Oxazoles,"2-methyl-c-5-(4-(5-methyl-2-phenyl-1,3-oxazol-4-yl)butyl)-1,3-dioxane-r-2-carboxylic acid",0
4529,Oxazoles,"(R)-4-hydroxymethyl-2-phenyl-4,5-dihydrooxazol-4-ylmethyl acetate",0
4530,Oxazoles,"(4'S,5'S)-2,6-bis(4'-(triisopropylsilyl)oxymethyl-5'-phenyl-1',3'-oxazolin-2'-yl)pyridine",0
4531,Oxides,PM-17 polyoxomolybdate,0
4532,Oxides,"N,N-dimethyloctylamine-N-oxide",0
4533,Oxides,"3-(allyloxy)-1,2-benzisothiazole 1,1-dioxide",0
4534,Oxides,Ni3O4,0
4535,Oxidoreductase,"STEAP2 protein, human",0
4536,Oxidoreductase,"tRNA dihydrouridine synthase-2, human",0
4537,Oxidoreductase,"Des1 protein, rat",0
4538,Oxidoreductase,"Des2 protein, rat",0
4539,Oxidoreductase,"corrin reductase, Brucella melitensis",0
4540,"Oxidoreductases, N-Demethylating","UTX protein, Drosophila",0
4541,Oximes,formamidoxime,0
4542,Oximes,"1,2-dimethoxy-ethylene-bis-N,N'-4-pyridiumaldoxime dichloride",0
4543,Oximes,fluoroethyl-desmethyl-ABP688,0
4544,Oximes,phenyl 2-pyridyl ketone oxime,0
4545,Oximes,darapladib,0
4546,Oximes,3-chloro-4-(4-hydroxyphenyl)salicylaldoxime,0
4547,Oximes,pentafluorobenzyloxime,0
4548,Oximes,fluorodeoxyglucose F18-maleimidehexyloxime,0
4549,Oxymetazoline,OMS 103HP,0
4550,Oxytocin,mono-6-deoxy-6-oxytocinyl-beta-cyclodextrin 5,0
4551,Palmitates,"2,3-dipalmitoyloxypropylarsonic acid",0
4552,Palmitates,"1,3-propanediol dipalmitate",0
4553,Palmitates,S-palmitoleoylglutathione,0
4554,Palmitates,estradiol 17-palmitate,0
4555,Palmitates,N-(4-methoxy-2-nitrophenyl)hexadecanamide,0
4556,Palmitates,2-amino-3-(palmitoylamino)benzoic acid,0
4557,Palmitates,4-amino-3-(palmitoylamino)benzoic acid,0
4558,Pantothenic Acid,Slim339,0
4559,Pentanes,isoamyl cinnamate,0
4560,Pentanoic Acids,bovidic acid,0
4561,Pentanones,"2,4-dimethyl-2-(thiophen-3-yl)-4-(thiophen-3-yl-S,S-dioxo)pentan-3-one",0
4562,Pentanones,"2,4-dimethyl-2,4-di(thiophen-3-yl)pentan-3-one",0
4563,Peptide Elongation Factors,"EEF1E1 protein, human",0
4564,Peptide Fragments,pituitary polypeptide P16,0
4565,Peptide Fragments,telokin,0
4566,Peptide Fragments,"joining peptide, pro-opiomelanocortin",0
4567,Peptide Fragments,daniplestim,0
4568,Peptide Fragments,"PU-15 protein, synthetic",0
4569,Peptide Fragments,OVA-8,0
4570,Peptide Fragments,MBP-8298,0
4571,Peptide Fragments,rD-7 peptide,0
4572,Peptide Fragments,"prostatic acid phosphatase (248-286), human",0
4573,Peptide Fragments,SALLRSIPA,0
4574,Peptide Fragments,"myelin oligodendrocyte glycoprotein (35-50), Ala(37)-",0
4575,Peptide Fragments,laminin G-like 4-5 peptide,0
4576,Peptide Fragments,influenza virus hemagglutinin peptide 2 (1-23),0
4577,Peptide Fragments,"myelin oligodendrocyte glycoprotein (74-96), human",0
4578,Peptide Fragments,chromogranin A (344-358),0
4579,Peptide Fragments,alanyl-glutamyl-seryl-asparagyl-glutamyl-aspartyl-glycyl-tyrosine,0
4580,Peptide Fragments,"intestinal fatty acid-binding protein (1-19), human",0
4581,Peptide Fragments,"intestinal fatty acid-binding protein (91-107), human",0
4582,Peptide Fragments,"intestinal fatty acid-binding protein (121-131), human",0
4583,Peptide Fragments,gelsolin (160-169),0
4584,Peptide Fragments,astressin-2B,0
4585,Peptide Fragments,beta-amyloid (15-28),0
4586,Peptide Fragments,"RLFi peptide, rat",0
4587,Peptide Fragments,AG73T peptide,0
4588,Peptide Fragments,"mini-TyrRS, human",0
4589,Peptide Fragments,CTAP octapeptide,0
4590,Peptide Fragments,amyloid beta-protein (16-20),0
4591,Peptide Fragments,"LIP1 proNGF peptide, human",0
4592,Peptide Fragments,"LIP2 proNGF peptide, human",0
4593,Peptide Fragments,beta-casein F (133-138),0
4594,Peptide Fragments,rubimetide,0
4595,Peptide Hydrolases,"SpyCEP protein, Streptococcus pyogenes",0
4596,Endopeptidases,"taspase1, Drosophila",0
4597,Peptide Termination Factors,"mtRF1a protein, human",0
4598,Peptide Termination Factors,"HMRF1L protein, human",0
4599,Peptides,ALL1 peptide,0
4600,Peptides,arginyl-leucyl-cysteinyl-arginyl-isoleucyl-valyl-valyl-isoleucyl-arginyl-valyl-cysteinyl-arginyl-seryl-aspartyl-aspartyl-aspartyl-glutamyl-glutamic acid (3-11)disulfide,0
4601,Peptides,arginyl-leucyl-cysteinyl-arginyl-isoleucyl-valyl-valyl-isoleucyl-arginyl-valyl-cysteinyl-arginyl-aspartyl-aspartyl-aspartyl-aspartyl-glutamyl-glutamic acid (3-11)disulfide,0
4602,Peptides,magainin-PGLa hybrid peptide,0
4603,Peptides,Z28 peptide,0
4604,Peptides,"peptide 4 kDa, Fagopyrum esculentum",0
4605,Peptides,FLPIVGAKL,0
4606,Peptides,INF7 peptide,0
4607,Peptides,KAI 9803,0
4608,Peptides,R18 peptide,0
4609,Peptides,AC3-I peptide,0
4610,Peptides,cavitein LG2,0
4611,Peptides,cavitein LG3,0
4612,Peptides,Wheel-FKFE,0
4613,Peptides,Anal-R peptide,0
4614,Peptides,Anal-S peptide,0
4615,Peptides,CBLB502,0
4616,Peptides,M1557 peptide,0
4617,Peptides,2G12.1 peptide,0
4618,Peptides,CDIP-2 peptide,0
4619,Peptides,BPI peptide,0
4620,Peptides,peptidimer-c,0
4621,Peptides,101.10 peptide,0
4622,Peptides,"HV-BBI peptide, Huia versabilis",0
4623,Peptides,DTS-108,0
4624,Peptides,mitoparan,0
4625,Peptides,S597 peptide,0
4626,Peptides,ideal amphipathic peptide,0
4627,Peptides,EAK 16-IV peptide,0
4628,Peptides,Sadat-Habdan mesenchymal stimulating peptide,0
4629,Peptides,COG112 peptide,0
4630,Peptides,AH 111585,0
4631,Cyclic Peptides,GE 2270 A,0
4632,Cyclic Peptides,bastadin 14,0
4633,Cyclic Peptides,bastadin 10,0
4634,Cyclic Peptides,bastadin 12,0
4635,Cyclic Peptides,2520A compound,0
4636,Cyclic Peptides,abyssenine A,0
4637,Cyclic Peptides,serinocyclin A,0
4638,Cyclic Peptides,serinocyclin B,0
4639,Cyclic Peptides,GE2270C1,0
4640,Cyclic Peptides,polydiscamide B,0
4641,Cyclic Peptides,polydiscamide C,0
4642,Cyclic Peptides,polydiscamide D,0
4643,Cyclic Peptides,cyclosquamosin D,0
4644,Cyclic Peptides,"5,10-dioxo-1,6-diazacyclodecane-2,7-dicarboxylic acid",0
4645,Cyclic Peptides,acetyl-norleucyl-cyclo(aspartyl-prolyl-2-naphthylalanyl-arginyl-tryptophyl-lysyl)-prolyl-valyinamide,0
4646,Cyclic Peptides,segetalin D,0
4647,Cyclic Peptides,cyclo(dehydrohistidyl-tryptophyl),0
4648,Cyclic Peptides,astressin-2B,0
4649,Cyclic Peptides,microsclerodermin C,0
4650,Cyclic Peptides,microsclerodermin D,0
4651,Cyclic Peptides,segetalin C,0
4652,Cyclic Peptides,bastadin 24,0
4653,Cyclic Peptides,bromobenzisoxazolone barettin,0
4654,Cyclic Peptides,nummularine-P,0
4655,Cyclic Peptides,sativanine-M,0
4656,Cyclic Peptides,YM753 compound,0
4657,Cyclic Peptides,RedYM compound,0
4658,Cyclic Peptides,stylopeptide 2,0
4659,Cyclic Peptides,technetium 99m RAFT-RGD,0
4660,Cyclic Peptides,majusculamide C,0
4661,Cyclic Peptides,axinastatin 5,0
4662,Cyclic Peptides,pedein A,0
4663,Cyclic Peptides,pedein B,0
4664,Cyclic Peptides,cyclo(valyl-ornithyl-leucyl-phenylalanyl-prolyl-lysyl)2,0
4665,Cyclic Peptides,cyclo(lysyl-lysyl-prolyl-tyrosyl-isoleucyl-leucyl-lysyl-lysyl-prolyl-tyrosyl-isoleucyl-leucyl),0
4666,Cyclic Peptides,NYAD-1 peptide,0
4667,Cyclic Peptides,protoporphyrin IX-cyclic(arginyl-glycyl-aspartyl-phenylalanyl-lysyl) conjugate,0
4668,Cyclic Peptides,RA-XXIV,0
4669,Cyclic Peptides,RA-XXIII,0
4670,Cyclic Peptides,mupain-1,0
4671,Perchlorates,phenylenediammonium diperchlorate,0
4672,Peroxidases,"EP2932 protein, Enterococcus faecalis",0
4673,Peroxidases,"Pxt protein, Drosophila",0
4674,Peroxides,Forte whitening agent,0
4675,Peroxides,OZ397,0
4676,Peroxides,OZ381,0
4677,Peroxides,nite white excel 2Z,0
4678,Peroxides,rembrant xtra comfort,0
4679,Peroxides,2-butanone peroxide,0
4680,Peroxides,hydroxymethyl hydroperoxide,0
4681,Petroleum,larimsh,0
4682,Phenanthrenes,MF63 compound,0
4683,Phenanthrenes,"4b,5,6,7,8,8a-hexahydro-2-hydroxy-4b,8,8-trimethylphenanthren-9(10H)-one",0
4684,Phenanthrenes,urceolatin,0
4685,Phenanthrenes,14-dehydroxy-14-fluorotriptolide,0
4686,Phenanthridines,oxyterihanine,0
4687,Phenanthrolines,"phenylimidazo(4,5-f)1,10-phenanthroline",0
4688,Phenanthrolines,"2,9-diamino-1,10-phenanthroline",0
4689,Phenanthrolines,"tris(1,10-phenanthrolin-2-ylaminoethyl)amine",0
4690,Phenanthrolines,"tris(1,10-phenanthrolin-2-ylaminopropyl)amine",0
4691,Phenanthrolines,"p-hydroxyphenylimidazo(f)1,10-phenanthroline ferrum(III)",0
4692,Phenanthrolines,tetrapyridoacridine,0
4693,Phenanthrolines,"2,9-di-(pyrid-2-yl)-1,10-phenanthroline",0
4694,Phenazines,ritterazine M,0
4695,Phenazines,"3-(4-chloro-6-p-glyoxalphenoxy-1,3,5-triazinylamino)-7-(dimethylamino)-2-methylphenazine",0
4696,Phenazines,ritterazine A,0
4697,Phenazines,"3-(4-chloro-6-p-maleimidylphenoxy-1,3,5-triazinylamino)-7-dimethylamino-2-methylphenazine",0
4698,Phenethylamines,phenoprolamine hydrochloride,0
4699,Phenethylamines,"2-(2,5-dimethoxy-4-isopropylsulfanylphenyl)ethanamine",0
4700,Phenols,"2-tridecyl-3-((2-tridecyl-3-acetoxy-4-methoxy-6-hydroxy)phenyl)-6-methoxy-1,4-benzoquinone",0
4701,Phenols,"2-tridecyl-3-((2-tridecyl-4,6-dihydroxy)phenyl)-6-methoxy-1,4-benzoquinone",0
4702,Phenols,"2,3-difluoro phenol",0
4703,Phenols,"4,4 -(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bis(phenol)",0
4704,Phenols,4-(heptyloxy)phenol,0
4705,Phenols,3-glucopyranosyloxy-1-(4-hydroxyphenyl)butanone,0
4706,Phenols,"4-methoxymethyl-2,6-dimethylphenol",0
4707,Phenols,"4-chloro-3-(5-methyl-3-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)-1,2,4-benzotriazin-7-yl)phenol",0
4708,Phenols,3-chloro-4-(4-hydroxyphenyl)salicylaldoxime,0
4709,Phenols,"N,N'-bis(2-(hydroxymethyl)benzyl)ethylenediamine",0
4710,Phenols,2-((E)-(2-(2-(pyridine-2-yl)- ethylthio)ethylimino)methyl)-4-bromophenol,0
4711,Phenols,"6-(4-((1E)-2-(3,5-dihydroxyphenyl)ethenyl)phenoxy)hexanoic acid",0
4712,Phenols,3-hydroxybisphenol A,0
4713,Phenothiazines,RP 12274,0
4714,Phenyl Ethers,"3,4,5-tribromo-6-methoxy-2-(2',4'-dibromophenoxy)phenol",0
4715,Phenyl Ethers,"2-(4-(2,4-dichlorophenoxy)phenoxy)propionic acid",0
4716,Phenyl Ethers,4-phenoxyphenol,0
4717,Phenylacetates,monaspilosin,0
4718,Phenylbutyrates,OSU-HDAC42 compound,0
4719,Phenylenediamines,poly(o-phenylenediamine),0
4720,Phenylpropionates,methyl 2-methylene-3-phenylpropanoate,0
4721,Phenylpropionates,3-(5-amino-2-hydroxy)phenyl-propionic acid,0
4722,Phenylpropionates,3-(4-azidophenyl)propionic acid,0
4723,Phenylpropionates,(2R)-((4-biphenylylsulfonyl)amino)-N-hydroxy-3-phenylpropionamide,0
4724,Phenylurea Compounds,1-(4-chlorophenyl)-3-(3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl)urea,0
4725,Phenylurea Compounds,AVN 944,0
4726,Phenylurea Compounds,1-(4-(3-amino-7-methoxybenzo(d)isoxazol-4-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea,0
4727,Phosphatidate Phosphatase,"PAH1 protein, S cerevisiae",0
4728,Phosphatidylserines,"1,2-dioctanoyl-sn-glycero-3-phosphoserine",0
4729,Phosphines,"2,3- O-isopropylidene-2,3-dihydroxyl-1,4-bis(diphenylphosphino)butane",0
4730,Phosphines,tris(cyclopentylphosphine),0
4731,Phosphines,"(N,N-diisobutylcarbamoylmethyl)phenyloctylphosphine oxide",0
4732,Phosphines,chlorodiisopropylphosphine,0
4733,Phosphines,tetrakis(tris(hydroxymethyl)phosphine)copper(I),0
4734,Phosphines,bis(bis(bis(hydroxymethyl)phosphino)ethane)copper(I),0
4735,Phosphines,trimethylphosphine oxide,0
4736,Phosphines,dimethylaminodifluorophosphine,0
4737,Phosphinic Acids,RXP 409,0
4738,Phosphinic Acids,methylphosphinic acid,0
4739,Phosphoenolpyruvate Sugar Phosphotransferase System,"PtsN protein, E coli",0
4740,PHOSPHOGLYCERATE KINASE,"Pgk1 protein, mouse",0
4741,Phosphoglycerate Mutase,"Gpm1 protein, Candida albicans",0
4742,Phospholipase D,"NAPE-PLD protein, rat",0
4743,Phospholipases A,"Lpx1 protein, S cerevisiae",0
4744,Phosphoric Monoester Hydrolases,"Sac3 protein, rat",0
4745,Phosphopeptides,"chrombacin h peptide, rat",0
4746,Protein phosphatase,"PPP1R3A protein, mouse",0
4747,Protein phosphatase,"Ppm1l, protein, mouse",0
4748,Protein phosphatase,"SSH3 protein, mouse",0
4749,Protein phosphatase,"SSH1 protein, mouse",0
4750,Phosphoproteins,"MPZL1 protein, mouse",0
4751,Phosphoproteins,"spry1 protein, Xenopus",0
4752,Phosphoproteins,"PHOS32 protein, Arabidopsis",0
4753,Phosphoproteins,"PHOS34 protein, Arabidopsis",0
4754,Phosphoproteins,"APOA1BP protein, mouse",0
4755,Organophosphates,2-aminoethyl phosphate,0
4756,Organophosphates,phosphoric acid mono(2-(2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl)ethyl)ester,0
4757,Organophosphates,"N,N',N''-tris(bis(sodium methyl phosphate)isophthalyl)-1,3,5-benzenetricarboxamide",0
4758,Organophosphates,raloxifene diphosphate,0
4759,Organophosphates,phosphoaspirin,0
4760,Organophosphates,2-methoxyestradiol 3-phosphate,0
4761,Organophosphates,2-methoxyestradiol 17-phosphate,0
4762,Organophosphates,"2-methoxyestradiol 3,17-diphosphate",0
4763,Organophosphates,4-N-hydroxyethyl-2'-deoxycytosine methyl phosphate diester,0
4764,Organophosphates,VPC32183,0
4765,Organophosphates,trimethyl carboxyphosphate,0
4766,Phosphotransferases,"TeiR protein, Comamonas testosteroni",0
4767,Phosphotransferases,"Ahp4 protein, Arabidopsis",0
4768,Phthalazines,poly(phthalazine ether sulfone ketone),0
4769,Phthalazines,"4,4'-dihydroxy-3,3'-dimethoxy-5,5'-biphenyl-1,1'-(diphthalazin-1-yl)methylhydrazone",0
4770,Phthalic Acids,5-nitroisophthalic acid,0
4771,Phthalic Acids,4-nitroisophthalic acid,0
4772,Phthalic Acids,3-nitroisophthalic acid,0
4773,Phthalic Acids,"4,5-dichlorophthalic acid",0
4774,Phthalic Acids,terephthalic acid isopropylamide,0
4775,Phthalic Acids,N(4)-(2-(diethylamino)ethyl)-2-iodo-N(1)-(4-methyl-1-(4-methyl-1-(4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-yl)terephthalamide,0
4776,Phthalic Acids,benzamido-N-prop-2-ynyl-N-cyclopentylcarboxamide,0
4777,Phthalic Acids,"benzamido-N,N-bis(cyclopentyl)carboxamide",0
4778,Phthalic Anhydrides,"cis-1,2,4,6-tetrahydrophthalic anhydride",0
4779,Phthalimides,benzophenone-N-methylphthalimide,0
4780,Phthalimides,4-aminophthalimide,0
4781,Phytosterols,"16-29-dihydroxy, 20-ene cyclolaudenol",0
4782,Phytosterols,beta-dauosterol,0
4783,Picolines,"N-(1-(4-(2,4-dimethoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)picolinamide",0
4784,Picolines,2-ethyl-6-methyl-3-hydroxypyridine fumarate,0
4785,Picolines,2-ethyl-6-methyl-3-hydroxypyridine lipoate,0
4786,Picolinic Acids,bis-dipicolylamine-Zinc(II),0
4787,Pipecolic Acids,3-hydroxypipecolic acid,0
4788,Pipecolic Acids,"3-hydroxy-4,5-dehydropipecolic acid",0
4789,Pipecolic Acids,"N-Boc-(2R,3R)-3-methyl-3-hydroxypipecolic acid",0
4790,Piperazines,"6-((2-(4-phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol",0
4791,Piperazines,N-(1-(2-(4-(2-methyl-3-(4-chlorophenyl)propionyl)-1-piperazinyl)-5-chlorophenyl)-3-methylbutyl)-3-(dimethylamino)propionamide,0
4792,Piperazines,5-(4-(4-chlorophenyl)piperazin-1-ylmethyl)-1H-indole,0
4793,Piperazines,"N-benzyl-N'-(2-hydroxy-3,4-dimethoxybenzyl)piperazine",0
4794,Piperazines,10-trifluoromethyl-16-(2-(hydroxyethyl)piperazine),0
4795,Piperazines,monospirocyclopiperazinium,0
4796,Piperazines,"3-methyl-9-(2-oxa-2lambda(5)-2H-1,3,2-oxazaphosphorine-2-cyclohexyl)-3,6,9-triazaspiro(5.5)undecane",0
4797,Piperazines,XRP44X compound,0
4798,Piperazines,"2-(3,5-dimethylpiperazin-1-yl)-1-(1-(1-methylcyclooctyl)piperidin-4-yl)-1H-benzimidazole",0
4799,Piperazines,"1,3-dimethyl-1,3-(4-fluorophenyl)-1,3-(3-butyl-(1-piperazinyl)propyl)-1,3-disiloxane",0
4800,Piperazines,GW791343,0
4801,Piperazines,piperazinium bis(4-hydroxybenzenesulphonate),0
4802,Piperazines,4-(4-(bis(4-fluorophenyl)methyl)piperazin-1-ylbut-2-enyloxy)acetic acid,0
4803,Piperazines,"2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione",0
4804,Piperazines,6-amino-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)-2-quinolinamine,0
4805,Piperazines,PB183 compound,0
4806,Piperazines,N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide,0
4807,Piperazines,balicatib,0
4808,Piperazines,eugenosedin B,0
4809,Piperazines,"N(6)-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo(d)thiazole-2,6-diamine",0
4810,Piperazines,"9-piperazin-1-ylpyrrolo(2,1-b)benzothiazepine",0
4811,Piperidines,stenusin,0
4812,Piperidines,"N-piperidin-1-yl-2,4-dichlorophenyl-1h-pyrazole-3-carboxamide",0
4813,Piperidines,cryptadine B,0
4814,Piperidines,cryptadine A,0
4815,Piperidines,"N-(3,5-di-tert-butylsalicylidene)-1-ethylcarboxylato-4-aminopiperidine",0
4816,Piperidines,1-(3-phenylpropyl)piperidine,0
4817,Piperidines,"2-(3,4-dichlorophenyl)-N-ethyl-N-(2-piperidin-1-ylethyl)ethanamine",0
4818,Piperidines,T-2328,0
4819,Piperidines,2-hydroxy-5-(3-iodoprop-2-en-1-oxy)-3-(4-phenylpiperidino)tetralin,0
4820,Piperidines,quinotoxine,0
4821,Piperidines,"4-(hexadecanoyloxy)-2,2,6,6-tetramethylpiperidine-1-oxy",0
4822,Piperidines,Wf-516,0
4823,Piperidines,N-(4-chlorobenzoyl)-N-(3-methoxypropyl)-1-(2-phenylethyl)-3-piperidinamine,0
4824,Piperidines,1-(1-(1-methylcyclooctyl)-4-piperidinyl)-2-((3R)-3-piperidinyl)-1H-benzimidazole,0
4825,Piperidines,"(5-(1-(2-fluorobenzyl)piperidin-4-ylmethoxy))quinazoline-2,4-diamine",0
4826,Piperidines,2-(18F)fluoro-ethoxy-3-methoxyphenyl)-1-(2-(4-fluoro-phenyl)ethyl-4-piperidine-methanol,0
4827,Piperidines,"2,2,6,6-tetramethyl-1-piperidine",0
4828,Piperidines,BMS-639623,0
4829,Piperidines,3-O-tert-butoxycarbonylspectaline,0
4830,Piperidines,"meso-2,3-dimethyl-1,4-bis(3,4-(2-(piperdino)ethoxyphenyl))butane tetrakishydrochloride",0
4831,Piperidines,3-hydroxy-2-hydroxymethylpiperidine,0
4832,Piperidines,2-hydroxymethyl-6-dodecylpiperidin-3-ol,0
4833,Piperidines,"(R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide",0
4834,Piperidones,"3,5-bis(benzylidene)-4-piperidone",0
4835,Piperidones,1-methyl-4-piperidone,0
4836,Piperidones,"7-(5-ethyl-1,3,4-thiadiazol-2-yl)-9-propyl-7-azaspiro(4,5)decane-6,8-dione",0
4837,Piperidones,"3,5-bis(3-(4-(dimethylamino)phenyl)prop-2-enylidene)-1-methyl-4-piperidone",0
4838,Piperidones,"3,5-bis(3-(4-methoxyphenyl)prop-2-enylidene)-1-methyl-4-piperidone",0
4839,Plant Extracts,Tadenan,0
4840,Plant Extracts,HMCO5 herbal extract,0
4841,Plant Extracts,femicur N,0
4842,Plant Extracts,Avlimil,0
4843,Plant Extracts,extralife,0
4844,Plant Extracts,Slim339,0
4845,Plant Extracts,Piper cubeba extract,0
4846,Plant Extracts,Traumaplant,0
4847,Plant Extracts,NR-ANX-C,0
4848,Plant Extracts,pilopool,0
4849,Plant Extracts,HemoHIM,0
4850,Plant Extracts,MAS063DP,0
4851,Plant Extracts,vocara,0
4852,Plant Extracts,coryzalia,0
4853,Plant Proteins,storage protein deamidase,0
4854,Plant Proteins,storage protein activator,0
4855,Plant Proteins,"CYP71D12 protein, Catharanthus roseus",0
4856,Plant Proteins,"flavonoid 8-hydroxylase, Chrysanthemum segetum",0
4857,Plant Proteins,Mung Bean Nuclease,0
4858,Plant Proteins,"116 kDa glycoprotein, Ulmus davidiana",0
4859,Plant Proteins,"peptide 4 kDa, Fagopyrum esculentum",0
4860,Plant Proteins,"Ziz m 1 protein, Indian jujube",0
4861,Polynucleotide Adenylyltransferase,"Star-PAP protein, human",0
4862,Poly(ADP-ribose) Polymerases,"Parp14 protein, mouse",0
4863,Poly(ADP-ribose) Polymerases,"Parp9 protein, mouse",0
4864,Polyamines,beta-cyclodextrin-poly(amidoamine) copolymer,0
4865,Polybrominated Biphenyls,"3,4,5-tribromo-6-methoxy-2-(2',4'-dibromophenoxy)phenol",0
4866,Polycyclic Compounds,dechlorane plus,0
4867,Polycyclic Compounds,heptacene,0
4868,Polycyclic Compounds,"4-nitro-13-amino-(2,2)paracyclophane",0
4869,Polycyclic Compounds,AT-11 compound,0
4870,"Polycyclic Hydrocarbons, Aromatic",epi-raikovenal,0
4871,"Polycyclic Hydrocarbons, Aromatic",raikovenal,0
4872,Polyesters,poly(lactide-co-trimethylenecarbonate-co-epsilon-caprolactone),0
4873,Polyesters,"poly-alpha,beta-(N-(2-hydroxyethyl)aspartamide)-g-polylactide",0
4874,Polyesters,PLAAP polymer,0
4875,Polyesters,corethane 70A,0
4876,Polyethylene Glycols,Polyoxyl 40 Stearate,0
4877,Polyethylene Glycols,poly(ethylene glycol) monolaurate,0
4878,Polyethylene Glycols,femglide,0
4879,Polyethylene Glycols,poly-(butadiene-b-ethylenoxide),0
4880,Polyethylene Glycols,poly(ethylene glycol fumarate-co-hexamethylene carbonate-fumarate),0
4881,Polyethylene Glycols,sodium nonylphenol polyoxyethylene ether sulfate,0
4882,Polyethylene Glycols,"monopegylated granulocyte-macrophage colony-stimulating factor, human",0
4883,Polyethylene Glycols,poly(ethylene glycol)-co-(glycidyl methacrylate-iminodiacetic acid),0
4884,Polyethylene Glycols,4-nitrophenyloxycarbonyl-polyethyleneglycol,0
4885,Polyethylene Glycols,poly(ethylenepropylene)-co-poly(ethyleneoxide),0
4886,Polyethylene Glycols,poly(lactic-co-glycolic acid)-polyethylene glycol-poly(lactic-co-glycolic acid),0
4887,Polyethylene Glycols,poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol),0
4888,Polyethylene Glycols,poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) copolymer,0
4889,Polyethylene Glycols,EZN-2208,0
4890,Polyethylene Glycols,poly(ethylene glycol)-di-DT-hydrazide,0
4891,Polyethylene Glycols,AH 111585,0
4892,Polyethylene Glycols,poly(ethylene oxide)-block-poly(glycerol monoacrylate),0
4893,Polyethyleneimine,PEI600-avidin,0
4894,Polyglactin 910,poly(lactic-co-glycolic acid)-polyethylene glycol-poly(lactic-co-glycolic acid),0
4895,Polyglutamic Acid,vanadyl-poly (gamma-glutamic acid),0
4896,Polymers,"poly(9,9-bis(6'-N,N,N-trimethylammonium)hexyl)fluorenephenylene bromide",0
4897,Polymers,Poly(aniline-2-sulfonic acid),0
4898,Polymers,poly(N-isopropylac-yamide-co-3-methacryloxy-propyl-trimethoxysilane),0
4899,Polymers,poly((ethyl alanato) (p-phenyl phenoxy) phosphazene),0
4900,Polymers,polyisobutylene succinimide,0
4901,Polymers,"poly(acenaphtho(1,2-b)thieno(3,4-e)pyrazine)",0
4902,Polymers,polyisobutylene-block-poly(methacrylic acid),0
4903,Polymers,poly(octadecanoic anhydride),0
4904,Polymers,poly(imidazole-2-dimethylaminoethylamino)phosphazene,0
4905,Polymers,glycidyl azide polymer,0
4906,Polymethacrylic Acids,poly(octadecyl methacrylate),0
4907,Polymethacrylic Acids,hexadecyltrimethylammonium polymethacrylate,0
4908,Polymethacrylic Acids,poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol),0
4909,Polymethacrylic Acids,poly(methacrylamide-co-methacrylic acid),0
4910,Polysaccharides,polyguluronate sulfate,0
4911,Polystyrenes,Chromosorb 101,0
4912,Polyurethanes,corethane 70A,0
4913,Polyurethanes,thoralon,0
4914,Polyvinyls,divinylbenzene-N-vinylpyrrolidone copolymer,0
4915,Porphyrinogens,dioxadiazuliporphyrinogen,0
4916,Porphyrins,"3(1),3(2)-didehydrophytochlorin",0
4917,Porphyrins,rubyrin,0
4918,Porphyrins,dioxadiazuliporphyrin,0
4919,Porphyrins,meso-tetra(pentafluorophenyl)porphyrin,0
4920,Porphyrins,dithiabenzisapphyrin,0
4921,Porphyrins,meso-tetra(4-nido-carboranylphenyl)porphyrin,0
4922,Porphyrins,m-benziporphodimethene,0
4923,Porphyrins,"5,10,15,20-tetraphenyl- 21H, 23H-porphinetetrasulfonate",0
4924,Porphyrins,meso-tetrakis(4-trimethylammoniumphenyl)porphyrin,0
4925,prednisolone,"dipyridamole, prednisolone drug combination",0
4926,Pregnancy Proteins,"Plet-1 protein, mouse",0
4927,Pregnancy Proteins,"Plet-1 protein, human",0
4928,Pregnancy Proteins,"Rtl1 protein, mouse",0
4929,Procollagen-Proline Dioxygenase,"P4HB protein, human",0
4930,Procollagen-Proline Dioxygenase,"P4hb protein, mouse",0
4931,Procollagen-Proline Dioxygenase,"P4hb protein, rat",0
4932,Propylene Glycols,poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) copolymer,0
4933,Propylene Glycols,"1,3-propanediol distearate",0
4934,Propylene Glycols,"1,3-propanediol dicaprylate",0
4935,Propylene Glycols,"1,3-propanediol dipalmitate",0
4936,Propionates,cinnamyl propionate,0
4937,Propionates,3-sulfopropanoate,0
4938,Propionates,"isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate",0
4939,Propionates,micromelone A,0
4940,Propionates,micromelone B,0
4941,Propionates,2-(2-chloro-5-((3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)methyl)phenoxy)propionic acid,0
4942,Propylamines,N-methyl-3-(3-iodopyridin-2-yloxy)-3-phenylpropylamine,0
4943,Propylamines,"N,N-di(3-aminopropyl)amine",0
4944,Propylamines,3-(trimethoxysilyl)propylamine,0
4945,Protein Kinases,"SteC protein, Salmonella typhimurium",0
4946,Protein Kinases,"SaeS protein, Staphylococcus aureus",0
4947,Protein Kinases,"PATMK protein, Entamoeba histolytica",0
4948,Protein Kinases,"YFH7 protein, S cerevisiae",0
4949,Protein Kinases,"GASSHO1 protein, Arabidopsis",0
4950,Protein Kinases,"GASSHO2 protein, Arabidopsis",0
4951,Protein Kinases,"Mob1b protein, mouse",0
4952,Protein Kinases,"NIPI-3 protein, C elegans",0
4953,Histone-Lysine N-Methyltransferase,"SWD2 protein, S cerevisiae",0
4954,Histone-Lysine N-Methyltransferase,"NSD protein, Drosophila",0
4955,Histone-Lysine N-Methyltransferase,"Set2 protein, S pombe",0
4956,Histone-Lysine N-Methyltransferase,"SET8 protein, mouse",0
4957,Protein Precursors,"LIP1 proNGF peptide, human",0
4958,Protein Precursors,"LIP2 proNGF peptide, human",0
4959,Transglutaminases,"Ghalpha protein, rat",0
4960,Protein Tyrosine Kinase,"WEE1 protein, Xenopus",0
4961,Proteins,"Cue110 protein, mouse",0
4962,Proteins,"haponin protein, human",0
4963,Proteins,"Pcdp1 protein, mouse",0
4964,Proteins,"Pcdp1 protein, human",0
4965,Proteins,"Amn protein, rat",0
4966,Proteins,"FAM83H protein, human",0
4967,Proteins,"Rgcl-2A protein, rat",0
4968,Proteins,"Rgcl-2B protein, rat",0
4969,Proteins,"poly-alpha,beta-(N-(2-hydroxyethyl)aspartamide)-g-polylactide",0
4970,Proteins,"Wdtc1 protein, mouse",0
4971,Proteins,"Bbs2 protein, mouse",0
4972,Proteins,poly(valyl-glycyl-glycyl-leucyl-glycyl),0
4973,Proteins,artificial protein 284,0
4974,Proteins,"Opa3 protein, mouse",0
4975,Proteins,"CC2D2A protein, human",0
4976,Proteins,"Tex11 protein, mouse",0
4977,Proteins,"hiwi protein, rat",0
4978,Proteins,MEP-mel protein,0
4979,Proteins,"Ucma protein, mouse",0
4980,Proteins,"Ucma protein, human",0
4981,Proteins,"CAMK2N1 protein, human",0
4982,Proteins,poly(S-n-hexadecylhomocysteine),0
4983,Proteins,"HSPC111 protein, human",0
4984,Proteins,"Gm114 protein, mouse",0
4985,Proteoglycan,"Nyx protein, rat",0
4986,Proteoglycan,"Kera protein, zebrafish",0
4987,Proto-Oncogene Proteins,"TET1 protein, human",0
4988,Protoporphyrins,protoporphyrin IX-cyclic(arginyl-glycyl-aspartyl-phenylalanyl-lysyl) conjugate,0
4989,Pteridines,"methyl 1-(4-(2,4-diaminopteridin-6-ylmethylamino)benzoyl)piperidine-4-carboxylate",0
4990,Pteridines,"methyl 1-(4-((2,4-diaminopteridin-6-ylmethyl)methylamino)benzoyl)piperidine-4-carboxylate",0
4991,Pteridines,NP 40208,0
4992,Pterins,"6-acetyl-7,7-dimethyl-5,6,7,8-tetrahydropterin",0
4993,Purine Nucleosides,"2-amino-9-(2,3-dideoxy-2,3-dihydroarabinofuranosyl)-6-methoxy-9H-purine",0
4994,Purine Nucleotides,2'-deoxyribosyl-2-amino-6-(2-methylthioethyl)purine nucleoside triphosphate,0
4995,Purines,"9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-",0
4996,Purines,6-(3'-chloropropylthio)purine,0
4997,Purines,6-(6'-deoxy-1'-O-methyl-beta-D-ribofuranose)purine,0
4998,Purines,6-(3'-(thioethylamine)propylthio)purine,0
4999,Purines,Regulatory particle-Inhibiting Peptoid-1,0
5000,Purines,"cis-((7-(6-chloro-9H-purin-9-yl)methyl)-2,3-diphenyl-6,7-dihydro-5H-cyclopenta(b)pyrazin-5-yl)methanol",0
5001,Pyrans,epoxymollugin,0
5002,Pyrans,rhopaloic acid A,0
5003,Pyrans,6-O-acetylshanzhiside methyl ester,0
5004,Pyrans,scanlonenyne,0
5005,Pyrans,6-hydroxy-2H-pyran-3-carbaldehyde,0
5006,Pyrazines,3-acetylaminopyrazine-2-carboxylic acid,0
5007,Pyrazines,"3-((3-(trifluoromethyl)phenyl)amino)pyrazine-2,5-dicarbonitrile",0
5008,Pyrazines,methyl pyrazinylketone 4-hydroxybenzoyl hydrazone,0
5009,Pyrazines,methyl pyrazinylketone 4-aminobenzoyl hydrazone,0
5010,Pyrazines,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",0
5011,Pyrazines,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",0
5012,Pyrazines,"N-(1-(5-(2-(1H-indol-3-yl)ethyl)-4-(2,4-dimethoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)pyrazine-2-carboxamide",0
5013,Pyrazines,"poly(acenaphtho(1,2-b)thieno(3,4-e)pyrazine)",0
5014,Pyrazines,"pyrido(2,3-e)pyrrolo(1,2-a)pyrazine",0
5015,Pyrazines,"3-oxo-1,1-diphenyltetrahydrooxazolo(3,4-a)pyrazine-7-carboxylic acid 4-fluorobenzylamide",0
5016,Pyrazines,"cis-2,3-diphenyl-6,7-dihydro-5H-cyclopenta(b)pyrazine-5,7-dimethanol",0
5017,Pyrazines,"cis-((7-(6-chloro-9H-purin-9-yl)methyl)-2,3-diphenyl-6,7-dihydro-5H-cyclopenta(b)pyrazin-5-yl)methanol",0
5018,Pyrazines,"4-((2-N,N-dimethyl)amino)ethylspiro((dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno(2,3-b)naphtho-4',9'-dione))",0
5019,Pyrazines,"4-(2-pyrrolidine)ethylspiro((dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno(2,3-b)naphtho-4',9'-dione))",0
5020,Pyrazines,"3-(2,3,5-trichlorophenyl)pyrazine-2,6-diamine",0
5021,Pyrazoles,GW406381X,0
5022,Pyrazoles,"5-(4-chlorophenyl)-3-((E)-2-cyclohexylethenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole",0
5023,Pyrazoles,"3,5-pyrazoledicarboxylic acid",0
5024,Pyrazoles,"N-piperidin-1-yl-2,4-dichlorophenyl-1h-pyrazole-3-carboxamide",0
5025,Pyrazoles,"7-(2-(4-fluorophenyl)-4-isopropyl-5-(4-methylbenzylcarbamoyl)-2H-pyrazol-3-yl)-3,5-dihydroxyheptanoic acid",0
5026,Pyrazoles,DGS-658,0
5027,Pyrazoles,JNJ-28330835,0
5028,Pyrazoles,"4-(3-benzyl-4-(5-(2-fluorophenyl)-ruan-2-ylmethylene)-5-oxo-4,5-dihydropyrazol-1-yl)benzoic acid",0
5029,Pyrazoles,"pyrazolo(1,5-a)pyrimidine",0
5030,Pyrazoles,"1,3-diphenyl-1H-pyrazolo(3,4-b)quinoline",0
5031,Pyrazoles,5-amino-1-(4-methoxybenzoyl)-3-methylpyrazole,0
5032,Pyrazoles,5-amino-3-methyl-1-(2-nitrobenzoyl)pyrazole,0
5033,Pyrazoles,XRP44X compound,0
5034,Pyrazoles,"1-acetyl-3-(2,4-dichloro-5-fluoro-phenyl)-5-phenyl-pyrazoline",0
5035,Pyrazoles,"1,3-dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine",0
5036,Pyrazoles,ON09310,0
5037,Pyrazoles,"6,7-dihydro-4H-pyrazolo-(1,5-a)pyrrolo(3,4-d)pyrimidine-5,8-dione",0
5038,Pyrazoles,"2-(4-(pyridin-4-yl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)phenoxymethyl)quinoline succinic acid",0
5039,Pyrazoles,OSU03013,0
5040,Pyrazoles,"4-(5-(2,5-dimethylphenyl)-3-(trifluoromethyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0
5041,Pyrazoles,SI-83 compound,0
5042,Pyrazoles,CNB 001,0
5043,Pyrazoles,AM4113,0
5044,Pyrazoles,"4-amino-1-tert-butyl-3-(1'-naphthylmethyl)pyrazolo(3,4-d)pyrimidine",0
5045,Pyrazoles,GGTI-DU40,0
5046,Pyrazoles,LY2109761,0
5047,Pyrazoles,"N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide",0
5048,Pyrazoles,dihydropyrazole-1-carboxylic acid-(4-chlorophenyl amide),0
5049,Pyrazoles,"1-(3,5-dimethyl-1H-pyrazol-4-yl)ethanone",0
5050,Pyrazoles,1H-pyrazole-3-carboxy-4-methyl-5-phenyl-(1H-indol-3-ylmethylene)hydrazide,0
5051,Pyrenes,"(1-((pyren-1-yl)propoxy)-3,5-bis(bis(2-pyridylmethyl)aminomethyl)benzene)zinc(II)",0
5052,Pyrenes,1-(p-ethynyl-phenylethynyl)-pyrene,0
5053,Pyrenes,INA((R)-1-O-(1-pyrenylmethyl)glycerol),0
5054,Pyrenes,"8,16-dicyano(2.2)metacyclophane-1,9-diene",0
5055,Pyrenes,"8-methoxypyrene-1,3,6-trisulfonic acid trisodium salt",0
5056,Pyridazines,GW406381X,0
5057,Pyridazines,"4(7)-amino-6(5)H-imidazo(4,5-d)pyridazin-7(4)-one",0
5058,Pyridazines,2-tert-butyl-4-chloro-5-(4-(2-fluoroethoxymethyl)benzyloxy)-3-(2H)-pyridazinone,0
5059,Pyridines,"1,3-bis(di-2-pyridylphosphino)propane",0
5060,Pyridines,"(1-((pyren-1-yl)propoxy)-3,5-bis(bis(2-pyridylmethyl)aminomethyl)benzene)zinc(II)",0
5061,Pyridines,xestamine C,0
5062,Pyridines,xestamine E,0
5063,Pyridines,xestamine H,0
5064,Pyridines,1-(4-chlorophenyl)-3-(3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl)urea,0
5065,Pyridines,N-(2-methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide,0
5066,Pyridines,"1-fluoro-2-(3-pyridinyl)ethylidene-1,1-bisphosphonic acid",0
5067,Pyridines,fluoroethyl-desmethyl-ABP688,0
5068,Pyridines,3-fluoro-5-((pyridin-3-yl)ethynyl)benzonitrile,0
5069,Pyridines,1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid,0
5070,Pyridines,"1-terpyridyl-2,3,4,5,6-pentaphenylbenzene",0
5071,Pyridines,pyridine N-imine,0
5072,Pyridines,3-(dimethylboryl)pyridine,0
5073,Pyridines,CCT129202,0
5074,Pyridines,pymeprazole,0
5075,Pyridines,"1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-methyl-1,3-dihydrofuro(3,4-c)pyridine-7-ol",0
5076,Pyridines,LY686017,0
5077,Pyridines,DDP733,0
5078,Pyridines,3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one,0
5079,Pyridines,"(2,6-pyridinediylbis(methylene nitrilo)) tetraacetic acid",0
5080,Pyridines,"N-(6-Chloropyridin-3-yl)-3,4-difluorobenzamide",0
5081,Pyridines,"3,3'-dinitro-2,2'-dithiodipyridine",0
5082,Pyridines,N-methyl-3-(3-iodopyridin-2-yloxy)-3-phenylpropylamine,0
5083,Pyridines,"7-(2-thienyl)imidazo(4,5-b)pyridine",0
5084,Pyridines,"2,6 distyrylpyridine",0
5085,Pyridines,2-iodopyridine,0
5086,Pyridines,MK-9470,0
5087,Pyridines,2-(6-((2-(3-hydroxypropyl)-5-methylphenylamino)methyl)-2-(3-morpholin-4-ylpropylamino)benzoimidazol-1-ylmethyl)-6-methylpyridin-3-ol,0
5088,Pyridines,2-oxo-4-(pyridin-3-yl)-3-butenoic acid,0
5089,Pyridines,3-(pyridin-3-yl)acrylaldehyde,0
5090,Pyridines,"2-(4,7-bis(2-pyridylmethyl)-1,4,7-triazacyclononan-1-yl)acetic acid",0
5091,Pyridines,"4-(1-ethylpropoxy)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridine",0
5092,Pyridines,NIBR-1282,0
5093,Pyridines,"1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine",0
5094,Pyridines,"4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine",0
5095,Pyridines,3-((5-(6-ethylpyridin-2-yl)-4-(quinoxalin-6-yl)thiazol-2-ylamino)methyl)benzamide,0
5096,Pyridines,3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)thiazol-2-ylamino)methyl)benzamide,0
5097,Pyridines,2-(pyridin-3-yl)-1-azabicyclo(2.2.2)octane,0
5098,Pyridines,desnitroimidacloprid,0
5099,Pyridines,"2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole",0
5100,Pyridines,"pyridyl-2,6-dinitrene",0
5101,Pyridines,"4-amino-2,6-diazido-3,5-dichloropyridine",0
5102,Pyridines,EMD 527040,0
5103,Pyridines,4-(3-cyclohexen-1-yl)pyridine,0
5104,Pyridines,"4-ethoxy-2-(2-hydroxy-3-(4-phenyl-1-piperazinyl))propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo(3,4-c)pyridine",0
5105,Pyridines,VPC32183,0
5106,Pyridines,2-((E)-(2-(2-(pyridine-2-yl)- ethylthio)ethylimino)methyl)-4-bromophenol,0
5107,Pyridines,"(6,7-dihydro-5H-cyclopenta(c)pyridin-7-yl(hydroxy)methylene)bis(phosphonic acid)",0
5108,Pyridines,"(4'S,5'S)-2,6-bis(4'-(triisopropylsilyl)oxymethyl-5'-phenyl-1',3'-oxazolin-2'-yl)pyridine",0
5109,Pyridines,Org 48762-0,0
5110,Pyridines,GGTI-DU40,0
5111,Pyridines,vorapaxar,0
5112,Pyridines,"1,2-bis(2-pyridyl)ethylene",0
5113,Pyridines,"3-(3-(3-trifluoropropylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine",0
5114,Pyridines,N-(2-((N-(4-phenoxypyridin-3-yl)acetamido)methyl)phenoxy)ethyl fluoride,0
5115,Pyridines,2-(oxymethyl)pyridine,0
5116,Pyridines,"2,7-dimethyl-3-nitro-4H-pyrido(1,2-a)pyrimidine-4-one",0
5117,Pyridinium Compounds,"4,(4-(dihexadecylamino)styryl)-N-methyl-pyridinium iodide",0
5118,Pyridinium Compounds,trans-4-(4-(dimethylamino)-styryl)-1-methylpyridinium iodide,0
5119,Pyridinium Compounds,"1,2-dimethoxy-ethylene-bis-N,N'-4-pyridiumaldoxime dichloride",0
5120,Pyridinium Compounds,niphatoxin C,0
5121,Pyridinium Compounds,hexakis(4-(N-butylpyridylium))benzene,0
5122,Pyridinium Compounds,4-(2-(3-methoxyphenyl)ethenyl)-N-methylpyridinium tetraphenylborate,0
5123,Pyridinium Compounds,trans-4-(4-(dimethylamino)styryl)-1-methylpyridinium-p-toluenesulfonate,0
5124,Pyridinium Compounds,"1-methyl-2,6-dimethyl-4-hydroxypyridinium",0
5125,Pyridinium Compounds,lonijaposide A,0
5126,Pyridinium Compounds,lonijaposide B,0
5127,Pyridinium Compounds,lonijaposide C,0
5128,Pyridones,"benzyl 3,4-dihydro-4-oxo-1(2H)-pyridinecarboxylate",0
5129,Pyridones,hermidin,0
5130,Pyridones,6-azido-5-formyl-2-pyridone,0
5131,Pyridones,penicidone A,0
5132,Pyridones,penicidone B,0
5133,Pyridones,penicidone C,0
5134,Pyridones,iromycin E,0
5135,Pyridones,ironmycin F,0
5136,Pyridones,N-methyl-3-(methoxycarbonyl)-4-hydroxy-2-pyridone,0
5137,Pyridones,FS 0311,0
5138,Pyrimidine Nucleosides,FV-100,0
5139,Pyrimidine Nucleosides,"3-(3-hydroxy-4-(hydroxymethyl)cyclopentyl)-6-(4-pentylphenyl)furo(2,3-d)pyrimidin-2(3H)-one",0
5140,Pyrimidine Nucleosides,"3-(2'-deoxyribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro(2,3-d)pyrimidin-2(3H)-one",0
5141,Pyrimidine Nucleosides,"3-(2'-deoxyribofuranosyl)-6-(4-(1-fluoroethoxy)phenyl)-2,3-dihydrofuro(2,3-d)pyrimidin-2(3H)-one",0
5142,Pyrimidine Nucleosides,5-methylpyrimidine-2-one 2'-deoxyribonucleoside,0
5143,Pyrimidine Nucleosides,phosphonoxin B1,0
5144,Pyrimidine Nucleosides,phosphonoxin B2,0
5145,Pyrimidines,(methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine,0
5146,Pyrimidines,JNJ 28871063,0
5147,Pyrimidines,"5-amino-2-methylsulfanyl-4-(3-(2-morpholin-4-ylacetylamino)phenyl)thieno(2,3-d)pyrimidine-6-carboxylic acid tert-butylamide",0
5148,Pyrimidines,"1,3,4,6,7,8-hexahydro-2H-pyrimido(1,2-a)pyrimidine",0
5149,Pyrimidines,"pyrimido(2,1-d)1,2,3,5- tetrazine",0
5150,Pyrimidines,"1,3-di-p-methoxybenzylpyrimidine-2-selenone",0
5151,Pyrimidines,PF 376304,0
5152,Pyrimidines,4-chloro-2-(methylthio)pyrimidine-5-carboxylic acid ethyl ester,0
5153,Pyrimidines,DGS-658,0
5154,Pyrimidines,DGS-666,0
5155,Pyrimidines,DGS-664A,0
5156,Pyrimidines,pyrrolopyrimidine,0
5157,Pyrimidines,"pyrazolo(1,5-a)pyrimidine",0
5158,Pyrimidines,"ethyl 3-(2-amino-4,6-bis(dimethylamino)pyrimidin-5-yl)-2-cyanoacrylate",0
5159,Pyrimidines,"2-((2-amino-4,6-di-1-piperidylpyrimidin-5-yl)methylene)malononitrile",0
5160,Pyrimidines,methoxy-annomontine,0
5161,Pyrimidines,HBF 0259,0
5162,Pyrimidines,"spiro(4-benzyloxy-2,3-isopropylidenedioxy-1-oxa-cyclopentane-5,5'-(2-benzoylmethylene-1,3-diazacyclohexane))",0
5163,Pyrimidines,"N,N-bis(2-methoxyethyl)-3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-pyrazolo(1,5-a)pyrimidin-7-amine",0
5164,Pyrimidines,manzacidin D,0
5165,Pyrimidines,5-fluoropyrimidin-2-olate,0
5166,Pyrimidines,SI-83 compound,0
5167,Pyrimidines,"7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid",0
5168,Pyrimidines,"5-(2-ethoxy-5-(4-(4-fluorophenyl)piperazinylsulfonyl)phenyl)-1-methyl-3N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one",0
5169,Pyrimidines,"5-(2-ethoxy-5-(N-phenylethylenediaminesulfonyl)phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one",0
5170,Pyrimidines,"5-(2-ethoxy-5-(N-acetic acid,N'-5-(2-ethoxy-5-sulfonyl)phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one-ethylenediaminesulfonylphenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one",0
5171,Pyrimidines,"thieno(3,2-d)pyrimidine-4-methanone",0
5172,Pyrimidines,"4-amino-1-tert-butyl-3-(1'-naphthylmethyl)pyrazolo(3,4-d)pyrimidine",0
5173,Pyrimidines,"7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido(3',2'-4,5)imidazo(1,2-a)pyrimidin-5-ium",0
5174,Pyrimidines,"N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide",0
5175,Pyrimidines,4-benzylamino-2-((4-morpholin-4-ylphenyl)amino)pyrimidine-5-carboxamide,0
5176,Pyrimidinones,"6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone",0
5177,Pyrimidinones,"N-methyl-3H-pyrrolo(2,3-d)pyrimidin-2(7H)-one",0
5178,Pyrimidinones,mirodenafil,0
5179,Pyrimidinones,N-dehydroxyethylmirodenafil,0
5180,Pyrimidinones,"9-(((dimethylamino)sulfonyl)(methyl)amino)-N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidine-2-carboxamide",0
5181,Pyrimidinones,"N-(2-(((4-fluorobenzyl)amino)carbonyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido(1,2-a)azepin-10-yl)-N,N',N'-trimethylethanediamide",0
5182,Pyrimidinones,"6,7-dihydro-4H-pyrazolo-(1,5-a)pyrrolo(3,4-d)pyrimidine-5,8-dione",0
5183,Pyrimidinones,"9-dimethylamino-3-cycloheptyl-3H-5-thia-1,3,6-triazafluoren-4-one",0
5184,Pyrimidinones,"9-dimethylamino-3-(4-methylphenyl)-3H-5-thia-1,3,6-triazafluoren-4-one",0
5185,Pyrimidinones,"1,2,5-selenadiazolo-(3,4-d)pyrimidine-5,7-(4H,6H)-dione",0
5186,Pyrimidinones,(tetrahydro)pyrimidin-2-one-5-carboxylate,0
5187,Pyrimidinones,"2,7-dimethyl-3-nitro-4H-pyrido(1,2-a)pyrimidine-4-one",0
5188,Pyrones,6'-O-isobutyryl aloenin A,0
5189,Pyrones,"( R)-6-(( S)-2-hydroxy-4-(4-hydroxyphenyl)butyl)-5,6-dihydropyran-2-one",0
5190,Pyrones,phellifuropyranone A,0
5191,Pyrones,etharvensin,0
5192,Pyrones,6-methoxycomaparvin,0
5193,Pyrones,6-methoxycomaparvin 5-methyl ether,0
5194,Pyrones,8'-O-demethylnigerone,0
5195,Pyrones,8'-O-demethylisonigerone,0
5196,Pyrones,"4-propyl-3,4-dihydro-2H-naphtho(1,2-b)pyran-5,6-dione",0
5197,Pyrones,bitungolide F,0
5198,Pyrones,inoscavin E,0
5199,Pyrones,annulin B,0
5200,Pyrones,salinipyrone A,0
5201,Pyrones,salinipyrone B,0
5202,Pyrones,eleutherinol,0
5203,Pyrones,5-benzyloxy-2-selenocyanataomethyl-4-pyranone,0
5204,Pyrones,5-methoxy-2-selenocyanatomethyl-4-pyranone,0
5205,Pyrones,alcanivorone,0
5206,Pyrones,6-demethylvermistatin,0
5207,Diphosphates,"3,7,11-trimethyl-12-(7-nitrobenzo(1,2,5)oxadiazo-4-ylamino)dodeca-2,6,10-trien-1-yl pyrophosphate",0
5208,Diphosphates,phytyl diphosphate,0
5209,Pyrroles,phosphoric acid mono(2-(2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl)ethyl)ester,0
5210,Pyrroles,"N-ethyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazine-6-carboxamide",0
5211,Pyrroles,"N-cyclopentyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazine-6-carboxamide",0
5212,Pyrroles,"N-methyl-3H-pyrrolo(2,3-d)pyrimidin-2(7H)-one",0
5213,Pyrroles,pyrrolopyrimidine,0
5214,Pyrroles,debromodispacamide B,0
5215,Pyrroles,debromodispacamide D,0
5216,Pyrroles,marinopyrrole A,0
5217,Pyrroles,marinopyrrole B,0
5218,Pyrroles,2-nitropyrrole,0
5219,Pyrroles,2-pyrrolepolyamide-2'-deoxyguaonsine 5'-phosphate,0
5220,Pyrroles,"2-(5-methylhexahydropyrrolo(3,4-c)pyrrol-2-yl)xanthen-9-one",0
5221,Pyrroles,manzacidin D,0
5222,Pyrroles,"6,7-dihydro-4H-pyrazolo-(1,5-a)pyrrolo(3,4-d)pyrimidine-5,8-dione",0
5223,Pyrroles,2-undecylpyrrole,0
5224,Pyrroles,"1,9-dideoxypreaxinellamine",0
5225,Pyrroles,axinellamine A,0
5226,Pyrroles,axinellamine B,0
5227,Pyrroles,"pyrido(2,3-e)pyrrolo(1,2-a)pyrazine",0
5228,Pyrroles,"2,5-diacetyl-3-methyl-1H-pyrrole",0
5229,Pyrroles,1-(1-methyl-1H-pyrrol-2-yl)-2-phenyl-2-(1-pyrrolidinyl)ethanone,0
5230,Pyrroles,"5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile",0
5231,Pyrroles,LPK-26,0
5232,Pyrroles,"pyrrolo(3,4-c)pyrazole-4,6-dione",0
5233,Pyrroles,"5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine",0
5234,Pyrroles,dihydrosventrin,0
5235,Pyrroles,KSPA-1,0
5236,Pyrroles,LY2109761,0
5237,Pyrroles,"2,2'-bidipyrrin",0
5238,Pyrroles,nagelamide K,0
5239,Pyrroles,nagelamide L,0
5240,Pyrroles,"9-piperazin-1-ylpyrrolo(2,1-b)benzothiazepine",0
5241,Pyrrolidines,peripentonine A,0
5242,Pyrrolidines,peripentonine B,0
5243,Pyrrolidines,peripentonine C,0
5244,Pyrrolidines,peripentadenine,0
5245,Pyrrolidines,ridaifen-B,0
5246,Pyrrolidines,TG101348,0
5247,Pyrrolidines,LC15-0133,0
5248,Pyrrolidines,4'-deaza-1'-aza-2'-deoxy-1'-(9-methylene)immucillin G,0
5249,Pyrrolidines,"4-chloro-3-(5-methyl-3-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)-1,2,4-benzotriazin-7-yl)phenyl benzoate",0
5250,Pyrrolidines,"(3-benzoyl-4,5-dioxo-2-phenyl-pyrrolidin-1-yl)acetic acid ethyl ester",0
5251,Pyrrolidines,1-(1-methyl-1H-pyrrol-2-yl)-2-phenyl-2-(1-pyrrolidinyl)ethanone,0
5252,Pyrrolidines,"N,N-dimethyl-2-(4'-N,N,N-trimethylaminophenyl)fulleropyrrolidinium iodide",0
5253,Pyrrolidinones,5-(3-methoxyphenyl)-3-(1-phenylethylamino)-1-(4-trifluoromethylphenyl)pyrrolidin-2-one,0
5254,Quinazolines,6-hydroxypropynyl-4-anilinoquinazoline,0
5255,Quinazolines,"(5-(1-(2-fluorobenzyl)piperidin-4-ylmethoxy))quinazoline-2,4-diamine",0
5256,Quinazolines,"N-benzyl-N-(6,7,8,9,10,11-hexahydro-13H-azocino(2,1-b)quinazolin-13-ylidene)amine",0
5257,Quinazolines,P53R3 compound,0
5258,Quinolines,"N-(8-quinolyl)-3,5-difluoro-benzenesulfonamide",0
5259,Quinolines,cryptadine B,0
5260,Quinolines,cryptadine A,0
5261,Quinolines,"7,7'-dihydroxy-8,8'- biquinolyl dipentanoate",0
5262,Quinolines,"2,2'-di-tert-butyl-7,7'-dihydroxy-8,8'-biquinolyl",0
5263,Quinolines,17-(3-((2-phenylquinolin-4-yl)carbonyloxy)propynyl)estradiol,0
5264,Quinolines,quinotoxine,0
5265,Quinolines,JNJ-26076713,0
5266,Quinolines,"1-tert-butyl-6-cyano-1,2,3,4-tetrahydroquinoline",0
5267,Quinolines,"methyl-2,7,7-trimethyl-4-(2-nitro-5-chlorophenyl)-5-oxo-l,4,5,6,7,8-hexahydroquinoline-3-carboxylate",0
5268,Quinolines,8-hydroxy-7-(4-sulfo-1-naphthylazo)-5-quinoline sulfonic acid,0
5269,Quinolines,"1,3-diphenyl-1H-pyrazolo(3,4-b)quinoline",0
5270,Quinolines,"11-propyl-6H-indole(2,3-b)quinoline",0
5271,Quinolines,"6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl)quinoline-3-carboxylic acid",0
5272,Quinolines,"N-(2-((2-((2-hydroxyethyl)amino)ethyl)amino)-5-quinolinyl)-2-tricyclo(3.3.1.1(3,7))dec-1-ylacetamide",0
5273,Quinolines,7-hydroxy-(8-oxazine-2-one)-quinoline,0
5274,Quinolines,BAG956,0
5275,Quinolines,"5,6,7,8-tetrahydroquinoline",0
5276,Quinolines,"4,4-dimethyl-1,2,3,4-tetrahydroquinoline",0
5277,Quinolines,"N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide",0
5278,Quinolines,"2-(4-(pyridin-4-yl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)phenoxymethyl)quinoline succinic acid",0
5279,Quinolines,"N'-(7-chloro-quinolin-4-yl)-N,N-dimethyl-ethane-1,2-diamine",0
5280,Quinolines,butyl-(7-fluoro-quinolin-4-yl)-amine,0
5281,Quinolines,"6-methyl-1,2,3,4-tetrahydroquinoline",0
5282,Quinolines,"N,N'-(4-methyl-1,2-phenylene)diquinoline-2-carboxamide",0
5283,Quinolines,Ki11502,0
5284,Quinolines,"dimethyl 5,6-dihydro-7-methoxy-5,5-dimethyl-6-(2-(2,5-dioxopyrrolidin-1-yl)acetyl)-1H-1-(4,5-dimethoxycarbonyl-1,3-dithiolo-2-spiro)thiopyrano(2,3-c)quinoline-2,3-dicarboxylate",0
5285,Quinolines,2-quinolinecarboxamide,0
5286,Quinolines,N-(2-diethylaminoethyl)-6-iodoquinoline-2-carboxamide,0
5287,Quinolines,"8,8'-(1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-7,16-diyl)-bis(methylene)diquinolin-7-ol",0
5288,Quinolinium Compounds,"1-methyl-2-(3-(1-methyl-1,2-dihydroquinolin-2-yliden)prop-1-enyl)quinolinium iodide",0
5289,Quinolinium Compounds,"1-aminoimidazo(5,1-a)isoquinolinium",0
5290,Quinolizines,(2-carboxy-2-cyanovinyl)julolidine farnesyl ester,0
5291,Quinones,o-azaquinone,0
5292,Quinones,tauranin,0
5293,Quinones,"4-deshydroxy-4-(N-methyl-(2-(((5-methoxy-1,2-dimethyl-4,7-dioxoindol-3-yl)methoxycarbonyl)(methyl)amino)ethyl)carbamoylmethyl)camptothecin",0
5294,Quinones,"methyl 2-amino-4,9-dihydro-4,9-dioxo-1-p-tolyl-1H-pyrrolo(3,2-g)isoquinoline-3-carboxylate",0
5295,Quinones,calix(4)diquinone,0
5296,Quinoxalines,"3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide",0
5297,Quinoxalines,"3-furylquinoxaline-2-carbonitrile 1,4-di-N-oxide",0
5298,Quinoxalines,"ethyl 3-phenylquinoxaline-2- carboxylate 1,4-di-N-oxide",0
5299,Quinoxalines,"3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide",0
5300,Quinoxalines,"9-chloro-2,3-dimethyl-6-(N,N-dimetylamino-2-oxoethyl)-6H-indolo(2,3-b)quinoxaline",0
5301,Quinoxalines,"3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline-1,4-dioxide",0
5302,Quinoxalines,EAPB0203,0
5303,Quinoxalines,LNP640,0
5304,Quinoxalines,3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide,0
5305,Quinoxalines,N-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide,0
5306,Quinuclidines,2-(pyridin-3-yl)-1-azabicyclo(2.2.2)octane,0
5307,T-Cell Receptor,"Valpha24 protein, human",0
5308,"Receptors, Cell Surface","Ptchd3 protein, mouse",0
5309,"Receptors, Cell Surface","Plx-2 protein, C elegans",0
5310,"Receptors, Cell Surface","choline-binding protein E, Streptococcus pneumoniae",0
5311,"Receptors, Cell Surface","FyuA protein, E coli",0
5312,"Receptors, Cell Surface","PDC-TREM protein, mouse",0
5313,"Receptors, Cell Surface","UNC5H4 protein, human",0
5314,"Receptors, Cell Surface","Fzd8 protein, human",0
5315,"Receptors, Cell Surface","Or67d protein, Drosophila",0
5316,Fc Receptor,"Fcalpha-mu receptor, human",0
5317,Fc Receptor,"Fcalpha-mu protein, mouse",0
5318,GABA-A Receptor,"GABRA5 protein, human",0
5319,GABA-A Receptor,"GABRG3 protein, human",0
5320,GABA-A Receptor,"GABRG1 protein, human",0
5321,"Receptors, Immunologic","Ncr3 protein, mouse",0
5322,"Receptors, Immunologic","LMIR5 protein, mouse",0
5323,"Receptors, Immunologic","LILRB3 protein, human",0
5324,"Receptors, Immunologic","LILRB5 protein, human",0
5325,"Receptors, Immunologic","Clec9a protein, mouse",0
5326,"Receptors, Immunologic","LILRA3 protein, human",0
5327,"Receptors, Mitogen","CLEC12A protein, mouse",0
5328,"Receptors, Mitogen","CLEC9a protein, human",0
5329,Nicotinic Receptors,"ACR-23 protein, C elegans",0
5330,Nicotinic Receptors,"UNC-29 protein, C elegans",0
5331,Prostaglandin Receptor,"prostanoid D receptor 1, mouse",0
5332,"Receptors, Virus","Flvcr1 protein, mouse",0
5333,Recombinant Fusion Proteins,hybrid hemoglobins,0
5334,Recombinant Fusion Proteins,human chorionic gonadotropin-diphtheria toxin fragment A,0
5335,Recombinant Fusion Proteins,"scFvRit-sFasL protein, human",0
5336,Recombinant Fusion Proteins,CD40LIg fusion protein,0
5337,Recombinant Fusion Proteins,tTF-RGD peptide,0
5338,Recombinant Fusion Proteins,TAT-PTEN fusion protein,0
5339,Recombinant Fusion Proteins,technetium 99m C2A-glutathione transferase,0
5340,Recombinant Fusion Proteins,"CR2-Crry fusion protein, mouse",0
5341,Recombinant Fusion Proteins,I-A(q)-bCII257-270 protein,0
5342,Recombinant Fusion Proteins,"GE fusion protein, mouse",0
5343,Recombinant Fusion Proteins,"GE2 fusion protein, human",0
5344,Recombinant Fusion Proteins,KH902 fusion protein,0
5345,Recombinant Fusion Proteins,"diphtheria toxin-GMCSF fusino protein, recombinant",0
5346,Recombinant Fusion Proteins,111In-CHX-A''-DTPA-Z(HER2;342) affibody,0
5347,Recombinant Fusion Proteins,metron factor-1,0
5348,Recombinant Fusion Proteins,CEC(dir)-CEC(ret) protein,0
5349,Recombinant Proteins,TPB 201 protein,0
5350,Recombinant Proteins,TPB 101 protein,0
5351,Recombinant Proteins,locteron,0
5352,Repressor Proteins,"ZNF256 protein, human",0
5353,Repressor Proteins,"PAX5-TEL fusion protein, human",0
5354,Repressor Proteins,"Myb4 protein, Arabidopsis",0
5355,Repressor Proteins,"IAA12 protein, Arabidopsis",0
5356,Repressor Proteins,"Grhl1 protein, mouse",0
5357,Repressor Proteins,"RBaK protein, human",0
5358,Repressor Proteins,"Maf1 protein, mouse",0
5359,Repressor Proteins,"ZNF418 protein, human",0
5360,Repressor Proteins,"KCTD1 protein, human",0
5361,Repressor Proteins,"Mta2 protein, mouse",0
5362,Repressor Proteins,"YgaV protein, E coli",0
5363,"Resins, Plant",pentalyn,0
5364,"Resins, Plant",copper seal dental cement,0
5365,Resorcinols,"2-tridecyl-3-((2-pentadecyl-4,6-dihydroxy)phenyl)-6-methoxy-1,4-benzoquinone",0
5366,Resorcinols,"4,6-diacetylresorcinol",0
5367,Resorcinols,"5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide",0
5368,Resorcinols,5-(11'Z-heptadecenyl)resorcinol,0
5369,Resorcinols,"5-(8'Z,11'Z-heptadecadienyl)resorcinol",0
5370,Retinoids,retinyl retinoate,0
5371,rhenium,dirhenium decacarbonyl,0
5372,Rhodamines,"rhodamine B 4-N,N-dimethylaminobenzaldehyde hydrazone",0
5373,Rhodamines,rhodamine B thiolactone,0
5374,Rhodamines,"N,N'-dioctadecylrhodamine",0
5375,Ribonucleases,"RNase J, Thermus thermophilus",0
5376,Ribonucleases,ribonuclease T-tat,0
5377,Ribonucleases,"ERN1 protein, Xenopus",0
5378,Ribonucleoproteins,"Mkrn2 protein, Xenopus",0
5379,Ribonucleoproteins,"Larp7 protein, human",0
5380,Ribonucleosides,2'-O-(carbomoylmethyl)ribonucleoside H-phosphonate,0
5381,Ribonucleosides,"6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl)quinoline-3-carboxylic acid",0
5382,Ribonucleotides,"10-(2-deoxy-beta -D-ribofuranosyl)-pyrimido(4',5' :4,5)-pyrimido(1,6-a)indole-6,9(7H)-dione",0
5383,Ribosomal Proteins,"RPS14 protein, human",0
5384,Ribosomal Proteins,"Rpl12 protein, S pombe",0
5385,Ribosomal Proteins,"Nsa1 protein, S cerevisiae",0
5386,Ribulose-Bisphosphate Carboxylase,rubimetide,0
5387,RNA Cap Analogs,m(7)GpppsG nucleotide,0
5388,RNA Polymerase II,"POLR2F protein, human",0
5389,DNA-Directed RNA Polymerase,"RpoTp protein, Arabidopsis",0
5390,DNA-Directed RNA Polymerase,"RpoTmp protein, Arabidopsis",0
5391,Proline-Specific tRNA,alanyl-tRNA(Pro),0
5392,Root Canal Filling Materials,ceramicrete,0
5393,Rubredoxins,rubrerythrins,0
5394,Salicylates,p-cresyl salicylate,0
5395,Salicylates,"1,3-dimethyl-3-butenyl salicylate",0
5396,Salicylates,hexyl salicylate,0
5397,Salicylates,isobutyl salicylate,0
5398,Salicylates,3-methyl-2-butenyl salicylate,0
5399,Salicylates,methyl 4-methylsalicylate,0
5400,Salicylates,pentyl salicylate,0
5401,Salicylates,phenethyl salicylate,0
5402,Salicylates,"N-(3,5-di-tert-butylsalicylidene)-1-ethylcarboxylato-4-aminopiperidine",0
5403,Salicylates,Holisal,0
5404,Salicylates,methyl salicylate 2-O-beta-D-glucoside,0
5405,Salsoline Alkaloids,salsoline B,0
5406,Saponins,"2,3,23-trihydroxyurs-12-en-28-oic acid O-xylopyranosyl-1-3-rhamnopyranosyl-1-4-glucopyranosyl-1-6-glucopyranosyl ester",0
5407,Saponins,3-O-(alpha-L-2-O-sulphonylarabinopyranosyl)-pomolic acid-28-O-(beta-D-glucopyranosyl) ester,0
5408,Saponins,3-O-(beta-D-2-O-sulphonylglucopyranosyl)-pomolic acid-28-O-(beta-D-glucopyranosyl) ester,0
5409,Saponins,pharbitoside A,0
5410,Saponins,pharbitoside B,0
5411,Saponins,balanitin 6,0
5412,Saponins,pithelucoside A,0
5413,Saponins,pithelucoside B,0
5414,Saponins,pithelucoside C,0
5415,Saponins,SK-PC-B70M,0
5416,Saponins,aspafilioside E,0
5417,Saponins,aspafilioside F,0
5418,Saponins,ardipusilloside III,0
5419,Saponins,achyranthoside G,0
5420,Saponins,achyranthoside H,0
5421,Saponins,lobatoside E,0
5422,Saponins,"2,3beta,19-trihydroxyurs-12-en-28-oic acid beta-D-glucopyranosyl ester",0
5423,Saponins,"28-O-isopentyryl-3,16,22,28-tetrahydroxyoleanane-3-O-(rhamnopyranosyl-1-3'-galactopyranosyl-1-4')galacturonopyranoside",0
5424,Saponins,zygophyloside O,0
5425,Saponins,zygophyloside P,0
5426,Saponins,3-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-galactopyranosyl-(1-3)-(beta-D-glucopyranosyl-(1-2))-beta-D-glucuronopyranosyl 22-O-angeloyl-A1-barrigenol,0
5427,Saponins,3-O-alpha-rhamnopyranosyl-(1-4)-beta-D-galactopyranosyl-(1-3)-(beta-D-glucopyranosyl-(1-2))-beta-D-glucuronopyranosyl 22-O-angeloylerythrodiol,0
5428,Saponins,reinioside C,0
5429,Scorpion Venoms,"GaTx1 protein, Leiurus quinquestriatus hebraeus",0
5430,Semicarbazones,"1-phenyl-1,2-propanedione-2-oximethiosemicarbazone",0
5431,Semicarbazones,metaflumizone,0
5432,Serine Endopeptidases,"TMPRSS4 protein, human",0
5433,Serine Endopeptidases,"neurobin protein, mouse",0
5434,Serologic tests,Streptozyme test,0
5435,Sesquiterpenes,cedrene,0
5436,Sesquiterpenes,alpha-curcumene,0
5437,Sesquiterpenes,acetyl cedrene,0
5438,Sesquiterpenes,vernodalin,0
5439,Sesquiterpenes,isobicyclogermacrenal,0
5440,Sesquiterpenes,lepidozenal,0
5441,Sesquiterpenes,eremantholide C,0
5442,Sesquiterpenes,upial,0
5443,Sesquiterpenes,eupalinin A,0
5444,Sesquiterpenes,"3,4,9-trihydroxy-9-methyl-3a,5,5a,9,9a,9b-hexahydronaphtho(1,2-b)furan-2,6(3H,4H)-dione",0
5445,Sesquiterpenes,laurencenone B,0
5446,Sesquiterpenes,9-deoxyelatol,0
5447,Sesquiterpenes,isodactyloxene A,0
5448,Sesquiterpenes,tinosinenside,0
5449,Sesquiterpenes,chloramultilide B,0
5450,Sesquiterpenes,chloramultilide C,0
5451,Sesquiterpenes,chloramultilide D,0
5452,Sesquiterpenes,"allo-aromadendrane-10alpha,14-diol",0
5453,Sesquiterpenes,8beta-epoxyangeloyloxy-9alpha-ethoxy-14-oxo-acanthospermolide,0
5454,Sesquiterpenes,8beta-angeloyloxy-9alpha-ethoxy-14-oxo-acanthospermolide,0
5455,Sesquiterpenes,"(4betaH)-5alpha-hydroxy-8alpha-(2-methylbut-2-enoyloxy)-2-oxo-1(10),11(13)-guaiadien-12,6alpha-olide",0
5456,Sesquiterpenes,"(4betaH)-8alpha-(2-methylbut-2-enoyloxy)-2-oxo-1(5),10(14),11(13)-guaiatrien-12,6alpha-olide",0
5457,Sesquiterpenes,"2,5-epoxy-2beta-hydroxy-4alpha-methoxy-8alpha-(2-methylbut-2-enoyloxy)-4(15),10(14),11(13)-germacratrien-12,6alpha-olide",0
5458,Sesquiterpenes,xanthinosin,0
5459,Sesquiterpenes,laurentristich-4-ol,0
5460,Sesquiterpenes,illudinine,0
5461,Sesquiterpenes,lairdinol A,0
5462,Sesquiterpenes,echinopine A,0
5463,Sesquiterpenes,echinopine B,0
5464,Sesquiterpenes,cinnamadin,0
5465,Sesquiterpenes,"cinnamodial 11alpha,12beta-dimethyl acetal",0
5466,Sesquiterpenes,calealactone A,0
5467,Sesquiterpenes,"3-hydroxy-1,5,7H-guaia-4(15),10(14),11(13)-trien-12-oic acid glucopyranosyl ester",0
5468,Sesquiterpenes,clavigerin B,0
5469,Sesquiterpenes,clavigerin C,0
5470,Sesquiterpenes,clavigerin A,0
5471,Sesquiterpenes,tauranin,0
5472,Sesquiterpenes,"1alpha(beta-D-glucopyranosyloxy)eudesma-3alpha,4beta,11-triol",0
5473,Sesquiterpenes,"2,9-dihydroxydehydrocostus lactone",0
5474,Sesquiterpenes,1-oxo-9-desoxycacalol,0
5475,Sesquiterpenes,deoxyelephantopin,0
5476,Sesquiterpenes,2-deoxy-7-O-methyllemnacarnol,0
5477,Sesquiterpenes,2-deoxy-12 alpha-ethoxy-7-O-methyllemnacarnol,0
5478,Sesquiterpenes,2-deoxy-12 alpha-methoxy-7-O-methyllemnacarnol,0
5479,Sesquiterpenes,radicol,0
5480,Sesquiterpenes,dictamol,0
5481,Sesquiterpenes,"3 beta,8 alpha-dihydroxy-13-pyrrolidine-4(15),10(14)-(1 alpha H,5 alpha H,6 beta H,11 beta H)-guaiadien-12,6-olide",0
5482,Sesquiterpenes,isointermedeol,0
5483,Sesquiterpenes,lemnafricanol,0
5484,Sesquiterpenes,nerolidol-3-O-rhamnopyranosyl-1-4-rhamnopyranosyl-1-2-(rhamnopyranosyl-1-6)-glucopyranoside,0
5485,Sesquiterpenes,4-oxo-bedfordia acid,0
5486,Sesquiterpenes,(2-carboxy-2-cyanovinyl)julolidine farnesyl ester,0
5487,Sesquiterpenes,chloropupukeananin,0
5488,Sesquiterpenes,3-angeloyloxyfuranoeremophilane,0
5489,Sesquiterpenes,3-methacryloyloxyfuranoeremophilane,0
5490,Sesquiterpenes,nanaimoal,0
5491,Sesquiterpenes,CJ-01 compound,0
5492,Sesquiterpenes,hiyodorilactone B,0
5493,Sesquiterpenes,guaiaglehnin A,0
5494,Sesquiterpenes,icariside C3,0
5495,Sesquiterpenes,beta-oplopenol,0
5496,Sesquiterpenes,"4-(3-(3,3-dimethyloxiran-2-yl)-1-methylpropyl)-1-methylcyclohex-2-en-1ol",0
5497,Sesquiterpenes,tianmushanol,0
5498,Sesquiterpenes,8-O-methyltianmushanol,0
5499,Sesquiterpenes,rotundone,0
5500,Sesquiterpenes,buagafuran,0
5501,Sesquiterpenes,ainsliadimer A,0
5502,Sesquiterpenes,"11alpha H-6 beta-angeloyloxy-15-carboxyeremophil-7-en-12,8-olide",0
5503,Sialyltransferases,"ST8SiaII protein, mouse",0
5504,Sigma Factor,"RpoN protein, Burkholderia cenocepacia",0
5505,Silanes,poly(N-isopropylac-yamide-co-3-methacryloxy-propyl-trimethoxysilane),0
5506,Silanes,"1,2-dicyanodisilane",0
5507,Silanes,1-(2-aminoethyl)-3-aminopropyl trimethoxysilane,0
5508,Silanes,trivinyl(3-chloropropyl)silane,0
5509,Silanes,trivinyl(3-iodopropyl)silane,0
5510,Silanes,trivinyl(3-hydroxypropyl)silane,0
5511,Silanes,p-chloromethylphenyltrichlorosilane,0
5512,Silanes,7-carboxylsilane,0
5513,Silanes,octadecyldimethylchlorosilane,0
5514,Silanes,trimethoxyvinylsilane,0
5515,Silanes,3-(trimethoxysilyl)propylamine,0
5516,Silicic Acid,monticellite,0
5517,Siloxanes,"1,3-dimethyl-1,3-p-fluorophenyl-1,3-(3-morpholinopropyl)-1,3-disiloxane",0
5518,Siloxanes,"1,3-dimethyl-1,3-(4-fluorophenyl)-1,3-(3-butyl-(1-piperazinyl)propyl)-1,3-disiloxane",0
5519,Siloxanes,divinyltetramethyldisiloxane,0
5520,Sitosterols,"3beta,6alpha,11,20beta,24-pentahydroxy- 9,11-seco-5alpha-24-ethylcholest-7,28-diene-9-one",0
5521,Sitosterols,"3-(1',2'-ethandiol)-24-methylcholest-8(9),22E-diene-3beta,5alpha,6alpha,7alpha,11alpha-pentaol",0
5522,Sitosterols,"24-methylcholest-7,22 E-diene-3beta,5alpha,6beta,25-tetraol",0
5523,Sodium Fluoride,Duofluorid-F,0
5524,Somatostatin,CTAP octapeptide,0
5525,Growth Hormone,methione-equine growth hormone,0
5526,Spider Venoms,"Ltc1 peptide, Lachesana tarabaevi",0
5527,Spider Venoms,"Ltc2a peptide, Lachesana tarabaevi",0
5528,Spider Venoms,"huwentoxin-V, Ornithoctonus huwena",0
5529,Spiro Compounds,ritterazine N,0
5530,Spiro Compounds,"27-hydroxy-13,19-didesmethyl spirolide C",0
5531,Spiro Compounds,RWJ-339489,0
5532,Spiro Compounds,JNJ-17158063,0
5533,Spiro Compounds,RWJ-676070,0
5534,Spiro Compounds,monospirocyclopiperazinium,0
5535,Spiro Compounds,spirowallichiione,0
5536,Spiro Compounds,"3,3-pentamethylene-4-butyrolactam",0
5537,Spiro Compounds,"5,5'6,6'-terahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobisindane",0
5538,Spiro Compounds,"6,6',7,7'-tetrahydroxy-4,4,4',4'-tetramethyl-2,2'-spirobichroman",0
5539,Spiro Compounds,OZ397,0
5540,Spiro Compounds,OZ381,0
5541,Spiro Compounds,ritterazine A,0
5542,Spiro Compounds,fredericamycin E,0
5543,Spiro Compounds,"8,8,10,10-tetramethyl-1-azaspiro(5.5)undecane",0
5544,Spiro Compounds,99-408 compound,0
5545,Spiro Compounds,99-411 compound,0
5546,Spiro Compounds,seco-milbemycin A,0
5547,Spiro Compounds,seco-milbemycin B,0
5548,Spiro Compounds,JNJ-27390467,0
5549,Spiro Compounds,BAS 100,0
5550,Spiro Compounds,pestafolide A,0
5551,Spiro Compounds,chrysogenamide A,0
5552,Starch,Arista,0
5553,Stearates,"1,3-propanediol distearate",0
5554,Stearates,glycerol 1-stearate,0
5555,Stearic Acids,poly(octadecanoic anhydride),0
5556,Steroids,ritterazine B,0
5557,Steroids,ritterazine N,0
5558,Steroids,"3-O-beta-D-glucopyranosyl-stigmasta-5,11(12)-diene",0
5559,Steroids,"24beta-ethylcholesta-5, 9(11), 22E-trien-3beta-benzoate",0
5560,Steroids,"3,3-difluoro-5beta-cholan-24-oic acid",0
5561,Steroids,ritterazine A,0
5562,Steroids,kurilensoside A,0
5563,Steroids,kurilensoside B,0
5564,Steroids,kurilensoside C,0
5565,Stilbenes,4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene,0
5566,Stilbenes,"cis-3,4',5-trimethoxy-3'-aminostilbene",0
5567,Stilbenes,"cis-3,4',5-trimethoxy-3'-hydroxystilbene",0
5568,Stilbenes,plagiochin E,0
5569,Stilbenes,"4,4'-bis(2-imidazolidinylimino)-1,2-diphenylethane",0
5570,Stilbenes,"3,3',4,5'-tetramethoxystilbene",0
5571,Stilbenes,13-hydroxykompasinol A,0
5572,Stilbenes,scirpusin C,0
5573,Strontium,Hyposen,0
5574,Styrenes,4-mercaptomethylstyrene,0
5575,Styrenes,4'-methoxy-2-styrylchromone,0
5576,Styrenes,amberlyst-15,0
5577,Styrenes,"1-styryl-9H-pyrido(3,4-b)indole",0
5578,Styrenes,eugenosedin B,0
5579,Styrenes,methyl acrylate-co-divinylbenzene,0
5580,Subtilisins,"subtilase cytotoxin, E coli",0
5581,Succinate Dehydrogenase,"SDH1 protein, S cerevisiae",0
5582,Succinimides,polyisobutylene succinimide,0
5583,Succinimides,SuO-BGL06 compound,0
5584,Succinimides,N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline,0
5585,Succinate-CoA Ligases,"ScsbetaA protein, Drosophila",0
5586,Sugar Acids,polyoxamic acid,0
5587,Sugar Alcohols,allitol,0
5588,Sugar Alcohols,TMG-chitotriomycin,0
5589,Sugar Phosphates,arabinose-3-phosphate,0
5590,Sugar Phosphates,"glucitol-1,6-bis-phosphate",0
5591,Sulfoglycosphingolipids,N-palmitoylsulfatide,0
5592,Sulfoglycosphingolipids,3-O-sulfogalactosyl-1'-1-N-heptadecanoylsphingosine,0
5593,Sulfhydryl Compounds,N-(2-(4-(aminosulfonyl)phenyl)ethyl)-2-(2-thienyl)acetamide,0
5594,Sulfhydryl Compounds,troposulfenin,0
5595,Sulfhydryl Compounds,"6,6-dimethyl-2-(phenylimino)-6,7-dihydro-5H-benzo-(1,3)oxathiol-4-one",0
5596,Sulfhydryl Compounds,4-mercaptomethylstyrene,0
5597,Sulfhydryl Compounds,"ferrocene-1,1'-dithiol",0
5598,Sulfhydryl Compounds,"1,9-nonanedithiol",0
5599,Sulfides,4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid,0
5600,Sulfides,"1,2,2-trithioeethyl ethylguaiacol",0
5601,Sulfides,"N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)-5-fluorobenzylamine",0
5602,Sulfides,"N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)-5-bromobenzylamine",0
5603,Sulfides,"N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)-5-iodobenzylamine",0
5604,Sulfides,AgBiS2,0
5605,Sulfides,fluorapacin,0
5606,Sulfides,4-nitrophenyl methyl sulfide,0
5607,Sulfides,bis(2-phenylthioethyl)methylamine,0
5608,Sulfides,2-((4-(4-(acridin-9-ylamino)phenylthio)phenyl)(2-hydroxyethyl)amino)ethan-1-ol,0
5609,Sulfides,3-((4-(4-(acridin-9-ylamino)phenylthio)phenyl)(3-hydroxypropyl)amino)propan-1-ol,0
5610,Sulfides,XM 462,0
5611,Sulfinic Acids,1-methanesulfonyloxy-2-methoxyethane,0
5612,Sulfinic Acids,S-benzyl phenylmethanethiosulfinate,0
5613,Sulfonamides,"N-(8-quinolyl)-3,5-difluoro-benzenesulfonamide",0
5614,Sulfonamides,"N-(2-(1-((4-fluorophenyl)sulfonyl)-1H-indol-4-yloxy)ethyl)-N,N-dimethylamine",0
5615,Sulfonamides,metacept-1,0
5616,Sulfonamides,"N,N-dibromo-p-toluenesulfonamide",0
5617,Sulfonamides,N-(2-((4-N-ethylthiosemicarbazone)methyl)phenyl)-p-toluenesulfonamide,0
5618,Sulfonamides,"N-(3-(1-cyclopropyl-1-(2,4-difluorophenyl)ethyl)-1H-indol-7-yl)methanesulfonamide",0
5619,Sulfonamides,squaric acid amide,0
5620,Sulfonamides,"N-methyl-N-(3-((2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl)-pyridin-2-yl)-methanesulfonamide",0
5621,Sulfonamides,tetraaquabis(sulfisoxazole)nickel,0
5622,Sulfonamides,bis(sulfapyridine)nickel,0
5623,Sulfonamides,4-t-butylphenyl-N-(4-imidazol-1-ylphenyl)sulfonamide,0
5624,Sulfonamides,TG101348,0
5625,Sulfonamides,mirodenafil,0
5626,Sulfonamides,N-dehydroxyethylmirodenafil,0
5627,Sulfonamides,PLX 4720,0
5628,Sulfonamides,navitoclax,0
5629,Sulfonamides,N-1H-benzimidazol-5-ylbenzenesulfonamide,0
5630,Sulfonamides,"4-(5,5-dimethyl-3-oxo-cyclohex-1-enylamino)benzenesulfonamide",0
5631,Sulfonamides,S 0859 compound,0
5632,Sulfonamides,ON09310,0
5633,Sulfonamides,"N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide",0
5634,Sulfonamides,OSU03013,0
5635,Sulfonamides,T2384,0
5636,Sulfonamides,"4-(5-(2,5-dimethylphenyl)-3-(trifluoromethyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0
5637,Sulfonamides,"3-(1-methyl-1H-indol-3-ylmethylene)-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide",0
5638,Sulfonamides,GSK837149A,0
5639,Sulfonamides,SB-791016,0
5640,Sulfonamides,"methyl 2-(3-methyl-(2-fluoro-4-chloro-5-ethylsulfonamidephenyl)-4,5-dihydro-5-oxo-1H-1,2,4-triazol-4-yl)methylenephenyl-2-methoxyiminoacetate",0
5641,Sulfonamides,2-(N-(2-chlorophenyl)carbamoyl)benzenesulfonamide,0
5642,Sulfonamides,2-(N-(4-chlorophenyl)carbamoyl)benzenesulfonamide,0
5643,Sulfonamides,2-amino-4-chloro-N-(1-(4-phenyl-1-(propylsulfonyl)piperidin-4-yl)ethyl)benzamide,0
5644,Sulfones,Sch 036,0
5645,Sulfones,chlorodifluoromethyl phenyl sulfone,0
5646,Sulfones,triazin 17-2,0
5647,Sulfones,acid blue 22,0
5648,Sulfones,GSK0660,0
5649,Sulfones,"5-(2-ethoxy-5-(4-(4-fluorophenyl)piperazinylsulfonyl)phenyl)-1-methyl-3N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one",0
5650,Sulfones,"5-(2-ethoxy-5-(N-phenylethylenediaminesulfonyl)phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one",0
5651,Sulfones,"5-(2-ethoxy-5-(N-acetic acid,N'-5-(2-ethoxy-5-sulfonyl)phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one-ethylenediaminesulfonylphenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one",0
5652,Sulfones,desiodoflubendiamide,0
5653,Sulfonic Acids,Poly(aniline-2-sulfonic acid),0
5654,Sulfonic Acids,"5-bromo-7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonic acid",0
5655,Sulfonic Acids,"1,1,2,2-tetrafluoroethanesulfonic acid",0
5656,Sulfonic Acids,8-hydroxy-7-(4-sulfo-1-naphthylazo)-5-quinoline sulfonic acid,0
5657,Sulfonic Acids,5-methylimidazolium 3-carboxy-4-hydroxybenzenesulfonate,0
5658,Sulfonic Acids,RB 150,0
5659,Sulfonic Acids,9-(4-(trifluoromethyl)phenoxy)nonane-1-sulfonate,0
5660,Sulfonic Acids,STX289,0
5661,Sulfonic Acids,poly(aniline-co-2-amino-4-hydroxybenzenesulfonic acid),0
5662,Sulfoxides,4-nitrophenyl methyl sulfoxide,0
5663,Sulfur Compounds,calcium sulfoaluminate,0
5664,Sulfuric Acid Esters,1-sulfate-3-myristoyl-5-pentadecylbenzene,0
5665,sulfurtransferase,"MOCS3 protein, human",0
5666,"Suppressor Factors, Immunologic","PIBF1 protein, human",0
5667,Terpenes,longestin,0
5668,Terpenes,annuionone H,0
5669,Terpenes,"1,4,7 cyclononatriene",0
5670,Terpenes,novofumigatonin,0
5671,Terpenes,fumigatonin,0
5672,Terpenes,annuionone B,0
5673,Terpenes,tanarifuranonol,0
5674,Terpenes,22-epoxyberkeleydione,0
5675,Terpenes,miniolutelide A,0
5676,Terpenes,miniolutelide B,0
5677,Terpenes,xuxuarine E*,0
5678,Terpenes,xuxuarine Ebeta,0
5679,Terpenes,grifolinone C,0
5680,"tetanus toxoid vaccine, inactivated",Hib-MenCY-TT vaccine,0
5681,Tetrahydronaphthalenes,2-hydroxy-5-(3-iodoprop-2-en-1-oxy)-3-(4-phenylpiperidino)tetralin,0
5682,Tetrahydronaphthalenes,"N-(5,6,7,8-tetrahydronaphthalen-2-yl)guanidine",0
5683,Tetrazoles,4-(hydroxybutyl)carbamic acid 2-(5-(1-(2-amino-2-methylpropionylamino)-2-benzyloxyethyl)tetrazol-1-yl)ethyl ester,0
5684,Tetrazoles,PF 376304,0
5685,Tetrazoles,HBF 0259,0
5686,Tetrazoles,pratosartan,0
5687,Tetrazoles,"1,3-bis(tetrazol-5-yl)triazenate",0
5688,Thiadiazines,"2-benzyl-4-(4-(t-butyl)chlorobenzyl)-7-methyl-1,1,3-trioxo-2,4-dihydropyrazolo(4,5-e)(1,4)thiadiazine",0
5689,Thiadiazoles,"3-(3-(propylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine",0
5690,Thiadiazoles,"7-(5-ethyl-1,3,4-thiadiazol-2-yl)-9-propyl-7-azaspiro(4,5)decane-6,8-dione",0
5691,Thiadiazoles,"2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid",0
5692,Thiadiazoles,NP00111,0
5693,Thiadiazoles,"3-(3-(3-trifluoropropylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine",0
5694,Thiazepines,"benzimidazolo(2,1-b)benzo(e)thiazepin-5(10H)-one",0
5695,Thiazepines,"4-(2-dimethylaminoethyl)-4,5,6,7-tetrahydro-7-(4-methoxyphenyl)-5-oxothieno(2,3-b)(1,4)thiazepin-6-yl acetate",0
5696,Thiazepines,"9-piperazin-1-ylpyrrolo(2,1-b)benzothiazepine",0
5697,Thiazines,"N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide",0
5698,Thiazines,"N-(4-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide",0
5699,Thiazoles,BN82451,0
5700,Thiazoles,"8-oxo-5,6,7,8-tetrahydro-thiazolo(3,2-a)(1,3)diazepin-3-carboxylate",0
5701,Thiazoles,3-benzyloxycarbonylmethyl-4-methylthiazol-3-ium,0
5702,Thiazoles,masitinib,0
5703,Thiazoles,1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid,0
5704,Thiazoles,2-(1-(2-fluorophenyl)ethylamino)-5-methyl-5-(trifluoromethyl)thiazol-4(5H)-one,0
5705,Thiazoles,largazole,0
5706,Thiazoles,"3-dodecyl-5-(2-methoxyethyl)-4-methyl-1,3-thiazol-3-ium",0
5707,Thiazoles,KP-496,0
5708,Thiazoles,2-(4-(2-((3-(5-(Pyridin-2-ylthio)thiazol-2-yl)ureido)methyl)-1H-imidazol-4-yl)phenoxy)acetic acid,0
5709,Thiazoles,"3-(allyloxy)-1,2-benzisothiazole 1,1-dioxide",0
5710,Thiazoles,"N-cyclohexyl-6-(((2-methoxyethyl)(methyl)amino)methyl)-N-methylthiazolo(3,2-a)benzimidazole-2-carboxamide",0
5711,Thiazoles,"2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone",0
5712,Thiazoles,BMS-640994,0
5713,Thiazoles,3-((5-(6-ethylpyridin-2-yl)-4-(quinoxalin-6-yl)thiazol-2-ylamino)methyl)benzamide,0
5714,Thiazoles,3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)thiazol-2-ylamino)methyl)benzamide,0
5715,Thiazoles,BILS 22 BS,0
5716,Thiazoles,archazolide A,0
5717,Thiazoles,2-(3-noradamantylamino)-1-thia-3-azaspiro(4.4)non-2-en-4-one,0
5718,Thiazoles,4-methyl-5-formyl-thiazole,0
5719,Thiazoles,2-amino-5-methylthiazole,0
5720,Thiazoles,"2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethanohydrazide",0
5721,Thiazoles,2-(4-hydroxyanilino)-4-(4-chlorophenyl)thiazole,0
5722,Thiazoles,(-)-dysithiazolamide,0
5723,Thiazoles,"methyl-2-(5-((3-benzyl-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl)-2-furyl)benzoate",0
5724,Thiocyanates,"1-(3,4-dihydroxyphenyl)-2-thiocyanate-ethanone",0
5725,Thiohydantoins,pseudothiohydantoin 7,0
5726,Thiolester Hydrolases,"Usp22 protein, human",0
5727,Thiolester Hydrolases,"EntH protein, E coli",0
5728,Thiones (chemical),"6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone",0
5729,Thiones (chemical),ammonium dithionate,0
5730,Thiones (chemical),16a-thiocamptothecin,0
5731,Thionucleosides,"3',5'-bis(tert-butyldimethylsilyl)-S-(benzoylvinyl)thioguanine",0
5732,Thionucleosides,"3',5'-bis(tert-butyldimethylsilyl)-S-(4-nitrobenzoylvinyl)thioguanine",0
5733,Thionucleosides,"3',5'-bis(tert-butyldimethylsilyl)-S-(2-benzoyl-3-oxo-2-butenyl)thioguanine",0
5734,Thiophenes,"2-chloro-N-(1-(2,3-dihydroxypropyl)-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-6H-thieno(2,3-b)pyrrole-5-carboxamide",0
5735,Thiophenes,"5-amino-2-methylsulfanyl-4-(3-(2-morpholin-4-ylacetylamino)phenyl)thieno(2,3-d)pyrimidine-6-carboxylic acid tert-butylamide",0
5736,Thiophenes,2-acetylbenzothiophene-S-oxide,0
5737,Thiophenes,milfasartan,0
5738,Thiophenes,"2,4-dimethyl-2-(thiophen-3-yl)-4-(thiophen-3-yl-S,S-dioxo)pentan-3-one",0
5739,Thiophenes,"2,4-dimethyl-2,4-di(thiophen-3-yl)pentan-3-one",0
5740,Thiophenes,"2-((4-hydroxy-3-methoxybenzylidene)amino)-N-(2-methylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",0
5741,Thiophenes,poly(3-acetylthiophene),0
5742,Thiophenes,"tetraceno(2,3-b)thiophene",0
5743,Thiophenes,"4-(2-dimethylaminoethyl)-4,5,6,7-tetrahydro-7-(4-methoxyphenyl)-5-oxothieno(2,3-b)(1,4)thiazepin-6-yl acetate",0
5744,Thiophenes,"poly(9,9-dioctylfluorene-co-3,4-di-methylthieno(2,3-b)thiophene)",0
5745,Thiophenes,poly(dimethyldioctylquaterthiophene-alt-oxadiazole),0
5746,Thiophenes,"benzo(1,2-b-4,5-b')bis(b)benzothiophene",0
5747,Thiophenes,4-nitrobenzoic acid ((5-nitro-2-thiopheneyl)methylene)hydrazide,0
5748,Thiophenes,"9-dimethylamino-3-cycloheptyl-3H-5-thia-1,3,6-triazafluoren-4-one",0
5749,Thiophenes,"9-dimethylamino-3-(4-methylphenyl)-3H-5-thia-1,3,6-triazafluoren-4-one",0
5750,Thiophenes,GSK0660,0
5751,Thiophenes,NIP-004,0
5752,Thiosemicarbazones,pyrrole-2-carboxyaldehyde thiosemicarbazone,0
5753,Thiosemicarbazones,2-hexyl-1-cyclopentanone thiosemicarbazone,0
5754,Thiosemicarbazones,2-methylcyclohexanone thiosemicarbazone,0
5755,Thiosemicarbazones,ethylglyoxal bis(thiosemicarbazonato)copper(II),0
5756,Thymidine Kinase,sitimagene ceradenovec,0
5757,Thymine Nucleotides,"5-diacetoxymethyl-cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine",0
5758,Thymine Nucleotides,"dTDP-3-acetamido-3,6-dideoxyglucose",0
5759,Toluidines,acetochlor mercapturate,0
5760,Toluidines,teriflunomide,0
5761,Toluidines,salicylidene-p-toluidine,0
5762,Tosyl Compounds,3-(hydroxy(tosyloxy)iodo)benzoic acid,0
5763,Tosyl Compounds,tert-butyl 3-tosyloxybutanoate,0
5764,Tosyl Compounds,S-tert-butyl 3-tosyloxybutanethioate,0
5765,TRANSCRIPTION FACTOR,"Poxm protein, Drosophila",0
5766,TRANSCRIPTION FACTOR,"YARP protein, human",0
5767,TRANSCRIPTION FACTOR,"YY1AP-related protein, rat",0
5768,TRANSCRIPTION FACTOR,"vgll2b protein, zebrafish",0
5769,TRANSCRIPTION FACTOR,"tead3a protein, zebrafish",0
5770,TRANSCRIPTION FACTOR,"ATXN7L3 protein, human",0
5771,TRANSCRIPTION FACTOR,"Eny2 protein, human",0
5772,TRANSCRIPTION FACTOR,"Sgf11 protein, Drosophila",0
5773,TRANSCRIPTION FACTOR,"Sizn1 protein, mouse",0
5774,TRANSCRIPTION FACTOR,"Rrn3 protein, S pombe",0
5775,TRANSCRIPTION FACTOR,"RTF1 protein, human",0
5776,TRANSCRIPTION FACTOR,"Rds2 protein, S cerevisiae",0
5777,TRANSCRIPTION FACTOR,"Sfmbt2 protein, mouse",0
5778,TRANSCRIPTION FACTOR,"calcium response transcription factor 1, rat",0
5779,TRANSCRIPTION FACTOR,"ELK3 protein, human",0
5780,TRANSCRIPTION FACTOR,"Isx protein, mouse",0
5781,TRANSCRIPTION FACTOR,"MAMLD1 protein, human",0
5782,TRANSCRIPTION FACTOR,"znf148 protein, zebrafish",0
5783,TRANSCRIPTION FACTOR,"PTL protein, Arabidopsis",0
5784,TRANSCRIPTION FACTOR,"RHOX5 protein, human",0
5785,TRANSCRIPTION FACTOR,"CNOT1 protein, human",0
5786,TRANSCRIPTION FACTOR,"GLUT4 enhancer factor, mouse",0
5787,TRANSCRIPTION FACTOR,"MYB76 protein, Arabidopsis",0
5788,TRANSCRIPTION FACTOR,"CASZ1 protein, Xenopus",0
5789,TRANSCRIPTION FACTOR,"Myb113 protein, Arabidopsis",0
5790,TRANSCRIPTION FACTOR,"Myb114 protein, Arabidopsis",0
5791,TRANSCRIPTION FACTOR,"LZF1 protein, Arabidopsis",0
5792,TRANSCRIPTION FACTOR,"Orb2 protein, Drosophila",0
5793,TRANSCRIPTION FACTOR,"NKX5-3 protein, mouse",0
5794,TRANSCRIPTION FACTOR,"Mych protein, zebrafish",0
5795,TRANSCRIPTION FACTOR,"MYB44 protein, Arabidopsis",0
5796,TRANSCRIPTION FACTOR,"YjjQ protein, E coli",0
5797,TRANSCRIPTION FACTOR,"onecut3a protein, zebrafish",0
5798,TRANSCRIPTION FACTOR,"ELF6 protein, Arabidopsis",0
5799,TRANSCRIPTION FACTOR,"REF6 protein, Arabidopsis",0
5800,TRANSCRIPTION FACTOR,"ZFAT protein, mouse",0
5801,TRANSCRIPTION FACTOR,"ZFAT protein, human",0
5802,TRANSCRIPTION FACTOR,"MYB11 protein, Arabidopsis",0
5803,TRANSCRIPTION FACTOR,"NsrR protein, E coli",0
5804,TRANSCRIPTION FACTOR,"NKX5-3 protein, human",0
5805,TRANSCRIPTION FACTOR,"ZNF469 protein, human",0
5806,TRANSCRIPTION FACTOR,"Rtr1 protein, S cerevisiae",0
5807,TRANSCRIPTION FACTOR,"Myb72 protein, Arabidopsis",0
5808,TRANSCRIPTION FACTOR,"zinc finger protein 2, Arabidopsis",0
5809,TRANSCRIPTION FACTOR,"Tle6 protein, human",0
5810,TRANSCRIPTION FACTOR,"McbR protein, E coli",0
5811,Triazines,IB05204,0
5812,Triazines,"N-ethyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazine-6-carboxamide",0
5813,Triazines,"N-cyclopentyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazine-6-carboxamide",0
5814,Triazines,"2,4,6-tris(4-((2-methylbenzimidazol-1-yl)methyl)phenyl)-1,3,5-triazine",0
5815,Triazines,"3-ureidobenzo-1,2,4-triazine 1-N-oxide",0
5816,Triazines,triazin 17-2,0
5817,Triazines,"3-(4-chloro-6-p-glyoxalphenoxy-1,3,5-triazinylamino)-7-(dimethylamino)-2-methylphenazine",0
5818,Triazines,"3-(2-(4-(naphthalen-1-yl)piperazin-1-yl)ethyl)benzo(d)(1,2,3)triazin-4(3H)-one",0
5819,Triazines,Wheel-FKFE,0
5820,Triazines,"1,5-bis(4,6-dichloro-1,3,5-triazinylamino)naphthalene",0
5821,Triazines,"2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione",0
5822,Triazines,"4-chloro-3-(5-methyl-3-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)-1,2,4-benzotriazin-7-yl)phenol",0
5823,Triazines,"4-chloro-3-(5-methyl-3-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)-1,2,4-benzotriazin-7-yl)phenyl benzoate",0
5824,Triazines,"8-(2-methoxybenzyl)-4-(N-methylamino)-2-n-propylpyrazolo(1,5-a)-1,3,5-triazine",0
5825,Triazines,"2-trifluoromethyl-8-(2-methoxybenzyl)-4-(N-methylamino)pyrazolo(1,5-a)-1,3,5-triazine",0
5826,Triazines,"5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine",0
5827,Triazines,"1,3-bis(tetrazol-5-yl)triazenate",0
5828,Triazines,"3-(4-chloro-6-p-maleimidylphenoxy-1,3,5-triazinylamino)-7-dimethylamino-2-methylphenazine",0
5829,Triazoles,LY686017,0
5830,Triazoles,"1H-benzotriazolium-1-(bis(dimethyl-amino)methylene)-5-chloro-hexafluorophosphate (1-),3-oxide",0
5831,Triazoles,"1-hydroxyethyl-4-amino-1,2,4-triazolium nitrate",0
5832,Triazoles,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",0
5833,Triazoles,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",0
5834,Triazoles,"N-(1-(4-(2,4-dimethoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)picolinamide",0
5835,Triazoles,"N-(1-(5-(2-(1H-indol-3-yl)ethyl)-4-(2,4-dimethoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)pyrazine-2-carboxamide",0
5836,Triazoles,"1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine",0
5837,Triazoles,"4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine",0
5838,Triazoles,"methyl 2-(3-methyl-(2-fluoro-4-chloro-5-ethylsulfonamidephenyl)-4,5-dihydro-5-oxo-1H-1,2,4-triazol-4-yl)methylenephenyl-2-methoxyiminoacetate",0
5839,Triazoles,"7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid",0
5840,Triazoles,"1-ribofuranosyl-3-ethynyl-(1,2,4)triazole",0
5841,Triglycerides,"2-(12-ricinoleoylricinoleoyl)-1,3-diricinoleoylglycerol",0
5842,Trihexosylceramides,corrugoside,0
5843,Trimethylsilyl Compounds,cinnamyltrimethylsilane,0
5844,Trimethylsilyl Compounds,"1,2-bis(trimethylsilyl)benzene",0
5845,Trimethylsilyl Compounds,2-(3-(trimethoxysilyl)propyldisulfanyl)propionic acid,0
5846,Trimethylsilyl Compounds,2-fluoro-6-O-(trimethylsilylethyl)-2'-deoxyinosine,0
5847,Trisaccharides,glucuronosyl-1-3-galactopyranosyl-1-3-N-acetylgalactosamine,0
5848,Triterpenes,3-O-(alpha-L-2-O-sulphonylarabinopyranosyl)-pomolic acid-28-O-(beta-D-glucopyranosyl) ester,0
5849,Triterpenes,3-O-(beta-D-2-O-sulphonylglucopyranosyl)-pomolic acid-28-O-(beta-D-glucopyranosyl) ester,0
5850,Triterpenes,"3,15-dioxo-21alpha-hydroxyfriedelane",0
5851,Triterpenes,pharbitoside A,0
5852,Triterpenes,pharbitoside B,0
5853,Triterpenes,"3alpha, 24-dihydroxyurs-12-ene",0
5854,Triterpenes,endecaphyllacin A,0
5855,Triterpenes,endecaphyllacin B,0
5856,Triterpenes,"3,6-dihydroxyurs-12-en-27-oic acid",0
5857,Triterpenes,walsucochin A,0
5858,Triterpenes,walsucochin B,0
5859,Triterpenes,spirowallichiione,0
5860,Triterpenes,"2,3-seco-taraxer-14-ene-2,3,28-trioic acid 2,3-dimethyl ester",0
5861,Triterpenes,"2,3-seco-taraxer-14-ene-2,3,28-trioic acid 3-methyl ester",0
5862,Triterpenes,"2,3,19-trihydroxyurs-12-en-28-oic acid",0
5863,Triterpenes,"16-29-dihydroxy, 20-ene cyclolaudenol",0
5864,Triterpenes,endodesmiadiol,0
5865,Triterpenes,thalianol,0
5866,Triterpenes,alisol P,0
5867,Triterpenes,"9,19-cyclolanost-24-en-3-one",0
5868,Triterpenes,"3beta-hydroxyurs-12-en-27, 28-dioic acid",0
5869,Triterpenes,"3beta,6beta,23-trihydroxyurs-12-en-28-oic acid",0
5870,Triterpenes,renchanglactone A,0
5871,Triterpenes,ganoderic acid D,0
5872,Triterpenes,okhotoside B1,0
5873,Triterpenes,okhotoside B2,0
5874,Triterpenes,okhotoside B3,0
5875,Triterpenes,rhabdastrellic acid A,0
5876,Triterpenes,synaptoside A,0
5877,Triterpenes,synaptoside A1,0
5878,Triterpenes,lobatoside E,0
5879,Triterpenes,"2,3beta,19-trihydroxyurs-12-en-28-oic acid beta-D-glucopyranosyl ester",0
5880,Triterpenes,"3beta,24,25-trihydroxycycloartane",0
5881,Triterpenes,dryopteric acid A,0
5882,Triterpenes,dryopteric acid B,0
5883,Triterpenes,"24,24-dimethyltirucall-9(11),25-dien-3-one",0
5884,Triterpenes,trinorlupeol,0
5885,Triterpenes,zygophyloside O,0
5886,Triterpenes,zygophyloside P,0
5887,Triterpenes,lanopropic acid,0
5888,Triterpenes,intybusoloid,0
5889,Triterpenes,cichoridiol,0
5890,Triterpenes,3-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-galactopyranosyl-(1-3)-(beta-D-glucopyranosyl-(1-2))-beta-D-glucuronopyranosyl 22-O-angeloyl-A1-barrigenol,0
5891,Triterpenes,3-O-alpha-rhamnopyranosyl-(1-4)-beta-D-galactopyranosyl-(1-3)-(beta-D-glucopyranosyl-(1-2))-beta-D-glucuronopyranosyl 22-O-angeloylerythrodiol,0
5892,Triterpenes,"3alpha, 30-dihydroxylup-20(29)-en-27-oic acid",0
5893,Triterpenes,"(20S)-3alpha, 29-dihydroxylupan-27-oic acid",0
5894,Triterpenes,"protosta-13(17),24-dien-3beta-ol",0
5895,Triterpenes,achilleol B,0
5896,Trityl Compounds,4-methoxytritylthio chloride,0
5897,Tropanes,N-(4-(4-azido-3-(125I)iodophenyl)butyl)-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane,0
5898,Tryptamines,5-chlorotryptamine,0
5899,Tyrosine-tRNA Ligase,"mini-TyrRS, human",0
5900,Ubiquitins,"Urm1 protein, human",0
5901,Umbelliferones,icariside I,0
5902,Umbelliferones,"6,7-di-O-glucopyranosylesculetin",0
5903,Uridine Diphosphate Sugars,6''-O-2-nitrobenzyl uridine-5'-diphosphogalactose,0
5904,Uronic Acids,iminuronic acid,0
5905,Uroporphyrinogens,N(D)-methyl-1-formylbilane,0
5906,"Vaccines, Attenuated",imvamune,0
5907,Valerates,cinnamyl isovalerate,0
5908,Valerates,"7,7'-dihydroxy-8,8'- biquinolyl dipentanoate",0
5909,Valerates,"2,2-dimethylpropionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethylpropionyloxymethyl)propyl ester",0
5910,Vanadates,vanadyl-poly (gamma-glutamic acid),0
5911,"Variant Surface Glycoproteins, Trypanosoma","glycoprotein GP82, Trypanosoma cruzi",0
5912,Venoms,helokinestatin,0
5913,Vinca Alkaloids,2'-hydroxyethyl apovincaminate,0
5914,Vinyl Compounds,2-methoxy-4-vinylphenol,0
5915,Vinyl Compounds,"1,4,7-tris(carboxymethyl)-10-(vinylsulfone)-1,4,7,10-tetraazacyclododecane",0
5916,Vinyl Compounds,trivinyl(3-chloropropyl)silane,0
5917,Vinyl Compounds,trivinyl(3-iodopropyl)silane,0
5918,Vinyl Compounds,trivinyl(3-hydroxypropyl)silane,0
5919,Vinyl Compounds,vinyl trifluoroacetate,0
5920,Vinyl Compounds,trimethoxyvinylsilane,0
5921,Vinyl Compounds,diethylene glycol vinyl ether,0
5922,Viral Fusion Proteins,"A27 protein, vaccinia virus",0
5923,Viral Fusion Proteins,"F protein, human respiratory syncytial virus",0
5924,Viral Fusion Proteins,"EGF-IL-18 fusion protein, mouse",0
5925,Viral Proteins,"Mu Mom protein, bacteriophage Mu",0
5926,Viral Proteins,"HA2 protein, Helicoverpa armigera nucleopolyhedrovirus",0
5927,Viral Proteins,"UL53 protein, human herpesvirus 2",0
5928,Viral Proteins,"US4 protein, human herpesvirus 2",0
5929,Viral Proteins,"p33 protein, Kaposi's sarcoma-associated herpesvirus",0
5930,Wasp Venoms,mitoparan,0
5931,Waxes,"3,9-di-9-oxotetradocosanecarboxy-11-oxohexacosane",0
5932,Xanthenes,ohioensin G,0
5933,Xanthenes,ohioensin F,0
5934,Xanthenes,2-(1-amino-1-carboxy-2-(9H-xanthen-9-yl)ethyl)-1-fluorocyclopropanecarboxylic acid,0
5935,Xanthenes,"2-(1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl)-1-fluorocyclopropanecarboxylic acid, 6-heptyl ester",0
5936,Xanthines,"1,3-dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine",0
5937,Xanthines,cellulose xanthate,0
5938,Zinc Oxide-Eugenol Cement,intrafill,0
5939,17-Hydroxysteroid Dehydrogenases,"17beta-hydroxysteroid dehydrogenase type 13, mouse",0
5940,3-Oxoacyl-(Acyl-Carrier-Protein) Synthase,"FabH protein, Mycobacterium tuberculosis",0
5941,"3',5'-Cyclic-Nucleotide Phosphodiesterase","PDE8A protein, rat",0
5942,4-Butyrolactone,murrayacoumarin B,0
5943,Calcium Channel,"Cacna1f protein, rat",0
5944,Calcium Channel,"stj protein, Drosophila",0
5945,Calcium Channel,"TPCN2 protein, human",0
5946,Dideoxynucleosides,"N,N'-dideoxythymidine-3,4,9,10-perylene-tetracarboxylic acid diimide",0
5947,Dinucleoside Phosphates,cyclic diadenosine phosphate,0
5948,Dinucleoside Phosphates,uridine adenosine tetraphosphate,0
5949,HLA-A Antigens,HLA-A*32:15 antigen,0
5950,HLA-A Antigens,HLA-A*31:17 antigen,0
5951,HLA-A Antigens,HLA-A*34:01:02 antigen,0
5952,HLA-A Antigens,HLA-A*23:18 antigen,0
5953,HLA-A Antigens,HLA-A*33:14 antigen,0
5954,HLA-B Antigens,HLA-B*48:01:02 antigen,0
5955,HLA-B Antigens,HLA-B*46:12 antigen,0
5956,HLA-C Antigens,HLA-C*07:16 antigen,0
5957,HLA-C Antigens,HLA-C*07:51 antigen,0
5958,HLA-C Antigens,HLA-C*03:38:02 antigen,0
5959,HLA-C Antigens,HLA-C*03:46 antigen,0
5960,HLA-C Antigens,HLA-C*05:17 antigen,0
5961,HLA-C Antigens,HLA-C*06 antigen,0
5962,sulfotransferase,"TPST2 protein, mouse",0
5963,"Fibrinogens, Abnormal",fibrinogen Praha II,0
5964,"Fibrinogens, Abnormal",fibrinogen Novy Jicin,0
5965,"Fibrinogens, Abnormal",fibrinogen gamma',0
5966,"Fibrinogens, Abnormal",fibrinogen Hershey IV,0
5967,DNA Modification Methylases,"MGMT protein, mouse",0
5968,Leukotrienes,eoxin C4,0
5969,Quinolones,"2-chloro-N-(1-(2,3-dihydroxypropyl)-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-6H-thieno(2,3-b)pyrrole-5-carboxamide",0
5970,Quinolones,3-methyl-2-(2-octenyl)-4-quinolone,0
5971,Quinolones,bis(12)-hupyridone,0
5972,Quinolones,"methyl 2-amino-4,9-dihydro-4,9-dioxo-1-p-tolyl-1H-pyrrolo(3,2-g)isoquinoline-3-carboxylate",0
5973,Quinolones,4-(4-ethyl-phenyl)-3-(2-methyl-3H-imidazol-4-yl)-2-quinolone-6-carbonitrile,0
5974,Quinolones,"1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone",0
5975,Quinolones,"10-(3-cyclopropylaminomethyl-4-fluoro-1-pyrrolidinyl)-9-fluoro-3-fluoromethyl-2,3-dihydro-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid",0
5976,Oncogene Proteins,"NUT protein, human",0
5977,Oncogene Proteins,"Hras protein, rat",0
5978,Oncogene Proteins,"Rab8b protein, human",0
5979,"Oncogene Proteins, Fusion","TMPRSS2-ETV5 fusion protein, human",0
5980,"Oncogene Proteins, Fusion","Slc45A3-ETV5 fusion protein, human",0
5981,"Oncogene Proteins, Fusion","PAX5-TEL fusion protein, human",0
5982,"Oncogene Proteins, Fusion","AML1-LAF4 fusion protein, human",0
5983,"Oncogene Proteins, Fusion","IGH-CCND1 fusion protein, human",0
5984,"Oncogene Proteins, Fusion","TMPRSS2-ETS fusion protein, human",0
5985,"Oncogene Proteins, Fusion","TMPRSS2-ETV1 fusion protein, human",0
5986,"Oncogene Proteins, Fusion","TMPRSS2-ETV4 fusion protein, human",0
5987,"Oncogene Proteins, Fusion","MLL-MLLT3 fusion protein, human",0
5988,"Oncogene Proteins, Fusion","RIF1-PKD1L1 protein, human",0
5989,"Oncogene Proteins, Fusion","ALK-RANBP2 fusion protein, human",0
5990,"Oncogene Proteins, Fusion","RBM6-RBM5 fusion protein, human",0
5991,"Oncogene Proteins, Fusion","ETV6-GOT1 fusion protein, human",0
5992,Trans-Activators,"churc1 protein, zebrafish",0
5993,Trans-Activators,"Eya4 protein, mouse",0
5994,Trans-Activators,"Mta2 protein, mouse",0
5995,Organotechnetium Compounds,technetium Tc 99m (EDDA-HYNIC)octreotate,0
5996,Organotechnetium Compounds,technetium 99m C2A-glutathione transferase,0
5997,Organotechnetium Compounds,technetium 99m P1827DS,0
5998,Organotechnetium Compounds,(99m)Tc-bis-amino-bis-thiol-phenylbenzothiazole,0
5999,Organotechnetium Compounds,(99m)TcN(PNP)Pip-DTC,0
6000,Organotechnetium Compounds,99mTc-MAMA-BTA,0
6001,Organotechnetium Compounds,technetium 99m RAFT-RGD,0
6002,Organotechnetium Compounds,technetium 99m HYNIC-annexin B1,0
6003,Organotechnetium Compounds,technetium 99m MAS3-SDF-1alpha,0
6004,Viral Structural Proteins,"D8L protein, vaccinia virus",0
6005,Viral Structural Proteins,"P protein, human respiratory syncytial virus",0
6006,CD Antigens,"LILRB3 protein, human",0
6007,CD Antigens,"LILRB5 protein, human",0
6008,Single-Strand Specific DNA and RNA Endonucleases,"Endonuclease S1, Aspergillus",0
6009,Single-Strand Specific DNA and RNA Endonucleases,"Nuclease P1, Penicillium citrinum",0
6010,Single-Strand Specific DNA and RNA Endonucleases,Mung Bean Nuclease,0
6011,Eicosanoids,"14-ethyl-2,5,11-trimethyl-4,13,19,20-tetraoxa-tricyclo(14.2.1.1(7,10))eicosane-3,12-dione",0
6012,Minor Histocompatibility Antigens,"H60b protein, mouse",0
6013,Minor Histocompatibility Antigens,"H60c protein, mouse",0
6014,Protozoan Proteins,"CGM1 protein, Trypanosoma brucei",0
6015,Protozoan Proteins,"Pfs47 protein, Plasmodium falciparum",0
6016,Protozoan Proteins,"glycoprotein GP82, Trypanosoma cruzi",0
6017,Protozoan Proteins,"LdARL-3A protein, Leishmania",0
6018,Protozoan Proteins,"HDP protein, Plasmodium falciparum",0
6019,Protozoan Proteins,"microneme protein 8, Toxoplasma gondii",0
6020,Helminth Proteins,"CsCF-6 protein, Clonorchis sinensis",0
6021,Cell Adhesion Molecules,"periostin-like factor, mouse",0
6022,Cell Adhesion Molecules,"microneme protein 8, Toxoplasma gondii",0
6023,"Cell Adhesion Molecules, Neuronal","contactin 6 protein, mouse",0
6024,"Cell Adhesion Molecules, Neuronal","synCAM-2 protein, rat",0
6025,"Cell Adhesion Molecules, Neuronal","PUNC protein, human",0
6026,Cadherins,"protocadherin 20 protein, mouse",0
6027,Cadherins,"protocadherin beta16, mouse",0
6028,Cadherins,"Pcdh12 protein, rat",0
6029,Cadherins,"CDH-4 protein, C elegans",0
6030,Cadherins,"protocadherin 17, human",0
6031,Cadherins,"protocadherin-18, zebrafish",0
6032,Serpins,"Serpina3k protein, rat",0
6033,Granulocyte-Macrophage Colony-Stimulating Factor,"monopegylated granulocyte-macrophage colony-stimulating factor, human",0
6034,cytokine,metron factor-1,0
6035,Transforming Growth Factor alpha,transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38),0
6036,Cyclins,"FAM58A protein, human",0
6037,Benzoquinones,p-hydroxymethoxybenzobijuglone,0
6038,Benzoquinones,"2-tridecyl-3-((2-tridecyl-3-acetoxy-4-methoxy-6-hydroxy)phenyl)-6-methoxy-1,4-benzoquinone",0
6039,Benzoquinones,"2-tridecyl-3-((2-tridecyl-4,6-dihydroxy)phenyl)-6-methoxy-1,4-benzoquinone",0
6040,Benzoquinones,"2-tridecyl-3-((2-pentadecyl-4,6-dihydroxy)phenyl)-6-methoxy-1,4-benzoquinone",0
6041,Benzoquinones,parvifoliquinone,0
6042,Benzoquinones,"N-(3-carboxylpropyl)-5-amino-2-hydroxy-3-tridecyl-1,4-benzoquinone",0
6043,Benzoquinones,acremine G,0
6044,Benzoquinones,"2,5-diamino-3,6-dichloro-1,4-benzoquinone",0
6045,Benzoquinones,DMAG-N-oxide,0
6046,Benzoquinones,sargahydroquinoic acid,0
6047,Benzoquinones,grifolinone C,0
6048,Endothelial Growth Factors,"EGFL7 protein, human",0
6049,Amyloid beta-Peptides,beta-amyloid (15-28),0
6050,Amyloid beta-Peptides,amyloid beta-protein (16-20),0
6051,Aspartic Acid Endopeptidases,"SPPL2b protein, human",0
6052,Aspartic Acid Endopeptidases,"Gvp36 protein, S cerevisiae",0
6053,Proto-Oncogene Proteins p21(ras),"Kras protein, rat",0
6054,Extracellular Matrix Proteins,"Oc90 protein, zebrafish",0
6055,Extracellular Matrix Proteins,"cochlin protein, rat",0
6056,Extracellular Matrix Proteins,"HAPLN3 protein, Xenopus",0
6057,Extracellular Matrix Proteins,"Cthrc1 protein, mouse",0
6058,Kinesin,"KIF6 protein, human",0
6059,Kinesin,"Kid protein, mouse",0
6060,Kinesin,"KAP3A protein, human",0
6061,Kinesin,"nephrocystin-3, human",0
6062,Kinesin,"nephrocystin-3, mouse",0
6063,Kinesin,"Kif17 protein, zebrafish",0
6064,Kinesin,"MRH2 protein, Arabidopsis",0
6065,Organoselenium Compounds,"2,3-bis(mesitylseleno)propenol",0
6066,Organoselenium Compounds,1-isopropyl-3-methylbenzimidazole-2-selenone,0
6067,Organoselenium Compounds,"1,3-di-p-methoxybenzylpyrimidine-2-selenone",0
6068,Organoselenium Compounds,4'-selenouridine,0
6069,Organoselenium Compounds,4'-selenocytidine,0
6070,Organoselenium Compounds,p-methoxy-diphenyl diselenide,0
6071,Organoselenium Compounds,ethaselen-1,0
6072,Organoselenium Compounds,5-benzyloxy-2-selenocyanataomethyl-4-pyranone,0
6073,Organoselenium Compounds,5-methoxy-2-selenocyanatomethyl-4-pyranone,0
6074,RNA-Binding Proteins,"mbl-1 protein, C elegans",0
6075,RNA-Binding Proteins,"Xmas-2 protein, Drosophila",0
6076,RNA-Binding Proteins,"CSDC2 protein, human",0
6077,RNA-Binding Proteins,"MOEP19 protein, mouse",0
6078,RNA-Binding Proteins,"Luc7L2 protein, mouse",0
6079,RNA-Binding Proteins,"ZC3HAV1 protein, human",0
6080,RNA-Binding Proteins,"Pet54 protein, S cerevisiae",0
6081,RNA-Binding Proteins,"Mbnl2 protein, mouse",0
6082,RNA-Binding Proteins,"swm protein, Drosophila",0
6083,RNA-Binding Proteins,"LARP-1 protein, C elegans",0
6084,RNA-Binding Proteins,"RBM28 protein, human",0
6085,RNA-Binding Proteins,"ZFP36L3 protein, mouse",0
6086,RNA-Binding Proteins,"NRDE-3 protein, C elegans",0
6087,Bacterial Capsules,"capsular polysaccharide, Streptococcus suis type 2",0
6088,Bacterial Capsules,"capsular polysaccharide, streptococcal group B type II",0
6089,Bacterial Capsules,"capsular polysaccharide, meningococcal group B",0
6090,Bacterial Capsules,capsular polysaccharide K14,0
6091,Bacterial Capsules,Haemophilus influenzae type b polysaccharide vaccine,0
6092,Bacterial Capsules,"capsular polysaccharide, type 10, Klebsiella",0
6093,Bacterial Capsules,"capsular polysaccharide, type 2, Klebsiella",0
6094,Bacterial Capsules,capsular polysaccharide K12,0
6095,Bacterial Capsules,capsular polysaccharide K92,0
6096,Bacterial Capsules,capsular polysaccharide K5,0
6097,Bacterial Capsules,capsular polysaccharide K7,0
6098,Bacterial Capsules,capsular polysaccharide K74,0
6099,Bacterial Capsules,capsular polysaccharide K22,0
6100,Bacterial Capsules,"capsular polysaccharide type 6, Actinobacillus pleuropneumoniae",0
6101,Bacterial Capsules,capsular polysaccharide type 21b,0
6102,Bacterial Capsules,capsular polysaccharide K4,0
6103,Bacterial Capsules,"capsular polysaccharide, type 8, Staphylococcus aureus",0
6104,Bacterial Capsules,capsular polysaccharide K49,0
6105,Bacterial Capsules,"capsular polysaccharide, klebsiella k15",0
6106,Bacterial Capsules,"capsular polysaccharide, streptoccal group B type V",0
6107,Bacterial Capsules,"capsular polysaccharide type 7, Actinobacillus pleuropneumoniae",0
6108,Bacterial Capsules,capsular polysaccharide K2,0
6109,Bacterial Capsules,capsular polysaccharide K38,0
6110,Bacterial Capsules,capsular polysaccharide K98,0
6111,Bacterial Capsules,"K10 capsular antigen, E coli",0
6112,Bacterial Capsules,capsular polysaccharide K96,0
6113,Bacterial Capsules,"K48 capsular polysaccharide, Escherichia coli",0
6114,Bacterial Capsules,capsular polysaccharide K3,0
6115,Bacterial Capsules,group B streptococcal type Ia capsular polysaccharide-tetanus toxoid vaccine,0
6116,Bacterial Capsules,group B streptococcal type Ib capsular polysaccharide-tetanus toxoid vaccine,0
6117,Bacterial Capsules,group B streptococcal type III capsular polysaccharide-tetanus toxoid vaccine,0
6118,Bacterial Capsules,capsular polysaccharide 35A,0
6119,Bacterial Capsules,capsular polysaccharide 19F,0
6120,Bacterial Capsules,capsular polysaccharide 33F,0
6121,Bacterial Capsules,"type 3 capsular polysaccharide, Streptococcus pneumoniae",0
6122,Bacterial Capsules,"capsular polysaccharide, Bacteroides vulgatus",0
6123,Bacterial Capsules,capsular polysaccharide K24,0
6124,Bacterial Capsules,"capsular polysaccharide, haemophilus influenzae type C",0
6125,Bacterial Capsules,"capsular polysaccharide, haemophilus influenzae type F",0
6126,Bacterial Capsules,"capsular polysaccharide, Streptococcus pneumoniae type 15B",0
6127,alpha-beta T-Cell Receptor,"T cell receptor Vbeta6, human",0
6128,glycosyltransferase,"MltF protein, E coli",0
6129,glycosyltransferase,"BUS-8 protein, C elegans",0
6130,Synapsins,"SYN3 protein, human",0
6131,Human Platelet Antigens,"HPA-8bw antigen, human",0
6132,CD8 Antigens,"Cd8b1 protein, mouse",0
6133,Levonorgestrel,lybrel,0
6134,Protein Tyrosine Phosphatase,"prostatic acid phosphatase (248-286), human",0
6135,Protein Tyrosine Phosphatase,"Ptp2 protein, S cerevisiae",0
6136,Protein Tyrosine Phosphatase,"Siw14 protein, S cerevisiae",0
6137,Dentin-Bonding Agents,rebilda DC,0
6138,Annexins,technetium 99m HYNIC-annexin B1,0
6139,Hepatitis B Vaccines,hepatitis B vaccine AS04,0
6140,Protein-Serine-Threonine Kinases,"target of rapamycin protein, S cerevisiae",0
6141,Protein-Serine-Threonine Kinases,"fray protein, Drosophila",0
6142,Protein-Serine-Threonine Kinases,"VRK3 protein, rat",0
6143,Protein-Serine-Threonine Kinases,"HIPK4 protein, human",0
6144,Protein-Serine-Threonine Kinases,"ERN1 protein, Xenopus",0
6145,Protein-Serine-Threonine Kinases,"gck-3 protein, C elegans",0
6146,Protein-Serine-Threonine Kinases,"YeaG protein, E coli",0
6147,Protein-Serine-Threonine Kinases,"ERN1 protein, human",0
6148,Protein-Serine-Threonine Kinases,"RP2 protein, Arabidopsis",0
6149,Protein-Serine-Threonine Kinases,"EIF2AK4 protein, human",0
6150,Protein-Serine-Threonine Kinases,"Tssk2 protein, mouse",0
6151,Protein-Serine-Threonine Kinases,"Tssk4 protein, mouse",0
6152,Protein-Serine-Threonine Kinases,"Plk2 protein, rat",0
6153,N-Acetylglucosaminyltransferases,"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3",0
6154,N-Acetylglucosaminyltransferases,"B3gnt1 protein, mouse",0
6155,"Ribonucleoprotein, U1 Small Nuclear","CG7564 protein, Drosophila",0
6156,"Ribonucleoprotein, U1 Small Nuclear","Snu56 protein, S cerevisiae",0
6157,"Receptors, Opioid, delta","OPRD1 protein, human",0
6158,Fibroblast Growth Factor Receptors,"fibroblast growth factor-21 receptor, mouse",0
6159,"Receptors, Interleukin-1","ST2L protein, mouse",0
6160,"Receptors, Opioid, kappa","Ro1 protein, mouse",0
6161,"Chlorine Compounds, Inorganic",trichloronitritodiammineplatinum(IV),0
6162,Aluminum Compounds,calcium sulfoaluminate,0
6163,"Calcium Compounds, Inorganic",calcium sulfoaluminate,0
6164,Connexins,"pannexin 1, rat",0
6165,Connexins,"pannexin 2, rat",0
6166,Connexins,"Panx1 protein, mouse",0
6167,Connexins,"Cx36.7 protein, zebrafish",0
6168,Connexins,"pannexin 3 protein, mouse",0
6169,Organosilicon Compounds,"O(6)-allyl-3',5'-di-O-(tert-butyldimethylsilyl)-2'-deoxyguanosine",0
6170,"Silicon Compounds, Inorganic","1,2,3,4,5-hexaphenylsilole",0
6171,"Platinum Compounds, Inorganic",trichloronitritodiammineplatinum(IV),0
6172,Lignans,manassantin A,0
6173,Lignans,rabdosiin,0
6174,Lignans,helioxanthin,0
6175,Lignans,eupomatilone 7,0
6176,Lignans,herpetone,0
6177,Lignans,"(2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone",0
6178,Lignans,"3,3',5,5'-tetramethoxy-4,4'-dihydroxy-7,9'-7',9-diepoxylignan-4-O-glucopyranoside",0
6179,Lignans,Piper cubeba extract,0
6180,Lignans,neojusticin C,0
6181,Lignans,procumbenoside D,0
6182,Lignans,procumbenoside C,0
6183,Lignans,acanthoside D,0
6184,Lignans,forsythialan A,0
6185,Lignans,forsythialan B,0
6186,Lignans,binankadsurin A,0
6187,Lignans,acutissimalignan A,0
6188,Lignans,acutissimalignan B,0
6189,Lignans,neglschisandrin A,0
6190,Lignans,neglschisandrin B,0
6191,Lignans,pinoresinol 4-O-glucopyranoside,0
6192,Acid Anhydride Hydrolases,"RppH protein, E coli",0
6193,Malaria Vaccines,MSP1(42)-FVO alhydrogel vaccine,0
6194,Malaria Vaccines,MSP1(42)-3D7 alhydrogel vaccine,0
6195,Phosphotransferases (Alcohol Group Acceptor),"PIP5K4 protein, Arabidopsis",0
6196,Phosphotransferases (Alcohol Group Acceptor),"AlsK protein, E coli",0
6197,Phosphotransferases (Alcohol Group Acceptor),"Trpt1 protein, mouse",0
6198,Phosphotransferases (Alcohol Group Acceptor),"THI22 protein, S cerevisiae",0
6199,Phosphotransferases (Alcohol Group Acceptor),"PNKP protein, human",0
6200,Phosphotransferases (Alcohol Group Acceptor),"CerkL protein, mouse",0
6201,Cyclic GMP-Dependent Protein Kinases,"for protein, Drosophila",0
6202,Immediate-Early Proteins,"US1 protein, human herpesvirus 2",0
6203,Isothiocyanates,3-morpholinopropyl isothiocyanate,0
6204,antiporter,"NHA2 protein, mouse",0
6205,antiporter,"NHA2 protein, human",0
6206,Sodium-Hydrogen Antiporter,"PBO-4 protein, C elegans",0
6207,Sodium-Hydrogen Antiporter,"PBO-5 protein, C elegans",0
6208,Isocyanates,"2,4,6-tribromophenyl isocyanate",0
6209,Isocyanates,7-methyl-indole ethyl isothiocyanate,0
6210,Epithelial Component Present,Stage IA Vulvar Carcinoma AJCC v6,1
6211,Adnexal Differentiation,Malignant Apocrine Neoplasm,1
6212,Epithelial Component Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
6213,Benign Cellular Infiltrate,Hemangioma of intra-abdominal structure,1
6214,Malignant Cellular Infiltrate,Hereditary Prostate Carcinoma,1
6215,Epithelial Component Present,Neuroendocrine Tumors,1
6216,Childhood Lesion,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
6217,Epithelial Component Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
6218,Radial Growth Phase,Stage III Superficial Spreading Melanoma AJCC v7,1
6219,Neuroendocrine Differentiation,Ovarian Carcinoid Tumor,1
6220,Mixed Cellular Population,Recurrent Ovarian Carcinosarcoma,1
6221,Childhood Lesion,Childhood Bladder Carcinoma,1
6222,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
6223,Benign Cellular Infiltrate,Deep Lipoma,1
6224,Benign Cellular Infiltrate,Aldosterone-Producing Adrenal Cortex Adenoma,1
6225,Carcinomatous Component Present,Adenoid cystic carcinoma of oropharynx,1
6226,Neuroendocrine Differentiation,Stage III Merkel Cell Carcinoma AJCC v7,1
6227,Perineural spread,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
6228,Follicular Cell Differentiation,Follicular thyroid carcinoma,1
6229,Secondary Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,1
6230,Neuroendocrine Differentiation,Digestive System Small Cell Neuroendocrine Carcinoma,1
6231,Regional Disease,Locally Advanced Unresectable Sarcoma,1
6232,Malignant Cellular Infiltrate,Malignant Leptomeningeal Neoplasm,1
6233,Exophytic Polypoid Lesion,Colon adenoma,1
6234,Childhood Lesion,Pediatric Extraocular Retinoblastoma,1
6235,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
6236,High Grade Lesion,Fusion-Positive Alveolar Rhabdomyosarcoma,1
6237,Malignant Cellular Infiltrate,Splenic Lymphoblastic Lymphoma,1
6238,HMB-45-Positive Neoplastic Cells Present,Benign Uterine Corpus PEComa,1
6239,Carcinomatous Component Present,Adenoid cystic carcinoma of submandibular gland,1
6240,Slow Growing Mass,Recurrent Olfactory Neuroblastoma,1
6241,Mitotic Activity,Recurrent Childhood Glioblastoma,1
6242,Increased Cellularity Present,Anaplastic astrocytoma,1
6243,Epithelial Component Present,Appendix Tubular Adenoma,1
6244,Capsular Invasion,"Thymoma, type B1, malignant",1
6245,Fibrotic Stroma Formation,Tubulocystic renal cell carcinoma,1
6246,Refractory Disease,Refractory Small Intestinal Carcinoma,1
6247,Epithelial Component Present,Locally Advanced Head and Neck Carcinoma,1
6248,Malignant Cellular Infiltrate,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
6249,Nodular lesions,Thyroid Gland Hyperfunctioning Adenoma,1
6250,Malignant Germinomatous Cellular Infiltrate,germinoma of brain,1
6251,Infiltrative Growth Pattern,Refractory Glioblastoma,1
6252,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
6253,Stromal Invasion,Malignant Ovarian Mucinous Tumor,1
6254,Cutaneous Involvement,Eccrine porocarcinoma,1
6255,Papillary Pattern,Bladder Papillary Urothelial Carcinoma,1
6256,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,1
6257,Epithelial Component Present,Parotid Gland Acinic Cell Carcinoma,1
6258,Epithelial Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma,1
6259,Pseudoglandular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
6260,Benign Cellular Infiltrate,Hidradenoma Papilliferum,1
6261,Malignant Cellular Infiltrate,Bartholin Gland Adenocarcinoma,1
6262,Carcinomatous Component Present,Metastatic Penile Cancer,1
6263,Malignant Cellular Infiltrate,Non-small cell lung cancer stage I,1
6264,Primary Lesion,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
6265,Borderline Lesion,"Endometrioid adenoma, borderline malignancy",1
6266,Sarcomatous Component Present,Carcinosarcoma of ovary,1
6267,Lymphoplasmacytic Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
6268,Macrofollicular Structures Present,Macrofollicular adenoma,1
6269,Epithelial Component Present,Colorectal Signet Ring Cell Carcinoma,1
6270,Neuroendocrine Differentiation,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
6271,Carcinomatous Component Present,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
6272,Carcinomatous Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6273,Secondary Lesion,Adenocarcinoma of the prostate metastatic,1
6274,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
6275,Well Differentiated Neuroendocrine Lesion,Stage I Digestive System Neuroendocrine Tumor AJCC v7,1
6276,Papillary Pattern,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,1
6277,Vascular Channel Formation,Angiomatosis,1
6278,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor G2,1
6279,Childhood Lesion,Childhood Germinomatous Germ Cell Tumor,1
6280,Human Papillomavirus Negative,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
6281,Pregnancy Complications,Placenta Previa,1
6282,Clinical TNM Finding,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
6283,Papillary Pattern,Bladder Papillary Clear Cell Adenocarcinoma,1
6284,Malignant Cellular Infiltrate,Stage II Esophageal Cancer AJCC v7,1
6285,Epithelial Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
6286,Neuroendocrine Differentiation,Neuroendocrine neoplasm of appendix,1
6287,Epithelial Component Present,Adenomatous polyp of colon,1
6288,Refractory Disease,Platinum-Resistant Primary Peritoneal Carcinoma,1
6289,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,1
6290,Primary Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
6291,Malignant Cellular Infiltrate,Mediastinal T Acute Lymphoblastic Leukemia,1
6292,Epithelial Component Present,Squamous cell carcinoma of conjunctiva,1
6293,Malignant Cellular Infiltrate,Stage IIIA Uveal Melanoma AJCC v7,1
6294,Diffuse Pattern,Stage II Adult Immunoblastic Lymphoma,1
6295,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
6296,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v8 Stage,1
6297,Epithelial Component Present,Adenocarcinoma,1
6298,Exophytic Polypoid Lesion,Frontal sinus polyp,1
6299,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v8 Stage,1
6300,Malignant Cellular Infiltrate,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
6301,Carcinomatous Component Present,Gastric Pylorus Carcinoma,1
6302,Epithelial Component Present,Grade 1 Clear Cell Renal Cell Carcinoma,1
6303,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
6304,Recurrent disease,Recurrent Childhood Brain Stem Astrocytoma,1
6305,Recurrent disease,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
6306,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
6307,Adnexal Differentiation,Dermal Duct Tumor,1
6308,Malignant Cellular Infiltrate,Rectosigmoid Adenocarcinoma,1
6309,Fibrosis,Primary mediastinal large B-cell lymphoma stage II,1
6310,Well Differentiated Neuroendocrine Lesion,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
6311,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
6312,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
6313,Slow Growing Mass,Cellular Ependymoma,1
6314,Exophytic Polypoid Lesion,Esophageal Spindle Cell Carcinoma,1
6315,Carcinomatous Component Present,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6316,Mast Cells 10 Percent or More of Peripheral Blood White Cells,"Leukemia, Mast-Cell",1
6317,Hemorrhagic,Adult Angiosarcoma,1
6318,Stromal Invasion,Low Grade Ovarian Serous Adenocarcinoma,1
6319,Hereditary Lesion,Myeloid Neoplasms with Germline GATA2 Mutation,1
6320,Epithelial Component Present,Stage III Colorectal Cancer AJCC v7,1
6321,Epithelial Component Present,Borderline Resectable Carcinoma,1
6322,Recurrent disease,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
6323,Cystic Change,Adenolymphoma,1
6324,Malignant Cellular Infiltrate,Mature B-Cell Non-Hodgkin Lymphoma,1
6325,Epithelial Component Present,Locally Advanced Bile Duct Carcinoma,1
6326,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
6327,Epithelial Component Present,Metanephric Tumor,1
6328,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
6329,Low Mitotic Activity,Pancreatic Vipoma,1
6330,Low Mitotic Activity,Malignant Pancreatic Vipoma,1
6331,Malignant Cellular Infiltrate,sarcoma of small intestine,1
6332,Malignant Cellular Infiltrate,sarcoma of esophagus,1
6333,Aggressive Clinical Course,Childhood Burkitt Leukemia,1
6334,Epithelial Component Present,Stage IIB Eyelid Carcinoma AJCC v8,1
6335,Benign Cellular Infiltrate,Verrucous keratotic hemangioma,1
6336,Infiltrative Growth Pattern,"Anaplastic Astrocytoma, IDH-Mutant",1
6337,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma,1
6338,Epithelial Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
6339,More than 5 Mitoses per 50HPF,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
6340,Malignant Cellular Infiltrate,Histiocytoid Breast Carcinoma,1
6341,Epithelial Component Present,Recurrent Fibrolamellar Carcinoma,1
6342,Malignant Cellular Infiltrate,fibrosarcoma of soft tissue,1
6343,Dysplasia,Small Intestinal High Grade Intraepithelial Neoplasia,1
6344,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Brain,1
6345,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
6346,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,de novo Myelodysplastic Syndrome,1
6347,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Carcinoma,1
6348,Indolent Clinical Course,Lung Myolipoma,1
6349,Epithelial Component Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
6350,Secondary Lesion,Metastatic Oral Cavity Carcinoma,1
6351,Pathologic TNM Finding,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
6352,Malignant Cellular Infiltrate,Choriocarcinoma combined with other germ cell elements,1
6353,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of spleen,1
6354,Low Mitotic Activity,Pancreatic Vipoma,1
6355,Cavernous Vascular Space Formation,Intracranial cavernous hemangioma,1
6356,Childhood Lesion,childhood nasal type extranodal NK/T-cell lymphoma,1
6357,Perineural spread,Adenoid cystic carcinoma of the oral cavity recurrent,1
6358,Cutaneous Involvement,Unresectable Head and Neck Squamous Cell Carcinoma,1
6359,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
6360,Carcinomatous Component Present,"Adenocarcinoma, endocervical type",1
6361,Malignant Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v7,1
6362,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
6363,Malignant Cellular Infiltrate,"Squamous cell carcinoma, metastatic",1
6364,Malignant Cellular Infiltrate,Krukenberg Tumor,1
6365,Epithelial Component Present,Rectal Small Cell Neuroendocrine Carcinoma,1
6366,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
6367,Vascular proliferation,"Castleman Disease, Hyaline-Vascular Type",1
6368,Well Differentiated Neuroendocrine Lesion,"Glucagonoma, malignant",1
6369,Malignant Cellular Infiltrate,Adult T Acute Lymphoblastic Leukemia,1
6370,Carcinomatous Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7,1
6371,Carcinomatous Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
6372,Acinar Cell Differentiation,Pancreatic Acinar Cell Cystadenoma,1
6373,Epithelial Component Present,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6374,Epithelial Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
6375,Epithelial Component Present,Serous cystadenocarcinoma of pancreas,1
6376,Malignant Cellular Infiltrate,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",1
6377,Well-Circumscribed Lesion,Benign Prostate Phyllodes Tumor,1
6378,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v7,1
6379,Mixture of Germ Cell Neoplastic Components Present,Central Nervous System Mixed Germ Cell Tumor,1
6380,Indolent Clinical Course,Myxoma,1
6381,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
6382,Malignant Cellular Infiltrate,Stage II Lip Basal Cell Carcinoma,1
6383,Osseous Differentiation,Osteosarcoma recurrent,1
6384,Primary Lesion,Primary Peritoneal Cancer by AJCC v7 Stage,1
6385,Extraosseous Lesion,Peripheral Odontogenic Fibroma,1
6386,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
6387,Hyperplastic Tissue Present,Prostatic Atypical Adenomatous Hyperplasia,1
6388,Increased Cellularity Present,Neuroblastoma,1
6389,Cervical lymphadenopathy,Sinus histiocytosis,1
6390,Childhood Lesion,Childhood Cerebellar Astrocytoma,1
6391,Epithelial Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7,1
6392,Malignant Cellular Infiltrate,Bartholin Gland Adenosquamous Carcinoma,1
6393,Epithelial Component Present,Stage IIIA Bladder Cancer AJCC v8,1
6394,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type stage IV,1
6395,Monomorphic Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
6396,Epithelial Component Present,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,1
6397,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to brain,1
6398,Carcinomatous Component Present,Recurrent Salivary Gland Cancer,1
6399,Chromogranin A Positive Neoplastic Cells Present,Strumal carcinoid,1
6400,Carcinomatous Component Present,Stage IB Lung Cancer AJCC v7,1
6401,Well-Circumscribed Lesion,Anaplastic Kidney Wilms Tumor,1
6402,Malignant Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v8,1
6403,Indolent Clinical Course,calcifying aponeurotic fibroma,1
6404,Mixed Cellular Population,Combined Lung Large Cell Neuroendocrine Carcinoma,1
6405,Multinodular Mass,Angiosarcoma of spleen,1
6406,Recurrent disease,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
6407,Epithelial Component Present,Stage IV Merkel Cell Carcinoma AJCC v7,1
6408,Poorly Differentiated Lesion,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
6409,Multinodular Mass,Angiosarcoma NCI Grade 3,1
6410,Carcinomatous Component Present,Stage 0 Rectal Cancer AJCC v8,1
6411,Unclassifiable Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
6412,Malignant Cellular Infiltrate,Proximal Urethral Carcinoma,1
6413,Neuroendocrine Differentiation,Nasopharyngeal Paraganglioma,1
6414,Carcinomatous Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
6415,Therapy-Related Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
6416,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
6417,"Undifferentiated ""Fetal-Type"" Tissues Present",Central Nervous System Immature Teratoma,1
6418,Dysplasia,Small Intestinal Tubulovillous Adenoma,1
6419,Malignant Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
6420,Villous Pattern,Tubulovillous adenoma,1
6421,Slow Growing Mass,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
6422,Malignant Cellular Infiltrate,Endometrial Squamous Cell Carcinoma,1
6423,Pushing Tumor Margin,Anal Verrucous Carcinoma,1
6424,Absence of Stromal Invasion,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
6425,Epithelial Component Present,Biochemically Recurrent Prostate Carcinoma,1
6426,Severe dysplasia,Intraductal Cribriform Breast Adenocarcinoma,1
6427,Cutaneous Involvement,Psoriasiform eczema,1
6428,Invasive Lesion,Invasive carcinoma of breast,1
6429,Malignant Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant",1
6430,Epithelial Component Present,Colorectal Neuroendocrine Neoplasm,1
6431,Multinodular Mass,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
6432,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
6433,Malignant Cellular Infiltrate,Adenocarcinoma of ampulla of Vater,1
6434,Carcinomatous Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
6435,Local disease,Fibrolipoma,1
6436,Epithelial Component Present,Cervical Serous Adenocarcinoma,1
6437,Immunologic Deficiency Syndromes,AIDS-Related Vulvovaginal Candidiasis,1
6438,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ureter,1
6439,Malignant Cellular Infiltrate,Sellar Chordoma,1
6440,Carcinomatous Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
6441,Mixture of Germ Cell Neoplastic Components Present,Adult Central Nervous System Mixed Germ Cell Tumor,1
6442,Well-Circumscribed Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
6443,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v8,1
6444,Carcinomatous Component Present,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
6445,Cystic Change,Recurrent Malignant Ovarian Brenner Tumor,1
6446,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
6447,Malignant Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone,1
6448,Malignant Cellular Infiltrate,Malignant Skeletal Muscle Neoplasm,1
6449,Follicular Cell Differentiation,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
6450,Resectable Mass,Hepatoblastoma resectable,1
6451,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
6452,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
6453,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage IV,1
6454,Malignant Cellular Infiltrate,AIDS-Related Malignant Cervical Neoplasm,1
6455,Solid Growth Pattern,"Invasive Lobular Breast Carcinoma, Solid Variant",1
6456,Malignant Cellular Infiltrate,Gastric Intestinal-Type Adenocarcinoma,1
6457,Indolent Clinical Course,benign neoplasm of lower jaw bone,1
6458,Adulthood Lesion,Localized Non-Resectable Adult Liver Carcinoma,1
6459,High Grade Lesion,Recurrent Childhood Giant Cell Glioblastoma,1
6460,Benign Cellular Infiltrate,Ganglioneuroma of skin,1
6461,Neuropil Present,Poorly Differentiated Neuroblastoma,1
6462,Malignant Cellular Infiltrate,Stage IIA Uveal Melanoma AJCC v7,1
6463,Epithelial Component Present,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
6464,Dysplasia,"Glandular intraepithelial neoplasia, grade III",1
6465,Cystic Lesion,Papillary craniopharyngioma,1
6466,Neuroendocrine Differentiation,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,1
6467,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
6468,Microvascular Proliferation,Adult Brain Stem Gliosarcoma,1
6469,Carcinomatous Component Present,Stage I Laryngeal Cancer AJCC v6 and v7,1
6470,Metastatic Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,1
6471,Adnexal Differentiation,Primary Cutaneous Mucinous Carcinoma,1
6472,Adnexal Differentiation,Syringoma,1
6473,Indolent Clinical Course,Uterine Corpus Adenofibroma,1
6474,Malignant Cellular Infiltrate,Metastatic Ureter Carcinoma,1
6475,Squamous metaplasia of bladder,Metastatic Bladder Squamous Cell Carcinoma,1
6476,Single Cell Necrosis,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
6477,Immunologic Deficiency Syndromes,AIDS-Related Human Papillomavirus Infection,1
6478,Mixed Cellular Population,Ovarian mixed epithelial carcinoma,1
6479,Malignant Cellular Infiltrate,Stage IIC Cutaneous Melanoma AJCC v6 and v7,1
6480,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v6,1
6481,Childhood Lesion,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,1
6482,Neuroendocrine Differentiation,Extra-Adrenal Paraganglioma,1
6483,Intracanalicular Growth Pattern,"Phyllodes tumor, benign",1
6484,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma recurrent,1
6485,Exophytic Polypoid Lesion,Fibrous polyp,1
6486,Malignant Cellular Infiltrate,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
6487,Intraocular Lesion,Recurrent Primary Vitreoretinal Lymphoma,1
6488,Malignant Cellular Infiltrate,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
6489,Cutaneous Involvement,Vulvar Keratoacanthoma,1
6490,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",1
6491,Carcinomatous Component Present,carcinoma of eye,1
6492,Well-Circumscribed Lesion,Refractory Myxoid Liposarcoma,1
6493,Papillary Pattern,Vestibular Micropapillomatosis,1
6494,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation,1
6495,Malignant Cellular Infiltrate,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
6496,Epithelial Component Present,Papillary Lung Adenocarcinoma,1
6497,Malignant Cellular Infiltrate,Stage II Adult Burkitt Lymphoma,1
6498,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
6499,No Identifiable Line of Differentiation,"Undifferentiated Sarcoma, Not Otherwise Specified",1
6500,Carcinomatous Component Present,Gastric Cardia Adenocarcinoma,1
6501,Hereditary Lesion,Gardner Syndrome,1
6502,Malignant Cellular Infiltrate,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
6503,Absence of Stromal Invasion,Borderline Fallopian Tube Endometrioid Tumor,1
6504,Schwannian Stroma More than 50 Percent of the Tumor Volume,malignant ganglioneuroblastoma of adrenal gland,1
6505,Malignant Cellular Infiltrate,Metastatic Signet Ring Cell Breast Carcinoma,1
6506,Necrotic changes (finding),Small cell carcinoma of the cervix,1
6507,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",1
6508,Malignant Cellular Infiltrate,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
6509,Malignant Cellular Infiltrate,Macrotrabecular Hepatoblastoma,1
6510,Dermal Involvement,Vaginal Blue Nevus,1
6511,Epithelial Component Present,Cystadenocarcinoma of pancreas,1
6512,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
6513,Immunosuppression-Related Post-Transplant Toxicity,Acute humoral allograft nephropathy,1
6514,No Evidence of Hormonal Immunoreactivity Present,Pituitary Gland Oncocytic Adenoma,1
6515,Epithelial Component Present,Clear cell adenoma,1
6516,Malignant Cellular Infiltrate,Invasive carcinoma of breast,1
6517,Malignant Cellular Infiltrate,Endometrial Stromal Sarcoma,1
6518,Nuclear Pseudoinclusion,Childhood Thyroid Gland Papillary Carcinoma,1
6519,Solitary mass,Locally Advanced Epithelioid Hemangioendothelioma,1
6520,Intermediate Filaments Present,Recurrent Rhabdoid Tumor,1
6521,Monomorphic Cellular Infiltrate,Skin Basaloid Carcinoma,1
6522,Malignant Cellular Infiltrate,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
6523,Fibromyxoid Stroma Formation,Nonossifying Fibromyxoid Tumor,1
6524,Childhood Lesion,Childhood Ependymal Tumor,1
6525,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
6526,Extraocular Dissemination of Disease,Ocular Melanoma with Extraocular Extension,1
6527,Microinvasive tumor,Borderline Ovarian Serous Tumor with Microinvasion,1
6528,Malignant Cellular Infiltrate,Esophageal Well Differentiated Squamous Cell Carcinoma,1
6529,Cutaneous Involvement,Lentigo maligna melanoma,1
6530,Cutaneous Involvement,melanoma of scrotum,1
6531,Necrotic changes (finding),Bartholin Gland Small Cell Carcinoma,1
6532,Carcinomatous Component Present,Tracheal Carcinoma,1
6533,Cutaneous Involvement,Epidermolysis Bullosa,1
6534,Thin-Walled Branching Vascular Pattern,Thymus Solitary Fibrous Tumor,1
6535,Cutaneous Involvement,Vulvar Adenocarcinoma of Sweat Gland Type,1
6536,Papillary Pattern,Multicentric Thyroid Gland Papillary Carcinoma,1
6537,Childhood Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
6538,Vascular Channel Formation,Adult Angiosarcoma,1
6539,Biphasic Pattern,Cystadenofibroma of fallopian tube,1
6540,Dysplasia,Colonic tubulovillous adenoma,1
6541,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia,1
6542,Cystic Change,"Papillary cystadenoma, borderline malignancy",1
6543,Carcinomatous Component Present,Mucoepidermoid Carcinoma,1
6544,Epithelial Component Present,Colorectal Sessile Serrated Adenoma/Polyp,1
6545,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
6546,Nuclear Atypia,Brain Glioblastoma,1
6547,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma,1
6548,Well Differentiated Neuroendocrine Lesion,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
6549,Malignant Cellular Infiltrate,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,1
6550,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
6551,Mesenchymal Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
6552,Perineural spread,Lipomatosis of Nerve,1
6553,Benign Cellular Infiltrate,Benign tumor of penis,1
6554,Peripheral Nuclear Palisading,Platinum-Sensitive Lung Small Cell Carcinoma,1
6555,Epithelial Component Present,Apudoma,1
6556,Metastatic Lesion,Metastatic Gastric Carcinoma,1
6557,Exophytic Polypoid Lesion,Colorectal Sessile Serrated Adenoma/Polyp,1
6558,Therapy-Related Toxicity,Transplant-Related Kaposi Sarcoma,1
6559,Cutaneous Involvement,Skin appendage adenoma,1
6560,Benign Cellular Infiltrate,Mediastinal Rhabdomyoma,1
6561,Malignant Cellular Infiltrate,Secondary malignant neoplasm of liver,1
6562,Carcinomatous Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
6563,Malignant Cellular Infiltrate,Lymphoma of colon,1
6564,Complex Glandular Pattern,Uterine Corpus Atypical Polypoid Adenomyoma,1
6565,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
6566,Indolent Clinical Course,Intravenous leiomyomatosis,1
6567,Secondary Lesion,Locally Advanced Angiosarcoma,1
6568,Epithelial Component Present,Typical Ovarian Thecoma,1
6569,Multilayered Rosette Formation,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
6570,Malignant Cellular Infiltrate,Vulvar Sebaceous Carcinoma,1
6571,Neuroendocrine Differentiation,Well Differentiated Pancreatic Endocrine Tumor,1
6572,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
6573,Mesenchymal Component Present,Pleomorphic adenoma of lacrimal gland,1
6574,High Grade Lesion,Brain Stem Glioblastoma,1
6575,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer,1
6576,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",1
6577,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma,1
6578,Infiltrative Growth Pattern,Collecting Duct Carcinoma of the Kidney,1
6579,Epithelial Component Present,Stage IVB Basal Cell Lip Carcinoma,1
6580,Histiocytosis haematophagic,Recurrent Hemophagocytic Lymphohistiocytosis,1
6581,Malignant Cellular Infiltrate,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
6582,Benign Cellular Infiltrate,Pulmonary Sclerosing Hemangioma,1
6583,Lytic lesion,Osteoclastic Giant Cell-Rich Tumor of Bone,1
6584,Epithelial Component Present,Vulvar Adenocarcinoma of Mammary Gland Type,1
6585,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type C",1
6586,Favorable Clinical Outcome,Cutaneous Mastocytosis,1
6587,Epithelial Component Present,Stage I Ureter Cancer AJCC v8,1
6588,Mixed Cellular Population,Malignant Parotid Gland Mixed Tumor,1
6589,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v6 and v7,1
6590,Metastatic Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,1
6591,Delicate Vascular Network Formation,Recurrent Clear Cell Renal Cell Carcinoma,1
6592,Primary Lesion,Primary peritoneal carcinoma,1
6593,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v8,1
6594,Childhood Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
6595,Malignant Cellular Infiltrate,Stage II Vulvar Cancer AJCC v8,1
6596,Exophytic Polypoid Lesion,tubulopapillary adenoma of extrahepatic bile duct,1
6597,Malignant Cellular Infiltrate,Stage IIIA Cervical Cancer AJCC v8,1
6598,Carcinomatous Component Present,Malignant neoplasm of stomach stage IV,1
6599,'Starry-sky' pattern,Burkitt's tumor of spleen,1
6600,Epidermal Involvement,Hidroacanthoma simplex,1
6601,Neuroendocrine Differentiation,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
6602,Pathologic TNM Finding,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6603,Carcinomatous Component Present,Stage III Anal Cancer AJCC v8,1
6604,Biphasic Pattern,Uterine Corpus Carcinosarcoma,1
6605,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v6,1
6606,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
6607,Chronic Inflammatory Infiltrate,Histiocytoma,1
6608,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage III,1
6609,Malignant Cellular Infiltrate,Stage III Colorectal Cancer AJCC v7,1
6610,Primary Lesion,BCLC Stage D Hepatocellular Carcinoma,1
6611,Varicosity,Infective Phlebitis,1
6612,Epithelial Component Present,Preinvasive Neoplasm of the Ampullary Region,1
6613,Childhood Lesion,Childhood Recurrent Malignant Solid Neoplasm,1
6614,Childhood Lesion,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,1
6615,Thin-Walled Branching Vascular Pattern,Infiltrating angiolipoma,1
6616,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia,1
6617,Malignant Cellular Infiltrate,Sarcoma by AJCC Grade,1
6618,Metastatic Lesion,Mesothelioma malignant advanced,1
6619,Apocrine Differentiation,Carcinoma of apocrine gland,1
6620,Cutaneous Involvement,Eyelid Sebaceous Gland Carcinoma,1
6621,Epithelial Component Present,Human Papillomavirus-Related Adenosquamous Carcinoma,1
6622,Secondary Lesion,Colon Carcinoma Metastatic in the Liver,1
6623,Malignant Cellular Infiltrate,Stage IA Lung Cancer AJCC v7,1
6624,Dysplasia,Colorectal Adenoma with Moderate Dysplasia,1
6625,Recurrent Genetic Abnormalities Present,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,1
6626,Malignant Cellular Infiltrate,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
6627,Epithelial Component Present,Prognostic Stage IIB Breast Cancer AJCC v8,1
6628,Malignant Cellular Infiltrate,Malignant Outer Hair Sheath and Infundibulum Neoplasm,1
6629,Malignant Cellular Infiltrate,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
6630,Geographic Necrosis,Sellar Embryonal Carcinoma,1
6631,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic",1
6632,Malignant Cellular Infiltrate,Locally Advanced Gastrointestinal Stromal Tumor,1
6633,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm,1
6634,Carcinomatous Component Present,Hereditary Papillary Renal Carcinoma,1
6635,Malignant Cellular Infiltrate,Mantle cell lymphoma stage IV,1
6636,Carcinomatous Component Present,squamous cell carcinoma of ovary,1
6637,Tissue Differentiation Uncertain,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
6638,Refractory Disease,Refractory Neuroblastoma,1
6639,Trabecular Pattern,"Adenoma, Trabecular",1
6640,Carcinomatous Component Present,Nasopharyngeal cancer recurrent,1
6641,Epithelial Component Present,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
6642,Malignant Cellular Infiltrate,Choroid Epithelioid Cell Melanoma,1
6643,Infiltrating Tumor Margins Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
6644,Epithelial Component Present,Anatomic Stage IIB Breast Cancer AJCC v8,1
6645,Carcinomatous Component Present,Metastatic Lung Adenocarcinoma,1
6646,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",1
6647,Neuroendocrine Differentiation,small cell carcinoma of gallbladder,1
6648,Exophytic Papillary Lesion,Condylomata Acuminata,1
6649,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
6650,Carcinomatous Component Present,Seminal Vesicle Adenocarcinoma,1
6651,Mild cytologic atypia,Laryngeal verrucous carcinoma recurrent,1
6652,Carcinomatous Component Present,Pathologic Stage IA Gastric Cancer AJCC v8,1
6653,Slow Growing Mass,olfactory neuroblastoma of nasal cavity,1
6654,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic-Phase",1
6655,Low Mitotic Activity,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
6656,Carcinomatous Component Present,"Carcinoma, diffuse type",1
6657,Indolent Clinical Course,Cardiac Intramuscular Hemangioma,1
6658,Epithelial Component Present,Platinum-Resistant Primary Peritoneal Carcinoma,1
6659,Severe cytologic atypia,Digestive System Large Cell Neuroendocrine Carcinoma,1
6660,Epithelial Component Present,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
6661,Primary Lesion,Well Differentiated Hepatocellular Carcinoma,1
6662,Locally Aggressive Lesion,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,1
6663,Childhood Lesion,Stage I Childhood Anaplastic Large Cell Lymphoma,1
6664,In Situ Lesion,Stage 0 Oropharyngeal Carcinoma,1
6665,Malignant Cellular Infiltrate,"Bronchiolo-alveolar carcinoma, non-mucinous",1
6666,Slow Growing Mass,Ependymoma,1
6667,High Mitotic Activity,large cell neuroendocrine carcinoma of bladder,1
6668,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
6669,Metastatic Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
6670,Less than 2 Mitoses per 10HPF,Thymic Typical Carcinoid Tumor,1
6671,Malignant Cellular Infiltrate,Primary Cutaneous Hodgkin Lymphoma,1
6672,Adulthood Lesion,Stage IIB Adult Soft Tissue Sarcoma AJCC v7,1
6673,Invasive Lesion,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
6674,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
6675,Anaplasia,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
6676,Absence of Invasion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
6677,Malignant Cellular Infiltrate,Fetal Lung Adenocarcinoma,1
6678,Ineffective hematopoiesis,Refractory anaemia with excess blasts,1
6679,Epithelial Component Present,Advanced Prostate Adenocarcinoma,1
6680,Malignant Cellular Infiltrate,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
6681,Well-Circumscribed Lesion,Syringocystadenoma Papilliferum,1
6682,Increased Cellularity Present,Childhood Brain Anaplastic Astrocytoma,1
6683,Benign Cellular Infiltrate,benign neoplasm of lower jaw bone,1
6684,Microvascular Proliferation,Glioblastoma multiforme of spinal cord,1
6685,Epithelial Component Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
6686,Exophytic Polypoid Lesion,Esophageal Spindle Cell Carcinoma,1
6687,Epithelial Component Present,Stage II Ampulla of Vater Cancer AJCC v7,1
6688,Severe dysplasia,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
6689,Malignant Cellular Infiltrate,Metastatic hepatocellular carcinoma,1
6690,Exophytic Polypoid Lesion,Juvenile polyp,1
6691,Malignant Cellular Infiltrate,Vulvar adenocarcinoma,1
6692,Microvascular Proliferation,Cerebral Glioblastoma,1
6693,Malignant Cellular Infiltrate,Recurrent T-Cell Prolymphocytic Leukemia,1
6694,Epithelial Component Present,Mixed germ cell-sex cord-stromal tumor,1
6695,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,1
6696,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
6697,Cellular Pleomorphism,Malignant Testicular Sex Cord-Stromal Tumor,1
6698,Malignant Cellular Infiltrate,Burkitt Lymphoma by Ann Arbor Stage,1
6699,Carcinomatous Component Present,Collecting Duct Carcinoma of the Kidney,1
6700,Acantholysis,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
6701,Absence of Invasion,Stage 0 Oropharyngeal Carcinoma,1
6702,Hereditary Lesion,Glucagon Cell Hyperplasia and Neoplasia,1
6703,Epithelial Component Present,Adamantinoma,1
6704,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,1
6705,Compartmentalized Pattern,Senile Sebaceous Hyperplasia,1
6706,Mixed Cellular Population,Anal Ectopic Fibroadenoma,1
6707,Carcinomatous Component Present,Metaplastic carcinoma of breast,1
6708,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma,1
6709,Carcinomatous Component Present,Transitional cell carcinoma of bladder,1
6710,Local disease,Vulvar Fibrolipoma,1
6711,Cutaneous Involvement,Malignant Outer Hair Sheath and Infundibulum Neoplasm,1
6712,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
6713,Epithelial Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
6714,Malignant Cellular Infiltrate,Small cell lung cancer recurrent,1
6715,Epithelial Component Present,Childhood Lung Small Cell Carcinoma,1
6716,Immunologic Deficiency Syndromes,Transplant-Related Hematologic Malignancy,1
6717,Carcinomatous Component Present,Gallbladder Cribriform Carcinoma,1
6718,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma,1
6719,Epithelial Component Present,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
6720,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
6721,Malignant Cellular Infiltrate,Malignant tumor of iris,1
6722,Carcinomatous Component Present,Paget Disease of the Scrotum,1
6723,Locally Aggressive Lesion,Polymorphus Hemangioendothelioma,1
6724,Malignant Cellular Infiltrate,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
6725,Epithelial Component Present,Stage II Distal Bile Duct Cancer AJCC v8,1
6726,Acute inflammation,Acute lymphadenitis,1
6727,Carcinomatous Component Present,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
6728,Carcinomatous Component Present,Stage IIIB Lung Cancer AJCC v8,1
6729,Malignant Cellular Infiltrate,Acral Lentiginous Malignant Melanoma,1
6730,Mixed Cellular Population,"Mixed Tumor, Not Otherwise Specified",1
6731,Epithelial Component Present,Wolffian tumor,1
6732,Carcinomatous Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
6733,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
6734,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
6735,Benign Cellular Infiltrate,Benign Infratentorial Neoplasms,1
6736,Epithelial Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
6737,Mitotic Activity,Proneural Glioblastoma,1
6738,Poorly Differentiated Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma,1
6739,Primary Lesion,Adult Brain Stem Glioma,1
6740,Malignant Component Present,"Struma ovarii, malignant",1
6741,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
6742,Carcinomatous Component Present,Metastatic Oropharyngeal Carcinoma,1
6743,Carcinomatous Component Present,"Carcinoma, Ovarian Epithelial",1
6744,Recurrent disease,Recurrent Primary Lymphoma of Bone,1
6745,In Situ Lesion,Intraductal carcinoma and lobular carcinoma in situ,1
6746,Malignant Cellular Infiltrate,Recurrent Malignant Head and Neck Neoplasm,1
6747,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
6748,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor G1,1
6749,Oligodendroglial Component Present,Oligodendroglial Neoplasm,1
6750,Cutaneous Involvement,Cutaneous Mastocytosis,1
6751,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
6752,Dysplasia,Colorectal Tubular Adenoma,1
6753,Malignant Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
6754,Secondary Lesion,Locally Advanced Melanoma,1
6755,Malignant Cellular Infiltrate,Stage IS Testicular Cancer AJCC v6 and v7,1
6756,Well Differentiated Neuroendocrine Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,1
6757,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1,1
6758,Exophytic Polypoid Lesion,Rectal polyp,1
6759,Malignant Cellular Infiltrate,Mediastinal Angiosarcoma,1
6760,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v7,1
6761,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
6762,Dysplasia,High Grade Glandular Intraepithelial Neoplasia,1
6763,Malignant Cellular Infiltrate,Bile duct mucinous adenocarcinoma,1
6764,Multinodular Mass,Metastatic Dermatofibrosarcoma Protuberans,1
6765,Cutaneous Involvement,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
6766,Low Grade Lesion,Grade I Chondrosarcoma,1
6767,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v7,1
6768,Vascular Channel Formation,Malignant Blood Vessel Neoplasm,1
6769,Epithelial Component Present,"Thymoma, type AB",1
6770,Epithelial Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
6771,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma,1
6772,Absence of Invasion,Carcinoma in situ of prostate,1
6773,Benign Cellular Infiltrate,Benign neoplasm of sweat gland,1
6774,Epithelial Component Present,Urothelial carcinoma ureter recurrent,1
6775,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1A,1
6776,Metastatic Lesion,Metastatic thymic carcinoma,1
6777,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
6778,Carcinomatous Component Present,Conventional (Clear Cell) Renal Cell Carcinoma,1
6779,Blasts of Mixed Phenotype Present,Acute bilineal leukemia,1
6780,Metastatic Lesion,Secondary Cerebral Hodgkin Lymphoma,1
6781,Fibrotic Stroma Formation,High Grade Mucoepidermoid Breast Carcinoma,1
6782,Low Grade Lesion,Low Grade Broad Ligament Serous Adenocarcinoma,1
6783,Dysplasia,High Grade Gastric Intraepithelial Neoplasia,1
6784,Adulthood Lesion,Indolent Adult Non-Hodgkin Lymphoma,1
6785,Resectable Mass,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
6786,Epithelial Component Present,Childhood Thyroid Gland Medullary Carcinoma,1
6787,Malignant Cellular Infiltrate,ENSAT Stage III Adrenal Cortex Carcinoma,1
6788,Metaplasia,Bladder squamous cell carcinoma stage I,1
6789,Carcinomatous Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8,1
6790,"Fully Differentiated ""Adult-Type"" Tissues Present",Malignant teratoma of testis,1
6791,Epithelial Component Present,Cervical Adenosquamous Carcinoma,1
6792,Indolent Clinical Course,"Odontogenic tumor, benign",1
6793,Epithelial Component Present,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
6794,High Mitotic Activity,Stage I Lung Small Cell Carcinoma AJCC v7,1
6795,Rapidly Enlarging Mass,Cranial Nodular Fasciitis,1
6796,Storiform Growth Pattern,Malignant fibrous histiocytoma metastatic,1
6797,Carcinomatous Component Present,Papillary squamous cell carcinoma,1
6798,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus,1
6799,Epithelial Component Present,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
6800,Malignant Cellular Infiltrate,Stage IA Adult Soft Tissue Sarcoma AJCC v7,1
6801,Carcinomatous Component Present,undifferentiated carcinoma of extrahepatic bile duct,1
6802,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
6803,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
6804,Carcinomatous Component Present,Small cell neuroendocrine carcinoma of bladder,1
6805,Neuroendocrine Differentiation,Neuroendocrine neoplasm of gallbladder,1
6806,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
6807,Microvascular Proliferation,Adult Brain Glioblastoma,1
6808,Carcinomatous Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
6809,Epithelial Component Present,Posterior Pharyngeal Wall Carcinoma,1
6810,Epithelial Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
6811,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
6812,Necrotic changes (finding),Glioblastoma by Gene Expression Profile,1
6813,Benign Cellular Infiltrate,Infantile hemangioma,1
6814,Malignant Cellular Infiltrate,Prostate Sarcoma,1
6815,Carcinomatous Component Present,Maxillary Sinus Squamous Cell Carcinoma,1
6816,Malignant Cellular Infiltrate,ROSE Cluster 1,1
6817,Epithelial Component Present,Neuroendocrine neoplasm of lung,1
6818,Malignant Cellular Infiltrate,Small intestine carcinoma,1
6819,Metastatic Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
6820,Malignant Cellular Infiltrate,Childhood Periosteal Osteosarcoma,1
6821,CD1a-Positive Neoplastic Cells Present,Eosinophilic Granuloma,1
6822,Well Differentiated Neuroendocrine Lesion,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
6823,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
6824,Malignant Cellular Infiltrate,Hereditary Leiomyomatosis and Renal Cell Cancer,1
6825,Epithelial Component Present,Stage II Breast Cancer AJCC v6 and v7,1
6826,Local disease,Localized Lymphoma,1
6827,Infiltrative Growth Pattern,Adult Glioblastoma,1
6828,Malignant Cellular Infiltrate,polyembryoma of ovary,1
6829,Carcinomatous Component Present,Serous surface papillary carcinoma,1
6830,Infiltrative Growth Pattern,Glioblastoma by Gene Expression Profile,1
6831,Epithelial Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,1
6832,Recurrent disease,Recurrent Skin Angiosarcoma,1
6833,Malignant Cellular Infiltrate,Childhood Acute Monoblastic Leukemia,1
6834,Epithelial Component Present,Midgut Carcinoid Tumor,1
6835,Epithelial Component Present,"Cystadenocarcinoma, Papillary",1
6836,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2,1
6837,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1
6838,Malignant Cellular Infiltrate,Refractory Acute Leukemia,1
6839,Epithelial Component Present,Stage IIA Lung Cancer AJCC v7,1
6840,Stromal Invasion,Recurrent Ovarian Transitional Cell Carcinoma,1
6841,Focal dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
6842,Epithelial Component Present,Serous cystadenoma of pancreas,1
6843,Malignant Cellular Infiltrate,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
6844,Metastatic Lesion,Stage IV Laryngeal Carcinoma,1
6845,Malignant Cellular Infiltrate,Stage IV Laryngeal Carcinoma,1
6846,Concentric Perivascular Arrangement of Tumor Cells,Myopericytoma,1
6847,Hyperplastic Tissue Present,Complex endometrial hyperplasia without atypia,1
6848,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
6849,Malignant Cellular Infiltrate,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,1
6850,Benign Cellular Infiltrate,Mediastinal Chondroma,1
6851,Peripheral Nuclear Palisading,Small cell carcinoma of lung,1
6852,Osseous Differentiation,Osteoma,1
6853,Childhood Lesion,Recurrent Childhood Optic Nerve Astrocytoma,1
6854,Metastatic Lesion,Metastatic Malignant Neoplasm in the Adult Brain,1
6855,Absence of Stromal Invasion,Borderline epithelial tumor of ovary,1
6856,Carcinomatous Component Present,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
6857,Primary Lesion,Recurrent Kidney Wilms Tumor,1
6858,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
6859,Absence of Basal Cell Layer,Prostate Acinar Adenocarcinoma,1
6860,Koilocytotic atypia,Cervical Papillary Squamous Cell Carcinoma,1
6861,Anaplasia,Anaplastic Hemispheric Astrocytoma,1
6862,Diffuse Pattern,Giant Cell Glioblastoma,1
6863,More than 10 Mitoses per 10HPF,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
6864,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
6865,Malignant Cellular Infiltrate,Tonsillar Undifferentiated Carcinoma,1
6866,Malignant Cellular Infiltrate,Locally Advanced Skin Squamous Cell Carcinoma,1
6867,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v7,1
6868,Indolent Clinical Course,"Lipomatosis, Multiple Symmetrical",1
6869,Malignant Cellular Infiltrate,Metastatic Oral Cavity Carcinoma,1
6870,Epithelial Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v7,1
6871,Non-Invasive Lesion,Stage 0a Bladder Cancer AJCC v8,1
6872,Cambium Layer,Botryoid-Type Embryonal Rhabdomyosarcoma,1
6873,Epithelial Component Present,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
6874,Malignant Cellular Infiltrate,Vaginal Mucinous Adenocarcinoma,1
6875,Solitary Skin Tumor,Skin Mastocytoma,1
6876,Storiform Growth Pattern,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
6877,Well Differentiated Neuroendocrine Lesion,Regional Digestive System Neuroendocrine Tumor G1,1
6878,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
6879,Epithelial Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
6880,Capillary Sized Vascular Channel Formation,Trichodiscoma,1
6881,Moderate dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
6882,Recurrent disease,Recurrent Adult Immunoblastic Lymphoma,1
6883,Benign Cellular Infiltrate,Spindle cell nevus of Reed,1
6884,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Vipoma,1
6885,Malignant Cellular Infiltrate,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma,1
6886,Questionable Invasive Lesion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
6887,Epithelial Component Present,"Extra-adrenal paraganglioma, malignant",1
6888,Primary Lesion,"Occipital Lobe, Parietal Lobe, and Ventricular Ependymal Tumor",1
6889,Benign Cellular Infiltrate,Childhood Craniopharyngioma,1
6890,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
6891,Epithelial Component Present,Stage II Adult Liver Cancer AJCC v7,1
6892,Epithelial Component Present,malignant neoplasm of large intestine stage IV,1
6893,Mesenchymal Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
6894,Pregnancy Complications,Morbidly adherent placenta (disorder),1
6895,Malignant Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia,1
6896,Absence of Invasion,Carcinoma in situ of small intestine,1
6897,Benign Cellular Infiltrate,Benign neoplasm of spleen,1
6898,Epithelial Component Present,Thecoma,1
6899,Dentin formation,Ameloblastic fibrodentinoma,1
6900,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2a,1
6901,Encapsulated Mass,Thyroid Gland Mucinous Follicular Adenoma,1
6902,Malignant Cellular Infiltrate,alveolar rhabdomyosarcoma of orbit,1
6903,Epithelial Component Present,Advanced Cervical Adenocarcinoma,1
6904,Epithelial Component Present,Refractory Malignant Endocrine Neoplasm,1
6905,In Situ Lesion,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
6906,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v7,1
6907,Malignant Cellular Infiltrate,Squamous cell carcinoma of skin,1
6908,Peau d'orange surface of breast,Inflammatory carcinoma of breast stage III,1
6909,Secondary Lesion,Advanced Renal Cell Carcinoma,1
6910,Dysplasia,High grade cervical glandular intraepithelial neoplasia,1
6911,Nuclear Molding,Stage IA Lung Small Cell Carcinoma AJCC v7,1
6912,Malignant Cellular Infiltrate,"Neuroectodermal Tumor, Primitive",1
6913,Absence of Invasion,Stage 0 Colorectal Cancer AJCC v8,1
6914,Epithelial Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
6915,Pathologic TNM Finding,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
6916,Epithelial Component Present,Parotid Gland Undifferentiated Carcinoma,1
6917,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
6918,Carcinomatous Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
6919,Malignant Cellular Infiltrate,undifferentiated carcinoma of ureter,1
6920,Congenital Lesion,GIANT PIGMENTED HAIRY NEVUS,1
6921,Osseous Component Present,Bizarre parosteal osteochondromatous proliferation,1
6922,Pregnancy Complications,"Pregnancy, Ovarian",1
6923,Epithelial Component Present,Mild esophageal dysplasia,1
6924,Well Differentiated Lesion,Vaginal Papillary Carcinoma,1
6925,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
6926,Epithelial Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
6927,Epithelioid Differentiation,"Epithelioid mesothelioma, malignant",1
6928,Mixed Cellular Population,mucinous adenocarcinofibroma of ovary,1
6929,Epithelial Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx,1
6930,Carcinomatous Component Present,Renal Pelvis and Ureter Urothelial Carcinoma,1
6931,Endobronchial Lesion,Lung Mixed Squamous Cell and Glandular Papilloma,1
6932,One Germ Layer Present,Monodermal Testicular Teratoma,1
6933,Metaplasia,Nephrogenic metaplasia,1
6934,Metastatic Lesion,Adenocarcinoma of the prostate metastatic,1
6935,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Lipoleiomyoma,1
6936,Malignant Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
6937,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones,1
6938,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v8,1
6939,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa,1
6940,Epithelial Component Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma,1
6941,Abundant Intracytoplasmic Lipofuscin Present,Heavily Pigmented Adrenal Cortical Adenoma,1
6942,More than 10 Mitoses per 10HPF,Stage II Lung Small Cell Carcinoma AJCC v7,1
6943,Primary Lesion,Periosteal Osteosarcoma,1
6944,Recurrent disease,Recurrent Male Reproductive System Carcinoma,1
6945,Malignant Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v7,1
6946,Epithelial Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
6947,Malignant Cellular Infiltrate,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7,1
6948,Malignant Cellular Infiltrate,sarcoma of penis,1
6949,Epithelial Component Present,Small Intestinal Mucinous Adenocarcinoma,1
6950,Monomorphic Cellular Infiltrate,Adult Oligodendroglioma,1
6951,Benign Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma,1
6952,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
6953,Refractory Disease,Refractory Adrenal Gland Pheochromocytoma,1
6954,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
6955,Recurrent Lymphoma,Grade III Lymphomatoid Granulomatosis,1
6956,Primary Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
6957,Tumor Droplets Present,Adenoameloblastoma,1
6958,Well-Circumscribed Lesion,Juvenile Polyp of the Small Intestine,1
6959,Cervical Glandular Dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
6960,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor,1
6961,Carcinomatous Component Present,Childhood Choroid Plexus Carcinoma,1
6962,Malignant Cellular Infiltrate,clear cell adenocarcinoma of gallbladder,1
6963,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Hypocellular Myelodysplastic Syndrome,1
6964,Hyaline Cartilage Differentiation,Secondary Chondrosarcoma,1
6965,Carcinomatous Component Present,Grade 2 Endometrial Mucinous Adenocarcinoma,1
6966,Immunologic Deficiency Syndromes,Immunodeficiency-Associated Lymphoproliferative Disorder,1
6967,Adulthood Lesion,Lugano Classification Stage IV Adult Lymphoma AJCC v8,1
6968,Mesenchymal Differentiation,"Transitional cell carcinoma, spindle cell",1
6969,Carcinomatous Component Present,Stage IVA Vaginal Cancer AJCC v6 and v7,1
6970,Acinar Cell Differentiation,Pancreatic Acinar Cell Neoplasm,1
6971,Malignant Cellular Infiltrate,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
6972,Well Differentiated Neuroendocrine Lesion,Gastric Gastrin-Producing Neuroendocrine Tumor,1
6973,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8,1
6974,Carcinomatous Component Present,Cervical Papillary Squamous Cell Carcinoma,1
6975,Ulcer,Esophageal Neuroendocrine Tumor G2,1
6976,Carcinomatous Component Present,Pharyngeal Carcinoma,1
6977,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage I,1
6978,Epithelial Component Present,Stage IVB Lung Cancer AJCC v8,1
6979,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
6980,Malignant Cellular Infiltrate,Posterior Tongue Adenoid Cystic Carcinoma,1
6981,Mixed Cellular Population,Mixed Neoplasm,1
6982,Epithelial Component Present,Thecoma,1
6983,Malignant Cellular Infiltrate,Adenocarcinoma in situ in tubular adenoma,1
6984,Malignant Cellular Infiltrate,undifferentiated carcinoma of anal canal,1
6985,Stromal Invasion,Ovarian epithelial cancer stage II,1
6986,Malignant Cellular Infiltrate,Stage III Adult Hodgkin Lymphoma,1
6987,Vascular Channel Formation,Cardiac hemangioma,1
6988,Epithelial Component Present,Recurrent Parathyroid Gland Carcinoma,1
6989,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v6,1
6990,Malignant Cellular Infiltrate,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
6991,Malignant Cellular Infiltrate,Squamous cell carcinoma of pharynx,1
6992,Immunologic Deficiency Syndromes,AIDS-Related Cryptococcosis,1
6993,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7,1
6994,Solid Growth Pattern,Breast Solid Neuroendocrine Carcinoma,1
6995,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
6996,Malignant Cellular Infiltrate,Malignant neoplasm of major salivary gland,1
6997,Whorling Growth Pattern,Transitional Meningioma,1
6998,Metastatic Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
6999,Childhood Lesion,Recurrent Childhood Liver Cancer,1
7000,Carcinomatous Component Present,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
7001,Absence of Invasion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
7002,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
7003,Whorling Growth Pattern,Transitional Meningioma,1
7004,Malignant Cellular Infiltrate,Sarcomatoid Renal Cell Carcinoma,1
7005,Carcinomatous Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
7006,Epithelial Component Present,Peripheral Breast Papilloma,1
7007,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,1
7008,Severe cytologic atypia,Recurrent Pancreatic Neuroendocrine Carcinoma,1
7009,Follicular Cell Differentiation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
7010,Epithelial Component Present,Stage I Esophageal Cancer AJCC v7,1
7011,Epithelial Component Present,Papillary serous cystadenocarcinoma,1
7012,Juvenile Lesion,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,1
7013,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Indolent multiple myeloma,1
7014,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),1
7015,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v8,1
7016,Diffuse Cellular Infiltrate,Lymphoid interstitial pneumonia,1
7017,Hereditary Lesion,BRCA2 Syndrome,1
7018,White blood cell count increased (lab result),"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
7019,Malignant Cellular Infiltrate,Stage IVB Lung Cancer AJCC v8,1
7020,Precise Histogenesis Unknown,Neoplasm of Uncertain Histogenesis,1
7021,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Soft Tissue Amyloid Neoplasm,1
7022,Epithelial Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant",1
7023,Malignant Cellular Infiltrate,Metastases to adrenals,1
7024,Carcinomatous Component Present,"Glandular intraepithelial neoplasia, grade III",1
7025,Benign Cellular Infiltrate,Ganglioneuroma of skin,1
7026,Malignant Cellular Infiltrate,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,1
7027,Malignant Cellular Infiltrate,Inflammatory Leiomyosarcoma,1
7028,Epithelial Component Present,Triple-Negative Breast Carcinoma,1
7029,Adulthood Lesion,Adult Oligodendroglial Tumor,1
7030,Epithelial Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
7031,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
7032,Carcinomatous Component Present,Stage IV Skin Cancer,1
7033,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
7034,Epithelial Component Present,Stage IIIA Colon Cancer AJCC v7,1
7035,Carcinomatous Component Present,Stage II Distal Bile Duct Cancer AJCC v8,1
7036,Indolent Clinical Course,Breast Epithelioid Hemangioma,1
7037,Malignant Cellular Infiltrate,Cardiac Malignant Peripheral Nerve Sheath Tumor,1
7038,Intermediate Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2,1
7039,Monomorphic Cellular Infiltrate,Childhood Brain Oligodendroglioma,1
7040,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
7041,Malignant Cellular Infiltrate,ROSE Cluster 3,1
7042,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
7043,Malignant Cellular Infiltrate,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1
7044,Cutaneous Involvement,Dermatologic disorders,1
7045,Primary Lesion,Recurrent Gliosarcoma,1
7046,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma recurrent,1
7047,Pathologic TNM Finding,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7048,Thick-Walled Vessels Present,Hepatic Angiomyolipoma,1
7049,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Adenocarcinoma,1
7050,Cutaneous Involvement,"Dermatitis, Irritant",1
7051,Follicular Structures Present,Microfollicular adenoma,1
7052,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
7053,Benign Cellular Infiltrate,Hybrid nerve sheath tumor,1
7054,Slow Growing Mass,Acral Fibromyxoma,1
7055,Severe dysplasia,Stage 0 Ampulla of Vater Cancer AJCC v8,1
7056,Carcinomatous Component Present,Nonencapsulated sclerosing tumor,1
7057,Malignant Cellular Infiltrate,Adrenal neuroblastoma,1
7058,Carcinomatous Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
7059,Severe dysplasia,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
7060,Non-Malignant Cellular Infiltrate,Lymphadenitis,1
7061,Benign Cellular Infiltrate,Benign neoplasm of oral cavity,1
7062,Malignant Cellular Infiltrate,Myxoid/Round Cell Liposarcoma,1
7063,Secondary Lesion,Metastatic Vaginal Carcinoma,1
7064,Carcinomatous Component Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma,1
7065,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of extrahepatic bile duct,1
7066,Encapsulated Mass,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,1
7067,Unresectable Mass,Unresectable Sarcoma,1
7068,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia,1
7069,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia with Eosinophilia,1
7070,Metastatic Lesion,Metastatic Breast Carcinoma,1
7071,Carcinomatous Component Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
7072,Cutaneous Involvement,Acanthosis Nigricans,1
7073,Recurrent disease,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
7074,Malignant Cellular Infiltrate,Adrenal Cancer,1
7075,Malignant Cellular Infiltrate,Refractory anemia with excess blasts I,1
7076,Benign Cellular Infiltrate,Mediastinal Chondroma,1
7077,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
7078,Minimal Invasion Present,"Bronchiolo-alveolar carcinoma, non-mucinous",1
7079,Unresectable Mass,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
7080,Carcinomatous Component Present,Small intestine carcinoma recurrent,1
7081,Carcinomatous Component Present,Basal cell carcinoma - follicular,1
7082,Epithelial Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8,1
7083,Malignant Cellular Infiltrate,Recurrent Kidney Wilms Tumor,1
7084,Malignant Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
7085,Carcinomatous Component Present,adenocarcinoma of ureter,1
7086,Cribriform Pattern,Rectal Cribriform Comedo-Type Adenocarcinoma,1
7087,Concentric Aggregates of Intermediate Filaments Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
7088,Neuroendocrine Differentiation,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
7089,Epithelial Component Present,Vulvar Cancer by AJCC v7 Stage,1
7090,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Wildtype",1
7091,"Fully Differentiated ""Adult-Type"" Tissues Present",Malignant teratoma of testis,1
7092,Malignant Cellular Infiltrate,"Acute myeloid leukemia, minimal differentiation",1
7093,Carcinomatous Component Present,Transplant-Related Bladder Urothelial Carcinoma,1
7094,Stromal Invasion,Stage IIIC Ovarian Cancer AJCC v8,1
7095,Neoplastic Cells with TFH Cell Phenotype Present,Follicular T-cell lymphoma,1
7096,Malignant Cellular Infiltrate,Locally Advanced Unresectable Bone Sarcoma,1
7097,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer AJCC v6,1
7098,Epithelial Component Present,Stage I Rectal Cancer AJCC v8,1
7099,Metastatic Lesion,Advanced Sarcoma,1
7100,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
7101,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v6,1
7102,Locally Aggressive Lesion,Desmoplastic fibroma,1
7103,Monomorphic Cellular Infiltrate,Adult Ependymoma,1
7104,Low Mitotic Activity,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
7105,Malignant Cellular Infiltrate,"NK-Cell Lymphoma, Unclassifiable",1
7106,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of spleen,1
7107,Carcinomatous Component Present,Stage IVB Vaginal Cancer AJCC v8,1
7108,Epithelial Component Present,Grade 2 Clear Cell Renal Cell Carcinoma,1
7109,Malignant Cellular Infiltrate,Cardiac Biphasic Synovial Sarcoma,1
7110,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
7111,Epithelial Component Present,Fibroadenoma of breast,1
7112,Malignant Cellular Infiltrate,Stage IIIC Uveal Melanoma AJCC v7,1
7113,Mitotic Activity,Recurrent Giant Cell Glioblastoma,1
7114,Benign Cellular Infiltrate,Pleural Schwannoma,1
7115,Local disease,Osteosarcoma localised,1
7116,Metastatic Lesion,Colon Carcinoma Metastatic in the Lung,1
7117,Carcinomatous Component Present,Infiltrating Urothelial Carcinoma,1
7118,Tubular Pattern,Tubulovillous adenoma,1
7119,Malignant Cellular Infiltrate,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
7120,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
7121,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v8,1
7122,Well-Circumscribed Lesion,Colorectal Traditional Serrated Adenoma,1
7123,Epithelial Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
7124,Childhood Lesion,Recurrent Childhood Cerebellar Astrocytoma,1
7125,Secondary Lesion,Vaginal adenocarcinoma metastatic,1
7126,Primitive Mesenchymal Stroma Formation,Pulmonary Blastoma,1
7127,Anaplasia,MGMT-Unmethylated Glioblastoma,1
7128,Epithelial Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,1
7129,Childhood Lesion,Pediatric Extraocular Retinoblastoma,1
7130,Mixed Cellular Population,Serous adenofibroma,1
7131,Benign Cellular Infiltrate,Deep Leiomyoma,1
7132,Necrotic changes (finding),Refractory Extensive Stage Lung Small Cell Carcinoma,1
7133,Adulthood Lesion,Adult Pleomorphic Hepatocellular Carcinoma,1
7134,Solitary mass,Sellar Chondroid Chordoma,1
7135,Diffuse Pattern,Grade III Lymphomatoid Granulomatosis,1
7136,More than 10 Mitoses per 10HPF,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
7137,Epithelial Component Present,Benign Breast Eccrine Spiradenoma,1
7138,Epithelial Component Present,Juvenile fibroadenoma of breast,1
7139,Carcinomatous Component Present,Stage III Intrahepatic Bile Duct Cancer AJCC v8,1
7140,Malignant Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v7,1
7141,Malignant Cellular Infiltrate,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
7142,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Colon,1
7143,Epithelial Component Present,Ovarian Sclerosing Stromal Tumor,1
7144,Malignant Cellular Infiltrate,Morpheic basal cell carcinoma,1
7145,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage 0,1
7146,Exophytic Polypoid Lesion,Rectal polyp,1
7147,Carcinomatous Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
7148,Vascular Channel Formation,Spindle cell hemangioma,1
7149,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage III,1
7150,Hyperkeratosis,Cervical Warty Carcinoma,1
7151,Pregnancy Complications,Clinical Chorioamnionitis,1
7152,Carcinomatous Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
7153,Malignant Cellular Infiltrate,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
7154,Primary Lesion,Primary Peritoneal High Grade Serous Adenocarcinoma,1
7155,Epithelial Component Present,Polymorphous low grade adenocarcinoma of salivary gland,1
7156,Vascular Channel Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
7157,Benign Cellular Infiltrate,Frontal Sinus Inverted Papilloma,1
7158,Well Differentiated Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1,1
7159,Fibrotic Stroma Formation,Ovarian Serous Adenofibroma,1
7160,In Situ Lesion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
7161,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
7162,Metastatic/Recurrent Disease,Vulvar Alveolar Soft Part Sarcoma,1
7163,Benign Cellular Infiltrate,Benign neoplasm of sebaceous gland,1
7164,Epithelial Component Present,Medullary carcinoma of breast,1
7165,Carcinomatous Component Present,External Ear Carcinoma,1
7166,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Stage,1
7167,Carcinomatous Component Present,Combined Lung Carcinoma,1
7168,Adnexal Differentiation,Malignant Vulvar Sweat Gland Neoplasm,1
7169,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia Not Otherwise Specified,1
7170,Rosenthal Fibers Present,Rosette-forming glioneuronal tumor of the fourth ventricle,1
7171,Benign Cellular Infiltrate,Respiratory papilloma,1
7172,Congenital Lesion,Small Congenital Melanocytic Nevus,1
7173,Malignant Cellular Infiltrate,Laryngeal squamous cell carcinoma recurrent,1
7174,Malignant Cellular Infiltrate,Stage II Breast Cancer AJCC v6 and v7,1
7175,Collagenous Stroma Formation,Sclerosing PEComa,1
7176,Malignant Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
7177,Malignant Cellular Infiltrate,Kaposi Sarcoma,1
7178,Carcinomatous Component Present,Resectable Pancreatic Ductal Adenocarcinoma,1
7179,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage III Plasma Cell Myeloma,1
7180,Primary Lesion,Alveolar soft part sarcoma non-metastatic,1
7181,Malignant Cellular Infiltrate,Advanced Digestive System Neuroendocrine Neoplasm,1
7182,Necrotic changes (finding),Colorectal Small Cell Neuroendocrine Carcinoma,1
7183,Epithelial Component Present,Pancreatic carcinoma resectable,1
7184,Firm mass,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
7185,Indolent Clinical Course,Solitary Adult Fibroma,1
7186,Primary Lesion,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
7187,Well Differentiated Neuroendocrine Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
7188,Recurrent disease,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
7189,Malignant Cellular Infiltrate,Stage IIA Distal Bile Duct Cancer AJCC v8,1
7190,Carcinomatous Component Present,Adenocarcinoma of anal canal,1
7191,Malignant Cellular Infiltrate,Adenocarcinoma in tubulovillous adenoma,1
7192,Osteoid formation,Liver Extraskeletal Osteosarcoma,1
7193,Malignant Cellular Infiltrate,Malignant neoplasm of ovary,1
7194,Cutaneous Involvement,Perifollicular fibroma,1
7195,Mixed Cellular Population,Cystadenofibroma of fallopian tube,1
7196,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma by AJCC v8 Stage,1
7197,Absence of Invasion,Carcinoma in situ of cecum,1
7198,Dysplasia,Cecum Villous Adenoma,1
7199,Neuroendocrine Differentiation,Intestinal Neuroendocrine Tumor,1
7200,Epithelial Component Present,Vulvar Neuroendocrine Carcinoma,1
7201,Non-Invasive Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
7202,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
7203,atypia morphology,Atypical hyperplasia of breast,1
7204,Malignant Cellular Infiltrate,Bladder Squamous Cell Carcinoma,1
7205,Indolent Clinical Course,Intramuscular Myxoma,1
7206,Hyaline Cartilage Differentiation,Grade I Chondrosarcoma,1
7207,High Mitotic Activity,Small cell carcinoma of lung,1
7208,Monocytosis,Refractory Chronic Myelomonocytic Leukemia,1
7209,Spindle Cell Component Present,Pleural Biphasic Synovial Sarcoma,1
7210,Malignant Cellular Infiltrate,Recurrent Adult Soft Tissue Sarcoma,1
7211,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage I,1
7212,Malignant Cellular Infiltrate,Melanoma recurrent,1
7213,Malignant Cellular Infiltrate,Serous cystadenocarcinoma ovary,1
7214,Carcinomatous Component Present,Stage IIIB Cervical Cancer AJCC v6 and v7,1
7215,Malignant Cellular Infiltrate,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
7216,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor,1
7217,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Tumor G1,1
7218,Biphasic Pattern,Benign Prostate Phyllodes Tumor,1
7219,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
7220,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage I,1
7221,Malignant Cellular Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v7,1
7222,Poorly Differentiated Lesion,Stage IB Lung Large Cell Carcinoma AJCC v7,1
7223,Benign Cellular Infiltrate,Benign Infratentorial Neoplasms,1
7224,Metastatic Lesion,Metastatic Lip Carcinoma,1
7225,Nuclear pleomorphism,Recurrent Salivary Duct Carcinoma,1
7226,Epithelial Component Present,Lung Lymphoepithelioma-Like Carcinoma,1
7227,Exophytic Polypoid Lesion,Polyp of gallbladder,1
7228,Monoclonal Cellular Population Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
7229,Exophytic Polypoid Lesion,Gingival fibroepithelial polyp,1
7230,Diffuse Pattern,Colon Diffuse Large B-Cell Lymphoma,1
7231,Carcinomatous Component Present,Fibroepithelioma of Pinkus,1
7232,Cystic Change,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
7233,Epithelial Component Present,Rectal Carcinoma,1
7234,Carcinomatous Component Present,Colon Cancer by AJCC v8 Stage,1
7235,High Grade Lesion,Frontal Lobe Anaplastic Astrocytoma,1
7236,Secondary Lesion,Metastatic Kidney Medullary Carcinoma,1
7237,Increased Cellularity Present,Familial Neuroblastoma,1
7238,Hydropic Villous Change,"Hydatidiform Mole, Invasive",1
7239,Hyperplastic Tissue Present,C-cell hyperplasia of thyroid,1
7240,Benign Cellular Infiltrate,Mucinous cystadenoma of ovary,1
7241,Hydropic Villous Change,"Hydatidiform Mole, Invasive",1
7242,Carcinomatous Component Present,Skin carcinoma,1
7243,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
7244,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v6 Stage,1
7245,Tissue of Mullerian Origin Present,Papillary adenofibroma,1
7246,Lymphoplasmacytic Infiltrate,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
7247,Malignant Cellular Infiltrate,Stage 1 Neuroblastoma,1
7248,Adulthood Lesion,Adult Unfavorable Prognosis Hodgkin Lymphoma,1
7249,Malignant Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
7250,Secondary Lesion,Metachronous Osteosarcoma,1
7251,Epithelial Component Present,Stage IV Bladder Cancer AJCC v8,1
7252,Malignant Cellular Infiltrate,Pharyngeal Carcinoma,1
7253,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7,1
7254,Epithelial Component Present,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1
7255,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
7256,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
7257,Cellular Stratification,Borderline Ovarian Mucinous Tumor,1
7258,Malignant Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v8,1
7259,Collagenous Stroma Formation,Mammary-Type Myofibroblastoma,1
7260,Malignant Cellular Infiltrate,Stage III Adult Lymphoblastic Lymphoma,1
7261,Exophytic Polypoid Lesion,Appendix Villous Adenoma,1
7262,Dermal Involvement,Cellular Blue Nevus,1
7263,Carcinomatous Component Present,Refractory Pancreatic Carcinoma,1
7264,Lymphoplasmacytic Infiltrate,HHV8-Positive Multicentric Castleman Disease,1
7265,Myxoid Stroma Formation,Cellular Myxoma,1
7266,Benign Cellular Infiltrate,Hidrocystoma,1
7267,Metastatic Lesion,Transitional cell carcinoma metastatic,1
7268,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
7269,Carcinomatous Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1
7270,Vascular Channel Formation,Chorioangioma,1
7271,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v6,1
7272,Epithelial Component Present,Vaginal Carcinosarcoma,1
7273,Cutaneous Involvement,Dermatophytosis of groin and perianal area,1
7274,Pseudostratified Columnar Tumor Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
7275,Lepidic Growth Pattern,"Bronchiolo-alveolar carcinoma, non-mucinous",1
7276,Undifferentiated Lesion,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
7277,Carcinomatous Component Present,Labia Majora Carcinoma,1
7278,Malignant Cellular Infiltrate,Childhood Undifferentiated Pleomorphic Sarcoma,1
7279,Metastatic Lesion,Pancreatic adenocarcinoma metastatic,1
7280,Epithelial Component Present,Breast Columnar Cell Mucinous Carcinoma,1
7281,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
7282,Carcinomatous Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
7283,Carcinomatous Component Present,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7,1
7284,Stromal Invasion,FIGO Stage IIIB Ovarian Cancer,1
7285,Carcinomatous Component Present,Hepatitis Virus-Related Hepatocellular Carcinoma,1
7286,Epithelial Component Present,Relapsed Hypopharynx Carcinoma,1
7287,Vascular proliferation,Giant Cell Tumor of Soft Tissue,1
7288,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of appendix,1
7289,Carcinomatous Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
7290,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia,1
7291,Secondary Lesion,Secondary malignant neoplasm of large intestine,1
7292,Lobulated Growth Pattern,Myxoma of the Endocardium,1
7293,Malignant Cellular Infiltrate,Malignant neoplasm of spleen,1
7294,Neuroendocrine Differentiation,Esophageal Large Cell Neuroendocrine Carcinoma,1
7295,Malignant Cellular Infiltrate,Resectable Digestive System Carcinoma,1
7296,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
7297,Epithelial Component Present,Retroperitoneal Carcinoma,1
7298,Epithelial Component Present,Stage IV Merkel Cell Carcinoma AJCC v7,1
7299,Epithelial Component Present,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
7300,Malignant Cellular Infiltrate,Glottic Squamous Cell Carcinoma,1
7301,Malignant Cellular Infiltrate,Stage IVC Pharyngeal Carcinoma,1
7302,Low Grade Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1,1
7303,Primary Lesion,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
7304,Necrotic changes (finding),small cell carcinoma of breast,1
7305,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage II,1
7306,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
7307,Benign Cellular Infiltrate,Lung Squamous Cell Papilloma,1
7308,Metastatic Lesion,Advanced Carcinoid Tumor,1
7309,Carcinomatous Component Present,Squamous cell carcinoma of mouth,1
7310,Metastatic/Recurrent Disease,Bladder Alveolar Soft Part Sarcoma,1
7311,Childhood Lesion,Congenital Mesoblastic Nephroma,1
7312,Malignant Germinomatous Cellular Infiltrate,Intracranial Germinoma,1
7313,Cutaneous Involvement,Precancerous Dermatitis,1
7314,Sarcomatous Component Present,Malignant phyllodes tumor of breast,1
7315,Slow Growing Mass,Hemangioblastoma,1
7316,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,1
7317,High Grade Lesion,Pericardial Synovial Sarcoma,1
7318,Resectable Mass,Borderline Resectable Pancreatic Carcinoma,1
7319,Exophytic Papillary Lesion,Vulvar Warty Carcinoma,1
7320,Epithelial Component Present,Aflatoxins-Related Hepatocellular Carcinoma,1
7321,Keratin pearl formation,keratinizing squamous cell carcinoma of nasal cavity,1
7322,Exophytic Polypoid Lesion,Pyloric Gland Adenoma,1
7323,Carcinomatous Component Present,Ductal Breast Carcinoma,1
7324,Epithelial Component Present,Intraepithelial Neoplasia in Barrett Esophagus,1
7325,Carcinomatous Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
7326,Malignant Cellular Infiltrate,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
7327,Epithelial Component Present,Locally Advanced Thymic Carcinoma,1
7328,Metastatic Lesion,Metastatic Soft Tissue Sarcoma,1
7329,Epithelial Component Present,Stage IV Renal Pelvis Cancer AJCC v7,1
7330,Well-Circumscribed Lesion,Small Intestinal Tubular Adenoma,1
7331,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma,1
7332,Malignant Cellular Infiltrate,High Grade Malignant Neoplasm,1
7333,Carcinomatous Component Present,Stage IIA Gallbladder Cancer AJCC v8,1
7334,Malignant Cellular Infiltrate,EBV-Related Carcinoma,1
7335,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8,1
7336,Malignant Cellular Infiltrate,Pancreatic adenocarcinoma resectable,1
7337,Antoni A Pattern,Sympathetic Schwannoma,1
7338,Carcinomatous Component Present,Large cell lung cancer stage II,1
7339,Malignant Cellular Infiltrate,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
7340,Lymphoplasmacytic Infiltrate,Undifferentiated carcinoma of nasopharynx,1
7341,Malignant Cellular Infiltrate,Major Salivary Gland Carcinoma,1
7342,Epithelial Component Present,Adenoma of the Colon with Intramucosal Adenocarcinoma,1
7343,Clinical TNM Finding,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
7344,Malignant Cellular Infiltrate,Esophageal Non-Hodgkin Lymphoma,1
7345,Carcinomatous Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
7346,Increased Cellularity Present,Cellular fibroma,1
7347,Fibrotic Stroma Formation,Resectable Pancreatic Ductal Adenocarcinoma,1
7348,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood,1
7349,Malignant Cellular Infiltrate,Recurrent Paget Disease of the Anal Canal,1
7350,Chronic lymphocytic inflammation,Micronodular thymoma with lymphoid stroma,1
7351,Chronic Inflammatory Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis,1
7352,High Mitotic Activity,"Perivascular epithelioid tumor, malignant",1
7353,Malignant Cellular Infiltrate,Testicular embryonal carcinoma,1
7354,Necrotic changes (finding),Adult Brain Glioblastoma,1
7355,Carcinomatous Component Present,Nasal cavity carcinoma,1
7356,Mild dysplasia,Low Grade Conjunctival Intraepithelial Neoplasia,1
7357,Osseous Differentiation,Stage II Osteosarcoma AJCC v7,1
7358,Epithelial Component Present,Locally Advanced Salivary Gland Carcinoma,1
7359,Epithelial Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
7360,Malignant Cellular Infiltrate,Bladder adenocarcinoma recurrent,1
7361,Malignant Cellular Infiltrate,Anaplastic Kidney Wilms Tumor,1
7362,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage II,1
7363,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
7364,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
7365,Malignant Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v7,1
7366,Carcinomatous Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v8,1
7367,Carcinomatous Component Present,Gallbladder adenocarcinoma,1
7368,Benign Cellular Infiltrate,Benign neoplasm of sweat gland,1
7369,Malignant Cellular Infiltrate,Malignant neoplasm of lacrimal duct,1
7370,Pregnancy Complications,Pre-Eclampsia,1
7371,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
7372,Epithelial Component Present,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
7373,Slow Growing Mass,Pineocytoma,1
7374,Desmoplastic Stroma Formation,Desmoplastic Nevus,1
7375,Malignant Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v8,1
7376,Cystic Change,Bile duct cystadenocarcinoma,1
7377,Multifocal Lesion,Multiple Lobular Capillary Hemangiomas,1
7378,Malignant Cellular Infiltrate,Stage IV Laryngeal Carcinoma,1
7379,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
7380,Indolent Clinical Course,Multiple Lobular Capillary Hemangiomas,1
7381,Extensive Stage Lesion,Advanced Carcinoma,1
7382,Epithelial Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
7383,Secondary Lesion,Metastatic Unresectable Basal Cell Carcinoma,1
7384,Malignant Cellular Infiltrate,CARCINOMA OF VULVA,1
7385,Well Differentiated Neuroendocrine Lesion,Stage I Gastric Neuroendocrine Tumor AJCC v8,1
7386,Mixed Cellular Population,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
7387,Fever,HHV8-Positive Multicentric Castleman Disease,1
7388,Adulthood Lesion,Adult Pineocytoma,1
7389,Capillary Sized Vascular Channel Formation,canalicular adenoma of salivary gland,1
7390,Childhood Lesion,Metastatic Childhood Soft Tissue Sarcoma,1
7391,Malignant Cellular Infiltrate,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
7392,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Germ Cell Tumor,1
7393,Malignant Cellular Infiltrate,AIDS-Related Anal Carcinoma,1
7394,Malignant Cellular Infiltrate,Recurrent Extrahepatic Bile Duct Carcinoma,1
7395,Carcinomatous Component Present,Bowen's Disease,1
7396,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
7397,Papillary Pattern,Anal Papillary Hidradenoma,1
7398,Epithelial Component Present,Stage IV Major Salivary Gland Carcinoma without Metastasis,1
7399,In Situ Lesion,Stage 0is Renal Pelvis Cancer AJCC v8,1
7400,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v8,1
7401,Hepatomegaly,Refractory Hepatosplenic T-Cell Lymphoma,1
7402,Carcinomatous Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7,1
7403,Epithelial Component Present,Gastric carcinoma stage IV,1
7404,Epithelial Component Present,Clear cell odontogenic carcinoma,1
7405,Secondary Lesion,Secondary Neoplasm,1
7406,Cutaneous Involvement,Fibrofolliculoma,1
7407,Epithelial Component Present,External Ear Carcinoma,1
7408,Multinodular Mass,Poorly Differentiated Angiosarcoma,1
7409,Follicular Cell Differentiation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
7410,Chromogranin A Positive Neoplastic Cells Present,Ampulla of Vater Neuroendocrine Tumor G1,1
7411,Intraductal Lesion,Noninfiltrating intraductal papillary adenocarcinoma,1
7412,Carcinomatous Component Present,Bladder Cancer by AJCC v7 Stage,1
7413,Epithelial Component Present,Refractory Breast Carcinoma,1
7414,Refractory Disease,Refractory Primary Amyloidosis,1
7415,Pseudoglandular Pattern,Acantholytic squamous cell carcinoma,1
7416,Low Grade Lesion,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
7417,Malignant Cellular Infiltrate,T-cell lymphoma stage IV,1
7418,Well-Circumscribed Lesion,Colorectal Peutz-Jeghers Polyp,1
7419,Neuroendocrine Differentiation,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
7420,Carcinomatous Component Present,Carcinoma of supraglottis,1
7421,Cutaneous Involvement,Stage IB Merkel Cell Carcinoma AJCC v7,1
7422,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
7423,Epithelial Component Present,Gastric Mixed Adenocarcinoma,1
7424,Metastatic Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
7425,Malignant Cellular Infiltrate,"Testicular Seminoma, Tubular Variant",1
7426,Ineffective hematopoiesis,Recurrent High Risk Myelodysplastic Syndrome,1
7427,Intracanalicular Growth Pattern,"Phyllodes tumor, benign",1
7428,Papillary Pattern,Sphenoid Sinus Schneiderian Papilloma,1
7429,Epithelial Component Present,Stage IV Rectal Cancer AJCC v8,1
7430,Malignant Cellular Infiltrate,Lentigo maligna recurrent,1
7431,Malignant Cellular Infiltrate,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
7432,Local disease,Localized Bone Ewing Sarcoma,1
7433,Nodular Pattern,Distal-Type Epithelioid Sarcoma,1
7434,Malignant Cellular Infiltrate,Laryngeal Giant Cell Carcinoma,1
7435,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
7436,Hyperkeratosis,Laryngeal verrucous carcinoma,1
7437,Malignant Cellular Infiltrate,Human Papillomavirus-Related Cervical Carcinoma,1
7438,Carcinomatous Component Present,Stage IA2 Cervical Cancer,1
7439,Carcinomatous Component Present,Vaginal adenocarcinoma,1
7440,Benign Cellular Infiltrate,Parotid Gland Warthin Tumor,1
7441,Exophytic Papillary Lesion,verrucous carcinoma of vagina,1
7442,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course,1
7443,Indolent Clinical Course,Adenomatoid tumor of epididymis,1
7444,Epithelial Component Present,Breast Carcinoma Metastatic in the Liver,1
7445,Indolent Clinical Course,Osteochondromatosis,1
7446,Carcinomatous Component Present,Stage IIIB Fallopian Tube Cancer AJCC v8,1
7447,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I,1
7448,Carcinomatous Component Present,Metastatic Pharyngeal Carcinoma,1
7449,Nuclear Pseudoinclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
7450,Cutaneous Involvement,Pre-Malignant Skin Epithelial Lesion,1
7451,Bone Marrow Dysplasia Present,Refractory Neutropenia,1
7452,Epithelial Component Present,Stage 0 Breast Cancer AJCC v6 and v7,1
7453,Epithelial Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
7454,Defective Heavy Chain Present,gamma-Chain Disease,1
7455,Carcinomatous Component Present,Stage II Lip and Oral Cavity Cancer AJCC v8,1
7456,Somatostatin Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
7457,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vulva,1
7458,Osteoid formation,Childhood Extraskeletal Osteosarcoma,1
7459,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v7,1
7460,Epithelial Component Present,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
7461,Malignant Cellular Infiltrate,carcinosarcoma of liver,1
7462,Myxoid Stroma Formation,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
7463,Non-Hereditary Lesion,"Papillary renal cell carcinoma, sporadic",1
7464,Nodular Pattern,Eccrine spiradenoma,1
7465,Borderline Lesion,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",1
7466,Infiltrative Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma,1
7467,Malignant Cellular Infiltrate,Hypodiploid B Acute Lymphoblastic Leukemia,1
7468,Metastatic Lesion,Locally Metastatic Malignant Neoplasm,1
7469,Epithelial Component Present,Gallbladder Mixed Adenoneuroendocrine Carcinoma,1
7470,Radial Growth Phase,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,1
7471,Malignant Cellular Infiltrate,Papillary adenocarcinoma,1
7472,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor,1
7473,Estrogen receptor negative,Metastatic Triple-Negative Breast Carcinoma,1
7474,Benign Cellular Infiltrate,"Adenoma, Basal Cell",1
7475,Monomorphic Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
7476,Increased Cellularity Present,Unresectable Neuroblastoma,1
7477,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage III,1
7478,Monoclonal Paraproteinemia,Smoldering myeloma,1
7479,Endophytic Tumor Growth,Lower Gingival Verrucous Carcinoma,1
7480,Malignant Cellular Infiltrate,Recurrent Parotid Gland Acinic Cell Carcinoma,1
7481,Vascular Channel Formation,Prostate Kaposi Sarcoma,1
7482,Malignant Cellular Infiltrate,Rhabdomyosarcoma of the orbit,1
7483,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIA,1
7484,Benign Cellular Infiltrate,Benign neoplasm of sebaceous gland,1
7485,Monomorphic Cellular Infiltrate,Head and Neck Basaloid Carcinoma,1
7486,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
7487,Benign Cellular Infiltrate,Vaginal Angiomyofibroblastoma,1
7488,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
7489,Low Mitotic Activity,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
7490,Epithelial Component Present,Choroid Plexus Papilloma,1
7491,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v6,1
7492,Secondary Lesion,Secondary carcinoma,1
7493,Mitotic Activity,Adult Gliosarcoma,1
7494,Benign Cellular Infiltrate,Vaginal Blue Nevus,1
7495,Malignant Cellular Infiltrate,"Neoplasms, Unknown Primary",1
7496,Borderline Resectable Mass,Borderline Resectable Carcinoma,1
7497,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,1
7498,Aberrant Thyroid Tissue Present,Struma Ovarii,1
7499,Malignant Cellular Infiltrate,Thymic Squamous Cell Carcinoma,1
7500,Invasive Lesion,TSH-Producing Pituitary Gland Carcinoma,1
7501,Cutaneous Involvement,Bullous lichen planus,1
7502,Malignant Cellular Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
7503,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
7504,Carcinomatous Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma,1
7505,Tissue Differentiation Uncertain,"Sarcoma, Epithelioid",1
7506,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage III,1
7507,Indolent Clinical Course,Benign neoplasm of tongue,1
7508,High Grade Lesion,Refractory Extensive Stage Lung Small Cell Carcinoma,1
7509,Indolent Clinical Course,Intracranial cavernous hemangioma,1
7510,Malignant Cellular Infiltrate,Malignant melanoma of choroid,1
7511,Eccrine Differentiation,Eccrine ductal carcinoma,1
7512,Refractory Disease,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
7513,Malignant Cellular Infiltrate,Urothelial carcinoma bladder recurrent,1
7514,Infantile Lesion,Desmoplastic infantile ganglioglioma,1
7515,Benign Cellular Infiltrate,Hemangioma of intracranial structure,1
7516,Encapsulated Mass,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
7517,Childhood Lesion,Pediatric Neoplasm,1
7518,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v8,1
7519,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PCM1-JAK2,1
7520,Malignant Cellular Infiltrate,Recurrent Hairy Cell Leukemia,1
7521,Malignant Cellular Infiltrate,Stage IIA Osteosarcoma AJCC v7,1
7522,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma,1
7523,Epithelial Component Present,Tubulocystic renal cell carcinoma,1
7524,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Immature Teratoma,1
7525,Benign Cellular Infiltrate,Urethral Leiomyoma,1
7526,Adulthood Lesion,Stage IV Adult Burkitt Lymphoma,1
7527,Cutaneous Involvement,regressing melanoma of skin,1
7528,Epithelial Component Present,Retroperitoneal Carcinoma,1
7529,Malignant Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
7530,Papillary Pattern,Lung Glandular Papilloma,1
7531,Dysplasia,Colonic tubulovillous adenoma,1
7532,Severe dysplasia,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
7533,Adulthood Lesion,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8,1
7534,Epithelial Component Present,Stage II Duodenal Neuroendocrine Tumor AJCC v8,1
7535,Cutaneous Involvement,Nevoid Melanoma,1
7536,Locally Aggressive Lesion,Breast Inflammatory Myofibroblastic Tumor,1
7537,Malignant Cellular Infiltrate,Prostate cancer stage D,1
7538,Carcinomatous Component Present,Cholangiocarcinoma recurrent,1
7539,Malignant Cellular Infiltrate,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
7540,Lobular Pattern,Pilar tumor,1
7541,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma transformed recurrent,1
7542,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
7543,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8,1
7544,Epithelial Component Present,Stage IV Rectal Carcinoma,1
7545,Malignant Cellular Infiltrate,Childhood Acute Monoblastic Leukemia,1
7546,Gastric-Type Epithelial Differentiation,Foveolar-Type Adenoma,1
7547,Epithelial Component Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
7548,Absence of Invasion,Bladder Urothelial Carcinoma in Situ,1
7549,Therapy-Related Toxicity,Lymphoproliferative disorder caused by methotrexate,1
7550,Epithelial Component Present,Salivary Gland Oncocytic Carcinoma,1
7551,Carcinomatous Component Present,Adenocarcinoma of pancreas,1
7552,Epithelial Component Present,Clear Cell Adrenal Cortical Adenoma,1
7553,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic,1
7554,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
7555,Epithelial Component Present,Water-clear cell adenoma,1
7556,Malignant Cellular Infiltrate,Fusion-Negative Alveolar Rhabdomyosarcoma,1
7557,Cystic Change,cystadenocarcinoma of intrahepatic bile duct,1
7558,High Mitotic Activity,Vaginal Large Cell Neuroendocrine Carcinoma,1
7559,Carcinomatous Component Present,Gastric Body Carcinoma,1
7560,Malignant Cellular Infiltrate,Ganglioneuroblastoma,1
7561,Malignant Cellular Infiltrate,AIDS-Related Carcinoma,1
7562,Epithelial Component Present,Secretory breast carcinoma,1
7563,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Cortex,1
7564,Malignant Cellular Infiltrate,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,1
7565,Diffuse Pattern,Adult Diffuse Astrocytoma,1
7566,Cutaneous Involvement,Acral Skin Nevus,1
7567,Neuroendocrine Differentiation,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
7568,Epithelial Component Present,"Transitional cell carcinoma, spindle cell",1
7569,Malignant Cellular Infiltrate,Colorectal Angiosarcoma,1
7570,Lymphoplasmacytic Infiltrate,Childhood Brain Germinoma,1
7571,Exophytic Polypoid Lesion,Gastric Cronkhite Canada Polyposis,1
7572,Carcinomatous Component Present,High Grade Ductal Breast Carcinoma In Situ,1
7573,Malignant Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
7574,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
7575,Primary Site Unknown,Squamous Cell Carcinoma of Unknown Primary,1
7576,Well-Circumscribed Lesion,Classic Rhabdomyoma,1
7577,Hypergammaglobulinemia,Multi-centric Castleman's Disease,1
7578,Malignant Cellular Infiltrate,Stage I Testicular Cancer AJCC v6 and v7,1
7579,Malignant Cellular Infiltrate,Hereditary Renal Cell Carcinoma,1
7580,Carcinomatous Component Present,Bile duct cystadenocarcinoma,1
7581,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
7582,Neuroendocrine Differentiation,"Neuroendocrine carcinoma, metastatic",1
7583,Malignant Cellular Infiltrate,Progressive Hairy Cell Leukemia Initial Treatment,1
7584,Malignant Cellular Infiltrate,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
7585,Carcinomatous Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
7586,Indolent Clinical Course,Lipoma of skin,1
7587,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
7588,Low Mitotic Activity,Localized Digestive System Neuroendocrine Tumor G1,1
7589,Necrotic changes (finding),Endometrial Large Cell Neuroendocrine Carcinoma,1
7590,Papillary Pattern,Solid Papillary Breast Carcinoma,1
7591,Malignant Cellular Infiltrate,Childhood Synovial Sarcoma,1
7592,Metastatic Lesion,Locally Advanced Small Intestinal Carcinoma,1
7593,Skin Papule,Trichoepithelioma,1
7594,Malignant Cellular Infiltrate,Pleural mesothelioma malignant advanced,1
7595,Carcinomatous Component Present,Sublingual Gland Adenocarcinoma,1
7596,No Identifiable Line of Differentiation,Central Nervous System Undifferentiated Pleomorphic Sarcoma,1
7597,Malignant Cellular Infiltrate,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
7598,Hyaline Cartilage Differentiation,Enchondroma,1
7599,Syncytial Pattern,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
7600,Fibrosis,Breast Blunt Duct Adenosis,1
7601,Malignant Cellular Infiltrate,Stage IVA Gallbladder Cancer AJCC v8,1
7602,Histiocytosis haematophagic,Refractory Hemophagocytic Lymphohistiocytosis,1
7603,Benign Cellular Infiltrate,Hemangioma of bone,1
7604,Enterochromaffin-Like Type Granules Present,Gastric Carcinoid Tumor,1
7605,Melanosomes Present,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
7606,Glial Differentiation,Dysembryoplastic neuroepithelial tumor,1
7607,Epithelial Component Present,Recurrent Ovarian Mucinous Adenocarcinoma,1
7608,Carcinomatous Component Present,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
7609,Carcinomatous Component Present,Grade 3 Colon Adenocarcinoma,1
7610,Necrotic changes (finding),Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
7611,Carcinomatous Component Present,Large cell lung cancer stage III,1
7612,Tissue Differentiation Uncertain,Adult Alveolar Soft Part Sarcoma,1
7613,Mixed Cellular Population,Adenosarcoma,1
7614,Recurrent disease,Recurrent Malignant Extragonadal Germ Cell Tumor,1
7615,Epithelial Component Present,Gastric Cancer by AJCC v7 Stage,1
7616,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,1
7617,Squamoid Differentiation,Acanthomatous ameloblastoma,1
7618,Absence of Invasion,Stage 0is Renal Pelvis Cancer AJCC v8,1
7619,High Grade Lesion,Advanced Synovial Sarcoma,1
7620,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
7621,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
7622,Epithelial Component Present,Minor Salivary Gland Acinic Cell Carcinoma,1
7623,Epithelial Component Present,Stage 0 Vulvar Cancer,1
7624,Cystic Change,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
7625,Benign Cellular Infiltrate,Junctional nevus,1
7626,Malignant Cellular Infiltrate,Bone Cancer by AJCC v7 Stage,1
7627,Epithelial Component Present,AIDS-Related Carcinoma,1
7628,Malignant Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v7 Stage,1
7629,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Cellular Variant,1
7630,Thick-Walled Vessels Present,Kidney Epithelioid Type Angiomyolipoma,1
7631,Epithelial Component Present,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
7632,Benign Cellular Infiltrate,Childhood Central Nervous System Mature Teratoma,1
7633,Anaplasia,Recurrent Childhood Giant Cell Glioblastoma,1
7634,Malignant Cellular Infiltrate,Oropharyngeal Poorly Differentiated Carcinoma,1
7635,Tissue of Mullerian Origin Present,Serous adenofibroma,1
7636,Childhood Lesion,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
7637,Non-Malignant Cellular Infiltrate,Follicular Bronchitis/Bronchiolitis,1
7638,Primary Lesion,Recurrent Childhood Cerebral Astrocytoma,1
7639,Bone Marrow Dysplasia Present,Refractory anaemia with excess blasts,1
7640,Slow Growing Mass,Kadish Stage C Olfactory Neuroblastoma,1
7641,Cutaneous Involvement,Stage I Skin Cancer,1
7642,Benign Cellular Infiltrate,"Oncocytoma, renal",1
7643,Endophytic Tumor Growth,Ureter Inverted Papilloma,1
7644,Primary Lesion,Primary Childhood Soft Tissue Sarcoma,1
7645,Malignant Cellular Infiltrate,Undifferentiated Neuroblastoma,1
7646,Necrotic changes (finding),Digestive System Small Cell Neuroendocrine Carcinoma,1
7647,Metastatic Lesion,Metastatic Vulvar Carcinoma,1
7648,Cutaneous Involvement,Dysplastic Nevus,1
7649,Epithelial Component Present,Stage I Thymoma AJCC v8,1
7650,Well Differentiated Neuroendocrine Lesion,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
7651,Epithelial Component Present,Metastatic Pancreatic Neuroendocrine Carcinoma,1
7652,Carcinomatous Component Present,Metastatic hepatocellular carcinoma,1
7653,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
7654,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7,1
7655,Secondary Lesion,Secondary malignant neoplasm of small intestine,1
7656,Carcinomatous Component Present,Stage I Esophageal Cancer,1
7657,Increased Cellularity Present,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
7658,Epithelial Component Present,Respiratory papilloma,1
7659,Papillary Pattern,"Cystadenoma, Papillary",1
7660,Carcinomatous Component Present,Hereditary Female Breast Carcinoma,1
7661,Tubular Structures Present,"Adenocarcinoma, Tubular",1
7662,Malignant Cellular Infiltrate,Fallopian Tube Squamous Cell Carcinoma,1
7663,Carcinomatous Component Present,Locally Advanced Salivary Gland Carcinoma,1
7664,Malignant Cellular Infiltrate,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
7665,Carcinomatous Component Present,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
7666,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v6,1
7667,Serrated Glandular Architecture,Colorectal Traditional Serrated Adenoma,1
7668,Diffuse Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
7669,S-100-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
7670,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
7671,Metastatic Lesion,Locally Advanced Cervical Carcinoma,1
7672,Exophytic Polypoid Lesion,Cyst of Skene's duct,1
7673,Epithelial Component Present,Metastatic Lobular Breast Carcinoma,1
7674,Malignant Cellular Infiltrate,Ovarian epithelial cancer stage II,1
7675,Carcinomatous Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
7676,Mucoid Stroma Formation,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
7677,Epithelial Component Present,Soft Palate Squamous Cell Carcinoma,1
7678,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II,1
7679,Monomorphic Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
7680,Malignant Cellular Infiltrate,Primary malignant neoplasm of oculomotor nerve,1
7681,Adulthood Lesion,Lugano Classification Stage IIE Adult Lymphoma AJCC v8,1
7682,Increased Cellularity Present,Anaplastic Oligodendroglioma,1
7683,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
7684,Mesenchymal Component Present,Soft Palate Pleomorphic Adenoma,1
7685,Cystic Change,Breast Mucinous Cystadenocarcinoma,1
7686,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v6 Stage,1
7687,Low Mitotic Activity,Appendix Neuroendocrine Tumor,1
7688,Neuroectodermal Differentiation,Kadish Stage A Olfactory Neuroblastoma,1
7689,Refractory Disease,Refractory Childhood Hodgkin Lymphoma,1
7690,Metastatic Lesion,Metastatic Thyroid Gland Follicular Carcinoma,1
7691,Epithelial Component Present,Ileal Neuroendocrine Tumor,1
7692,Epithelial Component Present,Verrucous carcinoma of oral cavity,1
7693,Malignant Cellular Infiltrate,Hepatitis Virus-Related Hepatocellular Carcinoma,1
7694,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v8,1
7695,Malignant Cellular Infiltrate,Resectable Malignant Liver Neoplasm,1
7696,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage I,1
7697,Borderline Lesion,Borderline Breast Phyllodes Tumor,1
7698,Well Differentiated Neuroendocrine Lesion,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
7699,Koilocytotic atypia,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
7700,Intravascular Fibrin Thrombus Formation,Angiolipoma,1
7701,Vascular Channel Formation,Thyroid Angiosarcoma,1
7702,Refractory Disease,Refractory Malignant Peripheral Nerve Sheath Tumor,1
7703,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts II,1
7704,'Starry-sky' pattern,Classical Burkitt Lymphoma,1
7705,Malignant Cellular Infiltrate,Hereditary Male Breast Carcinoma,1
7706,Malignant Cellular Infiltrate,"Thymoma, type B2, malignant",1
7707,Composite Lesion,"Ganglioneuroblastoma, Nodular",1
7708,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma,1
7709,Cutaneous Involvement,Follicular mycosis fungoides,1
7710,Dilated Terminal Duct Lobular Units Present,Columnar Cell Hyperplasia of the Breast,1
7711,Malignant Cellular Infiltrate,Stage I Anal Canal Cancer AJCC v6 and v7,1
7712,Epithelial Component Present,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
7713,Malignant Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia,1
7714,Malignant Cellular Infiltrate,Refractory Endometrial Serous Adenocarcinoma,1
7715,Malignant Cellular Infiltrate,Hairy cell leukemia variant,1
7716,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
7717,Epithelial Component Present,Secretory adenoma of pituitary,1
7718,Epithelial Component Present,Metastatic Pharyngeal Carcinoma,1
7719,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant recurrent,1
7720,Adnexal Differentiation,Invasive Apocrine Breast Carcinoma,1
7721,atypia morphology,Borderline Ovarian Endometrioid Adenofibroma,1
7722,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-2,1
7723,Epithelial Component Present,Non-Functioning Endocrine Neoplasm,1
7724,Malignant Cellular Infiltrate,Stage 0 Merkel Cell Carcinoma AJCC v7,1
7725,Lytic lesion,Giant Cell Lesion of Small Bones,1
7726,Cutaneous Involvement,Digital papillary eccrine carcinoma of skin,1
7727,Carcinomatous Component Present,Cholangiolocellular Carcinoma,1
7728,Neuroendocrine Differentiation,Recurrent Neuroendocrine Neoplasm,1
7729,Firm mass,Refractory Malignant Peripheral Nerve Sheath Tumor,1
7730,Papillary Pattern,Ovarian Surface Papilloma,1
7731,Epithelial Component Present,Stage IIA Penile Cancer AJCC v8,1
7732,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
7733,Low Grade Lesion,Metastatic Epithelioid Hemangioendothelioma,1
7734,Carcinomatous Component Present,Unresectable Bladder Urothelial Carcinoma,1
7735,Ground Glass Nuclear Inclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
7736,Malignant Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
7737,Malignant Cellular Infiltrate,Stage I Adult Liver Cancer AJCC v7,1
7738,Insular Pattern,Somatostatinoma,1
7739,Invasive Lesion,Breast Solid Neuroendocrine Carcinoma,1
7740,Cartilaginous Differentiation,Soft tissue chondroma,1
7741,Well-Circumscribed Lesion,Peutz-Jeghers polyps of small bowel,1
7742,Childhood Lesion,Childhood Infratentorial Ependymoma,1
7743,Metastatic Lesion,Breast Carcinoma Metastatic in the Skin,1
7744,Epithelial Component Present,Pancreatic Intraductal Neoplasms,1
7745,Carcinomatous Component Present,Stage III Prostate Carcinoma,1
7746,Benign Cellular Infiltrate,Benign neoplasm of chest wall,1
7747,Epithelial Component Present,Transitional cell carcinoma of ureter,1
7748,Invasive Lesion,Adenocarcinoma of the prostate metastatic,1
7749,Secondary Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
7750,Matrical Differentiation,Basal cell carcinoma - follicular,1
7751,Lepidic Growth Pattern,Lung Non-Mucinous Adenocarcinoma In Situ,1
7752,Epithelial Component Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
7753,Carcinomatous Component Present,Adrenocortical carcinoma,1
7754,Carcinomatous Component Present,Invasive Mucinous Lung Adenocarcinoma,1
7755,Anaplasia,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
7756,Malignant Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v8,1
7757,Indolent Clinical Course,Mediastinal Rhabdomyoma,1
7758,Carcinomatous Component Present,Stage II Penile Cancer AJCC v6,1
7759,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
7760,Diffuse Pattern,Stage II Adult Immunoblastic Lymphoma,1
7761,Extraocular Dissemination of Disease,Extraocular retinoblastoma,1
7762,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma,1
7763,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
7764,Malignant Cellular Infiltrate,Uveal Melanoma Metastatic in the Liver,1
7765,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1B,1
7766,Primary Lesion,Clear Cell Hepatocellular Carcinoma,1
7767,Epithelial Component Present,Stage IIB Penile Cancer AJCC v8,1
7768,Primary Lesion,Infratentorial Ependymal Tumor,1
7769,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage IV,1
7770,Carcinomatous Component Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
7771,Secondary Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,1
7772,High Grade Lesion,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
7773,Smooth Muscle Component Present,Epithelioid Type Angiomyolipoma,1
7774,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
7775,Primary Lesion,Adult Gliosarcoma,1
7776,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Gastric Type",1
7777,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
7778,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v8 Stage,1
7779,Glial Differentiation,Anaplastic ganglioglioma,1
7780,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma recurrent,1
7781,Cutaneous Involvement,Basal cell carcinoma - adamantinoid,1
7782,Dysplasia,Gallbladder adenoma,1
7783,Malignant Cellular Infiltrate,undifferentiated carcinoma of urethra,1
7784,Carcinomatous Component Present,Lung Cancer by AJCC v8 Stage,1
7785,Epithelial Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8,1
7786,Cutaneous Involvement,Verrucous epidermal nevus,1
7787,Malignant Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
7788,Malignant Cellular Infiltrate,Malignant tumor of pleura,1
7789,Biphasic Pattern,Pericanalicular fibroadenoma,1
7790,Primary Lesion,anaplastic large cell lymphoma of central nervous system,1
7791,Immunologic Deficiency Syndromes,AIDS related complication,1
7792,Cutaneous Involvement,Large cell acanthoma,1
7793,Epithelial Component Present,Ductal Breast Carcinoma,1
7794,Malignant Cellular Infiltrate,undifferentiated carcinoma of extrahepatic bile duct,1
7795,Refractory Disease,Refractory Hairy Cell Leukemia,1
7796,CD1a-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
7797,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
7798,Malignant Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant",1
7799,Epithelial Component Present,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7800,Geographic Necrosis,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
7801,Epithelial Component Present,Oral Cavity Monomorphic Adenoma,1
7802,Anaplasia,Classical Glioblastoma,1
7803,Malignant Cellular Infiltrate,squamous cell carcinoma of urethra,1
7804,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
7805,Carcinomatous Component Present,Lung adenocarcinoma recurrent,1
7806,Deep Lesion,Unresectable Desmoid-Type Fibromatosis,1
7807,Lymphadenopathy,HHV8-Positive Multicentric Castleman Disease,1
7808,Primary Lesion,Indolent Systemic Mastocytosis,1
7809,Spindle Cell Component Present,Cardiac Biphasic Synovial Sarcoma,1
7810,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2,1
7811,Benign Cellular Infiltrate,Pyogenic granuloma of oral mucosa,1
7812,Neuroendocrine Differentiation,Colorectal Neuroendocrine Neoplasm,1
7813,Perivascular Arrangement of Tumor Cells,Myopericytoma,1
7814,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2,1
7815,Refractory Disease,Refractory Head and Neck Carcinoma,1
7816,CD30-Positive Neoplastic Cells Present,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,1
7817,Epithelial Component Present,Nasopharyngeal cancer recurrent,1
7818,Malignant Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
7819,Malignant Cellular Infiltrate,Stage 0 Anal Cancer AJCC v8,1
7820,Adulthood Lesion,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8,1
7821,Unresectable Mass,Unresectable Adrenal Gland Pheochromocytoma,1
7822,Cystic Change,Cystic teratoma,1
7823,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma,1
7824,Carcinomatous Component Present,Comedocarcinoma,1
7825,Non-Invasive Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
7826,Epithelial Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
7827,Benign Cellular Infiltrate,Diffuse neurofibroma,1
7828,Epithelial Component Present,Cervical Adenosquamous Carcinoma,1
7829,Storiform Growth Pattern,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
7830,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma,1
7831,Villous Pattern,Villous adenoma of rectum,1
7832,Malignant Cellular Infiltrate,Malignant Giant Cell Tumor of Bone,1
7833,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma recurrent,1
7834,Carcinomatous Component Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
7835,Malignant Cellular Infiltrate,undifferentiated carcinoma of urethra,1
7836,Secondary Lesion,Secondary malignant neoplasm of vagina,1
7837,Neuroectodermal Differentiation,Mediastinal Neuroblastoma,1
7838,Osseous Differentiation,Small cell osteosarcoma,1
7839,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v7 Stage,1
7840,Indolent Clinical Course,Lipoma of axilla,1
7841,Benign Cellular Infiltrate,Cellular angiofibroma,1
7842,Carcinomatous Component Present,Adenosquamous cell lung cancer recurrent,1
7843,Anaplasia,Childhood Glioblastoma,1
7844,Childhood Lesion,Childhood Acute Myelomonocytic Leukemia,1
7845,Metastatic Lesion,Lymphangitis carcinomatosa,1
7846,Benign Cellular Infiltrate,Vestibular Micropapillomatosis,1
7847,Infantile Lesion,Infantile fibrosarcoma,1
7848,Invasive Lesion,Low Grade Mucoepidermoid Breast Carcinoma,1
7849,Monomorphic Cellular Infiltrate,Childhood Oligodendroglioma,1
7850,Carcinomatous Component Present,Appendix Carcinoma by AJCC v7 Stage,1
7851,Epithelial Component Present,"Carcinoma, Large Cell",1
7852,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v8 Stage,1
7853,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
7854,Malignant Cellular Infiltrate,Recurrent Childhood Liver Cancer,1
7855,Malignant Cellular Infiltrate,apocrine adenocarcinoma of vulva,1
7856,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma,1
7857,Epithelial Component Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
7858,Carcinomatous Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
7859,Malignant Cellular Infiltrate,Mucosal Melanoma,1
7860,Malignant Cellular Infiltrate,Stage IV Cutaneous Melanoma AJCC v6 and v7,1
7861,Epithelial Component Present,Gallbladder Flat Biliary Intraepithelial Neoplasia,1
7862,Pathologic TNM Finding,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
7863,Well-Circumscribed Lesion,Endometrial Polyp,1
7864,Epithelial Component Present,Acanthoma,1
7865,Intraductal Lesion,Intraductal Breast Papillomatosis,1
7866,Malignant Cellular Infiltrate,Stage IA Vaginal Cancer AJCC v8,1
7867,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Carcinoma,1
7868,Well-Circumscribed Lesion,Central Nervous System Myofibroblastoma,1
7869,Carcinomatous Component Present,keratinizing squamous cell carcinoma of vulva,1
7870,Carcinomatous Component Present,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
7871,Carcinomatous Component Present,large cell neuroendocrine carcinoma of breast,1
7872,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
7873,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,1
7874,Malignant Cellular Infiltrate,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
7875,Secondary Lesion,Metastatic Malignant Solid Neoplasm,1
7876,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational choriocarcinoma,1
7877,Malignant Cellular Infiltrate,Adult Epithelioid Hemangioendothelioma,1
7878,Exophytic Polypoid Lesion,Anal Inflammatory Cloacogenic Polyp,1
7879,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
7880,Recurrent disease,Recurrent Plasmablastic Lymphoma,1
7881,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gastric Choriocarcinoma,1
7882,Epithelial Component Present,Stage IIIB Adult Liver Cancer AJCC v7,1
7883,Immunosuppression-Related Post-Transplant Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
7884,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
7885,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage I,1
7886,Malignant Cellular Infiltrate,Stage III Adult Burkitt Lymphoma,1
7887,Secondary Lesion,Metastatic Bladder Small Cell Carcinoma,1
7888,Carcinomatous Component Present,Hormone Receptor Positive Breast Carcinoma,1
7889,Carcinomatous Component Present,Breast Carcinoma Metastatic in Lymph Node,1
7890,Hypercellular bone marrow,"Leukemia, Myeloid, Chronic-Phase",1
7891,Epithelial Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
7892,High Grade Lesion,Metastatic Dermatofibrosarcoma Protuberans,1
7893,Pseudoglandular Pattern,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
7894,Carcinomatous Component Present,Stage I Penile Cancer AJCC v6,1
7895,Nuclear pleomorphism,Childhood Pleomorphic Rhabdomyosarcoma,1
7896,Indolent Clinical Course,Rectal Lipoma,1
7897,Well-Circumscribed Lesion,Vulvar Nodular Hidradenoma,1
7898,Benign Cellular Infiltrate,Cutaneous leiomyoma,1
7899,Low Mitotic Activity,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
7900,Cutaneous Involvement,Recurrent Skin Carcinoma,1
7901,Primary Lesion,Temporal Lobe Anaplastic Astrocytoma,1
7902,Cribriform Pattern,"Testicular Seminoma, Cribriform Variant",1
7903,Carcinomatous Component Present,Stage III Adult Liver Cancer AJCC v7,1
7904,Encapsulated Mass,Benign cystic nephroma,1
7905,Epithelial Component Present,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
7906,Antoni A Pattern,Cerebellopontine Angle Schwannoma,1
7907,Epithelial Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
7908,Carcinomatous Component Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
7909,Hereditary Lesion,"Anemia, Diamond-Blackfan",1
7910,Epithelial Component Present,Anal Intraepithelial Neoplasia 1,1
7911,Perineural spread,adenoid cystic carcinoma of esophagus,1
7912,Pseudoglandular Pattern,Sellar Embryonal Carcinoma,1
7913,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
7914,Indolent Clinical Course,Elastofibroma,1
7915,Regional Disease,Locally Advanced Angiosarcoma,1
7916,Epithelial Component Present,Squamous cell carcinoma of lung,1
7917,Epithelial Component Present,Stage IVA Colon Cancer AJCC v8,1
7918,Malignant Cellular Infiltrate,Pathologic Stage 0 Gastric Cancer AJCC v8,1
7919,Epithelial Component Present,Thyroid Gland Follicular Adenoma,1
7920,Cartilaginous Component Present,Subungual exostoses,1
7921,Cystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
7922,Refractory Disease,Refractory Lymphoproliferative Disorder,1
7923,Metastatic/Recurrent Disease,Bladder Alveolar Soft Part Sarcoma,1
7924,Epithelial Component Present,Unresectable Skin Basal Cell Carcinoma,1
7925,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
7926,Lobulated Growth Pattern,Ventricular myxoma,1
7927,Childhood Lesion,Recurrent Childhood Visual Pathway Astrocytoma,1
7928,Favorable Clinical Outcome,Type D Lymphomatoid Papulosis,1
7929,High Mitotic Activity,small cell carcinoma of salivary gland,1
7930,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage III,1
7931,Malignant Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
7932,Rapidly Enlarging Mass,alveolar rhabdomyosarcoma of orbit,1
7933,Infiltrating Tumor Margins Present,Malignant Phyllodes Tumor of Prostate,1
7934,Carcinomatous Component Present,Locally Advanced Unresectable Carcinoma,1
7935,Epithelial Component Present,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
7936,Malignant Cellular Infiltrate,Recurrent Endometrial Cancer,1
7937,Mixed Cellular Population,Benign Ovarian Seromucinous Tumor,1
7938,Low Mitotic Activity,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
7939,Malignant Cellular Infiltrate,Metastatic Rectal Carcinoma,1
7940,Nuclear Clearing,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
7941,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7942,Benign Cellular Infiltrate,Seborrheic keratosis,1
7943,Benign Cellular Infiltrate,Dartoic myoma,1
7944,Recurrent disease,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
7945,Epidermal Involvement,Eccrine porocarcinoma,1
7946,Deep Lesion,Unresectable Desmoid-Type Fibromatosis,1
7947,Mass of body structure,Mediastinal Myeloid Sarcoma,1
7948,Follicular Cell Differentiation,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
7949,Benign Cellular Infiltrate,"Acanthoma, Pilar Sheath",1
7950,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma,1
7951,Carcinomatous Component Present,CARCINOMA OF VULVA,1
7952,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Serous",1
7953,Diffuse Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
7954,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
7955,Dysplasia,Squamous Cell Carcinoma In Situ of the Nipple,1
7956,Psammoma Body Formation,Calcifying Fibrous Pseudotumor,1
7957,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
7958,Carcinomatous Component Present,Ovarian cancer stage III,1
7959,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Carcinosarcoma,1
7960,Acinar Cell Differentiation,Recurrent Prostate Acinar Adenocarcinoma,1
7961,Monoclonal Cellular Population Present,Skin Mastocytoma,1
7962,Cutaneous Involvement,Pemphigus Vulgaris,1
7963,Carcinomatous Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
7964,Histiocytoid Differentiation,Histiocytoid Breast Carcinoma,1
7965,Malignant Cellular Infiltrate,Pharyngeal Carcinoma,1
7966,Malignant Cellular Infiltrate,Uterine Ligament Adenocarcinoma,1
7967,Malignant Cellular Infiltrate,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
7968,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage IV,1
7969,Benign Cellular Infiltrate,Benign Lung PEComa,1
7970,Carcinomatous Component Present,Grade 3 Rectal Adenocarcinoma,1
7971,Stromal Invasion,large cell neuroendocrine carcinoma of ovary,1
7972,Cutaneous Involvement,Lentigo maligna melanoma,1
7973,Pathologic TNM Finding,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7974,Carcinomatous Component Present,Tongue Carcinoma,1
7975,Malignant Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v6,1
7976,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7,1
7977,Epithelial Component Present,Palate carcinoma,1
7978,Carcinomatous Component Present,Laryngeal Cancer by AJCC v7 Stage,1
7979,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v7,1
7980,Cutaneous Involvement,Signet Ring Melanoma,1
7981,Malignant Cellular Infiltrate,liposarcoma of mediastinum,1
7982,In Situ Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
7983,Infiltrative Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma,1
7984,Neuroendocrine Differentiation,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
7985,Secondary Lesion,Locally Advanced Salivary Gland Carcinoma,1
7986,Well Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
7987,Cutaneous Involvement,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
7988,CD4-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
7989,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
7990,Secondary Lesion,Locally Advanced Unresectable Sarcoma,1
7991,Alternative Fascicle (Bundle) Pattern,Deep Leiomyoma,1
7992,Metastatic Lesion,Breast Carcinoma Metastatic in the Brain,1
7993,Malignant Cellular Infiltrate,Composite Lymphoma,1
7994,Epithelial Component Present,Locally Advanced Unresectable Cervical Carcinoma,1
7995,Cutaneous Involvement,Apocrine Neoplasm,1
7996,Solitary mass,Central Nervous System Epithelioid Hemangioendothelioma,1
7997,Osteoid formation,Extraskeletal Osteosarcoma,1
7998,Alternative Fascicle (Bundle) Pattern,Vulvar Leiomyoma,1
7999,Epithelial Component Present,Flat adenoma,1
8000,Epithelial Component Present,Stage IB1 Cervical Cancer,1
8001,Rapidly Enlarging Mass,Embryonal Rhabdomyosarcoma,1
8002,Carcinomatous Component Present,Anaplastic thyroid carcinoma,1
8003,Metastatic/Recurrent Disease,Liver Synovial Sarcoma,1
8004,Adnexal Differentiation,Malignant eccrine spiradenoma,1
8005,Benign Cellular Infiltrate,Oral Cavity Benign Granular Cell Tumor,1
8006,Peripheral Nuclear Palisading,large cell neuroendocrine carcinoma of lung,1
8007,Epithelial Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
8008,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
8009,Epithelial Component Present,Stage IIIC Breast Cancer AJCC v6,1
8010,Epithelial Component Present,Breast Columnar Cell Mucinous Carcinoma,1
8011,Exophytic Polypoid Lesion,Endocervical polyp,1
8012,Epithelial Component Present,adenocarcinoma of extrahepatic bile duct,1
8013,High Mitotic Activity,Gastroesophageal Junction Neuroendocrine Carcinoma,1
8014,Preserved Nuclear Polarity,"Transitional cell papilloma, benign",1
8015,Ground Glass Nuclear Inclusion,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
8016,Epithelial Component Present,Carcinoid tumor of the liver,1
8017,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
8018,Infantile Lesion,Fibrous Hamartoma of Infancy,1
8019,Malignant Cellular Infiltrate,Unresectable Sarcoma,1
8020,Exophytic Polypoid Lesion,Gingival fibroepithelial polyp,1
8021,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
8022,Osteoid formation,Extraskeletal osteosarcoma metastatic,1
8023,Refractory Disease,Refractory T Lymphoblastic Lymphoma,1
8024,Dilated Vascular Space Formation,Telangiectatic Glomangioma,1
8025,Epithelial Component Present,Throat cancer,1
8026,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v8,1
8027,Extensive Stage Lesion,Peritoneal mesothelioma malignant advanced,1
8028,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
8029,Malignant Cellular Infiltrate,T-cell lymphoma stage IV,1
8030,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
8031,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
8032,Carcinomatous Component Present,"Paget's Disease, Mammary",1
8033,Malignant Cellular Infiltrate,Stage III Malignant Mediastinal Germ Cell Tumor,1
8034,Infiltrative Growth Pattern,"Perivascular epithelioid tumor, malignant",1
8035,Malignant Cellular Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8,1
8036,Primary Lesion,Pilocytic astrocytoma of cerebellum,1
8037,Carcinomatous Component Present,Primary solid type intraosseous squamous cell carcinoma,1
8038,Carcinomatous Component Present,Warty Carcinoma of the Penis,1
8039,Epithelial Component Present,Prostate Adenosquamous Carcinoma,1
8040,Myomatous Stroma Formation,"Cervical Adenomyoma, Endometrial Type",1
8041,Malignant Cellular Infiltrate,Malignant Vulvar Sweat Gland Neoplasm,1
8042,Secondary Lesion,Locally Advanced Gastrointestinal Stromal Tumor,1
8043,Epithelial Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
8044,Perivascular fibrosis,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma,1
8045,Malignant Cellular Infiltrate,Stage II Oropharyngeal Carcinoma,1
8046,Infiltrative Growth Pattern,MGMT-Methylated Glioblastoma,1
8047,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma,1
8048,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
8049,Refractory Disease,Refractory Malignant Head and Neck Neoplasm,1
8050,Childhood Lesion,Childhood Ovarian Yolk Sac Tumor,1
8051,Epithelial Component Present,Urothelial carcinoma recurrent,1
8052,Benign Cellular Infiltrate,Benign epithelial tumor of ovary,1
8053,Massive Sinusoidal Histiocytic Infiltrate,Sinus histiocytosis,1
8054,Lobulated Growth Pattern,Cutaneous myxoma,1
8055,Calcitonin Positive Neoplastic Cells Present,Sporadic Thyroid Gland Medullary Carcinoma,1
8056,Benign Cellular Infiltrate,Eccrine hidrocystoma,1
8057,Malignant Cellular Infiltrate,Cutaneous Mantle Cell Lymphoma,1
8058,Benign Cellular Infiltrate,Urethral Leiomyoma,1
8059,Childhood Lesion,Childhood Cerebral Astrocytoma,1
8060,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
8061,Malignant Cellular Infiltrate,Cardiac Synovial Sarcoma,1
8062,Benign Cellular Infiltrate,Soft Palate Pleomorphic Adenoma,1
8063,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma,1
8064,Cystic Change,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
8065,Malignant Cellular Infiltrate,Stage III Adult Burkitt Lymphoma,1
8066,Primary Lesion,Epithelioid sarcoma non-metastatic,1
8067,High Mitotic Activity,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
8068,Dysplasia,Appendix High Grade Intraepithelial Neoplasia,1
8069,Fever,Multi-centric Castleman's Disease,1
8070,Immunologic Deficiency Syndromes,Non-Destructive Post-Transplant Lymphoproliferative Disorder,1
8071,Epithelial Component Present,Squamous cell carcinoma with horn formation,1
8072,Architectural Distortion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
8073,Metastatic Lesion,Locally Advanced Angiosarcoma,1
8074,Carcinomatous Component Present,Mucinous adenocarcinoma of colon,1
8075,Severe dysplasia,Rectal Adenoma with Severe Dysplasia,1
8076,Epithelial Component Present,Grade 4 Clear Cell Renal Cell Carcinoma,1
8077,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8,1
8078,Biphasic Pattern,Ovarian Seromucinous Adenofibroma,1
8079,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
8080,Epithelial Component Present,Breast Neuroendocrine Neoplasm,1
8081,Epithelial Component Present,Laryngeal verrucous carcinoma recurrent,1
8082,Cutaneous Involvement,Bullous Dermatitis,1
8083,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
8084,Childhood Lesion,Recurrent Childhood Pilocytic Astrocytoma,1
8085,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma metastatic,1
8086,Severe dysplasia,Stage 0 Gastric Cancer AJCC v6 and v7,1
8087,Epithelial Component Present,Small Intestinal Mixed Adenoneuroendocrine Carcinoma,1
8088,Malignant Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v8,1
8089,Cutaneous Involvement,Primary Cutaneous Follicle Center Lymphoma,1
8090,Pregnancy Complications,Chorioamnionitis,1
8091,Epithelial Component Present,small cell carcinoma of extrahepatic bile duct,1
8092,Malignant Cellular Infiltrate,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
8093,Epithelial Component Present,Proximal Urethral Carcinoma,1
8094,Malignant Cellular Infiltrate,Esophageal Liposarcoma,1
8095,Malignant Cellular Infiltrate,Non-hodgkin lymphoma of colon,1
8096,High Grade Lesion,Esophageal Synovial Sarcoma,1
8097,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
8098,Malignant Cellular Infiltrate,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,1
8099,Malignant Cellular Infiltrate,Acute bilineal leukemia,1
8100,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
8101,Mitotic Activity,MGMT-Unmethylated Glioblastoma,1
8102,Malignant Cellular Infiltrate,Metastatic melanoma,1
8103,Metastatic Lesion,Metastatic Lip Carcinoma,1
8104,Carcinomatous Component Present,Choroid Plexus Carcinoma,1
8105,Poorly Differentiated Neuroendocrine Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,1
8106,Malignant Cellular Infiltrate,Bladder Lymphoma,1
8107,Carcinomatous Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
8108,Malignant Cellular Infiltrate,Stage II Esophageal Adenocarcinoma AJCC v7,1
8109,Childhood Lesion,Childhood Pineal Parenchymal Cell Neoplasm,1
8110,Epithelial Component Present,Human Papillomavirus-Related Verrucous Carcinoma,1
8111,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
8112,Pathologic TNM Finding,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
8113,Malignant Cellular Infiltrate,Stage I Adult Burkitt Lymphoma,1
8114,Carcinomatous Component Present,Squamous cell carcinoma of conjunctiva,1
8115,Local disease,Intramuscular lipoma,1
8116,Malignant Cellular Infiltrate,Non-small cell lung cancer recurrent,1
8117,Carcinomatous Component Present,Renal cell carcinoma recurrent,1
8118,Adulthood Lesion,Adult Myxopapillary Ependymoma,1
8119,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of spleen,1
8120,Malignant Cellular Infiltrate,Adenoid basal carcinoma of cervix uteri,1
8121,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
8122,Well Differentiated Lesion,Upper Gingival Verrucous Carcinoma,1
8123,Epithelial Component Present,Stage IIIb Penile Cancer AJCC v7,1
8124,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage IV,1
8125,Malignant Cellular Infiltrate,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
8126,Rare Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,1
8127,Mitotic Activity,yolk sac tumor of mediastinum,1
8128,Malignant Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
8129,Malignant Cellular Infiltrate,Localized Resectable Adult Liver Carcinoma,1
8130,High Mitotic Activity,Combined Lung Large Cell Neuroendocrine Carcinoma,1
8131,Epithelial Component Present,"Adenoma, Villous",1
8132,Malignant Cellular Infiltrate,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
8133,Carcinomatous Component Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
8134,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of nasal cavity,1
8135,Microcystic Change,Childhood Fibrillary Astrocytoma,1
8136,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
8137,Dysplasia,Vaginal Tubular Adenoma,1
8138,Diffuse Pattern,Diffuse large B-cell lymphoma of central nervous system,1
8139,Collagenous Stroma Formation,Sclerosing Epithelioid Fibrosarcoma,1
8140,Low Mitotic Activity,Stage I Digestive System Neuroendocrine Tumor AJCC v7,1
8141,Malignant Cellular Infiltrate,Malignant Testicular Sex Cord-Stromal Tumor,1
8142,Epithelial Component Present,Carcinoma of larynx,1
8143,Malignant Cellular Infiltrate,Sclerosing rhabdomyosarcoma,1
8144,Epithelial Component Present,Squamous cell carcinoma of scrotum,1
8145,Epithelial Component Present,Esophageal Neuroendocrine Tumor G1,1
8146,Epithelial Component Present,Blepharal carcinoma,1
8147,Absence of Invasion,Adenocarcinoma in situ in tubulovillous adenoma,1
8148,Immunologic Deficiency Syndromes,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
8149,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,1
8150,Childhood Lesion,Pediatric Extraocular Retinoblastoma,1
8151,Endophytic Tumor Growth,Verrucous carcinoma of oral cavity,1
8152,Low Mitotic Activity,Advanced Pancreatic Neuroendocrine Tumor,1
8153,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Fetiform Teratoma,1
8154,Cutaneous Involvement,Tumor of dermis,1
8155,Cartilaginous Differentiation,Primary chondrosarcoma of bone,1
8156,Anaplasia,Spindle cell squamous cell carcinoma,1
8157,Epithelial Component Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
8158,Severe dysplasia,Stage 0 Oropharyngeal Carcinoma,1
8159,Primary Lesion,Neuroblastoma recurrent,1
8160,Alternative Fascicle (Bundle) Pattern,Leiomyoma of esophagus,1
8161,Malignant Cellular Infiltrate,Adenocarcinoma with osseous metaplasia,1
8162,High Grade Lesion,Vulvar Alveolar Rhabdomyosarcoma,1
8163,Crystal deposition,Adult Alveolar Soft Part Sarcoma,1
8164,Malignant Cellular Infiltrate,Early Favorable Non-Hodgkin Lymphoma,1
8165,Immunologic Deficiency Syndromes,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
8166,Epithelial Component Present,Choroid Plexus Papilloma,1
8167,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8,1
8168,Vascular Channel Formation,Intra-Abdominal Lymphangioma,1
8169,Epithelial Component Present,Stage I Lip Carcinoma,1
8170,Malignant Cellular Infiltrate,Ghost Cell Odontogenic Carcinoma,1
8171,Serotonin Positive Neoplastic Cells Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
8172,Benign Cellular Infiltrate,Benign neoplasm of epididymis,1
8173,Malignant Cellular Infiltrate,Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma,1
8174,Carcinomatous Component Present,Stage IVA Major Salivary Gland Cancer AJCC v8,1
8175,Mild cytologic atypia,Verrucous carcinoma of the oral cavity recurrent,1
8176,Splenomegaly,Splenic Manifestation of Hairy Cell Leukemia,1
8177,Epithelial Component Present,Transplant-Related Renal Cell Carcinoma,1
8178,Epithelial Component Present,Villous adenoma of rectum,1
8179,Collagenous Stroma Formation,Alveolar adenoma,1
8180,Glandular Pattern,intestinal type adenocarcinoma of gallbladder,1
8181,Epithelial Component Present,Rectal Sarcomatoid Carcinoma,1
8182,Organoid Pattern,Vulvar Alveolar Soft Part Sarcoma,1
8183,Tubal Diverticulosis,Salpingitis isthmica nodosa,1
8184,Chronic lymphocytic inflammation,Lung Inflammatory Myofibroblastic Tumor,1
8185,Mixed Cellular Population,Stage III Uterine Corpus Adenosarcoma AJCC v8,1
8186,Immunologic Deficiency Syndromes,AIDS-Related Gastric Kaposi Sarcoma,1
8187,Refractory Disease,Refractory Laryngeal Squamous Cell Carcinoma,1
8188,Well Differentiated Lesion,Warty Carcinoma of the Penis,1
8189,Malignant Cellular Infiltrate,Childhood Refractory Malignant Solid Neoplasm,1
8190,High Grade Lesion,Tongue Alveolar Soft Part Sarcoma',1
8191,Malignant Cellular Infiltrate,adenoid cystic carcinoma of pharynx,1
8192,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
8193,Carcinomatous Component Present,small cell carcinoma of larynx,1
8194,Unresectable Mass,Unresectable Pleural Malignant Mesothelioma,1
8195,Mitotic Activity,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
8196,Absence of Invasion,Stage 0is Renal Pelvis Cancer AJCC v8,1
8197,Malignant Cellular Infiltrate,Stage IIIB Uveal Melanoma AJCC v7,1
8198,Intermediate Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2,1
8199,Malignant Cellular Infiltrate,Medulloepithelioma,1
8200,Local disease,Solitary Adult Fibroma,1
8201,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
8202,Malignant Cellular Infiltrate,Esophageal carcinoma recurrent,1
8203,Malignant Cellular Infiltrate,Stage 0 Testicular Seminoma AJCC v6 and v7,1
8204,Epithelial Component Present,adenoma of intrahepatic bile duct,1
8205,Carcinomatous Component Present,Adenocarcinoma of the prostate stage II,1
8206,Epithelial Component Present,Stage I Colon Cancer AJCC v6 and v7,1
8207,Malignant Cellular Infiltrate,Transplant-Related Skin Squamous Cell Carcinoma,1
8208,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
8209,Dysplasia,Small Intestinal Tubulovillous Adenoma,1
8210,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7,1
8211,Low Mitotic Activity,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,1
8212,Necrotic changes (finding),Glioblastoma with Primitive Neuronal Component,1
8213,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7,1
8214,Eosinophilic inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
8215,Secondary Lesion,Metastatic Endometrial Carcinoma,1
8216,Childhood Lesion,Pediatric Intraocular Retinoblastoma,1
8217,Epithelial Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
8218,Regional Disease,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
8219,Carcinomatous Component Present,Cervix carcinoma recurrent,1
8220,In Situ Lesion,Carcinoma in situ in a polyp,1
8221,Benign Cellular Infiltrate,leiomyoma of trachea,1
8222,Dysplasia,Mild esophageal dysplasia,1
8223,Indolent Clinical Course,Colon Lipoma,1
8224,Malignant Cellular Infiltrate,Upper Gingival Squamous Cell Carcinoma,1
8225,Epithelial Component Present,Stage IV Paranasal Sinus Cancer AJCC v7,1
8226,Alternative Fascicle (Bundle) Pattern,Bladder Leiomyoma,1
8227,Malignant Cellular Infiltrate,Refractory Oral Cavity Squamous Cell Carcinoma,1
8228,Epithelial Component Present,Biliary Intraepithelial Neoplasia,1
8229,Secondary Lesion,Secondary malignant neoplasm of vulva,1
8230,Perineural spread,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
8231,Epithelial Component Present,Desmoplastic trichoepithelioma,1
8232,Carcinomatous Component Present,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
8233,Unresectable Mass,Unresectable Adrenal Cortex Carcinoma,1
8234,Hyalinized Vessels Present,Third Ventricle Pilocytic Astrocytoma,1
8235,Antoni A Pattern,Benign Bone Schwannoma,1
8236,Anaplasia,Frontal Lobe Anaplastic Astrocytoma,1
8237,Metastatic Lesion,Breast Carcinoma Metastatic in Lymph Node,1
8238,Malignant Cellular Infiltrate,Clinical Stage IIB Cutaneous Melanoma AJCC v8,1
8239,Carcinomatous Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
8240,Benign Cellular Infiltrate,Central Nervous System Chondroma,1
8241,Tumor Vascular Invasion,"Gastrinoma, malignant",1
8242,Carcinomatous Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
8243,Cutaneous Involvement,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
8244,High Grade Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
8245,Malignant Cellular Infiltrate,Non-Hodgkin Breast Lymphoma,1
8246,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Vipoma,1
8247,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma,1
8248,Malignant Cellular Infiltrate,Gastric Tubular Adenocarcinoma,1
8249,Benign Cellular Infiltrate,Papilloma of buccal mucosa,1
8250,Neuroendocrine Differentiation,Benign neuroendocrine tumor,1
8251,Cytoplasmic Membrane-Bound Granules Present,Merkel cell carcinoma,1
8252,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v7,1
8253,Local disease,Localized Gastric Carcinoma,1
8254,Ineffective hematopoiesis,de novo Myelodysplastic Syndrome,1
8255,Delicate Arborizing Vascular Channel Formation,Recurrent Myxoid Liposarcoma,1
8256,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Liver,1
8257,Epithelial Component Present,Vulvar Cancer by AJCC v7 Stage,1
8258,Malignant Cellular Infiltrate,Gastric Liposarcoma,1
8259,Malignant Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma,1
8260,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
8261,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
8262,Geographic Necrosis,Teratocarcinoma,1
8263,Secondary Lesion,Secondary Central Nervous System Lymphoma,1
8264,Epithelial Component Present,Low-grade intraurothelial neoplasia,1
8265,Cutaneous Involvement,Pagetoid reticulosis,1
8266,Papillary Pattern,Renal Pelvis Urothelial Papilloma,1
8267,Carcinomatous Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
8268,Malignant Cellular Infiltrate,mucinous adenocarcinofibroma of ovary,1
8269,Malignant Cellular Infiltrate,Carcinoma Metastatic to the Skin,1
8270,Hemorrhagic,Mediastinal Angiosarcoma,1
8271,Presence of a Hormonal Syndrome,Pancreatic Somatostatinoma,1
8272,Cutaneous Involvement,Neuronevus,1
8273,Malignant Cellular Infiltrate,Stage I Rectal Cancer AJCC v8,1
8274,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v8,1
8275,Low Grade Neuroendocrine Lesion,Carcinoid tumor of intestine,1
8276,Malignant Cellular Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
8277,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast,1
8278,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage III,1
8279,Malignant Cellular Infiltrate,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
8280,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,"Amyloidosis, Familial",1
8281,Epithelial Component Present,Stage II Vaginal Cancer AJCC v6 and v7,1
8282,Carcinomatous Component Present,Transplant-Related Bladder Urothelial Carcinoma,1
8283,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
8284,Malignant Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
8285,Hyperplastic Tissue Present,Hyperplasia of Brunner glands of duodenum,1
8286,Chronic Inflammatory Infiltrate,Childhood Ovarian Dysgerminoma,1
8287,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
8288,Epithelial Component Present,papillary adenoma of extrahepatic bile duct,1
8289,Well Differentiated Neuroendocrine Lesion,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
8290,Epithelial Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8291,Mucoid Stroma Formation,Myxopapillary ependymoma,1
8292,Pseudoalveolar Pattern,Vulvar Alveolar Soft Part Sarcoma,1
8293,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
8294,Therapy-Related Toxicity,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,1
8295,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
8296,Congenital Lesion,Congenital spondylolysis,1
8297,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8298,Epithelial Component Present,Squamous cell papilloma of eyelid,1
8299,Carcinomatous Component Present,carcinoma of eye,1
8300,Malignant Cellular Infiltrate,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
8301,Malignant Cellular Infiltrate,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
8302,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
8303,Exophytic Polypoid Lesion,Peutz Jehgers polyp,1
8304,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v7,1
8305,Biphasic Pattern,Advanced Uterine Corpus Carcinosarcoma,1
8306,Refractory Disease,Refractory Malignant Mesothelioma,1
8307,Carcinomatous Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
8308,Epithelial Component Present,Jejunal Neuroendocrine Tumor G1,1
8309,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,1
8310,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma refractory,1
8311,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of nasal cavity,1
8312,Increased Cellularity Present,Localized Unresectable Neuroblastoma,1
8313,Malignant Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v8,1
8314,Castration Resistance,Intermediate Atypical Prostate Carcinoma,1
8315,Malignant Cellular Infiltrate,Noninfiltrating Intraductal Carcinoma,1
8316,Disease regression,Regressing Non-Cutaneous Melanoma,1
8317,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
8318,Recurrent disease,Recurrent Childhood Soft Tissue Sarcoma,1
8319,Carcinomatous Component Present,Refractory Endometrial Clear Cell Adenocarcinoma,1
8320,Papillary Pattern,Papillary neoplasm,1
8321,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7,1
8322,Lobulated Growth Pattern,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
8323,Pregnancy Complications,Good Prognosis Metastatic Gestational Trophoblastic Tumor,1
8324,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Cystic Teratoma,1
8325,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
8326,Epithelial Component Present,Carcinoma of lung,1
8327,Secondary Lesion,Locally Advanced Small Intestinal Carcinoma,1
8328,Malignant Cellular Infiltrate,Stage IC Ovarian Cancer AJCC v8,1
8329,Osseous Differentiation,Refractory Osteosarcoma,1
8330,Pain,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,1
8331,Malignant Cellular Infiltrate,Kaposi's sarcoma of esophagus,1
8332,Malignant Cellular Infiltrate,Morpheic basal cell carcinoma,1
8333,Hyperplastic Tissue Present,Adrenal hyperplasia,1
8334,Malignant Cellular Infiltrate,Refractory Malignant Solid Neoplasm,1
8335,Severe cytologic atypia,Childhood Pleomorphic Rhabdomyosarcoma,1
8336,Malignant Cellular Infiltrate,Stage III Ovarian Teratoma AJCC v6 and v7,1
8337,Nodular Pattern,Grade 2 Cutaneous Follicular Lymphoma,1
8338,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia,1
8339,Primary Lesion,Posterior Cranial Fossa Ependymal Tumor,1
8340,Malignant Cellular Infiltrate,Metastatic Renal Cell Carcinoma,1
8341,Malignant Cellular Infiltrate,Stage IB Retroperitoneal Sarcoma AJCC v8,1
8342,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
8343,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
8344,Childhood Lesion,Childhood Glioblastoma,1
8345,Carcinomatous Component Present,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
8346,Cytoplasmic Membrane-Bound Granules Present,Recurrent Merkel Cell Carcinoma,1
8347,Mallory Bodies,Acute alcoholic liver disease,1
8348,Regional Disease,Locally Advanced Lung Carcinoma,1
8349,Sarcomatoid Features,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
8350,Myxoid Changes Present,Dermal nerve sheath myxoma,1
8351,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v6 Stage,1
8352,Carcinomatous Component Present,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8,1
8353,Carcinomatous Component Present,Metastatic Signet Ring Cell Breast Carcinoma,1
8354,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7,1
8355,Metastatic Lesion,Advanced B-Cell Neoplasm,1
8356,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid carcinoma ovary,1
8357,Myxoid Stroma Formation,Metastatic Chordoma,1
8358,Malignant Cellular Infiltrate,Plasma Cell Myeloma by RISS Stage,1
8359,Regional Disease,Locally Advanced Malignant Solid Neoplasm,1
8360,Diffuse Pattern,Adult Grade III Lymphomatoid Granulomatosis,1
8361,Cutaneous Involvement,Papillary Eccrine Carcinoma,1
8362,Recurrent disease,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
8363,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
8364,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
8365,Presence of a Hormonal Syndrome,Secretory adenoma of pituitary,1
8366,Carcinomatous Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,1
8367,Epithelial Component Present,Laryngeal Adenosquamous Carcinoma,1
8368,Well-Circumscribed Lesion,Cervix adenomatous polyp,1
8369,Carcinomatous Component Present,Breast Carcinoma with Osseous Metaplasia,1
8370,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma recurrent,1
8371,Osseous Differentiation,Metastatic osteosarcoma,1
8372,Benign Cellular Infiltrate,Disseminated Juvenile Xanthogranuloma,1
8373,Benign Cellular Infiltrate,Adamantinous Craniopharyngioma,1
8374,Malignant Cellular Infiltrate,Ann Arbor Stage IVA Hodgkin Lymphoma,1
8375,Malignant Cellular Infiltrate,Papillary Lung Adenocarcinoma,1
8376,Epidermal Involvement,Hidroacanthoma simplex,1
8377,Malignant Cellular Infiltrate,Mediastinal Myeloid Sarcoma,1
8378,Epithelial Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v7,1
8379,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v8,1
8380,Epithelial Component Present,Extrahepatic Bile Duct Carcinoid Tumor,1
8381,Non-Invasive Lesion,Renal Pelvis Urothelial Papilloma,1
8382,Malignant Cellular Infiltrate,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",1
8383,Pathologic TNM Finding,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
8384,Alternative Fascicle (Bundle) Pattern,Breast Leiomyoma,1
8385,Cutaneous Involvement,Sweat gland adenocarcinoma,1
8386,Epithelial Component Present,Small Intestinal Tubular Adenoma,1
8387,Absence of Stromal Invasion,Borderline Fallopian Tube Mucinous Tumor,1
8388,Tubular Pattern,Appendix Tubulovillous Adenoma,1
8389,Carcinomatous Component Present,Prostate Acinar Adenocarcinoma,1
8390,Epithelial Component Present,Recurrent Adrenal Cortex Carcinoma,1
8391,"Undifferentiated ""Fetal-Type"" Tissues Present",Malignant teratoma of testis,1
8392,Carcinomatous Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
8393,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7,1
8394,Indolent Clinical Course,Central odontogenic fibroma,1
8395,Rosette-Like Configurations Present,Adenoameloblastoma,1
8396,Malignant Cellular Infiltrate,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
8397,Carcinomatous Component Present,Squamous cell carcinoma,1
8398,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v6,1
8399,Papillary Pattern,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
8400,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
8401,Neuroectodermal Differentiation,Regional Neuroblastoma,1
8402,Epithelial Component Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
8403,Malignant Cellular Infiltrate,Gliomatosis Cerebri Type II,1
8404,Cutaneous Involvement,Paraganglioma-Like Dermal Melanocytic Tumor,1
8405,Indolent Clinical Course,Cerebral Hemisphere Lipoma,1
8406,Recurrent disease,Recurrent Lymphoproliferative Disorder,1
8407,Epithelial Component Present,Stage IVB Vulvar Cancer AJCC v8,1
8408,Secondary Lesion,Metastatic Unresectable Sarcoma,1
8409,Malignant Cellular Infiltrate,Pancreatic Cancer by AJCC v6 and v7 Stage,1
8410,Secondary Lesion,Peritoneal mesothelioma malignant advanced,1
8411,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
8412,Malignant Cellular Infiltrate,Recurrent Myxoid Liposarcoma,1
8413,Benign Cellular Infiltrate,Fallopian Tube Serous Adenofibroma,1
8414,Epithelial Component Present,Squamous cell carcinoma of colon,1
8415,Epithelial Component Present,Melanoacanthoma,1
8416,Carcinomatous Component Present,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
8417,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8,1
8418,Benign Cellular Infiltrate,Cartilaginous exostosis,1
8419,Carcinomatous Component Present,"Adenocarcinoma, Tubular",1
8420,Moderate dysplasia,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
8421,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Cellular Leiomyoma,1
8422,Tissue of Mullerian Origin Present,Female Reproductive System Adenofibroma,1
8423,Poorly Differentiated Lesion,Occult Lung Large Cell Carcinoma,1
8424,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v7,1
8425,Apocrine Differentiation,External Auditory Canal Ceruminous Adenoma,1
8426,Malignant Cellular Infiltrate,Refractory Rhabdoid Tumor,1
8427,Clinical TNM Finding,Clinical Stage III Cutaneous Melanoma AJCC v8,1
8428,Neuroendocrine Differentiation,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
8429,Necrotic changes (finding),Bartholin Gland Small Cell Carcinoma,1
8430,Nodular Pattern,Ann Arbor Stage I Grade 2 Follicular Lymphoma,1
8431,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,1
8432,Poorly Differentiated Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
8433,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma by Ann Arbor Stage,1
8434,Carcinomatous Component Present,High Grade Mucoepidermoid Breast Carcinoma,1
8435,High Mitotic Activity,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
8436,Malignant Cellular Infiltrate,FIGO Stage IIIC Ovarian Cancer,1
8437,Malignant Cellular Infiltrate,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
8438,Carcinomatous Component Present,Fibrolamellar Hepatocellular Carcinoma,1
8439,Diffuse Lesion,Breast Angiomatosis,1
8440,Secondary Lesion,Osteosarcoma Arising in Paget Disease of Bone,1
8441,Childhood Lesion,Childhood Cerebral Astrocytoma,1
8442,Epithelial Component Present,Appendix adenoma,1
8443,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
8444,Epithelial Component Present,Metastatic non-small cell lung cancer,1
8445,Swelling,Bizarre parosteal osteochondromatous proliferation,1
8446,Mitotic Activity,Neural Glioblastoma,1
8447,Childhood Lesion,Childhood Burkitt Lymphoma,1
8448,Glandular Pattern,Malignant Pancreatic Somatostatinoma,1
8449,Clinical TNM Finding,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,1
8450,Carcinomatous Component Present,mixed acinar-endocrine carcinoma of pancreas,1
8451,Cutaneous Involvement,Eyelid Xanthoma,1
8452,Malignant Cellular Infiltrate,Endocervical Carcinoma,1
8453,Cutaneous Involvement,Transplant-Related Skin Squamous Cell Carcinoma,1
8454,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,carcinosarcoma of fallopian tube,1
8455,Cutaneous Involvement,Nodular melanoma,1
8456,High Mitotic Activity,Small cell carcinoma of prostate,1
8457,Benign Cellular Infiltrate,Leiomyomatosis,1
8458,Neuroectodermal Differentiation,Ganglioneuroblastoma,1
8459,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hurthle Cell Carcinoma,1
8460,Eccrine Differentiation,Syringoma,1
8461,Carcinomatous Component Present,Colon cancer recurrent,1
8462,Malignant Cellular Infiltrate,Stage IA Vulvar Carcinoma AJCC v6,1
8463,Carcinomatous Component Present,Colon Carcinoma,1
8464,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
8465,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps,1
8466,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma,1
8467,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v8,1
8468,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
8469,Hereditary Lesion,BRCA1 Syndrome,1
8470,Carcinomatous Component Present,Bladder Mixed Adenocarcinoma,1
8471,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
8472,Monoclonal Cellular Population Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
8473,Carcinomatous Component Present,Oropharyngeal lymphoepithelioma stage III,1
8474,Malignant Cellular Infiltrate,Anal Intraepithelial Neoplasia 3,1
8475,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v7,1
8476,Epithelial Component Present,Recurrent Ampulla of Vater Adenocarcinoma,1
8477,Epithelial Component Present,Basal cell carcinoma,1
8478,Superficial Lesion,Vulvar Superficial Angiomyxoma,1
8479,Childhood Lesion,Childhood B Lymphoblastic Lymphoma,1
8480,Intraductal Lesion,Intraductal papillary breast neoplasm,1
8481,Non-Invasive Lesion,Stage 0a Renal Pelvis Cancer AJCC v8,1
8482,'Starry-sky' pattern,Adult Burkitt Lymphoma,1
8483,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor,1
8484,Poorly Differentiated Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
8485,Increased Cellularity Present,Childhood Pineoblastoma,1
8486,Carcinomatous Component Present,Refractory Lung Non-Small Cell Carcinoma,1
8487,Perineural spread,Adenoid cystic carcinoma of trachea,1
8488,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
8489,Malignant Cellular Infiltrate,Stage IIC Prostate Cancer AJCC v8,1
8490,High Grade Lesion,Adult Gliosarcoma,1
8491,Epithelial Component Present,Hormone refractory prostate cancer,1
8492,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,1
8493,Carcinomatous Component Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
8494,Stromal Invasion,Mucinous cystadenocarcinoma of ovary,1
8495,Carcinomatous Component Present,Primary serous papillary carcinoma of peritoneum,1
8496,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v6 and v7,1
8497,Epithelial Component Present,Mild esophageal dysplasia,1
8498,Malignant Cellular Infiltrate,Lymphohistiocytoid Mesothelioma,1
8499,Secondary Lesion,Hepatic cancer metastatic,1
8500,Indolent Clinical Course,Gastric Plexiform Fibromyxoma,1
8501,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Subependymal Glioma,1
8502,Epithelial Component Present,Transitional cell carcinoma of ureter,1
8503,Malignant Cellular Infiltrate,Ovarian cancer stage III,1
8504,Well-Circumscribed Lesion,Cervical Wilms Tumor,1
8505,Epithelial Component Present,Prognostic Stage I Breast Cancer AJCC v8,1
8506,Epithelial Component Present,Thymus Epithelial Neoplasm by AJCC v8 Stage,1
8507,Epithelial Component Present,Esophageal squamous cell carcinoma recurrent,1
8508,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
8509,Exophytic Polypoid Lesion,Gastric Cronkhite Canada Polyposis,1
8510,Epithelial Component Present,"Thymoma, type B2",1
8511,Lymphoplasmacytic Infiltrate,Pulmonary nodular lymphoid hyperplasia,1
8512,Epithelial Component Present,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
8513,Mild cytologic atypia,verrucous carcinoma of vulva,1
8514,Papillary Pattern,Laryngeal verrucous carcinoma recurrent,1
8515,Epithelial Component Present,Squamous cell carcinoma with horn formation,1
8516,Epithelial Component Present,Pedunculated conjunctival papilloma,1
8517,Carcinomatous Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
8518,Carcinomatous Component Present,Stage II Fallopian Tube Cancer,1
8519,"Undifferentiated ""Fetal-Type"" Tissues Present",Central Nervous System Immature Teratoma,1
8520,Epithelial Component Present,Intrahepatic Cholangiocarcinoma,1
8521,Malignant Cellular Infiltrate,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,1
8522,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma,1
8523,Malignant Cellular Infiltrate,Throat cancer,1
8524,Carcinomatous Component Present,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
8525,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage IV,1
8526,Carcinomatous Component Present,Metastatic signet ring cell carcinoma,1
8527,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders,1
8528,Follicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
8529,Mucoid Stroma Formation,Mucinous adenocarcinoma gastric,1
8530,Well Differentiated Lesion,Conventional Schwannoma,1
8531,Malignant Cellular Infiltrate,Refractory Malignant Solid Neoplasm,1
8532,Malignant Cellular Infiltrate,Gastric Squamous Cell Carcinoma,1
8533,Invasive Lesion,Infiltrating Bladder Carcinoma,1
8534,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v8,1
8535,Parakeratosis,Plantar wart,1
8536,Dysplasia,Adenoma of small intestine,1
8537,Encapsulated Mass,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
8538,Exophytic Polypoid Lesion,Endocervical polyp,1
8539,Well-Circumscribed Lesion,Gliomatosis Cerebri Type II,1
8540,Malignant Cellular Infiltrate,Leukemia recurrent,1
8541,High Grade Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
8542,Carcinomatous Component Present,Childhood Paranasal Sinus Carcinoma,1
8543,Epithelial Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
8544,Epithelial Component Present,Unresectable Renal Pelvis Urothelial Carcinoma,1
8545,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
8546,Precise Histogenesis Unknown,Medullary Hemangioblastoma,1
8547,Immunologic Deficiency Syndromes,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
8548,Biphasic Pattern,Malignant Vulvar Phyllodes Tumor,1
8549,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
8550,atypia morphology,Borderline Fallopian Tube Mucinous Tumor,1
8551,Mild cytologic atypia,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
8552,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa,1
8553,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of lung,1
8554,'Starry-sky' pattern,Burkitt's lymphoma of small intestine,1
8555,In Situ Lesion,Stage 0 Gallbladder Cancer AJCC v8,1
8556,Lymphoplasmacytic Infiltrate,Lung Spindle Cell Carcinoma,1
8557,Childhood Lesion,Childhood Soft Tissue Sarcoma,1
8558,Epithelial Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
8559,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage IV,1
8560,Malignant Cellular Infiltrate,Malignant neoplasm of trachea,1
8561,Acanthosis,Condyloma acuminata of cervix,1
8562,Childhood Lesion,Childhood Solid Neoplasm,1
8563,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2,1
8564,Peripheral Nuclear Palisading,Refractory Lung Small Cell Carcinoma,1
8565,Carcinomatous Component Present,Primary ameloblastic carcinoma,1
8566,Malignant Cellular Infiltrate,Low grade myofibroblastic sarcoma,1
8567,Secondary Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,1
8568,Epithelial Component Present,Appendix Tubulovillous Adenoma,1
8569,Glandular Differentiation,"Carcinoid, Goblet Cell",1
8570,Necrotic changes (finding),Malignant Solitary Fibrous Tumor,1
8571,Benign Cellular Infiltrate,Benign Ameloblastoma,1
8572,Malignant Cellular Infiltrate,PRETEXT Stage 4 Hepatoblastoma,1
8573,Pain,Osteoclastic Giant Cell-Rich Tumor of Bone,1
8574,Intestinal metaplasia,Gastric Mixed Adenocarcinoma,1
8575,Pseudo-'onion bulb' formation,Intraneural perineurioma,1
8576,Malignant Cellular Infiltrate,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
8577,Malignant Cellular Infiltrate,Kaposi's sarcoma of extrahepatic bile duct,1
8578,Malignant Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma,1
8579,Dysplasia,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,1
8580,Epithelial Component Present,Hereditary Ovarian Carcinoma,1
8581,Cutaneous Involvement,"Nevus, Blue",1
8582,Malignant Cellular Infiltrate,Mediastinal Extraskeletal Osteosarcoma,1
8583,Epithelial Component Present,Squamous cell papilloma of eyelid,1
8584,Epithelial Component Present,Metastatic Lung Carcinoma,1
8585,Anaplasia,Childhood Gliosarcoma,1
8586,Absence of Invasion,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
8587,Mixed Cellular Population,Lung Adenofibroma,1
8588,Malignant Cellular Infiltrate,Resectable Undifferentiated Pleomorphic Sarcoma,1
8589,Retiform Structures Comprise 90% or More of the Tumor,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
8590,Borderline Resectable Mass,Borderline Resectable Malignant Neoplasm,1
8591,Malignant Cellular Infiltrate,adenoid cystic carcinoma of pharynx,1
8592,Epithelial Component Present,Refractory Malignant Thymoma,1
8593,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
8594,Malignant Cellular Infiltrate,Metastatic Bone Sarcoma,1
8595,Malignant Cellular Infiltrate,Malignant neoplasm of olfactory nerve,1
8596,Epithelial Component Present,Recurrent Cervical Adenosquamous Carcinoma,1
8597,Cystic Change,Breast Mucinous Cystadenocarcinoma,1
8598,Carcinomatous Component Present,Posterior Tongue Mucoepidermoid Carcinoma,1
8599,Endobronchial Mass,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation,1
8600,Epithelial Component Present,Appendix Tubular Carcinoid,1
8601,Malignant Cellular Infiltrate,Thoracic NUT Carcinoma,1
8602,Cystic Lesion,Unresectable Craniopharyngioma,1
8603,Malignant Cellular Infiltrate,Thymic Clear Cell Carcinoma,1
8604,Cystic Change,Hidrocystoma,1
8605,Exophytic Polypoid Lesion,Polyp of sphenoidal sinus,1
8606,No Identifiable Line of Differentiation,Giant Cell Fibrous Histiocytoma,1
8607,Malignant Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v7,1
8608,Cutaneous Involvement,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
8609,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
8610,Malignant Cellular Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
8611,Bone Marrow Dysplasia Present,Adult Myelodysplastic Syndrome,1
8612,Secondary Lesion,Metastatic Prostate Small Cell Carcinoma,1
8613,Vascular Channel Formation,Gastric Hemangioma,1
8614,Multinodular Pattern,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
8615,Eccrine Differentiation,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
8616,Recurrent disease,Recurrent Childhood Burkitt Lymphoma,1
8617,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v7,1
8618,Nerve palsy,Facial Nerve Palsy Related to Trauma,1
8619,Anastomosing Strands of Tumor Cells Present,Odontoameloblastoma,1
8620,Angiocentric Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
8621,Carcinomatous Component Present,Adult Penile Carcinoma,1
8622,Immunologic Deficiency Syndromes,AIDS-Related Anal Canal Carcinoma,1
8623,Cutaneous Involvement,Erythrokeratodermia variabilis,1
8624,Childhood Lesion,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,1
8625,Malignant Cellular Infiltrate,Stage IVA Osteosarcoma AJCC v7,1
8626,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
8627,Mixed Cellular Population,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
8628,Local disease,Pagetoid reticulosis,1
8629,Epithelial Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v8,1
8630,Nuclear Atypia,Glioblastoma,1
8631,Carcinomatous Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
8632,Fibrosis,"Breast Fibrocystic Change, Proliferative Type without Atypia",1
8633,Absence of Invasion,Stage 0 Cervical Cancer AJCC v6,1
8634,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of ovary,1
8635,Epithelial Component Present,Stage III Carcinoma of Stomach,1
8636,Malignant Cellular Infiltrate,Vaginal Carcinosarcoma,1
8637,Benign Cellular Infiltrate,Plexiform Neurofibroma,1
8638,Therapy-Related Toxicity,Transplant-Related Hematologic Malignancy,1
8639,Carcinomatous Component Present,Papillary thyroid carcinoma,1
8640,Carcinomatous Component Present,Stage IIIA Colorectal Cancer AJCC v7,1
8641,Biphasic Pattern,Ovarian Clear Cell Adenofibroma,1
8642,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
8643,Papillary Pattern,papillomatosis of extrahepatic bile duct,1
8644,Malignant Cellular Infiltrate,Intestinal Neuroendocrine Carcinoma,1
8645,Metastatic Lesion,Small intestine adenocarcinoma metastatic NOS,1
8646,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
8647,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Signet Ring Variant",1
8648,CD1a-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis,1
8649,Recurrent disease,Endometrioid adenocarcinoma recurrent,1
8650,Benign Cellular Infiltrate,Adenomyoma,1
8651,Epithelial Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
8652,Myxoid Stroma Formation,Right atrial myxoma,1
8653,Anaplasia,Childhood Gliosarcoma,1
8654,Carcinomatous Component Present,Childhood Small Intestinal Carcinoma,1
8655,Vascular Channel Formation,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
8656,Myxoid Stroma Formation,Epithelioid hemangioendothelioma of lung,1
8657,Malignant Cellular Infiltrate,Cervix carcinoma recurrent,1
8658,Recurrent disease,Recurrent Malignant Ovarian Transitional Cell Tumor,1
8659,Infiltrating Tumor Margins Present,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,1
8660,Chronic lymphocytic inflammation,Abdominal Inflammatory Myofibroblastic Tumor,1
8661,Carcinomatous Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma,1
8662,Benign Cellular Infiltrate,Dermal nerve sheath myxoma,1
8663,Malignant Cellular Infiltrate,Epithelioid Cell Melanoma,1
8664,Absence of Muscle Invasion,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
8665,Small Lesion,Luteoma,1
8666,Eosinophilic inflammation,Breast Inflammatory Myofibroblastic Tumor,1
8667,Diffuse Pattern,Anaplastic Hemispheric Astrocytoma,1
8668,Epithelial Component Present,Thymic Adenocarcinoma,1
8669,Benign Cellular Infiltrate,Congenital hemangioma,1
8670,Malignant Cellular Infiltrate,Occult Lung Non-Small Cell Carcinoma,1
8671,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage III,1
8672,Epithelial Component Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
8673,Nerve palsy,Cranial nerve palsies,1
8674,Low Grade Lesion,Childhood Parosteal Osteosarcoma,1
8675,Epidermotropic Lymphocytic Infiltrate,Pagetoid reticulosis,1
8676,Malignant Cellular Infiltrate,Urothelial cancer of renal pelvis,1
8677,High Mitotic Activity,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
8678,Serrated Glandular Architecture,Rectal Serrated Adenocarcinoma,1
8679,Carcinomatous Component Present,Urethral Cancer by AJCC v7 Stage,1
8680,Epithelial Component Present,Serous Tubal Intraepithelial Carcinoma,1
8681,Epithelial Component Present,Stage IV Adult Liver Cancer AJCC v7,1
8682,Adulthood Lesion,Adult Brain Glioblastoma,1
8683,Severe cytologic atypia,Colon Small Cell Neuroendocrine Carcinoma,1
8684,Congenital Lesion,Proliferative dermal lesion in congenital nevus,1
8685,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v7,1
8686,Cutaneous Involvement,Vulvar Papillary Hidradenoma,1
8687,S-100-Positive Neoplastic Cells Present,Epithelioid Type Angiomyolipoma,1
8688,Immunologic Deficiency Syndromes,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
8689,Nodular Pattern,Recurrent Grade 1 Follicular Lymphoma,1
8690,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v7,1
8691,Malignant Cellular Infiltrate,Sphenoid Sinus Squamous Cell Carcinoma,1
8692,Carcinomatous Component Present,Recurrent Thyroid Gland Medullary Carcinoma,1
8693,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 3 Follicular Lymphoma,1
8694,Endocervical Type Epithelium Present,"Cervical Adenomyoma, Endocervical Type",1
8695,Carcinomatous Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
8696,Epithelial Component Present,Bladder transitional cell carcinoma stage III,1
8697,Malignant Cellular Infiltrate,Marginal zone lymphoma recurrent,1
8698,Cartilaginous Differentiation,Childhood Mesenchymal Chondrosarcoma,1
8699,Carcinomatous Component Present,HPV positive oropharyngeal squamous cell carcinoma,1
8700,Refractory Disease,Mantle cell lymphoma refractory,1
8701,Metastatic Lesion,Secondary malignant neoplasm of urethra,1
8702,Carcinomatous Component Present,Stage IVA Major Salivary Gland Cancer AJCC v8,1
8703,Thrombocytosis,"Thrombocythemia, Essential",1
8704,Neuroendocrine Differentiation,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
8705,Refractory Disease,Refractory Primary Effusion Lymphoma,1
8706,Indolent Clinical Course,calcifying aponeurotic fibroma,1
8707,Capillary Sized Vascular Channel Formation,Retinal hemangioblastoma,1
8708,Indolent Clinical Course,benign lipoma of gallbladder,1
8709,High Mitotic Activity,neuroendocrine carcinoma of anal canal,1
8710,Adulthood Lesion,Adult Central Nervous System Germinoma,1
8711,Carcinomatous Component Present,Ductal Carcinoma In Situ with Microinvasion,1
8712,Malignant Cellular Infiltrate,T-cell lymphoma stage II,1
8713,Epithelial Component Present,Bladder Diffuse Clear Cell Adenocarcinoma,1
8714,Cutaneous Involvement,Blastic plasmacytoid dendritic cell neoplasm,1
8715,Dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
8716,Necrotic changes (finding),Malignant Lung PEComa,1
8717,Sebaceous Differentiation,Salivary Gland Sebaceous Lymphadenoma,1
8718,Malignant Cellular Infiltrate,Adenocarcinoid tumor,1
8719,Carcinomatous Component Present,Cholangiocarcinoma resectable,1
8720,Malignant Cellular Infiltrate,Stage III Carcinoma of Stomach,1
8721,Myxoid Stroma Formation,Locally Advanced Chordoma,1
8722,Malignant Cellular Infiltrate,Angiocentric lymphoma stage IV,1
8723,Childhood Lesion,Childhood Pineoblastoma,1
8724,Recurrent disease,Recurrent Breast Angiosarcoma,1
8725,Absence of Invasion,Stage 0 Vulvar Carcinoma,1
8726,Malignant Cellular Infiltrate,Prostate Cancer by Whitmore-Jewett Stage,1
8727,Malignant Cellular Infiltrate,Unilateral Breast Carcinoma,1
8728,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligoastrocytoma,1
8729,Epithelial Component Present,Carcinoma of lung,1
8730,Primary Lesion,Recurrent Childhood Anaplastic Astrocytoma,1
8731,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile astrocytoma,1
8732,Malignant Cellular Infiltrate,Small intestine carcinoma recurrent,1
8733,Vascular Channel Formation,Cardiac Capillary Hemangioma,1
8734,High Grade Lesion,Combined Lung Carcinoma,1
8735,Malignant Cellular Infiltrate,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,1
8736,Epithelial Component Present,adenosquamous carcinoma of skin,1
8737,Immunosuppression-Related Post-Transplant Toxicity,Steroid Refractory Graft Versus Host Disease,1
8738,Epithelial Component Present,Refractory Lung Small Cell Carcinoma,1
8739,Cystic Change,Benign mixed epithelial and stromal tumor of kidney,1
8740,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma AJCC v7,1
8741,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
8742,Proliferation of Follicular Dendritic Cells Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
8743,Adulthood Lesion,Recurrent Adult Non-Hodgkin Lymphoma,1
8744,Slow Growing Mass,Unresectable Craniopharyngioma,1
8745,Benign Cellular Infiltrate,Uterine Corpus Lipoleiomyoma,1
8746,Epithelial Component Present,"Carcinoid, Goblet Cell",1
8747,Malignant Cellular Infiltrate,Recurrent Primary Lymphoma of Bone,1
8748,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Neoplasm,1
8749,Secondary Lesion,Uveal Melanoma Metastatic in the Liver,1
8750,Epithelial Component Present,large cell neuroendocrine carcinoma of lung,1
8751,Epithelial Component Present,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas,1
8752,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
8753,Biphasic Pattern,Perineal Ectopic Fibroadenoma,1
8754,Carcinomatous Component Present,Pericardial Carcinomatosis,1
8755,Carcinomatous Component Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
8756,Epithelial Component Present,Anal Canal Neuroendocrine Neoplasm,1
8757,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type I,1
8758,Well-Circumscribed Lesion,Adenomatous Polyps,1
8759,No Evidence of Hormonal Immunoreactivity Present,Null Cell Pituitary Gland Adenoma,1
8760,Toxic effect,Aflatoxins-Related Hepatocellular Carcinoma,1
8761,Locally Aggressive Lesion,Central Nervous System Desmoid-Type Fibromatosis,1
8762,High Grade Lesion,Solid Alveolar Rhabdomyosarcoma,1
8763,Pseudopapillary Pattern,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
8764,High Mitotic Activity,Recurrent Anaplastic Oligoastrocytoma,1
8765,Malignant Cellular Infiltrate,Malignant mesothelioma of pericardium,1
8766,Ineffective hematopoiesis,Alkylating Agent-Related Acute Myeloid Leukemia,1
8767,Benign Cellular Infiltrate,Benign Adult Brain Stem Neoplasm,1
8768,Malignant Cellular Infiltrate,Acute myeloid leukemia with abnormal marrow eosinophils,1
8769,Apocrine Differentiation,Carcinoma of apocrine gland,1
8770,Exophytic Papillary Lesion,Urethral Condyloma Acuminatum,1
8771,Unfavorable Clinical Outcome,Intermediate Atypical Prostate Carcinoma,1
8772,Malignant Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v6 and v7,1
8773,Epithelial Component Present,High Grade Salivary Gland Carcinoma,1
8774,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8,1
8775,Well Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
8776,Malignant Cellular Infiltrate,Solar Radiation-Related Malignant Neoplasm,1
8777,Secondary Lesion,Metastatic Triple-Negative Breast Carcinoma,1
8778,Epithelial Component Present,Squamous cell carcinoma of skin,1
8779,Carcinomatous Component Present,Stage IVB Oral Cavity Cancer AJCC v6 and v7,1
8780,Malignant Cellular Infiltrate,Sarcoma of vulva,1
8781,Malignant Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma,1
8782,S-100-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis,1
8783,Primary Lesion,Synovial sarcoma non-metastatic,1
8784,Refractory Disease,Refractory Malignant Female Reproductive System Neoplasm,1
8785,Malignant Cellular Infiltrate,Stage IIB Bone Sarcoma AJCC v7,1
8786,Erythroid hyperplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
8787,Glial Differentiation,Childhood Brain Stem Gliosarcoma,1
8788,Carcinomatous Component Present,"Papillary renal cell carcinoma, sporadic",1
8789,Follicular Structures Present,Thyroid Gland Hyperfunctioning Adenoma,1
8790,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
8791,Stromal Invasion,Stage IIA Ovarian Cancer AJCC V6 and v7,1
8792,Epithelial Component Present,Vulvar Seborrheic Keratosis,1
8793,Childhood Lesion,Rhabdoid Tumor of the Kidney,1
8794,Epithelial Component Present,Stage III Rectosigmoid Cancer AJCC v7,1
8795,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
8796,Primary Lesion,Recurrent Childhood Glioblastoma,1
8797,Lymphoplasmacytic Infiltrate,HHV8-Positive Multicentric Castleman Disease,1
8798,Malignant Cellular Infiltrate,Papillary mucinous cystadenocarcinoma,1
8799,Juvenile Lesion,Juvenile Type Testicular Granulosa Cell Tumor,1
8800,Neuroendocrine Differentiation,Mediastinal Paraganglioma,1
8801,Sebaceous Differentiation,Sebaceous Adenocarcinoma,1
8802,Pushing Tumor Margin,Verrucous carcinoma of the oral cavity recurrent,1
8803,Primary Lesion,Chondroblastic osteosarcoma,1
8804,Epithelial Component Present,Stage IVB Vaginal Cancer AJCC v8,1
8805,Malignant Cellular Infiltrate,Childhood Gliomatosis Cerebri,1
8806,Benign Cellular Infiltrate,Spindle Cell Oncocytoma of the Adenohypophysis,1
8807,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
8808,Multifocal Lesion,Multiple Endocrine Neoplasia Type 1,1
8809,Secondary Lesion,Secondary malignant neoplasm of pharynx,1
8810,Benign Cellular Infiltrate,benign endometrioid tumor of ovary,1
8811,Epithelial Component Present,"Basal cell carcinoma, infundibulocystic",1
8812,Hyalinized Stroma Formation,malignant epithelioid hemangioendothelioma of liver,1
8813,Antoni A Pattern,Benign Esophageal Schwannoma,1
8814,Epithelial Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm,1
8815,Epithelial Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
8816,Cutaneous Involvement,Pyogenic granuloma of skin and subcutaneous tissue,1
8817,Malignant Cellular Infiltrate,"Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",1
8818,Low Cellularity Present,Desmoplastic fibroblastoma,1
8819,Primary Lesion,Brain Stem Glioblastoma,1
8820,Malignant Cellular Infiltrate,Cutaneous Malignant Melanoma 2,1
8821,Cutaneous Involvement,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
8822,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
8823,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v8,1
8824,Smooth Muscle Component Present,Epithelioid Type Angiomyolipoma,1
8825,Slow Growing Mass,Childhood Myxopapillary Ependymoma,1
8826,Apocrine Differentiation,apocrine adenocarcinoma of vulva,1
8827,Carcinomatous Component Present,Salivary Gland Myoepithelial Carcinoma,1
8828,Malignant Cellular Infiltrate,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage,1
8829,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
8830,Epithelial Component Present,Hidradenoma Papilliferum,1
8831,Extensive Stage Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
8832,Multicentric Lesion,Multicentric Breast Carcinoma,1
8833,Epithelial Component Present,Foveolar-Type Adenoma,1
8834,Epithelial Component Present,Stage IIIB Lung Large Cell Carcinoma AJCC v7,1
8835,Carcinomatous Component Present,Metastatic Renal Pelvis Urothelial Carcinoma,1
8836,Benign Cellular Infiltrate,Benign neoplasm of sternum,1
8837,Increased Cellularity Present,Cellular Myxoma,1
8838,Immunosuppression-Related Post-Transplant Toxicity,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
8839,Childhood Lesion,Childhood Lymphoma,1
8840,Splenomegaly,"Leukemia, Myeloid, Chronic-Phase",1
8841,Thyroglobulin Positive Neoplastic Cells Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
8842,Carcinomatous Component Present,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
8843,Recurrent disease,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
8844,Diffuse Pattern,Adult Brain Stem Gliosarcoma,1
8845,Malignant Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v7,1
8846,Malignant Cellular Infiltrate,Body Cavity Primary Effusion Lymphoma,1
8847,Absence of Invasion,Lung Adenocarcinoma In Situ,1
8848,Benign Cellular Infiltrate,Benign Genitourinary System Neoplasm,1
8849,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
8850,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Chronic Neutrophilic Leukemia,1
8851,Fibrotic Stroma Formation,Peripheral Intrahepatic Cholangiocarcinoma,1
8852,Secondary Lesion,Small intestine carcinoma metastatic,1
8853,Childhood Lesion,recurrent childhood acute myeloid leukemia,1
8854,Epithelial Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
8855,Adulthood Lesion,Adult Intracranial Germ Cell Tumor,1
8856,Multinodular Pattern,Vulvar Proximal-Type Epithelioid Sarcoma,1
8857,Tubular Structures Present,Tubular breast carcinoma,1
8858,Secondary Lesion,Advanced Cutaneous Melanoma of the Extremity,1
8859,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma refractory,1
8860,Malignant Cellular Infiltrate,Extragonadal Seminoma,1
8861,Epithelial Component Present,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8862,Nodular Pattern,Pulmonary nodular lymphoid hyperplasia,1
8863,Papillary Pattern,Paranasal Sinus Schneiderian Papilloma,1
8864,Neuroendocrine Differentiation,Low Grade Lung Neuroendocrine Neoplasm,1
8865,Primary Lesion,Adult Meningeal Melanoma,1
8866,Recurrent disease,Recurrent Acute Leukemia,1
8867,Five or Less Mitoses per 50HPF,Benign Gastric Gastrointestinal Stromal Tumor,1
8868,Necrotic changes (finding),Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
8869,Epithelial Component Present,Childhood Salivary Gland Carcinoma,1
8870,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v8,1
8871,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
8872,Precise Histogenesis Unknown,Cerebellar hemangioblastoma,1
8873,Malignant Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v7,1
8874,Malignant Cellular Infiltrate,Localized Peripheral Primitive Neuroectodermal Tumor,1
8875,Epithelial Component Present,Colon adenoma,1
8876,Therapy-Related Toxicity,Methotrexate-Associated Peripheral T-Cell Lymphoma,1
8877,Malignant Cellular Infiltrate,Recurrent Childhood Hepatocellular Carcinoma,1
8878,Pushing Tumor Margin,Laryngeal verrucous carcinoma recurrent,1
8879,Epithelial Component Present,Gallbladder Neuroendocrine Carcinoma,1
8880,Tubular Pattern,Appendix Tubulovillous Adenoma,1
8881,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
8882,Malignant Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
8883,Epithelial Component Present,Stage I Skin Cancer,1
8884,Malignant Cellular Infiltrate,Meningeal Carcinomatosis,1
8885,Biphasic Pattern,Ovarian Serous Adenofibroma,1
8886,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia,1
8887,Rapidly Enlarging Mass,Rhabdomyosarcoma,1
8888,Secondary Lesion,Secondary malignant neoplasm of vulva,1
8889,Plasma cell inflammation,Cardiac Inflammatory Myofibroblastic Tumor,1
8890,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
8891,Malignant Cellular Infiltrate,Intermediate Cell Type Iris Melanoma,1
8892,Benign Cellular Infiltrate,Lipomatosis of Nerve,1
8893,Childhood Lesion,Childhood Nasal Cavity Carcinoma,1
8894,Cystic Change,Papillary serous cystadenocarcinoma,1
8895,Diffuse Pattern,"Trophoblastic Tumor, Placental Site",1
8896,Malignant Cellular Infiltrate,squamous cell carcinoma of ureter,1
8897,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
8898,Secondary Lesion,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
8899,Epithelial Component Present,"Neoplasms, Fibroepithelial",1
8900,Childhood Lesion,Grade III Childhood Astrocytoma,1
8901,Epithelial Component Present,mucinous adenocarcinofibroma of ovary,1
8902,Papillary Pattern,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
8903,Epithelial Component Present,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
8904,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma,1
8905,Extensive Stage Lesion,Advanced Lung Carcinoma,1
8906,Hemorrhagic Neuroblastic Nodules Present,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
8907,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
8908,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx recurrent,1
8909,Epithelial Component Present,Stage III Urethral Cancer AJCC v7,1
8910,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
8911,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
8912,Malignant Cellular Infiltrate,Myxosarcoma,1
8913,Indolent Clinical Course,"Lymphangioma, Cystic",1
8914,Primary Lesion,Recurrent Fibrolamellar Carcinoma,1
8915,Monomorphic Cellular Infiltrate,Vaginal Basaloid Carcinoma,1
8916,High Mitotic Activity,Minor Salivary Gland Small Cell Carcinoma,1
8917,Epithelial Component Present,serous surface papillary carcinoma of ovary,1
8918,Carcinomatous Component Present,Bartholin Gland Adenocarcinoma,1
8919,Childhood Lesion,Recurrent Childhood Diffuse Astrocytoma,1
8920,Malignant Cellular Infiltrate,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,1
8921,Benign Cellular Infiltrate,Benign Outer Hair Sheath and Infundibulum Neoplasm,1
8922,Epithelial Component Present,Recurrent Endometrial Cancer,1
8923,Hemorrhagic,Peripheral Intraneural Angiosarcoma,1
8924,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
8925,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
8926,Local disease,Lipoma of the tongue,1
8927,Adulthood Lesion,Adult Diffuse Astrocytoma,1
8928,Juvenile Lesion,Juvenile Xanthogranuloma,1
8929,Malignant Cellular Infiltrate,Stage II Colon Cancer AJCC v7,1
8930,Cutaneous Involvement,Dermatofibrosarcoma Protuberans,1
8931,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
8932,Malignant Cellular Infiltrate,Clinical Stage IVA Gastric Cancer AJCC v8,1
8933,Invasive Lesion,Adenocarcinoma of the prostate stage III,1
8934,Necrotic changes (finding),Endometrial Large Cell Neuroendocrine Carcinoma,1
8935,Malignant Cellular Infiltrate,Recurrent Kidney Wilms Tumor,1
8936,Indolent Clinical Course,Hemangioma of subcutaneous tissue,1
8937,Malignant Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
8938,Mitotic Activity,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",1
8939,Malignant Cellular Infiltrate,Salivary duct carcinoma,1
8940,Malignant Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor,1
8941,Carcinomatous Component Present,Squamous cell carcinoma of rectum,1
8942,Primary Lesion,Recurrent Childhood Rhabdomyosarcoma,1
8943,Malignant Cellular Infiltrate,Refractory Transformed Non-Hodgkin Lymphoma,1
8944,Follicular Cell Differentiation,minimally invasive follicular carcinoma of the thyroid gland,1
8945,Heterologous Elements Present,"Uterine Carcinosarcoma, Heterologous Type",1
8946,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
8947,Adulthood Lesion,Adult Acute Monocytic Leukemia,1
8948,Hyperkeratosis,Vulvar Warty Carcinoma,1
8949,Epithelial Component Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
8950,atypia morphology,Borderline Fallopian Tube Neoplasm,1
8951,Recurrent disease,Recurrent Digestive System Carcinoma,1
8952,Biphasic Pattern,Pleural Biphasic Mesothelioma,1
8953,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,1
8954,Osteoid formation,Kidney Extraskeletal Osteosarcoma,1
8955,Carcinomatous Component Present,Mucinous adenocarcinoma of appendix,1
8956,High Grade Lesion,Ovarian Rhabdomyosarcoma,1
8957,Intermediate Filaments Present,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
8958,Myomatous Stroma Formation,Uterine Corpus Adenomyoma,1
8959,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma refractory,1
8960,Nests of Nevus Cells Resembling Nerve Bundles Present,Neuronevus,1
8961,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
8962,Mild cytologic atypia,Buccal Mucosa Verrucous Carcinoma,1
8963,High Grade Lesion,Poorly Differentiated Fibrosarcoma,1
8964,Collagenous Stroma Formation,Pelvic Fibromatosis,1
8965,Borderline Lesion,Borderline Exocrine Pancreatic Neoplasm,1
8966,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v8,1
8967,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
8968,Childhood Lesion,Childhood Mediastinal Neurogenic Neoplasm,1
8969,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Tumor G1,1
8970,Carcinomatous Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8,1
8971,Nuclear Atypia,Epithelioid glioblastoma,1
8972,Papillary Pattern,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
8973,Metastatic Lesion,Locally Advanced Unresectable Cervical Carcinoma,1
8974,Absence of Invasion,Pathologic Stage 0 Gastric Cancer AJCC v8,1
8975,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast,1
8976,Villous Pattern,Villous adenoma of rectum,1
8977,Epithelial Component Present,Broad Ligament Papillary Cystadenoma,1
8978,Aggressive Clinical Course,Adult Burkitt Leukemia,1
8979,Melanin-Forming Neuroepithelial Cells Present,"Neuroectodermal Tumor, Melanotic",1
8980,Carcinomatous Component Present,Stage IA1 Cervical Cancer,1
8981,Epithelial Component Present,Metastatic Lung Carcinoma,1
8982,Refractory Disease,Refractory Malignant Urinary System Neoplasm,1
8983,Nuclear Pseudoinclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
8984,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma of central nervous system,1
8985,Benign Cellular Infiltrate,Myolipoma,1
8986,Epithelial Component Present,Renal Adenoma,1
8987,Regional Disease,Locally Advanced Unresectable Malignant Neoplasm,1
8988,Cutaneous Involvement,Basal cell carcinoma - keratotic,1
8989,Benign Cellular Infiltrate,Thyroid Gland Hyperfunctioning Adenoma,1
8990,Low Grade Lesion,Grade I Chondrosarcoma,1
8991,Malignant Cellular Infiltrate,Squamous cell carcinoma of lip,1
8992,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma transformed recurrent,1
8993,Parakeratosis,Common wart,1
8994,Malignant Cellular Infiltrate,Primary serous papillary carcinoma of peritoneum,1
8995,Epithelial Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
8996,Neuronal Differentiation,Ganglioneuroma,1
8997,Spindle Cell Component Present,Metanephric stromal tumor,1
8998,Adulthood Lesion,Adult cystic teratoma,1
8999,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
9000,Epithelial Component Present,Breast cancer recurrent,1
9001,Carcinomatous Component Present,Stage IB Esophageal Cancer AJCC v7,1
9002,Ground Glass Nuclear Inclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
9003,Epithelial Component Present,Thymoma by AJCC v8 Stage,1
9004,Epithelial Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
9005,Malignant Cellular Infiltrate,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
9006,Malignant Cellular Infiltrate,"Spindle cell melanoma, type A",1
9007,Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma,1
9008,Epithelial Component Present,Juvenile type ovarian granulosa cell tumor,1
9009,Benign Cellular Infiltrate,Dermal Duct Tumor,1
9010,Malignant Cellular Infiltrate,Malignant neoplasm of mandible,1
9011,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
9012,Malignant Cellular Infiltrate,Squamous cell carcinoma,1
9013,Epithelial Component Present,Recurrent Acinic Cell Breast Carcinoma,1
9014,Single Cell Necrosis,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
9015,Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
9016,Prominent In Situ Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
9017,Necrotic changes (finding),small cell carcinoma of breast,1
9018,Epithelial Component Present,Pathologic Stage IA Gastric Cancer AJCC v8,1
9019,Clinical TNM Finding,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
9020,Chronic Inflammatory Infiltrate,Cutaneous Lymphomatoid Granulomatosis,1
9021,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v7,1
9022,Epithelial Component Present,Stage IV Lung Cancer AJCC v8,1
9023,Carcinomatous Component Present,Adenocarcinoma of rete ovarii,1
9024,Pericanalicular Growth Pattern,Pericanalicular fibroadenoma,1
9025,Cutaneous Involvement,Acral Skin Nevus,1
9026,Atypical Mitotic Figures,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
9027,Epithelial Component Present,Soft Palate Squamous Cell Carcinoma,1
9028,Well-Circumscribed Lesion,Hyperplastic Polyp,1
9029,Microcystic Change,Recurrent Childhood Fibrillary Astrocytoma,1
9030,Epithelial Component Present,adenoid cystic carcinoma of lung,1
9031,Malignant Cellular Infiltrate,Recurrent Adult Lymphoblastic Lymphoma,1
9032,Malignant Cellular Infiltrate,"Carcinoma bladder stage I, without cancer in situ",1
9033,Epithelial Component Present,Vulvar Cancer by AJCC v8 Stage,1
9034,Carcinomatous Component Present,Stage IVB Laryngeal Cancer AJCC v7,1
9035,Carcinomatous Component Present,Stage IB2 Cervical Cancer AJCC v8,1
9036,Childhood Lesion,Recurrent Childhood Medulloblastoma,1
9037,Hyperkeratosis,Desmoplastic trichilemmoma,1
9038,Adulthood Lesion,Stage III Adult Liver Cancer AJCC v7,1
9039,Recurrent disease,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
9040,Indolent Clinical Course,Central Nervous System Hibernoma,1
9041,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
9042,Regional Disease,Locally Advanced Unresectable Cervical Carcinoma,1
9043,Epithelial Component Present,Malignant Testicular Sertoli Cell Tumor,1
9044,High Grade Lesion,Fibroblastic osteosarcoma,1
9045,Severe dysplasia,Adenocarcinoma in situ in a polyp,1
9046,Stromal Invasion,Ovarian Cancer by FIGO Stage,1
9047,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
9048,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
9049,Diffuse Lesion,Pleural Carcinomatosis,1
9050,Malignant Cellular Infiltrate,Small Size Posterior Uveal Melanoma,1
9051,Epithelial Component Present,Cervical Adenosquamous Carcinoma,1
9052,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Adenocarcinoma,1
9053,Indolent Clinical Course,Cutaneous Fibrous Histiocytoma,1
9054,Localized Lesion,Chest Wall Solitary Plasmacytoma,1
9055,Malignant Cellular Infiltrate,Stage III Childhood Anaplastic Large Cell Lymphoma,1
9056,Epithelial Component Present,Stomach Carcinoma,1
9057,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
9058,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
9059,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2,1
9060,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v8,1
9061,Childhood Lesion,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
9062,Epithelial Component Present,Rectal Cancer by AJCC v8 Stage,1
9063,Primary Lesion,Chondroblastic osteosarcoma,1
9064,Epithelial Component Present,Adenocarcinoma of the prostate metastatic,1
9065,Absence of Invasion,Carcinoma in situ of small intestine,1
9066,Dysplasia,Cervical intraepithelial neoplasia grade 2,1
9067,Epithelial Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
9068,Cutaneous Involvement,Stage IA Mycosis Fungoides AJCC v7,1
9069,Malignant Cellular Infiltrate,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
9070,Hypocellular Tissue,Intramuscular Myxoma,1
9071,Carcinomatous Component Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
9072,Glucagon-Like Peptide Positive Neoplastic Cells Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
9073,High Mitotic Activity,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
9074,Epithelial Component Present,Maxillary Sinus Carcinoma,1
9075,Malignant Cellular Infiltrate,"Adenocarcinoma, Oxyphilic",1
9076,Indolent Clinical Course,Piloleiomyoma,1
9077,Malignant Cellular Infiltrate,Recurrent Hematologic Malignancy,1
9078,Ineffective hematopoiesis,Refractory Neutropenia,1
9079,Mixed Cellular Population,Recurrent Childhood Anaplastic Oligoastrocytoma,1
9080,Immature Granulocytes in Peripheral Blood Increased,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
9081,Epithelial Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
9082,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Sebaceous Adenoma,1
9083,Primary Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
9084,Carcinomatous Component Present,mucinous adenocarcinoma of salivary gland,1
9085,Cartilaginous Component Present,Chondroblastic osteosarcoma,1
9086,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanocytic Nevus,1
9087,Immunologic Deficiency Syndromes,Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
9088,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
9089,Cutaneous Involvement,Invasive Apocrine Breast Carcinoma,1
9090,Carcinomatous Component Present,Stage IVB Prostate Cancer AJCC v8,1
9091,Malignant Cellular Infiltrate,Grade 4 Malignant Neoplasm,1
9092,Necrotic changes (finding),Colon Small Cell Neuroendocrine Carcinoma,1
9093,Cartilaginous Differentiation,mesenchymal chondrosarcoma of bone,1
9094,Absence of Stromal Invasion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
9095,Carcinomatous Component Present,Stage IA2 Cervical Cancer,1
9096,Carcinomatous Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8,1
9097,Well-Circumscribed Lesion,Stage II Kidney Wilms Tumor,1
9098,Secondary Lesion,Metastatic Squamous Cell Breast Carcinoma,1
9099,Malignant Cellular Infiltrate,Pharyngeal cancer stage I,1
9100,Pathologic TNM Finding,Pathologic Stage I Gastric Cancer AJCC v8,1
9101,Epithelial Component Present,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
9102,Lesion with Diameter Greater than 15mm,Medium/Large Size Posterior Uveal Melanoma,1
9103,Malignant Cellular Infiltrate,Hard Palate Adenoid Cystic Carcinoma,1
9104,High Grade Lesion,Occult Lung Small Cell Carcinoma,1
9105,Epithelial Component Present,Lepidic Predominant Adenocarcinoma,1
9106,Hyperplastic Tissue Present,Focal Epithelial Hyperplasia,1
9107,Pushing Tumor Margin,Urethral Verrucous Carcinoma,1
9108,Malignant Cellular Infiltrate,Papillary thyroid carcinoma,1
9109,In Situ Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
9110,Secondary Lesion,Secondary malignant neoplasm of vulva,1
9111,Malignant Cellular Infiltrate,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
9112,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
9113,Slow Growing Painless Mass,Nodular tenosynovitis,1
9114,Carcinomatous Component Present,Stage IIB Prostate Cancer AJCC v7,1
9115,Malignant Cellular Infiltrate,Angiocentric lymphoma stage II,1
9116,Epithelial Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
9117,Infiltrative Growth Pattern,Lipofibromatosis,1
9118,Carcinomatous Component Present,clear cell adenocarcinoma of urethra,1
9119,Epithelial Component Present,Squamous cell carcinoma in situ with questionable stromal invasion,1
9120,Malignant Cellular Infiltrate,Unresectable Pancreatic Neuroendocrine Carcinoma,1
9121,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
9122,Mixed Cellular Population,Borderline Ovarian Endometrioid Cystadenofibroma,1
9123,Epithelial Component Present,Cervical Basaloid Carcinoma,1
9124,Exophytic Papillary Lesion,Warty Carcinoma of the Penis,1
9125,Epithelial Component Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
9126,Well-Circumscribed Lesion,Ovarian Myxoid Liposarcoma,1
9127,Carcinomatous Component Present,Stage IIB Esophageal Carcinoma,1
9128,Childhood Lesion,St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8,1
9129,Intracellular Accumulation of Lipids,Childhood Pleomorphic Xanthoastrocytoma,1
9130,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
9131,Anaplasia,Giant cell carcinoma of lung,1
9132,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
9133,Childhood Lesion,Childhood Testicular Mixed Germ Cell Tumor,1
9134,Biphasic Pattern,Tibial adamantinoma,1
9135,Carcinomatous Component Present,Synchronous Bilateral Breast Carcinoma,1
9136,Carcinomatous Component Present,Refractory Endometrial Mixed Cell Adenocarcinoma,1
9137,Malignant Cellular Infiltrate,Primary Cutaneous Follicle Center Lymphoma,1
9138,Malignant Cellular Infiltrate,Ureter Lymphoma,1
9139,Absence of Invasion,Bowenoid papulosis,1
9140,Therapy-Related Toxicity,Iatrogenic Kaposi Sarcoma,1
9141,High Grade Lesion,Childhood Gliosarcoma,1
9142,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia,1
9143,Trabecular Pattern,Somatostatinoma,1
9144,Carcinomatous Component Present,Neuroendocrine carcinoma of appendix,1
9145,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of breast,1
9146,Carcinomatous Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7,1
9147,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
9148,Absence of Invasion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
9149,Epithelial Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
9150,Carcinomatous Component Present,Head and neck cancer metastatic,1
9151,Myxoid Stroma Formation,Myxoma of the Endocardium,1
9152,Necrotic changes (finding),Small cell carcinoma of the cervix,1
9153,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12),1
9154,Carcinomatous Component Present,Disseminated carcinoma,1
9155,Hyperplastic Tissue Present,Prostatic Atypical Adenomatous Hyperplasia,1
9156,Malignant Cellular Infiltrate,Stage IV Cervical Cancer AJCC v8,1
9157,Low Cellularity Present,Recurrent Childhood Pilocytic Astrocytoma,1
9158,Storiform Growth Pattern,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
9159,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent,1
9160,Carcinomatous Component Present,Refractory Endometrial Serous Adenocarcinoma,1
9161,Epithelial Component Present,Stage I Lung Cancer AJCC v6,1
9162,Carcinomatous Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
9163,Epithelial Component Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
9164,Mixed Cellular Population,Mucinous cystadenofibroma,1
9165,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),1
9166,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
9167,Epithelial Component Present,Breast Carcinoma with Osseous Metaplasia,1
9168,Papillary Pattern,Papilloma,1
9169,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
9170,Cutaneous Involvement,Crusted scabies,1
9171,Carcinomatous Component Present,Localized Unresectable Adult Hepatocellular Carcinoma,1
9172,Epithelial Component Present,cystadenocarcinoma of salivary gland,1
9173,Carcinomatous Component Present,Stage IIIB Gallbladder Cancer AJCC v8,1
9174,Childhood Lesion,Childhood Astrocytoma,1
9175,Malignant Cellular Infiltrate,Stage IIA Colorectal Cancer AJCC v8,1
9176,Benign Cellular Infiltrate,Tendon Sheath Lipoma,1
9177,Pseudoencapsulated Mass,Melanotic malignant nerve sheath tumor,1
9178,Benign Cellular Infiltrate,Perifollicular fibroma,1
9179,Serrated Glandular Architecture,Colorectal Traditional Serrated Adenoma,1
9180,Malignant Cellular Infiltrate,Combined Lung Large Cell Neuroendocrine Carcinoma,1
9181,S-100-Positive Neoplastic Cells Present,Sclerosing PEComa,1
9182,Malignant Cellular Infiltrate,Vulvar Alveolar Soft Part Sarcoma,1
9183,Vascular Channel Formation,Hemangioma of intra-abdominal structure,1
9184,Adulthood Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
9185,Metastatic Lesion,Liposarcoma metastatic,1
9186,Low Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
9187,Adulthood Lesion,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
9188,Biphasic Pattern,Uterine Corpus Carcinosarcoma,1
9189,Chronic Inflammatory Infiltrate,Dysgerminoma of ovary,1
9190,Cellular Pleomorphism,Atypical neurofibroma,1
9191,Nuclear Palisading,Palisaded Lymph Node Myofibroblastoma,1
9192,Collagenous Stroma Formation,Benign mixed epithelial and stromal tumor of kidney,1
9193,Epithelial Component Present,Carcinoma of lower gum,1
9194,Epithelial Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7,1
9195,Metastatic Lesion,Locally Advanced Gastrointestinal Stromal Tumor,1
9196,Macrocystic Change,Pancreatic Macrocystic Serous Cystadenoma,1
9197,Malignant Cellular Infiltrate,Refractory Neuroblastoma,1
9198,Low Mitotic Activity,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
9199,Exophytic Polypoid Lesion,Vaginal Villous Adenoma,1
9200,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Conventional Leiomyosarcoma,1
9201,Well-Circumscribed Lesion,Cardiac rhabdomyoma,1
9202,Anaplasia,Childhood Anaplastic Oligodendroglioma,1
9203,Malignant Cellular Infiltrate,clear cell adenocarcinoma of urethra,1
9204,Macule,Mucosal lentiginous melanoma,1
9205,Malignant Cellular Infiltrate,Lentigo maligna recurrent,1
9206,Clinical TNM Finding,Clinical Stage 0 Gastric Cancer AJCC v8,1
9207,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1
9208,Recurrent Genetic Abnormalities Present,Hypodiploid B Acute Lymphoblastic Leukemia,1
9209,Carcinomatous Component Present,Stage IV Anal Canal Cancer AJCC v6 and v7,1
9210,Solid Growth Pattern,Breast Solid Neuroendocrine Carcinoma,1
9211,Tubular Pattern,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
9212,Immunologic Deficiency Syndromes,AIDS-related anal cancer recurrent,1
9213,Epithelial Component Present,Anatomic Stage IIIB Breast Cancer AJCC v8,1
9214,Increased Cellularity Present,Cellular Ependymoma,1
9215,Malignant Cellular Infiltrate,Cervical Basaloid Carcinoma,1
9216,Primary Lesion,Recurrent Primary Cutaneous Lymphoma,1
9217,Childhood Lesion,Childhood Cerebellar Anaplastic Astrocytoma,1
9218,Primary Lesion,High grade surface osteosarcoma,1
9219,Primary Lesion,Adult Brain Stem Mixed Glioma,1
9220,"Fully Differentiated ""Adult-Type"" Tissues Present",Vaginal Dermoid Cyst,1
9221,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,1
9222,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
9223,Non-Malignant Cellular Infiltrate,Submandibular lymphadenitis,1
9224,Comedo Necrosis,Rectal Cribriform Comedo-Type Adenocarcinoma,1
9225,Cellular Pleomorphism,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
9226,Clinical TNM Finding,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
9227,Neuroendocrine Differentiation,Endometrial Small Cell Carcinoma,1
9228,Neuroendocrine Differentiation,Intestinal Neuroendocrine Neoplasm,1
9229,Epithelial Component Present,Gastric Carcinoma with Lymphoid Stroma,1
9230,Solitary mass,Metastatic Chordoma,1
9231,Tissue Differentiation Uncertain,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
9232,Mesenchymal Component Present,Cellular Pleomorphic Adenoma,1
9233,Absence of Invasion,Adenocarcinoma in situ in villous adenoma,1
9234,Secondary Lesion,Advanced Kaposi Sarcoma,1
9235,Pseudorosette Formation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
9236,Carcinomatous Component Present,Gallbladder adenocarcinoma,1
9237,Epithelial Component Present,Clinical Stage I Gastric Cancer AJCC v8,1
9238,Hereditary Lesion,Bannayan-Riley-Ruvalcaba Syndrome,1
9239,Carcinomatous Component Present,Renal medullary carcinoma,1
9240,Carcinomatous Component Present,Stage I Vaginal Cancer AJCC v6 and v7,1
9241,Carcinomatous Component Present,Ovarian Cancer by AJCC v8 Stage,1
9242,Clinical TNM Finding,Retinoblastoma by AJCC v8 Clinical Stage,1
9243,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
9244,Epithelial Component Present,Paraganglioma,1
9245,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
9246,Well-Circumscribed Lesion,Ovarian Endometrioid Cystadenoma,1
9247,Adulthood Lesion,Stage IV adult soft tissue sarcoma,1
9248,Follicular Structures Present,Macrofollicular adenoma,1
9249,Diffuse Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",1
9250,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8,1
9251,Benign Cellular Infiltrate,Benign Gastric Soft Tissue Neoplasm,1
9252,Regional Disease,Ureteric cancer regional,1
9253,Recurrent disease,Liposarcoma recurrent,1
9254,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
9255,Cutaneous Involvement,Scar Tissue,1
9256,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma,1
9257,Epithelial Component Present,carcinosarcoma of lung,1
9258,Cutaneous Involvement,Cervical Blue Nevus,1
9259,Epithelial Component Present,Non functioning pancreatic endocrine tumor,1
9260,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
9261,Lobulated Growth Pattern,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,1
9262,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis,1
9263,Malignant Cellular Infiltrate,Malignant neoplasm of middle ear,1
9264,Malignant Cellular Infiltrate,Adult Pineoblastoma,1
9265,Malignant Cellular Infiltrate,Undifferentiated Fallopian Tube Carcinoma,1
9266,Malignant Cellular Infiltrate,Colorectal Large Cell Neuroendocrine Carcinoma,1
9267,Neuroendocrine Differentiation,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
9268,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
9269,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 2,1
9270,Malignant Cellular Infiltrate,Lung Micropapillary Adenocarcinoma,1
9271,Secondary Lesion,Breast Carcinoma Metastatic in the Spine,1
9272,Diffuse Pattern,Recurrent Childhood Giant Cell Glioblastoma,1
9273,Malignant Cellular Infiltrate,Ann Arbor Stage IA Hodgkin Lymphoma,1
9274,Fibrotic Stroma Formation,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
9275,Islands of Odontogenic Epithelium Present,Central odontogenic fibroma,1
9276,Benign Cellular Infiltrate,Cervical Mullerian Papilloma,1
9277,Pathologic TNM Finding,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
9278,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma refractory,1
9279,Carcinomatous Component Present,mucinous adenocarcinoma of ovary,1
9280,More than 10 Mitoses per 10HPF,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
9281,Malignant Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma,1
9282,Malignant Cellular Infiltrate,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
9283,Distortion of the Hair Follicle,Fibrofolliculoma,1
9284,Recurrent disease,Recurrent Ovarian Mucinous Adenocarcinoma,1
9285,Calcitonin Positive Neoplastic Cells Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
9286,Malignant Cellular Infiltrate,Pediatric Intraocular Retinoblastoma,1
9287,Carcinomatous Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
9288,Mixed Cellular Population,Carcinosarcoma of ovary,1
9289,Malignant Cellular Infiltrate,Locally Advanced Prostate Adenocarcinoma,1
9290,Cartilaginous Differentiation,Intermediate Chondrogenic Neoplasm,1
9291,Malignant Cellular Infiltrate,Malignant neoplasm of ureter,1
9292,Malignant Cellular Infiltrate,Hodgkin's disease of intrapelvic lymph nodes,1
9293,Malignant Cellular Infiltrate,Uterine Ligament Endometrioid Adenocarcinoma,1
9294,Secondary Lesion,Melanoma of Unknown Primary,1
9295,Malignant Cellular Infiltrate,Anatomic Stage IA Breast Cancer AJCC v8,1
9296,Benign Cellular Infiltrate,Benign tumor of iris,1
9297,Malignant Cellular Infiltrate,Small Intestinal T-Cell Non-Hodgkin Lymphoma,1
9298,Malignant Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v7,1
9299,Cartilaginous Differentiation,Grade III Chondrosarcoma,1
9300,Carcinomatous Component Present,Carcinoma Arising in Nasal Papillomatosis,1
9301,Malignant Cellular Infiltrate,Undifferentiated carcinoma of esophagus,1
9302,Bilateral Disease,Synchronous Bilateral Breast Carcinoma,1
9303,Epithelial Component Present,Refractory Paranasal Sinus Squamous Cell Carcinoma,1
9304,Malignant Cellular Infiltrate,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
9305,Invasive Lesion,Metastatic Dermatofibrosarcoma Protuberans,1
9306,Benign Cellular Infiltrate,hemangioma of mediastinum,1
9307,Malignant Cellular Infiltrate,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
9308,Metastatic Lesion,Metastatic Lung Adenosquamous Carcinoma,1
9309,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
9310,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
9311,Vascular Channel Formation,Kaposi's sarcoma of conjunctiva,1
9312,Well-Circumscribed Lesion,chondroma of lung,1
9313,Thyroglobulin Positive Neoplastic Cells Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
9314,Carcinomatous Component Present,Invasive Lobular Breast Carcinoma,1
9315,Mixed Cellular Population,Testicular gonadoblastoma,1
9316,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
9317,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
9318,Intracanalicular Growth Pattern,Phyllodes Tumor,1
9319,Malignant Cellular Infiltrate,Recurrent Adult Acute Lymphoblastic Leukemia,1
9320,Epithelial Component Present,Low grade appendiceal mucinous neoplasm,1
9321,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
9322,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
9323,Severe cytologic atypia,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
9324,Nuclear Atypia,Recurrent Anaplastic Astrocytoma,1
9325,Epithelial Component Present,Fundic gland polyp,1
9326,Malignant Cellular Infiltrate,Ampulla of Vater Clear Cell Adenocarcinoma,1
9327,Non Lipogenic Sarcomatous Stroma Present,"Liposarcoma, Dedifferentiated",1
9328,Malignant Cellular Infiltrate,Childhood Malignant Ovarian Germ Cell Tumor,1
9329,Malignant Cellular Infiltrate,Crohn Disease-Associated Colorectal Adenocarcinoma,1
9330,Anaplasia,Anaplastic Oligoastrocytoma,1
9331,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Serous",1
9332,Malignant Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
9333,Pseudoglandular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
9334,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
9335,Diffuse Lesion,Papillomatosis,1
9336,Therapy-Related Toxicity,Treatment related leukaemia,1
9337,Chronic lymphocytic inflammation,"Thymoma, type B1, malignant",1
9338,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
9339,Carcinomatous Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
9340,Recurrent Lymphoma,EBV-Related Burkitt Lymphoma,1
9341,Epithelial Component Present,Refractory Endometrial Serous Adenocarcinoma,1
9342,Malignant Cellular Infiltrate,Diffuse malignant mesothelioma,1
9343,Malignant Cellular Infiltrate,Testicular Monophasic Choriocarcinoma,1
9344,Hyperkeratosis,Verrucous carcinoma of penis,1
9345,Carcinomatous Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
9346,Indolent Clinical Course,lipoma of esophagus,1
9347,Carcinomatous Component Present,signet ring cell carcinoma of breast,1
9348,Severe cytologic atypia,Gastric Small Cell Carcinoma,1
9349,Stromal Invasion,FIGO Stage IVB Ovarian Cancer,1
9350,Hyperplastic Tissue Present,Atypical adenomatous hyperplasia,1
9351,Calcitonin Positive Neoplastic Cells Present,Childhood Thyroid Gland Medullary Carcinoma,1
9352,Nodular Pattern,Ann Arbor Stage II Grade 3 Follicular Lymphoma,1
9353,High Grade Lesion,Pleural Monophasic Synovial Sarcoma,1
9354,Honeycomb Pattern,Recurrent Childhood Oligodendroglioma,1
9355,Well Differentiated Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1,1
9356,Epithelial Component Present,Mucinous cystadenocarcinoma appendix,1
9357,Refractory Disease,Refractory Malignant Neoplasm of Multiple Primary Sites,1
9358,Epithelial Component Present,Stage II Penile Cancer AJCC v8,1
9359,Pregnancy Complications,Stage III Gestational Trophoblastic Tumor AJCC v7,1
9360,Epithelial Component Present,Stage IV Distal Bile Duct Cancer AJCC v8,1
9361,Benign Cellular Infiltrate,Benign neoplasm of buccal mucosa,1
9362,Malignant Cellular Infiltrate,Malignant Diencephalic Neoplasm,1
9363,Malignant Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver,1
9364,Malignant Cellular Infiltrate,Angiocentric lymphoma stage II,1
9365,Cutaneous Involvement,Clinical Stage III Cutaneous Melanoma AJCC v8,1
9366,Malignant Cellular Infiltrate,Stage IIA Uterine Sarcoma AJCC v7,1
9367,Malignant Cellular Infiltrate,Salivary duct carcinoma,1
9368,Pushing Tumor Margin,verrucous carcinoma of bladder,1
9369,Malignant Cellular Infiltrate,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,1
9370,HMB-45-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
9371,Malignant Cellular Infiltrate,Thoracic Esophagus Adenocarcinoma,1
9372,Necrotic changes (finding),Malignant Uterine Corpus PEComa,1
9373,Slow Growing Mass,Adult Pilocytic Astrocytoma,1
9374,Infantile Lesion,Neonatal leukemia,1
9375,Epithelial Component Present,Acquired cystic disease associated renal cell carcinoma,1
9376,Cutaneous Involvement,Dartoic myoma,1
9377,Malignant Cellular Infiltrate,Unresectable Rhabdomyosarcoma,1
9378,Unresectable Mass,Unresectable Thyroid Gland Carcinoma,1
9379,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
9380,Metastatic Lesion,Uveal Melanoma Metastatic in the Liver,1
9381,Biphasic Pattern,Benign phyllodes neoplasm of breast,1
9382,Epithelial Component Present,Medullary carcinoma of breast,1
9383,Anaplasia,"Transitional cell carcinoma, spindle cell",1
9384,Thin-Walled Branching Vascular Pattern,Malignant Solitary Fibrous Tumor,1
9385,Neuroendocrine Differentiation,Digestive System Large Cell Neuroendocrine Carcinoma,1
9386,Cutaneous Involvement,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
9387,Venous Type Vascular Channel Formation,Venous Angioleiomyoma,1
9388,Islands of Neuropil-Like Matrix Present,Glioneuronal Tumor with Neuropil-Like Islands,1
9389,Well Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G1,1
9390,Epithelial Component Present,Submandibular Gland Undifferentiated Carcinoma,1
9391,Hyperplastic Tissue Present,Adrenocortical hyperplasia,1
9392,Malignant Cellular Infiltrate,Secondary Central Nervous System Lymphoma,1
9393,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
9394,Epithelial Component Present,Trichoadenoma,1
9395,Malignant Cellular Infiltrate,Recurrent Lymphomatoid Granulomatosis,1
9396,Epithelial Component Present,Stage III Colon Cancer AJCC v8,1
9397,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
9398,High Mitotic Activity,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
9399,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
9400,Indolent Clinical Course,Bone Leiomyoma,1
9401,Benign Cellular Infiltrate,Ossifying Renal Tumor of Infancy,1
9402,Mesenchymal Component Present,Soft Palate Pleomorphic Adenoma,1
9403,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage,1
9404,Malignant Cellular Infiltrate,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
9405,Carcinomatous Component Present,Stage III Lip and Oral Cavity Cancer AJCC v8,1
9406,Well-Circumscribed Lesion,Villous adenoma of duodenum,1
9407,Locally Aggressive Lesion,Intermediate Osteogenic Neoplasm,1
9408,Epithelial Component Present,Lung Small Cell Carcinoma by AJCC v7 Stage,1
9409,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
9410,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7,1
9411,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma,1
9412,HMB-45-Positive Neoplastic Cells Present,Sclerosing PEComa,1
9413,Unresectable Mass,Unresectable Esophageal Carcinoma,1
9414,Carcinomatous Component Present,Stage I Distal Bile Duct Cancer AJCC v8,1
9415,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage,1
9416,Epithelial Component Present,High Grade Intraepithelial Neoplasia,1
9417,Malignant Cellular Infiltrate,Malignant Bladder Paraganglioma,1
9418,Malignant Cellular Infiltrate,Colon Kaposi Sarcoma,1
9419,Cutaneous Involvement,Deep seated dermatophytosis,1
9420,Papillary Pattern,"Cystadenocarcinoma, Papillary",1
9421,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma,1
9422,Diffuse Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
9423,Severe cytologic atypia,Colon Small Cell Neuroendocrine Carcinoma,1
9424,Malignant Cellular Infiltrate,Adenocarcinoma of prostate,1
9425,Childhood Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
9426,Dysplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,1
9427,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Stage,1
9428,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
9429,Epithelial Component Present,Hepatic cancer metastatic,1
9430,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v8,1
9431,Neuroendocrine Differentiation,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
9432,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with FLT3/ITD Mutation,1
9433,In Situ Lesion,"Urinary bladder carcinoma stage I, with cancer in situ",1
9434,Immunosuppression-Related Post-Transplant Toxicity,Renal Allograft Thrombosis,1
9435,Cutaneous Involvement,Warty dyskeratoma,1
9436,Benign Cellular Infiltrate,"Nevus, Spindle Cell",1
9437,Primary Lesion,Childhood Cerebral Ependymoma,1
9438,Vascular Channel Formation,Cutaneous Radiation-Related Angiosarcoma,1
9439,Carcinomatous Component Present,Neuroendocrine carcinoma of the bladder,1
9440,Dysplasia,Intrahepatic Bile Duct Microcystic Adenoma,1
9441,Carcinomatous Component Present,Adenocarcinoma in tubular adenoma,1
9442,Hyperplastic Tissue Present,Endometrial cystic hyperplasia,1
9443,Malignant Cellular Infiltrate,"Pancreatic carcinoma, familial",1
9444,Carcinomatous Component Present,Stage IA Gastric Carcinoma,1
9445,Cutaneous Involvement,Paraganglioma-Like Dermal Melanocytic Tumor,1
9446,Papillary Pattern,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,1
9447,Melanin Pigment Present,Melanocytic nevus of skin,1
9448,Vascular proliferation,Giant cell angiofibroma,1
9449,High Mitotic Activity,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
9450,Secondary Lesion,Locally Advanced Bone Sarcoma,1
9451,Malignant Cellular Infiltrate,Stage III Colon Cancer AJCC v7,1
9452,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
9453,Cutaneous Involvement,Precancerous Dermatitis,1
9454,Malignant Cellular Infiltrate,Glottis Verrucous Carcinoma,1
9455,More than 10 Mitoses per 10HPF,Occult Lung Small Cell Carcinoma,1
9456,Primary Lesion,Cerebral Non-Hodgkin Lymphoma,1
9457,Primary Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
9458,Carcinomatous Component Present,Unresectable Skin Carcinoma,1
9459,Ineffective hematopoiesis,Recurrent Myelodysplastic Syndrome,1
9460,Anaplasia,Osteoblastic Osteosarcoma,1
9461,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia with Eosinophilia,1
9462,Tubular Pattern,tubulopapillary adenoma of extrahepatic bile duct,1
9463,Anaplasia,Sarcomatoid carcinoma of the lung,1
9464,Neuroendocrine Differentiation,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
9465,Epithelial Component Present,Thymic Carcinoma,1
9466,Epithelial Component Present,mucinous adenocarcinofibroma of ovary,1
9467,Childhood Lesion,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
9468,Cavernous Vascular Space Formation,"Hemangioma, Cavernous",1
9469,Carcinomatous Component Present,Periampullary Adenocarcinoma,1
9470,Carcinomatous Component Present,Poorly Cohesive Gastric Carcinoma,1
9471,Mitotic Activity,Childhood Glioblastoma,1
9472,Tissue Differentiation Uncertain,Malignant Soft Tissue Tumor of Uncertain Differentiation,1
9473,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
9474,Endophytic Tumor Growth,Ureter Inverted Papilloma,1
9475,Malignant Cellular Infiltrate,Papillary thyroid carcinoma,1
9476,Primary Lesion,Stage IIB Osteosarcoma AJCC v7,1
9477,Epithelial Component Present,Stage III Esophageal Cancer,1
9478,Necrotic changes (finding),Metastatic Malignant Peripheral Nerve Sheath Tumor,1
9479,Metastatic/Recurrent Disease,Alveolar soft part sarcoma non-metastatic,1
9480,Storiform Growth Pattern,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
9481,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
9482,Mesenchymal Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
9483,Glandular Pattern,intestinal type adenocarcinoma of gallbladder,1
9484,Malignant Cellular Infiltrate,Stage IV Lung Small Cell Carcinoma AJCC v7,1
9485,Monomorphic Cellular Infiltrate,Childhood Ependymoma,1
9486,Malignant Cellular Infiltrate,Malignant Mesothelioma of Peritoneum,1
9487,Carcinomatous Component Present,Stage I Vaginal Cancer AJCC v6 and v7,1
9488,Absence of Invasion,External Ear Actinic Keratosis,1
9489,Cutaneous Involvement,Mycosis fungoides refractory,1
9490,Cutaneous Involvement,Lymphangioma of skin,1
9491,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
9492,Epithelial Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
9493,Fenestrated Pattern,Vulvar Trichoepithelioma,1
9494,Lymphoplasmacytic Infiltrate,Waldenstrom Macroglobulinemia,1
9495,Granuloma,Granulomatous slack skin disease,1
9496,Malignant Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,1
9497,Epithelial Component Present,tubular adenoma of extrahepatic bile duct,1
9498,Thick-Walled Hyalinized Vessels Present,Trigeminal schwannoma,1
9499,Malignant Cellular Infiltrate,Unresectable Malignant Neoplasm,1
9500,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Mutant",1
9501,Benign Cellular Infiltrate,Giant Fibrovascular Esophageal Polyp,1
9502,Mixed Cellular Population,Recurrent Ovarian Carcinosarcoma,1
9503,Hyalinized Stroma Formation,Hemangiopericytoma of meninges,1
9504,Benign Cellular Infiltrate,Benign Mixed Tumor of the Vulva,1
9505,Polymorphic Cellular Infiltrate,"Langerhans Cell Histiocytosis, Disseminated",1
9506,Ineffective hematopoiesis,de novo Myelodysplastic Syndrome,1
9507,Carcinomatous Component Present,Stage IV Lung Squamous Cell Carcinoma AJCC v7,1
9508,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum,1
9509,Cutaneous Involvement,Circumscribed storiform collagenoma,1
9510,Malignant Cellular Infiltrate,Squamous cell carcinoma of tongue,1
9511,Metastatic/Recurrent Disease,Malignant Soft Tissue Tumor of Uncertain Differentiation,1
9512,Benign Cellular Infiltrate,intraductal papilloma of salivary gland,1
9513,Pushing Tumor Margin,Buccal Mucosa Verrucous Carcinoma,1
9514,Cutaneous Involvement,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
9515,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma,1
9516,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7,1
9517,Recurrent disease,Recurrent Acute Myelomonocytic Leukemia,1
9518,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
9519,Mixed Cellular Population,clear cell adenocarcinofibroma of ovary,1
9520,Intestinal metaplasia,Intestinal Metaplasia of Bladder Urachal Epithelium,1
9521,Cystic Change,Melanoacanthoma,1
9522,Tissue Differentiation Uncertain,Epithelioid sarcoma recurrent,1
9523,Neuroectodermal Differentiation,Recurrent tumors of the Ewing's family,1
9524,Lymphoplasmacytic Infiltrate,Undifferentiated carcinoma of nasopharynx,1
9525,High Plasma Renin Activity,Juxtaglomerular tumor,1
9526,Glomeruloid Vessels Present,Juvenile Pilocytic Astrocytoma,1
9527,Cutaneous Involvement,Hemangioma of skin,1
9528,Necrotic changes (finding),Refractory Malignant Peripheral Nerve Sheath Tumor,1
9529,Carcinomatous Component Present,Recurrent ovarian cancer,1
9530,Malignant Cellular Infiltrate,Gallbladder Sarcoma,1
9531,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
9532,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
9533,Vascular Channel Formation,Uterine Angiosarcoma,1
9534,Adulthood Lesion,Adult T Lymphoblastic Lymphoma,1
9535,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma,1
9536,Malignant Cellular Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v8,1
9537,Malignant Cellular Infiltrate,Locally Advanced Paraganglioma,1
9538,Carcinomatous Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8,1
9539,Prominent In Situ Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
9540,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
9541,Malignant Cellular Infiltrate,Thyroid Gland Adenocarcinoma,1
9542,Exophytic Polypoid Lesion,Hamartomatous polyp,1
9543,Epithelial Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
9544,Primary Lesion,Stage II Primary Peritoneal Cancer AJCC v8,1
9545,Epithelial Component Present,FSH-Producing Gonadotroph Adenoma,1
9546,Erythema,Inflammatory carcinoma of breast stage IV,1
9547,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage I,1
9548,Malignant Cellular Infiltrate,Carcinoma of Male Breast,1
9549,Metastatic Lesion,Metastatic osteosarcoma,1
9550,Malignant Cellular Infiltrate,Pleural mesothelioma malignant recurrent,1
9551,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma recurrent,1
9552,Benign Cellular Infiltrate,Desmoplastic trichilemmoma,1
9553,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of nasal cavity,1
9554,Malignant Cellular Infiltrate,Bladder Papillary Urothelial Carcinoma,1
9555,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,1
9556,Sarcomatous Component Present,Carcinosarcoma,1
9557,Well-Circumscribed Lesion,Borderline cystadenoma,1
9558,Benign Cellular Infiltrate,Hemangioma of choroid,1
9559,Adnexal Differentiation,Apocrine breast carcinoma,1
9560,Primary Lesion,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
9561,Epithelial Component Present,Intermediate Grade Lung Neuroendocrine Neoplasm,1
9562,Human Papillomavirus Negative,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
9563,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v8,1
9564,Carcinomatous Component Present,Recurrent Lobular Breast Carcinoma,1
9565,Well Differentiated Neuroendocrine Lesion,Glucagonoma,1
9566,Malignant Cellular Infiltrate,Adult Central Nervous System Mixed Germ Cell Tumor,1
9567,Childhood Lesion,Postsurgical Stage III Hepatoblastoma,1
9568,Malignant Cellular Infiltrate,Undifferentiated carcinoma of stomach,1
9569,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Childhood Acute Myelomonocytic Leukemia,1
9570,Epithelial Component Present,"Adenoma, Trabecular",1
9571,High Mitotic Activity,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
9572,Recurrent disease,Verrucous carcinoma of the oral cavity recurrent,1
9573,More than 5 Mitoses per 50HPF,Metastatic Gastrointestinal Stromal Tumor,1
9574,Malignant Germinomatous Cellular Infiltrate,Childhood Germinomatous Germ Cell Tumor,1
9575,Malignant Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v6 and v7,1
9576,Malignant Cellular Infiltrate,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
9577,Malignant Cellular Infiltrate,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8",1
9578,Borderline Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
9579,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
9580,Low Grade Lesion,Cellular Congenital Mesoblastic Nephroma,1
9581,Well Differentiated Lesion,Supraglottic Verrucous Carcinoma,1
9582,Carcinomatous Component Present,Lymphangitis carcinomatosa,1
9583,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
9584,More than 5 Mitoses per 50HPF,Locally Advanced Gastrointestinal Stromal Tumor,1
9585,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
9586,High Grade Lesion,Small cell lung cancer recurrent,1
9587,Diffuse Pattern,EZB Diffuse Large B-Cell Lymphoma,1
9588,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v7 Stage,1
9589,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v7,1
9590,Malignant Cellular Infiltrate,Choroidal and Ciliary Body Melanoma by AJCC v8 Stage,1
9591,Benign Cellular Infiltrate,Hemangioma of gingiva,1
9592,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8,1
9593,Tissue of Mullerian Origin Present,Serous adenofibroma,1
9594,Carcinomatous Component Present,Borderline Resectable Pancreatic Carcinoma,1
9595,Malignant Cellular Infiltrate,adult nasal type extranodal NK/T-cell lymphoma,1
9596,Malignant Cellular Infiltrate,Refractory Primary Cutaneous Lymphoma,1
9597,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
9598,Malignant Cellular Infiltrate,Breast Carcinoma with Osteoclastic Giant Cells,1
9599,Carcinomatous Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
9600,Non-Invasive Lesion,Low-grade intraurothelial neoplasia,1
9601,Cartilaginous Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia,1
9602,Chemotherapeutic Agent Toxicity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
9603,Secondary Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,1
9604,Epithelial Component Present,Vagina Carcinoma,1
9605,Benign Cellular Infiltrate,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin,1
9606,Carcinomatous Component Present,Adult Salivary Gland Carcinoma,1
9607,Malignant Cellular Infiltrate,Secondary malignant neoplasm of lip,1
9608,Epithelial Component Present,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
9609,'Starry-sky' pattern,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
9610,Anaplasia,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
9611,Benign Cellular Infiltrate,Thyroid Gland Clear Cell Follicular Adenoma,1
9612,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage,1
9613,Malignant Cellular Infiltrate,Pathologic Stage I Cutaneous Melanoma AJCC v8,1
9614,Dysplasia,Appendix Mucinous Cystadenoma,1
9615,Hyperplastic Epithelial Tissue Present,Atypical Ductal Breast Hyperplasia,1
9616,Intestinal metaplasia,"Vulvar Adenocarcinoma, Intestinal-Type",1
9617,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
9618,Cutaneous Involvement,"Dermatofibrosarcoma Protuberans, Myxoid",1
9619,Primary Lesion,Recurrent tumors of the Ewing's family,1
9620,Epithelial Component Present,Stage IIIB Eyelid Carcinoma AJCC v8,1
9621,Malignant Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v8 Stage,1
9622,Edematous Stroma Formation,Testicular Spermatocytic Seminoma with Sarcoma,1
9623,Lymphoplasmacytic Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
9624,Diffuse Pattern,Centroblastic lymphoma stage IV,1
9625,Pathologic TNM Finding,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
9626,Dysplasia,Biliary Intraepithelial Neoplasia-3,1
9627,Metastatic Lesion,"Kaposi's sarcoma, metastatic",1
9628,Malignant Cellular Infiltrate,Refractory Primary Cutaneous Lymphoma,1
9629,Epithelial Component Present,Resectable Renal Cell Carcinoma,1
9630,Recurrent disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
9631,Malignant Cellular Infiltrate,Refractory Rhabdoid Tumor,1
9632,Severe dysplasia,Stage 0is Ureter Cancer AJCC v7,1
9633,Cystic Change,Clear cell cystadenofibroma,1
9634,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Teratoma,1
9635,Malignant Cellular Infiltrate,Malignant neoplasm of respiratory system,1
9636,Benign Cellular Infiltrate,Mixed Cell Adrenal Cortical Adenoma,1
9637,Malignant Cellular Infiltrate,Luminal A Breast Carcinoma,1
9638,Lobulated Growth Pattern,Primary chondrosarcoma of bone,1
9639,High Mitotic Activity,Stage II Lung Small Cell Carcinoma AJCC v7,1
9640,Extensive Stage Lesion,Mesothelioma malignant advanced,1
9641,Cutaneous Involvement,Proliferative dermal lesion in congenital nevus,1
9642,Recurrent disease,Malignant neoplasm of hypopharynx recurrent,1
9643,Absence of Invasion,Ampulla of Vater Tubular Adenoma,1
9644,Cutaneous Involvement,Pityriasis Lichenoides et Varioliformis Acuta,1
9645,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
9646,Carcinomatous Component Present,Stage IV Ampulla of Vater Cancer AJCC v8,1
9647,Metastatic Lesion,Malignant fibrous histiocytoma metastatic,1
9648,Carcinomatous Component Present,Breast cancer recurrent,1
9649,High Mitotic Activity,Rectal Small Cell Neuroendocrine Carcinoma,1
9650,Epithelial Component Present,Stage II Nasal Cavity Cancer AJCC v6 and v7,1
9651,Stromal Invasion,FIGO Stage IC3 Ovarian Cancer,1
9652,Carcinomatous Component Present,Breast Carcinoma with Osseous Metaplasia,1
9653,Severe dysplasia,Stage 0 Lip Carcinoma,1
9654,Carcinomatous Component Present,Basal cell carcinoma - keratotic,1
9655,Capillary Sized Vascular Channel Formation,Pyogenic granuloma of skin and subcutaneous tissue,1
9656,Vascular Channel Formation,Hemangioma of intra-abdominal structure,1
9657,Fibrotic Stroma Formation,mucinous adenocarcinofibroma of ovary,1
9658,Low Mitotic Activity,Ileal Neuroendocrine Tumor,1
9659,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Cystadenoma,1
9660,Benign Cellular Infiltrate,Lactating adenoma,1
9661,Carcinomatous Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
9662,Clinical TNM Finding,Gastric Cancer by AJCC v8 Clinical Stage,1
9663,Epithelial Component Present,Polymorphous low grade adenocarcinoma of salivary gland,1
9664,Malignant Cellular Infiltrate,Mediastinal Synovial Sarcoma,1
9665,Epithelial Component Present,Large cell neuroendocrine carcinoma,1
9666,Epithelial Component Present,Vulvar Adenocarcinoma of Sweat Gland Type,1
9667,Papillary Pattern,Papillary carcinoma of the breast,1
9668,Cutaneous Involvement,Spongiotic dermatitis,1
9669,Malignant Cellular Infiltrate,Intracranial Liposarcoma,1
9670,Borderline Lesion,Type E Lymphomatoid Papulosis,1
9671,Indolent Clinical Course,benign fibrous histiocytoma of bone,1
9672,Severe cytologic atypia,neuroendocrine carcinoma of anal canal,1
9673,Myxoid Changes Present,Osteochondromyxoma,1
9674,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
9675,Invasive Lesion,Invasive Lobular Breast Carcinoma,1
9676,Epithelial Component Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
9677,Malignant Cellular Infiltrate,Necrotic intraocular melanoma,1
9678,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
9679,Malignant Cellular Infiltrate,Stage IA Hepatocellular Carcinoma AJCC v8,1
9680,Carcinomatous Component Present,Stage IIIC Lung Cancer AJCC v8,1
9681,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma recurrent,1
9682,Papillary Pattern,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
9683,Malignant Cellular Infiltrate,Metastatic Adrenal Gland Pheochromocytoma,1
9684,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype",1
9685,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IV,1
9686,Epithelial Component Present,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,1
9687,Resectable Mass,Resectable Pleural Malignant Mesothelioma,1
9688,Refractory Disease,Refractory Plasmablastic Lymphoma,1
9689,Epithelial Component Present,Stage III Penile Cancer AJCC v8,1
9690,Primary Lesion,Lentigo maligna recurrent,1
9691,Well Differentiated Lesion,Laryngeal verrucous carcinoma,1
9692,Microvascular Proliferation,Adult Glioblastoma,1
9693,Mitotic Activity,yolk sac tumor of mediastinum,1
9694,Malignant Cellular Infiltrate,"Neoplasm, malignant, uncertain whether primary or metastatic",1
9695,Malignant Cellular Infiltrate,Recurrent Chronic Leukemia,1
9696,Acute inflammation,Acute lymphadenitis,1
9697,Villous atrophy,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,1
9698,Carcinomatous Component Present,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
9699,Carcinomatous Component Present,Colorectal Medullary Carcinoma,1
9700,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
9701,Generalized Dysplasia,Filiform Serrated Adenoma,1
9702,Carcinomatous Component Present,Stage I Hepatocellular Carcinoma AJCC v8,1
9703,Benign Cellular Infiltrate,Pleomorphic adenoma of lacrimal gland,1
9704,Carcinomatous Component Present,Apocrine breast carcinoma,1
9705,Storiform Growth Pattern,Metastatic Dermatofibrosarcoma Protuberans,1
9706,Carcinomatous Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
9707,Anaplasia,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
9708,Benign Cellular Infiltrate,Regressing nevus,1
9709,Well-Circumscribed Lesion,Choroid Plexus Papilloma,1
9710,Metastatic Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
9711,Malignant Cellular Infiltrate,Stage IVA Uterine Sarcoma AJCC v7,1
9712,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,1
9713,Malignant Cellular Infiltrate,Serous Tubal Intraepithelial Carcinoma,1
9714,Intramucosal Lesion,Intramucosal Adenocarcinoma,1
9715,Human Papillomavirus Negative,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
9716,Malignant Cellular Infiltrate,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,1
9717,Epithelial Component Present,Stage IIB Vaginal Cancer AJCC v8,1
9718,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1
9719,Malignant Cellular Infiltrate,Stage IB Vulvar Carcinoma AJCC v6,1
9720,Tubular Pattern,Appendix Tubulovillous Adenoma,1
9721,Epithelial Component Present,small cell carcinoma of ureter,1
9722,Diffuse Pattern,Diffuse large B-cell lymphoma of central nervous system,1
9723,Primary Lesion,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
9724,Nuclear Atypia,Anaplastic Brain Stem Astrocytoma,1
9725,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v8,1
9726,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
9727,Carcinomatous Component Present,Broad Ligament Serous Adenocarcinoma,1
9728,Carcinomatous Component Present,intestinal type adenocarcinoma of gallbladder,1
9729,Papillary Pattern,inverted ductal papilloma of salivary gland,1
9730,Carcinomatous Component Present,Pancreatic Foamy Gland Adenocarcinoma,1
9731,Epithelial Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v8,1
9732,Lobulated Growth Pattern,Intramuscular Myxoma,1
9733,Carcinomatous Component Present,Triple-Negative Breast Carcinoma,1
9734,Carcinomatous Component Present,Carcinoma of lung,1
9735,Secondary Lesion,Advanced Gastric Neuroendocrine Carcinoma,1
9736,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
9737,Diffuse Lesion,Pseudomyxoma Peritonei,1
9738,Malignant Cellular Infiltrate,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
9739,Epithelial Component Present,Non-Small Cell Adenocarcinoma,1
9740,Malignant Cellular Infiltrate,Advanced Carcinoid Tumor,1
9741,Fibrosis,Breast Blunt Duct Adenosis,1
9742,Metastatic Lesion,Advanced Neuroendocrine Carcinoma,1
9743,Childhood Lesion,Childhood Lymphoma,1
9744,Malignant Cellular Infiltrate,"Medulloblastoma, Not Otherwise Specified",1
9745,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v8,1
9746,Epithelial Component Present,Common wart,1
9747,Low Grade Lesion,Borderline Ovarian Serous Tumor with Microinvasion,1
9748,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type B Melanoma,1
9749,Micronodular Pattern,Micronodular thymoma with lymphoid stroma,1
9750,Malignant Cellular Infiltrate,Central Nervous System Kaposi Sarcoma,1
9751,Thin-Walled Branching Vascular Pattern,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
9752,Neuroendocrine Differentiation,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
9753,Monoclonal Cellular Population Present,"Mastocytosis, Diffuse Cutaneous",1
9754,Malignant Cellular Infiltrate,Parotid Gland Non-Hodgkin Lymphoma,1
9755,Diffuse Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,1
9756,Prominent Collagen Rosette Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
9757,Benign Cellular Infiltrate,Cerebral Hemisphere Lipoma,1
9758,No Identifiable Line of Differentiation,Undifferentiated spindle cell sarcoma,1
9759,Carcinomatous Component Present,Unresectable Gallbladder Carcinoma,1
9760,Neuroectodermal Differentiation,Unresectable Neuroblastoma,1
9761,Malignant Cellular Infiltrate,Childhood Anaplastic Ependymoma,1
9762,Cartilaginous Differentiation,Secondary Central Chondrosarcoma,1
9763,Carcinomatous Component Present,Esophageal Cancer by AJCC v7 Stage,1
9764,Malignant Cellular Infiltrate,Sarcoma by AJCC Grade,1
9765,Neuroendocrine Differentiation,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
9766,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
9767,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma,1
9768,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor,1
9769,Carcinomatous Component Present,Mucoepidermoid carcinoma of skin,1
9770,Malignant Cellular Infiltrate,Clear cell squamous cell carcinoma of skin,1
9771,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma,1
9772,Malignant Cellular Infiltrate,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
9773,Primary Lesion,Infratentorial Ependymal Tumor,1
9774,Increased Cellularity Present,Ovarian Cellular Fibroma,1
9775,Benign Cellular Infiltrate,Lipoma of external auditory meatus,1
9776,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma recurrent,1
9777,Diffuse Pattern,Recurrent Gliosarcoma,1
9778,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
9779,Metastatic Lesion,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
9780,Malignant Cellular Infiltrate,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
9781,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type",1
9782,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity recurrent,1
9783,Carcinomatous Component Present,Luminal B Breast Carcinoma,1
9784,Carcinomatous Component Present,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7,1
9785,Malignant Cellular Infiltrate,Nasopharyngeal carcinoma,1
9786,Malignant Cellular Infiltrate,Pelvic Rhabdomyosarcoma,1
9787,Mesenchymal Metaplasia,Adenocarcinoma with cartilaginous and osseous metaplasia,1
9788,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v7,1
9789,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
9790,Malignant Cellular Infiltrate,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
9791,Papillary Pattern,Hidradenoma Papilliferum,1
9792,Cutaneous Involvement,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
9793,More than 5 Mitoses per 50HPF,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
9794,Benign Cellular Infiltrate,Benign neoplasm of peritoneum,1
9795,Severe dysplasia,Stage 0is Urethral Cancer AJCC v8,1
9796,Refractory Disease,Refractory Ovarian Carcinoma,1
9797,Epithelial Component Present,Acantholytic acanthoma,1
9798,Malignant Cellular Infiltrate,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
9799,Low Grade Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1,1
9800,Slow Growing Mass,Hemangioblastoma,1
9801,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
9802,Malignant Cellular Infiltrate,Classical Glioblastoma,1
9803,Keratin pearl formation,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
9804,Recurrent disease,recurrent adult acute myeloid leukemia,1
9805,Epithelial Component Present,Stage 0a Penile Cancer AJCC v8,1
9806,Intraocular Lesion,Refractory Primary Vitreoretinal Lymphoma,1
9807,Benign Cellular Infiltrate,Benign Mediastinal Germ Cell Tumor,1
9808,Favorable Clinical Outcome,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,1
9809,Carcinomatous Component Present,Stage IV Laryngeal Carcinoma,1
9810,Malignant Cellular Infiltrate,Recurrent Olfactory Neuroblastoma,1
9811,Intraductal Lesion,Sclerosing Breast Papilloma,1
9812,Papillary Pattern,Intraductal papilloma of breast,1
9813,Epithelial Component Present,Adenosquamous cell lung cancer recurrent,1
9814,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuromatosis,1
9815,Extensive Stage Lesion,Advanced Cutaneous Melanoma of the Extremity,1
9816,Cutaneous Involvement,Benign Germinative Follicular Epithelium Neoplasm,1
9817,Intraocular Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
9818,Secondary Lesion,Locally Advanced Skin Squamous Cell Carcinoma,1
9819,High Grade Lesion,Unresectable Synovial Sarcoma,1
9820,Carcinomatous Component Present,Invasive Lobular Breast Carcinoma,1
9821,Osseous Differentiation,Intraosseous well differentiated osteosarcoma,1
9822,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,1
9823,Malignant Cellular Infiltrate,Malignant Uterine Ligament Neoplasm,1
9824,Epithelial Component Present,Lung Typical Carcinoid Tumor,1
9825,Sarcomatous Component Present,Malignant Cystosarcoma Phyllodes,1
9826,Malignant Cellular Infiltrate,Serous cystadenocarcinoma of pancreas,1
9827,Recurrent disease,Centroblastic lymphoma recurrent,1
9828,Borderline Lesion,Moderate pancreatic duct dysplasia,1
9829,Recurrent disease,Recurrent Childhood Soft Tissue Sarcoma,1
9830,Carcinomatous Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
9831,Epithelial Component Present,Fallopian Tube Endometrioid Polyp,1
9832,Malignant Cellular Infiltrate,Childhood Epithelioid Sarcoma,1
9833,Benign Cellular Infiltrate,Epididymal Papillary Cystadenoma,1
9834,Carcinomatous Component Present,Esophageal Large Cell Neuroendocrine Carcinoma,1
9835,Anaplasia,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
9836,Burn injury,Old Burn Scar-Related Neoplasm,1
9837,Papillary Pattern,Lung Micropapillary Adenocarcinoma,1
9838,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q23;q21),1
9839,High Grade Lesion,Fusion-Positive Alveolar Rhabdomyosarcoma,1
9840,Malignant Cellular Infiltrate,Malignant neoplasm of exocervix,1
9841,Carcinomatous Component Present,Small cell lung cancer extensive stage,1
9842,Epithelial Component Present,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
9843,Epithelial Component Present,Vulvar Warty Carcinoma,1
9844,Carcinomatous Component Present,Stage I Appendix Carcinoma AJCC v8,1
9845,Carcinomatous Component Present,Stage IV Urethral Cancer AJCC v7,1
9846,Epithelial Component Present,Prostate Carcinoma Metastatic in the Bone,1
9847,CD56-Positive Neoplastic Cells Present,childhood nasal type extranodal NK/T-cell lymphoma,1
9848,Lymphoplasmacytic Infiltrate,Pulmonary nodular lymphoid hyperplasia,1
9849,Malignant Cellular Infiltrate,Adult Meningeal Melanoma,1
9850,Benign Cellular Infiltrate,Juxtaglomerular tumor,1
9851,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Hepatocellular Carcinoma,1
9852,Childhood Lesion,Rare Childhood Malignant Neoplasm,1
9853,Extensive Stage Lesion,Advanced Digestive System Carcinoma,1
9854,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma,1
9855,Primary Lesion,Hepatocellular Carcinoma by AJCC v7 Stage,1
9856,Malignant Cellular Infiltrate,Common Variant Anaplastic Large Cell Lymphoma,1
9857,Cavernous Vascular Space Formation,Liver Cavernous Hemangioma,1
9858,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma metastatic,1
9859,Benign Cellular Infiltrate,Cavernous hemangioma of orbit,1
9860,Epithelial Component Present,Colon Neuroendocrine Tumor,1
9861,Epithelial Component Present,Adenoma of lung,1
9862,Pleural effusion disorder,Pulmonary lymphangioleiomyomatosis,1
9863,Recurrent disease,Recurrent Acute Erythroid Leukemia,1
9864,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
9865,Epithelial Component Present,Eyelid Carcinoma by AJCC v7 Stage,1
9866,Epithelial Component Present,"Adenoma, Villous",1
9867,Carcinomatous Component Present,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
9868,Malignant Cellular Infiltrate,Recurrent Hematologic Malignancy,1
9869,Carcinomatous Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
9870,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of ovary,1
9871,Monoclonal Langerhans Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
9872,Well Differentiated Lesion,Grade 1 Colorectal Adenocarcinoma,1
9873,Secondary Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
9874,Chronic lymphocytic inflammation,Pleomorphic Xanthoastrocytoma,1
9875,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage I,1
9876,Benign Cellular Infiltrate,Benign neoplasm of oral cavity,1
9877,Necrotic changes (finding),Small cell lung cancer extensive stage,1
9878,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
9879,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
9880,Recurrent Lymphoma,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
9881,Epithelial Component Present,Squamous cell carcinoma of the paranasal sinus,1
9882,Carcinomatous Component Present,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
9883,Presence of a Hormonal Syndrome,"Glucagonoma, malignant",1
9884,Epithelial Component Present,Gastric Intestinal-Type Adenocarcinoma,1
9885,Malignant Cellular Infiltrate,Recurrent Central Nervous System Non-Hodgkin Lymphoma,1
9886,Malignant Cellular Infiltrate,Central Nervous System Kaposi Sarcoma,1
9887,Malignant Cellular Infiltrate,Refractory B-Cell Prolymphocytic Leukemia,1
9888,Childhood Lesion,Recurrent Childhood Cerebellar Astrocytoma,1
9889,Epithelial Component Present,Carcinoma in situ of middle ear,1
9890,Benign Cellular Infiltrate,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
9891,Carcinomatous Component Present,Stage IIIA Anal Cancer AJCC v8,1
9892,Fibrosis,Mediastinal (Thymic) Large B-Cell Lymphoma,1
9893,Hyperplastic Tissue Present,Parathyroid hyperplasia,1
9894,Slow Growing Mass,Kadish Stage C Olfactory Neuroblastoma,1
9895,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm,1
9896,Keratin pearl formation,Clear cell squamous cell carcinoma of skin,1
9897,Immunologic Deficiency Syndromes,Chronic graft-versus-host disease,1
9898,Malignant Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,1
9899,Adulthood Lesion,Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma,1
9900,Low Mitotic Activity,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
9901,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
9902,Well-Circumscribed Lesion,Pyloric Gland Adenoma,1
9903,Thick-Walled Hyalinized Vessels Present,Peripheral Nerve Schwannoma,1
9904,Epithelial Component Present,Anatomic Stage IIIB Breast Cancer AJCC v8,1
9905,Malignant Cellular Infiltrate,Unresectable Skin Basal Cell Carcinoma,1
9906,High Grade Lesion,Recurrent Glioblastoma,1
9907,Epithelial Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
9908,Well Differentiated Neuroendocrine Lesion,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,1
9909,Benign Cellular Infiltrate,Ovarian Papillary Cystadenoma,1
9910,Malignant Cellular Infiltrate,Undifferentiated (Embryonal) Sarcoma,1
9911,Malignant Cellular Infiltrate,Locally Advanced Chordoma,1
9912,Malignant Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
9913,Malignant Cellular Infiltrate,Prostate Acinar Adenocarcinoma,1
9914,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer recurrent,1
9915,Epithelial Component Present,Glottic Squamous Cell Carcinoma,1
9916,Malignant Cellular Infiltrate,Stage IV Colon Cancer AJCC v8,1
9917,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
9918,Microvascular Proliferation,Diencephalic Glioblastoma,1
9919,Solitary mass,Bronchioloalveolar Adenocarcinoma,1
9920,Malignant Cellular Infiltrate,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
9921,Carcinomatous Component Present,Liver carcinoma,1
9922,Cutaneous Involvement,Vulvar Blue Nevus,1
9923,Well Differentiated Neuroendocrine Lesion,Advanced Carcinoid Tumor,1
9924,Epithelial Component Present,Endometrioid carcinoma of prostate,1
9925,Malignant Cellular Infiltrate,Malignant Central Nervous System Neoplasm,1
9926,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma,1
9927,Nodular Pattern,Hodgkin's disease nodular sclerosis stage IV,1
9928,In Situ Lesion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
9929,Necrotic changes (finding),Cerebral Glioblastoma,1
9930,Neuroendocrine Differentiation,Benign neuroendocrine tumor,1
9931,Carcinomatous Component Present,Adenoid cystic carcinoma of oropharynx,1
9932,Follicular Structures Present,Thyroid Gland Clear Cell Follicular Adenoma,1
9933,Epithelial Component Present,recurrent gastric cancer,1
9934,Storiform Growth Pattern,Malignant fibrous histiocytoma metastatic,1
9935,Carcinomatous Component Present,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
9936,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
9937,Refractory Disease,Refractory Malignant Endocrine Neoplasm,1
9938,Malignant Cellular Infiltrate,Recurrent Rhabdoid Tumor,1
9939,Malignant Cellular Infiltrate,Acute Megakaryocytic Leukemias,1
9940,Epithelial Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
9941,Cutaneous Involvement,Mycosis fungoides stage II,1
9942,Diffuse Pattern,Temporal Lobe Anaplastic Astrocytoma,1
9943,Slow Growing Mass,Adult Subependymoma,1
9944,Shadow Cells Present,Pilomatrixoma,1
9945,Well Differentiated Neuroendocrine Lesion,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
9946,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Acute Myeloid Leukemia (AML-M2),1
9947,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage II,1
9948,Malignant Cellular Infiltrate,Refractory Leiomyosarcoma,1
9949,High Mitotic Activity,Gallbladder Neuroendocrine Carcinoma,1
9950,Hyalinized Stroma Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
9951,Non-Invasive Lesion,Ampulla of Vater Villous Adenoma,1
9952,Birbeck Granules Present,Recurrent Langerhans Cell Histiocytosis,1
9953,Follicular Cell Differentiation,Papillary Thyroid Microcarcinoma,1
9954,Epithelial Component Present,Malignant Intrathoracic Paravertebral Paraganglioma,1
9955,Collagenous Stroma Formation,Sclerosing Epithelioid Fibrosarcoma,1
9956,Epithelial Component Present,Adult Type Ovarian Granulosa Cell Tumor,1
9957,Metastatic Lesion,"Neoplasms, Unknown Primary",1
9958,Carcinomatous Component Present,Stage IIIB Breast Carcinoma,1
9959,Antoni A Pattern,Benign Esophageal Schwannoma,1
9960,More than 10 Mitoses per 10HPF,Stage IV Lung Small Cell Carcinoma AJCC v7,1
9961,Epithelial Component Present,Pancreatic intraepithelial neoplasia,1
9962,Benign Cellular Infiltrate,Hamartoma of lung,1
9963,Immunologic Deficiency Syndromes,HIV Encephalopathy,1
9964,Epithelial Component Present,Recurrent Thyroid Gland Papillary Carcinoma,1
9965,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
9966,Malignant Cellular Infiltrate,Cervical Malignant Peripheral Nerve Sheath Tumor,1
9967,Childhood Lesion,Childhood Cerebral Astrocytoma,1
9968,Cutaneous Involvement,"Acanthoma, Clear Cell",1
9969,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage I,1
9970,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
9971,Well-Circumscribed Lesion,Pancreatic Solid Serous Adenoma,1
9972,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Testicular Immature Teratoma,1
9973,Carcinomatous Component Present,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
9974,Nodular Pattern,Grade 3b Follicular Lymphoma,1
9975,Immunosuppression-Related Post-Transplant Toxicity,Non-Destructive Post-Transplant Lymphoproliferative Disorder,1
9976,Malignant Cellular Infiltrate,Lung Melanoma,1
9977,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v7,1
9978,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v6,1
9979,Malignant Cellular Infiltrate,Refractory Pancreatic Carcinoma,1
9980,Carcinomatous Component Present,Stage II Renal Pelvis Cancer AJCC v7,1
9981,Infiltrative Growth Pattern,Classical Glioblastoma,1
9982,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v8,1
9983,Adulthood Lesion,Non-Hodgkin Lymphoma During Pregnancy,1
9984,Carcinomatous Component Present,Metastatic Oral Cavity Carcinoma,1
9985,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
9986,Neuroendocrine Differentiation,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
9987,Carcinomatous Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8,1
9988,Plexiform Vasculature Present,Endometrial stromal nodule,1
9989,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v6 and v7,1
9990,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma,1
9991,Malignant Cellular Infiltrate,Urethral Cancer by AJCC v8 Stage,1
9992,Neuroendocrine Differentiation,Prostate Neuroendocrine Neoplasm,1
9993,Childhood Lesion,Benign Childhood Brain Neoplasm,1
9994,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland,1
9995,Carcinomatous Component Present,Vaginal clear cell adenocarcinoma,1
9996,Malignant Cellular Infiltrate,Bladder Papillary Clear Cell Adenocarcinoma,1
9997,Malignant Cellular Infiltrate,Tubular breast carcinoma,1
9998,Squamous metaplasia of bladder,verrucous carcinoma of bladder,1
9999,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v8,1
10000,Carcinomatous Component Present,Unresectable Renal Pelvis Urothelial Carcinoma,1
10001,Diffuse Pattern,large B-cell diffuse lymphoma of accessory sinus,1
10002,Malignant Cellular Infiltrate,Localized Unresectable Neuroblastoma,1
10003,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v8,1
10004,Malignant Cellular Infiltrate,Stage I Adult Liver Cancer AJCC v7,1
10005,Carcinomatous Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
10006,Carcinomatous Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
10007,Malignant Cellular Infiltrate,Sweat gland adenocarcinoma,1
10008,Epithelial Component Present,Stage IIIB Prostate Cancer AJCC v8,1
10009,Immunoglobulin Deposition,Refractory Primary Amyloidosis,1
10010,Hyperplastic Tissue Present,Drug-induced gingival hyperplasia,1
10011,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant",1
10012,Malignant Cellular Infiltrate,Malignant Peritoneal Germ Cell Tumor,1
10013,Epithelial Component Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
10014,Hypercellular bone marrow,Chronic Neutrophilic Leukemia,1
10015,Intraductal Lesion,Intracystic papillary adenoma,1
10016,Metastatic Lesion,Metastatic Malignant Neoplasm in the Viscera,1
10017,Primary Lesion,Temporal Lobe Ependymal Tumor,1
10018,Malignant Cellular Infiltrate,Adrenal Cortex Carcinoma by AJCC v7 Stage,1
10019,Hyperplastic Tissue Present,Utricle-Associated Mucosal Gland Hyperplasia,1
10020,Recurrent disease,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent,1
10021,Adulthood Lesion,Adult Central Nervous System Germ Cell Tumor,1
10022,Myxoid Stroma Formation,Fibromyxosarcoma,1
10023,Metaplasia,Squamous Lung Dysplasia,1
10024,Epithelial Component Present,Pericardial Carcinomatosis,1
10025,High Grade Lesion,Anaplastic Brain Stem Astrocytoma,1
10026,Low Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1,1
10027,Malignant Cellular Infiltrate,Renal cell carcinoma recurrent,1
10028,Stromal Invasion,Recurrent BRCA-Mutated Ovarian Carcinoma,1
10029,Childhood Lesion,Childhood Mediastinal Neurogenic Neoplasm,1
10030,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
10031,Cutaneous Involvement,Epidermolysis Bullosa Dystrophica,1
10032,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
10033,Myxoid Stroma Formation,Skull Base Chordoma,1
10034,Carcinomatous Component Present,Stage IV Prostate Carcinoma,1
10035,Multinodular Mass,Colorectal Angiosarcoma,1
10036,Primary Lesion,Recurrent Anaplastic Oligodendroglioma,1
10037,atypia morphology,Adult Grade III Lymphomatoid Granulomatosis,1
10038,Fibrosis,Primary mediastinal large B-cell lymphoma stage I,1
10039,Well Developed Rough Endoplasmic Reticulum Present,Densely Granulated Somatotroph Adenoma,1
10040,Stromal Invasion,Ovarian adenocarcinoma,1
10041,Malignant Cellular Infiltrate,Cervical Adenocarcinoma,1
10042,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant advanced,1
10043,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
10044,Adulthood Lesion,Adult Central Nervous System Germinoma,1
10045,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of esophagus,1
10046,Epithelial Component Present,Anal carcinoma,1
10047,Sarcomatous Component Present,Carcinosarcoma,1
10048,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
10049,Malignant Cellular Infiltrate,Early gastric cancer,1
10050,Eccrine Differentiation,Eccrine carcinoma of skin,1
10051,High Grade Lesion,Alveolar soft part sarcoma non-metastatic,1
10052,Malignant Cellular Infiltrate,Cervical carcinoma stage II AJCC v7,1
10053,Malignant Cellular Infiltrate,Prognostic Stage IIB Breast Cancer AJCC v8,1
10054,Tubular Pattern,Appendix Tubulovillous Adenoma,1
10055,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
10056,Nuclear pleomorphism,Pleomorphic lobular carcinoma in situ of breast,1
10057,Diffuse Pattern,Centroblastic lymphoma refractory,1
10058,Cutaneous Involvement,Pathologic Stage IIB Cutaneous Melanoma AJCC v8,1
10059,Epithelial Component Present,Stage II Fallopian Tube Cancer,1
10060,Well Differentiated Neuroendocrine Lesion,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,1
10061,Malignant Cellular Infiltrate,Penile Cancer by AJCC v7 Stage,1
10062,Epithelial Component Present,Recurrent Parotid Gland Carcinoma,1
10063,Chemotherapeutic Agent Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
10064,Malignant Cellular Infiltrate,Malignant Lung PEComa,1
10065,Epithelial Component Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
10066,Multifocal Lesion,Atypical Adenomatous Lung Hyperplasia,1
10067,Malignant Cellular Infiltrate,Anal Intraepithelial Neoplasia 3,1
10068,Epithelial Component Present,Cervical Warty Carcinoma,1
10069,Carcinomatous Component Present,Platinum-Resistant Lung Small Cell Carcinoma,1
10070,Benign Cellular Infiltrate,Benign Ovarian Thecoma,1
10071,Mitotic Activity,Childhood Glioblastoma,1
10072,Epithelial Component Present,Stage 0a Ureter Cancer AJCC v8,1
10073,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma,1
10074,Malignant Cellular Infiltrate,Childhood Burkitt Leukemia,1
10075,Microvascular Proliferation,Glioblastoma,1
10076,Malignant Cellular Infiltrate,Skin Lymphangiosarcoma,1
10077,Benign Cellular Infiltrate,Benign Smooth Muscle Neoplasm,1
10078,Biphasic Pattern,Giant fibroadenoma of breast,1
10079,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
10080,Locally Aggressive Lesion,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
10081,Primary Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
10082,Severe cytologic atypia,Gastroesophageal Junction Neuroendocrine Carcinoma,1
10083,Fibrotic Stroma Formation,Brenner Tumor,1
10084,Malignant Cellular Infiltrate,Pancreatic Foamy Gland Adenocarcinoma,1
10085,Hyperkeratosis,Plantar Verrucous Skin Carcinoma,1
10086,Well Differentiated Neuroendocrine Lesion,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
10087,Peripheral Nuclear Palisading,large cell neuroendocrine carcinoma of lung,1
10088,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
10089,Cutaneous Involvement,External Ear Squamous Cell Carcinoma,1
10090,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage IV,1
10091,Diffuse Pattern,Childhood Diffuse Astrocytoma,1
10092,Perivascular fibrosis,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage,1
10093,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v8,1
10094,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v6 Stage,1
10095,Carcinomatous Component Present,Carcinoma of supraglottis,1
10096,Malignant Cellular Infiltrate,Pleomorphic Rhabdomyosarcoma,1
10097,Villous Pattern,Colonic tubulovillous adenoma,1
10098,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
10099,Neuroendocrine Differentiation,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
10100,Malignant Cellular Infiltrate,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,1
10101,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v7,1
10102,Epithelial Component Present,Skin Squamous Cell Carcinoma In Situ,1
10103,Malignant Cellular Infiltrate,Blastema Predominant Kidney Wilms Tumor,1
10104,Epithelial Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
10105,Cellular Pleomorphism,Malignant Uterine Corpus PEComa,1
10106,Malignant Cellular Infiltrate,Choroid Spindle Cell Melanoma,1
10107,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
10108,Benign Cellular Infiltrate,Adenomatoid Tumor,1
10109,Mitotic Activity,Testicular yolk sac tumor stage I,1
10110,Carcinomatous Component Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,1
10111,Locally Aggressive Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
10112,Epithelial Component Present,'Refractory Paraganglioma',1
10113,Malignant Cellular Infiltrate,Anatomic Stage IIIA Breast Cancer AJCC v8,1
10114,Recurrent disease,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
10115,Secondary Lesion,Locally Advanced Squamous Cell Carcinoma,1
10116,Malignant Cellular Infiltrate,Metastatic Kidney Medullary Carcinoma,1
10117,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course,1
10118,Malignant Cellular Infiltrate,Malignant tumor of epididymis,1
10119,Microvascular Proliferation,Pilocytic Astrocytoma,1
10120,Secondary Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
10121,Malignant Cellular Infiltrate,Stage III Hodgkin Lymphoma,1
10122,Extensive Stage Lesion,Advanced Favorable Non-Hodgkin Lymphoma,1
10123,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
10124,Malignant Cellular Infiltrate,ROSE Cluster 8,1
10125,Perivascular Arrangement of Tumor Cells,Sclerosing PEComa,1
10126,Carcinomatous Component Present,Ghost Cell Odontogenic Carcinoma,1
10127,Primary Lesion,Primary mediastinal large B-cell lymphoma recurrent,1
10128,Epithelial Component Present,Adenocarcinoma of lung stage IIIB,1
10129,Malignant Cellular Infiltrate,Splenic T Lymphoblastic Lymphoma,1
10130,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
10131,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma refractory,1
10132,Refractory Disease,Refractory B-Cell Prolymphocytic Leukemia,1
10133,Malignant Cellular Infiltrate,Malignant Pulmonary Artery Neoplasm,1
10134,Epithelial Component Present,FIGO Stage IC1 Ovarian Cancer,1
10135,Indolent Clinical Course,Capillary hemangioma of eyelid,1
10136,Malignant Cellular Infiltrate,Advanced Uterine Corpus Carcinosarcoma,1
10137,Benign Cellular Infiltrate,Schwannoma of the Twelfth Cranial Nerve,1
10138,Carcinomatous Component Present,Bladder squamous cell carcinoma stage I,1
10139,Epithelial Component Present,Stage IVB Hepatocellular Carcinoma AJCC v8,1
10140,Monoclonal Paraproteinemia,Indolent multiple myeloma,1
10141,Epithelial Component Present,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
10142,Nodular Pattern,Follicular T-cell lymphoma,1
10143,Epithelial Component Present,Stage IIIA Fallopian Tube Cancer AJCC v8,1
10144,Exophytic Polypoid Lesion,Bile duct adenoma,1
10145,Malignant Cellular Infiltrate,Mycosis fungoides refractory,1
10146,Necrotic changes (finding),Childhood Glioblastoma,1
10147,Necrotic changes (finding),small cell carcinoma of kidney,1
10148,Childhood Lesion,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
10149,Malignant Cellular Infiltrate,"Papillary renal cell carcinoma, sporadic",1
10150,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v8,1
10151,Malignant Cellular Infiltrate,Stage III Colon Cancer AJCC v8,1
10152,Epithelial Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
10153,Lytic lesion,Cranial Nodular Fasciitis,1
10154,Infiltrative Growth Pattern,Lipofibromatosis,1
10155,Childhood Lesion,Childhood Acute Myeloid Leukemia with Maturation,1
10156,Epithelial Component Present,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
10157,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Serous",1
10158,Osteoid formation,Kidney Extraskeletal Osteosarcoma,1
10159,Benign Cellular Infiltrate,Senile angioma,1
10160,Adulthood Lesion,Adult Synovial Sarcoma,1
10161,Epithelial Component Present,Stage III Vulvar Cancer AJCC v6,1
10162,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v7,1
10163,Childhood Lesion,Recurrent Childhood Medulloblastoma,1
10164,Benign Cellular Infiltrate,Benign Ovarian Seromucinous Tumor,1
10165,Malignant Cellular Infiltrate,Low Grade Ovarian Serous Adenocarcinoma,1
10166,Thrombocytosis,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
10167,Cellular Pleomorphism,Adult Undifferentiated Pleomorphic Sarcoma,1
10168,Malignant Cellular Infiltrate,Grade II Chondrosarcoma,1
10169,Malignant Cellular Infiltrate,Malignant melanoma of retina,1
10170,Epithelial Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
10171,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
10172,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
10173,Immature Myeloid Cells Increased in Bone Marrow,Treatment related acute myeloid leukaemia,1
10174,Malignant Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma,1
10175,Diffuse Pattern,Pleural Biphasic Mesothelioma,1
10176,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
10177,Malignant Cellular Infiltrate,Stage IIB Gallbladder Cancer AJCC v8,1
10178,Unresectable Mass,Unresectable Digestive System Neuroendocrine Carcinoma,1
10179,Epithelial Component Present,Advanced Head and Neck Carcinoma,1
10180,Splenomegaly,Refractory T-Cell Prolymphocytic Leukemia,1
10181,Malignant Cellular Infiltrate,Refractory T-Cell Prolymphocytic Leukemia,1
10182,Epithelial Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
10183,Malignant Cellular Infiltrate,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
10184,Aggressive Clinical Course,Invasive micropapillary carcinoma of breast,1
10185,Fibrotic Stroma Formation,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
10186,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II,1
10187,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v8 Stage,1
10188,Well-Circumscribed Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
10189,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer recurrent,1
10190,Epithelial Component Present,Esophageal Neuroendocrine Tumor G1,1
10191,Lymphoplasmacytic Infiltrate,Splenic Lymphoplasmacytic Lymphoma,1
10192,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
10193,Thin-Walled Branching Vascular Pattern,Epidural Spinal Canal Angiolipoma,1
10194,Cutaneous Involvement,Corn of toe,1
10195,Vascular Channel Formation,Angiomatosis,1
10196,High Grade Lesion,Osteosarcoma Arising in Paget Disease of Bone,1
10197,Non-Hereditary Lesion,Sporadic Gastric Adenocarcinoma,1
10198,Secondary Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
10199,Malignant Cellular Infiltrate,Stage IVC Rectal Cancer AJCC v8,1
10200,Benign Cellular Infiltrate,Testicular Dermoid Cyst,1
10201,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
10202,Recurrent disease,Prostate cancer recurrent,1
10203,Malignant Cellular Infiltrate,FIGO Stage IIIA1(i) Ovarian Cancer,1
10204,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v8,1
10205,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma,1
10206,Low Mitotic Activity,Malignant Vipoma,1
10207,Epithelial Component Present,Thoracic Esophagus Squamous Cell Carcinoma,1
10208,Epithelial Component Present,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
10209,Metastatic Lesion,Pericardial mesothelioma malignant advanced,1
10210,Epithelial Component Present,Stage 0 Anal Cancer AJCC v8,1
10211,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
10212,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage II,1
10213,Primary Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
10214,Epithelial Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
10215,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
10216,Epithelial Component Present,ACTH-producing pituitary tumor,1
10217,Invasive Lesion,Acinar Prostate Mucinous Adenocarcinoma,1
10218,Absence of Invasion,Ampulla of Vater Tubulovillous Adenoma,1
10219,Adulthood Lesion,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,1
10220,Dysplasia,Foveolar-Type Adenoma,1
10221,Malignant Cellular Infiltrate,Marginal zone lymphoma stage IV,1
10222,Epithelial Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
10223,Malignant Cellular Infiltrate,Plantar Verrucous Skin Carcinoma,1
10224,Epithelial Component Present,Esophageal carcinoma,1
10225,Benign Cellular Infiltrate,Plexiform Schwannoma,1
10226,Malignant Cellular Infiltrate,ganglioneuroblastoma of mediastinum,1
10227,Neuroendocrine Differentiation,Meckel Diverticulum Neuroendocrine Tumor G1,1
10228,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
10229,Endophytic Tumor Growth,verrucous carcinoma of vagina,1
10230,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma,1
10231,Epithelial Component Present,Stage IIIC Anal Cancer AJCC v8,1
10232,Biphasic Pattern,Vaginal Adenosarcoma,1
10233,Epithelial Component Present,Bladder Mixed Adenocarcinoma,1
10234,Chronic lymphocytic inflammation,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
10235,High Mitotic Activity,neuroendocrine carcinoma of anal canal,1
10236,Malignant Cellular Infiltrate,FIGO Stage IC2 Ovarian Cancer,1
10237,Infiltrative Growth Pattern,Collecting Duct Carcinoma of the Kidney,1
10238,Malignant Cellular Infiltrate,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
10239,Malignant Cellular Infiltrate,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
10240,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor,1
10241,Well Differentiated Lesion,Cervical Squamotransitional Carcinoma,1
10242,Refractory Disease,Refractory cancer,1
10243,Neuroendocrine Differentiation,Combined Lung Small Cell and Squamous Cell Carcinoma,1
10244,Recurrent disease,recurrent adult acute myeloid leukemia,1
10245,Adulthood Lesion,Adult Leiomyosarcoma,1
10246,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
10247,Malignant Cellular Infiltrate,Cutaneous Liposarcoma,1
10248,Anaplasia,Recurrent Childhood Anaplastic Oligoastrocytoma,1
10249,Hyperplastic Tissue Present,Drug-induced gingival hyperplasia,1
10250,Hypercellular bone marrow,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
10251,Immature Myeloid Cells Increased in Bone Marrow,Treatment related acute myeloid leukaemia,1
10252,Fibrosis,"Breast Fibrocystic Change, Proliferative Type without Atypia",1
10253,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7,1
10254,Indolent Clinical Course,Bizarre leiomyoma,1
10255,Childhood Lesion,Recurrent Childhood Kidney Neoplasm,1
10256,Carcinomatous Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx,1
10257,Malignant Cellular Infiltrate,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
10258,Neuroendocrine Differentiation,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
10259,Malignant Cellular Infiltrate,Parotid Gland Carcinoma,1
10260,Malignant Cellular Infiltrate,Metastatic thymic carcinoma,1
10261,Mucoid Stroma Formation,mucinous adenocarcinoma of gallbladder,1
10262,Locally Aggressive Lesion,Unresectable Desmoid-Type Fibromatosis,1
10263,Well-Circumscribed Lesion,Syringocystadenoma Papilliferum,1
10264,Geographic Necrosis,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
10265,Metastatic/Recurrent Disease,Adult Clear Cell Sarcoma of Soft Parts,1
10266,Malignant Cellular Infiltrate,Stage IV Appendix Carcinoma AJCC v8,1
10267,Carcinomatous Component Present,Stage IV Colon Carcinoma,1
10268,Borderline Lesion,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
10269,Childhood Lesion,Stage III Childhood Non-Hodgkin Lymphoma,1
10270,Secondary Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
10271,Low Mitotic Activity,Descending Colon Neuroendocrine Tumor G1,1
10272,Carcinomatous Component Present,"Papillary squamous cell carcinoma, non-invasive",1
10273,High Mitotic Activity,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
10274,Carcinomatous Component Present,Stage 0a Ureter Cancer AJCC v8,1
10275,Adulthood Lesion,Adult Pineocytoma,1
10276,Radial Growth Phase,Superficial spreading malignant melanoma of skin,1
10277,Infiltrative Growth Pattern,MGMT-Methylated Glioblastoma,1
10278,Hyperplastic Tissue Present,Follicular Lymph Node Hyperplasia,1
10279,Neuronal Differentiation,Ganglioglioma,1
10280,Malignant Cellular Infiltrate,Stage 0 Gallbladder Cancer AJCC v8,1
10281,Carcinomatous Component Present,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7,1
10282,Myxoid Stroma Formation,Metastasizing Chondroblastoma,1
10283,Carcinomatous Component Present,"Uterine Carcinosarcoma, Homologous Type",1
10284,Absence of a Hormonal Syndrome,Null Cell Pituitary Gland Adenoma,1
10285,Cutaneous Involvement,Dermoid cyst of skin,1
10286,Lepidic Growth Pattern,Lung Non-Mucinous Adenocarcinoma In Situ,1
10287,Malignant Cellular Infiltrate,Vaginal Mesonephric Adenocarcinoma,1
10288,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of rectum,1
10289,High Grade Lesion,Endometrial Dedifferentiated Carcinoma,1
10290,Malignant Cellular Infiltrate,Infiltrating Urothelial Carcinoma,1
10291,Tricholemmal Differentiation,Trichilemmoma,1
10292,Villous Pattern,Appendix Villous Adenoma,1
10293,Epithelial Component Present,Penile Cancer by AJCC v6 Stage,1
10294,Chronic lymphocytic inflammation,Gastric Carcinoma with Lymphoid Stroma,1
10295,Carcinomatous Component Present,Malignant neoplasm of stomach stage IV,1
10296,Primary Lesion,Fourth Ventricle Ependymal Tumor,1
10297,Adulthood Lesion,Stage IV Adult Hodgkin Lymphoma,1
10298,Indolent Clinical Course,Ectopic hamartomatous thymoma,1
10299,Epithelial Component Present,Bladder Urachal Adenocarcinoma,1
10300,Carcinomatous Component Present,Biliary Tract Carcinoma,1
10301,Desmoplastic Stroma Formation,Adult Desmoplastic Small Round Cell Tumor,1
10302,Malignant Cellular Infiltrate,Malignant neoplasm of labium majus,1
10303,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor,1
10304,Well-Circumscribed Lesion,Gardner Syndrome,1
10305,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v7,1
10306,Epithelial Component Present,Cervical Squamous Cell Carcinoma In Situ,1
10307,Cutaneous Involvement,Dermatophytosis,1
10308,Childhood Lesion,Congenital Mesoblastic Nephroma,1
10309,Exophytic Papillary Lesion,Warty Carcinoma of the Penis,1
10310,Childhood Lesion,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
10311,Malignant Cellular Infiltrate,Poorly Differentiated Fibrosarcoma,1
10312,Hyperplastic Epithelial Tissue Present,Breast hyperplasia,1
10313,Anaplasia,Adult Anaplastic Astrocytoma,1
10314,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
10315,Vascular proliferation,Uterine Corpus Dissecting Leiomyoma,1
10316,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
10317,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,1
10318,Childhood Lesion,Childhood Multilocular Cystic Renal Neoplasm,1
10319,Carcinomatous Component Present,small cell carcinoma of breast,1
10320,Delicate Vascular Network Formation,Hereditary clear cell renal cell carcinoma,1
10321,Carcinomatous Component Present,adenoid cystic carcinoma of esophagus,1
10322,Cutaneous Involvement,Lymphangioma of skin,1
10323,Adulthood Lesion,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8,1
10324,Biphasic Pattern,Fallopian Tube Serous Adenofibroma,1
10325,Malignant Cellular Infiltrate,Locally Advanced Melanoma,1
10326,Carcinomatous Component Present,Grade 2 Endometrial Mucinous Adenocarcinoma,1
10327,Epithelial Component Present,Recurrent Pancreatic Cystadenocarcinoma,1
10328,Slow Growing Mass,Pilocytic Astrocytoma,1
10329,Dysplastic Dentin Formation,Dentinogenic Ghost Cell Tumor,1
10330,Adulthood Lesion,Recurrent Adult Brain Neoplasm,1
10331,Increased Cellularity Present,Familial Neuroblastoma,1
10332,Epithelial Component Present,Stage 0 Pharynx Carcinoma,1
10333,Carcinomatous Component Present,Stage IV Paranasal Sinus Cancer AJCC v7,1
10334,Malignant Cellular Infiltrate,Kadish Stage C Olfactory Neuroblastoma,1
10335,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Perihilar Variant,1
10336,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage I,1
10337,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
10338,Recurrent Genetic Abnormalities Present,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
10339,Tissue Differentiation Uncertain,Cellular Myxoma,1
10340,Malignant Cellular Infiltrate,Malignant melanoma of ciliary body,1
10341,Hereditary Lesion,Wiskott-Aldrich Syndrome,1
10342,Neuronal Differentiation,Ganglioneuroma,1
10343,Epithelial Component Present,Lung Carcinoma Metastatic in the Liver,1
10344,Epithelial Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
10345,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v8,1
10346,Hyalinized Stroma Formation,Metastatic Epithelioid Hemangioendothelioma,1
10347,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Gene Mutation,1
10348,S-100-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, malignant",1
10349,Primary Lesion,Lateral Ventricle Ependymal Tumor,1
10350,Malignant Cellular Infiltrate,Teratocarcinoma,1
10351,Pain,Osteoid osteoma,1
10352,Immunoglobulin Heavy Chain Deposition,Heavy Chain Deposition Disease,1
10353,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm,1
10354,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage III,1
10355,Carcinomatous Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
10356,Cicatrix,Old Burn Scar-Related Cutaneous Melanoma,1
10357,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
10358,Malignant Cellular Infiltrate,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
10359,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
10360,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH",1
10361,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Apoplectic Leiomyoma,1
10362,Neuroectodermal Differentiation,Stage 2B Neuroblastoma,1
10363,Radiation Sickness,Mucositis following radiation therapy,1
10364,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7,1
10365,Malignant Cellular Infiltrate,Malignant neoplasm of pharynx,1
10366,Multinodular Pattern,Adult Extraskeletal Myxoid Chondrosarcoma,1
10367,Benign Cellular Infiltrate,Capillary hemangioma of orbit,1
10368,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
10369,Adulthood Lesion,Adult Brain Stem Astrocytoma,1
10370,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
10371,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
10372,Secondary Lesion,Metastatic Lip and Oral Cavity Carcinoma,1
10373,Desmoplastic Stroma Formation,Childhood Desmoplastic Small Round Cell Tumor,1
10374,Unresectable Mass,Unresectable Leiomyosarcoma,1
10375,Perivascular Arrangement of Tumor Cells,Epithelioid Type Angiomyolipoma,1
10376,Rapidly Enlarging Mass,Gallbladder Rhabdomyosarcoma,1
10377,Gastric dysplasia,villous adenoma of stomach,1
10378,High Grade Lesion,"Synovial sarcoma, biphasic",1
10379,Malignant Cellular Infiltrate,Childhood T Lymphoblastic Leukemia/Lymphoma,1
10380,Metastatic Lesion,Metastatic Colon Carcinoma,1
10381,Malignant Cellular Infiltrate,Spindle cell liposarcoma,1
10382,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
10383,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v8,1
10384,Unresectable Mass,Unresectable Sarcoma,1
10385,Epithelial Component Present,Low Grade Corneal Intraepithelial Neoplasia,1
10386,Epithelial Component Present,Recurrent Urethral Cancer,1
10387,Vascular Channel Formation,Mediastinal Angiosarcoma,1
10388,Malignant Cellular Infiltrate,Malignant neoplasm of pituitary gland,1
10389,Malignant Cellular Infiltrate,Sarcoma NCI Grade 1,1
10390,Epithelial Component Present,Nodulo-ulcerative basal cell carcinoma,1
10391,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
10392,Epithelial Component Present,Colorectal Mixed Adenoneuroendocrine Carcinoma,1
10393,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
10394,Carcinomatous Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,1
10395,Carcinomatous Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
10396,Indolent Clinical Course,Uterine Corpus Atypical Polypoid Adenomyoma,1
10397,Malignant Cellular Infiltrate,Recurrent Lip Basal Cell Carcinoma,1
10398,Cord-Like Pattern,Syringoma,1
10399,Low Mitotic Activity,Esophageal Neuroendocrine Tumor,1
10400,Recurrent disease,Recurrent Non-Cutaneous Melanoma,1
10401,Epithelial Component Present,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
10402,Peripheral Nuclear Palisading,Platinum-Resistant Lung Small Cell Carcinoma,1
10403,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
10404,Humoral hypercalcemia of malignancy (disorder),"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
10405,Malignant Cellular Infiltrate,Occult Lung Cancer AJCC v8,1
10406,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
10407,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma recurrent,1
10408,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v8,1
10409,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 3,1
10410,Papillary Pattern,Bladder Papillary Urothelial Neoplasm,1
10411,Thick-Walled Hyalinized Vessels Present,Mediastinal Schwannoma,1
10412,Non-Invasive Lesion,Bladder Urothelial Papilloma,1
10413,Hyperplastic Tissue Present,Lobular Endocervical Glandular Hyperplasia,1
10414,Malignant Cellular Infiltrate,Recurrent Grade 3a Follicular Lymphoma,1
10415,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma,1
10416,Epithelial Component Present,Anal Adenocarcinoma within Anorectal Fistula,1
10417,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
10418,Malignant Cellular Infiltrate,Acute myeloid leukemia with multilineage dysplasia,1
10419,Refractory Disease,'Refractory Paraganglioma',1
10420,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
10421,Intracanalicular Growth Pattern,Breast Complex Fibroadenoma,1
10422,Syncytial Pattern,Nasopharyngeal lymphoepithelioma recurrent,1
10423,Anaplasia,Giant cell carcinoma of lung,1
10424,Carcinomatous Component Present,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
10425,Follicular Cell Differentiation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
10426,Epithelial Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
10427,Benign Cellular Infiltrate,Ureter Schwannoma,1
10428,Epithelial Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma,1
10429,Malignant Cellular Infiltrate,undifferentiated carcinoma of larynx,1
10430,Local disease,Central Nervous System Hibernoma,1
10431,Infiltrating Tumor Margins Present,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
10432,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v8,1
10433,Microcystic Change,Fibrillary Astrocytoma,1
10434,Multilocular Lesion,Multilocular Thymic Cyst,1
10435,Malignant Cellular Infiltrate,Medullary carcinoma of breast,1
10436,Diffuse Pattern,Childhood Gemistocytic Astrocytoma,1
10437,Recurrent disease,Recurrent Childhood Anaplastic Oligoastrocytoma,1
10438,Nuclear Atypia,Epithelioid glioblastoma,1
10439,Metastatic Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
10440,Epithelial Component Present,Squamous cell carcinoma with horn formation,1
10441,Exophytic Polypoid Lesion,Juvenile polyp,1
10442,Neuroendocrine Differentiation,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
10443,Neuroendocrine Differentiation,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
10444,High Grade Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
10445,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Erythroleukemia,1
10446,Stromal Invasion,FIGO Stage IIIA1(i) Ovarian Cancer,1
10447,Immunologic Deficiency Syndromes,Non-Destructive Post-Transplant Lymphoproliferative Disorder,1
10448,Necrotic changes (finding),Refractory Dedifferentiated Liposarcoma,1
10449,Hyperplastic Tissue Present,Flat Urothelial Hyperplasia,1
10450,Metastatic Lesion,Extra-osseous Ewing's sarcoma metastatic,1
10451,Malignant Cellular Infiltrate,Malignant Proliferating Pilar Tumor,1
10452,Carcinomatous Component Present,Prognostic Stage IV Breast Cancer AJCC v8,1
10453,Malignant Cellular Infiltrate,Ovarian cancer stage III,1
10454,Diffuse Lesion,Recurrent respiratory papillomatosis,1
10455,Malignant Cellular Infiltrate,Acute leukemia,1
10456,Perivascular Arrangement of Tumor Cells,Myopericytoma,1
10457,Epithelial Component Present,sialadenoma papilliferum of salivary gland,1
10458,Epithelial Component Present,Childhood Carcinoid Tumor,1
10459,Metastatic Lesion,Secondary malignant neoplasm of lymph node,1
10460,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
10461,Childhood Lesion,Childhood Periosteal Osteosarcoma,1
10462,Carcinomatous Component Present,Stage IIA Esophageal Adenocarcinoma AJCC v7,1
10463,Well-Circumscribed Lesion,Stage V Kidney Wilms Tumor,1
10464,Regional Disease,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
10465,Drop Metastasis,Drop Metastasis in the Spinal Cord,1
10466,Nuclear Grooves,Papillary thyroid carcinoma,1
10467,Mitotic Activity,Childhood Giant Cell Glioblastoma,1
10468,Childhood Lesion,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,1
10469,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7,1
10470,Cutaneous Involvement,Eyelid Sebaceous Gland Carcinoma,1
10471,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
10472,Geographic Necrosis,Teratocarcinoma,1
10473,Cutaneous Involvement,Sweat gland adenocarcinoma,1
10474,Malignant Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8,1
10475,Aggressive Clinical Course,Adult Burkitt Leukemia,1
10476,Primary Lesion,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
10477,Neuroendocrine Differentiation,Stage III Lung Small Cell Carcinoma AJCC v7,1
10478,Schwannian Stroma Predominant Component of the Tumor Volume,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
10479,Epithelial Component Present,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,1
10480,Monoclonal Cellular Population Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
10481,Epithelial Component Present,Adenomatous Polyposis Coli,1
10482,Malignant Cellular Infiltrate,Adult Grade III Meningioma,1
10483,Malignant Cellular Infiltrate,Recurrent Head and Neck Carcinoma,1
10484,High Grade Lesion,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
10485,Tissue Differentiation Uncertain,Pericardial Synovial Sarcoma,1
10486,Malignant Cellular Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v8,1
10487,High Grade Lesion,Epithelioid Sarcoma NCI Grade 3,1
10488,Cutaneous Involvement,Skin Sarcomatoid Basal Cell Carcinoma,1
10489,Epithelial Component Present,AIDS-related anal cancer recurrent,1
10490,Exophytic Papillary Lesion,Condyloma acuminata of vagina,1
10491,Hypertensive disease,Hypertensive Encephalopathy,1
10492,No Identifiable Line of Differentiation,"Undifferentiated Sarcoma, Not Otherwise Specified",1
10493,Pathologic TNM Finding,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
10494,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8,1
10495,Clinical TNM Finding,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
10496,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
10497,Well Differentiated Lesion,verrucous carcinoma of vagina,1
10498,Benign Cellular Infiltrate,Laryngeal Leiomyoma,1
10499,Primary Lesion,Stage IA Osteosarcoma AJCC v7,1
10500,Mixed Cellular Population,Cellular Pleomorphic Adenoma,1
10501,Malignant Cellular Infiltrate,Colon Mantle Cell Lymphoma,1
10502,Epithelial Component Present,Mixed cell adenoma,1
10503,Childhood Lesion,Recurrent Childhood Ependymoma,1
10504,Childhood Lesion,Childhood Unfavorable Prognosis Hodgkin Lymphoma,1
10505,Carcinomatous Component Present,Carcinoma in Situ,1
10506,Epithelial Component Present,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
10507,Malignant Cellular Infiltrate,Abdominal Rhabdomyosarcoma,1
10508,Epithelial Component Present,Stage IV Ampulla of Vater Cancer AJCC v8,1
10509,Carcinomatous Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
10510,Carcinomatous Component Present,Intestinal-Type Sinonasal Adenocarcinoma,1
10511,Epithelial Component Present,Stage I Ovarian Cancer AJCC v6 and v7,1
10512,Recurrent Lymphoma,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
10513,Cutaneous Involvement,Stage IVB Basal Cell Lip Carcinoma,1
10514,Indolent Clinical Course,Central Nervous System Leiomyoma,1
10515,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
10516,Malignant Cellular Infiltrate,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
10517,Epithelial Component Present,HPV positive oropharyngeal squamous cell carcinoma,1
10518,Carcinomatous Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
10519,Diffuse Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
10520,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of salivary gland,1
10521,Multifocal Lesion,Lipomatosis of Nerve,1
10522,Infiltrative Growth Pattern,Protoplasmic astrocytoma,1
10523,Malignant Cellular Infiltrate,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
10524,Epithelial Component Present,Bladder adenocarcinoma recurrent,1
10525,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
10526,Malignant Cellular Infiltrate,Unresectable Lung Carcinoma,1
10527,Local disease,Tendon Sheath Lipoma,1
10528,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland,1
10529,Malignant Cellular Infiltrate,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
10530,Invasive Lesion,Bladder transitional cell carcinoma stage III,1
10531,Epithelial Component Present,Ovarian gynandroblastoma,1
10532,Malignant Cellular Infiltrate,Lung Enteric Adenocarcinoma,1
10533,Malignant Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v7,1
10534,Carcinomatous Component Present,Submandibular Gland Adenocarcinoma,1
10535,Benign Cellular Infiltrate,Atrial myxoma,1
10536,Splenomegaly,Blast Phase,1
10537,Malignant Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,1
10538,Carcinomatous Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
10539,Adnexal Differentiation,Hidroacanthoma simplex,1
10540,Vascular Channel Formation,Hemangioma of spleen,1
10541,Tissue Differentiation Uncertain,Ventricular myxoma,1
10542,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Seminoma,1
10543,Non-Invasive Lesion,Non-Invasive Urothelial Neoplasm,1
10544,Indolent Clinical Course,Intermediate Rhabdomyoma,1
10545,Refractory Disease,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
10546,Indolent Clinical Course,Lipoblastoma,1
10547,Cutaneous Involvement,Sweat gland carcinoma,1
10548,Epithelial Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma,1
10549,Epithelial Component Present,Stage III Rectosigmoid Cancer AJCC v6,1
10550,Monomorphic Cellular Infiltrate,Adult Ependymoma,1
10551,Increased Cellularity Present,Stage 1 Neuroblastoma,1
10552,Recurrent disease,B-cell lymphoma recurrent,1
10553,Cutaneous Involvement,Stage IV Skin Cancer,1
10554,Carcinomatous Component Present,Esophageal Cancer by AJCC v6 Stage,1
10555,Cafe-au-Lait Spots,Refractory Neurofibromatosis Type 1,1
10556,Malignant Cellular Infiltrate,Malignant nipple neoplasm,1
10557,Carcinomatous Component Present,Laryngeal squamous cell carcinoma recurrent,1
10558,Papillary Pattern,"Papillomatosis, glandular",1
10559,Malignant Cellular Infiltrate,Anaplastic small cell lymphoma,1
10560,Malignant Cellular Infiltrate,Malignant Meningioma,1
10561,High Grade Lesion,Refractory Dedifferentiated Liposarcoma,1
10562,Malignant Cellular Infiltrate,Uterine Corpus Carcinosarcoma,1
10563,Malignant Cellular Infiltrate,Hereditary Leiomyomatosis and Renal Cell Cancer,1
10564,Locally Aggressive Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
10565,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
10566,Malignant Cellular Infiltrate,PRETEXT Stage 4 Hepatoblastoma,1
10567,Secondary Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
10568,Malignant Cellular Infiltrate,Transitional cell carcinoma of bladder,1
10569,Fibrosis,Primary mediastinal large B-cell lymphoma stage I,1
10570,Malignant Cellular Infiltrate,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
10571,Malignant Cellular Infiltrate,melanoma of scrotum,1
10572,Hyaline Cartilage Differentiation,Soft tissue chondroma,1
10573,Adulthood Lesion,Adult Central Nervous System Immature Teratoma,1
10574,Malignant Cellular Infiltrate,Virus-Related Carcinoma,1
10575,Epithelial Component Present,Stage III Colorectal Cancer,1
10576,Cystic Change,High Grade Mucoepidermoid Breast Carcinoma,1
10577,Metastatic/Recurrent Disease,Vulvar Alveolar Soft Part Sarcoma,1
10578,'Starry-sky' pattern,Burkitt's tumor of spleen,1
10579,High Grade Lesion,Secondary osteosarcoma,1
10580,Tumor Vascular Invasion,Malignant Testicular Leydig Cell Tumor,1
10581,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 3,1
10582,Carcinomatous Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
10583,Epithelial Component Present,Large cell carcinoma of lung,1
10584,Nuclear Grooves,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
10585,Painless Mass,chondroma of lung,1
10586,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
10587,Recurrent disease,Recurrent Subsequent Malignant Neoplasm,1
10588,Malignant Cellular Infiltrate,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
10589,Malignant Cellular Infiltrate,Bartholin Gland Transitional Cell Carcinoma,1
10590,Malignant Cellular Infiltrate,Liposarcoma metastatic,1
10591,Thyroglobulin Positive Neoplastic Cells Present,Follicular thyroid carcinoma,1
10592,Carcinomatous Component Present,Mammary Analog Secretory Carcinoma of Salivary Gland,1
10593,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage I Plasma Cell Myeloma,1
10594,Favorable Clinical Outcome,Mature Ganglioneuroma,1
10595,Epithelial Component Present,Metastatic Thyroid Gland Carcinoma,1
10596,Monoclonal Langerhans Cells Present,Refractory Langerhans Cell Histiocytosis,1
10597,No Identifiable Line of Differentiation,Undifferentiated round cell sarcoma,1
10598,Mixed Cellular Population,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
10599,Adnexal Differentiation,Invasive Apocrine Breast Carcinoma,1
10600,Carcinomatous Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
10601,Epithelial Component Present,Stage IIIB Breast Carcinoma,1
10602,Fibrous Septa Present,Dysgerminoma of ovary,1
10603,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
10604,Epithelial Component Present,Borderline Ovarian Serous Adenofibroma,1
10605,Malignant Cellular Infiltrate,Diffuse Blastoid B-Cell Lymphoma,1
10606,Carcinomatous Component Present,Recurrent Primary Peritoneal Carcinoma,1
10607,Benign Cellular Infiltrate,Eccrine acrospiroma,1
10608,Well-Circumscribed Lesion,Polyp of small intestine,1
10609,Unresectable Mass,Locally Advanced Unresectable Soft Tissue Sarcoma,1
10610,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
10611,Carcinomatous Component Present,"Hepatocellular carcinoma, scirrhous",1
10612,Vascular Channel Formation,Cavernous hemangioma of the face,1
10613,Malignant Cellular Infiltrate,Gallbladder papillary adenocarcinoma,1
10614,Tissue Differentiation Uncertain,Childhood Kidney Angiomyolipoma,1
10615,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage II,1
10616,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v6 Stage,1
10617,Carcinomatous Component Present,Sublingual Gland Adenocarcinoma,1
10618,Calcitonin serum level increased,Sporadic Thyroid Gland Micromedullary Carcinoma,1
10619,Epithelial Component Present,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
10620,Nuclear Clearing,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
10621,Well-Circumscribed Lesion,Gliomatosis Cerebri Type II,1
10622,Malignant Cellular Infiltrate,Rectal Micropapillary Adenocarcinoma,1
10623,Cavernous Vascular Space Formation,Intracranial cavernous hemangioma,1
10624,High Mitotic Activity,large cell neuroendocrine carcinoma of appendix,1
10625,Carcinomatous Component Present,Hereditary Fallopian Tube Carcinoma,1
10626,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Gangliocytic Paraganglioma,1
10627,Recurrent disease,Recurrent Primitive Neuroectodermal Tumor,1
10628,Juvenile Lesion,Juvenile Type Testicular Granulosa Cell Tumor,1
10629,Carcinomatous Component Present,Lung Basaloid Squamous Cell Carcinoma,1
10630,Ineffective hematopoiesis,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
10631,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Lung,1
10632,Epithelial Component Present,Adenocarcinoma of rectum,1
10633,Malignant Cellular Infiltrate,Stage IVA Colon Cancer AJCC v8,1
10634,Carcinomatous Component Present,Mucoepidermoid carcinoma of salivary gland,1
10635,Carcinomatous Component Present,Metastatic Parathyroid Gland Carcinoma,1
10636,Resectable Mass,Localized Resectable Adult Hepatocellular Carcinoma,1
10637,Monomorphic Cellular Infiltrate,Refractory Ependymoma,1
10638,Epithelial Component Present,Superior and Inferior Paraaortic Paraganglioma,1
10639,Malignant Cellular Infiltrate,Hereditary Kidney Wilms Tumor,1
10640,Malignant Cellular Infiltrate,Stage IIB Breast Carcinoma,1
10641,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v8,1
10642,Epithelial Component Present,Adenoma of the nipple,1
10643,High Grade Lesion,Childhood Rhabdomyosarcoma,1
10644,Carcinomatous Component Present,Advanced Laryngeal Squamous Cell Carcinoma,1
10645,Malignant Cellular Infiltrate,Stage II Cervical Cancer AJCC v6,1
10646,Benign Cellular Infiltrate,Breast Pleomorphic Adenoma,1
10647,Carcinomatous Component Present,Bartholin Gland Transitional Cell Carcinoma,1
10648,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
10649,Epithelial Component Present,Colon Neuroendocrine Tumor,1
10650,Malignant Cellular Infiltrate,BAP1-Mutant Clear Cell Renal Cell Carcinoma,1
10651,Carcinomatous Component Present,Sebaceous Breast Carcinoma,1
10652,Adulthood Lesion,Acute Adult T-Cell Leukemia/Lymphoma,1
10653,Negative Peripheral Blood,Aleukemic Monocytic Leukemia Cutis,1
10654,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",1
10655,Cystic Change,Melanoacanthoma,1
10656,Exophytic Polypoid Lesion,Skin tag,1
10657,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
10658,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Stage,1
10659,Indolent Clinical Course,Hemangioma of skin,1
10660,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7,1
10661,Solitary mass,Sellar Dedifferentiated Chordoma,1
10662,Papillary Pattern,Ethmoid Sinus Inverted Papilloma,1
10663,Borderline Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
10664,Cytoplasmic Membrane-Bound Granules Present,Stage 0 Merkel Cell Carcinoma AJCC v7,1
10665,Epithelial Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
10666,Large Spaces Filled with Blood Present,"Bone Cysts, Aneurysmal",1
10667,Multifocal Lesion,Periductal Breast Myoepitheliosis,1
10668,Epithelial Component Present,Colorectal Cancer by AJCC v6 Stage,1
10669,Carcinomatous Component Present,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
10670,Epithelial Component Present,Gallbladder squamous cell carcinoma,1
10671,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor,1
10672,Malignant Cellular Infiltrate,Myxoid liposarcoma metastatic,1
10673,Tissue of Mullerian Origin Present,Mucinous cystadenofibroma,1
10674,Adnexal Differentiation,Vulvar Sebaceous Carcinoma,1
10675,Benign Cellular Infiltrate,Eccrine dermal cylindroma,1
10676,Perineural spread,Adenoid cystic carcinoma of submandibular gland,1
10677,Multifocal Lesion,Multiple polyps,1
10678,Malignant Cellular Infiltrate,Broad Ligament Serous Adenocarcinoma,1
10679,Carcinomatous Component Present,"Adenocarcinoma, Clear Cell",1
10680,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Sarcoma,1
10681,Malignant Cellular Infiltrate,Angiocentric lymphoma stage I,1
10682,CD1a-Positive Neoplastic Cells Present,Letterer-Siwe Disease,1
10683,Hereditary Lesion,Shwachman syndrome,1
10684,Childhood Lesion,Childhood Acute Lymphoblastic Leukemia,1
10685,Epithelial Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
10686,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
10687,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma,1
10688,Cartilaginous Differentiation,Juxtacortical chondrosarcoma,1
10689,Epithelial Component Present,Lipid-rich carcinoma,1
10690,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v8,1
10691,Epithelial Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
10692,Invasive Lesion,Secretory breast carcinoma,1
10693,Papillary Pattern,Serous surface papillary carcinoma,1
10694,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
10695,Epithelial Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
10696,Papillary Pattern,Sphenoid Sinus Schneiderian Papilloma,1
10697,Poorly Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
10698,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
10699,Epithelial Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
10700,Epithelial Component Present,Borderline cystadenoma,1
10701,Epithelial Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7,1
10702,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Adenocarcinoma,1
10703,Lobulated Growth Pattern,Locally Advanced Chordoma,1
10704,Immature Granulocytes in Peripheral Blood Under 10 Percent,"Leukemia, Myelomonocytic, Chronic",1
10705,Immunologic Deficiency Syndromes,AIDS-Related Gastric Kaposi Sarcoma,1
10706,Myxoid Stroma Formation,Myxoid liposarcoma metastatic,1
10707,Lesion with Diameter Greater than 10mm,Pituitary Gland Macroadenoma,1
10708,Indolent Clinical Course,Congenital hemangioma,1
10709,Malignant Cellular Infiltrate,Stage IVA Gallbladder Carcinoma,1
10710,Malignant Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
10711,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage I,1
10712,Cutaneous Involvement,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
10713,Pain,mesenchymal chondrosarcoma of bone,1
10714,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Polystotic",1
10715,Carcinomatous Component Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
10716,Microcystic Change,Juvenile Pilocytic Astrocytoma,1
10717,Benign Cellular Infiltrate,Eccrine hidrocystoma,1
10718,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v7 Stage,1
10719,Adulthood Lesion,Adult Central Nervous System Immature Teratoma,1
10720,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v8,1
10721,Malignant Cellular Infiltrate,hepatoid adenocarcinoma of gallbladder,1
10722,Malignant Cellular Infiltrate,Clinical Stage IVA Gastric Cancer AJCC v8,1
10723,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pancreas,1
10724,Adulthood Lesion,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,1
10725,Malignant Cellular Infiltrate,Waldenstrom Macroglobulinemia,1
10726,Single Cell Necrosis,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
10727,Carcinomatous Component Present,Colorectal Cancer by AJCC v7 Stage,1
10728,Entrapped Respiratory Epithelium Present,Hamartoma of lung,1
10729,Refractory Disease,Refractory Laryngeal Squamous Cell Carcinoma,1
10730,Epithelial Component Present,Stage IV Laryngeal Carcinoma,1
10731,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
10732,Malignant Cellular Infiltrate,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
10733,High Grade Lesion,Rhabdomyosarcoma of the orbit,1
10734,Childhood Lesion,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
10735,Childhood Lesion,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
10736,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland,1
10737,Malignant Cellular Infiltrate,Unresectable Synovial Sarcoma,1
10738,Pseudoglandular Pattern,Childhood Ovarian Embryonal Carcinoma,1
10739,Carcinomatous Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
10740,Malignant Cellular Infiltrate,Malignant tumor of choroid plexus,1
10741,Acantholysis,Acantholytic acanthoma,1
10742,Epithelial Component Present,Masaoka-Koga Stage IIa,1
10743,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
10744,Follicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
10745,Carcinomatous Component Present,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
10746,Epithelial Component Present,Bile duct clear cell adenocarcinoma,1
10747,Monocytosis,Recurrent Chronic Myelomonocytic Leukemia,1
10748,Epithelial Component Present,Breast adenocarcinoma,1
10749,Malignant Cellular Infiltrate,Fusion-Positive Rhabdomyosarcoma,1
10750,Mucoid Stroma Formation,mucinous adenocarcinoma of rectum,1
10751,Carcinomatous Component Present,Major Salivary Gland Adenoid Cystic Carcinoma,1
10752,Benign Cellular Infiltrate,"Acanthoma, Clear Cell",1
10753,Secondary Lesion,Vaginal adenocarcinoma metastatic,1
10754,Heterologous Elements Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
10755,Epithelial Component Present,Stage I Gallbladder Cancer AJCC v6,1
10756,Invasive Lesion,Breast Carcinoma with Osteoclastic Giant Cells,1
10757,Epithelial Component Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
10758,Adnexal Differentiation,Sebaceous adenoma,1
10759,Epithelial Component Present,Stage IVA Vaginal Cancer AJCC v8,1
10760,Benign Cellular Infiltrate,Lymphangioendothelioma,1
10761,Recurrent disease,Recurrent Rhabdoid Tumor,1
10762,Absence of Invasion,Bowen's Disease,1
10763,Mesenchymal Differentiation,"Transitional cell carcinoma, spindle cell",1
10764,Malignant Cellular Infiltrate,Pineal Region Choriocarcinoma,1
10765,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma,1
10766,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
10767,Polymorphic Cellular Infiltrate,"Langerhans Cell Histiocytosis, Polystotic",1
10768,Refractory Disease,Refractory Malignant Peripheral Nerve Sheath Tumor,1
10769,Malignant Cellular Infiltrate,Lung Lymphoepithelioma-Like Carcinoma,1
10770,Malignant Cellular Infiltrate,Leiomyosarcoma of uterus,1
10771,Malignant Cellular Infiltrate,Squamous cell carcinoma of the nasal cavity,1
10772,Cystic Change,Borderline Ovarian Serous Cystadenofibroma,1
10773,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myelomonocytic, Chronic",1
10774,Epithelial Component Present,Adenoid Cystic Carcinoma,1
10775,Malignant Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma,1
10776,Diffuse Lesion,"Papillomatosis, glandular",1
10777,Thick-Walled Hyalinized Vessels Present,Conventional Schwannoma,1
10778,Cystic Change,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,1
10779,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Spine,1
10780,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Lymphoma AJCC v8,1
10781,Carcinomatous Component Present,Small Intestinal Undifferentiated Carcinoma,1
10782,Adnexal Differentiation,Carcinoma ex Eccrine Spiradenoma,1
10783,Epithelial Component Present,inverted ductal papilloma of salivary gland,1
10784,Hypocellular Tissue,Cellular Myxoma,1
10785,Carcinomatous Component Present,Ovarian adenocarcinoma,1
10786,Secondary Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
10787,Dysplasia,Rectal Tubular Adenoma,1
10788,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
10789,Tubular Pattern,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
10790,Epithelial Component Present,granulosa cell tumor,1
10791,Metastatic Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
10792,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
10793,Perivascular Arrangement of Tumor Cells,Benign Uterine Corpus PEComa,1
10794,Benign Cellular Infiltrate,Leiomyoma of esophagus,1
10795,Perivascular Arrangement of Tumor Cells,Papillary Meningioma,1
10796,Malignant Cellular Infiltrate,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
10797,Malignant Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm,1
10798,Lobulated Growth Pattern,Pyogenic granuloma of oral mucosa,1
10799,Dysplasia,Colon Traditional Serrated Adenoma,1
10800,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v7,1
10801,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma,1
10802,Anaplasia,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
10803,Cutaneous Involvement,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
10804,Metaplasia,Nephrogenic metaplasia,1
10805,Carcinomatous Component Present,Localized Parathyroid Gland Carcinoma,1
10806,Finding related to pregnancy,Hodgkin Lymphoma During Pregnancy,1
10807,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis,1
10808,Malignant Cellular Infiltrate,Brain Glioblastoma,1
10809,Epithelial Component Present,Breast Cancer by AJCC v7 Stage,1
10810,Indolent Clinical Course,Histiocytoid hemangioma,1
10811,Malignant Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v6 and v7,1
10812,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
10813,Malignant Cellular Infiltrate,Malignant Esophageal Neoplasm by Anatomic Region,1
10814,Malignant Cellular Infiltrate,Small intestine carcinoma stage I,1
10815,Acanthosis,Urethral Condyloma Acuminatum,1
10816,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
10817,Epithelial Component Present,Locally Advanced Prostate Carcinoma,1
10818,Cellular Pleomorphism,Giant Cell Fibrous Histiocytoma,1
10819,Epithelial Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
10820,Malignant Cellular Infiltrate,Early Hepatocellular Carcinoma,1
10821,Carcinomatous Component Present,Locally Advanced Prostate Carcinoma,1
10822,Infiltrating Tumor Margins Present,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
10823,Cytologic atypia,Anaplastic Astroblastoma,1
10824,Low Mitotic Activity,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
10825,Invasive Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
10826,Malignant Cellular Infiltrate,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
10827,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v6 Stage,1
10828,Papillary Pattern,Borderline Ovarian Serous Adenofibroma,1
10829,Epithelial Component Present,Papillary Breast Neoplasm,1
10830,Lymphadenopathy,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
10831,Carcinomatous Component Present,Hereditary Ovarian Carcinoma,1
10832,Fibrous Septa Present,"Bone Cysts, Aneurysmal",1
10833,Childhood Lesion,Childhood Testicular Germ Cell Tumor,1
10834,Malignant Cellular Infiltrate,Gastric Tubular Adenocarcinoma,1
10835,Hyalinized Stroma Formation,Hemangiopericytoma of meninges,1
10836,Carcinomatous Component Present,Carcinoma of larynx,1
10837,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by DS Stage,1
10838,'Starry-sky' pattern,Stage III Childhood Burkitt Lymphoma,1
10839,Thick-Walled Hyalinized Vessels Present,Cerebellopontine Angle Schwannoma,1
10840,Extensive Stage Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
10841,Epithelial Component Present,Nipple Duct Carcinoma,1
10842,Epithelial Component Present,Intracystic papillary adenoma,1
10843,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Neoplasm,1
10844,Papillary Pattern,Hereditary Papillary Renal Carcinoma,1
10845,Chromogranin A Positive Neoplastic Cells Present,Esophageal Neuroendocrine Tumor G1,1
10846,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Polyp,1
10847,Dysplasia,Stage 0 Vulvar Cancer,1
10848,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v7,1
10849,Necrotic changes (finding),Low Grade Malignant Peripheral Nerve Sheath Tumor,1
10850,More than 5 Mitoses per 50HPF,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
10851,Metastatic Lesion,Bladder cancer stage IV,1
10852,Malignant Cellular Infiltrate,Recurrent Lip Basal Cell Carcinoma,1
10853,Carcinomatous Component Present,Metaplastic carcinoma of breast,1
10854,Malignant Cellular Infiltrate,Telangiectatic osteosarcoma,1
10855,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
10856,Solitary mass,malignant epithelioid hemangioendothelioma of liver,1
10857,Malignant Cellular Infiltrate,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1
10858,Carcinomatous Component Present,Colorectal Neuroendocrine Carcinoma,1
10859,Indolent Clinical Course,Central Nervous System Myofibroblastoma,1
10860,Cartilaginous Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
10861,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8,1
10862,Malignant Cellular Infiltrate,Stage I Superficial Spreading Melanoma AJCC v7,1
10863,Carcinomatous Component Present,Squamous cell carcinoma of rectum,1
10864,Chronic lymphocytic inflammation,Lymphoid interstitial pneumonia,1
10865,Low Mitotic Activity,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
10866,Epithelial Component Present,Refractory Nasopharyngeal Carcinoma,1
10867,Malignant Cellular Infiltrate,Stage II Liver Cancer,1
10868,Pseudoencapsulated Mass,Cardiac Malignant Peripheral Nerve Sheath Tumor,1
10869,Carcinomatous Component Present,Recurrent Thyroid Gland Papillary Carcinoma,1
10870,Malignant Cellular Infiltrate,Advanced Sarcoma of the Extremity,1
10871,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v7,1
10872,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v8,1
10873,Malignant Cellular Infiltrate,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,1
10874,Adulthood Lesion,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
10875,Local disease,Liver Lipoma,1
10876,Exophytic Polypoid Lesion,Polyp of sphenoidal sinus,1
10877,Malignant Cellular Infiltrate,Familial Neuroblastoma,1
10878,Cutaneous Involvement,Herpes zoster dermatitis,1
10879,Lobulated Growth Pattern,HNF1alpha-Inactivated Hepatocellular Adenoma,1
10880,Carcinomatous Component Present,large cell neuroendocrine carcinoma of ovary,1
10881,Carcinomatous Component Present,undifferentiated carcinoma of salivary gland,1
10882,Carcinomatous Component Present,Basal cell carcinoma - adamantinoid,1
10883,Anaplasia,MGMT-Unmethylated Glioblastoma,1
10884,Mitotic Activity,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
10885,Malignant Cellular Infiltrate,Papillary Eccrine Carcinoma,1
10886,Carcinomatous Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
10887,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia refractory,1
10888,Benign Cellular Infiltrate,Thyroid Gland Hemangioma,1
10889,Neuroendocrine Differentiation,Intestinal Neuroendocrine Neoplasm,1
10890,Numerous Stromal Mast Cells Present,Palisaded Lymph Node Myofibroblastoma,1
10891,Carcinomatous Component Present,Colorectal Sarcomatoid Carcinoma,1
10892,Malignant Cellular Infiltrate,Secondary malignant neoplasm of chest wall,1
10893,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
10894,Lymphoplasmacytic Infiltrate,Medullary carcinoma of breast,1
10895,Rhabdomyosarcomatous Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
10896,Epithelial Component Present,Carcinoma of lung,1
10897,Cellular Changes Resembling Foveolar Epithelium Cells,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
10898,Encapsulated Mass,Thyroid Gland Follicular Adenoma,1
10899,Hyperplastic Tissue Present,Endometrial Hyperplasia,1
10900,Indolent Clinical Course,Cavernous hemangioma of orbit,1
10901,Carcinomatous Component Present,"Gallbladder Adenocarcinoma, Biliary Type",1
10902,Diffuse Pattern,Gemistocytic astrocytoma,1
10903,Diffuse Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",1
10904,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
10905,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8,1
10906,Malignant Cellular Infiltrate,Refractory Uterine Corpus Carcinoma,1
10907,Dysplasia,Cervical intraepithelial neoplasia grade 2,1
10908,Benign Cellular Infiltrate,Bizarre leiomyoma,1
10909,Edematous Stroma Formation,Spermatocytic seminoma,1
10910,Malignant Cellular Infiltrate,Stage IVB Ovarian Cancer AJCC v8,1
10911,Malignant Cellular Infiltrate,undifferentiated sarcoma of ovary,1
10912,Papillary Pattern,Stage 0a Ureter Cancer AJCC v7,1
10913,Epithelial Component Present,Benign Apocrine Neoplasm,1
10914,Hyperplastic Tissue Present,Foveolar hyperplasia,1
10915,Malignant Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",1
10916,Malignant Cellular Infiltrate,Malignant neoplasm of gallbladder,1
10917,Epithelial Component Present,Stage IIB Lung Large Cell Carcinoma AJCC v7,1
10918,Epithelial Component Present,Esophageal Basaloid Carcinoma,1
10919,Benign Cellular Infiltrate,benign neoplasm of heart,1
10920,Indolent Clinical Course,Extrahepatic Bile Duct Fibroma,1
10921,Malignant Cellular Infiltrate,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
10922,Acanthosis,Laryngeal verrucous carcinoma stage IV,1
10923,Malignant Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Intermixed",1
10924,Epithelial Component Present,Stage IV Lung Cancer AJCC v6,1
10925,Biphasic Pattern,Advanced Uterine Corpus Carcinosarcoma,1
10926,High Mitotic Activity,Vulvar Small Cell Carcinoma,1
10927,Erythema,Superficial basal cell carcinoma,1
10928,Epithelial Component Present,Papillomatosis,1
10929,Metastatic Lesion,Metastatic Gastric Neuroendocrine Carcinoma,1
10930,Slow Growing Mass,Vertebral chordoma,1
10931,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
10932,Carcinomatous Component Present,Stage III Lung Cancer AJCC v8,1
10933,Tubular Structures Present,Ovarian Sertoli Cell Tumor with Lipid Storage,1
10934,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
10935,Malignant Cellular Infiltrate,leiomyosarcoma,1
10936,Recurrent disease,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
10937,Deep Lesion,Perineural Hemangioma,1
10938,Serrated Glandular Architecture,Rectal Traditional Serrated Adenoma,1
10939,Childhood Lesion,Childhood Adrenal Gland Pheochromocytoma,1
10940,Indolent Clinical Course,Benign Skeletal Muscle Neoplasm,1
10941,Recurrent disease,Malignant fibrous histiocytoma recurrent,1
10942,Epithelial Component Present,Non-Small Cell Lung Carcinoma,1
10943,Epithelial Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
10944,Carcinomatous Component Present,Stage III Oropharyngeal Carcinoma AJCC v6,1
10945,Sarcomatous Component Present,Advanced Uterine Corpus Carcinosarcoma,1
10946,Secondary Lesion,Metastatic Vaginal Carcinoma,1
10947,Diffuse Pattern,Splenic diffuse red pulp small B-cell lymphoma,1
10948,Metastatic/Recurrent Disease,Adult Desmoplastic Small Round Cell Tumor,1
10949,Low Mitotic Activity,Small Intestinal Carcinoid Tumor,1
10950,Unifocal Lesion,"Langerhans cell histiocytosis, unifocal",1
10951,Dysplasia,intraepithelial glandular neoplasia of cervix,1
10952,Malignant Cellular Infiltrate,Recurrent Mixed Phenotype Acute Leukemia,1
10953,Well Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
10954,Nuclear Expression of STAT6 Protein,Thymus Solitary Fibrous Tumor,1
10955,Malignant Cellular Infiltrate,Recurrent Childhood Central Nervous System Embryonal Neoplasm,1
10956,Epithelial Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
10957,Epithelial Component Present,Pituitary Gland Microadenoma,1
10958,Epithelial Component Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
10959,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
10960,Malignant Cellular Infiltrate,Adult Medulloblastoma,1
10961,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intracranial Meningioma,1
10962,Malignant Cellular Infiltrate,Recurrent Urinary System Carcinoma,1
10963,Carcinomatous Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v8,1
10964,Exophytic Polypoid Lesion,Colonic tubulovillous adenoma,1
10965,Malignant Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v6 and v7,1
10966,Malignant Cellular Infiltrate,Rectal Sarcomatoid Carcinoma,1
10967,Epithelial Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
10968,Nuclear Pseudoinclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
10969,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma,1
10970,Borderline Lesion,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",1
10971,Epithelial Component Present,"Cystadenoma, Papillary",1
10972,Epithelial Component Present,Malignant Ovarian Granulosa Cell Tumor,1
10973,Hyaline Cartilage Differentiation,Enchondromatosis,1
10974,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v7,1
10975,Angiocentric Pattern,Recurrent Childhood Lymphomatoid Granulomatosis,1
10976,Well Differentiated Neuroendocrine Lesion,insulinoma,1
10977,Epithelial Component Present,large cell neuroendocrine carcinoma of thymus,1
10978,Angiocentric Pattern,Recurrent Lymphomatoid Granulomatosis,1
10979,Vascular Channel Formation,Childhood Epithelioid Hemangioendothelioma,1
10980,Adnexal Differentiation,Apocrine cystadenoma,1
10981,Malignant Cellular Infiltrate,Secondary malignant neoplasm of eye,1
10982,Local disease,Mesothelioma malignant localized,1
10983,Low Grade Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
10984,Mixed Cellular Population,Breast Fibroepithelial Neoplasm,1
10985,Adnexal Differentiation,Trichilemmoma,1
10986,Epithelial Component Present,lymphoepithelial squamous cell carcinoma of salivary gland,1
10987,Carcinomatous Component Present,Rectal Cancer by AJCC v7 Stage,1
10988,Childhood Lesion,Recurrent Childhood Anaplastic Oligoastrocytoma,1
10989,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast with Atypia,1
10990,Malignant Cellular Infiltrate,Angioendotheliomatosis,1
10991,Malignant Cellular Infiltrate,Stage IB Lung Cancer AJCC v7,1
10992,Neuroectodermal Differentiation,Olfactory Neuroblastoma,1
10993,Metaplasia,Metastatic Bladder Squamous Cell Carcinoma,1
10994,Papillary Pattern,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
10995,Mitotic Activity,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma,1
10996,Benign Cellular Infiltrate,Fallopian tube leiomyoma,1
10997,Therapy-Related Toxicity,Methotrexate-Associated Peripheral T-Cell Lymphoma,1
10998,Osteoid formation,Osteoma,1
10999,Clinical TNM Finding,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11000,Carcinomatous Component Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
11001,Malignant Cellular Infiltrate,Superficial spreading malignant melanoma of skin,1
11002,Epithelial Component Present,Primary myoepithelial carcinoma of lung,1
11003,Malignant Cellular Infiltrate,Stage III Adult Soft Tissue Sarcoma AJCC v7,1
11004,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v6 Stage,1
11005,Neuroendocrine Differentiation,Vaginal Neuroendocrine Carcinoma,1
11006,Carcinomatous Component Present,Stage II Renal Cell Cancer,1
11007,Epithelial Component Present,Hard Palate Squamous Cell Carcinoma,1
11008,Spontaneous Regression,"Retinoblastoma, spontaneously regressed",1
11009,Adulthood Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
11010,Diffuse Pattern,Childhood Glioblastoma,1
11011,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v7 Stage,1
11012,Invasive Lesion,Bladder transitional cell carcinoma stage II,1
11013,Papillary Pattern,Primary serous papillary carcinoma of peritoneum,1
11014,Mixed Cellular Population,"Uterine Carcinosarcoma, Heterologous Type",1
11015,Malignant Cellular Infiltrate,AIDS-Related Malignant Anal Neoplasm,1
11016,Carcinomatous Component Present,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
11017,Microvascular Proliferation,Acinar cell carcinoma of pancreas,1
11018,Carcinomatous Component Present,Stage III Breast Cancer AJCC v7,1
11019,Cutaneous Involvement,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
11020,Malignant Cellular Infiltrate,Recurrent Childhood Medulloblastoma,1
11021,Malignant Cellular Infiltrate,Classical Hodgkin's Lymphoma,1
11022,High Grade Lesion,Uterine Corpus High Grade Endometrial Stromal Sarcoma,1
11023,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Carcinoma,1
11024,Metastatic Lesion,Disseminated adenocarcinoma,1
11025,Cutaneous Involvement,Eccrine dermal cylindroma,1
11026,High Mitotic Activity,Esophageal Large Cell Neuroendocrine Carcinoma,1
11027,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v8,1
11028,Mitotic Activity,Recurrent Childhood Glioblastoma,1
11029,Carcinomatous Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
11030,Osteoid formation,Cardiac Extraskeletal Osteosarcoma,1
11031,Epithelial Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
11032,Malignant Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
11033,Koilocytotic atypia,Warty Carcinoma of the Penis,1
11034,Malignant Cellular Infiltrate,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
11035,Local disease,Inner Ear Lipoma,1
11036,Epithelial Component Present,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
11037,Resectable Mass,Pancreatic adenocarcinoma resectable,1
11038,Cutaneous Involvement,Cutaneous T Lymphoblastic Leukemia/Lymphoma,1
11039,Benign Cellular Infiltrate,Follicular Myxoma,1
11040,Recurrent disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
11041,Dysplasia,Pancreatic Intraepithelial Neoplasia-1,1
11042,Cutaneous Involvement,Lichen Sclerosus et Atrophicus,1
11043,Adulthood Lesion,Stage I Adult Immunoblastic Lymphoma,1
11044,Exophytic Polypoid Lesion,Polyp of gallbladder,1
11045,Mitotic Activity,Anaplastic Diencephalic Astrocytoma,1
11046,Malignant Cellular Infiltrate,mucinous adenocarcinoma of bladder,1
11047,Biphasic Pattern,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
11048,Epithelial Component Present,Small cell lung cancer extensive stage,1
11049,Keratin pearl formation,Skin Basaloid Carcinoma,1
11050,Carcinomatous Component Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
11051,Metastatic Lesion,Metastatic Genitourinary System Carcinoma,1
11052,Malignant Cellular Infiltrate,carcinosarcoma of fallopian tube,1
11053,Benign Cellular Infiltrate,Odontogenic myxoma,1
11054,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate,1
11055,Recurrent disease,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
11056,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v6 and v7,1
11057,Malignant Cellular Infiltrate,Pigmented Basal Cell Carcinoma,1
11058,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,lipid-rich carcinoma of breast,1
11059,Geographic Necrosis,Childhood Embryonal Carcinoma,1
11060,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Isolated del(5q),1
11061,Cutaneous Involvement,Cutaneous Radiation-Related Angiosarcoma,1
11062,Carcinomatous Component Present,Oropharyngeal Carcinoma by AJCC v7 Stage,1
11063,Malignant Cellular Infiltrate,Stage IIIC Gastric Cancer AJCC v7,1
11064,Biphasic Pattern,Juvenile Pilocytic Astrocytoma,1
11065,Malignant Cellular Infiltrate,Epiglottic carcinoma,1
11066,Low Mitotic Activity,Pancreatic Somatostatinoma,1
11067,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8,1
11068,Lymphoplasmacytic Infiltrate,Pulmonary nodular lymphoid hyperplasia,1
11069,Lobulated Growth Pattern,Left atrial myxoma,1
11070,Epithelial Component Present,Appendix Traditional Serrated Adenoma,1
11071,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
11072,Benign Cellular Infiltrate,Benign Neoplasm,1
11073,Cutaneous Involvement,Skin Papilloma,1
11074,Malignant Cellular Infiltrate,Liver carcinoma,1
11075,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v8 Stage,1
11076,Carcinomatous Component Present,Human Papillomavirus-Related Verrucous Carcinoma,1
11077,Primary Lesion,Recurrent Childhood Gliomatosis Cerebri,1
11078,Cutaneous Involvement,"Carcinoma, Skin Appendage",1
11079,Epithelial Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
11080,Carcinomatous Component Present,Stage 0 Urethral Cancer AJCC v7,1
11081,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
11082,Infiltrative Growth Pattern,Infantile digital fibromatosis,1
11083,Borderline Lesion,Borderline Ovarian Mucinous Tumor,1
11084,Malignant Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v8,1
11085,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of lung,1
11086,Malignant Cellular Infiltrate,Lobular carcinoma in situ of breast,1
11087,Well-Circumscribed Lesion,Cystadenoma of pancreas,1
11088,Antoni A Pattern,Ureter Schwannoma,1
11089,Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,1
11090,Malignant Cellular Infiltrate,Malignant tenosynovial giant cell tumor,1
11091,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v6,1
11092,Carcinomatous Component Present,Anaplastic thyroid carcinoma,1
11093,Neuroendocrine Differentiation,Endometrial Small Cell Carcinoma,1
11094,Unresectable Mass,Localized Unresectable Adult Hepatocellular Carcinoma,1
11095,Malignant Cellular Infiltrate,Nasopharyngeal cancer recurrent,1
11096,Carcinomatous Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
11097,Clinical TNM Finding,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
11098,Epithelial Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma,1
11099,Cutaneous Involvement,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
11100,Malignant Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v7,1
11101,Indolent Clinical Course,Right atrial myxoma,1
11102,Malignant Cellular Infiltrate,Malignant tumor of pyriform fossa,1
11103,Hereditary Lesion,Hereditary Fallopian Tube Carcinoma,1
11104,Epithelioid Differentiation,"Epithelioid mesothelioma, malignant",1
11105,Carcinomatous Component Present,Bladder transitional cell carcinoma stage II,1
11106,Thyroglobulin Positive Neoplastic Cells Present,Microfollicular adenoma,1
11107,Epithelial Component Present,Mucin-producing adenocarcinoma,1
11108,Malignant Cellular Infiltrate,Stage IVB Uterine Sarcoma AJCC v7,1
11109,Cutaneous Involvement,Epidermolysis Bullosa,1
11110,Mixed Cellular Population,Breast Fibroepithelial Neoplasm,1
11111,Malignant Cellular Infiltrate,leiomyosarcoma of bone,1
11112,Epithelial Component Present,Stage III Bladder Cancer AJCC v8,1
11113,Endobronchial Lesion,Lung Glandular Papilloma,1
11114,Invasive Lesion,Minimally Invasive Thymoma,1
11115,Perivascular Arrangement of Tumor Cells,Glomus Tumor,1
11116,Benign Cellular Infiltrate,Soft tissue chondroma,1
11117,'Starry-sky' pattern,Sporadic Burkitt's lymphoma,1
11118,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,endometrioid adenofibroma of ovary,1
11119,Osseous Differentiation,Osteogenic Neoplasm,1
11120,Carcinomatous Component Present,Advanced Adult Hepatocellular Carcinoma,1
11121,Well Differentiated Lesion,Grade I Chondrosarcoma,1
11122,Villous Pattern,Vaginal Villous Adenoma,1
11123,Vascular Channel Formation,Cavernous hemangioma of the face,1
11124,Fibrotic Stroma Formation,Fibrolipoma,1
11125,Epithelial Component Present,Nasopharyngeal Differentiated Carcinoma,1
11126,Malignant Cellular Infiltrate,Childhood Ovarian Embryonal Carcinoma,1
11127,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
11128,Carcinomatous Component Present,Refractory Breast Carcinoma,1
11129,Malignant Cellular Infiltrate,Stage III Childhood Anaplastic Large Cell Lymphoma,1
11130,Benign Cellular Infiltrate,Cardiac hemangioma,1
11131,Secondary Lesion,Hormone refractory prostate cancer,1
11132,Alcohol Toxicity,Alcohol-Related Hepatocellular Carcinoma,1
11133,Indolent Clinical Course,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
11134,Pathologic TNM Finding,Pathologic Stage IB Cutaneous Melanoma AJCC v8,1
11135,Dysplasia,High Grade Penile Intraepithelial Neoplasia,1
11136,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-0,1
11137,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v8,1
11138,Epithelial Component Present,Carcinosarcoma of ovary,1
11139,Vascular Channel Formation,Blue rubber bleb nevus syndrome,1
11140,Benign Cellular Infiltrate,Benign neoplasm of thyroid gland,1
11141,Mild cytologic atypia,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
11142,Diffuse Pattern,Pleural Sarcomatoid Mesothelioma,1
11143,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v7,1
11144,Epithelial Component Present,Stage I Colon Cancer AJCC v8,1
11145,Well-Circumscribed Lesion,Intermediate Rhabdomyoma,1
11146,Tumor Vascular Invasion,Malignant Pancreatic Somatostatinoma,1
11147,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
11148,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
11149,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Recurrent Acute Monoblastic and Monocytic Leukemia,1
11150,"Fully Differentiated ""Adult-Type"" Tissues Present",Immature Gastric Teratoma,1
11151,Histiocytosis,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
11152,Epithelial Component Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
11153,Malignant Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
11154,Epithelial Component Present,Borderline Resectable Pancreatic Carcinoma,1
11155,Epithelial Component Present,Stage IIIC Colorectal Cancer AJCC v7,1
11156,Systemic disease,Systemic Anaplastic Large Cell Lymphoma,1
11157,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma,1
11158,Malignant Cellular Infiltrate,Malignant Ovarian Serous Tumor,1
11159,Malignant Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
11160,Benign Cellular Infiltrate,Benign neoplasm of rectum,1
11161,Benign Cellular Infiltrate,Venous hemangioma,1
11162,Preserved Nuclear Polarity,Ureter Urothelial Papilloma,1
11163,Malignant Cellular Infiltrate,Myelodysplastic-Myeloproliferative Diseases,1
11164,Pseudoencapsulated Mass,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
11165,HMB-45-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
11166,Epithelial Component Present,Anatomic Stage IIIB Breast Cancer AJCC v8,1
11167,Metastatic Lesion,"Kaposi's sarcoma, metastatic",1
11168,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Gene Mutation,1
11169,Cutaneous Involvement,Eccrine porocarcinoma,1
11170,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v7 Stage,1
11171,Childhood Lesion,Mixed epithelial-mesenchymal hepatoblastoma,1
11172,Necrotic changes (finding),Small cell carcinoma of lung,1
11173,Hypergammaglobulinemia,HHV8-Positive Multicentric Castleman Disease,1
11174,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
11175,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
11176,Malignant Cellular Infiltrate,Angiocentric lymphoma stage IV,1
11177,Epithelial Component Present,Recurrent Ampulla of Vater Adenocarcinoma,1
11178,Diffuse Pattern,Neural Glioblastoma,1
11179,Carcinomatous Component Present,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
11180,Epithelial Component Present,Recurrent Endometrial Cancer,1
11181,Cutaneous Involvement,Stevens-Johnson Syndrome,1
11182,'Starry-sky' pattern,Burkitt's lymphoma of small intestine,1
11183,Carcinomatous Component Present,Recurrent Ampulla of Vater Adenocarcinoma,1
11184,Epithelial Component Present,Intracystic papillary adenoma,1
11185,Recurrent disease,Laryngeal squamous cell carcinoma recurrent,1
11186,Epithelial Component Present,Invasive Mixed Breast Carcinoma,1
11187,Vascular Channel Formation,Cerebral hemangioma,1
11188,Benign Cellular Infiltrate,Benign neoplasm of fallopian tube,1
11189,Vascular Channel Formation,Intermediate Blood Vessel Neoplasm,1
11190,Indolent Clinical Course,Ameloblastic fibroma,1
11191,Epithelial Component Present,Pancreatic Intraductal Neoplasms,1
11192,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Carcinoma,1
11193,Benign Cellular Infiltrate,Parotid Gland Warthin Tumor,1
11194,Carcinomatous Component Present,Gallbladder Cancer by AJCC v6 Stage,1
11195,Squamous Differentiation,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
11196,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
11197,Epithelial Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
11198,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
11199,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis of skin,1
11200,Carcinomatous Component Present,apocrine adenocarcinoma of vulva,1
11201,Carcinomatous Component Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
11202,Refractory Disease,Primary mediastinal large B-cell lymphoma refractory,1
11203,Anaplasia,Recurrent Childhood Anaplastic Oligodendroglioma,1
11204,Metastatic/Recurrent Disease,"Synovial sarcoma, spindle cell",1
11205,Superficial Lesion,Atypical Lipoma,1
11206,Benign Cellular Infiltrate,Pineal Region Mature Teratoma,1
11207,Dysplasia,Stage 0 Ureter Cancer AJCC v7,1
11208,Malignant Cellular Infiltrate,Sarcoma of soft tissue,1
11209,Recurrent disease,Recurrent Nevus,1
11210,Cutaneous Involvement,Cutaneous Fibrous Histiocytoma,1
11211,Pregnancy Complications,Placenta Previa,1
11212,Malignant Cellular Infiltrate,Malignant neoplasm of gallbladder,1
11213,Regional Disease,Crohn Disease,1
11214,Neuroendocrine Differentiation,Urinary System Paraganglioma,1
11215,Epithelial Component Present,Advanced Laryngeal Squamous Cell Carcinoma,1
11216,Nuclear Pseudoinclusion,Papillary Thyroid Microcarcinoma,1
11217,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
11218,Malignant Cellular Infiltrate,Thoracic NUT Carcinoma,1
11219,Carcinomatous Component Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
11220,Papillary Pattern,Esophageal squamous papilloma,1
11221,Solitary mass,Skull Base Chordoma,1
11222,Carcinomatous Component Present,Metastatic Adrenal Cortex Carcinoma,1
11223,Pathologic TNM Finding,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
11224,Malignant Cellular Infiltrate,Classic Variant of Chromophobe Renal Cell Carcinoma,1
11225,Chromogranin A Positive Neoplastic Cells Present,Anal Canal Neuroendocrine Tumor G1,1
11226,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v8,1
11227,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Superficial Epithelioma with Sebaceous Differentiation,1
11228,Carcinomatous Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
11229,Epithelial Component Present,Helicobacter Pylori-Related Carcinoma,1
11230,Malignant Cellular Infiltrate,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
11231,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
11232,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant",1
11233,Recurrent disease,Squamous cell carcinoma of the hypopharynx recurrent,1
11234,Pseudoencapsulated Mass,Refractory Malignant Peripheral Nerve Sheath Tumor,1
11235,Pain,Giant Cell Tumor of Bone,1
11236,Absence of Invasion,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
11237,Malignant Cellular Infiltrate,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
11238,Epithelial Component Present,Uterine Corpus Carcinoid Tumor,1
11239,Malignant Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v8,1
11240,Carcinomatous Component Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
11241,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
11242,Epithelial Component Present,Neuroendocrine cervical carcinoma,1
11243,Epithelial Component Present,Non-Functioning Pituitary Gland Neoplasm,1
11244,Malignant Cellular Infiltrate,mucinous adenocarcinoma of bladder,1
11245,Neuroectodermal Differentiation,Stage 2B Neuroblastoma,1
11246,Carcinomatous Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
11247,Malignant Cellular Infiltrate,Malignant Skeletal Muscle Neoplasm,1
11248,Malignant Cellular Infiltrate,Alveolar rhabdomyosarcoma,1
11249,Carcinomatous Component Present,High Grade Fallopian Tube Serous Adenocarcinoma,1
11250,Severe cytologic atypia,Small Intestinal Neuroendocrine Carcinoma,1
11251,Mild dysplasia,Low Grade Prostatic Intraepithelial Neoplasia,1
11252,Papillary Pattern,inverted ductal papilloma of salivary gland,1
11253,Osseous Differentiation,Cementoma,1
11254,Adnexal Differentiation,Outer Hair Sheath and Infundibulum Neoplasm,1
11255,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
11256,Malignant Cellular Infiltrate,Stage IVA Colorectal Cancer AJCC v7,1
11257,Insular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
11258,In Situ Lesion,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
11259,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia Cutis,1
11260,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v7 Stage,1
11261,Mesenchymal Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
11262,Carcinomatous Component Present,mucoepidermoid carcinoma of esophagus,1
11263,Well Differentiated Lesion,Vulvar Keratoacanthoma,1
11264,Progressive Disease,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
11265,Neuroendocrine Differentiation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
11266,Malignant Cellular Infiltrate,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
11267,Nuclear Pseudoinclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
11268,Indolent Clinical Course,"Chondromatosis, Synovial",1
11269,atypia morphology,"Papillary cystadenoma, borderline malignancy",1
11270,Malignant Cellular Infiltrate,"Lymphoma, Follicular, Grade 1",1
11271,Dysplasia,Gastric dysplasia,1
11272,Geographic Necrosis,Testicular embryonal carcinoma stage III,1
11273,Malignant Cellular Infiltrate,Gastrointestinal melanoma,1
11274,Diffuse Pattern,Anaplastic Brain Stem Astrocytoma,1
11275,Epithelial Component Present,Papillary transitional cell neoplasm of low malignant potential,1
11276,Malignant Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v6,1
11277,Carcinomatous Component Present,Infiltrating basal cell carcinoma,1
11278,Junctional Proliferation,Epithelioid and spindle cell nevus,1
11279,Malignant Cellular Infiltrate,Invasive Malignant Neoplasm,1
11280,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant",1
11281,Pathologic TNM Finding,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
11282,Acanthosis,Seborrheic keratosis,1
11283,Exophytic Polypoid Lesion,Polyp of sphenoidal sinus,1
11284,Rosenthal Fibers Present,Rosette-forming glioneuronal neoplasm,1
11285,Benign Cellular Infiltrate,Hemangioma of breast,1
11286,Poorly Differentiated Lesion,Renal medullary carcinoma,1
11287,Well-Circumscribed Lesion,Nodular tenosynovitis,1
11288,Diffuse Pattern,Temporal Lobe Anaplastic Astrocytoma,1
11289,Malignant Cellular Infiltrate,Childhood Undifferentiated Pleomorphic Sarcoma,1
11290,Comedo Necrosis,High Grade Ductal Breast Carcinoma In Situ,1
11291,Hereditary Lesion,Adenomatous Polyposis Coli,1
11292,Severe cytologic atypia,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
11293,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
11294,Hyperkeratosis,Vulvar Inverted Follicular Keratosis,1
11295,Malignant Cellular Infiltrate,Stage IC Eyelid Carcinoma AJCC v7,1
11296,Epithelial Component Present,Rectal Cribriform Comedo-Type Adenocarcinoma,1
11297,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v7,1
11298,Multifocal Lesion,Multiple Endocrine Neoplasia Type 2a,1
11299,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma,1
11300,Adnexal Differentiation,Benign neoplasm of adnexa of skin,1
11301,Malignant Cellular Infiltrate,Stage IIIC Colorectal Cancer AJCC v8,1
11302,Carcinomatous Component Present,hepatoid adenocarcinoma of bladder,1
11303,Poorly Differentiated Neuroendocrine Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
11304,Adnexal Differentiation,Hair Follicle Neoplasm,1
11305,Cutaneous Involvement,Carcinoma of anal margin,1
11306,Hemosiderin pigmentation,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
11307,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
11308,Cutaneous Involvement,Granular cell tumor of skin,1
11309,Myxoid Stroma Formation,Odontogenic myxofibroma,1
11310,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
11311,Islands of Odontogenic Epithelium Present,Basal Cell Ameloblastoma,1
11312,Epithelial Component Present,Metastatic Cervical Adenocarcinoma,1
11313,Increased Cellularity Present,Stage 1 Neuroblastoma,1
11314,Diffuse Pattern,Recurrent Childhood Anaplastic Astrocytoma,1
11315,Exophytic Polypoid Lesion,Colorectal Peutz-Jeghers Polyp,1
11316,Secondary Lesion,Metastatic Cervical Carcinoma,1
11317,Angiocentric Pattern,Recurrent Grade II Lymphomatoid Granulomatosis,1
11318,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v8,1
11319,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v6 Stage,1
11320,Carcinomatous Component Present,Stage IB Hepatocellular Carcinoma AJCC v8,1
11321,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma,1
11322,Cutaneous Involvement,Morpheic basal cell carcinoma,1
11323,Epithelial Component Present,Intermediate Grade Ductal Breast Carcinoma In Situ,1
11324,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage III,1
11325,Vascular Channel Formation,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
11326,Well-Circumscribed Lesion,Vulvar Cellular Angiofibroma,1
11327,Metastatic Lesion,Secondary malignant neoplasm of stomach,1
11328,Cutaneous Involvement,Blastic plasmacytoid dendritic cell neoplasm,1
11329,Severe cytologic atypia,Ampulla of Vater Neuroendocrine Carcinoma,1
11330,Carcinomatous Component Present,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11331,Malignant Cellular Infiltrate,Anaplastic Medulloblastoma,1
11332,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
11333,Indolent Clinical Course,Liver Lipoma,1
11334,Malignant Cellular Infiltrate,Small intestine carcinoma non-resectable,1
11335,Malignant Component Present,Ovarian Dermoid Cyst with Angiosarcoma,1
11336,Epithelial Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
11337,Malignant Cellular Infiltrate,Metastatic Lip Carcinoma,1
11338,Diffuse Pattern,Gliomatosis Cerebri Type I,1
11339,Malignant Cellular Infiltrate,Thymic Atypical Carcinoid Tumor,1
11340,Eccrine Differentiation,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
11341,Carcinomatous Component Present,Carcinoma of unknown primary,1
11342,Invasive Lesion,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
11343,Malignant Cellular Infiltrate,Refractory Hairy Cell Leukemia,1
11344,Immunosuppression-Related Post-Transplant Toxicity,Bone Marrow Transplantation Nephropathy,1
11345,Neuroendocrine Differentiation,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
11346,Cutaneous Involvement,Lymphangioma of skin,1
11347,Anaplasia,Anaplastic Malignant Neoplasm,1
11348,Malignant Cellular Infiltrate,Mucinous Adenocarcinoma,1
11349,Contiguous Disease,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,1
11350,Carcinomatous Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma,1
11351,Malignant Cellular Infiltrate,Colorectal Lymphoma,1
11352,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
11353,Carcinomatous Component Present,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
11354,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
11355,High Grade Lesion,rhabdomyosarcoma of liver,1
11356,Epithelial Component Present,Childhood Choroid Plexus Carcinoma,1
11357,Serrated Glandular Architecture,Rectal Traditional Serrated Adenoma,1
11358,Epithelial Component Present,Hereditary Leiomyomatosis and Renal Cell Cancer,1
11359,Malignant Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
11360,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
11361,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
11362,Vascular Channel Formation,Kaposi Sarcoma,1
11363,Necrotic changes (finding),Childhood Malignant Peripheral Nerve Sheath Tumor,1
11364,Adulthood Lesion,Adult Brain Glioblastoma,1
11365,Epithelial Component Present,Cervical Endometrioid Adenocarcinoma,1
11366,Chromogranin A Positive Neoplastic Cells Present,Gastrointestinal Carcinoid Tumor,1
11367,Carcinomatous Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
11368,Epithelial Component Present,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
11369,Epithelial Component Present,Small Intestinal Low Grade Intraepithelial Neoplasia,1
11370,Recurrent disease,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,1
11371,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma,1
11372,Epithelial Component Present,small cell carcinoma of appendix,1
11373,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
11374,Carcinomatous Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
11375,Epithelial Component Present,Ectopic hamartomatous thymoma,1
11376,Perineural spread,Desmoplastic Neurotropic Melanoma,1
11377,Cutaneous Involvement,Angioma serpiginosum,1
11378,Secondary Lesion,Secondary malignant neoplasm of skin,1
11379,Extensive Stage Lesion,Pleural mesothelioma malignant advanced,1
11380,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor,1
11381,Carcinomatous Component Present,Metastatic Lip Squamous Cell Carcinoma,1
11382,Metastatic Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
11383,Childhood Lesion,Childhood Malignant Ovarian Germ Cell Tumor,1
11384,Malignant Cellular Infiltrate,Stage IVA Lung Cancer AJCC v8,1
11385,Poorly Differentiated Lesion,Gingival Spindle Cell Carcinoma,1
11386,Epithelial Component Present,Adenocarcinoma in adenomatous polyp,1
11387,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
11388,Carcinomatous Component Present,Papillary Renal Cell Carcinoma,1
11389,Birbeck Granules Present,Tumors Derived from Langerhans Cells,1
11390,Benign Cellular Infiltrate,Parathyroid Gland Oncocytic Adenoma,1
11391,Benign Cellular Infiltrate,Uterine Corpus Atypical Polypoid Adenomyoma,1
11392,Benign Cellular Infiltrate,Benign neoplasm of accessory sinus,1
11393,Tissue Differentiation Uncertain,Aggressive angiomyxoma,1
11394,Carcinomatous Component Present,Vulvar Cancer by AJCC v8 Stage,1
11395,Neuroendocrine Differentiation,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
11396,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
11397,Borderline Lesion,Serous papillary cystic tumor of borderline malignancy,1
11398,Recurrent disease,Recurrent Extragonadal Seminoma,1
11399,Epithelial Component Present,Low-grade intraurothelial neoplasia,1
11400,Malignant Cellular Infiltrate,Pleural Epithelioid Hemangioendothelioma,1
11401,Epithelial Component Present,Malignant Testicular Sertoli Cell Tumor,1
11402,Indolent Clinical Course,Ectopic hamartomatous thymoma,1
11403,Benign Cellular Infiltrate,Maxillary Sinus Schneiderian Papilloma,1
11404,Recurrent disease,recurrent childhood acute myeloid leukemia,1
11405,Metastatic Lesion,Metastatic Jugulotympanic Paraganglioma,1
11406,Hypergammaglobulinemia,HHV8-Positive Multicentric Castleman Disease,1
11407,Epithelial Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
11408,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,1
11409,Epithelial Component Present,Anal cancer metastatic,1
11410,Epithelial Component Present,Epiglottic carcinoma,1
11411,Epithelial Component Present,Adult Type Granulosa Cell Tumor,1
11412,Carcinomatous Component Present,Recurrent Pancreatic Ductal Adenocarcinoma,1
11413,CD30-Positive Neoplastic Cells Present,Stage III Childhood Anaplastic Large Cell Lymphoma,1
11414,Epithelial Component Present,Refractory Endometrial Serous Adenocarcinoma,1
11415,Carcinomatous Component Present,large cell carcinoma of salivary gland,1
11416,Malignant Cellular Infiltrate,Pulmonary Artery Leiomyosarcoma,1
11417,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v6 and v7,1
11418,Epithelial Component Present,basaloid carcinoma of anus,1
11419,High Grade Lesion,Synovial sarcoma recurrent,1
11420,Carcinomatous Component Present,Stage II Gastric Carcinoma,1
11421,Unresectable Mass,Unresectable Malignant Solid Neoplasm,1
11422,Tissue Differentiation Uncertain,Childhood Clear Cell Sarcoma of Soft Parts,1
11423,Malignant Cellular Infiltrate,Multifocal Glioblastomas,1
11424,Malignant Cellular Infiltrate,Stage III Cervical Cancer AJCC v8,1
11425,Metastatic Lesion,Small intestine adenocarcinoma metastatic NOS,1
11426,Malignant Cellular Infiltrate,"Thymoma, type AB, malignant",1
11427,Carcinomatous Component Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
11428,Malignant Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
11429,Increased Cellularity Present,Ovarian Cellular Fibroma,1
11430,Neuroectodermal Differentiation,Stage 3 Neuroblastoma,1
11431,Carcinomatous Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,1
11432,Secondary Lesion,carcinoma ex pleomorphic adenoma of salivary gland,1
11433,Malignant Cellular Infiltrate,Liver Adenosquamous Carcinoma,1
11434,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Superficial basal cell carcinoma,1
11435,Primary Lesion,Lentigo maligna recurrent,1
11436,Epithelial Component Present,"Papillary renal cell carcinoma, sporadic",1
11437,Glomeruloid Vessels Present,Pilocytic Astrocytoma,1
11438,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck,1
11439,Carcinomatous Component Present,Breast Carcinoma with Choriocarcinomatous Features,1
11440,Vascular Channel Formation,Aggressive angiomyxoma,1
11441,High Grade Lesion,Stage IB Lung Small Cell Carcinoma AJCC v7,1
11442,Epithelial Component Present,Stage IIA Lung Cancer AJCC v8,1
11443,Recurrent disease,Recurrent Childhood Pilomyxoid Astrocytoma,1
11444,Malignant Cellular Infiltrate,Lung Pleomorphic Carcinoma,1
11445,Bone Marrow Involvement,Waldenstrom Macroglobulinemia,1
11446,High Mitotic Activity,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
11447,Deep Lesion,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
11448,Epithelial Component Present,Advanced Adult Hepatocellular Carcinoma,1
11449,Morphologic Overlap,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma,1
11450,Multifocal Lesion,Lipoblastomatosis,1
11451,Malignant Cellular Infiltrate,Precursor T-cell lymphoblastic lymphoma,1
11452,Malignant Cellular Infiltrate,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,1
11453,Carcinomatous Component Present,Metastatic Cervical Adenocarcinoma,1
11454,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
11455,Malignant Cellular Infiltrate,Breast Cancer by AJCC v6 Stage,1
11456,Malignant Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma,1
11457,Malignant Cellular Infiltrate,BCLC Stage A Hepatocellular Carcinoma,1
11458,Benign Cellular Infiltrate,Trichodiscoma,1
11459,High Grade Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
11460,Well-Circumscribed Lesion,Colorectal Mucin Poor Hyperplastic Polyp,1
11461,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage 0,1
11462,Tartrate Resistant Acid Phosphatase Positive Cells Present,Hairy Cell Leukemia,1
11463,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
11464,Cystic Change,"Cystadenocarcinoma, Papillary",1
11465,Malignant Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma,1
11466,Thyroglobulin Positive Neoplastic Cells Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
11467,Indolent Clinical Course,Cavernous hemangioma of retina,1
11468,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of pancreas,1
11469,Childhood Lesion,Childhood Central Nervous System Immature Teratoma,1
11470,Cutaneous Involvement,Superficial Epithelioma with Sebaceous Differentiation,1
11471,Malignant Cellular Infiltrate,Cutaneous Follicular Lymphoma,1
11472,Tissue Differentiation Uncertain,Juxta-Articular Myxoma,1
11473,Perineural spread,Posterior Tongue Adenoid Cystic Carcinoma,1
11474,Malignant Cellular Infiltrate,Postsurgical Stage III Hepatoblastoma,1
11475,Rapidly Enlarging Mass,Pleomorphic Rhabdomyosarcoma,1
11476,Epithelial Component Present,Tracheal Carcinoma,1
11477,Abundance of Small Lymphocytes,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
11478,Benign Cellular Infiltrate,Blue rubber bleb nevus syndrome,1
11479,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
11480,Epithelial Component Present,Vaginal Cancer by AJCC v7 Stage,1
11481,Malignant Cellular Infiltrate,Choroid Epithelioid Cell Melanoma,1
11482,Benign Cellular Infiltrate,Benign Genitourinary System Neoplasm,1
11483,Carcinomatous Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
11484,Malignant Cellular Infiltrate,Ewings sarcoma,1
11485,Malignant Cellular Infiltrate,Endometrioid carcinoma of prostate,1
11486,Epithelial Component Present,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
11487,Benign Cellular Infiltrate,Benign Diencephalic Neoplasm,1
11488,Epithelial Component Present,Clinical Stage IVB Gastric Cancer AJCC v8,1
11489,Hemorrhagic Neuroblastic Nodules Present,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
11490,Malignant Cellular Infiltrate,Plasmacytoma,1
11491,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",1
11492,Malignant Cellular Infiltrate,Refractory B-Cell Prolymphocytic Leukemia,1
11493,Therapy-Related Toxicity,Plasma Cell Post-Transplant Lymphoproliferative Disorder,1
11494,Carcinomatous Component Present,Penis carcinoma recurrent,1
11495,Epithelial Component Present,Head and neck cancer metastatic,1
11496,Tissue Differentiation Uncertain,"Synovial sarcoma, spindle cell",1
11497,Epithelial Component Present,Hepatic cancer stage IVA,1
11498,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma,1
11499,Epithelial Component Present,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
11500,Carcinomatous Component Present,clear cell adenocarcinoma of urethra,1
11501,Absence of Stromal Invasion,"Endometrioid adenoma, borderline malignancy",1
11502,Malignant Cellular Infiltrate,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
11503,Childhood Lesion,Childhood Anaplastic Oligoastrocytoma,1
11504,Human Papillomavirus Negative,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
11505,Dysplasia,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
11506,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
11507,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
11508,Marked Nuclear Atypia Present,Malignant Uterine Corpus PEComa,1
11509,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage,1
11510,Malignant Cellular Infiltrate,Recurrent Male Reproductive System Carcinoma,1
11511,Recurrent disease,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
11512,Malignant Cellular Infiltrate,Urothelial cancer of renal pelvis,1
11513,Carcinomatous Component Present,Stage IVB Vulvar Cancer AJCC v6 and v7,1
11514,Epithelial Component Present,Advanced Well Differentiated Neuroendocrine Neoplasm,1
11515,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Tubular Variant",1
11516,Carcinomatous Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
11517,Recurrent disease,Non-small cell lung cancer recurrent,1
11518,Poorly Differentiated Lesion,Large cell lung cancer stage IV,1
11519,Cutaneous Involvement,Desmoplastic trichilemmoma,1
11520,Endobronchial Lesion,Lung Mixed Squamous Cell and Glandular Papilloma,1
11521,Epithelial Component Present,BCLC Stage A Hepatocellular Carcinoma,1
11522,Hereditary Lesion,TUBEROUS SCLEROSIS 2 (disorder),1
11523,Mitotic Activity,Sellar Yolk Sac Tumor,1
11524,Epithelial Component Present,Adenomatous Polyposis Coli,1
11525,Benign Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma,1
11526,Epithelial Component Present,Stage III Liver Cancer,1
11527,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage I,1
11528,Childhood Lesion,Acute Megakaryoblastic Leukemia with NUP98-KDM5A,1
11529,Carcinomatous Component Present,Early-Stage Breast Carcinoma,1
11530,Nuclear Atypia,Proneural Glioblastoma,1
11531,Absence of Invasion,Bowen's Disease,1
11532,Epithelial Component Present,Prostate cancer stage C,1
11533,Metastatic Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,1
11534,Storiform Growth Pattern,Abdominal Undifferentiated Pleomorphic Sarcoma,1
11535,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia recurrent,1
11536,Well-Circumscribed Lesion,Pseudopolyposis of colon,1
11537,Recurrent disease,Recurrent tumors of the Ewing's family,1
11538,Neuroendocrine Differentiation,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
11539,Cutaneous Involvement,Moniliform hamartoma,1
11540,Carcinomatous Component Present,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7,1
11541,Exophytic Polypoid Lesion,Fundic gland polyp,1
11542,Malignant Cellular Infiltrate,Adult Pure Erythroid Leukemia,1
11543,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland,1
11544,Epithelial Component Present,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
11545,Carcinomatous Component Present,Primary myoepithelial carcinoma of lung,1
11546,Perineural spread,Cervical Adenoid Cystic Carcinoma,1
11547,Malignant Cellular Infiltrate,Ovarian Myxoid Liposarcoma,1
11548,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v7,1
11549,Fibrotic Stroma Formation,Vulvar Fibrolipoma,1
11550,Exophytic Polypoid Lesion,Colorectal Sessile Serrated Adenoma/Polyp,1
11551,Epithelial Component Present,Colorectal Mucinous Adenocarcinoma,1
11552,Cutaneous Involvement,"Lichen Planus, Oral",1
11553,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung,1
11554,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage III,1
11555,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
11556,Malignant Cellular Infiltrate,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",1
11557,Distortion of the Hair Follicle,Fibrofolliculoma,1
11558,Malignant Cellular Infiltrate,Cervical Adenocarcinoma In Situ,1
11559,Metaplasia,Bladder squamous cell carcinoma stage IV,1
11560,Papillary Pattern,Papillary serous cystadenoma,1
11561,Malignant Cellular Infiltrate,neuroblastoma of spinal cord,1
11562,Recurrent disease,Recurrent Malignant Ovarian Brenner Tumor,1
11563,Composite Lesion,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
11564,Stromal Invasion,BRCA-Mutated Ovarian Carcinoma,1
11565,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
11566,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
11567,Adulthood Lesion,Adult Acute Myeloid Leukemia without Maturation,1
11568,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
11569,Benign Cellular Infiltrate,Odontogenic myxofibroma,1
11570,Fascicular Pattern,Transitional Meningioma,1
11571,Histiocytosis,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
11572,Neuroendocrine Differentiation,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
11573,Cellular Pleomorphism,High grade surface osteosarcoma,1
11574,Malignant Cellular Infiltrate,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
11575,Clinical TNM Finding,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11576,Eosinophilic inflammation,Lung Inflammatory Myofibroblastic Tumor,1
11577,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,1
11578,Necrotic changes (finding),Brain Glioblastoma,1
11579,Malignant Cellular Infiltrate,Refractory Lung Small Cell Carcinoma,1
11580,Carcinomatous Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
11581,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7,1
11582,Carcinomatous Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
11583,Malignant Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
11584,Anaplasia,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
11585,Primary Lesion,Primary Vitreoretinal Lymphoma,1
11586,Malignant Cellular Infiltrate,Recurrent Endometrial Clear Cell Adenocarcinoma,1
11587,Carcinomatous Component Present,Gastric Cardia Adenocarcinoma,1
11588,Carcinomatous Component Present,Small Intestinal Adenocarcinoma by AJCC v8 Stage,1
11589,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma AJCC v7,1
11590,Non-Hereditary Lesion,Gastric Intramucosal Adenocarcinoma,1
11591,Severe dysplasia,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
11592,Refractory Disease,Refractory Neurofibromatosis Type 1,1
11593,Malignant Cellular Infiltrate,Kaposi Sarcoma NCI Grade 2,1
11594,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
11595,Malignant Cellular Infiltrate,Stage IIC Testicular Cancer AJCC v8,1
11596,Neuroendocrine Differentiation,Recurrent Adrenal Gland Pheochromocytoma,1
11597,Cauliflower-Like Mass,Lung Squamous Cell Papilloma,1
11598,Indolent Clinical Course,Airway Hemangioma,1
11599,Epithelial Component Present,ACTH-Producing Pituitary Gland Carcinoma,1
11600,In Situ Lesion,Bladder squamous cell carcinoma stage 0,1
11601,Epithelial Component Present,Refractory Uterine Corpus Carcinoma,1
11602,Epithelial Component Present,Cervical Atypical Carcinoid Tumor,1
11603,Epithelial Component Present,Stage IIIC Ovarian Cancer,1
11604,Epithelial Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
11605,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
11606,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
11607,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal,1
11608,Refractory Disease,Refractory Undifferentiated Pleomorphic Sarcoma,1
11609,Vascular Channel Formation,Kaposi's sarcoma of cornea,1
11610,High Mitotic Activity,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
11611,Anaplasia,Brain Glioblastoma,1
11612,Benign Cellular Infiltrate,benign granular cell tumor of gallbladder,1
11613,Neuroendocrine Differentiation,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
11614,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Liver,1
11615,Carcinomatous Component Present,Keratinizing Head and Neck Squamous Cell Carcinoma,1
11616,Carcinomatous Component Present,Noninfiltrating Intraductal Carcinoma,1
11617,Cutaneous Involvement,Mycosis fungoides refractory,1
11618,Benign Cellular Infiltrate,Benign neoplasm of adrenal medulla,1
11619,Fetiform Mass,Ovarian Fetiform Teratoma,1
11620,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland,1
11621,Osseous Component Present,Subungual exostoses,1
11622,Papillary Pattern,Inverted Squamous Cell Papilloma,1
11623,Dysplasia,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
11624,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
11625,Hypercellular bone marrow,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
11626,Metastatic Lesion,"Adenocarcinoma, metastatic",1
11627,Malignant Cellular Infiltrate,Ovarian Cancer by AJCC v8 Stage,1
11628,Primary Lesion,gliosarcoma,1
11629,Carcinomatous Component Present,Bladder cancer stage IV,1
11630,Epithelial Component Present,Stage IIA Small Intestinal Cancer AJCC v7,1
11631,Malignant Cellular Infiltrate,Resectable Liposarcoma,1
11632,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
11633,Epithelial Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma,1
11634,Inflammatory infiltrate,Malignant tenosynovial giant cell tumor,1
11635,Epithelial Component Present,mucinous adenocarcinoma of salivary gland,1
11636,Carcinomatous Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v7,1
11637,Severe dysplasia,Stage 0 Gastric Cancer AJCC v6 and v7,1
11638,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia,1
11639,Carcinomatous Component Present,"Adenocarcinoma, Scirrhous",1
11640,Epithelial Component Present,Localized Digestive System Neuroendocrine Tumor G1,1
11641,Borderline Lesion,Cutaneous Lymphomatoid Granulomatosis,1
11642,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I,1
11643,Malignant Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
11644,Secondary Lesion,Secondary malignant neoplasm of kidney,1
11645,Exophytic Polypoid Lesion,Gastric Non-Neoplastic Polyp,1
11646,Carcinomatous Component Present,Contralateral Breast Carcinoma,1
11647,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma,1
11648,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8,1
11649,Poorly Differentiated Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma,1
11650,Indolent Clinical Course,Ventricular myxoma,1
11651,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone metastatic,1
11652,Benign Cellular Infiltrate,Benign neoplasm of buccal mucosa,1
11653,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v8 Stage,1
11654,Malignant Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ",1
11655,Indolent Clinical Course,Cardiac Lipoma,1
11656,Malignant Cellular Infiltrate,"Undifferentiated Sarcoma, Not Otherwise Specified",1
11657,High Grade Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
11658,Well Differentiated Lesion,papillary carcinoma of penis,1
11659,Benign Cellular Infiltrate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
11660,Cellular Pleomorphism,Fibroblastic osteosarcoma,1
11661,Cutaneous Involvement,Benign Cutaneous Vascular Neoplasm,1
11662,Malignant Cellular Infiltrate,Unresectable Hepatocellular Carcinoma,1
11663,Serotonin Positive Neoplastic Cells Present,Carcinoid tumor of pancreas,1
11664,Malignant Cellular Infiltrate,Metastatic Adrenal Gland Pheochromocytoma,1
11665,Chronic lymphocytic inflammation,Adenolymphoma,1
11666,Cystic Change,Hidradenoma Papilliferum,1
11667,Metastatic Lesion,Locally Advanced Unresectable Malignant Neoplasm,1
11668,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
11669,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIB,1
11670,Malignant Cellular Infiltrate,St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8,1
11671,Metastatic Lesion,Metastatic Neuroendocrine Neoplasm,1
11672,Diffuse Lesion,Pericardial Carcinomatosis,1
11673,Absence of Stromal Invasion,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
11674,Malignant Cellular Infiltrate,Follicular mycosis fungoides,1
11675,Epithelial Component Present,Metastatic Thyroid Gland Papillary Carcinoma,1
11676,Indolent Clinical Course,Trichodiscoma,1
11677,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,1
11678,Multinodular Mass,Adult Angiosarcoma,1
11679,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
11680,Glial Differentiation,Ganglioglioma,1
11681,Epithelial Component Present,Testicular Sclerosing Sertoli Cell Tumor,1
11682,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
11683,Adnexal Differentiation,Pilomatrix carcinoma of skin,1
11684,Malignant Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
11685,Epithelial Component Present,Refractory Endometrial Carcinoma,1
11686,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage IV,1
11687,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia,1
11688,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia without Maturation,1
11689,Dysplasia,Adenomatous Polyposis Coli,1
11690,Carcinomatous Component Present,Salivary Gland Oncocytic Carcinoma,1
11691,Secondary Lesion,Advanced Melanoma,1
11692,Recurrent disease,Hodgkin's disease nodular sclerosis recurrent,1
11693,Pseudoencapsulated Mass,Refractory Malignant Peripheral Nerve Sheath Tumor,1
11694,Sarcomatoid Features,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
11695,Benign Cellular Infiltrate,Vulvar Cellular Angiofibroma,1
11696,Vascular Channel Formation,Lymphangioma of skin,1
11697,Carcinomatous Component Present,Adenosquamous cell lung cancer stage III,1
11698,Oligodendroglial Component Present,Childhood Oligodendroglioma,1
11699,Carcinomatous Component Present,Parietal cell carcinoma,1
11700,Endocervical Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
11701,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v8,1
11702,Benign Cellular Infiltrate,Polyp of external auditory meatus,1
11703,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
11704,Exophytic Polypoid Lesion,Epulides,1
11705,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
11706,Hyperplastic Tissue Present,Mesonephric Hyperplasia,1
11707,Vascular Channel Formation,Fibroblastic osteosarcoma,1
11708,Malignant Cellular Infiltrate,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
11709,Fibrotic Stroma Formation,mucinous adenocarcinofibroma of ovary,1
11710,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7,1
11711,Recurrent disease,Penis carcinoma recurrent,1
11712,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma,1
11713,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
11714,Metastatic Lesion,Secondary malignant neoplasm of axilla,1
11715,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage I,1
11716,Mitotic Activity,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
11717,High Mitotic Activity,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
11718,Pregnancy Complications,Hypertension associated disorders of pregnancy,1
11719,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,1
11720,Epithelial Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma,1
11721,Keratin pearl formation,Lung Basaloid Squamous Cell Carcinoma,1
11722,Epithelial Component Present,Carotid Body Paraganglioma,1
11723,Epithelial Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
11724,Cutaneous Involvement,"Dermatitis, Phototoxic",1
11725,Malignant Cellular Infiltrate,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
11726,Primary Lesion,Astrocytoma of brain,1
11727,Malignant Cellular Infiltrate,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
11728,Hepatomegaly,Recurrent Hepatosplenic T-Cell Lymphoma,1
11729,Mesenchymal Component Present,Malignant Vulvar Phyllodes Tumor,1
11730,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type",1
11731,Neuroendocrine Differentiation,Rectal Neuroendocrine Neoplasm,1
11732,High Grade Lesion,Stage II Lung Small Cell Carcinoma AJCC v7,1
11733,Epithelial Component Present,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11734,Malignant Cellular Infiltrate,Sarcoma of pelvis,1
11735,Micropapillary Pattern,Rectal Micropapillary Adenocarcinoma,1
11736,Multifocal Lesion,Multicentric Thyroid Gland Papillary Carcinoma,1
11737,Anaplasia,Anaplastic Hemispheric Astrocytoma,1
11738,Unfavorable Clinical Outcome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
11739,Secondary Lesion,Advanced Pancreatic Neuroendocrine Tumor,1
11740,Epithelial Component Present,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,1
11741,Epithelial Component Present,Multicentric Thyroid Gland Papillary Carcinoma,1
11742,Epithelial Component Present,"Papilloma, Squamous Cell",1
11743,Diffuse Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",1
11744,Carcinomatous Component Present,hepatoid adenocarcinoma of bladder,1
11745,Malignant Cellular Infiltrate,Refractory Head and Neck Carcinoma,1
11746,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
11747,Hereditary Lesion,Peutz-Jeghers Syndrome,1
11748,Indolent Clinical Course,Cavernous Angioleiomyoma,1
11749,Malignant Cellular Infiltrate,Advanced Digestive System Neuroendocrine Neoplasm,1
11750,Malignant Cellular Infiltrate,Chronic eosinophilic leukemia,1
11751,Secondary Lesion,Metastatic Hypopharyngeal Carcinoma,1
11752,Malignant Cellular Infiltrate,Carcinoma breast stage I,1
11753,Cutaneous Involvement,Cutaneous pseudolymphoma,1
11754,Generalized illness,Leiomyomatosis peritonealis disseminata,1
11755,Epithelial Component Present,Juvenile papillomatosis of breast,1
11756,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Thrombocytopenia,1
11757,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
11758,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
11759,Malignant Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
11760,Malignant Cellular Infiltrate,Advanced Oral Cavity Squamous Cell Carcinoma,1
11761,Metastatic Lesion,Advanced Prostate Carcinoma,1
11762,Carcinomatous Component Present,Stage II Rectal Cancer,1
11763,Malignant Cellular Infiltrate,Extraskeletal Osteosarcoma,1
11764,Single Cell Necrosis,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
11765,Malignant Cellular Infiltrate,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
11766,Mass of body structure,Mediastinal Myeloid Sarcoma,1
11767,Cutaneous Involvement,Pathologic Stage IIC Cutaneous Melanoma AJCC v8,1
11768,Exophytic Papillary Lesion,Upper Gingival Verrucous Carcinoma,1
11769,Epithelial Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8,1
11770,Papillary Pattern,tubulopapillary adenoma of gallbladder,1
11771,Carcinomatous Component Present,Refractory Ovarian Endometrioid Adenocarcinoma,1
11772,Epithelial Component Present,Stage II Ureter Cancer AJCC v7,1
11773,Mucoid Stroma Formation,Bile duct mucinous adenocarcinoma,1
11774,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v7,1
11775,Malignant Cellular Infiltrate,Refractory Medulloblastoma,1
11776,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
11777,Epithelial Component Present,Unresectable Urothelial Carcinoma,1
11778,Epithelial Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,1
11779,Malignant Cellular Infiltrate,Childhood Renal Cell Carcinoma,1
11780,Malignant Cellular Infiltrate,alk-positive anaplastic large cell lymphoma,1
11781,Absence of Stromal Invasion,Borderline Ovarian Serous Cystadenofibroma,1
11782,Secondary Lesion,Metastatic Bone Ewing Sarcoma,1
11783,Metastatic Lesion,Advanced Prostate Carcinoma,1
11784,Recurrent Genetic Abnormalities Present,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",1
11785,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
11786,Carcinomatous Component Present,Stage IB Lung Adenosquamous Carcinoma AJCC v7,1
11787,Indolent Clinical Course,Lymphangioma of skin,1
11788,Carcinomatous Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
11789,Epithelial Component Present,carcinoma of eye,1
11790,Well-Circumscribed Lesion,Rectal Sessile Serrated Adenoma/Polyp,1
11791,Acantholysis,Acantholytic squamous cell carcinoma of skin,1
11792,Cutaneous Involvement,Cutaneous schistosomiasis,1
11793,Carcinomatous Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7,1
11794,In Situ Lesion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
11795,Epithelial Component Present,Colorectal High Grade Intraepithelial Neoplasia,1
11796,Malignant Cellular Infiltrate,Stage IVC Rectal Cancer AJCC v8,1
11797,Invasive Lesion,Mucoepidermoid Breast Carcinoma,1
11798,Cutaneous Involvement,Mycosis fungoides stage II,1
11799,Metastatic Lesion,Metastatic Vulvar Carcinoma,1
11800,Malignant Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v8,1
11801,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage II,1
11802,Carcinomatous Component Present,Locally Advanced Bile Duct Carcinoma,1
11803,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,1
11804,Benign Cellular Infiltrate,Pineocytoma,1
11805,Locally Aggressive Lesion,Polymorphus Hemangioendothelioma,1
11806,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
11807,Malignant Cellular Infiltrate,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage,1
11808,Epithelial Component Present,Carcinoma Arising in Nasal Papillomatosis,1
11809,Malignant Cellular Infiltrate,Refractory WHO Grade III Glioma,1
11810,Dysplasia,Pancreatic Intraepithelial Neoplasia-3,1
11811,Fenestrating Pattern,Fibroepithelioma of Pinkus,1
11812,Slow Growing Mass,Adult Pineocytoma,1
11813,Malignant Cellular Infiltrate,Localized Unresectable Adult Hepatocellular Carcinoma,1
11814,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage I Plasma Cell Myeloma,1
11815,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
11816,Epithelial Component Present,adenoid cystic carcinoma of floor of mouth,1
11817,Malignant Cellular Infiltrate,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,1
11818,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pericardium,1
11819,Malignant Cellular Infiltrate,Infant Acute Undifferentiated Leukemia,1
11820,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
11821,Papillary Pattern,Condyloma acuminata of cervix,1
11822,Malignant Cellular Infiltrate,Adenocarcinoma with metaplasia,1
11823,Malignant Cellular Infiltrate,Stage II Ovarian Germ Cell Tumor AJCC v6 and v7,1
11824,Rapidly Enlarging Mass,Pleomorphic Rhabdomyosarcoma,1
11825,Neuroendocrine Differentiation,Familial Adrenal Gland Pheochromocytoma,1
11826,Malignant Cellular Infiltrate,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,1
11827,High Mitotic Activity,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
11828,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma,1
11829,Therapy-Related Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
11830,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",1
11831,Malignant Cellular Infiltrate,Thoracic Esophagus Squamous Cell Carcinoma,1
11832,Epithelial Component Present,"Cystadenocarcinoma, Serous",1
11833,Tissue Differentiation Uncertain,Ventricular myxoma,1
11834,Resectable Mass,Resectable Head and Neck Squamous Cell Carcinoma,1
11835,Malignant Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v7,1
11836,Chronic Inflammatory Infiltrate,Childhood Lymphomatoid Granulomatosis,1
11837,High Mitotic Activity,Thymic Small Cell Carcinoma,1
11838,Calcinosis,"Retinoblastoma, spontaneously regressed",1
11839,Carcinomatous Component Present,Disseminated squamous cell carcinoma,1
11840,Exophytic Papillary Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
11841,Slowly Progressive Clinical Course,Smoldering Systemic Mastocytosis,1
11842,Malignant Cellular Infiltrate,Pineal Region Yolk Sac Tumor,1
11843,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v8,1
11844,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v8,1
11845,Metastatic Lesion,Hepatic cancer metastatic,1
11846,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
11847,Well-Circumscribed Lesion,Gastric hyperplastic polyp,1
11848,Carcinomatous Component Present,Small Intestinal Neuroendocrine Carcinoma,1
11849,Well Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,1
11850,Malignant Cellular Infiltrate,Lip basal cell carcinoma,1
11851,Malignant Cellular Infiltrate,Centroblastic lymphoma stage II,1
11852,Carcinomatous Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
11853,Neuroectodermal Differentiation,Ganglioneuroblastoma,1
11854,Low Grade Lesion,Low Grade Liver Dysplastic Nodule,1
11855,Pseudopapillary Pattern,Papillary craniopharyngioma,1
11856,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma,1
11857,Neuroendocrine Differentiation,Duodenal Neuroendocrine Tumor,1
11858,Childhood Lesion,Childhood Yolk Sac Tumor,1
11859,'Starry-sky' pattern,Burkitt lymphoma associated with AIDS,1
11860,Adulthood Lesion,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,1
11861,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
11862,Epithelial Component Present,Bladder Urothelial Carcinoma in Situ,1
11863,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
11864,Malignant Cellular Infiltrate,Refractory Malignant Pharyngeal Neoplasm,1
11865,Malignant Cellular Infiltrate,Transplant-Related Malignant Neoplasm,1
11866,Chronic Inflammatory Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma,1
11867,Infiltrative Growth Pattern,MGMT-Methylated Glioblastoma,1
11868,Epithelial Component Present,Rectosigmoid cancer,1
11869,Carcinomatous Component Present,Prognostic Stage IIIA Breast Cancer AJCC v8,1
11870,Primary Lesion,Splenic marginal zone lymphoma recurrent,1
11871,Well-Circumscribed Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
11872,Epithelial Component Present,mucoepidermoid carcinoma of floor of mouth,1
11873,Mixed Cellular Population,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
11874,Lamellar Pattern,Recurrent Fibrolamellar Carcinoma,1
11875,Benign Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm,1
11876,Metastatic Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
11877,Indolent Clinical Course,Oral Cavity Adenoma,1
11878,Cutaneous Involvement,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
11879,Borderline Lesion,Childhood Grade III Lymphomatoid Granulomatosis,1
11880,Epithelial Component Present,Ampulla of Vater Tubular Adenoma,1
11881,Carcinomatous Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
11882,Peripheral Nuclear Palisading,Occult Lung Small Cell Carcinoma,1
11883,Mixed Cellular Population,Ovarian Adenosarcoma,1
11884,Diffuse Pattern,AIDS-Related Primary Effusion Lymphoma,1
11885,Cellular Pleomorphism,Unresectable Undifferentiated Pleomorphic Sarcoma,1
11886,Malignant Cellular Infiltrate,Pancreatic Endocrine Carcinoma,1
11887,Malignant Cellular Infiltrate,Stage IIIA Cervical Cancer AJCC v8,1
11888,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
11889,Increased Cellularity Present,Adult Pineoblastoma,1
11890,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
11891,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
11892,Epithelial Component Present,Non-small cell lung cancer stage I,1
11893,Malignant Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma,1
11894,Carcinomatous Component Present,Luminal A Prostate Carcinoma,1
11895,Benign Cellular Infiltrate,Benign Ovarian Serous Tumor,1
11896,High Grade Lesion,Refractory Extensive Stage Lung Small Cell Carcinoma,1
11897,Diffuse Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
11898,In Situ Lesion,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
11899,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor,1
11900,Cutaneous Involvement,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
11901,Papillary Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
11902,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage IV,1
11903,No Identifiable Line of Differentiation,Undifferentiated Epithelioid Sarcoma,1
11904,Trabecular Pattern,Moderately Differentiated Hepatocellular Carcinoma,1
11905,Carcinomatous Component Present,Lung squamous cell carcinoma recurrent,1
11906,Storiform Growth Pattern,Childhood Undifferentiated Pleomorphic Sarcoma,1
11907,Epithelial Component Present,Thyroid Gland Follicular Adenoma,1
11908,Malignant Cellular Infiltrate,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,1
11909,Malignant Cellular Infiltrate,Fibrosarcoma metastatic,1
11910,More than 5 Mitoses per 50HPF,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
11911,Metastatic Lesion,Pseudomyxoma Peritonei,1
11912,Radiation Sickness,Radiation-induced fibrous mediastinitis,1
11913,Pautrier-Like Microabscess Present,Acute Adult T-Cell Leukemia/Lymphoma,1
11914,Carcinomatous Component Present,Hereditary Fallopian Tube Carcinoma,1
11915,Epithelial Component Present,Colon Cancer by AJCC v7 Stage,1
11916,Malignant Cellular Infiltrate,Childhood Esophageal Carcinoma,1
11917,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
11918,Indolent Clinical Course,Oral Cavity Monomorphic Adenoma,1
11919,Malignant Cellular Infiltrate,Colon Medullary Carcinoma,1
11920,Mixed Cellular Population,Epithelial Predominant Kidney Wilms Tumor,1
11921,Recurrent disease,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
11922,Carcinomatous Component Present,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
11923,Malignant Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v7,1
11924,High Grade Lesion,Epithelioid Sarcoma NCI Grade 3,1
11925,Nested Pattern,Childhood Clear Cell Sarcoma of Soft Parts,1
11926,Papillary Pattern,Ethmoid Sinus Schneiderian Papilloma,1
11927,Cutaneous Involvement,Digital papillary eccrine carcinoma of skin,1
11928,Epithelial Component Present,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
11929,Neuroendocrine Differentiation,Gastrinoma,1
11930,Stromal Invasion,adenosquamous carcinoma of ovary,1
11931,Epithelial Component Present,Intraductal Non-Comedo Breast Adenocarcinoma,1
11932,Malignant Cellular Infiltrate,Nasal cavity carcinoma,1
11933,Carcinomatous Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
11934,Pseudopapillary Pattern,Adult Papillary Meningioma,1
11935,Nodular lesions,High Grade Liver Dysplastic Nodule,1
11936,Malignant Cellular Infiltrate,Malignant Ovarian Germ Cell Neoplasm,1
11937,Minimal Invasion Present,"Bronchiolo-alveolar carcinoma, non-mucinous",1
11938,Sonic Hedgehog/Patch Pathway Activated,"Recurrent Medulloblastoma, SHH-Activated",1
11939,Carcinomatous Component Present,Laryngeal verrucous carcinoma recurrent,1
11940,Epithelial Component Present,papillary adenoma of extrahepatic bile duct,1
11941,Carcinomatous Component Present,Renal Cell Cancer by AJCC v6 Stage,1
11942,Tubular Structures Present,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
11943,Mixed Cellular Population,Female Reproductive System Adenofibroma,1
11944,Histiocytosis haematophagic,Hemophagocytic Syndrome,1
11945,Malignant Cellular Infiltrate,Thoracic Esophagus Adenocarcinoma,1
11946,Epithelial Component Present,Tubulovillous adenoma,1
11947,Unclassifiable Lesion,"Peripheral T-Cell Lymphoma, Unclassifiable",1
11948,High Mitotic Activity,Testicular embryonal carcinoma stage III,1
11949,Malignant Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v6,1
11950,Epithelial Component Present,Breast Carcinoma with Osteoclastic Giant Cells,1
11951,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma refractory,1
11952,Primary Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
11953,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8,1
11954,Epithelial Component Present,Stage I Small Intestinal Adenocarcinoma AJCC v8,1
11955,Epithelial Component Present,Ectopic hamartomatous thymoma,1
11956,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",1
11957,Exophytic Polypoid Lesion,Vaginal Tubulovillous Adenoma,1
11958,Undifferentiated Lesion,"Retinoblastoma, undifferentiated",1
11959,Malignant Cellular Infiltrate,Bladder Diffuse Clear Cell Adenocarcinoma,1
11960,More than 5 Mitoses per 50HPF,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
11961,Malignant Cellular Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
11962,Exophytic Papillary Lesion,Lower Gingival Verrucous Carcinoma,1
11963,Therapy-Related Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
11964,Carcinomatous Component Present,Type I Endometrial Adenocarcinoma,1
11965,Secondary Lesion,Locally Advanced Squamous Cell Carcinoma,1
11966,Papillary Pattern,Nasopharyngeal Papillary Adenocarcinoma,1
11967,Secondary Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,1
11968,Malignant Cellular Infiltrate,Localized Parathyroid Gland Carcinoma,1
11969,Malignant Cellular Infiltrate,Metastatic Neuroendocrine Neoplasm,1
11970,Malignant Cellular Infiltrate,Teratocarcinoma,1
11971,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
11972,Infiltrative Growth Pattern,Infantile digital fibromatosis,1
11973,Epithelial Component Present,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
11974,Malignant Cellular Infiltrate,Occult Lung Squamous Cell Carcinoma,1
11975,Tumor Vascular Invasion,"Somatostatinoma, malignant",1
11976,IDH Gene Family Mutation Status Unknown,Anaplastic astrocytoma,1
11977,Epithelial Component Present,Stage IIB Gastric Cancer AJCC v7,1
11978,Exophytic Polypoid Lesion,Polyp of ethmoidal sinus,1
11979,Biphasic Pattern,Borderline Ovarian Mucinous Adenofibroma,1
11980,Myxoid Stroma Formation,Ovarian Myxoid Liposarcoma,1
11981,Hyalinized Vessels Present,Third Ventricle Pilocytic Astrocytoma,1
11982,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
11983,Epithelial Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland,1
11984,'Starry-sky' pattern,Stage IV Burkitt Lymphoma,1
11985,Carcinomatous Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11986,Angiocentric Pattern,Lymphomatoid Granulomatosis,1
11987,Lobulated Growth Pattern,Juxta-Articular Myxoma,1
11988,Benign Cellular Infiltrate,Benign neoplasm of lacrimal gland,1
11989,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
11990,Dysplasia,Bladder squamous cell carcinoma stage 0,1
11991,Diffuse Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
11992,More than 5 Mitoses per 50HPF,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
11993,Malignant Cellular Infiltrate,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
11994,Epithelial Component Present,Ear carcinoma,1
11995,Carcinomatous Component Present,Adenocarcinoma gastric recurrent,1
11996,Benign Cellular Infiltrate,"Chondromatosis, Synovial",1
11997,Secondary Lesion,Secondary malignant neoplasm of stomach,1
11998,Malignant Cellular Infiltrate,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
11999,Carcinomatous Component Present,Metastatic Penile Cancer,1
12000,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v6,1
12001,Malignant Cellular Infiltrate,Recurrent tumors of the Ewing's family,1
12002,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,1
12003,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage III,1
12004,Cutaneous Involvement,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
12005,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7,1
12006,Epithelial Component Present,Fallopian Tube Transitional Cell Carcinoma,1
12007,Epithelial Component Present,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
12008,Diffuse Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",1
12009,Vascular Channel Formation,Kaposi's sarcoma of cornea,1
12010,Malignant Cellular Infiltrate,Serous cystadenocarcinoma ovary,1
12011,Unresectable Mass,Metastatic Unresectable Sarcoma,1
12012,Carcinomatous Component Present,Large cell lung cancer stage I,1
12013,Immunologic Deficiency Syndromes,Transplant-Related Hematologic Malignancy,1
12014,Malignant Cellular Infiltrate,Minor Salivary Gland Undifferentiated Carcinoma,1
12015,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
12016,Epithelial Component Present,Papillary adenocarcinoma,1
12017,Benign Cellular Infiltrate,Benign Lung PEComa,1
12018,Malignant Cellular Infiltrate,Refractory Malignant Germ Cell Tumor,1
12019,Metastatic Lesion,Squamous Cell Carcinoma of Unknown Primary,1
12020,Locally Aggressive Lesion,Chest Wall Fibromatosis,1
12021,Epithelial Component Present,Metastatic Breast Neuroendocrine Neoplasm,1
12022,Neuroendocrine Differentiation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
12023,Mitotic Activity,Grade III Childhood Astrocytoma,1
12024,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage,1
12025,Malignant Cellular Infiltrate,Lymphoepithelial malignant thymoma,1
12026,Neuroendocrine Differentiation,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
12027,Malignant Cellular Infiltrate,Smoldering myeloma,1
12028,Epithelial Component Present,Gallbladder Cancer by AJCC v7 Stage,1
12029,Malignant Cellular Infiltrate,Occult Lung Carcinoma,1
12030,Malignant Cellular Infiltrate,Thymic Atypical Carcinoid Tumor,1
12031,Malignant Cellular Infiltrate,Childhood Thyroid Gland Papillary Carcinoma,1
12032,Epithelial Component Present,Appendix Neuroendocrine Tumor G2,1
12033,Benign Cellular Infiltrate,Adrenal Gland Schwannoma,1
12034,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
12035,Hemorrhagic,Childhood Angiosarcoma,1
12036,Epithelial Component Present,Stage III Anal Canal Cancer AJCC v6 and v7,1
12037,Recurrent disease,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
12038,Low Mitotic Activity,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
12039,Recurrent disease,Oropharyngeal cancer recurrent,1
12040,Epithelial Component Present,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
12041,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v8,1
12042,Lobulated Growth Pattern,Recurrent Chordoma,1
12043,Clinical TNM Finding,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
12044,Carcinomatous Component Present,Combined Lung Carcinoma,1
12045,Nuclear Atypia,Frontal Lobe Anaplastic Astrocytoma,1
12046,Epithelial Component Present,Follicular thyroid carcinoma,1
12047,Firm mass,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
12048,Malignant Cellular Infiltrate,Stage IIIA Esophageal Cancer AJCC v7,1
12049,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,1
12050,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
12051,Epithelial Component Present,Malignant Testicular Sertoli Cell Tumor,1
12052,Epithelial Component Present,Hereditary Leiomyomatosis and Renal Cell Cancer,1
12053,Rapidly Enlarging Mass,Refractory Rhabdomyosarcoma,1
12054,Dysplasia,Carcinoma in situ of trachea,1
12055,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v7,1
12056,Epithelial Component Present,Renal Pelvis Cancer by AJCC v7 Stage,1
12057,Malignant Cellular Infiltrate,Stage IIIC Gastric Cancer AJCC v7,1
12058,Epithelial Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
12059,Malignant Cellular Infiltrate,Intraductal carcinoma and lobular carcinoma in situ,1
12060,Tumor Vascular Invasion,Malignant Pancreatic Somatostatinoma,1
12061,Nuclear Pseudoinclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
12062,Benign Cellular Infiltrate,Benign neoplasm of cornea,1
12063,Well-Circumscribed Lesion,Cardiac rhabdomyoma,1
12064,Benign Cellular Infiltrate,Myxoid leiomyoma,1
12065,Malignant Cellular Infiltrate,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
12066,Polymorphic Cellular Infiltrate,Pulmonary Histiocytosis X,1
12067,Epithelial Component Present,Microfollicular adenoma,1
12068,Epithelial Component Present,Stage II Ureter Cancer AJCC v8,1
12069,Malignant Cellular Infiltrate,Hereditary Malignant Neoplasm,1
12070,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
12071,Malignant Cellular Infiltrate,Recurrent Fallopian Tube Serous Adenocarcinoma,1
12072,High Grade Lesion,Neural Glioblastoma,1
12073,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
12074,Dysplasia,Transitional cell carcinoma in situ,1
12075,Primary Lesion,Hepatocellular Carcinoma by AJCC v8 Stage,1
12076,Carcinomatous Component Present,Squamous cell carcinoma of oropharynx,1
12077,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction,1
12078,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v7,1
12079,Increased Cellularity Present,Cellular Blue Nevus,1
12080,Carcinomatous Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
12081,Malignant Cellular Infiltrate,BCLC Stage A Hepatocellular Carcinoma,1
12082,Adnexal Differentiation,Vulvar Trichoepithelioma,1
12083,Cutaneous Involvement,Eccrine ductal carcinoma,1
12084,In Situ Lesion,Adenocarcinoma in situ in tubular adenoma,1
12085,Metastatic Lesion,Secondary malignant neoplasm of lip,1
12086,Epithelial Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
12087,Nuclear Atypia,Anaplastic Diencephalic Astrocytoma,1
12088,Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma of colon,1
12089,Pregnancy Complications,Infection of amniotic cavity,1
12090,Childhood Lesion,Childhood Brain Germ Cell Tumor,1
12091,Childhood Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
12092,Epithelial Component Present,Grade 1 Rectal Adenocarcinoma,1
12093,Cystic Change,Cystadenofibroma of fallopian tube,1
12094,Malignant Cellular Infiltrate,Stage 0 Pharynx Carcinoma,1
12095,Pregnancy Complications,Placental polyp,1
12096,Carcinomatous Component Present,large cell neuroendocrine carcinoma of lung,1
12097,Carcinomatous Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
12098,Malignant Cellular Infiltrate,Sarcoma NCI Grade 3,1
12099,Non-Malignant Cellular Infiltrate,Mesenteric Lymphadenitis,1
12100,Refractory Disease,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
12101,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
12102,Malignant Cellular Infiltrate,Stage I Acral Lentiginous Melanoma AJCC v7,1
12103,Low Grade Cartilaginous Component Present,Dedifferentiated chondrosarcoma,1
12104,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage II,1
12105,Acanthosis,inverted follicular keratosis,1
12106,Well Differentiated Lesion,Well Differentiated Fibrosarcoma,1
12107,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis recurrent,1
12108,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage II,1
12109,Cutaneous Involvement,Primary Cutaneous Follicle Center Lymphoma,1
12110,Severe cytologic atypia,Small Intestinal Neuroendocrine Carcinoma,1
12111,Malignant Cellular Infiltrate,Primary Cutaneous Mucinous Carcinoma,1
12112,Carcinomatous Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
12113,Malignant Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,1
12114,Malignant Cellular Infiltrate,Stage IIA Rectal Cancer AJCC v8,1
12115,Malignant Cellular Infiltrate,Ovarian mixed epithelial carcinoma,1
12116,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
12117,High Grade Lesion,CIC-DUX Sarcoma,1
12118,Neuroendocrine Differentiation,Pancreatic Vipoma,1
12119,Well Differentiated Neuroendocrine Lesion,"Somatostatinoma, malignant",1
12120,Epithelial Component Present,Recurrent Thyroid Carcinoma,1
12121,Carcinomatous Component Present,Endometrial adenocarcinoma,1
12122,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v6 Stage,1
12123,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7,1
12124,Thyroglobulin Positive Neoplastic Cells Present,Childhood Thyroid Gland Follicular Carcinoma,1
12125,Malignant Cellular Infiltrate,Kaposi's sarcoma of conjunctiva,1
12126,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
12127,Malignant Cellular Infiltrate,Stage IVB Lung Cancer AJCC v8,1
12128,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage II,1
12129,Recurrent disease,Recurrent Rhabdomyosarcoma,1
12130,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v8,1
12131,Epithelial Component Present,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,1
12132,Mesenchymal Differentiation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
12133,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
12134,Cutaneous Involvement,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
12135,Epithelial Component Present,Stage IB Pancreatic Cancer AJCC v8,1
12136,Aberrant Thyroid Tissue Present,Struma Ovarii,1
12137,Malignant Cellular Infiltrate,Early gastric cancer,1
12138,Epithelial Component Present,Stage IIA Colorectal Cancer AJCC v8,1
12139,Epithelial Component Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
12140,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v8,1
12141,Benign Cellular Infiltrate,Proliferative fasciitis,1
12142,Primary Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
12143,Epithelial Component Present,Prostate cancer recurrent,1
12144,Mucoid Stroma Formation,Bile duct mucinous adenocarcinoma,1
12145,Vascular Channel Formation,Angiomatous Meningioma,1
12146,Pushing Tumor Margin,Human Papillomavirus-Related Verrucous Carcinoma,1
12147,Mixed Cellular Population,Blastema Predominant Kidney Wilms Tumor,1
12148,Adnexal Differentiation,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
12149,Childhood Lesion,Childhood Small Intestinal Leiomyosarcoma,1
12150,Carcinomatous Component Present,Large cell lung cancer stage IV,1
12151,Childhood Lesion,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8,1
12152,Melanin Pigment Present,Common blue nevus of skin,1
12153,Malignant Cellular Infiltrate,Pleomorphic Variant Mantle Cell Lymphoma,1
12154,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis,1
12155,Epithelial Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
12156,Eccrine Differentiation,Malignant Eccrine Neoplasm,1
12157,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity recurrent,1
12158,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v6,1
12159,Acanthosis,verrucous carcinoma of esophagus,1
12160,High Grade Lesion,Rhabdomyosarcoma of cervix uteri,1
12161,Borderline Lesion,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
12162,Ground Glass Nuclear Inclusion,Multicentric Thyroid Gland Papillary Carcinoma,1
12163,High Mitotic Activity,Occult Lung Small Cell Carcinoma,1
12164,Cutaneous Involvement,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
12165,Epithelial Component Present,Non-Functioning Pituitary Gland Neoplasm,1
12166,Benign Cellular Infiltrate,mediastinal lipomatosis,1
12167,Carcinomatous Component Present,cystadenocarcinoma of intrahepatic bile duct,1
12168,Malignant Cellular Infiltrate,Stage IB Adult Soft Tissue Sarcoma AJCC v7,1
12169,Benign Cellular Infiltrate,"Hemangioma, Cavernous",1
12170,Slow Growing Mass,Clivus Chondroid Chordoma,1
12171,Hereditary Lesion,Hereditary Multiple Exostoses,1
12172,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma,1
12173,Cutaneous Involvement,Verrucous keratotic hemangioma,1
12174,Disease regression,"Malignant melanoma, regressing",1
12175,Plexiform Growth Pattern,Plexiform Schwannoma,1
12176,Malignant Cellular Infiltrate,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
12177,Vascular Channel Formation,"Hemangioma, Cavernous, Central Nervous System",1
12178,Epithelial Component Present,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
12179,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage I site unspecified,1
12180,Carcinomatous Component Present,Tubular breast carcinoma,1
12181,Recurrent disease,Recurrent Mediastinal Lymphoma,1
12182,Well Differentiated Lesion,Well Differentiated Hepatocellular Carcinoma,1
12183,Metastatic Lesion,Cholangiocarcinoma metastatic,1
12184,Erythema,Inflammatory carcinoma of breast stage IV,1
12185,Indolent Clinical Course,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
12186,Epithelial Component Present,adenosquamous carcinoma of ovary,1
12187,Childhood Lesion,Childhood Acute Myeloid Leukemia,1
12188,Metastatic Lesion,Krukenberg Tumor,1
12189,Epithelial Component Present,Polymorphous low grade adenocarcinoma of salivary gland,1
12190,Primary Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
12191,High Mitotic Activity,Advanced Small Intestinal Neuroendocrine Carcinoma,1
12192,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
12193,Carcinomatous Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma,1
12194,Malignant Cellular Infiltrate,Acinar Prostate Mucinous Adenocarcinoma,1
12195,Indolent Clinical Course,Fibrolipoma,1
12196,Anaplasia,Glioblastoma,1
12197,Epithelial Component Present,Ovarian Serous Adenocarcinoma,1
12198,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid cyst of skin,1
12199,Secondary Lesion,Secondary Central Chondrosarcoma,1
12200,Epithelial Component Present,Stage IV Pharynx Carcinoma,1
12201,Therapy-Related Toxicity,Transplant-Related Bladder Urothelial Carcinoma,1
12202,Malignant Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
12203,Recurrent disease,Malignant neoplasm of bladder recurrent,1
12204,Malignant Cellular Infiltrate,Metastatic melanoma,1
12205,Neuroendocrine Differentiation,Combined Lung Large Cell Neuroendocrine Carcinoma,1
12206,Pseudopapillary Pattern,Testicular embryonal carcinoma,1
12207,Nuclear pleomorphism,High Grade Ductal Breast Carcinoma In Situ,1
12208,Capillary Sized Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
12209,Carcinomatous Component Present,Stage III Pancreatic Cancer AJCC v8,1
12210,Metastatic Lesion,Metastatic Unresectable Basal Cell Carcinoma,1
12211,Carcinomatous Component Present,Bronchogenic Carcinoma,1
12212,Insular Pattern,Somatostatinoma,1
12213,Absence of Invasion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
12214,High Grade Lesion,MGMT-Methylated Glioblastoma,1
12215,Epithelial Component Present,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
12216,Epithelial Component Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
12217,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
12218,Glomerular Hypertrophy,AIDS-Associated Nephropathy,1
12219,Dense Intercellular Reticulin Network Present,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
12220,Metastatic Lesion,"Sarcoma, metastatic",1
12221,Neuroendocrine Differentiation,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
12222,Tissue Differentiation Uncertain,Cutaneous myxoma,1
12223,Malignant Cellular Infiltrate,Thyroid Angiosarcoma,1
12224,Childhood Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
12225,Refractory Disease,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
12226,Malignant Cellular Infiltrate,adenocarcinoma of breast with spindle cell metaplasia,1
12227,Recurrent disease,Recurrent Langerhans Cell Histiocytosis,1
12228,Hereditary Lesion,"Colorectal cancer, hereditary nonpolyposis, type 1",1
12229,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage III Plasma Cell Myeloma,1
12230,Epithelial Component Present,Polymorphous low grade adenocarcinoma of salivary gland,1
12231,IDH Gene Family Mutation Status Unknown,oligodendroglioma,1
12232,Malignant Cellular Infiltrate,Malignant tumor of palate,1
12233,Hot Nodule,Thyroid Gland Hyperfunctioning Adenoma,1
12234,Carcinomatous Component Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
12235,Malignant Cellular Infiltrate,Central Nervous System Angiosarcoma,1
12236,Dense Intercellular Reticulin Network Present,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
12237,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v8,1
12238,Primary Lesion,Fourth Ventricle Ependymal Tumor,1
12239,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma of parotid gland,1
12240,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
12241,Cartilaginous Differentiation,Metastasizing Chondroblastoma,1
12242,Epithelial Component Present,Recurrent Digestive System Carcinoma,1
12243,Malignant Cellular Infiltrate,Small cell lung cancer recurrent,1
12244,Lymphoplasmacytic Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
12245,Fibrotic Stroma Formation,Thyroid Gland Mucoepidermoid Carcinoma,1
12246,Benign Cellular Infiltrate,Benign neoplasm of brain stem,1
12247,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligodendroglioma,1
12248,Malignant Cellular Infiltrate,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
12249,Dysplasia,Cervical Squamous Intraepithelial Neoplasia 1,1
12250,Carcinomatous Component Present,Gastric Squamous Cell Carcinoma,1
12251,Dysplasia,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
12252,Absence of Invasion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
12253,Malignant Cellular Infiltrate,Thymic Small Cell Carcinoma,1
12254,Malignant Cellular Infiltrate,Carcinoma of extrahepatic bile duct,1
12255,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v7,1
12256,Benign Cellular Infiltrate,Benign Notochordal Cell Tumor,1
12257,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage I,1
12258,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
12259,Carcinomatous Component Present,Locally Advanced Unresectable Basal Cell Carcinoma,1
12260,Primary Lesion,Peripheral neuroepithelioma of bone recurrent,1
12261,Carcinomatous Component Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
12262,Secondary Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
12263,Absence of Invasion,Lobular Neoplasia,1
12264,Severe dysplasia,Stage 0 Lip Carcinoma,1
12265,Endophytic Tumor Growth,Human Papillomavirus-Related Verrucous Carcinoma,1
12266,Carcinomatous Component Present,ACTH-Producing Pituitary Gland Carcinoma,1
12267,Malignant Cellular Infiltrate,Malignant neoplasm of scrotum,1
12268,Cystic Change,Papillary mucinous cystadenocarcinoma,1
12269,Malignant Cellular Infiltrate,Scirrhous carcinoma of breast,1
12270,Malignant Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8,1
12271,Benign Cellular Infiltrate,leiomyoma of trachea,1
12272,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
12273,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Sellar Choriocarcinoma,1
12274,Cutaneous Involvement,Malignant Proliferating Pilar Tumor,1
12275,Epithelial Component Present,Bladder squamous cell carcinoma stage II,1
12276,Carcinomatous Component Present,Combined Lung Carcinoma,1
12277,Epithelial Component Present,Penis carcinoma recurrent,1
12278,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
12279,Intermediate Grade Neuroendocrine Lesion,malignant gastrinoma of pancreas,1
12280,Epithelial Component Present,Thymic Typical Carcinoid Tumor,1
12281,Malignant Cellular Infiltrate,malignant neoplasm of breast stage I,1
12282,Malignant Cellular Infiltrate,Stage IIIa Penile Cancer AJCC v7,1
12283,Immunologic Deficiency Syndromes,AIDS-Related Diffuse Large B-cell Lymphoma,1
12284,Adulthood Lesion,Adult Acute Myeloblastic Leukemia,1
12285,Dysplasia,Small Intestinal Tubular Adenoma,1
12286,Refractory Disease,Refractory Kaposi Sarcoma,1
12287,Multinodular Pattern,Ancell-Spiegler cylindromas,1
12288,Metastatic Lesion,Disseminated Malignant Neoplasm,1
12289,Carcinomatous Component Present,Adenoid cystic carcinoma of trachea,1
12290,Invasive Lesion,Adenocarcinoma of the prostate stage II,1
12291,Absence of Invasion,Noninfiltrating Intraductal Carcinoma,1
12292,Indolent Clinical Course,Ventricular myxoma,1
12293,Tissue Differentiation Uncertain,Proximal-Type Epithelioid Sarcoma,1
12294,Childhood Lesion,Childhood Immunoblastic Lymphoma,1
12295,Epithelial Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
12296,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia,1
12297,Tissue of Mullerian Origin Present,Borderline Ovarian Serous Cystadenofibroma,1
12298,Dysplasia,Stage 0a Ureter Cancer AJCC v7,1
12299,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",1
12300,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage I,1
12301,Keratin pearl formation,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
12302,Malignant Cellular Infiltrate,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
12303,Carcinomatous Component Present,Serous cystadenocarcinoma ovary,1
12304,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage II,1
12305,Cystic Change,Dermoid Cyst of the Spinal Cord,1
12306,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
12307,Stromal Invasion,Refractory Ovarian Endometrioid Adenocarcinoma,1
12308,Malignant Cellular Infiltrate,Clinical Stage 0 Gastric Cancer AJCC v8,1
12309,Carcinomatous Component Present,Stage IC Ovarian Cancer AJCC v6 and v7,1
12310,Vascular Channel Formation,Adrenal Gland Angiosarcoma,1
12311,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
12312,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
12313,Carcinomatous Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
12314,Ground Glass Nuclear Inclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
12315,Recurrent disease,Thymoma malignant recurrent,1
12316,Epithelial Component Present,Stage I Gallbladder Cancer AJCC v6,1
12317,Malignant Cellular Infiltrate,Acute Myeloid Leukemia (AML-M2),1
12318,Stromal Invasion,Undifferentiated carcinoma of ovary,1
12319,Carcinomatous Component Present,Adenocarcinoma of lacrimal gland,1
12320,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
12321,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
12322,Epithelial Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
12323,Epithelial Component Present,Stage II Ovarian Cancer AJCC v8,1
12324,Microcystic Change,Adult Subependymoma,1
12325,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v7,1
12326,Malignant Cellular Infiltrate,Stage IIA Esophagus Carcinoma,1
12327,CD1a-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis,1
12328,Metastatic/Recurrent Disease,Lung Biphasic Synovial Sarcoma,1
12329,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
12330,Carcinomatous Component Present,Esophageal carcinoma recurrent,1
12331,Malignant Cellular Infiltrate,AIDS-Related Anal Carcinoma,1
12332,Invasive Lesion,Infiltrating duct and lobular carcinoma,1
12333,Endophytic Tumor Growth,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
12334,Malignant Cellular Infiltrate,Pediatric follicular lymphoma,1
12335,Malignant Cellular Infiltrate,Malignant neoplasm tonsil,1
12336,Indolent Clinical Course,Cartilaginous exostosis,1
12337,Philadelphia chromosome negative,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
12338,Monomorphic Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
12339,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Pathologic Stage,1
12340,Malignant Cellular Infiltrate,Invasive Ductal Breast Carcinoma,1
12341,Diffuse Pattern,large B-cell diffuse lymphoma of kidney,1
12342,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v7 Stage,1
12343,High Mitotic Activity,Recurrent Salivary Duct Carcinoma,1
12344,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
12345,Malignant Cellular Infiltrate,Stage IV Urethral Cancer AJCC v7,1
12346,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
12347,Malignant Cellular Infiltrate,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
12348,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm,1
12349,Malignant Cellular Infiltrate,Endometrial Stromal Sarcoma,1
12350,Adulthood Lesion,Aggressive Adult Non-Hodgkin Lymphoma,1
12351,Malignant Cellular Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
12352,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,1
12353,Refractory Disease,Refractory T Acute Lymphoblastic Leukemia,1
12354,Carcinomatous Component Present,Skin Pseudovascular Squamous Cell Carcinoma,1
12355,High Mitotic Activity,Childhood Lung Small Cell Carcinoma,1
12356,Adnexal Differentiation,Desmoplastic trichoepithelioma,1
12357,Primary Lesion,"lymphomatoid papulosis, type C",1
12358,Epithelial Component Present,Gastric adenoma,1
12359,Malignant Cellular Infiltrate,Esophageal Leiomyosarcoma,1
12360,Immature Myeloid Cells Increased in Bone Marrow,Alkylating Agent-Related Acute Myeloid Leukemia,1
12361,Malignant Cellular Infiltrate,Breast Diffuse Large B-Cell Lymphoma,1
12362,Well-Circumscribed Lesion,Conventional Lipoma,1
12363,Tissue Differentiation Uncertain,Advanced Synovial Sarcoma,1
12364,Malignant Cellular Infiltrate,adenosquamous carcinoma of skin,1
12365,Epithelial Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
12366,Epithelial Component Present,Grade 2 Invasive Breast Carcinoma,1
12367,Epithelial Component Present,Frontal Sinus Inverted Papilloma,1
12368,Borderline Lesion,"Post-transplant lymphoproliferative disorder, polymorphic",1
12369,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
12370,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
12371,Epithelial Component Present,Metastatic Vulvar Carcinoma,1
12372,Well-Circumscribed Lesion,Stage I Kidney Wilms Tumor,1
12373,Benign Cellular Infiltrate,Atypical neurofibroma,1
12374,Abundance of Small Lymphocytes,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma,1
12375,Cutaneous Involvement,Old Burn Scar-Related Cutaneous Melanoma,1
12376,Nuclear pleomorphism,Pleomorphic Variant Mantle Cell Lymphoma,1
12377,Epithelial Component Present,Plantar Verrucous Skin Carcinoma,1
12378,Adulthood Lesion,Stage IV Indolent Adult Non-Hodgkin Lymphoma,1
12379,Epithelial Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
12380,Poorly Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma,1
12381,Myxoid Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
12382,Lymphoplasmacytic Infiltrate,Germinoma,1
12383,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
12384,Diffuse Lesion,Carcinomatosis of peritoneal cavity,1
12385,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v6,1
12386,Carcinomatous Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
12387,HMB-45-Positive Neoplastic Cells Present,Lung PEComa,1
12388,Neuroectodermal Differentiation,malignant ganglioneuroblastoma of adrenal gland,1
12389,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v6 and v7,1
12390,Epithelial Component Present,Islet Cell Tumor,1
12391,Hyalinized Stroma Formation,Epithelioid hemangioendothelioma,1
12392,Intracytoplasmic Eosinophilic Inclusion,Recurrent Rhabdoid Tumor,1
12393,Thick-Walled Hyalinized Vessels Present,Benign Dermal Schwannoma,1
12394,Anaplasia,Grade III Childhood Astrocytoma,1
12395,Multifocal Lesion,Multiple Lobular Capillary Hemangiomas,1
12396,Cutaneous Involvement,Porokeratosis,1
12397,Polymorphic Cellular Infiltrate,Adult Langerhans Cell Histiocytosis,1
12398,Epithelial Component Present,Metaplastic carcinoma,1
12399,High Mitotic Activity,Testicular embryonal carcinoma stage I,1
12400,Carcinomatous Component Present,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
12401,Malignant Cellular Infiltrate,Gastric Neuroendocrine Carcinoma,1
12402,Papillary Pattern,tubulopapillary adenoma of gallbladder,1
12403,Malignant Cellular Infiltrate,Anaplastic Carcinoma of the Rectum,1
12404,Papillary Pattern,Vulvar Papillary Hidradenoma,1
12405,Decreased platelet count,Myeloid Neoplasms with Germline ANKRD26 Mutation,1
12406,Cutaneous Involvement,Pilar-Associated Mesenchyme Neoplasm,1
12407,Poorly Differentiated Neuroendocrine Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
12408,Absence of Invasion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
12409,Carcinomatous Component Present,Stage II Major Salivary Gland Cancer AJCC v8,1
12410,Dysplasia,Appendix adenoma,1
12411,Mitotic Activity,Brain Glioblastoma,1
12412,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Cancer AJCC v8,1
12413,Malignant Cellular Infiltrate,Grade 1 Colon Adenocarcinoma,1
12414,Carcinomatous Component Present,Penile Cancer by AJCC v7 Stage,1
12415,Malignant Cellular Infiltrate,Juxtacortical chondrosarcoma,1
12416,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,1
12417,Fibromuscular Stroma Formation,Bartholin Gland Adenomyoma,1
12418,Anaplasia,Diencephalic Glioblastoma,1
12419,Recurrent disease,Recurrent Digestive System Neuroendocrine Tumor G1,1
12420,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v8,1
12421,Benign Cellular Infiltrate,Elastofibroma,1
12422,Carcinomatous Component Present,Skin squamous cell carcinoma metastatic,1
12423,Carcinomatous Component Present,Unresectable Gastric Adenocarcinoma,1
12424,Low Mitotic Activity,Pancreatic Vipoma,1
12425,'Starry-sky' pattern,Burkitt's tumor of spleen,1
12426,Malignant Cellular Infiltrate,Uterine Ligament Adenocarcinoma,1
12427,Mild cytologic atypia,Subglottic Verrucous Carcinoma,1
12428,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v6 Stage,1
12429,Local disease,Lipoblastoma,1
12430,Malignant Cellular Infiltrate,leiomyosarcoma of retroperitoneum,1
12431,Tissue Differentiation Uncertain,Epithelioid sarcoma non-metastatic,1
12432,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7,1
12433,Carcinomatous Component Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
12434,Carcinomatous Component Present,"Transitional cell carcinoma, micropapillary",1
12435,Malignant Cellular Infiltrate,Childhood Hepatocellular Carcinoma,1
12436,Epithelial Component Present,Grade II Prostatic Intraepithelial Neoplasia,1
12437,Well-Circumscribed Lesion,Neoplastic Polyp,1
12438,Metastatic Lesion,Breast Carcinoma Metastatic in the Brain,1
12439,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
12440,Malignant Cellular Infiltrate,Burkitt-like lymphoma with 11q aberration,1
12441,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v7,1
12442,Hereditary Lesion,Neurofibromatosis aggravated,1
12443,Malignant Cellular Infiltrate,Bile duct cancer recurrent,1
12444,Malignant Cellular Infiltrate,Indolent Adult Non-Hodgkin Lymphoma,1
12445,Adnexal Differentiation,Piloleiomyoma,1
12446,High Grade Lesion,Spindle Cell/Sclerosing Rhabdomyosarcoma,1
12447,Malignant Cellular Infiltrate,Stage IVA Uterine Sarcoma AJCC v7,1
12448,Malignant Cellular Infiltrate,"Uterine Carcinosarcoma, Homologous Type",1
12449,Benign Cellular Infiltrate,Benign neoplasm of oral cavity,1
12450,Increased Cellularity Present,Cellular Myxoma,1
12451,Epithelial Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
12452,Adnexal Differentiation,Benign Pilar-Associated Mesenchyme Neoplasm,1
12453,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v7,1
12454,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
12455,Anaplasia,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
12456,Carcinomatous Component Present,Stage IA2 Cervical Cancer AJCC v8,1
12457,Epithelial Component Present,Vulvar Glandular Neoplasm,1
12458,Malignant Cellular Infiltrate,Sclerosing Epithelioid Fibrosarcoma,1
12459,Carcinomatous Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
12460,HMB-45-Positive Neoplastic Cells Present,Uterine Corpus PEComa,1
12461,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
12462,Malignant Cellular Infiltrate,Unresectable Lung Non-Small Cell Carcinoma,1
12463,Carcinomatous Component Present,Stage II Colon Cancer AJCC v7,1
12464,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Seminoma,1
12465,Epithelial Component Present,Stage IIC Colon Cancer AJCC v7,1
12466,Steatohepatitis,Inflammatory Hepatocellular Adenoma,1
12467,Neuroendocrine Differentiation,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
12468,Lymphoplasmacytic Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland,1
12469,Epithelial Component Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
12470,More than 5 Mitoses per 50HPF,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
12471,Malignant Cellular Infiltrate,Adult Systemic Anaplastic Large Cell Lymphoma,1
12472,Malignant Cellular Infiltrate,Malignant neoplasm of muscle,1
12473,Storiform Growth Pattern,Dermatofibrosarcoma protuberans with myoid differentiation,1
12474,Malignant Cellular Infiltrate,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
12475,Eccrine Differentiation,Malignant Eccrine Neoplasm,1
12476,Malignant Cellular Infiltrate,Invasive Mixed Breast Carcinoma,1
12477,Carcinomatous Component Present,Sarcomatoid Hepatocellular Carcinoma,1
12478,Cysts Containing Proteinaceous Fluid Present,"Cystadenoma, Serous",1
12479,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor,1
12480,Necrotic changes (finding),MGMT-Unmethylated Glioblastoma,1
12481,Carcinomatous Component Present,cystadenocarcinoma of salivary gland,1
12482,Angiodestructive Pattern,Grade I Lymphomatoid Granulomatosis,1
12483,Malignant Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma,1
12484,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
12485,Neuroendocrine Differentiation,Benign pheochromocytoma of adrenal gland,1
12486,Infiltrating Tumor Margins Present,Malignant Phyllodes Tumor of Prostate,1
12487,Malignant Cellular Infiltrate,Recurrent Pancreatic Neuroendocrine Carcinoma,1
12488,Epithelial Component Present,Breast Solid Neuroendocrine Carcinoma,1
12489,Carcinomatous Component Present,Stage IV Merkel Cell Carcinoma AJCC v7,1
12490,Hereditary Lesion,Hereditary Prostate Carcinoma,1
12491,Neuroendocrine Differentiation,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
12492,Cutaneous Involvement,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage,1
12493,Carcinomatous Component Present,BCLC Stage A Adult Hepatocellular Carcinoma,1
12494,Poorly Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
12495,Carcinomatous Component Present,Stage I Gastric Carcinoma,1
12496,High Mitotic Activity,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
12497,Diarrhea,Malignant Pancreatic Vipoma,1
12498,Exophytic Papillary Lesion,verrucous carcinoma of vulva,1
12499,Tissue Differentiation Uncertain,Intimal sarcoma,1
12500,Carcinomatous Component Present,Skin squamous cell carcinoma metastatic,1
12501,Malignant Cellular Infiltrate,Large cell lung cancer recurrent,1
12502,Blasts of Mixed Phenotype Present,Acute bilineal leukemia,1
12503,Acanthosis,Vaginal Warty Carcinoma,1
12504,Mixed Cellular Population,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,1
12505,Carcinomatous Component Present,Stage IVC Lip Cancer AJCC v6 and v7,1
12506,Epithelial Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
12507,Mesenchymal Differentiation,Adult Gliosarcoma,1
12508,Therapy-Related Toxicity,Treatment related acute myeloid leukaemia,1
12509,Carcinomatous Component Present,Retromolar Trigone Squamous Cell Carcinoma,1
12510,Lymphoplasmacytic Infiltrate,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
12511,Primary Lesion,Refractory Primary Vitreoretinal Lymphoma,1
12512,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v7 Stage,1
12513,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma,1
12514,Epithelial Component Present,"Papillary squamous cell carcinoma, non-invasive",1
12515,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Diffuse Leiomyomatosis,1
12516,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory,1
12517,Sebaceous Differentiation,Salivary Gland Sebaceous Lymphadenoma,1
12518,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Lymphoma AJCC v8,1
12519,Human Papillomavirus Positive,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
12520,Well-Circumscribed Lesion,Skin tag,1
12521,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
12522,Epithelial Component Present,Unresectable Digestive System Adenocarcinoma,1
12523,Monoclonal Cellular Population Present,Thyroid Gland Hyperfunctioning Adenoma,1
12524,Mucoid Stroma Formation,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
12525,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
12526,Anaplasia,Refractory Glioblastoma,1
12527,Metastatic Lesion,Metastatic Unresectable Sarcoma,1
12528,Congenital Lesion,Vulvar Congenital Melanocytic Nevus,1
12529,Adulthood Lesion,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,1
12530,Exophytic Papillary Lesion,sialadenoma papilliferum of salivary gland,1
12531,Indolent Clinical Course,Gingival Angiofibroma,1
12532,Malignant Cellular Infiltrate,Cervical Malignant Peripheral Nerve Sheath Tumor,1
12533,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Iris,1
12534,Adnexal Differentiation,Vulvar Sebaceous Carcinoma,1
12535,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
12536,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
12537,Deep Lesion,Sclerosing liposarcoma,1
12538,Malignant Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v7,1
12539,Malignant Cellular Infiltrate,Mycosis Fungoides by AJCC v7 Stage,1
12540,Cutaneous Involvement,Pilomatrix carcinoma of skin,1
12541,Epithelial Component Present,Colorectal Intraepithelial Neoplasia,1
12542,Malignant Cellular Infiltrate,Diffuse Blastoid B-Cell Lymphoma,1
12543,Malignant Cellular Infiltrate,Malignant Testicular Germ Cell Tumor,1
12544,Diffuse Pattern,Childhood Oligoastrocytoma,1
12545,Syncytial Pattern,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
12546,Epithelial Component Present,Bladder Urachal Urothelial Carcinoma,1
12547,Benign Cellular Infiltrate,Benign neoplasm of lacrimal gland,1
12548,Epithelial Component Present,Major Salivary Gland Adenocarcinoma,1
12549,Carcinomatous Component Present,Gastric Intestinal-Type Adenocarcinoma,1
12550,Indolent Clinical Course,Benign neoplasm of lymph vessels,1
12551,Malignant Cellular Infiltrate,Stage I Oropharyngeal Carcinoma,1
12552,Mitotic Activity,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
12553,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
12554,Alternative Fascicle (Bundle) Pattern,Pericardial Leiomyoma,1
12555,Malignant Cellular Infiltrate,Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,1
12556,Chronic lymphocytic inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
12557,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
12558,Primary Lesion,Osteosarcoma by AJCC v7 Stage,1
12559,Crystal deposition,Alveolar soft part sarcoma recurrent,1
12560,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Mature Teratoma,1
12561,High Mitotic Activity,Small cell lung cancer recurrent,1
12562,Malignant Cellular Infiltrate,Pathologic Stage IV Retinoblastoma AJCC v8,1
12563,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
12564,Primary Lesion,Hepatoblastoma recurrent,1
12565,Tissues Derived from Two or Three Embryonic Layers Present,Mature Ovarian Teratoma,1
12566,Papillary Pattern,Sclerosing Breast Papilloma,1
12567,Papillary Pattern,Follicular Variant Thyroid Gland Papillary Carcinoma,1
12568,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous and osseous metaplasia,1
12569,Epithelial Component Present,Distal Urethral Carcinoma,1
12570,Malignant Cellular Infiltrate,Oropharyngeal lymphepithelioma,1
12571,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
12572,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Lipid-rich carcinoma,1
12573,Malignant Cellular Infiltrate,Gastric Fundus Carcinoma In Situ AJCC v6 and v7,1
12574,Carcinomatous Component Present,Skin carcinoma,1
12575,Malignant Cellular Infiltrate,Central Nervous System Germinoma,1
12576,Malignant Cellular Infiltrate,Carcinoma of Littre Glands,1
12577,High Mitotic Activity,large cell neuroendocrine carcinoma of gallbladder,1
12578,Metastatic Lesion,Breast Carcinoma Metastatic in the Lung,1
12579,Malignant Cellular Infiltrate,"Carcinoma, Lobular",1
12580,Malignant Cellular Infiltrate,Ewing's sarcoma of bone,1
12581,Neuroendocrine Differentiation,Small cell lung cancer limited stage,1
12582,Malignant Cellular Infiltrate,Blepharal carcinoma,1
12583,Epithelial Component Present,High Grade Cervical Intraepithelial Neoplasia,1
12584,Epithelial Component Present,Stage III Colorectal Cancer AJCC v8,1
12585,Carcinomatous Component Present,Metastatic Oral Cavity Squamous Cell Carcinoma,1
12586,Benign Cellular Infiltrate,External Auditory Canal Ceruminous Adenoma,1
12587,Childhood Lesion,Recurrent Childhood Astrocytic Tumor,1
12588,Well Differentiated Lesion,Early Hepatocellular Carcinoma,1
12589,Epithelial Component Present,Invasive Breast Carcinoma by Histologic Grade,1
12590,Epithelial Component Present,Glomus vagale tumor,1
12591,Carcinomatous Component Present,Thyroid carcinoma,1
12592,Perivascular Arrangement of Tumor Cells,Lymphangiomyoma,1
12593,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
12594,Benign Cellular Infiltrate,Subglottic Hemangioma,1
12595,Neuroendocrine Differentiation,Laryngeal Paraganglioma,1
12596,Malignant Cellular Infiltrate,Central Nervous System Yolk Sac Tumor,1
12597,Epithelial Component Present,Rectal Carcinoma Metastatic in the Liver,1
12598,Non-Malignant Cellular Infiltrate,Follicular Bronchitis/Bronchiolitis,1
12599,Invasive Lesion,Metastatic Prostate Small Cell Carcinoma,1
12600,Neuronal Differentiation,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor,1
12601,Malignant Cellular Infiltrate,Carcinoma of Littre Glands,1
12602,Mitotic Activity,Adult Glioblastoma,1
12603,High Grade Lesion,Diffuse Blastoid B-Cell Lymphoma,1
12604,Osteoid formation,Breast Extraskeletal Osteosarcoma,1
12605,Malignant Cellular Infiltrate,Stage 0 Anal Cancer AJCC v8,1
12606,Intraductal Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
12607,Malignant Cellular Infiltrate,Liposarcoma recurrent,1
12608,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
12609,Recurrent disease,Marginal zone lymphoma recurrent,1
12610,High Grade Lesion,Recurrent Alveolar Rhabdomyosarcoma,1
12611,Cutaneous Involvement,"Acanthoma, Clear Cell",1
12612,Malignant Cellular Infiltrate,Stage IIA Bone Cancer AJCC v7,1
12613,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
12614,Malignant Cellular Infiltrate,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
12615,Malignant Cellular Infiltrate,Refractory Rhabdoid Tumor,1
12616,Polymorphic Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
12617,Malignant Cellular Infiltrate,Immunoblastic lymphoma associated with AIDS,1
12618,Borderline Lesion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
12619,Malignant Cellular Infiltrate,Refractory Primary Effusion Lymphoma,1
12620,Malignant Cellular Infiltrate,Cardiac Leiomyosarcoma,1
12621,Malignant Cellular Infiltrate,Osteosarcoma of bone,1
12622,Malignant Cellular Infiltrate,Central Nervous System Teratoma with Malignant Transformation,1
12623,Exophytic Papillary Lesion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
12624,Well-Circumscribed Lesion,Androgen-Producing Adrenal Cortex Adenoma,1
12625,Malignant Cellular Infiltrate,Brain Glioblastoma,1
12626,Stromal Invasion,Endometrioid carcinoma ovary,1
12627,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Multifocal superficial basal cell carcinoma,1
12628,Metastatic Lesion,Advanced Cervical Adenocarcinoma,1
12629,Benign Cellular Infiltrate,Benign Cervical Soft Tissue Neoplasm,1
12630,Epithelial Component Present,Large cell lung cancer stage IV,1
12631,Sarcomatous Component Present,Carcinosarcoma,1
12632,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
12633,Cystic Change,Ovarian Seromucinous Cystadenoma,1
12634,Pseudoglandular Pattern,teratocarcinoma of mediastinum,1
12635,Malignant Cellular Infiltrate,Erythroid Neoplasm,1
12636,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanoma,1
12637,Stromal Invasion,Malignant Brenner Tumor,1
12638,Mitotic Activity,Adult Anaplastic Astrocytoma,1
12639,Indolent Clinical Course,Deep Hemangioma,1
12640,Epithelial Component Present,Endometrial Clear Cell Adenocarcinoma,1
12641,Metastatic Lesion,Chondrosarcoma metastatic,1
12642,Cutaneous Involvement,Acrodermatitis,1
12643,Mixed Cellular Population,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
12644,Indolent Clinical Course,Breast Capillary Hemangioma,1
12645,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Glycogen-rich carcinoma,1
12646,Benign Cellular Infiltrate,Conventional Schwannoma,1
12647,Cystic Change,Recurrent Malignant Ovarian Brenner Tumor,1
12648,Dysplasia,Cervical Squamous Cell Carcinoma In Situ,1
12649,Malignant Cellular Infiltrate,B-cell lymphoma stage IV,1
12650,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC v8,1
12651,Malignant Cellular Infiltrate,Childhood Gliomatosis Cerebri,1
12652,Carcinomatous Component Present,Endometrial adenocarcinoma,1
12653,Papillary Pattern,Cervical Warty Carcinoma,1
12654,Malignant Cellular Infiltrate,Infratentorial Glioblastoma,1
12655,Borderline Lesion,IgM monoclonal gammopathy of uncertain significance,1
12656,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
12657,Metastatic Lesion,Secondary malignant neoplasm of rectum,1
12658,Carcinomatous Component Present,Resectable Carcinoma,1
12659,Malignant Cellular Infiltrate,Malignant neoplasm of soft palate,1
12660,Childhood Lesion,Childhood Meningeal Melanoma,1
12661,Congenital Lesion,Congenital kyphosis,1
12662,Malignant Cellular Infiltrate,Grade 3 Colorectal Adenocarcinoma,1
12663,Indolent Clinical Course,lipoma of mediastinum,1
12664,Malignant Cellular Infiltrate,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
12665,Unresectable Mass,Unresectable Liposarcoma,1
12666,Epithelial Component Present,Ureter Inverted Papilloma,1
12667,Malignant Cellular Infiltrate,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
12668,Low Grade Lesion,Adult Epithelioid Hemangioendothelioma,1
12669,Papillary Pattern,"Papillary cystadenoma, borderline malignancy",1
12670,Hypercellular bone marrow,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
12671,Malignant Cellular Infiltrate,Penile Cancer by AJCC v8 Stage,1
12672,Encapsulated Mass,Thyroid Gland Lipoadenoma,1
12673,Epithelial Component Present,Mixed Ductal-Endocrine Carcinoma,1
12674,High Mitotic Activity,Anaplastic adrenocortical carcinoma,1
12675,Malignant Cellular Infiltrate,"Paget's Disease, Mammary",1
12676,Recurrent disease,Malignant neoplasm of bladder recurrent,1
12677,Acinar Cell Differentiation,Minor Salivary Gland Acinic Cell Carcinoma,1
12678,Carcinomatous Component Present,Mucoepidermoid carcinoma of submandibular gland,1
12679,Malignant Cellular Infiltrate,Stage III Hilar Cholangiocarcinoma AJCC v8,1
12680,Epithelial Component Present,Stage IIIB Penile Cancer AJCC v8,1
12681,Cauliflower-Like Mass,Childhood Choroid Plexus Papilloma,1
12682,Well Differentiated Lesion,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
12683,Lymphadenopathy,Monocytoid B-cell lymphoma,1
12684,Carcinomatous Component Present,"Carcinoma, Basosquamous",1
12685,Papillary Pattern,Papillary Renal Cell Carcinoma,1
12686,Epithelial Component Present,Ovarian Mucinous Adenofibroma,1
12687,Carcinomatous Component Present,Stage IIIA Small Intestinal Cancer AJCC v7,1
12688,Bone Marrow Dysplasia Present,de novo Myelodysplastic Syndrome,1
12689,Necrotic changes (finding),Proneural Glioblastoma,1
12690,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v6,1
12691,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v8,1
12692,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v8,1
12693,Cutaneous Involvement,"NEVUS, EPIDERMAL (disorder)",1
12694,Epithelial Component Present,Esophageal Neuroendocrine Tumor G1,1
12695,Koilocytotic atypia,basaloid carcinoma of penis,1
12696,Malignant Cellular Infiltrate,Gestational choriocarcinoma,1
12697,Anaplasia,Anaplastic astrocytoma,1
12698,Malignant Cellular Infiltrate,Spindle cell squamous cell carcinoma,1
12699,Recurrent disease,Recurrent Myxoid Liposarcoma,1
12700,Epithelial Component Present,Plantar Verrucous Skin Carcinoma,1
12701,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage I,1
12702,Malignant Cellular Infiltrate,Pleomorphic Rhabdomyosarcoma,1
12703,Malignant Cellular Infiltrate,Advanced Carcinoid Tumor,1
12704,Papillary Pattern,Urethral Inverted Papilloma,1
12705,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v7,1
12706,Cutaneous Involvement,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
12707,Cavernous Lymphatic Space Formation,Cavernous lymphangioma,1
12708,Nodular Pattern,Grade 3b Follicular Lymphoma,1
12709,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
12710,Intraocular Lesion,Recurrent Primary Vitreoretinal Lymphoma,1
12711,Well-Circumscribed Lesion,Anal Canal Squamous Papilloma,1
12712,Primary Lesion,Lentigo maligna recurrent,1
12713,Carcinomatous Component Present,Bronchogenic Carcinoma,1
12714,Epithelial Component Present,Hormone refractory breast cancer,1
12715,Epithelial Component Present,Oral Cavity Adenoma,1
12716,Cutaneous Involvement,Telangiectatic Glomangioma,1
12717,Carcinomatous Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
12718,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with a Variant RARA Translocation,1
12719,Carcinomatous Component Present,Major Salivary Gland Mucoepidermoid Carcinoma,1
12720,Benign Cellular Infiltrate,Fallopian Tube Metaplastic Papillary Tumor,1
12721,Hemorrhagic,Aortic Angiosarcoma,1
12722,Neuroendocrine Differentiation,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
12723,Vascular Channel Formation,Superior Vena Cava Angiosarcoma,1
12724,Carcinomatous Component Present,Childhood Bladder Carcinoma,1
12725,Diffuse Pattern,Plasmablastic Lymphoma of the Oral Mucosa,1
12726,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
12727,Crooke Hyaline Change,Crooke Cell Adenoma,1
12728,Pregnancy Complications,Cesarean Scar Pregnancy,1
12729,Carcinomatous Component Present,Adenocarcinoma of rectum,1
12730,Malignant Cellular Infiltrate,Lepidic Predominant Adenocarcinoma,1
12731,Malignant Cellular Infiltrate,Clinical Stage IIA Gastric Cancer AJCC v8,1
12732,Capillary Sized Vascular Channel Formation,Bone Epithelioid Hemangioma,1
12733,Carcinomatous Component Present,Thymic Squamous Cell Carcinoma,1
12734,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
12735,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
12736,Hereditary Lesion,Wiskott-Aldrich Syndrome,1
12737,Benign Cellular Infiltrate,Desmoplastic Nevus,1
12738,Epithelial Component Present,Pancreatic adenocarcinoma metastatic,1
12739,Epithelial Component Present,"Pancreatic carcinoma, familial",1
12740,Diffuse Pattern,Primary Cutaneous Plasmablastic Lymphoma,1
12741,Epithelial Component Present,Papillary Epithelial Neoplasm,1
12742,Malignant Cellular Infiltrate,Malignant Vulvar Phyllodes Tumor,1
12743,Epithelial Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
12744,Solar Radiation Toxicity,Solar Radiation-Related Malignant Neoplasm,1
12745,Peripheral Nuclear Palisading,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
12746,Intracanalicular Growth Pattern,Malignant Vulvar Phyllodes Tumor,1
12747,Non-Invasive Lesion,Inverted papilloma of urinary bladder,1
12748,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Teratoma,1
12749,Malignant Cellular Infiltrate,Recurrent Primary Cutaneous Lymphoma,1
12750,Recurrent disease,Lung adenocarcinoma recurrent,1
12751,Borderline Lesion,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
12752,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v7,1
12753,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
12754,Malignant Cellular Infiltrate,"Hepatocellular carcinoma, scirrhous",1
12755,Epithelial Component Present,"Endocervical Adenocarcinoma, Usual Type",1
12756,Epithelial Component Present,Metastatic Lung Non-Small Cell Carcinoma,1
12757,Malignant Cellular Infiltrate,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8,1
12758,Diffuse Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
12759,Cellular Pseudostratification,cystic mucinous tumor of pancreas with moderate dysplasia,1
12760,Malignant Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
12761,Negative Peripheral Blood,Aleukemic leukemia,1
12762,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
12763,Malignant Cellular Infiltrate,Acute myeloid leukemia with abnormal marrow eosinophils,1
12764,Benign Cellular Infiltrate,Fibroma of tendon sheath,1
12765,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v6 Stage,1
12766,Junctional Proliferation,Spindle cell nevus of Reed,1
12767,High Grade Lesion,Primary Peritoneal High Grade Serous Adenocarcinoma,1
12768,Epithelial Component Present,Adenocarcinoma in adenomatous polyposis coli,1
12769,Primary Lesion,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
12770,Splenomegaly,Splenic Manifestation of Chronic Lymphocytic Leukemia,1
12771,Malignant Cellular Infiltrate,Stage IVC Pharyngeal Carcinoma,1
12772,Confluent Sheets of Anaplastic T-Lymphocytes Present,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
12773,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
12774,Tubular Structures Present,Tubular breast carcinoma,1
12775,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma,1
12776,Lymphoplasmacytic Infiltrate,Lung Lymphoepithelioma-Like Carcinoma,1
12777,Refractory Disease,Refractory Osteosarcoma,1
12778,Stromal Invasion,Stage IB Ovarian Cancer AJCC v8,1
12779,Lesion with Diameter of 5cm or Less,"Gastrointestinal stromal tumor, benign",1
12780,Epithelial Component Present,FIGO Stage IIIA1(ii) Ovarian Cancer,1
12781,Pregnancy Complications,Abruptio Placentae,1
12782,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
12783,Acinar Cell Differentiation,Prostate Acinar Adenocarcinoma,1
12784,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma,1
12785,Malignant Cellular Infiltrate,"Chondrosarcoma, Clear Cell",1
12786,Epithelial Component Present,Carcinoma ex pleomorphic adenoma of parotid gland,1
12787,Cutaneous Involvement,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
12788,Malignant Cellular Infiltrate,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8,1
12789,Increased Cellularity Present,Adult Anaplastic Ependymoma,1
12790,Stromal Invasion,Ovarian Serous Adenocarcinoma,1
12791,Neuroendocrine Differentiation,Breast Neuroendocrine Neoplasm,1
12792,Adnexal Differentiation,Eccrine dermal cylindroma,1
12793,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Thrombocytopenia,1
12794,Exophytic Polypoid Lesion,Colon Juvenile Polyp,1
12795,Exophytic Papillary Lesion,Urethral Condyloma Acuminatum,1
12796,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
12797,Non-Invasive Lesion,Ampulla of Vater Villous Adenoma,1
12798,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage III,1
12799,Epithelial Component Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
12800,Well-Circumscribed Lesion,Benign Vaginal Mixed Tumor,1
12801,Thick-Walled Hyalinized Vessels Present,Plexiform Schwannoma,1
12802,Anaplasia,Adult Systemic Anaplastic Large Cell Lymphoma,1
12803,Lymphadenopathy,Nodal marginal zone B-cell lymphoma recurrent,1
12804,Secondary Lesion,Intermediate Atypical Prostate Carcinoma,1
12805,Epithelial Component Present,Vulval intraepithelial neoplasia,1
12806,Local disease,Lipoma of pleura,1
12807,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
12808,Carcinomatous Component Present,Mucinous adenocarcinoma of appendix,1
12809,Cystic Change,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
12810,Carcinomatous Component Present,Tongue Carcinoma,1
12811,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8,1
12812,Secondary Lesion,Metastatic carcinoid tumor,1
12813,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v7,1
12814,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Variant MLL Translocations,1
12815,Infiltrative Growth Pattern,Malignant Uterine Corpus PEComa,1
12816,atypia morphology,Serous papillary cystic tumor of borderline malignancy,1
12817,Tubular Structures Present,Benign mixed epithelial and stromal tumor of kidney,1
12818,Dysplasia,Serous Tubal Intraepithelial Carcinoma,1
12819,Childhood Lesion,Childhood Cerebellar Neoplasm,1
12820,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary,1
12821,Nuclear pleomorphism,Hepatocellular Small Cell Change,1
12822,Non-Malignant Cellular Infiltrate,Acute lymphadenitis,1
12823,Epithelial Component Present,Thyroid Gland Black Follicular Adenoma,1
12824,Mucocele of appendix,Appendix Mucinous Cystadenoma,1
12825,Malignant Cellular Infiltrate,Kaposi's sarcoma of conjunctiva,1
12826,Systemic disease,Primary Systemic Amyloidosis,1
12827,Diffuse Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
12828,Epithelial Component Present,Adenocarcinoma of Unknown Primary,1
12829,Low Mitotic Activity,Glucagonoma,1
12830,Malignant Cellular Infiltrate,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
12831,Mixed Cellular Population,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
12832,Single Cell Necrosis,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
12833,Plexiform Growth Pattern,Schneiderian carcinoma,1
12834,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
12835,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q),1
12836,Malignant Cellular Infiltrate,Childhood Soft Tissue Sarcoma,1
12837,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
12838,Primary Lesion,Refractory Central Nervous System Lymphoma,1
12839,Epithelial Component Present,Grade II Penile Intraepithelial Neoplasia,1
12840,Perivascular Arrangement of Tumor Cells,Cavernous Angioleiomyoma,1
12841,Biphasic Pattern,Ovarian Mucinous Cystadenofibroma,1
12842,Epithelial Component Present,Low Grade Esophageal Glandular Intraepithelial Neoplasia,1
12843,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma,1
12844,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
12845,Neuroectodermal Differentiation,Stage 4S neuroblastoma,1
12846,Osteoid formation,Breast Extraskeletal Osteosarcoma,1
12847,High Grade Lesion,Refractory Lung Small Cell Carcinoma,1
12848,Epithelial Component Present,Invasive Ductal and Lobular Carcinoma,1
12849,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Mammary Gland Type,1
12850,Carcinomatous Component Present,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7,1
12851,Epithelial Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
12852,Absence of Invasion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12853,Increased Cellularity Present,Adrenal neuroblastoma,1
12854,Perivascular Arrangement of Tumor Cells,Benign Pericytic Neoplasm,1
12855,Malignant Cellular Infiltrate,Refractory Malignant Female Reproductive System Neoplasm,1
12856,Slow Growing Mass,Subependymal Glioma,1
12857,Malignant Cellular Infiltrate,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12858,Mucoid Stroma Formation,Adult Myxopapillary Ependymoma,1
12859,Primary Lesion,Supratentorial Ependymal Tumor,1
12860,Severe cytologic atypia,"Endometrial stromal sarcoma, high grade",1
12861,Prominent In Situ Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
12862,Glomeruloid Vessels Present,Third Ventricle Pilocytic Astrocytoma,1
12863,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
12864,Cutaneous Involvement,Vulvar Seborrheic Keratosis,1
12865,Epithelial Component Present,High Grade Appendix Mucinous Adenocarcinoma,1
12866,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Carcinosarcoma,1
12867,Benign Cellular Infiltrate,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,1
12868,Adulthood Lesion,Lugano Classification Stage IIE Adult Lymphoma AJCC v8,1
12869,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma,1
12870,Malignant Cellular Infiltrate,Advanced Favorable Non-Hodgkin Lymphoma,1
12871,Benign Cellular Infiltrate,Intramuscular lipoma,1
12872,High Grade Lesion,Synovial sarcoma recurrent,1
12873,Poorly Differentiated Lesion,Grade 3 Colon Adenocarcinoma,1
12874,Multifocal Multisystem Disease,Letterer-Siwe Disease,1
12875,Malignant Cellular Infiltrate,AIDS-Related Anal Canal Carcinoma,1
12876,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma,1
12877,High Mitotic Activity,Anal Canal Small Cell Neuroendocrine Carcinoma,1
12878,Epithelial Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
12879,Dermal Involvement,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
12880,Extensive Stage Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
12881,Indolent Clinical Course,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
12882,Cutaneous Involvement,Cutaneous Melanoma by AJCC v7 Stage,1
12883,Recurrent disease,Recurrent Childhood Brain Stem Glioma,1
12884,Recurrent disease,Recurrent Ovarian Endometrioid Adenocarcinoma,1
12885,Carcinomatous Component Present,Papillary thyroid carcinoma,1
12886,Bone Marrow Dysplasia Present,Refractory anaemia with excess blasts,1
12887,Metastatic Lesion,Metastatic Lung Adenosquamous Carcinoma,1
12888,Intraductal Lesion,Intraductal papillomatosis,1
12889,Secondary Lesion,"Kaposi's sarcoma, metastatic",1
12890,Malignant Cellular Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8,1
12891,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
12892,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia,1
12893,Malignant Cellular Infiltrate,Recurrent Soft Tissue Sarcoma,1
12894,Malignant Cellular Infiltrate,squamous cell carcinoma of urethra,1
12895,Malignant Cellular Infiltrate,Adenocarcinoma of small intestine,1
12896,Splenomegaly,Refractory T-Cell Prolymphocytic Leukemia,1
12897,Benign Cellular Infiltrate,Benign neoplasm of tonsil,1
12898,Malignant Cellular Infiltrate,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,1
12899,Malignant Cellular Infiltrate,Cecum Lymphoma,1
12900,Perineural spread,adenoid cystic carcinoma of lung,1
12901,Dysplasia,Gallbladder adenoma,1
12902,Indolent Clinical Course,Benign Fibroblastic Neoplasm,1
12903,Benign Cellular Infiltrate,Myofibroblastoma,1
12904,Borderline Lesion,Atypical Spitz Nevus,1
12905,Adulthood Lesion,Adult Undifferentiated Pleomorphic Sarcoma,1
12906,Poorly Differentiated Lesion,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
12907,Malignant Cellular Infiltrate,Mixed epithelioid and spindle cell melanoma,1
12908,Invasive Lesion,Inflammatory carcinoma of breast recurrent,1
12909,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
12910,Invasive Lesion,Inflammatory carcinoma of breast stage III,1
12911,Malignant Cellular Infiltrate,Unresectable Bone Sarcoma,1
12912,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
12913,Benign Cellular Infiltrate,Fetal rhabdomyoma,1
12914,Carcinomatous Component Present,Vulvar Small Cell Carcinoma,1
12915,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
12916,Recurrent disease,Recurrent Childhood Hodgkin Lymphoma,1
12917,Malignant Cellular Infiltrate,Myxoid liposarcoma metastatic,1
12918,Malignant Cellular Infiltrate,Malignant melanoma of eye,1
12919,Favorable Clinical Outcome,Retroperitoneal Ganglioneuroma,1
12920,Aggravated Disease,Neurofibromatosis aggravated,1
12921,Poorly Differentiated Lesion,Refractory Pancreatic Neuroendocrine Carcinoma,1
12922,Infiltrative Growth Pattern,MGMT-Unmethylated Glioblastoma,1
12923,Carcinomatous Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
12924,Diffuse Pattern,"Malignant lymphoma centroblastic, diffuse",1
12925,Benign Cellular Infiltrate,Benign Ovarian Serous Tumor,1
12926,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia,1
12927,Splenomegaly,Refractory T-Cell Prolymphocytic Leukemia,1
12928,Malignant Cellular Infiltrate,Metastatic Bone Sarcoma,1
12929,Capillary Sized Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
12930,Metastatic/Recurrent Disease,Epithelioid Sarcoma NCI Grade 3,1
12931,Microvascular Proliferation,Neural Glioblastoma,1
12932,Diffuse Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
12933,Epithelial Component Present,Squamous cell carcinoma of colon,1
12934,Mild dysplasia,Colorectal Adenoma with Mild Dysplasia,1
12935,Malignant Cellular Infiltrate,Pathologic Stage IB Cutaneous Melanoma AJCC v8,1
12936,Malignant Cellular Infiltrate,Stage 0 Lip Carcinoma,1
12937,Benign Cellular Infiltrate,Common wart,1
12938,Malignant Cellular Infiltrate,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,1
12939,High Grade Lesion,Synovial sarcoma recurrent,1
12940,Malignant Cellular Infiltrate,Stage III Lentigo Maligna Melanoma AJCC v7,1
12941,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
12942,Refractory Disease,Refractory Thymic Carcinoma,1
12943,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm,1
12944,Primary Lesion,gliosarcoma,1
12945,Adnexal Differentiation,Hidrocystoma,1
12946,Malignant Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v6 and v7,1
12947,Malignant Cellular Infiltrate,Laryngeal Squamous Cell Carcinoma,1
12948,Epithelial Component Present,Clinical Stage IVA Gastric Cancer AJCC v8,1
12949,Carcinomatous Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
12950,Intraductal Lesion,Sclerosing Breast Papilloma,1
12951,Malignant Cellular Infiltrate,Mycosis fungoides stage IV,1
12952,Epithelial Component Present,Benign Ovarian Mucinous Tumor,1
12953,Epithelial Component Present,Stage II Merkel Cell Carcinoma AJCC v7,1
12954,Epidermal Involvement,Eccrine porocarcinoma,1
12955,"Fully Differentiated ""Adult-Type"" Tissues Present",Immature Gastric Teratoma,1
12956,Pathologic TNM Finding,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
12957,Questionable Invasive Lesion,Atypical follicular adenoma,1
12958,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
12959,Desmoplastic Stroma Formation,"Adenocarcinoma, Scirrhous",1
12960,Hyaline Cartilage Differentiation,Mesenchymal Chondrosarcoma,1
12961,Nuclear Atypia,Adult Gliosarcoma,1
12962,Exophytic Polypoid Lesion,Oropharyngeal Polyp,1
12963,Koilocytotic atypia,Human Papillomavirus-Related Verrucous Carcinoma,1
12964,Papillary Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
12965,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
12966,Carcinomatous Component Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
12967,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation,1
12968,Malignant Cellular Infiltrate,Medium/Large Size Posterior Uveal Melanoma,1
12969,Non-Hereditary Lesion,Sporadic Breast Carcinoma,1
12970,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12971,Papillary Pattern,Childhood Myxopapillary Ependymoma,1
12972,Non-Invasive Lesion,Preinvasive Neoplasm of the Ampullary Region,1
12973,Mitotic Activity,Yolk Sac Tumor,1
12974,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Tumor G1,1
12975,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Carcinoma,1
12976,Childhood Lesion,Childhood Astrocytoma,1
12977,Mixed Cellular Population,Borderline Ovarian Endometrioid Adenofibroma,1
12978,Severe cytologic atypia,Metastatic Pancreatic Neuroendocrine Carcinoma,1
12979,Mesenchymal Component Present,Lung Adenofibroma,1
12980,Malignant Cellular Infiltrate,Pseudomyxoma Peritonei,1
12981,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
12982,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
12983,Malignant Cellular Infiltrate,Mesenchymal Glioblastoma,1
12984,Papillary Pattern,Lung Mixed Squamous Cell and Glandular Papilloma,1
12985,Anaplasia,Recurrent Gliosarcoma,1
12986,Metastatic Lesion,Pleural Carcinomatosis,1
12987,Numerous Stromal Mast Cells Present,Angiomyofibroblastoma,1
12988,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v7,1
12989,Hereditary Lesion,fanconi anemia complementation group g,1
12990,Epithelial Component Present,Stage II Penile Cancer AJCC v8,1
12991,Malignant Cellular Infiltrate,Cervical Adenosquamous Carcinoma,1
12992,Epithelial Component Present,Childhood Parathyroid Gland Carcinoma,1
12993,Sebaceous Differentiation,Sebaceous Gland Neoplasms,1
12994,Epithelial Component Present,Pancreatic Small Cell Neuroendocrine Carcinoma,1
12995,Childhood Lesion,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8,1
12996,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type recurrent,1
12997,Vascular Channel Formation,Hemangioma of breast,1
12998,Carcinomatous Component Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
12999,Epithelial Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8,1
13000,Recurrent disease,Recurrent Minor Salivary Gland Adenocarcinoma,1
13001,Epithelial Component Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,1
13002,Malignant Cellular Infiltrate,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8,1
13003,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage IV,1
13004,Childhood Lesion,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,1
13005,Carcinomatous Component Present,Localized Parathyroid Gland Carcinoma,1
13006,Malignant Cellular Infiltrate,Adult T Acute Lymphoblastic Leukemia,1
13007,Anaplasia,Ki-1+ Anaplastic Large Cell Lymphoma,1
13008,Papillary Pattern,Human Papillomavirus-Related Verrucous Carcinoma,1
13009,Epithelial Component Present,Stage IA Breast Cancer AJCC v7,1
13010,Malignant Cellular Infiltrate,Hypergranular promyelocytic leukemia,1
13011,Cutaneous Involvement,Grade 3 Cutaneous Follicular Lymphoma,1
13012,Absence of Invasion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
13013,Carcinomatous Component Present,Stage IIB Ampulla of Vater Cancer AJCC v7,1
13014,Malignant Cellular Infiltrate,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,1
13015,Plexiform Growth Pattern,Plexiform fibrohistiocytic tumor,1
13016,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage I,1
13017,Vascular Channel Formation,Cavernous hemangioma of the face,1
13018,Childhood Lesion,Childhood Kidney Angiomyolipoma,1
13019,Cutaneous Involvement,Acrodermatitis,1
13020,Benign Cellular Infiltrate,benign myoepithelioma of salivary gland,1
13021,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,1
13022,High Grade Lesion,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
13023,Mixed Cellular Population,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
13024,Cutaneous Involvement,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
13025,Carcinomatous Component Present,Medullary carcinoma of thyroid,1
13026,Malignant Cellular Infiltrate,Central Nervous System T-Cell Non-Hodgkin Lymphoma,1
13027,Tricholemmal Differentiation,Classic Type Trichilemmoma,1
13028,Adulthood Lesion,Adult Salivary Gland Carcinoma,1
13029,Epithelial Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
13030,Dysplasia,tubular adenoma of extrahepatic bile duct,1
13031,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v6 and v7,1
13032,Cutaneous Involvement,Scrotal Sarcoma,1
13033,Chronic lymphocytic inflammation,Cardiac Inflammatory Myofibroblastic Tumor,1
13034,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of trachea,1
13035,Epithelial Component Present,Bartholin Gland Small Cell Carcinoma,1
13036,Tissue Differentiation Uncertain,"Perivascular epithelioid tumor, malignant",1
13037,Intraductal Lesion,Intraductal papillary breast neoplasm,1
13038,Slow Growing Mass,Medullary Hemangioblastoma,1
13039,Malignant Cellular Infiltrate,Childhood Osteosarcoma,1
13040,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
13041,Epithelial Component Present,Stage IV Rectal Cancer AJCC v7,1
13042,Secondary Lesion,Distantly Metastatic Malignant Neoplasm,1
13043,Epithelial Component Present,Infiltrating Urothelial Carcinoma,1
13044,Fibrotic Stroma Formation,Borderline Ovarian Serous Adenofibroma,1
13045,Neuroendocrine Differentiation,"Glucagonoma, malignant",1
13046,Tissue Differentiation Uncertain,Pleural Monophasic Synovial Sarcoma,1
13047,Malignant Cellular Infiltrate,Childhood Pleomorphic Rhabdomyosarcoma,1
13048,Epithelial Component Present,Seborrheic keratosis,1
13049,Extraosseous Lesion,Extraskeletal osteosarcoma recurrent,1
13050,Immunologic Deficiency Syndromes,AIDS-Related Non-Hodgkin Lymphoma,1
13051,Glandular Differentiation,"Carcinoid, Goblet Cell",1
13052,Vascular Channel Formation,"Hemangioma, Intramuscular",1
13053,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
13054,Epithelial Component Present,Vaginal Neuroendocrine Carcinoma,1
13055,Malignant Cellular Infiltrate,Adult Pleomorphic Rhabdomyosarcoma,1
13056,Calcitonin serum level increased,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
13057,Childhood Lesion,Acute Megakaryoblastic Leukemia with NUP98-KDM5A,1
13058,Carcinomatous Component Present,Squamous cell carcinoma of esophagus,1
13059,Epithelial Component Present,Stage IA Cervical Cancer AJCC v6 and v7,1
13060,Malignant Cellular Infiltrate,T-cell/histiocyte rich large B-cell lymphoma,1
13061,Epithelial Component Present,Pancreatic intraepithelial neoplasia,1
13062,Extraosseous Lesion,Peripheral primitive neuroectodermal tumor of soft tissue,1
13063,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with hyperdiploidy,1
13064,VIP Positive Neoplastic Cells Present,Pancreatic Vipoma,1
13065,Epithelial Component Present,Adenocarcinoma of Accessory Sinus,1
13066,Oligodendroglial Component Present,Oligodendroglial Neoplasm,1
13067,Malignant Cellular Infiltrate,Hodgkin's lymphoma of small intestine,1
13068,Epithelial Component Present,Bladder squamous cell carcinoma stage III,1
13069,Well-Circumscribed Lesion,tubulovillous adenoma of stomach,1
13070,Melanoma Cells Present,Breast Carcinoma with Melanotic Features,1
13071,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Poorly Differentiated Neuroblastoma,1
13072,Epithelial Component Present,Skin squamous cell carcinoma metastatic,1
13073,Epithelial Component Present,Stage IV Vaginal Cancer AJCC v8,1
13074,Malignant Cellular Infiltrate,Refractory Endometrial Serous Adenocarcinoma,1
13075,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor,1
13076,Malignant Cellular Infiltrate,Colon cancer recurrent,1
13077,Carcinomatous Component Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
13078,Numerous Stromal Mast Cells Present,Vaginal Myofibroblastoma,1
13079,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v7,1
13080,Carcinomatous Component Present,Refractory Thymic Carcinoma,1
13081,High Grade Lesion,Recurrent Childhood Giant Cell Glioblastoma,1
13082,Carcinomatous Component Present,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
13083,Secondary Lesion,Metastatic Carcinoma,1
13084,Primary Lesion,Body Cavity Primary Effusion Lymphoma,1
13085,Well-Circumscribed Lesion,Metachronous Wilms Tumor,1
13086,Unclassifiable Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
13087,Chronic lymphocytic inflammation,Follicular Bronchitis/Bronchiolitis,1
13088,Malignant Cellular Infiltrate,"Spindle cell melanoma, type B",1
13089,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma recurrent,1
13090,Malignant Cellular Infiltrate,Adenocarcinoma of rectum,1
13091,Non Lipogenic Sarcomatous Stroma Present,Resectable Dedifferentiated Liposarcoma,1
13092,Recurrent disease,Marginal zone lymphoma recurrent,1
13093,Malignant Cellular Infiltrate,Ovarian mixed epithelial carcinoma,1
13094,Malignant Cellular Infiltrate,"Medulloblastoma, Not Otherwise Specified",1
13095,Primary Lesion,Infratentorial Glioblastoma,1
13096,Malignant Cellular Infiltrate,Post-Radiotherapy Breast Angiosarcoma,1
13097,Malignant Cellular Infiltrate,sarcoma of spinal cord,1
13098,Epithelial Component Present,Stage III Rectosigmoid Cancer AJCC v7,1
13099,Cutaneous Involvement,"Leishmaniasis, Cutaneous",1
13100,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v8,1
13101,Epithelial Component Present,Uterine Carcinosarcoma,1
13102,Malignant Cellular Infiltrate,Acute myeloid leukemia with BCR-ABL1,1
13103,Carcinomatous Component Present,Primary Peritoneal Serous Adenocarcinoma,1
13104,Malignant Cellular Infiltrate,Rhabdomyosarcoma with ganglionic differentiation,1
13105,Hemorrhagic,Adrenal Gland Angiosarcoma,1
13106,Epithelial Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
13107,Epithelial Component Present,Colorectal Mucinous Adenocarcinoma,1
13108,Childhood Lesion,Childhood Pilomyxoid Astrocytoma,1
13109,Increased Cellularity Present,Differentiating Neuroblastoma,1
13110,Carcinomatous Component Present,Metastatic Oral Cavity Carcinoma,1
13111,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
13112,Epithelial Component Present,Stage III Lip and Oral Cavity Cancer AJCC v8,1
13113,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v7,1
13114,Papillary Pattern,Ureter Inverted Papilloma,1
13115,Increased Cellularity Present,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
13116,Slow Growing Mass,Acral Fibromyxoma,1
13117,Cutaneous Involvement,Benign epithelial neoplasm of skin,1
13118,Moderate dysplasia,Colorectal Adenoma with Moderate Dysplasia,1
13119,Epithelial Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
13120,Epithelial Component Present,Nipple Duct Carcinoma,1
13121,Carcinomatous Component Present,Adenosquamous cell lung cancer,1
13122,Malignant Cellular Infiltrate,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
13123,Keratin pearl formation,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
13124,Benign Cellular Infiltrate,Melanoacanthoma,1
13125,Malignant Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v8,1
13126,Pseudoglandular Pattern,Central Nervous System Embryonal Carcinoma,1
13127,"Fully Differentiated ""Adult-Type"" Tissues Present",Testicular Dermoid Cyst,1
13128,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma,1
13129,Epithelial Component Present,Sinonasal undifferentiated carcinoma,1
13130,Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma of colon,1
13131,Nuclear pleomorphism,Anaplastic Embryonal Rhabdomyosarcoma,1
13132,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7,1
13133,Metastatic Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
13134,Invasive Lesion,Prolactin-Producing Pituitary Gland Carcinoma,1
13135,Cutaneous Involvement,Neurodermatitis,1
13136,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
13137,Polymorphic Cellular Infiltrate,Recurrent Langerhans Cell Histiocytosis,1
13138,Invasive Lesion,Grade 2 Invasive Breast Carcinoma,1
13139,Adulthood Lesion,recurrent adult acute myeloid leukemia,1
13140,Malignant Cellular Infiltrate,Malignant Synovial Neoplasm,1
13141,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Immature Teratoma,1
13142,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
13143,Malignant Cellular Infiltrate,Stage IIB Breast Carcinoma,1
13144,Malignant Cellular Infiltrate,Bladder cancer stage IV,1
13145,Epithelial Component Present,Stage IV Bladder Cancer AJCC v6,1
13146,Epithelial Component Present,Condyloma acuminata of vulva,1
13147,Malignant Cellular Infiltrate,Metastatic Ewing's Sarcoma,1
13148,Nodular lesions,Thyroid Gland Clear Cell Follicular Adenoma,1
13149,Tissue Differentiation Uncertain,Adult Desmoplastic Small Round Cell Tumor,1
13150,Malignant Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
13151,Malignant Cellular Infiltrate,Recurrent Childhood Soft Tissue Sarcoma,1
13152,Malignant Cellular Infiltrate,Adult Salivary Gland Carcinoma,1
13153,Malignant Cellular Infiltrate,Stage IV Indolent Adult Non-Hodgkin Lymphoma,1
13154,Epithelial Component Present,Breast Fibroepithelial Neoplasm,1
13155,Tricholemmal Differentiation,Trichilemmoma,1
13156,Non-Malignant Cellular Infiltrate,Submandibular lymphadenitis,1
13157,Carcinomatous Component Present,Renal Cell Carcinoma Associated with Neuroblastoma,1
13158,Single Cell Necrosis,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
13159,Malignant Cellular Infiltrate,AIDS-Related Primary Central Nervous System Lymphoma,1
13160,Carcinomatous Component Present,Childhood Esophageal Carcinoma,1
13161,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma metastatic,1
13162,Mixed Cellular Population,"Uterine Carcinosarcoma, Heterologous Type",1
13163,Biphasic Pattern,Malignant Mixed Mesodermal (Mullerian) Tumor,1
13164,Benign Cellular Infiltrate,Parotid Gland Lipoma,1
13165,Benign Cellular Infiltrate,Pancreatic Acinar Cell Cystadenoma,1
13166,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
13167,Angiodestructive Pattern,Grade III Lymphomatoid Granulomatosis,1
13168,Pushing Tumor Margin,Verrucous carcinoma of penis,1
13169,Severe dysplasia,Stage 0 Appendix Carcinoma AJCC v8,1
13170,Malignant Cellular Infiltrate,Uterine Angiosarcoma,1
13171,Refractory Disease,Refractory Malignant Pharyngeal Neoplasm,1
13172,Carcinomatous Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
13173,Anaplasia,Childhood Conventional Osteosarcoma,1
13174,Epithelial Component Present,Breast Phyllodes Tumor,1
13175,Papillary Pattern,Glottis Verrucous Carcinoma,1
13176,Neuroendocrine Differentiation,Stage IA Merkel Cell Carcinoma AJCC v7,1
13177,Diffuse Pattern,Childhood Brain Anaplastic Astrocytoma,1
13178,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma,1
13179,Epithelial Component Present,Bladder Adenocarcinoma,1
13180,Swelling,Subungual exostoses,1
13181,Malignant Cellular Infiltrate,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7,1
13182,Tubular Pattern,Appendix Tubulovillous Adenoma,1
13183,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
13184,Fibrotic Stroma Formation,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
13185,Less than 2 Mitoses per 10HPF,Lung Typical Carcinoid Tumor,1
13186,Nuclear Clearing,Follicular Variant Thyroid Gland Papillary Carcinoma,1
13187,Epithelial Component Present,Vaginal Squamous Papilloma,1
13188,Malignant Cellular Infiltrate,Secondary malignant neoplasm of female breast,1
13189,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage III,1
13190,Indolent Clinical Course,Leiomyoma of Gallbladder,1
13191,Malignant Cellular Infiltrate,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
13192,Malignant Cellular Infiltrate,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",1
13193,Exophytic Polypoid Lesion,Gastric Cronkhite Canada Polyposis,1
13194,Indolent Clinical Course,Benign neoplasm of hard palate,1
13195,High Grade Lesion,Glioblastoma,1
13196,Recurrent disease,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,1
13197,Epithelial Component Present,Vestibular Papilloma,1
13198,Epithelial Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
13199,Adulthood Lesion,Adult Nodular Sclerosis Classical Hodgkin Lymphoma,1
13200,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
13201,Exophytic Polypoid Lesion,Colon Adenoma with Severe Dysplasia,1
13202,Lobulated Growth Pattern,Chordoma of clivus,1
13203,Epithelial Component Present,Stage I Lung Cancer AJCC v8,1
13204,Invasive Lesion,Adenocarcinoma of the prostate stage I,1
13205,Epithelial Component Present,Fallopian Tube Endometrioid Polyp,1
13206,Indolent Clinical Course,Angiomyoma,1
13207,Carcinomatous Component Present,Poorly Cohesive Gastric Carcinoma,1
13208,Mixed Cellular Population,Nephroblastoma,1
13209,Cutaneous Involvement,Lymphangioma of skin,1
13210,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
13211,Ineffective hematopoiesis,Refractory Neutropenia,1
13212,Recurrent disease,Recurrent Acinic Cell Breast Carcinoma,1
13213,Metastatic Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
13214,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck,1
13215,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course,1
13216,Epithelial Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
13217,Cutaneous Involvement,Local infection skin/subcut tissue NOS,1
13218,Malignant Cellular Infiltrate,Prognostic Stage IIIA Breast Cancer AJCC v8,1
13219,Infiltrative Growth Pattern,"Fibromatosis, Plantar",1
13220,Secondary Lesion,Metastatic Malignant Germ Cell Tumor,1
13221,Sarcomatous Component Present,Uterine Corpus Carcinosarcoma,1
13222,Benign Cellular Infiltrate,Benign neoplasm of vulva,1
13223,Papillary Pattern,Stage 0a Bladder Cancer AJCC v8,1
13224,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),1
13225,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1,1
13226,Absence of Invasion,Carcinoma in situ of small intestine,1
13227,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
13228,Intracytoplasmic Eosinophilic Inclusion,Atypical Teratoid Rhabdoid Tumor,1
13229,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage IV,1
13230,Epithelial Component Present,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
13231,Splenomegaly,Recurrent T-Cell Prolymphocytic Leukemia,1
13232,Carcinomatous Component Present,Pilomatrix carcinoma of skin,1
13233,Malignant Cellular Infiltrate,Ethmoid Sinus Squamous Cell Carcinoma,1
13234,Peripheral Nuclear Palisading,large cell neuroendocrine carcinoma of lung,1
13235,Non-Invasive Lesion,Ampulla of Vater Tubulovillous Adenoma,1
13236,Carcinomatous Component Present,Minor Salivary Gland Squamous Cell Carcinoma,1
13237,Metastatic Lesion,Metastatic Neuroendocrine Neoplasm,1
13238,CD30-Positive Neoplastic Cells Present,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
13239,Primary Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
13240,Absence of Invasion,Intraepithelial Squamous Cell Carcinoma,1
13241,Neuroendocrine Differentiation,Pancreatic Endocrine Carcinoma,1
13242,Papillary Pattern,Papillary carcinoma in situ,1
13243,Carcinomatous Component Present,Grade 2 Colorectal Adenocarcinoma,1
13244,Poorly Differentiated Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
13245,Malignant Cellular Infiltrate,Recurrent Urethral Cancer,1
13246,Carcinomatous Component Present,Stage III Lip Basal Cell Carcinoma,1
13247,Epithelial Component Present,Vaginal Cancer by AJCC v8 Stage,1
13248,Epithelial Component Present,Platinum-Resistant Lung Small Cell Carcinoma,1
13249,Rare Lesion,Androgen-Producing Adrenal Cortex Adenoma,1
13250,Carcinomatous Component Present,Infiltrating basal cell carcinoma,1
13251,Vascular Channel Formation,Malignant Blood Vessel Neoplasm,1
13252,Cribriform Pattern,Acquired cystic disease associated renal cell carcinoma,1
13253,Increased Cellularity Present,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
13254,Diffuse Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
